<SEC-DOCUMENT>0001683168-22-005051.txt : 20220720
<SEC-HEADER>0001683168-22-005051.hdr.sgml : 20220720
<ACCEPTANCE-DATETIME>20220720171250
ACCESSION NUMBER:		0001683168-22-005051
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		92
FILED AS OF DATE:		20220720
DATE AS OF CHANGE:		20220720

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOCERA, INC.
		CENTRAL INDEX KEY:			0001756180
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE PRODUCTION - LIVESTOCK & ANIMAL SPECIALTIES [0200]
		IRS NUMBER:				161626611
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-264059
		FILM NUMBER:		221094886

	BUSINESS ADDRESS:	
		STREET 1:		2030 POWERS FERRY RD., SE, SUITE 212
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30339
		BUSINESS PHONE:		(404) 816-8240

	MAIL ADDRESS:	
		STREET 1:		2030 POWERS FERRY RD., SE, SUITE 212
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30339
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>nocera_s1a2.htm
<DESCRIPTION>AMENDMENT NO. 2
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:NCRA="http://nocera.company/20220331">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_NCRA_nocera.company_20220331 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20220101_20220331 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001756180 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DAmendmentDescription_Revising for shares and pricing -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityCentralIndexKey">0001756180</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:AmendmentFlag">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:AmendmentDescription">Revising for shares and pricing</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2022-03-31" id="xdx2ixbrl0118" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2021-12-31" id="xdx2ixbrl0119" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0277" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0279" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0280" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0281" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2021-01-012021-03-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0282" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0283" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2021-01-012021-03-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0286" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0289" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0290" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-03-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0292" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0293" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0294" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-03-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0296" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0299" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0300" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0301" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0302" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0304" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0306" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0321" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0338" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-01-012022-03-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0340" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0341" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0342" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0344" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0349" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0351" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-01-012022-03-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0352" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0353" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0356" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0359" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0360" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-01-012022-03-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0362" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0363" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0364" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0366" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0369" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0370" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0371" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-03-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0372" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0374" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0376" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ncra-20220331.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-01to2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_StatutoryAndOtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TotalNoceraStockholdersEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_StatutoryAndOtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TotalNoceraStockholdersEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_custom_StatutoryAndOtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_custom_TotalNoceraStockholdersEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_StatutoryAndOtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_TotalNoceraStockholdersEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_StatutoryAndOtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_TotalNoceraStockholdersEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_StatutoryAndOtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_TotalNoceraStockholdersEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:TwoCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:ThreeCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AllCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:AllCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AllCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:AllCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_XinFengConstructionCoLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NCRA:XinFengConstructionCoLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_XinFengConstructionCoLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NCRA:XinFengConstructionCoLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-10_custom_CWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:CWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-10_custom_DWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:DWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-08-10_custom_CWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:CWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-08-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-08-10_custom_DWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:DWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-08-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-27_custom_CWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:CWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-27_custom_DWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:DWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-27_custom_CWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:CWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-27_custom_DWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:DWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_country_HK">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:HK</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PrcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">NCRA:PrcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_YinChiehChengMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:YinChiehChengMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_YinChiehChengMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:YinChiehChengMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_MountainShareTransferMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MountainShareTransferMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_MountainShareTransferMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MountainShareTransferMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_TaisiElectricMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:TaisiElectricMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TaisiElectricMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:TaisiElectricMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-27_custom_SeriesAWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:SeriesAWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-01_custom_ClassAWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-01_custom_MichaelALittmanMember_custom_ClassAWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MichaelALittmanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-01_custom_MichaelALittmanMember_custom_ClassBWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MichaelALittmanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassBWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-02_custom_ClassAWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-012021-12-31_custom_ShunChihChuangMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:ShunChihChuangMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000929" toRefs="Footnote000948"></ix:relationship>
  <ix:relationship fromRefs="Fact000931" toRefs="Footnote000948"></ix:relationship>
  <ix:relationship fromRefs="Fact000933" toRefs="Footnote000949"></ix:relationship>
  <ix:relationship fromRefs="Fact000935" toRefs="Footnote000949"></ix:relationship>
  <ix:relationship fromRefs="Fact000945" toRefs="Footnote000950"></ix:relationship>
  <ix:relationship fromRefs="Fact000947" toRefs="Footnote000950"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><a href="#toc"><span style="font-size: 8pt">Table
of Contents</span></a></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As filed with the Securities and Exchange Commission
on July 20, 2022</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Registration No. 333-264059</b></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 12pt"><b>FORM
<span id="xdx_909_edei--DocumentType_c20220101__20220331_zxBiOCOTX0U2"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:DocumentType">S-1/A</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>(Pre-Effective
Amendment No. 2)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 12pt"><span id="xdx_901_edei--EntityRegistrantName_c20220101__20220331_zZDJ9YZV0Cqd"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityRegistrantName">Nocera,
Inc.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 35%; text-align: center"><b><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20220101__20220331_zqT7y0miVNT"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></td>
    <td style="width: 3%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 24%; text-align: center"><b>5900</b></td>
    <td style="width: 3%; text-align: center"><b>&#160;</b></td>
    <td style="border-bottom: black 1pt solid; width: 35%; text-align: center"><b><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20220101__20220331_zOzVHIv812hc"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityTaxIdentificationNumber">16-1626611</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">(State or Other Jurisdiction of Incorporation or Organization)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(Primary Standard Industrial Classification Code Number)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(I.R.S. Employer Identification No.)</td></tr>
</table>

<p style="margin: 0"><span style="font-size: 7pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_906_edei--EntityAddressAddressLine1_c20220101__20220331_zOiU87kwluL8"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressAddressLine1">3F (Building B)</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressAddressLine2_c20220101__20220331_z7bA5sET2gQj"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressAddressLine2">No. 185, Sec. 1</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressAddressLine3_c20220101__20220331_zEVpQwAwBc8c"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressAddressLine3">Datong Rd., Xizhi Dist.</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressCityOrTown_c20220101__20220331_zY9673Duwntk"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressCityOrTown">New Taipei City</ix:nonNumeric></span> <span id="xdx_901_edei--EntityAddressPostalZipCode_c20220101__20220331_zH1xwfSqbEY1"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressPostalZipCode">221</ix:nonNumeric></span>, Taiwan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_906_edei--CountryRegion_c20220101__20220331_zLAM54UxJ7Xk"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:CountryRegion">886</ix:nonNumeric></span>-<span id="xdx_90A_edei--CityAreaCode_c20220101__20220331_zyuOR1mG6R2k"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:CityAreaCode">910</ix:nonNumeric></span>-<span id="xdx_90B_edei--LocalPhoneNumber_c20220101__20220331_zLq2JDfbYzpi"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:LocalPhoneNumber">163-358</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Address, including zip code, and telephone number, including area code,</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">of registrant&#8217;s principal executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>Ross D. Carmel, Esq.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>Carmel, Milazzo &amp; Feil LLP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>55 West 39<sup>th</sup> Street, 18<sup>th</sup> Floor, New York, NY 10018</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>(212)
658-0458</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Name, address, including zip code, and telephone number, including area code, of agent for service)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="2" style="text-align: center">With copies to:</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; width: 50%"><b>Ross D. Carmel, Esq.</b></td>
    <td style="text-align: center; width: 50%"><b>Joseph Lucosky, Esq.</b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b>Philip Magri, Esq.</b></td>
    <td style="text-align: center"><b>Lawrence Metelitsa, Esq. </b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b>Carmel, Milazzo &amp; Feil LLP</b></td>
    <td style="text-align: center"><b>Lucosky Brookman LLP</b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b>55 West 39<sup>th</sup> Street, 18<sup>th</sup> Floor</b></td>
    <td style="text-align: center"><b>101 Wood Avenue South</b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b>New York, NY 10018</b></td>
    <td style="text-align: center"><b>Woodbridge, NJ 08830</b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b>Tel: (212) 658-0458</b></td>
    <td style="text-align: center"><b>Tel: (732) 395-4400</b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b>Fax: (646) 838-1314</b></td>
    <td style="text-align: center"><b>Fax: (732) 395-4401</b></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 6pt">Approximate date of commencement of proposed sale to the public: <b>As
soon as practicable after the effective date of this Registration Statement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 6pt">If any of the securities being registered on this Form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 6pt">If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number
of the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 6pt; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 6pt; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 6pt">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated
filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 52%; text-align: justify">Large accelerated filer <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td>
    <td style="width: 48%; text-align: justify">Accelerated filer <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span id="xdx_90B_edei--EntityFilerCategory_c20220101__20220331_zhdZGwT5ernf"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></td>
    <td style="text-align: justify">Smaller reporting company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_edei--EntitySmallBusiness_c20220101__20220331_zui5Gg2Q2J7b"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20220101__20220331_zEzjo27FsWp3"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 6pt; text-align: justify">If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided to Section 7(a)(2)(B) of the Securities Act. <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_edei--EntityExTransitionPeriod_c20220101__20220331_zW8plmnnX185"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The Registrant hereby amends this Registration
Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which
specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission
acting pursuant to said Section 8(a), may determine.</b></p>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="color: Red">The information in this
prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities
and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy
these securities in any state or other jurisdiction where the offer or sale is not permitted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="color: Red">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="color: Red"><b>Subject to Completion,
dated July 20, 2022</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="color: Red"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="color: Red"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span style="color: Red">PRELIMINARY
PROSPECTUS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="image_001.jpg" alt="" style="height: 40.5pt; width: 168.75pt" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2,350,000</b><b> Units</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Each Consisting of One Share of Common Stock
and<br />
One Warrant to Purchase Two Shares of Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are offering 2,350,000 units, each
unit consisting of one share of the Company&#8217;s common stock, $0.001 par value per share and one warrant to purchase two shares of
common stock. The units have no stand-alone rights and will not be certificated or issued as stand-alone securities. The shares of common
stock and the warrants comprising the units are immediately separable and will be issued separately in this offering. Each warrant is
immediately exercisable on the date of issuance and will expire five years from the date of issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">This
offering also includes the shares of common stock issuable upon the exercise of the warrants. The warrants will be issued in book-entry
form pursuant to a warrant agent agreement between us and </span>Mountain Share Transfer, LLC (the &#8220;Warrant Agent Agreement&#8221;),
who will be acting as the warrant agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently
estimate that the offering price will be between $3.50 and $4.00 per unit and the exercise price per warrant will be between $3.85
and $4.40 (110% of the offering price per unit). The final offering price of the units and exercise price of the warrants
will be determined by us and Spartan Capital Securities, LLC and Revere Securities LLC, the joint representatives of the underwriters
in connection with this offering, or the Representatives, taking into consideration several factors as described between the underwriters
and us at the time of pricing, including our historical performance and capital structure, prevailing market conditions, and overall
assessment of our business, and will not be based upon the price of our common stock quoted on the OTC pink sheets. Therefore, the assumed
public offering price used throughout this prospectus may not be indicative of the actual public offering price for our common stock
and the warrants. See &#8220;<i>Underwriting</i>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s common stock is quoted on
the OTC pink sheets under the symbol &#8220;NCRA.&#8221; The closing price of our common stock on July 19, 2022 was $4.00 per share
($6.00 as adjusted for the 2-for-3 reverse stock split). There is currently a limited public trading market for our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have applied to have our common stock listed
on the Nasdaq Capital Market under the symbol &#8220;NCRA,&#8221; which listing is a condition to this offering. Given the price range
per unit in this offering and the required pricing methodology of Nasdaq for public offerings that contain a warrant, we have applied
to Nasdaq under the alternative initial listing standard pursuant to Nasdaq Rule 5550(a)(1)(B) rather
than the $4.00 closing price listing standard. No assurance can be given that our application will be approved or, if we receive
approval, that a trading market will develop, or if developed, that it will be sustained or that the trading prices of our common stock
on the OTC will be indicative of the prices of our common stock is traded on the Nasdaq Capital Market. We cannot assure you that our
common stock will become eligible for trading on any exchange or market. We will not commence with this offering if our common stock
is not approved for listing on the Nasdaq Capital Market. We do not intend to apply for listing of the warrants on any exchange or market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise noted and other than in our
financial statements and the notes thereto, the share and per share information in this prospectus reflects a proposed 2-for-3 reverse
stock split of our outstanding common stock to occur concurrently with the effective date of the registration statement of which this
prospectus is a part and prior to the closing of this offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 2, 2021, the U.S. Securities and
Exchange Commission (the &#8220;SEC&#8221;) adopted final amendments implementing the disclosure and submission requirements under the
Holding Foreign Companies Accountable Act (the &#8220;HFCAA&#8221;), pursuant to which the SEC will identify a &#8220;Commission-Identified
Issuer&#8221; if an issuer has filed an annual report containing an audit report issued by a registered public accounting firm that the
Public Company Accounting Oversight Board (the &#8220;PCAOB&#8221;) has determined it is unable to inspect or investigate completely
because of a position taken by an authority in the foreign jurisdiction, and will then impose a trading prohibition on an issuer after
it is identified as and remains a Commission-Identified Issuer for three consecutive years. On December 16, 2021, the PCAOB issued a
report on its determinations that it is unable to inspect or investigate completely PCAOB-registered public accounting firms headquartered
in mainland China and in Hong Kong, because of positions taken by one or more authorities in such jurisdictions. Since the Company&#8217;s
auditor is located in Hong Kong, the Company&#8217;s auditor is included on a list of audit firms the PCAOB determined it is unable to
inspect or investigate completely because of a position taken by one or more authorities in Hong Kong, and is therefore subject to the
PCAOB&#8217;s determination. In May 2022, the Company was added to the SEC&#8217;s conclusive lists of issuers identified under the HFCAA,
or a Commission-Identified Issuer. Therefore, the Company will be delisted and its securities will be prohibited from being traded &#8220;over-the-counter&#8221;
if it remains identified as a Commission-Identified Issuer for three consecutive years. If the Company&#8217;s securities are unable
to be listed on another securities exchange by then, such a delisting or prohibition of trading would substantially impair your ability
to sell or purchase the Company&#8217;s securities when you wish to do so, and the risk and uncertainty associated with a potential delisting
or prohibition of trading would have a negative impact on the price of the Company&#8217;s securities. The Accelerating Holding Foreign
Companies Accountable Act (&#8220;AHFCAA&#8221;), passed by the U.S. Senate and if enacted, would require Commission-Identified Issuers
to comply with the PCAOB audits within two consecutive years instead of three consecutive years. In light of the PRC government&#8217;s
recent expansion of authority in Hong Kong, there are risks and uncertainties which the Company cannot foresee for the time being, and
rules and regulations in China can change quickly with little or no advance notice. See&#160;<i>&#8220;Risk Factors &#8211; If the Company
remains identified as a Commission-Identified Issuer for three consecutive years (or if the AHFCAA is enacted, two years), the Company&#8217;s
securities will be delisted or prohibited from trading &#8220;over-the-counter&#8221; under the Holding Foreign Companies Accountable
Act. The delisting or the cessation of trading &#8220;over-the-counter&#8221; of the Company&#8217;s securities, or the threat of their
being delisted or prohibited, may materially and adversely affect the value and/or liquidity of your investment. Additionally, the inability
of the PCAOB to conduct full inspections or investigations of the Company&#8217;s auditor deprives the Company&#8217;s investors of the
benefits of such inspections or investigations.&#8221;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Investing
in our securities involves a high degree of risk. See &#8220;<i><a href="#s4">Risk Factors</a></i>&#8221; beginning on page 12 of this prospectus
for a discussion of information that should be considered in connection with an investment in our securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Neither the Securities and Exchange Commission
(&#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
is truthful or complete. Any representation to the contrary is a criminal offense.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &#8220;emerging growth company&#8221;
under applicable SEC rules and will be subject to reduced public company reporting requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 68%; text-align: justify"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt; width: 1%"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; text-align: center"><b>Per Unit</b></td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: center"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: center"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: center"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; text-align: center"><b>Total</b></td>
    <td style="padding-bottom: 1pt; width: 1%"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #F2F2F2">
    <td>Public offering price</td>
    <td>$</td>
    <td style="text-align: right">[ <span style="font-family: Symbol">&#183;</span>]</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right">[ <span style="font-family: Symbol">&#183;</span>]</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>Underwriting discounts and commissions <sup>(1)</sup></td>
    <td>$</td>
    <td style="text-align: right">[ <span style="font-family: Symbol">&#183;</span>]</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right">[ <span style="font-family: Symbol">&#183;</span>]</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #F2F2F2">
    <td>Proceeds, before expenses, to us <sup>(2)</sup></td>
    <td>$</td>
    <td style="text-align: right">[ <span style="font-family: Symbol">&#183;</span>]</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right">[ <span style="font-family: Symbol">&#183;</span>]</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 3%">(1)</td>
    <td style="text-align: justify; width: 97%">We have also agreed to issue the Representatives warrants to purchase
shares of our common stock (the &#8220;Representative Warrants&#8221;) and to reimburse the underwriters for certain expenses. See &#8220;<i><a href="#s23">Underwriting</a></i>&#8221;
on page 91  for additional information regarding total underwriter compensation.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">(2)</td>
    <td style="text-align: justify">The amount of offering proceeds to us presented in this table does not give effect to any exercise
    of the: (i) Underwriters&#8217; over-allotment option we have granted to the underwriters as described below and (ii)&#160;the
    Representative Warrants.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have granted a 45-day option to the underwriters,
exercisable one or more times in whole or in part, to purchase up to an additional 352,500 units at the public offering price
per unit, less the underwriting discounts payable by us, in any combination solely to cover over-allotments, if any.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The underwriters expect to deliver the securities
against payment to the investors in this offering on or about ______________, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>Joint Book-Running Managers</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 51%; text-align: justify"><img src="image_002.jpg" alt="" style="height: 60pt; width: 224.25pt" /></td>
    <td style="width: 49%; text-align: center"><img src="image_003.jpg" alt="" style="height: 87pt; width: 100.5pt" /></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Prospectus dated </b>__________________<b>,
2022</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="toc"></span>Table of Contents<span style="font: normal 10pt Times New Roman, Times, Serif; text-transform: none"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif; text-transform: none">&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="width: 90%; text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s1">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in; width: 10%">ii</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s2">PROSPECTUS SUMMARY</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s3">OFFERING SUMMARY</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">8</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s4">RISK FACTORS</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">12</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s5">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">34</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s6">USE OF PROCEEDS</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">35</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s7">DETERMINATION OF OFFERING PRICE</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">36</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s8">MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">36</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s9">DIVIDEND POLICY</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">37</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s11">CAPITALIZATION</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">37</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s12">DILUTION</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">39</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s13">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">41</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s14">BUSINESS</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">59</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s15">DESCRIPTION OF PROPERTY</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">70</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s16">LEGAL PROCEEDINGS</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">70</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s17">DIRECTORS, EXECUTIVE OFFICERS &amp; CORPORATE GOVERNANCE</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">70</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s18">EXECUTIVE COMPENSATION</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">77</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s19">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">81</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s20">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">82</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s21">DESCRIPTION OF SECURITIES</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">83</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s22">SHARES ELIGIBLE FOR FUTURE SALE</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">90</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s23">UNDERWRITING</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">91</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#change">CHANGE IN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">98</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s24">EXPERTS</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">98</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s25">LEGAL MATTERS</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">98</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s26">WHERE YOU CAN FIND MORE INFORMATION</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">98</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in"><a href="#s27">INDEX TO FINANCIAL STATEMENTS</a></td>
    <td style="text-align: right; padding-top: 3pt; padding-bottom: 1pt; padding-left: 0in">F-1</td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Through and including </b>__________________<b>,
2022 (the 25<sup>th</sup> day after the date of this prospectus), all dealers that effect transactions in these securities, whether or
not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers&#8217; obligation to deliver
a prospectus when acting as underwriter and with respect to their unsold allotments or subscriptions.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should rely only on the information contained
in this prospectus or any prospectus supplement or amendment. Neither we, nor the underwriters, have authorized any other person to provide
you with information that is different from, or adds to, that contained in this prospectus. If anyone provides you with different or inconsistent
information, you should not rely on it. Neither we nor the underwriters take responsibility for and can provide no assurance as to the
reliability of, any other information that others may give you. You should assume that the information contained in this prospectus or
any free writing prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus
or of any sale of our securities. Our business, financial condition, results of operations and prospects may have changed since that date.
We are not making an offer of any securities in any jurisdiction in which such offer is unlawful.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No action is being taken in any jurisdiction outside
the United States to permit a public offering of our securities or possession or distribution of this prospectus in that jurisdiction.
Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about
and to observe any restrictions as to this public offering and the distribution of this prospectus applicable to that jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Value: 1; Name: PageNo -->i<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s1"></span>CAUTIONARY STATEMENT
REGARDING FORWARD-LOOKING STATEMENTS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus contains &#8220;forward-looking
statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933,
as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange
Act&#8221;). Forward-looking statements discuss matters that are not historical facts. Because they discuss future events or conditions,
forward-looking statements may include words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221;
&#8220;could,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;may,&#8221; &#8220;seek,&#8221; &#8220;plan,&#8221; &#8220;might,&#8221;
&#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;forecast,&#8221;
&#8220;potential,&#8221; and &#8220;continue&#8221; or the negatives thereof or similar expressions. Forward-looking statements speak
only as of the date they are made, are based on various underlying assumptions and current expectations about the future and are not guarantees
of future performance. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results,
level of activity, performance or achievement to be materially different from the results of operations or plans expressed or implied
by such forward-looking statements. <b>You are cautioned to not place undue reliance on these forward-looking statements, which speak
only as of their dates.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We cannot predict all the risks and uncertainties
that may impact our business, financial condition or results of operations. Accordingly, the forward-looking statements in this prospectus
should not be regarded as representations that the results or conditions described in such statements will occur or that our objectives
and plans will be achieved, and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements.
These forward-looking statements are found at various places throughout this prospectus and include information concerning possible or
projected future results of our operations, including statements about a potential acquisition or merger targets, strategies or plans;
business strategies; prospects; future cash flows; financing plans; plans and objectives of management; any other statements regarding
future acquisitions, future cash needs, future operations, business plans and future financial results; and any other statements that
are not historical facts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These forward-looking statements represent
our intentions, plans, expectations, assumptions and beliefs about future events and are subject to a variety of factors and risks,
including, but not limited to, those set forth under &#8220;<i><a href="#s4">Risk Factors</a></i>&#8221; starting on page 12 of this
prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Many of those risks and factors are outside of
our control and could cause actual results to differ materially from the results expressed or implied by those forward-looking statements.
Considering these risks, uncertainties and assumptions, the events described in the forward-looking statements might not occur or might
occur to a different extent or at a different time than we have described. You are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this prospectus. All subsequent written and oral forward-looking statements concerning
other matters addressed in this prospectus and attributable to us or any person acting on our behalf are expressly qualified in their
entirety by the cautionary statements contained or referred to in this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except to the extent required by law, we undertake
no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events,
conditions, circumstances or assumptions underlying such statements, or otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">Market Data</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Market data and certain industry data and forecasts
used throughout this prospectus were obtained from internal company surveys, market research, consultant surveys, publicly available information,
reports of governmental agencies and industry publications and surveys. Industry surveys, publications, consultant surveys and forecasts
generally state that the information contained therein has been obtained from sources believed to be reliable, but the accuracy and completeness
of such information is not guaranteed. To our knowledge, certain third-party industry data that includes projections for future periods
does not take into account the effects of the worldwide coronavirus pandemic. Accordingly, those third-party projections may be overstated
and should not be given undue weight. Forecasts are particularly likely to be inaccurate, especially over long periods of time. In addition,
we do not necessarily know what assumptions regarding general economic growth were used in preparing the forecasts we cite. Statements
as to our market position are based on the most currently available data. While we are not aware of any misstatements regarding the industry
data presented in this prospectus, our estimates involve risks and uncertainties and are subject to change based on various factors, including
those discussed under the heading &#8220;<i>Risk Factors</i>&#8221; in this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">ABOUT THIS PROSPECTUS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Throughout this prospectus, unless otherwise designated
or the context suggests otherwise,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 3%; text-align: right"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 96%; text-align: justify">all references to the &#8220;Company,&#8221; &#8220;Nocera,&#8221; the &#8220;registrant,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221; in this prospectus mean Nocera, Inc., a Nevada corporation, and its subsidiaries, including its variable interest entity (&#8220;VIE&#8221;);</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"> <span style="font-family: Symbol">&#183;</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">assumes a public offering price of $3.75 per unit, which is the midpoint of the $3.50 to $4.00
    range of the offering price per unit, a $4.13 per share exercise price for the warrants underlying the units (110% of the assumed
    offering price per unit);</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"> <span style="font-family: Symbol">&#183;</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#8220;year&#8221; or &#8220;fiscal year&#8221; means the Company&#8217;s fiscal year ending December 31<sup>st</sup>; </td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: justify">all dollar or $ references refer to United States dollars; and </td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: right">&#160;</td>
    <td>all NT dollar references refer to Taiwan&#8217;s New Taiwan dollar.</td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">TRADEMARKS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Solely for convenience, our trademarks and tradenames
referred to in this prospectus, may appear without the &#174; or &#8482; symbols, but such references are not intended to indicate in any
way that we will not assert, to the fullest extent under applicable law, our rights to these trademarks and tradenames. All other trademarks,
service marks and trade names included or incorporated by reference into this prospectus or the accompanying prospectus are the property
of their respective owners.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s2"></span>PROSPECTUS SUMMARY</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>This summary provides a brief overview of the
key aspects of our business and our securities. The reader should read the entire prospectus carefully, especially the risks of investing
in our securities discussed under &#8220;Risk Factors.&#8221; Some of the statements contained in this prospectus, including statements
under &#8220;Offering Summary&#8221; and &#8220;Risk Factors&#8221; as well as those noted in the documents incorporated herein by reference,
are forward-looking statements and may involve a number of risks and uncertainties. Our actual results and future events may differ significantly
based on a number of factors. The reader should not put undue reliance on the forward-looking statements in this document, which speak
only as of the date on the cover of this prospectus. </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Overview</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera, Inc. was incorporated in the State of
Nevada on February 1, 2002, with operations based in New Taipei City, Taiwan. Our primary business operations currently consist of designing,
developing and producing large scale recirculating aquaculture systems (&#8220;RASs&#8221;) for fish farms along with providing consulting,
technology transfer and aquaculture project management services to new and existing aquaculture management business services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RASs operate by filtering water from the
fish (or shellfish) tanks so it can be reused within the tank. This dramatically reduces the amount of water and space required to
intensively produce seafood products. The steps in RASs include solids removal, ammonia removal, Co2 removal and oxygenation. Prior
to 2021, Nocera was initially focused on the Chinese market due to opportunities presented by changes to regulations governing water
use for fish production in China. As of October 2020, we had delivered 551 fish tank systems to six separate Chinese-based fish
farms, and two fish tank systems to our Taiwan showroom. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2020, the government of Taiwan began
supporting the Green Power and Solar Sharing Fish Farms initiative. In view of the opportunities resulting from this initiative, in October
2020, Nocera ceased all of its operations in China and moved all of its technology and back-office operations to Taiwan. The Company now
only operates out of Taiwan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our current mission is to provide consulting
services and solutions in aquaculture projects to reduce water pollution and decrease the disease problems of fisheries. Our goal is
to become a global leader in the land-based aquaculture business. The Company is now poised to grow its existing operations in
Taiwan and expand into the development and management of land-based fish farms in Taiwan and North and South America. The Company
does not currently have any intentions of conducting operations in China or Hong Kong. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Nocera Recirculating Aquaculture System </i>&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;<img src="image_029.jpg" alt="" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Fig 1. Nocera Recirculating Aquaculture System</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>




<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Corporate Structure</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conduct our operations through (i) Xin Feng
Construction Co., Ltd, a Taiwan limited liability company (&#8220;XFC&#8221;); and (ii) Nocera Taiwan Branch, an unincorporated division
of the Company (&#8220;NTB&#8221;). The Company&#8217;s other subsidiaries, Grand Smooth Inc. Limited, a Hong Kong limited company (&#8220;GSI&#8221;),
which wholly-owns Guizhou Grand Smooth Technology Ltd., a People&#8217;s Republic of China (PRC) corporation (&#8220;GZ GST&#8221;),
are dormant and currently do not have any operations. The Company intends to keep such entities dormant and not conduct any operations
in the PRC or Hong Kong.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We acquired GSI in a reverse merger on December
31, 2018. Prior to the merger, we were a &#8220;shell company&#8221; as defined under Rule 12b-2 of the Exchange Act. GSI is the parent
holding company of GZ GST, which was incorporated on November 13, 2018, as a wholly foreign-owned enterprise established in the PRC. Both
GSI and GZ GZT are currently dormant and do not conduct any operations. The Company currently does not conduct any operations in China
or Hong Kong. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2020, Nocera added Xin-Feng Construction
Co. Ltd, a variable interest entity (&#8220;VIE&#8221;). Under the laws of Taiwan, foreign investments are typically restricted or prohibited
with respect to the operation of certain businesses in Taiwan (e.g., construction). As a result, it was necessary for us to add XFC as
a VIE in order to obtain a Class A construction license to construct indoor RASs and solar sharing fish farms. Without this license,
we would not be able to conduct this critical part of our business in Taiwan. XFC has obtained a Class A construction license in Taiwan
and we plan to use XFC for the investment in, and the construction of, indoor RASs and solar sharing fish farms. The Company is now looking
for opportunities to expand into the U.S. by building fish farms or transforming existing ones into high-tech and solar sharing enterprises.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NTB was established on January 14, 2021 in Taiwan.
In October 2021, Nocera began its eel trading business in response to domestic demands created by the COVID-19 lockdown. NTB currently
procures and sells eel in Taiwan and plans to trade other types of seafood, such as tilapia and milkfish, in the near future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and its management have invested more
than $2&#160;million in the development of the Company&#8217;s business operations to date and intend to use proceeds from this offering
to expand operations in Taiwan and enter into the U.S. market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Market Opportunity</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Global fish consumption has long been on the rise
at a rate higher than any other source of animal protein, and the trend is expected to continue. With overfishing already threatening
the earth&#8217;s marine ecosystem, it is anticipated that a significantly larger proportion of fish consumption would be farm-raised
instead of wild-caught in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also, the trade conflict between the U.S. and
China has led to a greater demand for non-Chinese origin seafood products from the U.S. market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On a broader perspective, as the world rapidly
begins a transition toward net zero carbon emissions in response to the ever-more pressing threat of climate change, it is foreseeable
that solar energy will be the go-to option for many countries as a new source of green energy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that the RAS, with its proven advantage
in producing more fish in a more cost-effective and environmentally friendly manner while offering greater location flexibility and the
potential for a &#8220;solar-fish sharing mode,&#8221; is a perfect solution to address the opportunities highlighted above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Consulting Services</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We also provide consulting services and solutions for aquaculture projects.
We currently provide such services in Taiwan and intend to expand into other international markets and the United States to increase revenues
and operate more efficiently. Our consultants use their RASs expertise to help customers increase production and operate more strategically
by branching into new diversified aquaculture species, and importantly, reducing water pollution and decreasing the disease problems of
fisheries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company plans to provide the following service
offerings:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">for qualified investors or investment groups who are interested in capitalizing on the potential of the
aquaculture industry and want to develop or take part in commercial fish farming or shrimp farming but lack the experience, design,
installation, build and management of aquaculture projects to meet these interests;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">a full range of pilot and management services to aquaculture companies and new aquaculture projects throughout
Taiwan and potentially the rest of the world, providing tailored solutions to meet customer needs and to fulfill our commitment, to encourage
and support clean water and clean fish products from the fish farm to the table; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">select equipment and materials from suppliers to provide unique service offerings structured to generate
higher profit margins.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe our experience from working closely
with our clients in the aquaculture industry in Taiwan gives us a competitive advantage in providing innovative aquaculture management
solutions that will generate positive results for us and our client companies. However, there can be no assurance we will be successful
in capitalizing on market opportunities or geographically expanding our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Strategy</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We plan to focus on countries with a growing
population and growing demand for food. By 2050, we will need to double the global food supply to feed the world&#8217;s growing population<span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup>[1]</sup></span>.
There is a growing need for new ways to produce high-quality local fish without putting more pressure on our natural ecosystems. Like
Taiwan, there are also many countries with a growing population and growing demand for high-protein food. We plan to go global by
building demo sites promoting our RASs and selling our price-competitive systems in these countries to meet their demand for food and
 satisfy their desire for a greener environment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2021, we moved our operation and market
focus from China to Taiwan. In 2021, we established a Nocera Taiwan Branch to focus on customers in a variety of sectors, such as individual
investors, government supported or funded companies, and international customers. We have received interest from areas like Japan, Thailand,
Jordan, South Africa and the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our revenues for the three months ended March
31, 2022 and 2021 were $<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,919,045 and $1,579,486, respectively,
and during the years ended December 31, 2021 and 2020, net sales were approximately $9.9&#160;million and approximately $1.2 million,
</span> respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Suppliers</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We intend to purchase raw materials and parts
and equipment from third parties locally in Taiwan and build and sell them to customers. We are not directly involved in the production
or manufacturing of readily available equipment, and we do not take a risk in the repair and maintenance of the equipment because of the
manufacturer&#8217;s maintenance policy. We have identified and sourced multiple suppliers in Taiwan, and our relationships with suppliers
are generally good. We expect that our suppliers will be able to meet the anticipated demand for our products in the foreseeable future.
There can be no assurance that our suppliers will continue to meet our needs, particularly as we ramp up our expansion into the U.S. and
other markets around the world.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Corporate History and Information</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera, Inc. was incorporated in the State
of Nevada on February 1, 2002, and is based in New Taipei City, Taiwan. Our principal executive offices are located at 3F (Building
B), No. 185, Sec. 1, Datong Rd., Xizhi Dist., New Taipei City 221, Taiwan. Our telephone number is 886-910-163-358. Our corporate website
address is located at <i>https://www.nocera.company/</i>. The contents of our website are not incorporated by reference into this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;__________</p>

































<p style="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup>[1]
</sup></span><span style="font-size: 8pt">Ranganathan et al, <i>How to Sustainably Feed 10 Billion People by 2050, in 21 Charts</i>,
WORLD RESOURCES INSTITUTE (Dec. 5, 2018); https://www.wri.org/insights/how-sustainably-feed-10-billion-people-2050-21-charts#:~:text=
How%20to%20Sustainably%20Feed%2010%20Billion%20People%20by%202050%2C%20in%2021%20Charts,-December%205%2C%202018&amp;text=There%20is%20a%20big%20shortfall,than%20there%20were%20in%202010.</span></p>

</div>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Listing on the Nasdaq Capital Market</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our common stock is currently quoted on the OTC
pink sheets under the symbol &#8220;NCRA.&#8221; In connection with this offering, we have applied to have our common stock listed on
the Nasdaq Capital Market under the symbol &#8220;NCRA.&#8221; Because the price range of the offering price per unit is under $4.00
and the required pricing methodology of Nasdaq for public offerings that contain a warrant, we have applied to Nasdaq under the alternative
listing standard. No assurance can be given that our application will be approved or, if we receive approval, that a trading market will
develop, or if developed, that it will be sustained or that the trading prices of our common stock on the OTC will be indicative of the
prices of our common stock is traded on the Nasdaq Capital Market. We cannot assure you that our common stock will become eligible for
trading on any exchange or market. We will not commence with this offering if our common stock is not approved for listing on the Nasdaq
Capital Market. We do not intend to apply for listing of the warrants on any exchange or market. If approved, we expect to list our
common stock on Nasdaq upon consummation of this offering, at which point our common stock will cease to be traded on the OTC. No assurance
can be given that our listing application will be approved. This offering will occur only if Nasdaq or another securities exchange approves
the listing of our common stock. If Nasdaq or another U.S. securities exchange does not approve the listing of our common stock, we will
not proceed with this offering. There can be no assurance that our common stock will be listed on the Nasdaq or another securities exchange.
We do not intend to apply for listing of the warrants on any exchange or market. <i>See &#8220;Risk Factors; We have applied to list
our common stock on Nasdaq under the alternative initial listing standard which could suppress the trading price of our common stock
and the liquidity of your investment.&#8221;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reverse Stock Split</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We intend to effect a reverse stock split of
our common stock at a ratio of 2-for-3 at the time of the effectiveness of the registration statement of which this prospectus forms
a part and prior to the closing of this offering. No fractional shares will be issued in connection with the reverse stock split and
all such fractional interests will be rounded up to the nearest whole number of shares of common stock. The conversion or exercise prices
of our issued and outstanding convertible securities, stock options and warrants will be adjusted accordingly. All information presented
in this prospectus other than in our consolidated financial statements and the notes thereto assumes a 2-for-3 reverse stock split of
our outstanding shares of common stock but not accounting for fractional shares resulting from the reverse stock split being rounded
up to the nearest whole number, and unless otherwise indicated, all such amounts and corresponding conversion price or exercise price
data set forth in this prospectus have been adjusted to give effect to such assumed reverse stock split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Holding Foreign Companies Accountable Act</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 16, 2021, the Public Company
Accounting Oversight Board (PCAOB) issued a report on its determinations that the PCAOB is unable to inspect or investigate
completely PCAOB-registered public accounting firms headquartered in mainland China and in Hong Kong, a Special Administrative
Region of the PRC, because of positions taken by the PRC authorities in those jurisdictions. The PCAOB made these determinations
pursuant to PCAOB Rule 6100, which provides a framework for how the PCAOB fulfills its responsibilities under the Holding Foreign
Companies Accountable Act. The report further listed in its Appendix A and Appendix B, Registered Public Accounting Firms Subject to
the Mainland China Determination and Registered Public Accounting Firms Subject to the Hong Kong Determination, respectively. The
audit report included in this registration statement for the year ended December 31, 2021, was issued by Centurion ZD CPA &amp; Co.
(&#8220;CZD CPA&#8221;), an audit firm headquartered in Hong Kong, a jurisdiction that the PCAOB has determined that the PCAOB is
unable to conduct inspections or investigate auditors. Our auditors, CZD CPA, is among those registered public accounting firms
listed by the PCAOB Hong Kong Determination, a determination announced by the PCAOB on December 16, 2021, which the PCAOB is unable
to inspect or investigate completely due to the fact it is headquartered in Hong Kong, a Special Administrative Region and
dependency of the PRC, because of a position taken by one or more authorities in Hong Kong. As a result, we and the investors in our
securities are deprived of the benefits of such PCAOB inspections, which could cause investors in our securities to lose confidence
in our reported financial information and the quality of our financial statements. Also, in May 2022, the Company was added to the
SEC&#8217;s conclusive lists of issuers identified under the HFCAA, or a Commission-Identified Issuer. Therefore, the Company will
be delisted and its securities will be prohibited from being traded &#8220;over-the-counter&#8221; if it remains identified as a
Commission-Identified Issuer for three consecutive years. Furthermore, on June 22, 2021, the U.S. Senate passed the AHFCAA, which,
if enacted, would amend the HFCAA and require the SEC to prohibit an issuer&#8217;s securities from trading on any U.S. stock
exchange or in the OTC trading market in the U.S. if the issuer remains identified as a Commission-Identified Issuer for two
consecutive years instead of three. In the future, if we do not engage an auditor that is subject to regular inspection by the PCAOB
for a period of three years, or two years if the AHFCAA is enacted, our securities will be prohibited from being traded on a U.S.
securities exchange or over-the-counter market, which would make it difficult for you to sell your common stock. See &#8220;<i>Risk
Factors &#8211; If the Company remains identified as a Commission-Identified Issuer for three consecutive years (or if the AHFCAA is
enacted, two years), the Company&#8217;s securities will be delisted or prohibited from trading &#8220;over-the-counter&#8221; under
the Holding Foreign Companies Accountable Act. The delisting or the cessation of trading &#8220;over-the-counter&#8221; of the
Company&#8217;s securities, or the threat of their being delisted or prohibited, may materially and adversely affect the value
and/or liquidity of your investment. Additionally, the inability of the PCAOB to conduct full inspections or investigations of the
Company&#8217;s auditor deprives the Company&#8217;s investors of the benefits of such inspections or investigations.</i>&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The HFCAA became law on December 18, 2020 and
requires, among other things, for the SEC to identify public companies that have retained a registered public accounting firm to issue
an audit report where the firm has a branch or office that: (1) is located in a foreign jurisdiction, and (2) PCAOB has determined that
it is unable to inspect or investigate completely because of a position taken by an authority in the foreign jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Effects of COVID-19 Outbreak</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2019, a novel strain of coronavirus
was reported to have surfaced in Wuhan, China, which has and is continuing to spread throughout China and other parts of the world, including
the United States. On January 30, 2020, the World Health Organization declared the outbreak of the coronavirus disease (COVID-19) a &#8220;Public
Health Emergency of International Concern.&#8221; On January 31, 2020, U.S. Health and Human Services Secretary Alex M. Azar II declared
a public health emergency for the United States to aid the U.S. healthcare community in responding to COVID-19, and on March 11, 2020,
the World Health Organization characterized the outbreak as a &#8220;pandemic.&#8221; A significant outbreak of COVID-19 and other infectious
diseases could result in a widespread health crisis that could adversely affect the economies and financial markets worldwide.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are monitoring the global outbreak and
spread of COVID-19 and taking steps in an effort to identify and mitigate the adverse impacts on, and risks to, our business posed
by its spread and the governmental and community reactions thereto. The current outbreak of COVID-19 has globally resulted in a loss
of life, business closures, restrictions on travel, and widespread cancellation of social gatherings. The extent to which the
COVID-19 pandemic impacts our business will depend on future developments, which are highly uncertain and cannot be predicted at
this time, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">new information which may emerge concerning the severity of the disease in Taiwan;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the duration and spread of the outbreak;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the severity of travel restrictions imposed by geographic areas in which we operate, mandatory or voluntary
business closures;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">regulatory actions taken in response to the pandemic, which may impact our offerings;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">other business disruptions that affect our workforce;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the impact on capital and financial markets; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">actions taken throughout the world, including in markets in which we operate, to contain the COVID-19
outbreak or treat its impact.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the current outbreak of COVID-19
has resulted in a widespread global health crisis and adversely affected global economies and financial markets, and similar public health
threats could do so in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The spread of COVID-19 has caused us to modify
our business practices, including employee travel, employee work locations in certain cases, and cancellation of physical participation
in certain meetings, events and conferences and further actions may be taken as required or recommended by government authorities or as
we determine are in the best interests of our employees, customers and other business partners. We are monitoring the global outbreak
of the pandemic in Taiwan, and are taking steps in an effort to identify and mitigate the adverse impacts on, and risks to, our business
posed by its spread and the governmental and community reactions thereto. See &#8220;<i>Risk Factors - Our business may be materially
adversely affected by the coronavirus (COVID-19) outbreak</i>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</div>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Summary Risk Factors</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business is subject to a number of risks.
You should be aware of these risks before making an investment decision. These risks are discussed more fully in the section of this prospectus
titled &#8220;<i><a href="#s4">Risk Factors,</a></i>&#8221; which begins on page 12 of this prospectus. Risks include, among others, that:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td>We have a limited operating history in an evolving industry, which makes it difficult to evaluate our future prospects and may increase
the risk that we will not be successful;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td>The Company&#8217;s failure to successfully market its brand and products could result in adverse financial consequences;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td>We are subject to certain risks by virtue of our international operations;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td>Natural disasters or other catastrophic events could harm our operations;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td>The primary substantial portion of our revenues will be derived from Taiwan;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td>Currency fluctuations may adversely affect our business and, if the NT dollar were to decline in value, that would reduce our revenue
in U.S. dollar terms;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td>We may be subject to product liability claims if people or properties are harmed by the services provided or products sold by us;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td>Our business may be materially adversely affected by the continuation of the coronavirus (COVID-19) outbreak;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td>We must comply with the Foreign Corrupt Practices Act while many of our competitors do not;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td>Third parties may assert that our employees or consultants have wrongfully used or disclosed confidential information or misappropriated
trade secrets;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td>Relations between the PRC and Taiwan could negatively affect our business and financial status and therefore the market value of your
investment;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    the Company remains identified as a Commission-Identified Issuer for three consecutive years (or if the AHFCAA is enacted, two years),
    the Company&#8217;s securities will be delisted or prohibited from trading &#8220;over-the-counter&#8221; under the Holding Foreign
    Companies Accountable Act. The delisting or the cessation of trading &#8220;over-the-counter&#8221; of the Company&#8217;s securities,
    or the threat of their being delisted or prohibited, may materially and adversely affect the value and/or liquidity of your investment.
    Additionally, the inability of the PCAOB to conduct full inspections or investigations of the Company&#8217;s auditor deprives the
    Company&#8217;s investors of the benefits of such inspections or investigations;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our contractual arrangements may not be as effective in providing
operational control as direct ownership and our VIE shareholders may fail to perform their obligations under our contractual arrangements;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="font-size: 10pt"><span style="font-family: Symbol">&#183;</td>
    <td>We have applied to list our common stock on Nasdaq under the alternative initial listing standard which could suppress the
    trading price of our common stock and the liquidity of your investment;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may lose the ability to use, or otherwise benefit from licenses
    and assets held by our VIE, which could render us unable to conduct some or all of our business operations and constrain our growth;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The speculative nature of warrants; and</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions in the warrants may discourage a third party from acquiring us.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</div>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>
<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;&#160;</p>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">Implications of
Being an Emerging Growth Company</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &#8220;emerging growth company,&#8221;
as defined in the Jobs Act. We will remain an emerging growth company until the earlier of (i) the last day of the fiscal year following
the fifth anniversary of the date of the first sale of our common stock pursuant to an effective registration statement under the Securities
Act; (ii) the last day of the fiscal year in which we have total annual gross revenues of $1.07 billion or more; (iii) the date on which
we have issued more than $1 billion in nonconvertible debt during the previous three years; or (iv) the date on which we are deemed to
be a large accelerated filer under applicable SEC rules. We expect that we will remain an emerging growth company for the foreseeable
future but cannot retain our emerging growth company status indefinitely and will no longer qualify as an emerging growth company on or
before the last day of the fiscal year following the fifth anniversary of the date of the first sale of our common stock pursuant to an
effective registration statement under the Securities Act. For so long as we remain an emerging growth company, we are permitted and intend
to rely on exemptions from specified disclosure requirements that are applicable to other public companies that are not emerging growth
companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These exemptions include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">being permitted to provide only two years of audited financial statements, in addition to any required
unaudited interim financial statements, with correspondingly reduced &#8220;<i>Management&#8217;s Discussion and Analysis of Financial
Condition and Results of Operations</i>&#8221; disclosure;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">not being required to comply with the requirement of auditor attestation of our internal controls over
financial reporting;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">not being required to comply with any requirement that may be adopted by the Public Company Accounting
Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information
about the audit and the financial statements;</td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">reduced disclosure obligations regarding executive compensation; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">not being required to hold a nonbinding advisory vote on executive compensation and stockholder approval
of any golden parachute payments not previously approved.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have taken advantage of certain reduced reporting
requirements in this prospectus. Accordingly, the information contained herein may be different from the information you receive from
other public companies in which you hold stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An emerging growth company can take advantage
of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards.
This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply
to private companies. We have irrevocably elected to avail ourselves of this extended transition period and, as a result, we will not
be required to adopt new or revised accounting standards on the dates on which adoption of such standards is required for other public
reporting companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are also a &#8220;smaller reporting company&#8221;
as defined in Rule 12b-2 of the Exchange Act, and have elected to take advantage of certain of the scaled disclosure available for smaller
reporting companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
</div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s3"></span>OFFERING SUMMARY</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 33%"><b>Issuer:</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 66%">Nocera, Inc., a Nevada corporation</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>Offered Securities <sup>(1)</sup>: </b></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2,350,000 units, each unit consisting
    of one share of common stock and one warrant to purchase two shares of common stock.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The units will not be certificated or issued in
    stand-alone form. The shares of our common stock and the warrants comprising the units are immediately separable upon issuance and will
    be issued separately in this offering.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants will be issued in book-entry
    form pursuant to the Warrant Agent Agreement between us and <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mountain
    Share Transfer, LLC, which will be acting as the warrant agent.</span></p></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>Offering Price per Unit (assumed):</b></td>
    <td>&#160;</td>
    <td style="text-align: justify">$3.75 per unit, the midpoint of the estimated $3.50 - $4.00 price range per unit in this offering.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>Over-Allotment Option:</b></td>
    <td>&#160;</td>
    <td style="text-align: justify">We have granted the underwriters a 45-day option to purchase up to an aggregate of 352,500
    units at the public offering price, less, in each case, underwriting discounts and commissions, on the same terms as set forth in
    this prospectus, solely to cover over-allotments, if any.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>Description of  Warrants:</b></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each warrant will be exercisable from the
    date of issuance until the fifth anniversary date of issuance date for $3.85 to $4.40 per share (110% of the public offering
    price of one unit), subject to adjustment in the event of stock dividends, stock splits, stock combinations, reclassifications, reorganizations
    or similar events affecting our common stock as described herein.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price shall be decreased
    to the reset price, which means the greater of (i) 50% of the exercise price and (ii) 100% of the last volume weighted average price
    immediately preceding the 90<sup>th</sup> calendar day following the initial exercise date if, on the date that is 90 calendar
    days immediately following the initial exercise date, the exercise price is less than the reset price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company may at any time, subject to the
prior written consent of the holder, reduce the then current exercise price to any amount and for any period of time deemed appropriate
by the Board of Directors (&#8220;Board&#8221;) subject to the rules and regulations of the trading market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A holder may not exercise any portion of a warrant
    to the extent that the holder, together with its affiliates and any other person or entity acting as a group, would own more than 4.99%
    of the outstanding common stock after exercise, as such percentage ownership is determined in accordance with the terms of the warrants,
    except that upon notice from the holder to us, the holder may waive such limitation up to a percentage, not in excess of 9.99%.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

</div>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 33%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 66%">The Company reserves the right to redeem all or a portion, on a pro rata basis, of the
    outstanding warrants, at any time and from time to time prior to their exercise, with a notice of redemption in writing to the holders
    (the &#8220;Redemption Notice&#8221;), giving not less than thirty (30) days&#8217; notice of such redemption at any time during
    which the warrants are exercisable (the &#8220;Notice Period&#8221;) if the ten (10)-day average variable weighted average price
    (VWAP) of the common stock is at or above 250% of the exercise price, as adjusted pursuant to the terms of the warrant, and the shares
    of common stock issuable upon exercise of the warrant have been registered pursuant to an effective registration statement with the
    SEC. The redemption price of the warrant shall be equal to 250% of the exercise price.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither
                                    the Company nor any of its subsidiaries shall, directly or indirectly, issue, offer, sell, grant
                                    any option or right to purchase, or otherwise dispose of (or announce any issuance, offer, sale,
                                    grant of any option or right to purchase or other disposition of) any equity security or any equity-linked
                                    or related security (including, without limitation, any &#8220;equity security&#8221; (as that term
                                    is defined under Rule 405 promulgated under the Securities Act)), any convertible securities, any
                                    debt, any preferred shares or any purchase rights (any such issuance, offer, sale, grant, disposition
                                    or announcement is referred to as a &#8220;Subsequent Placement&#8221;) unless the Company shall
                                    have first delivered to each holder that beneficially owns at least [&#8226;] warrants as of the time
                                    the Company engaged in a Subsequent Placement a written notice notifying the holder of his, her or
                                    its rights to participate in the Subsequent Placement pursuant to the terms of the warrant.</p>
</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">See &#8220;<i>Description of Securities &#8211; Warrants Issued in this Offering.</i>&#8221;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><b>Common Stock Outstanding Before Offering <sup>(2)</sup>:</b></td>
    <td>&#160;</td>
    <td style="text-align: justify">7,138,100 shares</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><b>Common Stock Outstanding After Offering <sup>(2) (3)</sup>:</b></td>
    <td>&#160;</td>
    <td style="text-align: justify">9,488,100 shares, or 9,840,600 shares if the underwriters exercise their over-allotment option
    in full.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><b>Use of Proceeds:</b></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We estimate that we will receive net proceeds
    from this offering of approximately $7.6 million, or approximately $8.8 million if the underwriters exercise the over-allotment
    option in full, assuming an initial public offering price of $3.75 per unit, and after deducting estimated underwriting discounts
    and commissions and estimated offering expenses payable by us.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently intend to use the net proceeds
    from this offering, together with our existing cash to invest and build RASs, acquire land in the United States to build a fish farm,
    and for fish farm and general working capital purposes. To date, we do not have any letters of intent or binding agreements for
    any acquisitions. See &#8220;<i>Use of Proceeds</i>.&#8221;</p></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td><b>Representative Warrants:</b></td>
    <td>&#160;</td>
    <td style="text-align: justify">The registration statement on Form S-1, of which this prospectus is a part, also registers the shares of common stock issuable
    upon the exercise of warrants issued to Representatives of the underwriters, or their designees, for $4.40 per share (110% of the
    assumed $3.75 offering price per Unit), including the shares underlying the underwriters&#8217; over-allotment option, as a portion
    of the underwriting compensation in connection with this offering (the &#8220;Representative Warrants&#8221;). The Representative
    Warrants will be exercisable at any time, and from time to time, in whole or in part, after the 180<sup>th</sup> day following the
    commencement of sales of units in this offering and until the four and half year anniversary of such initial exercise date. Please
    see &#8220;<i>Underwriting; Representative Warrants</i>.&#8221;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td><b>Underwriters Compensation:</b></td>
    <td>&#160;</td>
    <td>In connection with this offering, the underwriters will receive an underwriting discount equal to 8% of the gross proceeds from the sale of units in the offering. We will also reimburse the underwriters for certain out-of-pocket actual expenses related to the offering. See &#8220;<i>Underwriting</i>.&#8221;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td><b>Proposed Nasdaq Capital Market Listing:</b></td>
    <td>&#160;</td>
    <td>Our common stock currently trades on the OTC pink sheets under the symbol &#8220;NCRA.&#8221; We have applied to have our common
    stock listed on the Nasdaq Capital Market under the symbol &#8220;NCRA&#8221; under the alternative initial listing standard.
    The listing of our common stock on Nasdaq or another securities exchange is a condition of this offering. No assurance can be
    given that such listing will be approved or that a trading market will develop for our common stock. We do not intend to apply for
    listing of the warrants on any exchange or market. See &#8220;<i>Risk Factors; We have applied to list our common stock on Nasdaq
    under the alternative initial listing standard which could suppress the trading price of our common stock and the liquidity of your
    investme</i>nt.&#8221;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

</div>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>
<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">
<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><b>Lock-Up Agreements:</b></td>
    <td>&#160;</td>
    <td style="text-align: justify">Our executive officers and directors and any holder of 5% or more of the outstanding shares of common
    stock of the Company have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for 18
    months following the effective date of the registration statement for this offering. For additional information regarding our
    arrangement with the underwriters, please see &#8220;<i>Underwriting</i>.&#8221;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><b>Reverse Split:</b></td>
    <td>&#160;</td>
    <td style="text-align: justify">We intend to effectuate a 2-for-3 reverse split of our common stock immediately following the
    effective date of the registration statement for this offering but prior to the closing of this offering. Unless otherwise stated
    and other than in our financial statements and the notes thereto, all share and per share information in this prospectus reflects
    a reverse stock split.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><b>Dividend Policy:</b></td>
    <td>&#160;</td>
    <td style="text-align: justify">We have not historically paid dividends on our common stock and do not anticipate paying dividends on our common stock for the foreseeable future.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><b>Transfer Agent: </b></td>
    <td>&#160;</td>
    <td style="text-align: justify">Mountain Share Transfer, LLC, which has also agreed to serve as the warrant agent.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid"><b>Risk Factors:</b></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">An investment in our securities involves a high degree of risk. You should read this prospectus carefully, including the section entitled &#8220;<i><a href="#s4">Risk Factors</a></i>&#8221; starting on page 12 of this prospectus and the consolidated financial statements and the related notes to those statements included in this prospectus, before deciding to invest in our securities.</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 33%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 66%">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; text-align: justify">(1)</td>
    <td colspan="2" style="vertical-align: top; text-align: justify">After giving effect to the 2-for-3 reverse stock split. Does
    not account for fractional shares to be issued in rounding up fractional shares resulting from the reverse stock split to the nearest
    whole number.</td>
    </tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: top; text-align: justify">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td>(2)</td>
    <td colspan="2">Does not include:</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">53,334 shares of common stock issuable upon the conversion of 80,000 shares of Series A Preferred
    Stock;</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">2,666,667 shares of common stock issuable upon the exercise of Series A Warrants for $0.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75
    per share;</span></td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">676,667 shares of common
    stock issuable upon the exercise of outstanding Class A Warrants for $0.75 per</span> share;</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">433,334 shares of common stock issuable upon the exercise of outstanding Class B <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    for $1.50 per</span> share;</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">626,667 shares of common stock issuable upon the exercise of outstanding Class C <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    for $3.75 p</span>er share;</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">626,667 shares of common stock issuable upon the exercise of outstanding Class D <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    for $7.50 per share;</span> and</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">6,666,667 shares of common stock reserved for issuance under our 2018 Stock Option and Award
    Incentive Plan.</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td>(3)</td>
    <td colspan="2">Does not include:</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span>&#160;</td>
    <td>the securities listed under footnote (2);</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span>&#160;</td>
    <td>4,700,000 shares of common stock issuable upon the exercise of the warrants underlying the units;</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td>705,000 shares of common stock issuable upon the exercise of the warrants underlying the Underwriters&#8217; over-allotment
    option; and</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span>&#160;</td>
    <td>117,500 shares of common stock issuable upon the exercise of the Representative Warrants.</td>
    </tr>
  <tr>
    <td style="width: 4%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 91%">&#160;</td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise indicated, all information in this prospectus assumes that:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%">&#160;</td>
    <td style="text-align: left; width: 5%"> <span style="font-family: Symbol">&#183;</span>&#160;</td>
    <td style="text-align: left; width: 91%">a public offering price of $3.75 per unit, which is the midpoint of the range of
    the offering price per unit, a $4.13 per share exercise price for the warrants underlying the units;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"> <span style="font-family: Symbol">&#183;</span>&#160;</td>
    <td style="text-align: left">none of the warrants underlying the units in this offering have been exercised;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"> <span style="font-family: Symbol">&#183;</span>&#160;</td>
    <td style="text-align: left">no shares of common stock have been issued pursuant to any outstanding shares of preferred stock or warrants;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"> <span style="font-family: Symbol">&#183;</span>&#160;</td>
    <td style="text-align: left">no shares of common stock or warrants have been issued pursuant to the Underwriters&#8217; over-allotment option;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"> <span style="font-family: Symbol">&#183;</span>&#160;</td>
    <td style="text-align: left">no shares of common stock have been issued pursuant to the Representative Warrants; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"> <span style="font-family: Symbol">&#183;</span>&#160;</td>
    <td style="text-align: left">no awards have been granted under the Company&#8217;s 2018 Equity Incentive Plan.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
</div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">SUMMARY FINANCIAL
DATA</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables summarize our financial
data. We derived the summary financial statement data for the years ended December 31, 2021 and 2020 set forth below from our audited
financial statements and related notes contained in this prospectus, and the summary financial statement data for the three months
ended March 31, 2022 and March 31, 2021 set forth below from our unaudited financial statements and related notes contained in this prospectus.
The unaudited interim consolidated financial statements were prepared on a basis consistent with our audited consolidated financial statements
and include, in management&#8217;s opinion, all adjustments, consisting only of normal recurring adjustments, that we consider necessary
for a fair statement of the financial information set forth in those statements. Our historical results are not necessarily indicative
of the results that may be expected in the future. You should read the information presented below together with &#8220;<i>Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations</i>,&#8221; our financial statements, the notes to those statements
and the other financial information contained in this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Summary of Operations in U.S. Dollars</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Fiscal
                                            Year Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December
                                            31,</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three
                                            Months Ended March 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Unaudited)</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Net Sales</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">9,945,325</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,170,156</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">2,919,045</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,579,486</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">OPERATING EXPENSES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,419,684</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,325,696</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(860,953</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(235,235</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; padding-left: 10pt; text-align: left">Loss (gain) on foreign exchange</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">(Loss) Income from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,475,092</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(681,883</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(805,711</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">113,409</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">OTHER INCOME (LOSS)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,055</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,759</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">NET LOSS</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(9,619,079</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(639,070</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(805,720</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">49,490</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Loss per common share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1.0500</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.0538</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.00755</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.0054</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1.0500</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.0538</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.00755</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.0036</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Balance Sheet in U.S. Dollars</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Fiscal
                                            Year Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December
                                            31,</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three
                                            Months Ended March 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Unaudited)</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">2,444,009</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,023,531</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">1,961,777</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">607,452</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total Current Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,397,875</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,081,283</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,225,857</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,382,090</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,870,649</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,924,941</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,674,287</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,244,175</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total Current Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,100,685</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,374,549</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,974,657</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,542,807</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,100,685</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,374,549</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,974,657</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,545,807</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Working Capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,444,009</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,023,531</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,961,777</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">607,452</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,472,705</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,692,973</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,078,760</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,796,128</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total Stockholders&#8217; Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,769,964</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,550,392</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,699,630</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,701,368</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>
</div>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><span id="s4"></span>RISK FACTORS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Our business is subject to many risks and uncertainties,
which may affect our future financial performance. If any of the events or circumstances described below occur, our business and financial
performance could be adversely affected, our actual results could differ materially from our expectations, and the price of our securities
could decline. The risks and uncertainties discussed below are not the only ones we face. There may be additional risks and uncertainties
not currently known to us or that we currently do not believe are material that may adversely affect our business and financial performance.
You should carefully consider the risks described below, together with all other information included in this prospectus including our
financial statements and related notes, before making an investment decision. The statements contained in this prospectus that are not
historic facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially
from those set forth in or implied by forward-looking statements. If any of the following risks  occurs, our business, financial
condition or results of operations could be harmed. In that case, the trading price of our securities could decline, and investors in
our securities may lose all or part of their investment.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Risks Related to Our Business</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business may be materially adversely
affected by the coronavirus (COVID-19) outbreak.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current outbreak of COVID-19 has
globally resulted in the loss of life, business closures, restrictions on travel, and widespread cancellation of social gatherings.
The extent to which the COVID-19 pandemic impacts our business will depend on future developments, which are highly uncertain and
cannot be predicted at this time, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify; width: 92%">new information which may emerge concerning the severity of the disease; </td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="vertical-align: top; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify">the duration and spread of the outbreak; </td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="vertical-align: top; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify">the severity of travel restrictions imposed by geographic areas in which we operate, mandatory or voluntary business closures; </td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="vertical-align: top; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify">regulatory actions taken in response to the pandemic, which may impact merchant operations, consumer and merchant pricing, and our product offerings; </td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="vertical-align: top; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify">other business disruptions that affect our workforce; </td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="vertical-align: top; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify">the impact on capital and financial markets; and </td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="vertical-align: top; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify">actions taken throughout the world, including in markets in which we operate, to contain the COVID-19 outbreak or treat its impact. </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the current outbreak of COVID-19
has resulted in a widespread global health crisis and adversely affected global economies and financial markets, and similar public health
threats could do so in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Substantially all our revenues are concentrated
in Taiwan pending expansion into other international markets. Consequently, our results of operations will likely be adversely and may
be materially affected, to the extent that the COVID-19 pandemic or any epidemic harms Taiwan&#8217;s economy and society and the global
economy in general. Any potential impact to our results will depend on, to a large extent, future developments and new information that
may emerge regarding the duration and severity of the COVID-19 pandemic and the actions taken by government authorities and other entities
to contain the COVID-19 pandemic or treat its impact, almost all of which are beyond our control. If the disruptions posed by the COVID-19
pandemic or other matters of global concern continue for an extensive period of time, the operations of our business may be materially
adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent the COVID-19 pandemic or a similar
public health threat has an impact on our business, it is likely to also have the effect of heightening many of the other risks described
in this &#8220;<i>Risk Factors</i>&#8221; section.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have a limited operating history in an
evolving industry, which makes it difficult to evaluate our prospects and may increase the risk that we will not be successful.</i></b></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has a limited operating history on
which to base an evaluation of its business and prospects. The Company is subject to all the risks inherent in a small company seeking
to develop, market and distribute new services, particularly companies in evolving markets. The likelihood of the Company&#8217;s success
must be considered, in light of the problems, expenses, difficulties, complications and delays frequently encountered in connection with
the development, introduction, marketing and distribution of new products and services in a competitive environment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Such risks for the Company include, but are not
limited to, dependence on the success and acceptance of the Company&#8217;s services and the management of growth. In view of the Company&#8217;s
limited operating history, the Company believes that period-to-period comparisons of its operating results are not necessarily meaningful
and should not be relied upon as an indication of future performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is therefore subject to many of the
risks common to early-stage enterprises, including under-capitalization, cash shortages, limitations with respect to personnel, financial,
and other resources and lack of revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we fail to raise capital when needed
it will have a material adverse effect on the Company&#8217;s business, financial condition and results of operations.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has limited revenue-producing operations
and will require the proceeds from this offering to execute its full business plan. The Company believes the proceeds from this offering
will be sufficient to further its full business plan. However, the Company can give no assurance that all, or even a significant portion
of these units will be sold or, that the monies raised will be sufficient to execute the entire business plan of the Company. Further,
no assurance can be given if additional capital is needed as to how much additional capital will be required or that additional financing
can be obtained, or if obtainable, that the terms will be satisfactory to the Company, or that such financing would not result in a substantial
dilution of stockholder&#8217;s interest. A failure to raise capital when needed would have a material adverse effect on the Company&#8217;s
business, financial condition and results of operations. In addition, debt and other debt financings may involve a pledge of assets and
may be senior to the interests of equity holders. Any debt financing secured in the future could involve restrictive covenants relating
to capital raising activities and other financial and operational matters, which may make it more difficult for the Company to obtain
additional capital or to pursue business opportunities, including potential acquisitions. If adequate funds are not obtained, the Company
may be required to reduce, curtail or discontinue operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ability to obtain additional capital on acceptable
terms is subject to a variety of uncertainties, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>investors&#8217; perception of, and demand for, our securities;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>conditions of the U.S. and other capital markets in which we may seek to raise funds; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our future results of operations, financial condition and cash flow.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s failure to successfully
market its brands could result in adverse financial consequences.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company believes that continuing to strengthen
its brands is critical to achieving widespread acceptance of the Company, particularly in light of the competitive nature of the Company&#8217;s
market in which it operates. Promoting and positioning its brands will depend largely on the success of the Company&#8217;s marketing
efforts and the ability of the Company to provide high quality services. There can be no assurance that brand promotion activities will
yield increased revenues or that any such revenues would offset the expenses incurred by the Company in building its brand. If the Company
fails to promote and maintain its brand or incurs substantial expenses in an attempt to promote and maintain its brand or if the Company&#8217;s
existing or future strategic relationships fail to promote the Company&#8217;s brand or increase brand awareness, the Company&#8217;s
business, results of operations and financial condition would be materially adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may not generate the same level
of revenues from general construction projects.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our revenues for the three months ended March
31, 2022 and 2021 were approximately $2,919,045 and $1,579,486, respectively, and for the years ended December 31, 2021 and 2020 were
approximately $9.9 million and $1.2&#160;million, respectively. Three customers represented 97% of the Company&#8217;s total revenue for
the three months ended March 31, 2022, and two customers represented 98% of the Company&#8217;s total revenue for the three months ended
March 31, 2021. Also, there was one customer, The Fifth District Management Office of Taiwan Water Corporation, who represented approximately
58% of the Company&#8217;s total revenue for the year ended December 31, 2021, and two customers (JC Development Co., Ltd (&#8220;JCD&#8221;)
and Pan Li) who represented 96% of the Company&#8217;s total revenue for the prior year period. These customers are not located in mainland
China or Hong Kong. Our plan of operations is to shift away from general construction services to the construction of fish and solar power
farms. There can be no guarantee that such a shift in operations will generate the same levels of revenues previously generated through
our VIE.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no assurance that the Company
will be profitable.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no assurance that we will earn profits
in the future, or that profitability will be sustained. There is no assurance that future revenues will be sufficient to generate the
funds required to continue our business development and marketing activities. If we do not have sufficient capital to fund our operations,
we may be required to reduce our sales and marketing efforts or forego certain business opportunities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company may not have the ability
to manage its growth.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company anticipates that significant expansion
will be required to address potential growth in its customer base and market opportunities. The Company&#8217;s anticipated expansion
is expected to place a significant strain on the Company&#8217;s management, operational and financial resources. To manage any material
growth of its operations and personnel, the Company may be required to improve existing operational and financial systems, procedures
and controls and to expand, train and manage its employee base. There can be no assurance that the Company&#8217;s planned personnel,
systems, procedures and controls will be adequate to support the Company&#8217;s future operations, that management will be able to hire,
train, retain, motivate and manage required personnel or that the Company&#8217;s management will be able to successfully identify, manage
and exploit existing and potential market opportunities. If the Company is unable to manage growth effectively, its business, prospects,
financial condition and results of operations may be materially adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will need additional financing to grow our business.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, to expand operations
to meet customer demand, the Company will need to incur additional capital expenditures. These capital expenditures are intended to be
funded from third party sources, including the incurring of debt and/or the sale of additional equity securities. In addition to requiring
additional financing to fund capital expenditures, the Company may require additional financing to fund working capital, research and
development, sales and marketing, general and administrative expenditures, and operating losses. The incurrence of debt creates additional
financial leverage and therefore an increase in the financial risk of the Company&#8217;s operations. The sale of additional equity securities
will be dilutive to the interests of current equity holders. In addition, there can be no assurance that such additional financing, whether
debt or equity, will be available to the Company or that it will be available on acceptable commercial terms. Any inability to secure
such additional financing on appropriate terms could have a materially adverse impact on the business, financial condition and operating
results of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We rely on our executive officers. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s success is dependent on our
current executive officers. The Company&#8217;s success also depends in large part on the continued service of its key operational and
management personnel. The Company faces intense competition from its competitors, customers and other companies throughout the industry.
The loss of any our executive officers, specifically Mr. Yin-Chieh (Jeff) Cheng, our CEO, or any failure on the Company&#8217;s part to
hire, train and retain a sufficient number of qualified professionals could impair the business of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We rely on the performance of highly
skilled personnel, and if we are unable to attract, retain and motivate well-qualified employees, our business could be harmed.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is, and will be, heavily dependent
on the skill, acumen and services of the management and other employees of the Company. Our future success depends on our continuing ability
to attract, develop, motivate and retain highly qualified and skilled employees. Qualified individuals are in high demand, and we may
incur significant costs to attract them. In addition, the loss of any of our senior management or key employees could materially adversely
affect our ability to execute our business plan, and we may not be able to find adequate replacements. We cannot ensure that we will be
able to retain the services of any members of our senior management or other key employees. If we do not succeed in attracting well-qualified
employees or retaining and motivating existing employees, our business could be harmed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may have inadvertently violated
Section 13(k) of the Exchange Act (implementing Section 402 of the Sarbanes-Oxley Act of 2002) and may be subject to sanctions as a result.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 13(k) of the Exchange Act provides that
it is unlawful for a company that has a class of securities registered under Section 12 of the Exchange Act to, directly or indirectly,
including through any subsidiary, extend or maintain credit in the form of a personal loan to or for any director or executive officer
of the Company. In 2019, the Company did not have a corporate bank account established in Hong Kong or the U.S., and certain funds that
were supposed to be deposited into such corporate bank account were instead deposited into the personal bank account of our principal
stockholder as well as Chairman of the Board, President, Chief Executive Officer and Director, Yin-Chieh Cheng, which was considered to
be a personal loan made by the Company to Yin-Chieh Cheng and may have violated Section 13(k) of the Exchange Act. The receivable was
repaid to us in January 2020. Issuers that are found to have violated Section 13(k) of the Exchange Act may be subject to civil sanctions,
including injunctive remedies and monetary penalties, as well as criminal sanctions. The imposition of any of such sanctions on us could
have a material adverse effect on our business, financial position, results of operations or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Future acquisitions may have an adverse
effect on our ability to manage our business.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Selective acquisitions currently form part of
our strategy to further expand our business. If we are presented with appropriate opportunities, we may acquire additional businesses,
services or products that are complementary to our core business. Future acquisitions and the subsequent integration of new companies
into ours would require significant attention from our management. Future acquisitions would also expose us to potential risks, including
risks associated with the assimilation of new operations, services and personnel, unforeseen or hidden liabilities, the diversion of resources
from our existing businesses and technologies, the inability to generate sufficient revenue to offset the costs and expenses of acquisitions
and potential loss of, or harm to, relationships with employees as a result of the integration of new businesses. The diversion of our
management&#8217;s attention and any difficulties encountered in any integration process could have a material adverse effect on our ability
to manage our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The value of seafood which the Company sells
(e.g., eel) is subject to fluctuation which may result in volatility of our results of operations and the value of an investment in the
Company.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business is partly dependent upon the sale
of eel whose value is subject to fluctuation and which value greatly fluctuates. Our net sales and operating results vary significantly
due to the volatility of the value of eel and any other seafood that we sell which may result in the volatility of the market price of
our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are highly susceptible to changes
in market demand for the types of seafood for which our recirculating aquaculture systems are used.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A significant portion of our revenues is derived
from constructing recirculating aquaculture systems for fish farming. We, therefore, are highly susceptible to changes in market demand
for the seafood for which our systems are used, which may be impacted by factors over which we have limited or no control. Factors that
could lead to a decline in market demand for seafood in general and specifically the type of fish farmed using our systems include economic
conditions and evolving consumer preferences. A substantial downturn in market demand for such seafood may have a material adverse effect
on our business and on our results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>A portion of our revenues are derived from
a single product, eel, and therefore we are highly susceptible to changes in market demand, which may be affected by factors over which
we have limited or no control.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Approximately 30% of our revenues are derived
from a single product, eel. We, therefore, are highly susceptible to changes in market demand, which may be impacted by factors over which
we have limited or no control. Factors that could lead to a decline in market demand for eel include economic conditions and evolving
consumer preferences. A substantial downturn in market demand for eel may have a material adverse effect on our business and our results
of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are risks associated with outsourced
production that may result in a decrease in our profit.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The possibility of delivery delays, product defects
and other production-side risks stemming from outsourcers cannot be eliminated. In particular, inadequate production capacity among outsourced
manufacturers could result in the Company being unable to supply enough product amid periods of high product demand, the opportunity costs
of which could be substantial.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have limited insurance coverage.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not have any business liability, disruption
or litigation insurance coverage for our operations in Taiwan. Any uninsured occurrence of loss or litigation or business disruption
may result in the incurrence of substantial costs and the diversion of resources, which could have an adverse effect on our operating
results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Competitors and potential competitors may
develop products and technologies that make ours obsolete or garner greater market share than ours.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ability to compete successfully will depend
on our ability to demonstrate that our products are superior to and/or less expensive than other products available in the market. Some
of our competitors have the benefit of marketing their products under brand names that have better market recognition than ours or have
stronger marketing and distribution channels than we do. Increased competition as to any of our products could result in price reduction,
reduced margins and loss of market share, which could negatively affect our profitability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain of our competitors may benefit from government
support and other incentives that are not available to us. As a result, our competitors may be able to develop competing and/or superior
products and compete more aggressively and sustain that competition over a longer period of time than we can. As more companies develop
new intellectual property in our markets, a competitor could acquire patents or other rights that may limit our ability to successfully
market our product.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may produce products of inferior
quality which would cause us to lose customers.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we make an effort to ensure the quality
of our RASs, they could from time to time contain defects, anomalies or malfunctions that are undetectable at the time of shipment, installation
and initial testing. These defects, anomalies or malfunctions could be discovered after our products are shipped to customers and installed
and tested at the site, resulting in the return or exchange of our products or discontinuation of the use of our products, which could
negatively impact our operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our technologies or products are stolen,
misappropriated, or reverse engineered, others could use the technologies to produce competing technologies or products.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Third parties, including our collaborators, contractors,
and others involved in our business often have access to our technologies. If our technologies or products were stolen, misappropriated,
or reverse engineered, they could be used by other parties that may be able to reproduce our technologies or products using our technologies
for their own commercial gain. If this were to occur, it would be difficult for us to challenge this type of use, especially since we
do not own any patents or other intellectual property rights with respect to our technologies and products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to certain risks by
virtue of our international operations.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We mainly operate in Taiwan and plan to expand
to other international countries and the United States. We expect to expand our operations significantly by accessing new markets abroad
and expanding our service offerings. Our ability to manage our business and conduct our operations in other international countries and
the United States requires considerable management attention and resources and is subject to the particular challenges of supporting a
growing business in an environment of multiple languages, cultures, customs, legal systems, alternative dispute systems, regulatory systems
and commercial infrastructures. Furthermore, in most international markets, we would not be the first entrant, and our competitors may
be better positioned than we are to succeed. Expanding to other international countries and the United States may subject us to risks
that we have either not faced before or increase our exposure to risks that we currently face, including risks associated with:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">recruiting and retaining qualified, multi-lingual employees, including customer support personnel;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">increased competition from similar local businesses and potential preferences by local populations for
local providers;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="width: 92%">compliance with applicable foreign laws and regulations, including different liability standards and regulations;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="width: 92%">providing solutions in different languages for different cultures;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="width: 92%">credit risk and higher levels of payment fraud;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="width: 92%">compliance with anti-bribery laws;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="width: 92%">currency exchange rate fluctuations;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="width: 92%">foreign exchange controls that might prevent us from repatriating cash earned outside the United States;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="width: 92%">political and economic instability in some countries;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="width: 92%">double taxation of our international earnings and potentially adverse tax consequences due to changes in the tax laws of the United
States or the foreign jurisdictions in which we operate; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="width: 92%">higher costs of doing business in other international countries.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Natural disasters or other catastrophic
events could harm our operations.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our operations in the U.S. and Taiwan could be
subject to significant risk of natural disasters, including earthquakes, hurricanes, typhoons, flooding and tornadoes, as well as other
catastrophic events, such as terrorist attacks or wars. For example, our manufacturers are all located in Taiwan, which is susceptible
to typhoons and earthquakes. Any disruption in our manufacturers&#8217; manufacturing facilities arising from these and other natural
disasters or other catastrophic events could cause significant delays in the production or shipment of the components of our products
until such manufacturers are able to shift production to different facilities or until we are able to arrange for other third party manufacturers
to manufacture the components of our products. The affected manufacturers may not be able to obtain alternate capacity to manufacture
the components of our products or we may not be able to arrange for other third party manufacturers to manufacture the components of our
products on favorable terms or at all. The occurrence of any of these circumstances may adversely affect our financial condition and results
of operation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The primary substantial portion of
our revenues will be derived from Taiwan.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We anticipate that sales of our services in Taiwan
will represent our primary revenues in the near future. Any significant decline in the condition of the economy of Taiwan could adversely
affect consumer demand for our services, among other things, which in turn would have a material adverse effect on our business and financial
condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Currency fluctuations may adversely affect
our business and if the NT dollar were to decline in value, that would reduce our revenue in U.S. dollar terms.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our reporting currency is the U.S. dollar and
our operations in Taiwan use their local currency as their functional currencies. Substantially all of our revenue and expenses are in
NT dollars. We are subject to the effects of exchange rate fluctuations with respect to any of such currencies. For example, the value
of the NT dollar depends to a large extent on Taiwan government policies and Taiwan&#8217;s domestic and international economic and political
developments, as well as supply and demand in the local market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The income statements of our operations are translated
into U.S. dollars at the average exchange rates in each applicable period. To the extent the U.S. dollar strengthens against foreign currencies,
the translation of these foreign currencies denominated transactions results in reduced revenue, operating expenses and net income for
our international operations. Similarly, to the extent the U.S. dollar weakens against foreign currencies, the translation of these foreign
currency denominated transactions results in increased revenue, operating expenses and net income for our international operations. We
are also exposed to foreign exchange rate fluctuations as we convert the financial statements of our foreign subsidiaries into U.S. dollars
in consolidation. If there is a change in foreign currency exchange rates, the conversion of the foreign subsidiaries&#8217; financial
statements into U.S. dollars will lead to a translation gain or loss which is recorded as a component of other comprehensive income. In
addition, we have certain assets and liabilities that are denominated in currencies other than the relevant entity&#8217;s functional
currency. Changes in the functional currency value of these assets and liabilities create fluctuations that will lead to a transaction
gain or loss. We have not entered into agreements or purchased instruments to hedge our exchange rate risks, although we may do so in
the future. The availability and effectiveness of any hedging transaction may be limited, and we may not be able to successfully hedge
our exchange rate risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may be subject to product liability
claims if people or properties are harmed by the services sold by us.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The components of our products intended to be
sold by us, as part of our services, are manufactured by third parties. The components of our products may be defectively designed or
manufactured. As a result, sales of the products could expose us to liability claims relating to personal injury or property damage and
may require product recalls or other actions. Third parties subject to such injury or damage may bring claims or legal proceedings against
us as the reseller of the products. We do not currently maintain any third-party liability insurance or product liability insurance concerning
products we intend to sell in conjunction with our services. As a result, any material products liability claim or litigation could have
a material and adverse effect on our business, financial condition and results of operations. Even unsuccessful claims could result in
the expenditure of funds and managerial efforts in defending them and could have a negative impact on our reputation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Risk of litigation.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and/or its directors and officers
may be subject to a variety of civil or other legal proceedings, with or without merit. From time to time in the ordinary course of its
business, we may become involved in various legal proceedings, including commercial, employment and other litigation and claims, as well
as governmental and other regulatory investigations and proceedings. Such matters can be time-consuming, divert management&#8217;s attention
and resources and cause us to incur significant expenses. Furthermore, because litigation is inherently unpredictable, the results of
any such actions may have a material adverse effect on our business, operating results or financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Even if the claims are without merit, the costs
associated with defending these types of claims may be substantial, both in terms of time, money, and management distraction. The results
of litigation and claims to which we may be subject cannot be predicted with certainty. Even if these matters do not result in litigation
or are resolved in our favor or without significant cash settlements, these matters, and the time and resources necessary to litigate
or resolve them, could harm our business, results or operations and reputation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Third parties may assert that our
employees or consultants have wrongfully used or disclosed confidential information or misappropriated trade secrets.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We employ individuals who previously worked with
other companies, including our competitors or potential competitors. Although we try to ensure that our employees and consultants do not
use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our employees, consultants
or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary
information, of a former employer or other third party. Litigation may be necessary to defend against these claims. If we fail in defending
any such claims or settling those claims, in addition to paying monetary damages or a settlement payment, we may lose valuable intellectual
property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs
and be a distraction to management and other employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Regulatory Risks</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We must comply with the Foreign Corrupt
Practices Act while many of our competitors do not.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are required to comply with the United States
Foreign Corrupt Practices Act, which prohibits U.S. companies from engaging in bribery or other prohibited payments to foreign officials
for the purpose of obtaining or retaining business. Foreign companies, including some of our competitors, are not subject to these prohibitions.
Corruption, extortion, bribery, pay-offs, theft and other fraudulent practices occur from time to time in Taiwan. If our competitors engage
in these practices, they may receive preferential treatment from personnel of some companies, giving our competitors an advantage in securing
business or from government officials who might give them priority in obtaining new licenses, which would put us at a disadvantage. Although
we inform our personnel that such practices are illegal, we cannot assure you that our employees or other agents will not engage in such
conduct for which we might be held responsible. If our employees or other agents are found to have engaged in such practices, we could
suffer severe penalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Future laws, regulations and standards
relating to corporate governance and public disclosure may create uncertainty for public companies, which may increase legal and financial
compliance costs and make some activities more time consuming</i>.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Future laws, regulations and standards relating
to corporate governance and public disclosure are subject to varying interpretations, in many cases due to their lack of specificity,
and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies.
This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure
and governance practices. We intend to invest resources to comply with evolving laws, regulations and standards, and this investment
may result in increased general and administrative expenses and a diversion of management&#8217;s time and attention from revenue-generating
activities to compliance activities. If our efforts to comply with new laws, regulations, and standards differ from the activities intended
by regulatory or governing bodies due to ambiguities related to practice, regulatory authorities may initiate legal proceedings against
us and our business may be harmed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also expect that being listed on a national
exchange will make it more expensive for us to obtain director and officer liability insurance, and we may be required to accept
reduced coverage or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract
and retain qualified members of our Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Relations between the PRC and Taiwan
could negatively affect our business and financial status and therefore the market value of your investment.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Taiwan has a unique international political status.
The PRC does not recognize the sovereignty of Taiwan. Although significant economic and cultural relations have been established in recent
years between Taiwan and the PRC, relations have often been strained. The government of the PRC has threatened to use military force to
gain control over Taiwan in limited circumstances. Our principal executive offices are located in Taiwan and a substantial majority of
our net revenues are derived from our operations in Taiwan. Therefore, factors affecting military, political or economic conditions in
Taiwan could have a material adverse effect on our results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A significant disruption in the operations
of our suppliers in Taiwan, such as a trade war or political unrest, could materially adversely affect our business, financial condition
and results of operations.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any disruption in the operations of our suppliers
in Taiwan or in their ability to meet our needs, whether as a result of a natural disaster or other causes, could impair our ability to
operate our business on a day-to-day basis. Furthermore, since many of these third parties are located outside the U.S., we are exposed
to the possibility of disruption and increased costs in the event of changes in the policies of the U.S. or foreign governments, political
unrest or unstable economic conditions in any of the countries where we conduct such activities. For example, a trade war could lead to
higher tariffs. Any of these matters could materially and adversely affect our development timelines, business and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business, including our costs
and supply chain, is subject to risks associated with manufacturing.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a significant disruption in the
supply of the raw materials used in the manufacture of the components of the products we offer, the suppliers that we work with might
not be able to locate alternative suppliers of materials of comparable quality at an acceptable price. For example, natural disasters
may increase raw material costs and impact pricing with our suppliers, and cause shipping delays for the components of our products. Any
delays, interruption, damage to, or increased costs in the manufacture of the components of the products we offer could result in higher
prices to acquire the components of the products or non-delivery of the components of the products altogether, and could adversely affect
our operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If the Company remains identified as
a Commission-Identified Issuer for three consecutive years (or if the AHFCAA is enacted, two years), the Company&#8217;s securities will
be delisted or prohibited from trading &#8220;over-the-counter&#8221; under the Holding Foreign Companies Accountable Act. The delisting
or the cessation of trading &#8220;over-the-counter&#8221; of the Company&#8217;s securities, or the threat of their being delisted or
prohibited, may materially and adversely affect the value and/or liquidity of your investment. Additionally, the inability of the PCAOB
to conduct full inspections or investigations of the Company&#8217;s auditor deprives the Company&#8217;s investors of the benefits of
such inspections or investigations.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Holding Foreign Companies Accountable
Act was enacted on December&#160;18, 2020. The HFCAA states that if the SEC determines that an issuer has filed audit reports issued
by a registered public accounting firm that has not been subject to inspection by the PCAOB for three consecutive&#160; years, the
SEC shall prohibit the securities of the issuer from being traded on a national securities exchange or in the over-the-counter
trading market in the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s auditor, the independent
registered public accounting firm that issues the audit report included elsewhere in this prospectus, as an auditor of companies that
are traded publicly in the United States and a firm registered with the PCAOB, is subject to laws in the United States pursuant to which
the PCAOB conducts regular inspections to assess its compliance with the applicable professional standards. Since the Company&#8217;s
auditor is located in Hong Kong, it is included on a list of audit firms the PCAOB determined it is unable to inspect or investigate
completely because of a position taken by one or more authorities in Hong Kong, and is therefore subject to the PCAOB&#8217;s determination
and currently not inspected by the PCAOB.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March&#160;24, 2021, the SEC adopted interim
final rules relating to the implementation of certain disclosure and documentation requirements of the HFCAA. The Company would be required
to comply with these rules if the SEC identifies it as having a &#8220;non-inspection&#8221; year under a process to be subsequently
established by the SEC. The SEC is assessing how to implement other requirements of the HFCAA, including the listing and trading prohibition
requirements described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2021, the PCAOB issued a
proposed rule 6100,&#160;<i>Board Determinations Under the Holding Foreign Companies Accountable Act</i>, for public comment. The
proposed rule is related to the PCAOB&#8217;s responsibilities under the HFCAA, which would establish a framework for the PCAOB to
use when determining whether the PCAOB is unable to inspect or investigate completely registered public accounting firms located in
a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction. The proposed rule was adopted by
the PCAOB on September&#160;22, 2021 and approved by the SEC on November&#160;5, 2021. On December 2, 2021, the SEC adopted final
amendments implementing the disclosure and submission requirements under the HFCAA, pursuant to which the SEC will identify a
&#8220;Commission-Identified Issuer&#8221; if an issuer has filed an annual report containing an audit report issued by a registered
public accounting firm that the PCAOB has determined it is unable to inspect or investigate completely because of a position taken
by an authority in the foreign jurisdiction, and will then impose a trading prohibition on an issuer after it is identified as and
remains a Commission-Identified Issuer for three consecutive years. If the Company remains identified as a Commission-Identified
Issuer and has a &#8220;non-inspection&#8221; year, there is no assurance that it will be able to take remedial measures in a timely
manner.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 16, 2021, the PCAOB issued a report
on its determinations that it is unable to inspect or investigate completely PCAOB-registered public accounting firms headquartered in
mainland China and Hong Kong, because of positions taken by PRC authorities in such jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 22, 2021, the U.S. Senate
passed the Accelerating Holding Foreign Companies Accountable Act, which, if passed by the U.S. House of Representatives and signed
into law, would amend the HFCAA and reduce the number of consecutive non-inspection&#160;years required for triggering the listing
and trading prohibitions under the HFCAA from three years to two years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC may propose additional rules or guidance
that could impact the Company if its auditor is not subject to PCAOB inspection. For example, on August&#160;6, 2020, the President&#8217;s
Working Group on Financial Markets, or the PWG, issued the Report on Protecting United States Investors from Significant Risks from Chinese
Companies to the then President of the United States. This report recommended that the SEC implement five recommendations to address
companies from jurisdictions that do not provide the PCAOB with sufficient access to fulfil its statutory mandate. Some of the concepts
of these recommendations were implemented with the enactment of the HFCAA. However, some of the recommendations were more stringent than
the HFCAA. For example, if a company was not subject to PCAOB inspection, the report recommended that the transition period before a
company would be delisted would end on January&#160;1, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC has announced that the SEC staff is
preparing a consolidated proposal for the rules regarding the implementation of the HFCAA and to address the recommendations in the PWG
report. It is unclear when the SEC will complete its rulemaking and when such rules will become effective and what, if any, of the PWG
recommendations will be adopted. The SEC has also announced amendments to various annual report forms to accommodate the certification
and disclosure requirements of the HFCAA. There could be additional regulatory or legislative requirements or guidance that could impact
the Company if its auditor is not subject to PCAOB inspection. The implications of this possible regulation or guidance in addition to
the requirements of the HFCAA are uncertain, and such uncertainty could cause the market price of the Company&#8217;s securities to be
materially and adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the PCAOB is unable to conduct inspections
or full investigations of the Company&#8217;s auditor, in May 2022, the Company was added to the SEC&#8217;s conclusive lists of issuers
identified under the HFCAA, or a Commission-Identified Issuer. The Company will be delisted and its securities will be prohibited from
being traded &#8220;over-the-counter&#8221; if it remains identified as a Commission-Identified Issuer for three consecutive years (or
two if the AHFCAA is enacted). Such a delisting would substantially impair your ability to sell or purchase the Company&#8217;s securities
when you wish to do so, and the risk and uncertainty associated with a potential delisting could have a negative impact on the price
of the Company&#8217;s securities. Also, such a delisting could significantly affect the Company&#8217;s ability to raise capital on
acceptable terms, or at all, which would have a material adverse effect on the Company&#8217;s business, financial condition and prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inspections of other audit firms that the
PCAOB has conducted outside the PRC have identified deficiencies in those firms&#8217; audit procedures and quality control procedures,
which may be addressed as part of the inspection process to improve future audit quality. If the PCAOB were unable to conduct inspections
or full investigations of the Company&#8217;s auditor, the Company and investors in the Company&#8217;s securities would be deprived
of the benefits of such PCAOB inspections. In addition, the inability of the PCAOB to conduct inspections or full investigations of auditors
would make it more difficult to evaluate the effectiveness of the Company&#8217;s independent registered public accounting firm&#8217;s
audit procedures or quality control procedures as compared to auditors that are subject to the PCAOB inspections, which could cause investors
and potential investors to lose confidence in the audit procedures and reported financial information and the quality of the Company&#8217;s
financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our contractual arrangements may not
be as effective in providing operational control as direct ownership and our VIE shareholders may fail to perform their obligations under
our contractual arrangements.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the laws of Taiwan limit foreign equity
ownership in certain businesses in Taiwan, we operate such business in Taiwan through our VIE (variable interest entity), XFC, in which
we have no ownership interest and rely on a series of contractual arrangements with XFC and its respective equity holders to control and
operate the VIE. Our revenue and cash flows from such business are attributed to our VIE. The contractual arrangements may not be as effective
as direct ownership in providing us with control over our VIE. Direct ownership would allow us, for example, to directly or indirectly
exercise our rights as a shareholder to effect changes in the board of directors of our VIE, which, in turn, could effect changes, subject
to any applicable fiduciary obligations at the management level. However, under the contractual arrangements, as a legal matter, if our
VIE or its equity holders fail to perform their respective obligations under the contractual arrangements, we may have to incur substantial
costs and expend significant resources to enforce those arrangements and resort to litigation or arbitration and rely on legal remedies
under the laws of Taiwan. These remedies may include seeking specific performance or injunctive relief and claiming damages, any of which
may not be effective. In the event we are unable to enforce these contractual arrangements or we experience significant delays or other
obstacles in the process of enforcing these contractual arrangements, we may not be able to exert effective control over our VIE and may
lose control over the assets owned by our VIE. As a result, we may be unable to consolidate our VIE in our consolidated financial statements,
which could materially and adversely affect our financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may lose the ability to use, or otherwise
benefit from licenses and assets held by our VIE, which could render us unable to conduct some or all of our business operations and constrain
our growth.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our VIE, XFC, holds assets, approvals and licenses
that are necessary for the operation of a certain portion of our business to which foreign investments are typically restricted or prohibited
under the laws of Taiwan. Without our VIE, and if we are unable to maintain the Class A construction license that is necessary for us
to conduct our operations in Taiwan or fail to obtain any other required licenses, we will be unable to operate in Taiwan. The contractual
arrangements contain terms that specifically obligate the equity holders of our VIE to ensure the valid existence of our VIE and restrict
the disposition of material assets or any equity interest of our VIE. However, in the event the equity holders of our VIE breach the terms
of these contractual arrangements and voluntarily liquidate our VIE, or our VIE declares bankruptcy and all or part of its assets become
subject to liens or rights of third-party creditors, or are otherwise disposed of without our consent, we may be unable to operate some
or all of our business or otherwise benefit from the assets held by our VIE, which could have a material adverse effect on our business,
financial condition, and results of operations. Furthermore, if our VIE undergoes a voluntary or involuntary liquidation proceeding, its
equity holders or unrelated third-party creditors may claim rights to some or all of the assets of our VIE, thereby hindering our ability
to operate our business as well as constrain our growth. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Geopolitical
conditions, including trade disputes and direct or indirect acts of war or terrorism, could have an adverse effect on our operations and
financial results.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Since we operate on
a global basis, our operations could be disrupted by geopolitical conditions, trade disputes, international boycotts and sanctions, political
and social instability, acts of war, terrorist activity or other similar events. From time to time, we could have a large investment in
a particular asset type, a large revenue stream associated with a particular customer or industry, or a large number of customers located
in a particular geographic region. Decreased demand from a discrete event impacting a specific asset type, customer, industry, or region
in which we have a concentrated exposure could negatively impact our results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Recently, Russia initiated
significant military action against Ukraine. In response, the U.S. and certain other countries imposed significant sanctions and export
controls against Russia, Belarus and certain individuals and entities connected to Russian or Belarusian political, business, and financial
organizations, and the U.S. and certain other countries could impose further sanctions, trade restrictions, and other retaliatory actions
should the conflict continue or worsen. It is not possible to predict the broader consequences of the conflict, including related geopolitical
tensions, and the measures and retaliatory actions taken by the U.S. and other countries in respect thereof as well as any counter measures
or retaliatory actions by Russia or Belarus in response, including, for example, potential cyberattacks or the disruption of energy exports,
is likely to cause regional instability, geopolitical shifts, and could materially adversely affect global trade, currency exchange rates,
regional economies and the global economy. The situation remains uncertain, and while it is difficult to predict the impact of any of
the foregoing, the conflict and actions taken in response to the conflict could increase our costs, disrupt our supply chain, reduce our
sales and earnings, impair our ability to raise additional capital when needed on acceptable terms, if at all, or otherwise adversely
affect our business, financial condition, and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>We continue
to expand our international footprint and operations, and we may expand further in the future, which subjects us to a variety of risks
and complexities which, if not effectively managed, could negatively affect our business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We currently maintain
operations in Taiwan, and may in the future expand, or seek to expand, our operations to additional foreign jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">For example, operating
in Europe exposes us to political, legal and economic risks. In addition, a significant percentage of the production, downstream processing
and sales of our products occurs outside the United States or with vendors, suppliers or customers located outside the United States.
If tariffs or other restrictions are placed by the United States on foreign imports from Taiwan or other countries where we operate or
seek to operate, or any related counter-measures are taken, our business, financial condition, results of operations and growth prospects
may be harmed. Tariffs may increase our cost of goods, which could result in lower gross margins on certain of our products. If we raise
prices to account for any such increase in costs of goods, the competitiveness of the affected products could potentially be reduced.
In either case, increased tariffs on imports from Taiwan or other countries where we operate or seek to operate could materially and
adversely affect our business, financial condition and results of operations. Trade restrictions and sanctions implemented by the United
States or other countries, including sanctions imposed on Russia by the United States and other countries due to Russia&#8217;s recent
invasion of Ukraine, could materially and adversely affect our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to this Offering and our
Securities. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>While we are seeking to list our common
stock on Nasdaq under the alternative initial listing standard, there is no assurance that such security will be listed on Nasdaq.
</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While we are seeking to list our common stock
on the Nasdaq Capital Market, we cannot ensure that such security will be accepted for listing on Nasdaq. Should our common stock be
rejected for listing on Nasdaq, we will not continue with this offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have applied to list our common stock
on Nasdaq under the alternative initial listing standard which could suppress the trading price of our securities and the liquidity of
your investment.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Given the price range per unit in this offering
and the required pricing methodology of Nasdaq for public offerings that contain a warrant, we have applied to list our common stock
on the Nasdaq Capital Market under the alternative initial listing standard pursuant to Nasdaq Rule 5550(a)(1)(B) r<span style="color: #3D3D3D; background-color: white">ather
than the $<span style="background-color: white">4.00 closing price listing standard. A company that qualifies for
initial listing only under Nasdaq&#8217;s alternative listing standard could become a &#8220;penny stock&#8221; if it later fails the
net tangible assets and revenue tests after listing and does not satisfy any of the other exclusions from being a penny stock contained
in Rule 3a51-1 under the Exchange Act. In order to assist brokers&#8217; and dealers&#8217; compliance with the requirements of the penny
stock rules, Nasdaq monitors companies listed under the alternative requirement and publishes on its website on a daily basis a list
of any company that was initially listed under the alternative initial listing standard, which no longer satisfies the net tangible assets
or revenue test contained in Nasdaq Rule 5505(a)(1)(B), and which does not satisfy any of the other exclusions from being a penny stock
contained in Rule 3a51-1 under the Exchange Act. If a company initially lists with a bid price below $4.00 under the alternative initial
listing standard contained in Nasdaq Rule 5505(a)(1)(B), but subsequently achieves a $4.00 closing price for at least five consecutive
business days and, at the same time, satisfies all other initial listing criteria, it will no longer be considered as having listed under
the alternative requirement, and Nasdaq will notify the Company that it has qualified for listing under the price requirement contained
in Rule 5505(a)(1)(A). Although we satisfy the other listing requirements of the Nasdaq Capital Market, there is no guarantee that our
common stock will achieve a $4.00 closing price for at least consecutive trading days and that will be deemed to not have been listed
under the Nasdaq alternative listing standard. Until we are no longer considered to have been listed under Nasdaq&#8217;s alternative
initial listing standard, the trading prices and liquidity of your securities might be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Investors in this offering will experience
immediate and substantial dilution in net tangible book value.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The public offering price per unit is substantially
higher than the net tangible book value per share of our outstanding shares of common stock. As a result, investors in this offering
will incur an immediate dilution of $2.8348 per share, based on the public offering price of $4.00 per unit (the top of the range
of the offering price per unit). Investors in this offering will pay a price per unit that substantially exceeds the book value of
our assets after subtracting our liabilities. To the extent that the warrants sold in this offering are exercised, you will experience
further dilution. See &#8220;<i>Dilution</i>&#8221; for a more complete description of how the value of your investment will be diluted
upon the completion of this offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have identified material weaknesses
in our internal control over financial reporting. Failure to maintain effective internal controls could cause our investors to lose confidence
in us and adversely affect the market price of our common stock. If our internal controls are not effective, we may not be able to accurately
report our financial results or prevent fraud.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 404 of the Sarbanes-Oxley Act of 2002
(&#8220;Section 404&#8221;) requires that we maintain internal control over financial reporting that meets applicable standards. We may
err in the design or operation of our controls, and all internal control systems, no matter how well designed and operated, can provide
only reasonable assurance that the objectives of the control system are met. Because there are inherent limitations in all control systems,
there can be no assurance that all control issues have been or will be detected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In our
Form 10-Q for the quarter ended March 31, 2022 filed with the SEC on May 12, 2022, we identified certain material weaknesses in our internal
controls. Specifically, </span>we did not maintain effective controls over the control environment. Our weaknesses related to a lack
of a sufficient number of personnel with appropriate training and experience in U.S. general acceptable accounting principles (GAAP)
and SEC rules and regulations with respect to financial reporting functions. Furthermore, we lack robust accounting systems as well as
sufficient resources to hire such staff and implement these accounting systems.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are unable, or are perceived as unable,
to produce reliable financial reports due to internal control deficiencies, investors could lose confidence in our reported financial
information and operating results, which could result in a negative market reaction and a decrease in our stock price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our management will have broad discretion
over the use of any net proceeds from this offering and you may not agree with how we use the proceeds, and the proceeds may not be invested
successfully.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our management will have broad discretion as to
the use of any net proceeds from this offering and could use them for purposes other than those contemplated at the time of this offering
and in ways that do not necessarily improve our results of operations or enhance the value of our common stock. Accordingly, you will
be relying on the judgment of our management with regard to the use of any proceeds from this offering and you will not have the opportunity,
as part of your investment decision, to assess whether the proceeds are being used appropriately. The proceeds may be invested in a way
that does not yield a favorable, or any, return for you.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have a large number of authorized
but unissued shares of our common stock which will dilute your ownership position when issued.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our authorized capital stock consists of 200,000,000
shares of common stock, of which approximately 190,861,900 will remain available for issuance after this offering, including (i) shares
of common stock issuable upon the exercise of our outstanding preferred stock and warrants; (ii) awards reserved for issuance under our
2018 Plan; (iii) shares issuable upon the exercise of the underwriters&#8217; over-allotment option; (iv) the warrants underlying the
units sold in this offering and (v) the Representative Warrants. Our management will continue to have broad discretion to issue shares
of our common stock in a range of transactions, including capital-raising transactions, mergers, acquisitions and other transactions,
without obtaining stockholder approval, unless stockholder approval is required under law or, if our common stock is listed on Nasdaq,
under Nasdaq Rule 5635(b) which requires stockholder approval for change of control transactions where a stockholder acquires 20% of
a Nasdaq-listed company&#8217;s common stock or securities convertible into common stock, calculated on a post-transaction basis. If
our management determines to issue shares of our common stock from the large pool of authorized but unissued shares for any purpose in
the future and is not required to obtain stockholder approval, your ownership position would be diluted without your further ability
to vote on that transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Sales of our currently issued and outstanding
shares of common stock and shares of common stock underlying warrants may become freely tradable pursuant to Rule 144 and may dilute
the market for your shares and have a depressive effect on the price of the shares of our common stock.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Approximately 44.92% of the shares of common
stock that will be outstanding following this offering (including a total of 5,030,002 shares issuable pursuant to exercise of outstanding
warrants other than the warrants underlying the Units being sold pursuant to this offering and 53,334 shares of common stock issuable
upon the exercise of 80,000 shares of outstanding Series A Preferred Stock) are both &#8220;restricted securities&#8221; within the meaning
of Rule 144 under the Securities Act (&#8220;Rule 144&#8221;). As restricted securities, these shares may be resold only pursuant to
an effective registration statement or under the requirements of Rule 144 or other applicable exemptions from registration under the
Securities Act and as required under applicable state securities laws. Rule 144 provides in essence that a non-affiliate who has held
restricted securities for a period of at least six months may sell their shares of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Rule 144, affiliates who have held restricted
securities for a period of at least six months may, under certain conditions, sell every three months, in brokerage transactions, a number
of shares that does not exceed the greater of 1% of a company&#8217;s outstanding shares of common stock or the average weekly trading
volume during the four calendar weeks prior to the sale. A sale under Rule 144 or under any other exemption from the Securities Act,
if available, or pursuant to subsequent registrations of our shares of common stock, may have a depressive effect upon the price of our
shares of common stock in any active market that may develop.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>An active, liquid, and orderly market
for our common stock may not develop.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our common stock is expected to trade on Nasdaq
as of the effective date of the registration statement of which this prospectus forms a part. An active trading market for our common
stock may never develop or be sustained. If an active market for our common stock does not continue to develop or is not sustained, it
may be difficult for investors to sell their shares of common stock without depressing the market price and investors may not be able
to sell their securities at all. An inactive market may also impair our ability to raise capital by selling our securities and may impair
our ability to acquire other businesses, applications, or technologies using our securities as consideration, which, in turn, could materially
adversely affect our business and the market prices of your shares of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Shares of our common stock may continue
to be subject to illiquidity because our shares may continue to be thinly traded and may never become eligible for trading on a national
securities exchange.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While we have applied to have our common stock
listed for trading on the Nasdaq Capital Market in connection with this offering, we cannot assure you that our application will be approved
or even if approved, that we will maintain listing on Nasdaq or another national exchange. Our common stock is currently quoted on the
OTC Pink tier, which is not an exchange. Initial listing on a national securities exchange is subject to a variety of requirements, including
minimum trading price and minimum public &#8220;float&#8221; requirements, and could also be affected by the general skepticism of such
markets concerning companies that are the result of mergers with inactive publicly-held companies. There are also continuing eligibility
requirements for companies listed on public trading markets. If we are unable to satisfy the initial or continuing eligibility requirements
of any such market, then our common stock may not be listed or could be delisted. This could result in a lower trading price for our
common stock and may limit your ability to sell your shares, any of which could result in you losing some or all of your investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>We may issue preferred stock in different series with terms that
could dilute the voting power or reduce the value of our common stock.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While
we have no specific plan to issue preferred stock in different series, our amended and restated articles of incorporation, as
amended (&#8220;Articles of Incorporation&#8221;) authorizes us to issue, without the approval of our stockholders, one or more series
of preferred stock having such designation, relative powers, preferences (including preferences over our common stock respecting dividends
and distributions), voting rights, terms of conversion or redemption, and other relative, participating, optional, or other special rights,
if any, of the shares of each such series of preferred stock and any qualifications, limitations, or restrictions thereof, as our Board
may determine. The terms of one or more classes or series of preferred stock could dilute the voting power or reduce the value of our
common stock. For example, the repurchase or redemption rights or liquidation preferences we could assign to holders of a specific preferred
stock class could affect the residual value of the common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market valuation of our business
may fluctuate due to factors beyond our control and the value of your investment may fluctuate correspondingly.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market valuations of smaller reporting companies,
such as us, frequently fluctuate due to factors unrelated to the past or present operating performance of such companies. Our market valuation
may fluctuate significantly in response to a number of factors, many of which are beyond our control, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in securities analysts&#8217; estimates of our financial performance, although there are currently no analysts covering our
stock;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>fluctuations in stock market prices and volumes, particularly among securities of smaller reporting companies;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>fluctuations in related commodities prices; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>additions or departures of key personnel.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result, the value of your investment in
us may fluctuate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The trading prices of our common stock could be volatile and could decline following this offering at a time when you want to sell your holdings.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Numerous factors, many of which are beyond our
control, may cause the trading prices of our common stock to fluctuate significantly. These factors include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>quarterly variations in our results of operations or those of our competitors;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>delays in end-user deployments of products;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>announcements by us or our competitors of acquisitions, new products, significant contracts, commercial relationships or capital commitments;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>intellectual property infringements;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to develop and market new and enhanced products on a timely basis;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>commencement of, or our involvement in, litigation;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>major changes in our Board or management;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in governmental regulations;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in earnings estimates or recommendations by securities analysts;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the impact of the COVID-19 pandemic on capital markets;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our failure to generate material revenues;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our public disclosure of the terms of this financing and any financing which we consummate in the future;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>any acquisitions we may consummate;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>short selling activities;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in market valuations of similar companies; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in our capital structure, such as future issuances of securities or the incurrence of debt;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in the prices of commodities associated with our business; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>general economic conditions and slow or negative growth of end markets.</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Additionally, the
global economy and financial markets may be adversely affected by geopolitical events, including the current or anticipated impact of
military conflict and related sanctions imposed on Russia by the United States and other countries due to Russia&#8217;s recent invasion
of Ukraine.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities class action litigation is often instituted
against companies following periods of volatility in their stock price. This type of litigation could result in substantial costs to us
and divert our management&#8217;s attention and resources.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moreover, securities markets may from time to
time experience significant price and volume fluctuations for reasons unrelated to the operating performance of particular companies,
such as the uncertainty associated with the COVID-19 pandemic. These market fluctuations may adversely affect the price of our common
stock and other interests in our Company at a time when you want to sell your interest in us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Future sales or perceived sales of
our common stock could depress the trading prices of our common stock.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus covers 2,350,000 shares
of common stock and 4,700,000 shares of common stock issuable upon the exercise of the warrants underlying the units. If the holders
of these securities were to attempt to sell a substantial amount of their holdings at once, the market prices of our common stock could
decline. Moreover, the perceived risk of this potential dilution could cause stockholders to attempt to sell their securities and investors
to short such securities, a practice in which an investor sells securities that he or she does not own at prevailing market prices, hoping
to purchase such securities later at a lower price to cover the sale. As each of these events would cause the number of shares of our
common stock being offered for sale to increase, our common stock market price would likely further decline and if such market price
is less than the exercise price of the warrants, make the warrants worthless. All of these events could combine to make it very difficult
for us to sell equity or equity-related securities in the future at a time and price that we deem appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our common stock may be affected by limited
trading volume and price fluctuations, which could adversely impact the value of our common stock.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our common stock has experienced, and is likely
to experience in the future, significant price and volume fluctuations, which could adversely affect the market prices of our common stock
without regard to our operating performance. In addition, we believe that factors such as quarterly fluctuations in our financial results
and changes in the overall economy or the condition of the financial markets could cause the market prices of our common stock to fluctuate
substantially. These fluctuations may also cause short sellers to periodically enter the market in the belief that we will have poor results
in the future. We cannot predict the actions of market participants and, therefore, can offer no assurances that the market for our common
stock will be stable or appreciate over time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The proposed reverse stock split could
cause our common stock price to decline relative to its value before the split and decrease the liquidity of shares of our common stock.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We will effect a
2-for-3 reverse stock split of our issued and outstanding common stock at the time of effectiveness of this offering. There is no assurance
 that the reverse stock split will not cause an actual decline in the value of our outstanding common stock. The liquidity of the
shares of our common stock may be affected adversely by the reverse stock split given the reduced number of shares that will be outstanding
following the reverse stock split, especially if the market price of our common stock does not increase as a result of the reverse stock
split. In addition, the reverse stock split may increase the number of stockholders who own odd lots (less than 100 shares) of our common
stock, creating the potential for such stockholders to experience an increase in the cost of selling their shares and greater difficulty
effecting such sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently do not intend to declare
dividends on our common stock in the foreseeable future and, as a result, your returns on your investment may depend solely on the appreciation
of our common stock.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently do not expect to declare any dividends
on our common stock in the foreseeable future. Instead, we anticipate that all of our earnings in the foreseeable future will be used
to provide working capital, support our operations and finance the growth and development of our business. Any determination to declare
or pay dividends in the future will be at the discretion of our Board, subject to applicable laws and dependent upon a number of factors,
including our earnings, capital requirements and overall financial conditions. In addition, terms of any future debt or preferred securities
may further restrict our ability to pay dividends on our common stock. Accordingly, your only opportunity to achieve a return on your
investment in our common stock may be if the market price of our common stock appreciates and you sell your shares at a profit. The market
price for our common stock may never exceed, and may fall below, the price that you pay for such common stock. See &#8220;<i>Dividend
Policy</i>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because we initially became a reporting
company under the Exchange Act by means other than a traditional underwritten initial public offering, we may not be able to attract the
attention of research analysts at major brokerage firms.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Because we did not initially
become a reporting company by conducting an underwritten initial public offering of our common stock on a national securities exchange,
securities analysts of brokerage firms may not provide coverage of our Company. In addition, investment banks may be less likely to agree
to underwrite secondary offerings on our behalf than they might if we initially became a public reporting company by means of an underwritten
initial public offering on a national securities exchange, because they may be less familiar with our Company as a result of more limited
coverage by analysts and the media, and because we became public at an early stage in our development. The failure to receive research
coverage or support in the market for our shares will have an adverse effect on our ability to develop a liquid market for our common
stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Because we were
a shell company before we conducted a reverse merger, holders of restricted shares will not be able to rely on exemption Rule 144 to resell
their shares unless we comply with Rule 144(i). </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additional risks may exist as a result of our
becoming a public reporting company through a &#8220;reverse merger.&#8221; Certain SEC rules are more restrictive when applied to reverse
merger companies, such as the ability of stockholders to re-sell their shares pursuant to Rule 144.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Historically, the SEC has taken the position that
Rule 144 under the Securities Act is not available for the resale of securities initially issued by companies that are, or previously
were, blank check companies, to their promoters or affiliates despite technical compliance with the requirements of Rule 144. The SEC
has codified and expanded this position in its amendments effective on February 15, 2008, which applies to securities acquired both before
and after that date by prohibiting the use of Rule 144 for the resale of securities issued by shell companies (other than business transaction
related shell companies) or issuers that have been at any time previously a shell company. The SEC has provided an important exception
to this prohibition, however, if the following conditions are met:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">the issuer of the securities that was formerly a shell company has ceased to be a shell company;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange
Act;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">the issuer of the securities has filed all Exchange Act reports and material required to be filed, as
applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other
than Form 8-K reports; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">at least one year has elapsed from the time that the issuer filed current Form 10 type information with
the SEC reflecting its status as an entity that is not a shell company.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In addition, for proposed
sales under Rule 144(i)(2), there must be adequate current information about the issuing company publicly available before the sale can
be made. For reporting companies, this generally means that the companies have complied with the periodic reporting requirements of the
Exchange Act. As such, due to the fact that we were a shell company until the effective time of the reverse merger, holders of &#8220;restricted
securities&#8221; within the meaning of Rule 144 will be subject to the above conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>There is no public market for the warrants being offered
in this offering.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no public trading market for the
warrants offered by this prospectus, and we do not expect a market to develop. In addition, we do not intend to apply to list the warrants
on any exchange or market. Without an active market, the liquidity of the warrants will be limited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>We may redeem your unexpired warrants
prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We have the ability
to redeem outstanding warrants at any time after they become exercisable and prior to their expiration, at 250% of the exercise price,
as adjusted, provided that the VWAP of our common stock equals or exceeds 250% of the exercise price per share (as adjusted for stock
splits, stock dividends, reorganizations and the like) on each of the ten (10) trading days prior to the date on which we send proper
notice of such redemption, provided that on the date we give notice of redemption and during the entire period thereafter until the time
we redeem the warrants, we have an effective registration statement under the Securities Act covering the shares of common stock issuable
upon exercise of the warrants and a current prospectus relating to them is available. Redemption of the outstanding warrants could (i)
force a warrantholder to exercise his, her or its warrants and pay the exercise price therefore at a time when it may be disadvantageous
for the holder to do so, or (ii)&#160;to accept the redemption price which, at the time the outstanding warrants are called for redemption,
may be substantially less than the market value of its common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Warrants are speculative in nature.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants offered in this offering do not
confer any rights of common stock ownership on their holders, such as voting rights or the right to receive dividends, but rather merely
represent the right to acquire shares of our common stock at a fixed price for a limited period of time. Specifically, commencing on
the date of issuance, holders of the warrants may exercise their right to acquire the common stock and pay an assumed exercise price
of $4.13 per share (110% of the assumed $3.75 public offering price per unit), from time to time, until the fifth anniversary
from the date of issuance, after which date any unexercised warrants will expire and have no further value. In addition, there is no
established trading market for the warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the warrants are executory contracts,
they may have no value in a bankruptcy or reorganization proceeding.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event a bankruptcy or reorganization proceeding
is commenced by or against us, a bankruptcy court may hold that any unexercised warrants are executory contracts that are subject to rejection
by us with the approval of the bankruptcy court. As a result, holders of the warrants may, even if we have sufficient funds, not be entitled
to receive any consideration for their warrants or may receive an amount less than they would be entitled to if they had exercised their
warrants prior to the commencement of any such bankruptcy or reorganization proceeding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of our warrants will have
no rights as a common stockholder until they acquire our common stock.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Until investors acquire shares of our common stock
upon exercise of the warrants being offered in this offering, they will have no rights with respect to our common stock such as voting
rights or the right to receive dividends. Upon exercise of such warrants, holders will be entitled to exercise the rights of a common
stockholder only as to matters for which the record date occurs after the exercise date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Provisions of the warrants offered
by this prospectus could discourage an acquisition of us by a third party.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain provisions of the warrants offered by
this prospectus could make it more difficult or expensive for a third party to acquire us. The warrants prohibit us from engaging in certain
transactions constituting &#8220;fundamental transactions&#8221; unless, among other things, the surviving entity assumes our obligations
under the warrants. These and other provisions of the warrants offered by this prospectus could prevent or deter a third party from acquiring
us even where the acquisition could be beneficial to you.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we do not file and maintain a current
and effective prospectus relating to the common stock issuable upon exercise of the warrants, holders will only be able to exercise such
warrants on a &#8220;cashless basis.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we do not file and maintain a current and effective
registration statement relating to the common stock issuable upon exercise of the warrants at the time that holders wish to exercise such
warrants, they will only be able to exercise them on a &#8220;cashless basis&#8221; provided that an exemption from registration is available.
As a result, the number of shares of common stock that holders will receive upon exercise of the warrants will be fewer than it would
have been had such holder exercised his, her or its warrants for cash. Further, if an exemption from registration is not available, holders
would not be able to exercise on a cashless basis and would only be able to exercise their warrants for cash if a current and effective
registration statement relating to the common stock issuable upon exercise of the warrants is available. Under the terms of the underwriting
agreement, we have agreed to use our best efforts to meet these conditions and to file and maintain a current and effective registration
statement relating to the common stock issuable upon exercise of the warrants until the expiration of the warrants. However, we cannot
assure you that we will be able to do so. If we are unable to do so, the potential &#8220;upside&#8221; of the holder&#8217;s investment
in our Company may be reduced or the warrants may expire worthless.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may amend the terms of the warrants in
a way that may be adverse to holders with the approval by the holders of a majority of the then outstanding warrants.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Agent Agreement provides that the
terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision. All other
modifications or amendments, including any amendment to increase the exercise price of the warrants or shorten the exercise period of
the warrants, shall require the written consent of the registered holders of a majority of the then outstanding warrants which may be
contrary to your interests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants may have an adverse effect
on the market price of our common stock and make it more difficult to effect a business combination.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will be issuing warrants to purchase shares
of common stock as part of this offering. To the extent we issue shares of common stock to effect a future business combination, the potential
for the issuance of a substantial number of additional shares upon exercise of the warrants could make us a less attractive acquisition
vehicle in the eyes of a target business. Such warrants, when exercised, will increase the number of issued and outstanding shares of
common stock and reduce the value of the shares issued to complete the business combination. Accordingly, the warrants may make it more
difficult to effectuate a business combination or increase the cost of acquiring a target business. Additionally, the sale, or even the
possibility of a sale, of the shares of common stock underlying the warrants could have an adverse effect on the market price for our
securities or on our ability to obtain future financing. If and to the extent the warrants are exercised, you may experience dilution
to your holdings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our Warrant Agent Agreement will designate
the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive
forum for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of
warrant holders to obtain a favorable judicial forum for disputes with our Company.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Warrant Agent Agreement will provide that,
subject to applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way to the Warrant Agent Agreement,
including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District
Court for the Southern District of New York, and (ii) that we irrevocably submit to such jurisdiction, which jurisdiction shall be the
exclusive forum for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that such courts
represent an inconvenient forum.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the foregoing, these provisions
of the Warrant Agent Agreement will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other
claim for which the federal district courts of the United States of America are the sole and exclusive forum. Any person or entity purchasing
or otherwise acquiring any interest in any of our warrants shall be deemed to have notice of and to have consented to the forum provisions
in our Warrant Agent Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any action, the subject matter of which is
within the scope of the forum provisions of the Warrant Agent Agreement, is filed in a court other than courts of the State of New York
or the United States District Court for the Southern District of New York (a &#8220;foreign action&#8221;) in the name of any holder of
our warrants, such holder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located
in the State of New York in connection with any action brought in any such court to enforce the forum provisions (an &#8220;enforcement
action&#8221;), and (y) having service of process made upon such warrant holder in any such enforcement action by service upon such warrant
holder&#8217;s counsel in the foreign action as an agent for such warrant holder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This choice-of-forum provision may limit a warrant
holder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with our Company, which may discourage
such lawsuits. Alternatively, if a court were to find this provision of our Warrant Agent Agreement inapplicable or unenforceable with
respect to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such
matters in other jurisdictions, which could materially and adversely affect our business, financial condition and results of operations
and result in a diversion of the time and resources of our management and Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The market price of our securities may be
volatile or may decline regardless of our operating performance, and you may not be able to resell your shares of common stock at or above
the public offering price.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The price of our common stock in this offering
will be determined through negotiations between the underwriters and us and may vary from the market price of our common stock immediately
prior to or following our offering. If you purchase units in our public offering, you may not be able to resell shares of our common
stock at or above the public offering price. We cannot assure you that the public offering price of our common stock, or the market price
following our public offering, will equal or exceed the trading price of our stock on the OTC prior to our public offering. All investments
in securities involve the risk of loss of capital. No guarantee or representation is made that an investor will receive a return of its
capital. The market price of our common stock may fluctuate significantly in response to numerous factors, including development problems,
regulatory issues, technical issues, commercial challenges, competition, legislation, government intervention, industry developments,
trends and general business and economic conditions, many of which are beyond our control, including those risks set forth in this prospectus.
Following this offering, the public price of our common stock in the secondary market will be determined by private buy and sell transaction
orders collected from broker-dealers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If listed, we may not be able to satisfy
the listing requirements of Nasdaq to maintain a listing of our common stock.</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If our common stock is listed on Nasdaq, we must
meet certain financial and liquidity criteria to maintain such listing. If we violate the maintenance requirements for continued listing
of our common stock, our common stock may be delisted. In addition, our Board may determine that the cost of maintaining our listing on
a national securities exchange outweighs the benefits of such listing. A delisting of our common stock from Nasdaq may materially impair
our stockholders&#8217; ability to buy and sell our common stock and could have an adverse effect on the market price of, and the efficiency
of the trading market for, our common stock. In addition, the delisting of our common stock could significantly impair our ability to
raise capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &#8220;emerging growth company&#8221;
under the JOBS Act and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our
common stock less attractive to investors.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &#8220;emerging growth company,&#8221;
as defined in the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are not applicable
to other public companies that are not &#8220;emerging growth companies&#8221; including, but not limited to, not being required to comply
with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive
compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote
on executive compensation and stockholder approval of any golden parachute payments not previously approved. We cannot predict if investors
will find our common stock less attractive because we may rely on these exemptions. If some investors find our securities less attractive
as a result, there may be a less active trading market for our common stock and the price of such security may be more volatile.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, Section 107 of the JOBS Act also
provides that an &#8220;emerging growth company&#8221; can take advantage of the extended transition period provided in Section 7(a)(2)(B)
of the Securities Act for complying with new or revised accounting standards. In other words, an &#8220;emerging growth company&#8221;
can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We are choosing
to take advantage of the extended transition period for complying with new or revised accounting standards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will remain an &#8220;emerging growth company&#8221;
until the last day of the fiscal year following the fifth anniversary of the date of the first sale of our common stock pursuant to an
effective registration statement under the Securities Act, although we will lose that status sooner if our revenues exceed $1.07 billion,
if we issue more than $1 billion in non-convertible debt in a three year period, or if the market value of our common stock that is held
by non-affiliates exceeds $700&#160;million as of the last day of our most recently completed second fiscal quarter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our status as an &#8220;emerging growth
company&#8221; under the JOBS Act may make it more difficult to raise capital as and when we need it.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because of the exemptions from various reporting
requirements provided to us as an &#8220;emerging growth company&#8221; and because we will have an extended transition period for complying
with new or revised financial accounting standards, we may be less attractive to investors, and it may be difficult for us to raise additional
capital as and when we need it. Investors may be unable to compare our business with other companies in our industry if they believe that
our financial accounting is not as transparent as other companies in our industry. If we are unable to raise additional capital as and
when we need it, our financial condition and results of operations may be materially and adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The elimination of personal liability
against our directors and officers under Nevada law and the existence of indemnification rights held by our directors, officers and employees
may result in substantial expenses.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Articles of Incorporation and our
amended and restated bylaws (&#8220;Bylaws&#8221;) eliminate the personal liability of our directors and officers to us and our
stockholders for damages for breach of fiduciary duty as a director or officer to the extent permissible under Nevada law. Further,
our Articles of Incorporation and our Bylaws provide that we are obligated to indemnify each of our directors or officers to the
fullest extent authorized by Nevada law and, subject to certain conditions, advance the expenses incurred by any director or officer
in defending any action, suit or proceeding prior to its final disposition. Those indemnification obligations could expose us to
substantial expenditures to cover the cost of settlement or damage awards against our directors or officers, which we may be unable
to afford. Further, those provisions and resulting costs may discourage us or our stockholders from bringing a lawsuit against any
of our current or former directors or officers for breaches of their fiduciary duties, even if such actions might otherwise benefit
our stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to any charter provision,
by law or otherwise, the registrant has been advised that in the opinion of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;),
such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a
claim for indemnification against such liabilities (other than payment by the registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the Company will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by
it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Existing stockholders may sell significant
quantities of common stock.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The existing stockholders will beneficially own
approximately 75% of our common stock following the successful completion of this offering, approximately 72% if the underwriters&#8217;
exercise their over-allotment option in full. Notwithstanding that certain officers and directors and 5% or more stockholders will
be locked up for a period of 18 months following the completion of this offering, they may have acquired their shares at a lower price
than that of this offering. Accordingly, they may be incentivized to sell all or part of their holdings as soon as any applicable transfer
restrictions have ended and such sales could have a negative impact on the market price of our securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If securities or industry analysts do not
publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The trading market for our common stock
will depend in part on the research and reports that securities or industry analysts publish about us or our business. Several analysts
may cover our stock. If one or more of those analysts downgrade our stock or publish inaccurate or unfavorable research about our business,
our stock price would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us
regularly, demand for our stock could decrease, which might cause our stock price and trading volume to decline.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>In addition to the above risks, businesses
are often subject to risks not foreseen or fully appreciated by management. In reviewing this filing, potential investors should keep
in mind that other possible risks may adversely impact the Company&#8217;s business operations and the value of the Company&#8217;s securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s5"></span>SPECIAL NOTE REGARDING
FORWARD-LOOKING STATEMENTS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus contains
&#8220;forward-looking statements.&#8221; Forward-looking statements reflect the current view about future events. When used in this
prospectus, the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221;
&#8220;future,&#8221; &#8220;intend,&#8221; and &#8220;plan,&#8221; or the negative of these terms and similar expressions, as they
relate to us or our management, identify forward-looking statements. Such statements, include, but are not limited to, statements
contained in this prospectus relating to our business strategy, our future operating results and liquidity and capital resources
outlook. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and
other future conditions. Because forward&#8211;looking statements relate to the future, they are subject to inherent uncertainties,
risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated
by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance.
We caution you therefore against relying on any of these forward-looking statements. Important factors that could cause actual
results to differ materially from those in the forward-looking statements include, without limitation:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to effectively operate our business segments;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to manage our research, development, expansion, growth and operating expenses;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to evaluate and measure our business, prospects and performance metrics;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to compete, directly and indirectly, and succeed in a highly competitive and evolving industry;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to respond and adapt to changes in technology and customer behavior;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to develop, maintain and enhance a strong brand; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>other factors (including the risks contained in the section of this prospectus entitled &#8220;Risk Factors&#8221;) relating to our
industry, our operations and results of operations.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Should one or more of these risks or uncertainties
materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed,
estimated, expected, intended or planned.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Factors or events that could cause our actual
results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results,
levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States,
we do not intend to update any of the forward-looking statements to conform these statements to actual results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s6"></span>USE OF PROCEEDS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We estimate that the net proceeds from the
sale of units will be approximately $7.6 million, or approximately $8.8 million if the underwriters exercise in full the over-allotment
option to purchase additional shares, based on an assumed public offering price of $3.75 per unit (the midpoint of the offering price
per unit), and if the units are sold at the top of the estimated range at $4.00 per unit, net proceeds to us would be approximately $8.1
million, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. This estimate
excludes the proceeds, if any, from the exercise of the warrants in this offering. If all of the warrants sold in this offering were
to be exercised in cash at an assumed exercise price of $4.13 per share (110% of the midpoint of the offering price range per unit),
we would receive additional net proceeds of approximately $19.4 million. We cannot predict when or if the warrants will be exercised.
It is possible that the warrants may expire and may never be exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We intend to use the net proceeds from this offering,
and any proceeds from the exercise of the warrants underlying the units, for the following purposes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Proceeds:</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount:</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 53%; text-align: left">Gross proceeds</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">8,812,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Discounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(705,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Accountable expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(150,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Estimated printing, transfer agent, warrant agent and other expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(375,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">Net Proceeds</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">7,582,500</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold">Uses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Investment and building of RAS tanks</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,500,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Fish farm working capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,500,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Acquisition of fish farm land</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: left">Working capital</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,582,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><b>7,582,500</b></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This offering will allow us to invest and build
a U.S. fish farm. We intend to use a portion of the net proceeds to acquire land in the U.S. suitable for building RASs. To date, we do
not have any letters of intent or binding agreements for any acquisitions. The fish farming capital is the cost of raising fish, including
the fingerlings, fish feeds and labor costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each $0.25 increase (decrease) in the assumed
public offering price of $3.75 per unit would increase (decrease) the net proceeds to us from this offering by $504,500, or approximately
$621,575 if the underwriters exercise their over-allotment option in full, assuming the number of units offered by us, as set forth
on the cover page of this prospectus, remain the same and after deducting estimated underwriting discounts and commissions and estimated
offering expenses payable by us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The use of the proceeds represents management&#8217;s
estimates based on current business and economic conditions. We reserve the right to use the net proceeds we receive in the offering in
any manner we consider to be appropriate. Although we do not contemplate changes in the proposed use of proceeds, to the extent we find
that adjustment is required for other uses because of existing business conditions, the use of proceeds may be adjusted. The actual use
of the proceeds of this offering could differ materially from those outlined above as a result of several factors including those set
forth under &#8220;<i>Risk Factors</i>&#8221; and elsewhere in this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing information is an estimate based
on our current business plan. Pending our use of the net proceeds from this offering, we intend to invest the net proceeds in a variety
of capital preservation investments, including short-term, investment-grade, interest-bearing instruments and U.S. government securities.
We anticipate that the proceeds from this offering will enable us to further grow the business and increase cash flows from operations,
although there can be no assurance that will achieve such growth.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s7"></span>DETERMINATION OF
OFFERING PRICE</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offering price of the units will be negotiated
between the Representatives and us considering our historical performance and capital structure, prevailing market conditions, and overall
assessment of our business. Each unit consists of one share of our common stock and a warrant to purchase two shares of our common
stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s8"></span>MARKET FOR COMMON
EQUITY AND RELATED STOCKHOLDER MATTERS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our common stock is currently quoted on the OTC
pink sheets under the trading symbol &#8220;NCRA.&#8221; Quotations on the OTC reflect inter-dealer prices, without retail mark-up, or
mark-down commission, and may not represent actual transactions. On July 19, 2022, the reported closing price of our common stock
was $4.00 per share ($6.00) as adjusted for the 2-for-3 reverse stock split).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nasdaq Listing Application</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our common stock is currently quoted on the OTC
pink sheets under the symbol &#8220;NCRA.&#8221; In connection with this offering, we have applied to have our common stock listed on
the Nasdaq Capital Market under the symbol &#8220;NCRA,&#8221; which listing is a condition of this offering. If our listing application
is approved, we expect to list our common stock on Nasdaq upon consummation of this offering, at which point our common stock will cease
to be traded on the OTC. There can be no assurance that our listing application will be approved. This offering will occur only if Nasdaq
or another securities exchange approves the listing of our common stock. If Nasdaq or another U.S. securities exchange does not approve
the listing of our common stock, we will not proceed with this offering. We do not intend to apply for listing of the warrants on any
exchange or market. There can be no assurance that our common stock will be listed on the Nasdaq or another securities exchange. For more
information see the section &#8220;<i>Risk Factors</i>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Holders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of July 20, 2022, there were 7,138,100
shares of common stock issued and outstanding and 478 stockholders of record of our common stock. The number of stockholders of record
does not include certain beneficial owners of our common stock whose shares are held in the names of various dealers, clearing agencies,
banks, brokers and other fiduciaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Transfer Agent</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our transfer agent is Mountain Share Transfer,
LLC with offices located at<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #202124; background-color: white"><b>&#160;</b></span><span style="color: #202124; background-color: white">2030
Powers Ferry Rd Suite # 212, Atlanta, GA 30339</span>. Our transfer agent also will serve as the warrant agent for the warrants sold in
this offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s9"></span>DIVIDEND POLICY</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not declared any cash dividends since
inception, and we do not anticipate paying any dividends in the foreseeable future. Instead, we anticipate that all of our earnings will
be used to provide working capital, support our operations, and finance the growth and development of our business. The payment of dividends
is within the discretion of the Board and will depend on our earnings, capital requirements, financial condition, prospects, applicable
Nevada law, which provides that dividends are only payable out of surplus or current net profits, and other factors our Board might deem
relevant. There are no restrictions that currently limit our ability to pay dividends on our common stock other than those generally imposed
by applicable state law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s11"></span>CAPITALIZATION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth our consolidated
cash and capitalization, as of March 31, 2022. Such information is set forth on the following basis:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="width: 92%">on an actual basis; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">on
                                            a pro forma as adjusted basis, giving effect to the sale by us of 2,350,000 units
                                            at an assumed public offering price of $3.75 per unit (the midpoint of the price range
                                            set forth on the cover page of this prospectus, as adjusted for a reverse stock split of
                                            2-for-3), after deducting underwriting discounts and commissions and estimated offering expenses.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should read the <span><i>following
table in conjunction with &#8220;Use of Proceeds,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and
Results of Operations&#8221; and our financial statements and related notes included in this prospectus.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><i>The pro forma
as adjusted information set forth below is illustrative only and will be adjusted based on the actual public offering price and other</i></span>
terms of this offering determined at pricing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Actual</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">(Unaudited)</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Pro Forma</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">(Unaudited)</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Cash</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">1,961,777</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">9,544,277</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Short term liabilities, including deferred revenue due within one year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,974,657</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,974,657</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total liabilities including lease obligations - net of current portion</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,974,657</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,974,657</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify">Stockholders&#8217; equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Common stock, $0.001 par value, 200,000,000 shares authorized, 10,707,150 shares issued and
    outstanding</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10,707</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13,057</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Preferred Stock, $0.001 par value, 10,000,000 authorized, 2,000,000 designated as Series A Preferred
    Stock, 80,000 shares of Series A Preferred Stock issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,078,760</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,658,910</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Retained earnings (deficit)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,724,273</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,724,273</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total stockholders&#8217; equity</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,699,630</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">12,282,130</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After giving effect to the planned reverse stock
split of our common stock at a ratio of 2-for-3, the number of shares of common stock to be outstanding after this offering is based
on (i) shares outstanding as of March 31, 2022 totaling 7,138,100 and (ii) 2,350,000 shares included as part of this offering.
The total shares of common stock outstanding at March 31, 2022 (on a post-split basis) excludes the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 2%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,334 shares of common
    stock issuable upon the conversion of 80,000 shares of Series A Preferred Stock;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,666,667 shares of
    common stock issuable upon the exercise of Series A Warrants for $0.75 per share;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">676,667 shares of common
    stock issuable upon the exercise of outstanding Class A Warrants for $0.75 per share;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">433,334 shares of common
    stock issuable upon the exercise of outstanding Class B Warrants for $1.50 per share;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">626,667 shares of common
    stock issuable upon the exercise of outstanding Class C Warrants for $3.75 per share;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">626,667 shares of common
    stock issuable upon the exercise of outstanding Class D Warrants for $7.50 per share; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">6,666,667 shares of common stock reserved
    for issuance under our 2018 Stock Option and Award Incentive Plan.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise indicated, all information
in this prospectus assumes that:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 2%"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 95%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a public offering price of $3.75
    per unit, which is the midpoint of the range of the offering price per unit, a $4.13 per share exercise price for the
    warrants underlying the units;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">none of the warrants underlying the units in this
    offering have been exercised;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no shares of common stock have been issued pursuant
    to any outstanding shares of preferred stock or warrants;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no shares of common stock or warrants have been
    issued pursuant to the Underwriters&#8217; over-allotment option;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no shares of common stock have been issued pursuant
    to the Representative Warrants; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no awards have been granted under the Company&#8217;s
    2018 Equity Incentive Plan.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may also increase or decrease the number of
shares we are offering. A 500,000 unit increase or decrease in the number of units offered by us would increase or decrease pro forma
as adjusted cash and cash equivalents, additional paid-in capital, total stockholders&#8217; (deficit) equity and total capitalization
by approximately $1.7 million, assuming that the $3.75 assumed initial offering price per unit to the public remains the same,
and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. If the underwriters&#8217;
option to purchase additional units is exercised in full, (i) an additional 352,500 units would be issued and we would receive
approximately $1.2 million in additional net proceeds, based on an assumed initial offering price per unit of $3.75, which is
the midpoint of the price range set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and
commissions and estimated offering expenses payable by us; and (ii) cash and cash equivalents, total stockholders&#8217; equity and total
capitalization would each also increase by approximately $1.2 million.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s12"></span>DILUTION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you invest in our units in this offering, your
interest will be diluted to the extent of the difference between the assumed public offering price per share of common stock that is part
of the unit and the as adjusted net tangible book value per share of common stock immediately after this offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our net tangible book value is the amount of
our total tangible assets less our total liabilities. Our net tangible book value as of March 31, 2022 was $4,367,590, or $0.4079
per share of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pro forma as adjusted net tangible book value
is our net tangible book value after taking into account the effect of the sale of units in this offering at the assumed public offering
price of $3.75 per unit, the midpoint of the offering price range per unit and after deducting the underwriting discounts and
commissions and other estimated offering expenses payable by us. Our pro forma as adjusted net tangible book value as of March 31, 2022
would have been approximately $11.95 million, or $0.9152 per share. This amount represents an immediate increase in as adjusted
net tangible book value of approximately $0.5073 per share to our existing stockholders, and an immediate dilution of $2.8348
per share to new investors participating in this offering. Dilution per share to new investors is determined by subtracting pro forma
as adjusted net tangible book value per share after this offering from the public offering price per share paid by new investors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table illustrates this per share
dilution <sup>(1)</sup>:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%">Assumed public offering price per share</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">3.75</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Historical net tangible book value per share as of March 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.4079</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Increase in as adjusted pro forma net tangible book value per share attributable to the offering</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.5073</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Pro forma net tangible book value (deficit) per share as of March 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.9152</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Pro forma as adjusted net tangible book value per share after giving effect to this offering</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.9152</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Dilution in net tangible book value per share to new investors</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.8348</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does not include:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,334 shares
    of common stock issuable upon the conversion of 80,000 shares of Series A Preferred Stock;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,666,667 shares of
    common stock issuable upon the exercise of Series A Warrants for $0.75 per share;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">676,667 shares of common
    stock issuable upon the exercise of outstanding Class A Warrants for $0.75 per share;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">433,334 shares of common
    stock issuable upon the exercise of outstanding Class B Warrants for $1.50 per share;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">626,667 shares of common
    stock issuable upon the exercise of outstanding Class C Warrants for $3.75 per share;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">626,667 shares of common
    stock issuable upon the exercise of outstanding Class D Warrants for $7.50 per share;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,666,667 shares of
    common stock reserved for issuance under our 2018 Stock Option and Award Incentive Plan;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,000,000 shares of
    common stock issuable upon the exercise of the warrants underlying the units sold in this offering;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">352,500<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    shares of common stock issuable upon the exercise of the Underwriters&#8217; over-allotment option;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">705,000<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    shares of common stock issuable upon the exercise of the warrants underlying the Underwriters&#8217; over-allotment option; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">117,500<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    shares of common stock issuable upon exercise of the Representative Warrants.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A $0.25 increase (decrease) in the assumed
public offering price of $3.75 per unit would increase (decrease) the as adjusted net tangible book value per share by $0.0414, and the
dilution per share to new investors in this offering by $0.2086, assuming the number of units offered by us, as set forth on the
cover page of this prospectus, remains the same and after deducting the underwriting discounts and commissions and estimated offering
expenses payable by us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information above assumes that the underwriters
do not exercise their over-allotment option. If the underwriters exercise the over-allotment option in full, the as adjusted net tangible
book value will increase to $0.9818 per share, representing an immediate increase to existing stockholders of $0.5739 per share and
an immediate dilution of $2.7682 per share to new investors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that outstanding options or warrants
are exercised, you will experience further dilution. In addition, we may choose to raise additional capital due to market conditions or
strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that additional
capital is raised through the sale of equity or convertible debt securities, the issuance of these securities may result in further dilution
to our stockholders.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s13"></span>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><i>You should
read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial
statements and the related notes appearing at the end of this prospectus. Some of the information contained in this discussion and analysis
or set forth elsewhere in this prospectus, including information with respect to our plans and strategy for our business and related financing,
includes forward-looking statements that involve risks, uncertainties and assumptions. You should read the &#8220;Special Note Regarding
Forward-Looking Statements&#8221; and &#8220;Risk Factors&#8221; sections of this prospectus for a discussion of important factors that
could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in
the following discussion and analysis.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Overview</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2019, we provide land-based
recirculation aquaculture systems (&#8220;RASs&#8221;) for fish farming. Our primary business operations consist of the design, development
and production of RASs large scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture
project management services to new and existing aquaculture management business services. Through our branch office, we also procure and
sell eel in Taiwan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2020, the government of Taiwan began
supporting the Green Power and Solar Sharing Fish Farms initiative. In light of the opportunities resulting from this initiative, in October
2020, Nocera ceased all of its operations in China and moved all of its technology and back-office operations to Taiwan. Since then, the
Company has only conducted operations in Taiwan. The Company does not currently have any intentions of conducting operations in China
or Hong Kong.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Our current mission
is to provide consulting services and solutions in aquaculture projects to reduce water pollution and decrease the disease problems of
fisheries. Our goal is to become a global leader in the land-based aquaculture business. The Company is now poised to grow its existing
operations in Taiwan and expand into the development and management of land-based fish farms in Taiwan and North and South America.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective December 31, 2020, Nocera and Xin Feng
Construction Co., Ltd. (&#8220;XFC&#8221;), a funded limited liability company registered in Taiwan (R.O.C.), entered into a series of
contractual agreements (&#8220;XFC VIE Agreements&#8221;), whereby Nocera agreed to provide technical consulting and related services
to XFC. As a result, Nocera has been determined to be the primary beneficiary of XFC and XFC became a variable interest entity of Nocera,
and XFC will shift focus to support the construction activities of RASs fish farms of our clients and the development of the Company-owned
and operated fish farms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2021, we established a Nocera Taiwan Branch
(&#8220;NTB&#8221;) to focus on customers in a variety of sectors, such as individual investors, government supported or funded companies,
and international customers. We have received interest from areas like Japan, Thailand, Jordan, South Africa and the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2021, the Company launched
its first RAS demo site in Taiwan and engaged the demo site into the testing phase to raise eel. Currently, we are promoting our RASs
in Taiwan and looking for opportunities to cooperate with local solar energy industry and to expand our business into the U.S. We believe
the U.S. is a potentially lucrative market to penetrate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company employs a sales and marketing strategy
targeting Taiwan government-supported solar fish farms. The Company is planning on expanding its sales and marketing model through the
use of online marketing, data intelligence, and the establishment of a distributor network. The online marketing and data intelligence
is designed to generate sales leads internationally outside of Taiwan that can be directed to our sales department for further follow-up.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We plan to sell and develop fish farms in Taiwan,
the U.S., and Brazil. We expect to sell over five thousand tanks in the next five years. Our production facility is to be established
in Taiwan, and we plan to sell the systems in the Americas and European countries as well.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also have built a fish farming demo site
in Taiwan and intend to build fish farming demo sites in the United States in 2022 and Brazil in 2023, Japan in 2023 or 2024 and Thailand
in 2023 or 2024, to promote our fish farming systems to the global market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Key Factors Affecting our Performance</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of a number of factors, our historical
results of operations may not be comparable to our results of operations in future periods, and our results of operations may not be
directly comparable from period to period. Set forth below is a brief discussion of the key factors impacting our results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Known Trends and Uncertainties</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">Inflation</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prices of certain commodity products, including
raw materials, are historically volatile and are subject to fluctuations arising from changes in domestic and international supply and
demand, labor costs, competition, market speculation, government regulations, trade restrictions and tariffs. Increasing prices in the
component materials for our goods may impact the availability, the quality and the price of our products, as suppliers search for alternatives
to existing materials and increase the prices they charge. Our suppliers may also fail to provide consistent quality of products as they
may substitute lower cost materials to maintain pricing levels. Nocera&#8217;s cost base also reflects significant elements for freight,
including fuel, which has significantly increased due to the effects of the coronavirus (COVID-19) pandemic and Russia&#8217;s initiation
of military action against Ukraine. Rapid and significant changes in commodity prices such as fuel and plastic may negatively affect our
profit margins if Nocera is unable to mitigate any inflationary increases through various customer pricing actions and cost reduction
initiatives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">Geopolitical Conditions</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Our operations could
be disrupted by geopolitical conditions, trade disputes, international boycotts and sanctions, political and social instability, acts
of war, terrorist activity or other similar events. From time to time, we could have a large revenue stream associated with a particular
customer or a large number of customers located in a particular geographic region. Decreased demand from a discrete event impacting a
specific customer, industry, or region in which we have a concentrated exposure could negatively impact our results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Recently, Russia
initiated significant military action against Ukraine. In response, the U.S. and certain other countries imposed significant sanctions
and export controls against Russia, Belarus and certain individuals and entities connected to Russian or Belarusian political, business,
and financial organizations, and the U.S. and certain other countries could impose further sanctions, trade restrictions, and other retaliatory
actions should the conflict continue or worsen. It is not possible to predict the broader consequences of the conflict, including related
geopolitical tensions, and the measures and retaliatory actions taken by the U.S. and other countries in respect thereof as well as any
counter measures or retaliatory actions by Russia or Belarus in response, including, for example, potential cyberattacks or the disruption
of energy exports, is likely to cause regional instability, geopolitical shifts, and could materially adversely affect global trade,
currency exchange rates, regional economies and the global economy. The situation remains uncertain, and while it is difficult to predict
the impact of any of the foregoing, the conflict and actions taken in response to the conflict could increase our costs, reduce our sales
and earnings, impair our ability to raise additional capital when needed on acceptable terms, if at all, or otherwise adversely affect
our business, financial condition, and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 49 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Effects of the COVID-19 Pandemic</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current outbreak of COVID-19 has globally
resulted in the loss of life, business closures, restrictions on travel, and widespread cancellation of social gatherings. The spread
of COVID-19 has begun to cause some business disruption resulting in reduced net revenue in December 2019. While the disruption is currently
expected to be temporary, there is considerable uncertainty around the duration. Therefore, the Company expects this matter to negatively
impact its operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The extent to which the COVID-19 pandemic impacts
our business will depend on future developments, which are highly uncertain and cannot be predicted at this time, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify; width: 92%">new information which may emerge concerning the severity of the disease; </td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="vertical-align: top; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify">the duration and spread of the outbreak; </td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>

<tr>
    <td style="text-align: justify; width: 5%">&#160;&#160;</td>
    <td style="vertical-align: top; text-align: justify; width: 3%"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify; width: 92%">the severity of travel restrictions imposed by geographic areas in which we operate, mandatory or voluntary business closures; </td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="vertical-align: top; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify">regulatory actions taken in response to the pandemic, which may impact merchant operations, consumer and merchant pricing, and our product offerings; </td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="vertical-align: top; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify">other business disruptions that affect our workforce; </td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="vertical-align: top; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify">the impact on capital and financial markets; and </td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="vertical-align: top; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify">actions taken throughout the world, including in markets in which we operate, to contain the COVID-19 outbreak or treat its impact. </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the current outbreak of COVID-19
has resulted in a widespread global health crisis and adversely affected global economies and financial markets, and similar public health
threats could do so in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Substantially all our revenues were concentrated
in Taiwan pending expansion into other international markets. Consequently, our results of operations will likely be adversely, and may
be materially affected, to the extent that the COVID-19 pandemic or any epidemic harms Taiwan&#8217;s economy and society and the global
economy in general. Any potential impact to our results will depend on, to a large extent, future developments and new information that
may emerge regarding the duration and severity of the COVID-19 pandemic and the actions taken by government authorities and other entities
to contain the COVID-19 pandemic or treat its impact, almost all of which are beyond our control. If the disruptions posed by the COVID-19
pandemic or other matters of global concern continue for an extensive period of time, the operations of our business may be materially
adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent the COVID-19 pandemic or a similar
public health threat has an impact on our business, it is likely to also have the effect of heightening many of the other risks described
in the &#8220;<i>Risk Factors</i>&#8221; section.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 50 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Critical Accounting Policies, Estimates and Assumptions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We prepare our financial statements in conformity
with U.S. GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure
of contingent assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during
the financial reporting period. We continually evaluate these estimates and assumptions based on the most recently available information,
our own historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Since the use
of estimates is an integral component of the financial reporting process, actual results could differ from those estimates. Some of our
accounting policies require higher degrees of judgment than others in their application. We consider the policies discussed below to be
critical to an understanding of our financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC defines critical accounting policies
as those that are, in management&#8217;s view, most important to the portrayal of our financial condition and results of operations and
those that require significant judgments and estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounting principles we utilized in preparing
our consolidated financial statements conform in all material respects to U.S GAAP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reclassification </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior period amounts have been reclassified
to conform with current year presentation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in
conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses
during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the allowance
for doubtful receivables; the useful lives of property and equipment and intangible assets; impairment of long-lived assets; recoverability
of the carrying amount of inventory; fair value of financial instruments; provisional amounts based on reasonable estimates for certain
income tax effects of the Tax Cuts and Jobs Act (the &#8220;Tax Act&#8221;) and the assessment of deferred tax assets or liabilities.
These estimates are often based on complex judgments and assumptions that management believes to be reasonable but are inherently uncertain
and unpredictable. Actual results could differ from these estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b><i></i></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Fair Value Measurement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies ASC Topic 820, Fair Value
Measurements and Disclosures which defines fair value, establishes a framework for measuring fair value and expands financial statement
disclosure requirements for fair value measurements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 820 defines fair value as the price
that would be received from the sale of an asset or paid to transfer a liability (an exit price) on the measurement date in an orderly
transaction between market participants in the principal or most advantageous market for the asset or liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 51 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 820 specifies a hierarchy of valuation
techniques, which is based on whether the inputs into the valuation technique are observable or unobservable. The hierarchy is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt">&#160;</td>
    <td style="width: 24px; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 inputs to the valuation methodology are unobservable and significant to the fair value. Unobservable inputs are valuation technique inputs that reflect the Company&#8217;s own assumptions about the assumptions that market participants would use in pricing an asset or liability.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management of the Company is responsible for
determining the assets acquired, liabilities assumed and intangibles identified as of the acquisition date and considered a number of
factors including valuations from an independent appraiser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When available, the Company uses quoted market
prices to determine the fair value of an asset or liability. If quoted market prices are not available, the Company measures fair value
using valuation techniques that use, when possible, current market-based or independently sourced market parameters, such as interest
rates and currency rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2022 and 2021, there are
no assets or liabilities that are measured and reported at fair value on a recurring basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Cash and Cash Equivalents</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash and cash equivalents include all cash
on hand and cash in bank with no restrictions. The balance of cash as of March 31, 2022 and 2021 were $1,961,777 and $607,452, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Accounts Receivable, Net</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivable are stated at the original
amount less an allowance for doubtful accounts, if any, based on a review of all outstanding amounts at period end. An allowance is also
made when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of
the receivables. The Company analyzes the aging of the customer accounts, coverage of credit insurance, customer concentrations, customer
credit-worthiness, historical and current economic trends and changes in its customer payment patterns when evaluating the adequacy of
the allowance for doubtful accounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Prepaid Expenses and Other Assets, Net</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepaid expense and other assets, net consist
of receivable from a concert, prepaid rent and etc. Management reviews its receivable balance each reporting period to determine if an
allowance for doubtful accounts is required. An allowance for doubtful account is recorded in the period in which loss is determined to
be probable based on an assessment of specific evidence indicating doubtful collection, historical experience, account balance aging,
and prevailing economic conditions. Bad debts are written off against the allowance after all collection efforts have ceased.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 52 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Inventories</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories are stated at lower of cost or
net realizable value. Cost is determined using the weighted average method. Inventories include raw materials, work in progress and finished
goods. The variable production overhead is allocated to each unit of product on the basis of the actual use of the production facilities.
The allocation of fixed production overhead to the costs of conversion is based on the normal capacity of the production facilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where there is evidence that the utility of
inventories, in their disposal in the ordinary course of business, will be less than cost, whether due to physical deterioration, obsolescence,
changes in price levels, or other causes, the inventories are written down to net realizable value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Property and Equipment, Net</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are stated at cost less
accumulated depreciation. Cost represents the purchase price of the asset and other costs incurred to bring the asset into its existing
use. Maintenance, repairs, and betterments, including replacement of minor items, are charged to expense; major additions to physical
properties are capitalized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation of property and equipment is provided
using the straight-line method over their estimated useful lives, which are shown as follows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful life</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 38%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 52%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shorter of the remaining lease terms and estimated useful lives</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixture</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon sale or disposal, the applicable amounts
of asset cost and accumulated depreciation are removed from the accounts and the net amount less proceeds from disposal is charged or
credited to income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Goodwill and Intangible Assets</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize goodwill in accordance with ASC
350,&#160;<i>Intangibles&#8212;Goodwill and Other</i>. Goodwill is the excess of cost of an acquired entity over the amounts assigned
to assets acquired and liabilities assumed in a business combination. Goodwill is not amortized. Goodwill is tested for impairment annually
as of October 1st of each year, and is tested for impairment between annual tests if an event occurs or circumstances change that would
indicate the carrying amount may be impaired. An impairment charge for goodwill is recognized only when the estimated fair value of a
reporting unit, including goodwill, is less than its carrying amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize intangible assets in accordance
with ASC 350,&#160;<i>Intangibles&#8212;Goodwill and Other</i>. Acquired intangible assets subject to amortization are stated at cost
and are amortized using the straight-line method over the estimated useful lives of the assets. Intangible assets that are subject to
amortization are reviewed for potential impairment whenever events or circumstances indicate that carrying amounts may not be recoverable.
Assets not subject to amortization are tested for impairment at least annually.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimates of fair value are based on the
best information available as of the date of the assessment, which primarily incorporates management assumptions about expected future
cash flows. Although these assets are not currently impaired, there can be no assurance that future impairments will not occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 53 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Share-Based Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">We determine
our share-based compensation in accordance with ASC 718,&#160;</span><i>Compensation&#8212;Stock Compensation&#160;</i><span style="background-color: white">(ASC
718), which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees based
on the grant date fair value of the award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Determining the appropriate fair value model
and calculating the fair value of phantom award grants requires the input of subjective assumptions. We use the Black-Scholes pricing
model to value our phantom awards. Share-based compensation expense is calculated using our best estimates, which involve inherent uncertainties
and the application of management&#8217;s judgment. Significant estimates include our expected volatility. If different estimates and
assumptions had been used, our phantom unit valuations could be significantly different and related share-based compensation expense may
be materially impacted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Black-Scholes pricing model requires inputs
such as the risk-free interest rate, expected term, expected volatility and expected dividend yield. We base the risk-free interest rate
that we use in the Black-Scholes pricing model on zero coupon U.S. Treasury instruments with maturities similar to the expected term of
the award being valued. The expected term of phantom awards is estimated from the vesting period of the award and represents the weighted
average period that our phantom awards are expected to be outstanding. We estimated the volatility based on the historic volatility of
our guideline companies, which we feel best represent our Company. We have never paid and do not anticipate paying any cash dividends
in the foreseeable future and, therefore, we use an expected dividend yield of zero in the pricing model. We account for forfeitures as
they occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of management, all adjustments
(which include normal recurring adjustments) necessary to present a fair presentation of the Company&#8217;s condensed consolidated financial
position as of March 31, 2022, its consolidated results of operations for the three months ended March 31, 2022, cash flows for the
three months ended March 31, 2022 and change in equity for the three months ended March 31, 2022, as applicable, have been made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Critical accounting policies are those that
we consider the most critical to understanding our financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Impairment of Long-lived Assets</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews its long-lived assets for
impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no longer be recoverable. When
these events occur, the Company measures impairment by comparing the carrying value of the long-lived assets to the estimated undiscounted
future cash flows expected to result from the use of the assets and their eventual disposition. If the sum of the expected undiscounted
cash flow is less than the carrying amount of the assets, the Company would recognize an impairment loss, which is the excess of carrying
amount over the fair value of the assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Commitments and Contingencies</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the normal course of business, the Company
is subject to contingencies, including legal proceedings and claims arising out of its business that relate to a wide range of matters,
such as government investigations and tax matters. The Company recognizes a liability for such contingency if it determines it is probable
that a loss has occurred and a reasonable estimate of the loss can be made. The Company may consider many factors in making these assessments
including historical and the specific facts and circumstances of each matter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 54 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Revenue Recognition</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has early adopted ASU 2014-09,
Revenue from Contracts with Customers (Topic 606) and all subsequent ASUs that modified ASC 606 on January 1, 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The core principle of the guidance is that
an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, the Company applies
the following steps:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%; padding-left: 0.25in"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="padding-left: 13.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 1: Identify the contract(s) with a customer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%; padding-left: 0.25in"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="padding-left: 13.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 2: Identify the performance obligations in the contract</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%; padding-left: 0.25in"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="padding-left: 13.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 3: Determine the transaction price</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%; padding-left: 0.25in"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="padding-left: 13.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 4: Allocate the transaction price to the performance obligation in the contract</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%; padding-left: 0.25in"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="padding-left: 13.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considered revenue is recognized
when (or as) the Company satisfies performance obligations by transferring a promised goods and provide maintenance service to a customer.
Revenue is measured at the transaction price which is based on the amount of consideration that the Company expects to receive in exchange
for transferring the promised goods and providing maintenance service to the customer. Contracts with customers are comprised of invoices,
and written contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have arrangements for
returns from customers and does not have any future obligations directly or indirectly related to services resale by customers. The Company
has no sales incentive programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company provides goods, maintenance service
warranties for the goods sold with a period varying from 18 months to 72 months, with the majority of the periods being 18 months, and
exclusive sales agency license to its customers. For performance obligation related to providing products, the Company expects to recognize
the revenue according to the delivery of products. For performance obligation related to maintenance service warranties, the Company expects
to recognize the revenue on a ratable basis using a time-based output method. The performance obligations are typically satisfied as services
are rendered on a straight-line basis over the contract term, which is generally for 18 months as a majority of the maintenance service
warranties periods provided are 18 months. For performance obligation related to exclusive agency license, the Company recognizes the
revenue ratably upon the satisfaction over the estimated economic life of the license.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have amounts of contract
assets since revenue is recognized as control of goods is transferred. The contract liabilities consist of advance payments from customers
and deferred revenue. Advance payments from customers are expected to be recognized as revenue within 12 months. Deferred revenue is expected
to be recognized as revenue within 12 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Cost of Sales</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of sales consists primarily of material costs,
labor costs, depreciation, and related expenses, which are directly attributable to the production of the product. Write-down of inventories
to lower the of cost or net realizable value is also recorded in cost of sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 55 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Income Taxes</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes deferred tax assets
and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.
Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases
of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates,
applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary,
to reduce deferred tax assets to the amount expected to be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Leases</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU 2016-12,
Leases (ASC Topic 842), which amends the lease requirements in ASC Topic 840, Leases. Under the new lease accounting standard, a lessee
will be required to recognize a right-of-use asset and lease liability for most leases on the balance sheet. The new standard also modifies
the classification criteria and accounting for sales-type and direct financing leases, and enhances the disclosure requirements. Leases
will continue to be classified as either finance or operating leases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company adopted ASC Topic 842 using the modified
retrospective transition method effective January 1, 2019. There was no cumulative effect of initially applying ASC Topic 842 that required
an adjustment to the opening retained earnings on the adoption date nor revision of the balances in comparative periods. As a result of
the adoption, The Company recognized a lease liability and right-of-use asset for each of our existing lease arrangements. The adoption
of the new lease standard does not have a material impact on our consolidated income statement or our consolidated statement of cash flow.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Uncertain Tax Positions</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for uncertainty in income
taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position
for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be
sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit
as the largest amount that is more than 50% likely of being realized upon settlement. Interest and penalties related to uncertain tax
positions are recognized and recorded as necessary in the provision for income taxes. According to the PRC Tax Administration and Collection
Law, the statute of limitations is three years if the underpayment of taxes is due to computational errors made by the taxpayer or the
withholding agent. The statute of limitations is extended to five years under special circumstances, where the underpayment of taxes
is more than RMB 100,000. In the case of transfer pricing issues, the statute of limitation is ten years. There is no statute of limitation
in the case of tax evasion. The Company records interest and penalties on uncertain tax provisions as income tax expense. There are no
uncertain tax positions as of March 31, 2022 and 2021, and the Company has no accrued interest or penalties related to uncertain
tax positions. The Company does not believe that the unrecognized tax benefits will change over the next twelve months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Comprehensive (Loss) Income</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Comprehensive income or loss is comprised of
the Company&#8217;s net (loss) income and other comprehensive income or loss. The component of other comprehensive income or loss consists
solely of foreign currency translation adjustments, net of the income tax effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 56 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Foreign Currency Translation and Transactions</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s reporting currency is the
United States dollar (&#8220;US$&#8221;). The functional currency of our VIE in Taiwan is NT, and the functional currency of our Hong
Kong subsidiary is Hong Kong dollars (&#8220;HK$&#8221;). The functional currency of PRC companies is the Renminbi (&#8220;RMB&#8221;).
In the consolidated financial statements, the financial information of the Company&#8217;s subsidiary and the consolidated VIE has been
translated into US$. Assets and liabilities are translated at the exchange rates on the balance sheet date, equity amounts are translated
at historical exchange rates, except for changes in accumulated deficit during the year which is the result of income statement translation
process, and revenue, expense, gains or losses are translated using the average exchange rate during the year. Translation adjustments
are reported as foreign currency translation adjustments and are shown as a separate component of other comprehensive income or loss
in the consolidated statements of changes in equity and comprehensive (loss) income. The exchange rates as of March 31, 2022 and 2021
are 6.3462 and 6.5528, respectively. The annual average exchange rates for the year ended December 31, 2021 and 2020 are 6.3539 and 6.9001,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>(Loss) Earnings per Share</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic (loss) earnings per share is computed
by dividing net (loss) income attributable to holders of common stock by the weighted average number of common shares outstanding during
the year. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common
shares were exercised or converted into common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Recently Issued Accounting Standards</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See Note 3 to the Consolidated Financial Statements
included herewith.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Results of Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the consolidated
statements of operations of the Company for the three months ended March 31, 2022 and 2021 and the years ended December 31, 2021
and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 57 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Consolidated Statements of Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended March 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; text-align: left">Net sales</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">2,919,045</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">1,579,486</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Cost of sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,863,803</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,230,842</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Gross profit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">55,242</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">348,644</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">General and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(860,953</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(235,235</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(860,953</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(235,235</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">(Loss) Income from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(805,711</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">113,409</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,759</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">(Loss) Income before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(805,711</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111,650</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(62,160</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Net (loss) income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(805,720</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,490</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Net loss attributable to non-controlling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net (loss) income attributable to the company</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(805,720</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">49,490</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Comprehensive Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net (loss) income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(805,720</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,490</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Foreign currency translation (loss) gain</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(129,231</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,669</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Total comprehensive (loss) income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(934,951</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,159</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: comprehensive loss attributable to non-controlling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Comprehensive (loss) income attributable to the Company</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(934,951</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">51,159</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold">(Loss) Income per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0755</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0054</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0755</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0036</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold">Weighted average number of common shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,677,150</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,131,786</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,677,150</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,821,506</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 58 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Comparison of Results of Operations for the three months ended
March 31, 2022 and March 31, 2021</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Revenue</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue for the three months ended March 31,
2022 was $2,919,045 compared to $1,579,486 for the comparable period in 2021. The increase was mainly because of the revenue recognition
of the fish trading business from NTB for the three months ended March 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Gross profit</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gross profit for the three months ended March
31, 2022 was $55,242, compared to $348,644 for the comparable period in 2021. The decrease was primarily because there was a significant
increase in the cost of sales from NTB&#8217;s fish trading business for the three months ended March 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General and administrative expenses</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">General and administrative expenses were $860,953,
for the three months ended March 31, 2022, compared to approximately $235,235 for the comparable period in 2021. This increase was primarily
due to the increase of legal, accounting, and consulting fees for the three months ended March 31, 2022 in connection with securities
filings and other related matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Other income (expense)</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other expenses were $nil, for the three months
ended March 31, 2022, compared to $1,759 for the comparable period in 2021. The decrease was mainly the effect of interest expense recognized
for the three months ended March 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Net income attributable to the Company</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net loss attributable to the Company (excluding
net loss attributable to non-controlling interest) for the three months ended March 31, 2022 was $805,720 compared to net income attributable
to the Company (excluding net loss attributable to non-controlling interest) of $49,490 for the comparable period in 2021. The decrease
in income was because the Company recognized the expense from the issuance of 100,000 common shares as consideration for legal services
rendered.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 59 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 9%; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 91%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years ended December 31,</b></span></td></tr>
  </table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2020</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: left">Net Sales</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">9,945,325</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,170,156</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Cost of sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9,000,733</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(526,343</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Gross profit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">944,592</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">643,813</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">General and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,419,684</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,325,696</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,419,684</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,325,696</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Loss from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,475,092</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(681,883</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Other income (expense)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,055</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,479,147</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(681,847</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Income tax (expense) benefit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(139,932</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">42,777</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,619,079</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(639,070</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Less: Net loss attributable to non-controlling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6,705</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss attributable to the Company</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(9,619,079</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(632,365</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Comprehensive (loss) income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,619,079</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(639,070</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Foreign currency translation income (loss)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">63,248</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">31,081</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Total comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,555,831</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(607,989</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Less: Net loss attributable to non-controlling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,705</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Less: Foreign currency translation loss attributable to non-controlling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(499</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Comprehensive loss attributable to the Company</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(9,555,831</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(600,785</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-indent: 10pt">Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.0500</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0538</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-indent: 10pt">Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.0500</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0538</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Weighted average number of common shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-indent: 10pt">Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,160,862</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,752,447</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-indent: 10pt">Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,160,862</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,752,447</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 60 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Comparison of Results of Operations for the years ended December
31, 2021 and December 31, 2020</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Revenue</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue for the year ended December 31, 2021 was
approximately $9.9 million compared to approximately $1.2 million for the comparable period in 2020. The revenue for the year ended December
31, 2021 was mainly generated from inventory sales and XFC delivery of construction services to its customers. The revenue for the year
ended December 31, 2020 was driven by the deferred revenue recognition of the exclusive sales agency license revenue from JCD of selling
our fish farming containers in the Asia Pacific. As of December 31, 2021, the Company and JCD mutually agreed to the termination of the
Regional Agency Cooperation Agreement as of September 2019, as amended by the Regional Agency Cooperation Supplementary Agreement dated
as of May 31, 2020, by and between Grand Smooth Inc Ltd and JCD (the &#8220;Cooperation Agreement&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Gross profit</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gross profit for the year ended December 31, 2021
was approximately $0.9 million, compared to approximately $0.6 million for the comparable period in 2020. This increase in gross profit
margin was mainly because in 2021 we recognized the revenue generated from the delivery of construction services of XFC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General and administrative expenses</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">General and administrative expenses were $10.4
million, for the year ended December 31, 2021, compared to $1.3 million for the comparable period in 2020. This increase in general and
administrative expenses was mainly because, in 2021, we recognized significant share based compensation expenses to employees and consultants
for professional services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Other income (expense)</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Other expenses were $(4,055)
for the year ended December 31, 2021, compared to other income of $36 for the comparable period in 2020. The expenses for the year ended
December 31, 2021 were mainly due to interest expense.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2021, we recorded
an income tax expense of $135,444 as compared to income tax benefit of $42,777 for the comparable period in 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Net loss attributable to the Company</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net loss attributable to the Company (excluding
net loss attributable to non-controlling interest) for the year ended December 31, 2021 was approximately $9.6 million compared to net
loss attributable to the Company (excluding net income attributable to non-controlling interest) approximately of $0.6 million for the
comparable period in 2020. The significant decrease was mainly because in 2021 we recognized significant share based compensation expenses
to employees and consultants for professional services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Liquidity and Capital Resources</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had net cash provided by operating
activities for the three months ended March 31, 2022 and the cash balance was $1,961,777 as of March 31, 2022. The Company believes
its current cash balances coupled with anticipated cash flow from operating activities will be sufficient to meet its working capital
requirements for at least one year from the date of issuance of the accompanying consolidated financial statements. The Company continues
to control its cash expenses as a percentage of expected revenue on an annual basis and thus may use its cash balances in the short-term
to invest in revenue growth. Based on current internal projections, the Company believes it has and/or will generate sufficient cash
for its operational needs, for at least one year from the date of issuance of the accompanying consolidated financial statements. The
Company&#8217;s plans for its cash within the twelve months from March 31, 2022 and beyond are to (i) purchase a piece of land in the
United States and (ii) build our first land-based recirculating aquaculture fish farm. Management is also focused on growing the
Company&#8217;s existing product offering, as well as its customer base, to increase its revenues. The Company cannot give assurance
that it can increase its cash balances or limit its cash consumption and thus maintain sufficient cash balances for its planned operations
or future acquisitions. Future business demands may lead to cash utilization at levels greater than recently experienced. The Company
may need to raise additional capital in the future. However, the Company cannot assure that it will be able to raise additional capital
on acceptable terms, or at all. Subject to the foregoing, management believes that the Company has sufficient capital and liquidity to
fund its operations for at least one year from the date of issuance of the accompanying consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To date, we have funded our operations through
revenues, loans from our officers, and the issuance of equity securities. The Company obtained a financial support letter dated as
of May 7, 2020 from Mr. Yin-Chieh Cheng, the Chief Executive Officer, also the Chairman of the Board and a principal stockholder of the
Company. As of March 31, 2022, the Company owes Mr. Cheng a total of $7,653 as a reimbursement for amounts paid by Mr. Cheng on behalf
of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td style="width: 94%; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
    April 1, 2021, the Company entered in a securities purchase agreement with certain investors for an aggregate of 80,000 shares of
    its preferred stock at a per share purchase price of $2.50. As part of the transaction, the investors received one Class C Warrant
    and one Class D Warrant for the subscription of each preferred share. <span style="background-color: white">Each Class C Warrant consists
of the right to purchase one share of common stock at an exercise price of $3.75 per share exercisable for 36 months from the date of
issuance. </span> Each
    Class D Warrants consist of the right to purchase one share of the Company&#8217;s common stock at an exercise price of $7.50
    per share exercisable for 36 months from the date of issuance. The subscription was completed on August 10, 2021</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td style="width: 94%; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    August 2021, the Company issued 80,000 shares of preferred shares of $0.001 each at an issue price of $2.50 per share to certain
    investors credited as fully paid.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td style="width: 94%; padding-left: 3.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
    September 27, 2021, the Company entered into securities purchase agreements with investors, pursuant to which the Company issued
    in a registered direct offering, an aggregate of 32,000 shares of common stock of the Company at a per share purchase price of
    $3.75. In addition, the investors also received one Class C Warrant and one Class D Warrant for the subscription of each preferred
    share. On December 31, 2021, the Company consummated a private offering of 278,667 units at a purchase price of $7.50 per unit to
    28 investors for gross proceeds of $2,090,000. Each unit consisted of one share of the Company&#8217;s common stock and an &#8220;equity
    kicker&#8221; of one share of the Company&#8217;s common stock, for a total of 557,334 shares of common stock.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the net asset balance as of March 31,
2022 was $4,699,630, there is no substantial doubt as to the Company&#8217;s ability to continue as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table provides detailed information about our net
cash flows for the periods indicated:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For
                                            the quarters ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March
                                            31,</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left">Net cash used in operating activities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">(553,367</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">(258,573</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net cash used in financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,353</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(144,233</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Effect of the exchange rate change on cash</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">74,488</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10,727</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Decrease in cash</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(482,232</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(416,077</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Three Months Ended March 31, 2022 and 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Net cash used in operating activities</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash used in operating activities amounted
to $553,367 for the three months ended March 31, 2022. This reflected the effect of changes in operating assets and liabilities including
decreases in accounts receivable in the amount of $181,547 and an increase in accounts due from a related party of $458,145.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash used in operating activities amounted
to $258,573 for the three months ended March 31, 2021. This reflected the effect of changes in operating assets and liabilities including
decreases in accounts receivable in the amount of $303,302.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Net cash used by financing activities</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash used by financing activities amounted
to $3,353 for the three months ended March 31, 2022, which was repayment of bank loans and issuance of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash used by financing activities amounted
to $144,233 for the three months ended March 31, 2021, which was the repayment of bank loans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since we plan to build our land-based fish farming
demo sites in the US, Taiwan, Brazil, Japan, and Thailand to promote our fish farming systems to the global market, we expect that we
will require additional capital, which includes construction costs, marketing costs, operation costs, etc., to meet our long-term operating
requirements. We expect to obtain financing from stockholders or raise additional capital through, among other things, the sale of equity
or debt securities. The stockholders are committed to providing additional financing required when we try to raise additional capital
from third party investors or banks. However, there can be no assurance that we will be successful in raising this additional capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    <b>For the years ended</b></p>
					    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
					    <b>December 31,</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2020</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: left">Net cash provided by (used in) provided by operating activities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">251,729</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(129,824</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net cash (used in) provided by investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(25,067</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">770,943</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net cash (used in) provided by financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,203,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">217,479</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Effect of the exchange rate change on cash and cash equivalents</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,017</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">136,394</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Increase in cash and cash equivalents</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,430,495</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">994,992</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 63 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Fiscal Year Ended December 31, 2021 and 2020</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Net cash provided by (used in) operating activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash provided by operating activities amounted
to $251,729 for the year ended December 31, 2021. This reflected a net loss of $9,619,079, as adjusted for non-cash items primarily including
share-based compensation of $6,638,371, consultancy services settled by equities of $3,045,150 and offset by the effect of changes in
working capital including decreases of accounts receivable in the amount of $252,338.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash used in operating activities amounted
to $129,824 for the year ended December 31, 2020. This reflected a net loss of $639,070, as adjusted for non-cash items primarily including
impairment of GZ WFH of $522,291, depreciation of $74,958 and share-based compensation of $265,758, and offset by the effect of changes
in working capital including an increase of $ 268,285 of inventories.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Net cash (used in) provided by financing activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash provided by financing activities amounted
to $1,203,833 for the year ended December 31, 2021, which were primarily arising from proceeds from the issuances of shares of common
stock and preferred stock during the year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash used in financing activities amounted
to $486,271 for the year ended December 31, 2021, which was repayment of bank loans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash provided by financing activities
amounted to $217,479 for the year ended December 31, 2020, which was attributable to the proceeds from our stockholders primarily for
our daily operation. See &#8220;Note 14 to the consolidated financial statements included herewith.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Business Combinations</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We account for business acquisitions in accordance
with ASC 805,&#160;<i>Business Combinations</i>. We measure the cost of an acquisition as the aggregate of the acquisition date fair
values of the assets transferred and liabilities assumed and equity instruments issued. Transaction costs directly attributable to the
acquisition are expensed as incurred. We record goodwill for the excess of (i)&#160;the total costs of acquisition, fair value of any&#160;non-controlling&#160;interests
and acquisition date fair value of any previously held equity interest in the acquired business over (ii)&#160;the fair value of the identifiable
net assets of the acquired business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The acquisition method of accounting requires
us to exercise judgment and make estimates and assumptions based on available information regarding the fair values of the elements of
a business combination as of the date of acquisition, including the fair values of identifiable intangible assets, deferred tax asset
valuation allowances, liabilities related to uncertain tax positions and contingencies. We must also refine these estimates over a&#160;one-year&#160;measurement
period, to reflect any new information obtained about facts and circumstances that existed as of the acquisition date that, if known,
would have affected the measurement of the amounts recognized as of that date. If we are required to retroactively adjust provisional
amounts that we have recorded for the fair value of assets and liabilities in connection with an acquisition, these adjustments could
materially impact our results of operations and financial position. Estimates and assumptions that we must make in estimating the fair
value of future acquired technology, user lists and other identifiable intangible assets include future cash flows that we expect to generate
from the acquired assets. If the subsequent actual results and updated projections of the underlying business activity change compared
with the assumptions and projections used to develop these values, we could record impairment charges. In addition, we have estimated
the economic lives of certain acquired assets and these lives are used to calculate depreciation and amortization expense. If our estimates
of the economic lives change, depreciation or amortization expenses could be accelerated or slowed, which could materially impact our
results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Off-Balance Sheet Arrangements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have no off-balance sheet arrangements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recently Issued Accounting Pronouncements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please refer to the Note 3 to the Consolidated
Financial Statements included herewith.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s14"></span>BUSINESS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Overview</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera is a United States public company headquartered
in Taiwan engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture
facilities and consulting for third party operators of aquaculture facilities. We provide Land-Based Recirculation Aquaculture Systems
(&#8220;RASs&#8221;) for fish farming. Our primary business operations consist of the design, development and production of RAS large
scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services
to new and existing aquaculture management business services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Corporate Structure</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conduct our operations through (i) Xin Feng
Construction Co., Ltd, a Taiwan limited liability company (&#8220;XFC&#8221;); and (ii) Nocera Taiwan Branch, an unincorporated division
of the Company (&#8220;NTB&#8221;). The Company&#8217;s other subsidiaries, Grand Smooth Inc. Limited, a Hong Kong limited company (&#8220;GSI&#8221;),
which wholly-owns Guizhou Grand Smooth Technology Ltd., a People&#8217;s Republic of China (PRC) corporation (&#8220;GZ GST&#8221;),
are dormant and do not have any operations. The Company intends to keep such entities dormant and not conduct any operations in the
PRC or Hong Kong.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We acquired GSI, a limited company established
under the laws and regulations of Hong Kong on August 1, 2014, in a reverse merger on December 31, 2018. Prior to the merger, we were
a &#8220;shell company&#8221; as defined under Rule 12b-2 of the Exchange Act. GSI is the parent holding company of GZ GST, which was
incorporated on November 13, 2018, as a wholly foreign-owned enterprise established in the PRC. Both GSI and GZ GZT are currently dormant
and do not conduct any operations. The Company currently does not conduct any operations in China or Hong Kong. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2020, Nocera added Xin-Feng Construction
Co. Ltd, a variable interest entity (&#8220;VIE&#8221;). Under the laws of Taiwan, foreign investments are typically restricted or prohibited
with respect to the operation of certain businesses in Taiwan (e.g., construction). As a result, it was necessary for us to add XFC as
a VIE in order to obtain a Class A construction license to construct indoor RASs and solar sharing fish farms. XFC has obtained a Class
A construction license in Taiwan and we plan to use XFC for the investment in, and the construction of, indoor RASs and solar sharing
fish farms. The Company is now looking for opportunities to expand into the U.S. by building fish farms or transforming existing ones
into high-tech and solar sharing enterprises.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NTB was established on January 14, 2021 in Taiwan.
In October 2021, Nocera began its eel trading business in response to domestic demands created by the COVID-19 lockdown. NTB currently
procures and sells eel in Taiwan and plans to trade other types of seafood, such as tilapia and milkfish, in the near future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Corporate History</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera, Inc. was incorporated in the State of
Nevada on February 1, 2002, and is based in New Taipei City, Taiwan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Reverse Merger</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective December 31, 2018, Nocera completed
a reverse merger transaction pursuant to an Agreement and Plan of Merger with (i) GSI, (ii) GSI&#8217;s stockholders, Yin-Chieh (Jeff)
Cheng and Zhang Bi, who together owned shares constituting 100% of the issued and outstanding ordinary shares of GSI (the &#8220;GSI
Shares&#8221;) and (iii) GSI Acquisition Corp. Under the terms of the Agreement, the GSI Stockholders transferred to Nocera all of the
GSI Shares in exchange for the issuance of 6,666,667 shares of Nocera&#8217;s common stock. As a result of the reverse merger,
GSI became Nocera&#8217;s wholly-owned subsidiary and Mr. Cheng and Zhang Bi, the former stockholders of GSI, became Nocera&#8217;s controlling
stockholders. The share exchange transaction with GSI was treated as a reverse merger, with GSI as the accounting acquirer and Nocera
as the acquired party. GSI is a limited company established under the laws and regulations of Hong Kong on August 1, 2014 and is a holding
company without any assets or operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 66 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In anticipation of the reverse merger, GSI undertook
a reorganization and became the 100% holding company of Guizhou Grand Smooth Technology Ltd (&#8220;GZ GST&#8221;) and GSI Guizhou
Wan Feng Hu Intelligent Aquatic Technology Co. Limited (&#8220;GZ WFH&#8221;), which were all controlled by the same stockholders before
and after the reorganization, pursuant to a series of contractual agreements (the &#8220;GZ WFH VIE Agreements&#8221;). As a result,
GSI, through GZ GST, was determined to be the primary beneficiary of GZ WFH and GZ WFH became a variable interest entity of GSI. Accordingly,
GSI consolidated GZ WFH&#8217;s operations, assets and liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GZ WFH was incorporated in Xingyi City, Guizhou
Province, People&#8217;s Republic of China (&#8220;PRC&#8221;) on October 25, 2017, and was engaged in providing fish farming containers
service, which integrated sales, installments, and maintenance of aquaculture equipment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Divestiture of GZ WFH </span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 21, 2020, Nocera terminated its relationship
with GZ WFH and its management, and the GZ WFH Agreements between the parties were terminated as well.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequently, on October 8, 2020, Zhang Bi and
GZ WFH entered into a Settlement Agreement and Release with the Company wherein all claims as to GZ WFH&#8217;s debt (claim to shares
in Nocera or GZ GST) were compromised, settled, and otherwise resolved as to any and all claims or causes of action whatsoever against
Nocera for any matter, action, or representation as to Nocera, and any debt to ownership of Nocera or GZ GST up to the date of the settlement
agreement. The consideration for the settlement agreement was the mutual waiver of any and all claims against each other and GZ GST, and
GZ WFH (including Zhang Bi) waived any claims to Nocera stock, and the 3,166,667 shares of common stock of Nocera owned by Zhang Bi were
canceled.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">The VIE Agreements with XFC</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2020, Nocera exchanged 466,667
shares of the Company&#8217;s restricted common stock to stockholders of XFC in exchange for 100% controlling interest in XFC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2020, Nocera and XFC, a domestic
funded limited liability company registered in Taiwan (R.O.C.), entered into a series of contractual agreements whereby Nocera agreed
to provide technical consulting and related services to XFC. As a result, Nocera has been determined to be the primary beneficiary of
XFC, and XFC became a VIE of Nocera.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The VIE structure was adopted mainly because we
engage in business in an industry that prohibits foreign investment (e.g., construction) and which requires special licenses in Taiwan.
We are not currently planning to engage in business in mainland China or Hong Kong, and as a result, we are not currently required to
obtain any special licenses in mainland China or Hong Kong. Nocera has entered into the following contractual arrangements with a stockholder
of XFC, that enable the Company to (1) have the power to direct the activities that most significantly affect the economic performance
of XFC, and (2) receive the economic benefits of XFC that could be significant to XFC. The Company is fully and exclusively responsible
for the management of XFC, assumes all of the risks of losses of XFC and has the exclusive right to exercise all voting rights of XFC&#8217;s
stockholders. Therefore, in accordance with ASC 810 &#8220;Consolidation,&#8221; the Company is considered the primary beneficiary of
XFC and has consolidated XFC&#8217;s assets, liabilities, results of operations, and cash flows in the accompanying consolidated financial
statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">XFC will
shift focus to support the construction activities of RAS fish farms of our clients and the development of the Company-owned and operated
fish farms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><i><span style="text-decoration: underline">Reverse
Stock Split</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July [&#8226;], 2022, we effected a 2-for-3
reverse stock split of our outstanding common stock. All share amounts and dollar amounts have been adjusted for the reverse stock split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 67 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Significant Products &amp; Services</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company manufactures, sells, and installs
RASs for land-based fish farms. Originally, our systems were designed and constructed from used marine shipping containers. The Company
then developed its next generation of RASs, a cylindrical shaped tank that holds approximately 15,000 U.S. gallons of water, which the
Company believes makes them among the largest systems in the market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are several significant benefits to our
RASs:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the system provides a controlled and &#8220;traceable&#8221; environment;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the recirculating aquaculture system can be installed almost anywhere and requires minimal site preparation;
and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">it benefits local economies by providing fresher and, therefore, generally healthier fish.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera&#8217;s RASs include the fish tank, circulation
and filtration systems.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
  <tr style="vertical-align: top; background-color: #002060">
    <td colspan="2" style="border: #BFBFBF 1pt solid; text-align: justify"><span style="color: white"><b>Nocera Land-based RASs Overview </b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; text-align: justify; width: 35%">Height / width</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; text-align: justify; width: 25%">1.5m/10m</td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; text-align: justify">Main composition of our tank</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; text-align: justify">Environmental-friendly PE</td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; text-align: justify">Yield per growing season (Tilapia)</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; text-align: justify">11,000 lbs.</td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; text-align: justify">Fish farming density</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; text-align: justify">100-109 lb./m3</td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; text-align: justify">Price per RASs Total Solution </td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; text-align: justify">$35,000 USD</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s RASs can raise both freshwater
and saltwater fish, as well as a variety of crustaceans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Nocera Recirculating Aquaculture System </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="image_013.jpg" alt="" style="height: 168pt; width: 316.5pt" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 68 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also provides consulting services
to aquaculture projects, where we offer design innovation and RAS expertise to increase revenue, while decreasing operating expenses,
allowing clients to operate more efficiently while increasing production. Additionally, we show clients how to operate more strategically
by diversifying the species of fish raised to meet market demands. Our equipment enhances the management of fish farms by reducing the
incidence of disease among the fish populations while reducing water pollution from inland fish farms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Market Potential</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Global fish consumption has long been on the rise
at a rate higher than any other source of animal protein, and the trend is expected to continue. With overfishing already threatening
the earth&#8217;s marine ecosystem, it is anticipated that a significantly larger proportion of fish consumption would be farm-raised
instead of wild-caught in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The trade conflict between the U.S. and China
has led to a greater demand for non-Chinese originated seafood products from the U.S. and other markets. The global supply chain disruption
caused by COVID-19 also has made shipping costs and shipping arrangements highly unstable and unpredictable, which further contributes
to a greater demand for domestically produced seafood products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On a broader perspective, as the world begins
a transition towards net zero in response to the ever-more pressing threat of climate change, it is reasonably foreseeable that solar
energy will be the go-to option for many countries as a new and principal source of green energy. In 2020, the Taiwanese government instituted
a green power policy that requires all solar companies using farmland or fish farmland to have actual operating fish farms as a prerequisite
for a solar license grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RASs, with their advantage in producing more fish
in a more cost-effective and environmentally friendly manner, while offering greater location flexibility and the potential for a &#8220;solar-fish
sharing mode&#8221; is the perfect solution to the issues highlighted above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Market Analysis</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to the Food and Agriculture Organization&#8217;s
(FAO) latest report &#8220;The State of World Fisheries and Aquaculture 2020,&#8221; also referred to as &#8220;SOFIA 2020,&#8221; per
capita food fish consumption grew from 9 kilograms (live weight equivalent) in 1961 to 20.5 kilograms in 2018, equating to around 1.5%
growth each year. At the same time, since 1961, the average annual rise in global food fish consumption of 3.1 percent has outpaced the
population growth of 1.6% and exceeded the consumption escalation of all other animal protein foods (like beef, poultry, and milk), which
increased by 2.1 % per year (Food and Agriculture Organization of the United Nations, 2020, p. 2-3).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 69 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Over the past three decades, fish production from
aquaculture has grown by over 450%, significantly contributing to the increase in the global fish production, as shown in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;<img src="image_023.jpg" alt="" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2018, 52% of the fish consumed as food globally
were produced by the aquaculture sector, and the FAO estimated that the percentage will grow to 59% by 2030.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 70 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fast growth in the species of fish produced
through aquaculture is expected to be tilapia, carp, and pangasius/catfish. Currently, tilapia accounts for approximately 7% of all fish
raised in fish farms. Carp currently accounts for 20% of all fish raised in fish farms and is expected to rise to 21%. Pangasius/catfish
is expected to remain consistent at 5%. Other species expected to maintain a high share of production through aquaculture methods are
shrimp at 9%, and mollusks at 24%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Projected Species <span style="color: #404040">Shares</span>
in Aquaculture Production</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="border: #BFBFBF 1pt solid"><img src="image_015.jpg" alt="" style="height: 450px; width: 350px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Market Demand</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The escalation of trade tension in the US-China
trade war has caused the global fish market to become slightly uncertain. The higher trading volume of fish, such as tilapia and lobster,
was added to the tariff list in both China and the United States. However, not only these two regions were affected; trade volume has
decreased around the world since 2019. Undoubtedly, the COVID-19 pandemic plays an important role, bringing adverse effects to global
trade.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 71 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">China mostly imports Pacific salmon, cod, pollock,
flatfish, lobster, and crab from the U.S., and in 2017, these imports reached $1.3 billion (see &#8220;<i>US-China seafood trade flows
(2010-2017)</i>&#8221; table). Of the U.S. seafood exports, crustaceans are consumed locally in China, but most of the whitefish and salmon
are exported from the U.S. to China for processing and re-exporting. The seafood trade flow from China to the U.S. is even bigger &#8211;
having reached $2.7 billion in 2017. The majority of these trade flows consist of tilapia, shrimp, and squid, as well as re-exports of
salmon and whitefish.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>US-China seafood trade flows (2010-2017) table</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;<img src="image_024.jpg" alt="" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In April 2020, the U.S. and the Chinese government
signed the Phase One agreement. This agreement stipulated the removal of tariffs on some of the seafood products in which &#8220;tilapia,
frozen, each weighing not more than 115 grams&#8221; was included and exempted until August 7, 2020. During this period, exports to the
U.S. have regained momentum and reached a high in July with 46,0000 metric tons. However, in August 2020, the U.S. Trade Representative
(USTR) released the list of products that will receive a further extension on tariffs exclusions and tilapia is no longer on the list
and it is now under the 25% tariffs once again, and exports have already subsided in August and September. Accordingly, Nocera intends
to take advantage of this opportunity and enter the U.S. market in 2022. We only intend to meet U.S. local demands, but also to create
job opportunities in the U.S.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RASs and Solar Panels</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2020, the Taiwanese government instituted a
green power policy that requires all solar companies using farmland or fish farmland to have actual operating fish farms as a prerequisite
before a solar license will be granted. These local solar companies cannot obtain bank financing unless there is proof of fish farming
operations or harvest guarantees of fish. In addition to generating power, solar companies must operate a fish farm with production of
no less than 70% of the last three years&#8217; average within the township. Accordingly, all of these solar companies must have fish
farms located beneath their solar panels. This has resulted in a tremendous opportunity for Nocera to meet the demand of solar sharing
fish farms. We currently estimate that there will be a need for approximately 5,000 tank-based systems in Taiwan over the course of the
next couple of years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Feed-in tariff schemes are increasingly common
internationally as an incentive for adopting renewable energy. Nocera foresees global opportunities like those in Taiwan, as countries
around the world start setting net zero emissions targets and significantly limiting or phasing out carbon-emitting energy sources.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 72 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Business Model</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">RAS Sales - Manufacturing of equipment and providing services to land-based fish farms.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">Construction and management of solar sharing fish farms with expansion into the U.S. and Brazil.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">Investment and management of solar sharing fish farms.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">Procurement and sales of eel and other fish.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera provides tank-based recirculation aquaculture
systems for both fresh and saltwater fish and invests in fish farms by building high-tech RASs. The main business operation consists of
the design, development, and production of large-scale RAS fish tank systems, (aquaculture) for fish farms along with expert consulting,
technology transfer, and aquaculture project management services to new and existing aquaculture facilities and operators.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue Streams</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our revenues for the three months ended March
31, 2022 and 2021 were approximately $2,919,045 and $1,579,486, respectively. Three customers represented 97% of the Company&#8217;s total
revenue for the three months ended March 31, 2022, and two customers represented 98% of the Company&#8217;s total revenue for the three
months ended March 31, 2021. These customers are not located in mainland China or Hong Kong.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our revenues for the year ended December 31, 2021
and for the year ended December 31, 2020 were approximately $9.9 million and $1.2 million, respectively. There was one customer, The Fifth
District Management Office of Taiwan Water Corporation, which represented approximately 58% of the Company&#8217;s total revenue for the
year ended December 31, 2021, and two customers (JC Development Co., Ltd (&#8220;JCD&#8221;) and Pan Li) who represented 96% of the Company&#8217;s
total revenue for the prior year period. These customers are not located in mainland China or Hong Kong.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our future plan of operations is to shift away
from general construction services to the construction of fish and solar power farms, and we intend to enter the United States market
in 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Construction Services</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera is the only provider of RAS solar power
energy sharing and construction services in Taiwan. In 2021, Nocera acquired Xin-Feng Construction Co. Ltd (&#8220;XFC&#8221;) to support
the construction activities for the clients of Nocera and develop Taiwan fish farm segmentation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Eel Procurement and Sales</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2021, Nocera began its eel trading
business in response to domestic demands created by the COVID-19 lockdown. NTB currently procures and sells eel in Taiwan and plans to
trade other types of seafood, such as tilapia and milkfish, in Taiwan in the near future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2022, in light of current industry and global
market trends, Nocera believes the U.S. is a potentially lucrative market to penetrate. The Company is actively looking to acquire land
in the U.S. that would be suitable to establish one or more fish farms using its RASs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 73 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales &amp; Marketing Model</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2021, the Company moved its focus from
China to Taiwan and employed a sales and marketing strategy targeting government-supported solar fish farms. We further expanded our marketing
efforts through networking contacts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently sell and develop fish farms in Taiwan
and, in the near term, expand our sales and development efforts to the United States and Brazil. Nocera expects to sell over 5,000 tanks
in the next five years. Nocera&#8217;s production facility is to be established in Taiwan and plans to sell the systems in North and South
America and European countries as well.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company plans on expanding its sales and marketing
model through online marketing, data intelligence, and the establishment of a distributor network. The use of online marketing and data
intelligence is designed to generate sales leads internationally so that <b>we </b>can direct to our sales department to follow up and
close sales worldwide.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also have built a fish farming demo site in
Taiwan and intend to build fish farming demo sites in the United States in 2022, Brazil in 2023, Japan in 2023 or 2024 and Thailand in
2023 or 2024, to promote our fish farming systems to the global market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Project Potential</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RASs offer a variety of important advantages over
traditional fish farming methods. RASs maximize production with a limited supply of water and land, and allow nearly complete environmental
control, while also providing a higher level of location flexibility. on top of more efficient harvest and disease control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The traditional natural water body fish farming
method, where low densities of fish are reared in ponds, is vulnerable to disease, pollutants, and seasonally sub-optimal growing conditions.
By comparison, RASs require relatively small areas of land and use a smaller volume of water that is recirculated and filtered to prevent
disease spread and minimize pollutants. Nocera&#8217;s RASs can produce over 20,000 kilograms of fish annually in spaces as little as
1,900 square feet. Traditional fish farming methods would require 2.5 acres of outdoor water ponds to produce the same amount of fish.
With a smaller footprint, RASs harvesting should be more efficient than traditional fish farming methods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Approximately 90% of the recirculating water from
RASs is processed through the main filtering system. Nocera offers promising solutions with regard to water quality and waste control.
We believe these concerns will continue to magnify in the future as water demand keeps escalating. RASs also provide a highly controllable
environment that can be tailored for a wide range of fish species in both fresh water and salt water.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Competition</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market for aquaculture projects and services
is highly competitive. Many of the producers and sellers are large entities that have significantly greater resources than we have. Therefore,
we signed the XFC VIE Agreements to use XFC&#8217;s local resources in Taisi township, Taiwan to develop land-based RASs fish farms in
Taiwan and hopefully gain a competitive advantage. We also compete with small suppliers which provide smaller alternative aquaculture
solutions regionally, but due to the size of our projects, we believe that we should be able to offer a better price point.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 74 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera&#8217;s Competitive Edge</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the Company&#8217;s research, all other
players in the RAS market offer significantly smaller tank systems that we believe are more costly to operate and, therefore, result in
higher fish production costs. Nocera&#8217;s cost-effective tanks offer customers an economic incentive to use our systems and provide
us with a significant competitive edge vis-a-vis competitors. Advantages of using our systems include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">inexpensive and simple design and construction, as compared to other RASs tanks made in the EU and the
U.S.;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">mobility and flexibility, where our systems can be relocated and reused relatively; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">ease of installation, requiring only 3-5 hours to fully assemble a system.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Sales and Marketing</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera intends to create a brand and by its creation
of the brand, offer unique and better incentives to the consumers. Our target market is not only limited to the direct processing plants;
instead, consumers will be informed about the uniqueness of the fish product and the important health benefits of fish protein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Nocera plans to increase the species
selection and product form through the investment of the additional 500 tanks; among all we plan to build a hatchery system by collaborating
with professionals to promote and maintain healthy, self-sustaining populations of fish and other aquatic species. We are aiming for the
direct wholesale option, including live hauling, restaurants, supermarkets and specialty stores. More importantly, the distribution channel
will move towards online marketing as well to achieve a greater market share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Manufacturing Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently, the Company manufactures RASs through
its branch office in Taiwan. Additionally, Nocera provides consulting services regarding RAS technology transfer and aquaculture project
management services to customers in Taiwan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Government Regulation&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to many varying laws and regulations
in Taiwan and throughout the world, including, without limitation, those related to privacy, data protection, intellectual property, consumer
protection, e-commerce, marketing, advertising, messaging, rights of publicity, health and safety, employment and labor, product liability,
accessibility, competition, and taxation. These laws and regulations are constantly evolving and may be interpreted, applied, created,
or amended in a manner that could harm our current or future business and operations. In addition, certain governments may seek to block
or limit our products and services or otherwise impose other restrictions that may affect the accessibility or usability of any or all
of our products and services for an extended period of time or indefinitely.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our properties and operations are subject to a
number of environmental, health and safety laws and regulations in each of the jurisdictions in which we operate. Under certain of these
laws and regulations, we may be subject to joint and several liability for environmental investigations and cleanups, including at properties
that we currently or previously owned or operated, or at sites at which waste we generated was disposed of, even if the contamination
was not caused by us or was legal at the time it occurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are also subject to laws regulating consumer
products in the jurisdictions in which we sell our products. In the United States, for instance, certain of our products are subject to
the U.S. Consumer Product Safety Act, under which the U.S. Consumer Product Safety Commission may exclude products from the market that
are found to be unsafe or hazardous, require repair, replacement or refund of products, impose fines for noncompliance with requirements
and impose fines for failure to timely notify them of potential safety hazards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 75 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also, concerning the potential sale of eel and
any other seafood in the United States, we are subject to extensive regulation, including, among other things, the Food, Drug and Cosmetic
Act, as amended by the Food Safety Modernization Act (&#8220;FSMA&#8221;), the Public Health Security and Bioterrorism Preparedness and
Response Act of 2002, and the rules and regulations promulgated thereunder by the U.S. Food and Drug Administration (the &#8220;FDA&#8221;).
The FSMA was enacted to aid the effective prevention of food safety issues in the food supply. This comprehensive and evolving regulatory
program impacts how food is grown, packed, processed, shipped and imported into the United States and it governs compliance with Good
Manufacturing Practices regulations (&#8220;GMPs&#8221;). The FDA has finalized seven major rules to implement FSMA, recognizing that
ensuring the safety of the food supply is a shared responsibility among many different points in the global supply chain. The FSMA rules
are designed to make clear specific actions that must be taken at each of these points to prevent contamination. Some aspects of these
laws use a strict liability standard for imposing sanctions on corporate behavior. If we fail to comply with applicable laws and regulations,
we may be subject to civil remedies, including fines, injunctions, recalls, or seizures, and criminal sanctions, any of which could impact
our results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Nutrition Labeling and Education
Act of 1990 prescribes the format and content of certain information required to appear on the labels of food products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our operations and products are also subject to
state and local regulation, including the registration and licensing of plants, enforcement by state health agencies of various state
standards, and the registration and inspection of facilities. Compliance with federal, state and local regulations is costly and time-consuming.
Enforcement actions for violations of federal, state, and local regulations may include seizure and condemnation of products, cease and
desist orders, injunctions or monetary penalties. We believe that our practices are sufficient to maintain compliance with applicable
government regulations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to certain regulations by the U.S.
Federal Trade Commission. Advertising of our products is subject to such regulation pursuant to the Federal Trade Commission Act and the
regulations promulgated thereunder.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are also subject to certain health and safety
regulations, including regulations issued pursuant to the Occupational Safety and Health Act. These regulations require us to comply with
certain manufacturing, health, and safety standards to protect our employees from accidents.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business depends in part on environmental
regulations and programs of Taiwan that promote cleaner water sources to restore clean water to people. Our customers may be encouraged
with incentives by the local governments relating to aquaculture investment. The approvals of land, licenses or permits, are required
from relevant central and local government authorities. In addition, from time to time, relevant government authorities may impose new
regulations at a local level regulating fish farming. We believe that we have the skills to help our customers obtain all necessary licenses,
registrations and permits to comply with all requirements necessary to allow our customers and investors to conduct aquaculture business
in Taiwan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Seasonality</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the global growing demand for aquaculture
production along with the decreasing production from wild fisheries, our fish farming systems provide a controlled and traceable environment
for fish species, and therefore our business rarely suffers a seasonal impact.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Employees</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2022, we have a total
of 10 employees, all of whom are full-time. We are compliant with local prevailing wage and contractor licensing and have good relations
with our employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trademarks and Patents</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not own any trademarks or patents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s15"></span><span style="text-transform: none">DESCRIPTION
OF PROPERTY</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s corporate headquarters
are located at 3F (Building B), No. 185, Sec. 1, Datong Rd., Xizhi Dist., New Taipei City 221, Taiwan. This is the location from
which our Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer are based.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not own any real property.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s16"></span><span style="text-transform: none">LEGAL
PROCEEDINGS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are currently not a party to any legal or administrative
proceedings and are not aware of any pending or threatened legal or administrative proceedings against us in all material aspects. We
may from time to time become a party to various legal or administrative proceedings arising in the ordinary course of our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s17"></span>DIRECTORS, EXECUTIVE
OFFICERS &amp; CORPORATE GOVERNANCE</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following are our executive officers and
directors and their respective ages and positions as of the date of this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 33%"><b>Name</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 6%; text-align: center"><b>Age</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 40%"><b>Position</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 18%"><b>Director Since</b></td></tr>
  <tr style="vertical-align: top; background-color: #F2F2F2">
    <td>Yin-Chieh (Jeff) Cheng</td>
    <td>&#160;</td>
    <td style="text-align: center">43</td>
    <td>&#160;</td>
    <td>Chairman of the Board, CEO, President, Director<br />
(Principal Executive Officer)</td>
    <td>&#160;</td>
    <td style="text-align: center">December 31, 2018</td></tr>
  <tr style="vertical-align: top">
    <td>Shun-Chih (Jimmy) Chuang</td>
    <td>&#160;</td>
    <td style="text-align: center">33</td>
    <td>&#160;</td>
    <td>Chief Financial Officer<br />
(Principal Financial and Accounting Officer)</td>
    <td>&#160;</td>
    <td style="text-align: center">&#8211;</td></tr>
  <tr style="vertical-align: top; background-color: #F2F2F2">
    <td>Hsien-Wen (Stan) Yu</td>
    <td>&#160;</td>
    <td style="text-align: center">29</td>
    <td>&#160;</td>
    <td>Chief Operating Officer</td>
    <td>&#160;</td>
    <td style="text-align: center">&#8211;</td></tr>
  <tr style="vertical-align: top">
    <td>Gerald H. Lindberg</td>
    <td>&#160;</td>
    <td style="text-align: center">73</td>
    <td>&#160;</td>
    <td>Secretary, Director</td>
    <td>&#160;</td>
    <td style="text-align: center">December 31, 2021</td></tr>
  <tr style="vertical-align: top; background-color: #F2F2F2">
    <td>David Yu-Lung Kou</td>
    <td>&#160;</td>
    <td style="text-align: center">51</td>
    <td>&#160;</td>
    <td>Director</td>
    <td>&#160;</td>
    <td style="text-align: center">December 19, 2019</td></tr>
  <tr style="vertical-align: top">
    <td>Thomas A. Steele</td>
    <td>&#160;</td>
    <td style="text-align: center">73</td>
    <td>&#160;</td>
    <td>Director</td>
    <td>&#160;</td>
    <td style="text-align: center">December 19, 2019</td></tr>
  <tr style="vertical-align: top; background-color: #F2F2F2">
    <td>Hui-Ying Zhuang</td>
    <td>&#160;</td>
    <td style="text-align: center">48</td>
    <td>&#160;</td>
    <td>Director</td>
    <td>&#160;</td>
    <td style="text-align: center">December 19, 2019</td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Professional Backgrounds</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Yin-Chieh (Jeff) Cheng </i></b>serves as
Chairman of the Board, Chief Executive Officer, President and Director of the Company. Mr. Cheng served as our Chief Financial Officer
and Treasurer from December 27, 2018 until October 28, 2019. Prior to that role, from December 1, 2014 to the present, Mr. Yin-Chieh Cheng
acted as a director of Shengbo Accounting Firm in Shanghai. In that role, he was in charge of international tax consulting and cross border
transactions. Mr. Yin-Chieh Cheng holds a bachelor&#8217;s degree in Accounting from George Mason University in Virginia. Mr. Cheng is
qualified to serve as a director of the Company due to the valuable expertise and perspective he brings in his capacity as the Company&#8217;s
Chief Executive Officer and because of his extensive experience and knowledge of our industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Shun-Chih (Jimmy) Chuang </i></b>was appointed
as Chief Financial Officer of the Company on October 28, 2019. Prior to that role, from October 1, 2016 to June 30, 2019, Mr. Chuang was
a project manager at Deloitte &amp; Touche Financial Advisory Corporation in Taiwan where he was part of the Transaction Support practice.
In that role, he worked in Mergers and Acquisitions and Valuation services. Prior to that role, from September 2014 to September 2016,
Mr. Chuang was a semi-senior at Deloitte &amp; Touche in Taiwan where he was part of the Audit Function practice. In that role, he performed
audit services to various Taiwanese conglomerate companies. Mr. Chuang has a marketing degree from UC-Berkeley Extension, and a BS in
Accounting from Soochow University, Taiwan. He currently holds Certified Public Accounting licenses from the United States and Taiwan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Hsien-Wen (Stan) Yu</i></b> was appointed
as Chief Operating Officer of the Company on March 2, 2020. Prior to that role, Mr. Yu was the operations manager of the Company since
2019, where he managed SEC filings, operations of subsidiaries, and other back-office matters for Nocera. From February 1, 2019 to the
present, Mr. Yu founded and served as the chairman of VRTX Sports, Inc. In that role, he listened to the operation reports from his subordinates
and was the person in charge of corporate finance. Prior to that role, Mr. Yu was the founder and chairman of Recovery, Corp., a fitness
accessory company from July 1, 2014 to October 30, 2017, and an inventor of a self-myofascial release kit for shoulder injuries, RC Release,
since 2014.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 77 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Gerald H. Lindberg </i></b>was appointed
as Secretary and Director of the Company on December 31, 2021. In the past five years, working for Handover International, Mr. <span style="color: #222222; background-color: white">Lindberg
has provided substantial expertise and guidance as a consultant, has served as a board member and CFO of publicly traded companies, business
adviser, capital acquisition director, and operations officer to real world and Internet start-ups and helped raise capital for start-ups,
small cap, micro-cap, and nano-cap businesses in both the public and private sectors. </span>Earlier in his career, he was Section Chief,
Litigation Assistance Systems Section, Justice Management Division, United States Department of Justice, and an attorney-advisor with
the United States Department of Justice (1979-1982). <span style="color: #222222; background-color: white">Over the past 25 years, he
has been responsible for business plan preparation, early stage advising for corporate development and positioning for capital raising
including crowd funding, private placement memoranda, investor presentation development, equity, debt and hybrid funding, form preparation
and filing, offering syndicate coordination, sales/marketing strategy along with investment community relations and investor relations,
business development, licensing management, and assuring compliance with Federal and state regulations and fraud prevention software development.
His areas of specialty include technology and intellectual property management, digital entertainment, media and marketing, e-Commerce,
m-Commerce, and search engine design, database systems software design and development. </span>Mr. Lindberg earned his law degree from
Western New England University, School of Law, Springfield, MA. Mr. Lindberg is qualified to serve as a director of the Company due to
his <span style="color: #222222; background-color: white">substantial board and financial consulting experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>David Yu-Lung Kou </i></b>was appointed
as Director of the Company on December 19, 2019. Mr. Kou is an executive with diversified experience in global business operations, product
management, sales, marketing, and branding - including regional distribution and retail sales. He is experienced in (business) localization,
product (roadmap) planning, business and operation establishment, restructuring and crisis recovery. Mr. Kou has experience in turn-around
situations to achieve positive cash flow, strategic business planning and execution and innovative product creation and launch planning.
Mr. Kou is currently the Chief of Strategy and Planning for Wistron Corp. His former employment positions include General Manager of TP
Vision from 2015-2018, Vice President &#8211; Branded Business Operations at TPV from 2015-2018, a Business Advisor/Consultant of HokangTek
from 2014-2018, Business and Operations Advisor of Top Innovation from 2014-2018, and an Executive Director, Global Sales of HTC Corp.
from 2012-2014. He attended the University of Southern California earning an MSc. Electrical Engineering in 1991. Mr. Kou is qualified
to serve as a director of the Company due to his ability in sales and marketing and experience in international business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Thomas A. Steele</i></b> was appointed as
Director of the Company on December 19, 2019. Mr. Steele is currently retired. He was registered as a court interpreter Japanese to English
and Japan marketing consultant from 2010-2019. Mr. Steele served as a Foreign Service Officer with the U.S. Department of State, Washington,
DC for more than 21 years (1980-2001). After retiring from the State Department, he also served as secretary for Anbusa USA, at the 2005
and 2010 World&#8217;s Fair. He obtained a BA in Political Science, Music, Radio &amp; TV Broadcasting from the University of California,
Los Angeles while attending from 1965-1969. Mr. Steele is qualified to serve as a director of the Company due to his Japanese Language
Skills and experience in International Business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Hui-Ying Zhuang</i></b> was appointed as
a Director of the Company on December 19, 2019. Mr. Zhuang works as Vice President of Sales at Clyde Bergemann Power Group (2018-current)
with experience in technology and sales management, especially in solution-based consultative selling. Other positions he has held at
Clyde Bergemann Power Group include Vice President, Product and Sales Support, Air Pollution Control Products (2013-2018), Director of
Technology and Product Management, Air Pollution Control Product Division (2012-2013), Regional Sales Manager from 2006-2012 and a Boiler
Process Engineer from 2004-2006. He is experienced in product management, sales, plant operations and contract negotiation. Mr. Zhuang
has leadership experience in building and developing management teams and extensive international business working experience. He attended
the University of South Carolina earning an MBA in 2005. Mr. Zhuang is qualified to serve as a director of the Company due to his technical
experience in power generation and ability in Sales and Marketing functions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Family Relationships</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no family relationships among any of
our executive officers or directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 78 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Significant Employees</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Involvement in Certain Legal Proceedings</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To our knowledge, none of our current directors
or executive officers has, during the past ten (10) years:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%; text-align: left"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 92%; text-align: justify">been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of which he or she was a general partner or executive officer, either at the time of the bankruptcy filing or within two (2) years prior to that time;</td>
    </tr>

<tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="text-align: left; width: 3%">&#160;</td>
    <td style="text-align: justify; width: 92%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his or her involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">been the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.</td>
    </tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Code of Ethics</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board adopted a written code of ethics (&#8220;Code&#8221;)
that applies to our directors, officers and employees, including our principal executive officer, principal financial officer and principal
accounting officer or controller, or persons performing similar functions. We intend to post on our website a current copy of the Code
and all disclosures that are required by law in regard to any amendments to, or waivers from, any provision of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 79 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Board Leadership Structure and Risk Oversight</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has responsibility for the oversight
of our risk management processes and, either as a whole or through its committees, regularly discusses with management our major risk
exposures, their potential impact on our business and the steps we take to manage them. The risk oversight process includes receiving
regular reports from board committees and members of senior management to enable our Board to understand our risk identification, risk
management, and risk mitigation strategies with respect to areas of potential material risk, including operations, finance, legal, regulatory,
cybersecurity, strategic, and reputational risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Board of Directors</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business and affairs are managed under the
direction of our Board and committees of the Board. Directors serve until the next annual meeting and until their successors are elected
and qualified. Officers are appointed to serve at the pleasure of the Board, subject to all rights, if any, under any contract of employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Independence</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Our </span>Board
is composed of a majority of &#8220;independent directors&#8221; as defined under the rules of Nasdaq. We use the definition of &#8220;<i>independence</i>&#8221;
applied by Nasdaq to make this determination. Nasdaq Listing Rule 5605(a)(2) provides that an &#8220;<i>independent director</i>&#8221;
is a person other than an officer or employee of the company or any other individual having a relationship that, in the opinion of the
Company&#8217;s Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. The
Nasdaq listing rules provide that a director cannot be considered independent if:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; width: 92%">the director is, or at any time during the past three (3) years was, an employee of the Company;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">the director or a family member of the director accepted any compensation from the company in excess of $120,000 during any period of twelve (12) consecutive months within the three (3) years preceding the independence determination (subject to certain exemptions, including, among other things, compensation for Board or Board committee service);</td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify; width: 5%">&#160;</td>
    <td style="text-align: justify; width: 3%">&#160;</td>
    <td style="text-align: justify; width: 92%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">the director or a family member of the director is a partner in, controlling stockholder of, or an executive officer of an entity to which the company made, or from which the company received, payments in the current or any of the past three fiscal years that exceed 5% of the recipient&#8217;s consolidated gross revenue for that year or $200,000, whichever is greater (subject to certain exemptions);</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">the director or a family member of the director is employed as an executive officer of an entity where, at any time during the past three (3) years, any of the executive officers of the company served on the compensation committee of such other entity; or</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">the director or a family member of the director is a current partner of the company&#8217;s outside auditor, or at any time during the past three (3) years was a partner or employee of the company&#8217;s outside auditor, and who worked on the company&#8217;s audit.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under such definitions, <span style="background-color: white">our
Board has undertaken a review of the independence of each director. Based on the information provided by each director concerning his
or her background, employment and affiliations, our Board has determined that </span>David Yu-Lung Kou<span style="background-color: white">,
</span>Thomas A. Steele<span style="background-color: white">, and </span>Hui-Ying Zhuang <span style="background-color: white">are</span>
independent directors of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 80 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Committees of the Board of Directors</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has established an audit committee (the
&#8220;Audit Committee&#8221;), a compensation committee (the &#8220;Compensation Committee&#8221;) and a nominating and corporate governance
committee (the &#8220;Nominating and Corporate Governance Committee&#8221;). Our Board has not yet adopted procedures by which stockholders
may recommend nominees to the Board. The composition and responsibilities of each of the committees of our Board are described below.
Members serve on these committees until their resignation or until otherwise determined by our Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Audit Committee</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has established an Audit Committee.
David Yu-Lung Kou<span style="background-color: white">, </span>Thomas A. Steele<span style="background-color: white">, and </span>Hui-Ying
Zhuang serve as members of our Audit Committee. David Yu-Lung Kou serves as the Audit Committee Chairman. Under the Nasdaq listing standards
and applicable SEC rules, we are required to have at least three members of the Audit Committee, all of whom must be independent and financially
literate, and one member of the Audit Committee must qualify as an &#8220;audit committee financial expert&#8221; as defined in applicable
SEC rules. Each member of the Audit Committee is independent and David Yu-Lung Kou qualifies as an &#8220;audit committee financial expert&#8221;
under the SEC rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee&#8217;s duties, which are
specified in our Audit Committee Charter, include, but are not limited to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; width: 92%">reviewing and discussing with management and the independent auditor the annual audited financial statements, and recommending to the Board whether the audited financial statements should be included in our annual disclosure report;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">discussing with management and the independent auditor significant financial reporting issues and judgments made in connection with the preparation of our financial statements;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">discussing with management major risk assessment and risk management policies;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td>monitoring the independence of the independent auditor;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td>reviewing and approving all related-party transactions;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">inquiring and discussing with management our compliance with applicable laws and regulations;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">pre-approving all audit services and permitted non-audit services to be performed by our independent auditor, including the fees and terms of the services to be performed;</td></tr>

<tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="text-align: justify; width: 92%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td>appointing or replacing the independent auditor;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">determining the compensation and oversight of the work of the independent auditor (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related work;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">approving reimbursement of expenses incurred by our management team in identifying potential target businesses.</td></tr>
  </table>
<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 81 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Compensation Committee</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has established a Compensation Committee.
Under the Nasdaq listing standards and applicable SEC rules, we are required to have at least two members of the Compensation Committee,
all of whom must be independent. Thomas A. Steele <span style="background-color: white">and </span>Hui-Ying Zhuang, each of whom is an
independent director, serve as members of the Compensation Committee with Thomas A. Steele<span style="background-color: white">,</span>
serving as the Compensation Committee&#8217;s chairman. The Compensation Committee&#8217;s duties, which are specified in our Compensation
Committee Charter, include, but are not limited to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; width: 92%">reviews, approves and determines, or makes recommendations to our Board regarding, the compensation of our executive officers;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">administers our equity compensation plans;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">reviews and approves, or makes recommendations to our Board, regarding incentive compensation and equity compensation plans; and</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">establishes and reviews general policies relating to compensation and benefits of our employees.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee charter permits the
committee to retain or receive advice from a compensation consultant and outlines certain requirements to ensure the consultant's independence
or certain circumstances under which the consultant need not be independent. However, as of the date hereof, the Company has not retained
such a consultant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Nominating and Corporate Governance Committee</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has established a Nominating and Corporate
Governance Committee of which David Yu-Lung Kou <span style="background-color: white">and </span>Hui-Ying Zhuang serve as members with
Hui-Ying Zhuang also serving as the Chairman of the Nominating and Corporate Governance Committee. The Nominating and Corporate Governance
Committee&#8217;s duties, which are specified in its charter, include, but are not limited to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; width: 92%">identifying, reviewing and evaluating candidates to serve on our Board consistent with criteria approved by our Board;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">evaluating director performance on our Board and applicable committees of our Board and determining whether continued service on our Board is appropriate;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">evaluating nominations by stockholders of candidates for election to our Board; and</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">corporate governance matters.</td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Meetings of the Board of Directors</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During its fiscal year ended December 31, 2021,
the Board met five times and acted by written consent on numerous occasions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 82 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indemnification and Limitation on Liability
of Directors</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Articles of Incorporation limit the liability
of our directors to the fullest extent permitted by Nevada law. Nothing contained in the provisions will be construed to deprive any director
of his right to all defenses ordinarily available to the director nor will anything herein be construed to deprive any director of any
right he may have for contribution from any other director or other person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At present, there is no pending litigation or
proceeding involving any of our directors, officers, employees or agents where indemnification will be required or permitted. Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons
pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the Commission such indemnification is
against public policy as expressed in the Securities Act and is, therefore, unenforceable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Equity Incentive Plans</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2018, the Board and stockholders adopted the
Company&#8217;s 2018 Stock Option and Award Incentive Plan, effective December 31, 2018 (the &#8220;2018 Plan&#8221;). The 2018 Plan
provides for the grant of the following types of stock awards: (i) incentive stock options, (ii) no statutory stock options, and (iii)
stock purchase rights. The 2018 Plan is intended to help the Company secure and retain the services of eligible award recipients, provide
incentives for such persons to exert maximum efforts for the success of the Company and any affiliate and provide a means by which the
eligible recipients may benefit from increases in value of the common stock. The 2018 Plan is administered by the Compensation Committee.
The Board reserved 10,000,000 shares of common stock under the 2018 Plan. The number of shares of common stock reserved under the 2018
Plan was subsequently reduced to 6,666,667 as a result of the Company&#8217;s 2-for-3 reverse stock split on July [&#8226;], 2022.
As of July [&#8226;], 2022, the total amount of shares of common stock authorized and reserved for issuance under the 2018 Plan is
6,666,667. No awards have been granted to any of our officers or directors pursuant to the 2018 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s18"></span>EXECUTIVE COMPENSATION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table illustrates the compensation
paid by the Company to its executive officers. The disclosure is provided for the fiscal years ended December 31, 2021 and December
31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Name and Principal Position</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fiscal Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Salary($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Equity Awards($) <sup>(1)</sup></b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 32%; text-align: justify">Yin-Chieh (Jeff) Cheng <sup>(2)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 13%; text-align: center">2021</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">11,053,267</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">11,053,267</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Chairman of the Board, President, CEO, Director</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,831</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,831</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Shun-Chih (Jimmy) Chuang <sup>(3)</sup></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">655,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">697,073</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,558</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81,558</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Hsien-Wen (Stan) Yu <sup>(4)</sup></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">619,377</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">639,377</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Chief Operating Officer</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,469</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">67,469</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 3%; text-align: right">(1)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 96%; text-align: justify">The amounts shown represent the aggregate grant date fair value of these warrant awards granted during each fiscal year shown, computed in accordance with FASB ASC Topic 718.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right">(2)</td>
    <td>&#160;</td>
    <td style="text-align: justify">Pursuant to the Cheng Consulting Agreement, dated December 27, 2018, the Company agreed to issue Mr.
    Cheng 250,000 Series A Warrants per quarter for 20 quarters (i.e., 5 years) for a total amount of 5,000,000 Series A Warrants,
    subject to his continued services as the Chairman of the Board and Director of the Company. Each Series A Warrant is exercisable to
    purchase one share of common stock for $0.50 per share from the date of vesting until April 23, 2026. This award was valued at a
    total amount of $11,114,098 for the year ended December 31, 2021 using the Black Scholes methodology. The values of the award
    granted each year were $60,831 and $11,053,267 separately for the years ended December 31, 2020 and 2021 using the Black-Scholes
    methodology. Due to the 2-for-3 reverse stock split of the Company&#8217;s common stock on July [&#8226;], 2022, the amount of
    shares issuable upon the unexercised warrants was adjusted to 2,666,667 and the exercise price was adjusted to $0.75 per share.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right">(3)</td>
    <td>&#160;</td>
    <td style="text-align: justify">On June 1, 2020, the Company issued Mr. Chuang 50,000 Class A Warrants. The total value of the award
    was $39,558 for the year ended December 31, 2020. On December 1, 2021, the Company issued Mr. Chuang 75,000 Class A Warrants, and
    on December 31, 2021, the Company extended the termination date of Class A Warrant to April 23, 2026. The total value of the award
    granted to Mr. Chuang in 2021 was $655,073 for the year ended December 31, 2021 using the Black-Scholes methodology. Due to the 2-for-3
    reverse stock split of the Company&#8217;s common stock on July [&#8226;], 2022, the amount of shares issuable upon the unexercised
    warrants was adjusted to 2,000,000 and the exercise price was adjusted to $0.75 per share.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right">(4)</td>
    <td>&#160;</td>
    <td style="text-align: justify">On June 1, 2020, the Company issued Mr. Yu 60,000 Class A Warrants. The total value of the award was
    $47,469 for the year ended December 31, 2020. On December 1, 2021, the Company issued Mr. Yu 60,000 Class A Warrants, and on
    December 31, 2021, the Company extended the termination date of Class A Warrant to April 23, 2026. The total value of the award
    granted to Mr. Yu in 2021 was $619,377 for the year ended December 31, 2021 using the Black-Scholes methodology. Due to the 2-for-3
    reverse stock split of the Company&#8217;s common stock on July [&#8226;], 2022, the amount of shares issuable upon the unexercised
    warrants was adjusted to 80,000 and the exercise price was adjusted to $0.75 per share.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employment Agreements</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Chuang Employment Agreement</span></i>. Shun-Chih
Chuang, our Chief Financial Officer, and the Company entered into an Employment Agreement, dated as of August 16, 2019, as amended by
that certain Addendum, dated as of December 31, 2021 (the &#8220;Chuang Employment Agreement&#8221;). The term of the Chuang Employment
Agreement is for 5 years and at the end of such term, is automatically renewable on a month-to-month basis unless either party provides
notice to terminate to the other within 30 days of the end of the term. During the term and one year after the end of the term, Mr. Chuang
shall not solicit any person employed or engaged by the Company. Mr. Chuang&#8217;s employment may be terminated by the Company immediately
upon the occurrence of the following events: (i) the commission of any act by Mr. Chuang which, if prosecuted, would constitute a felony;
(ii) any material act or omission involving malfeasance or negligence in the performance of employment duties which has a materially adverse
effect on the Company and which has not been corrected in 30 days after written notice from the Company; (iii) failure or refusal by Mr.
Chuang to comply with the policies of the Company contained in any Company handbook or with the provisions of the Chuang Employment Agreement
if not cured within 10 days after the receipt of written notice from the Board; (iv) Mr. Chuang&#8217;s prolonged absence without the
consent of the Company; (v) Mr. Chuang&#8217;s gross neglect of his duties or willful insubordination to the Board or his superior officers;
(vi) the death of Mr. Chuang; or (vii) delivery of written notice of termination by the Company after Mr. Chuang has become unable to
perform his services by reason of illness or incapacity, which illness or incapacity results in Mr. Chuang&#8217;s failure to discharge
his duties under the Chuang Employment Agreement for an aggregate total of 60 days (whether consecutive or nonconsecutive) during any
180 day period. The Company pays Mr. Chuang $54,000 per year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Yu Employment Agreement</span></i>.
Hsien-Wen Yu, our Chief Operating Officer, and the Company entered into an Employment Agreement dated as of August 16, 2019, as amended
by that certain Addendum, dated as of December 31, 2021 (the &#8220;Yu Employment Agreement&#8221;). The term of the Yu Employment
Agreement is for 5 years and at the end of such term, is automatically renewable on a month-to-month basis unless either party provides
notice to terminate to the other within 30 days of the end of the term. During the term and one year after the end of the term, Mr. Yu
shall not solicit any person employed or engaged by the Company. Mr. Yu&#8217;s employment may be terminated by the Company immediately
upon the occurrence of the following events: (i) the commission of any act by Mr. Yu which, if prosecuted, would constitute a felony;
(ii) any material act or omission involving malfeasance or negligence in the performance of employment duties which has a materially
adverse effect on the Company and which has not been corrected in 30 days after written notice from the Company; (iii) failure or refusal
by Mr. Yu to comply with the policies of the Company contained in any Company handbook or with the provisions of the Yu Employment Agreement
if not cured within 10 days after the receipt of written notice from the Board; (iv) Mr. Yu&#8217;s prolonged absence without the consent
of the Company; (v) Mr. Yu&#8217;s gross neglect of his duties or willful insubordination to the Board or his superior officers; (vi)
the death of Mr. Yu; or (vii) delivery of written notice of termination by the Company after Mr. Yu has become unable to perform his
services by reason of illness or incapacity, which illness or incapacity results in Mr. Yu&#8217;s failure to discharge his duties under
the Yu Employment Agreement for an aggregate total of 60 days (whether consecutive or nonconsecutive) during any 180 day period. The
Company pays Mr. Yu $36,000 per year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Lindberg Employment Agreement</span></i>.
Gerald H. Lindberg, our Secretary and Director, and the Company entered into an Employment Agreement dated as of January 3, 2022 (the
&#8220;Lindberg Employment Agreement&#8221;). The term of the Lindberg Employment Agreement is for two years and at the end of such term,
is automatically renewable on a month-to-month basis unless either party provides notice to terminate to the other within 30 days of
the end of the term. During the term and one year after the end of the term, Mr. Lindberg shall not solicit any person employed or engaged
by the Company. Mr. Lindberg&#8217;s employment may be terminated by the Company immediately upon the occurrence of the following events:
(i) the commission of any act by Mr. Lindberg which, if prosecuted, would constitute a felony; (ii) any material act or omission involving
malfeasance or negligence in the performance of employment duties which has a materially adverse effect on the Company and which has
not been corrected in 30 days after written notice from the Company; (iii) failure or refusal by Mr. Lindberg to comply with the policies
of the Company contained in any Company handbook or with the provisions of the Lindberg Employment Agreement if not cured within 10 days
after the receipt of written notice from the Board; (iv) Mr. Lindberg&#8217;s prolonged absence without the consent of the Company; (v)
Mr. Lindberg&#8217;s gross neglect of his duties or willful insubordination to the Board or his superior officers; (vi) the death of
Mr. Lindberg; or (vii) delivery of written notice of termination by the Company after Mr. Lindberg has become unable to perform his services
by reason of illness or incapacity, which illness or incapacity results in Mr. Lindberg&#8217;s failure to discharge his duties under
the Lindberg Employment Agreement for an aggregate total of 60 days (whether consecutive or nonconsecutive) during any 180 day period.
<span style="background-color: white">The Company also granted Mr. Lindberg 60,000 Class C Warrants </span>consisting of the right to
purchase a total of 40,000 shares of common stock of the Company for $3.75 per share from the date of issuance, of which 20,000
Class C Warrants shall vest annually over a total period of three years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board Compensation</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Cheng Consulting Agreement</span>.</i> Yin-Chieh
(Jeff) Cheng, our Chairman of the Board, President, Chief Executive Officer and Director, and the Company entered into the Cheng Consulting
Agreement on December 27, 2018 (the &#8220;Cheng Consulting Agreement&#8221;). The Cheng Consulting Agreement appoints Mr. Cheng as the
Chairman of the Board and Director of the Company. The term of Mr. Cheng&#8217;s appointment for such positions is for the period between
December 27, 2018 and December 27, 2023. The Company or Mr. Chang may immediately terminate the Cheng Consulting Agreement upon a material
breach by the other party that has not been cured to the terminating party&#8217;s satisfaction within 30 days following written notice
of the said breach. Mr. Cheng may terminate on 30 days written notice for the Company&#8217;s uncured failure to meet its payment obligations
within 30 days of receiving written notice of such failure from Mr. Cheng. The Company does not pay Mr. Cheng any cash compensation for
his roles as Chairman of the Board and a Director of the Company. The Company, however, agreed to issue Mr. Cheng quarterly 250,000 Series
A Warrants per quarter for 20 quarters (i.e., 5 years) for a total amount of 5,000,000 Series A Warrants, subject to his continued services
as the Chairman of the Board and Director of the Company. The Series A Warrants are exercisable to purchase a total amount of 3,333,334
shares of common stock, with each Series A Warrant being exercisable from the date of vesting until April 23, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our directors are reimbursed for expenses incurred
by them in connection with attending Board meetings. However, our directors, other than Mr. Cheng, do not receive any other compensation
for serving on the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 85 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Outstanding Equity Awards</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information regarding
equity awards held by the named executive officers as of December 31, 2021:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrant awards</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of securities underlying unexercised warrant awards<br /> (#) exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of securities underlying unexercised warrant awards<br /> (#) unexercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrant award exercise price<br /> ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrant award expiration date</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 32%; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Yin-Chieh (Jeff) Cheng <sup>(1)</sup></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chairman of the Board, President, CEO, Director</p></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">1,333,334</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">1,333,334</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.75</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 15%; text-align: center">April 23, 2026</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shun-Chih (Jimmy) Chuang</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer <sup>(2)</sup></p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83,334</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">April 23, 2026 <br /></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Hsien-Wen (Stan) Yu</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Operating Officer <sup>(3)</sup></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">April 23, 2026 <br /></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 4%; text-align: left">(1)</td>
    <td style="width: 96%; text-align: justify">Pursuant to the Cheng Consulting Agreement, the Company agreed to issue Mr. Cheng
    250,000 Series A Warrants per quarter for 20 quarters (i.e., 5 years) for a total amount of 5,000,000 Series A Warrants. Quarterly
    issuances are subject to Mr. Cheng&#8217;s continued services as the Chairman of the Board and Director of the Company. On December
    31, 2021, the Company extended the expiration date of Series A Warrants to April 23, 2026. On May 29, 2020, Mr. Cheng exercised
    1,000,000 Series A Warrants and received an aggregate of 551,724 shares of common stock. The unexercised warrants were valued at
    $11,114,098 for the year ended December 31, 2021 using the Black Scholes methodology. The values of the warrants granted each year
    were $60,831 and $11,053,267 for the years ended December 31, 2020 and 2021, respectively, using the Black-Scholes methodology. The
    Series A Warrants originally consisted of the right to purchase one share of common stock of the Company for $0.50 per share. Due to
    the 2-for-3 reverse stock split of the Company&#8217;s common stock on July [&#8226;], 2022, however, the amount of shares issuable
    upon the unexercised warrants was adjusted to 2,666,667 and the exercise price was adjusted to $0.75 per share.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">(2)</td>
    <td style="text-align: justify">On June 1, 2020 and December 1, 2021, the Company issued Shun-Chih Chuang 50,000 and 75,000 Class A
    Warrants, respectively. On December 31, 2021, the Company extended the termination date of Class A Warrant to April 23, 2026. The
    total value of the award was $694,631 for the year ended December 31, 2021 using the Black-Scholes methodology. The Class A Warrants
    originally consisted of the right to purchase one share of common stock of the Company for $0.50 per share. Due to the 2-for-3
    reverse stock split of the Company&#8217;s common stock on July [&#8226;], 2022, however, the amount of shares issuable upon the
    unexercised warrants was adjusted to 83,334 and the exercise price was adjusted to $0.75 per share.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">(3)</td>
    <td style="text-align: justify">On June 1, 2020 and December 1, 2021, the Company issued Hsien-Wen Yu 60,000 Class A Warrants. On
    December 31, 2021, the Company extended the termination date of the Class A Warrants to April 23, 2026. The total value of the award
    was $666,846 for the year ended December 31, 2020 using the Black-Scholes methodology. The Class A Warrants originally consisted of
    the right to purchase one share of common stock of the Company for $0.50 per share. Due to the 2-for-3 reverse stock split of the
    Company&#8217;s common stock on  [&#8226;], 2022, however, the amount of shares issuable upon the unexercised warrants was
    adjusted to 80,000 and the exercise price was adjusted to $0.75 per share.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Severance and Change in Control Benefits</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None of the employment agreements with our named
executive officers provide severance benefits; however, the Cheng Consulting Agreement does provide certain change in control-related
benefits to our principal executive officer, including vesting acceleration upon the occurrence of certain defined events.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 86 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other Benefits</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We provide vacation and other paid holidays to
all employees, including our executive officers, which are comparable to those provided at peer companies. When offered, our executive
officers will be eligible to participate in all of our employee benefit plans, such as medical, dental, vision, group life, disability
and accidental death and dismemberment insurance, our Equity Incentive Plan and our 401(k) plan, in each case on the same basis as other
employees, subject to applicable law, should such benefits exist. At this time, we do not provide special benefits or other perquisites
to our executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indemnification</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company shall indemnify any and all of its
directors, officers, former directors, former officers and any person who may have served at its request as a director or officer of another
company in which it owns shares or of which it is a creditor, who were or are made a party or are threatened to be made a party to or
are involved in, any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative, arbitrative
or investigative (each a &#8220;Proceeding&#8221;), or any appeal in such a Proceeding or any inquiry or investigation that could lead
to such a Proceeding, against any and all liabilities, damages, reasonable and documented expenses (including reasonably incurred and
substantiated attorneys&#8217; fees), financial effects of judgments, fines, penalties (including excise and similar taxes and punitive
damages) and amounts paid in settlement in connection with such Proceeding by any of them. Such indemnification shall not be deemed exclusive
of any other rights to which those indemnified may be entitled otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that indemnification for
liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling our company pursuant to the
foregoing provisions, we have been informed that, in the opinion of the SEC, such indemnification is against public policy as expressed
in the Securities Act and is therefore unenforceable. If a claim for indemnification against such liabilities (other than the payment
by us of expenses incurred or paid by a director, officer or controlling person of our company in the successful defense of any action,
suit or proceeding) is asserted by any of our directors, officers or controlling persons in connection with the securities being registered,
we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by us is against public policy as expressed in the Securities Act and will be
governed by the final adjudication of that issue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s19"></span>SECURITY OWNERSHIP
OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth certain information,
as of July 20, 2022 with respect to the holdings of (1) each person who is the beneficial owner of more than 5% of Company voting
stock, (2) each of our directors, (3) each executive officer and (4) all of our current directors and executive officers as a group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Beneficial ownership of the voting stock is determined
in accordance with the rules of the SEC and includes any shares of company voting stock over which a person exercises sole or shared
voting or investment power, or of which a person has a right to acquire ownership at any time within 60 days of July 20, 2022.
Except as otherwise indicated, we believe that the persons named in this table have sole voting and investment power with respect to
all shares of voting stock held by them. Applicable percentage ownership in the following table is based on 7,138,100 shares of common
stock issued and outstanding on July 20, 2022, and after the offering assuming a unit offering consisting of shares of common
stock (excluding shares of common stock which may be sold upon exercise of the underwriters&#8217; over-allotment option), plus, for
each individual, any securities that individual has the right to acquire within 60 days of July 20, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the best of our knowledge, except as otherwise
indicated, each of the persons named in the table has sole voting and investment power with respect to the shares of our common stock
beneficially owned by such person, except to the extent such power may be shared with a spouse. To our knowledge, none of the shares listed
below are held under a voting trust or similar agreement, except as noted. To our knowledge, there is no arrangement, including any pledge
by any person of securities of the Company, the operation of which may at a subsequent date result in a change in control of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name and Address<br />
of Beneficial Owner <sup>(1)</sup></b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beneficially<br />
owned</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percent of Class<br />
Before Offering<sup>(2)</sup></b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percent of Class<br />
After Offering<sup>(3)</sup></b></span></td>
    <td>&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Officers and Directors</b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 23%">&#160;</td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 10%; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; width: 3%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 9%; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 8%; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; width: 3%">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yin-Chieh (Jeff) Cheng</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board, President, Chief Executive Officer, Director</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">5,528,391</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60.50<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">48.12%</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shun-Chih (Jimmy) Chuang</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">583,333</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.08%</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.09<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hsien-Wen (Stan) Yu</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,000</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11%</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gerald H. Lindberg</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secretary, Director</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#8211;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Yu-Lung Kou</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas A. Steele</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hui-Ying Zhuang</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Officers and Directors as a Group (total of 7 persons)</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">6,191,724</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66.57<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53.14<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5% Stockholders</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Erik S. Nelson</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">1,368,<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">401</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.09<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">13.22<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: bottom">(8)</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marina S. Fiorino</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">372,000</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.07%</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">3.82<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  </table>

<p style="margin: 0">&#160;</p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="vertical-align: bottom; width: 95%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise indicated, the principal address of the named officers and directors c/o Nocera, Inc., 3F (Building B), No. 185, Sec. 1, Datong Rd., Xizhi Dist., New Taipei City 221, Taiwan.</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on 7,138,100 shares of common stock issued and outstanding as of July 20, 2022. Any shares of common stock not outstanding
    which are issuable upon the exercise or conversion of other securities held by a person within the next 60 days are considered to
    be outstanding when computing such person&#8217;s ownership percentage of common stock but are not when computing anyone else&#8217;s
    ownership percentage.</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on 9,488,100 shares of common stock to be outstanding upon the consummation of the offering, assuming the warrants underlying
    the Units, and the underwriters&#8217; over-allotment option are not exercised.</span></td></tr>
  <tr>
    <td style="vertical-align: top">(4)</td>
    <td style="vertical-align: bottom; text-align: justify">Includes (i) 3,528,391 shares of common stock; and (ii) 2,000,000
    shares of common stock issuable upon the exercise for Series A Warrants at a price of $0.75 per share until April 23, 2026.</td></tr>
  </table>
<p style="margin: 0"></p>
<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="vertical-align: bottom; text-align: justify; width: 95%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 500,000 shares of common stock; and (ii) 83,334 shares of common stock issuable upon the exercise of Class A Warrants at a price
    of $0.75 per share until April 23, 2026.</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    80,000 shares of common stock issuable upon the exercise of Class A Warrants for $0.75 per share until April 23, 2026.</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 133,334 shares held by Nelson Fiorino Holdings, LLC, an entity of which Mr. Nelson has sole voting and dispositive control;
    (ii) 100,000 shares held by Coral Investment Partners, LP, an entity of which Erik Nelson is deemed to have voting and dispositive
    control; and (iii) 268,400 shares personally held by Mr. Nelson. This does not include 433,334 shares of common stock issuable
    upon the exercise of Class A Warrants for $0.75 per share until April 23, 2026 and 433,334 shares of common stock issuable upon the
    exercise of Class B Warrants for $1.50 per share until April 23, 2026 since such Class A Warrants and Class B Warrants contain blockers
    that prohibit Mr. Nelson from exercising warrants if such exercise will result in the beneficial ownership of more than 4.99% (or
    if Mr. Nelson elects, 9.99%) of the Company&#8217;s outstanding stock. Mr. Nelson was the former Secretary and Director of the Company
    and resigned on December 31, 2021. Mr. Nelson&#8217;s business address is 2030 Powers Ferry Road SE, Suite 212, Atlanta, GA 30339.</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    Mr. Nelson elects, he can exercise his Class A Warrants and Class B Warrants to purchase shares of common stock up to an amount that
    will result in the beneficial ownership of not more than 9.99%, which would be 161,000 shares. If Mr. Nelson does not elect to do
    so, he will own 8.41% after the offering.</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The address for Ms. Fiorino is 1 San Marzano sul Sarno, Italy 84010.</span></td></tr>
  </table>

<p style="margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s20"></span>CERTAIN RELATIONSHIPS
AND RELATED PARTY TRANSACTIONS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Other than
the compensation agreements and other arrangements described under &#8220;<i>Executive Compensation</i>&#8221; and &#8220;<i>Director
Compensation</i>&#8221; in this prospectus, since January 1, 2019, there has not been any transaction or series of similar transactions
to which we were, or will be, a party in which the amount involved exceeded, or will exceed, the lesser of (i) $120,000 or (ii) one percent
of the average of our total assets for the last two completed fiscal years, and in which any director, executive officer, holder of five
percent or more of any class of our capital stock or any member of the immediate family of, or entities affiliated with, any of the foregoing
persons, had, or will have, a direct or indirect material interest except for loans in the aggregate amount of $</span>1,615,217
from XFC to our main contractor in Taiwan, a company owned by a relative of a director of XFC, which bids on projects for XFC and provides
a performance bond for the projects.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s21"></span>DESCRIPTION OF
SECURITIES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are offering units in this offering at an
assumed public offering price of $3.75 per unit (the midpoint of the price range per unit). Each unit consists of one share of
our common stock and one warrant to purchase two shares of our common stock at an exercise price equal to $4.13, which is 110%
of the assumed public offering price per unit. Our units will not be certificated and the shares of our common stock and the warrants
part of such units are immediately separable and will be issued separately in this offering. We are also registering the shares of common
stock issuable upon exercise of the warrants. These securities are being issued pursuant to an underwriting agreement between us and
the underwriters. You should review the underwriting agreement and the form of warrant, each filed as exhibits to the registration statement
of which this prospectus is a part, for a complete description of the terms and conditions applicable to the warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following description of our securities is
only a summary and is qualified in its entirety by reference to the actual terms and provisions of the capital stock contained in our
Articles of Incorporation and our Bylaws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">General</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is authorized to issue two classes
of stock. The total number of shares of stock which the Company is authorized to issue is 210,000,000 shares of capital stock, 200,000,000
of which are common stock, $0.001 par value per share, of which 7,138,100 shares are outstanding, and 10,000,000 shares of which are
preferred stock, of which 2,000,000 shares are designated Series A Preferred Stock, par value $0.001, of which 80,000 shares are outstanding.
As of July 20, 2022, there were approximately 478 holders of record of our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The holders of our common stock are entitled to
the following rights:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Voting Rights</span></i>. Each share of our
common stock entitles its holder to one vote per share on all matters to be voted or consented upon by the stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Dividend Rights</span></i>. Subject to limitations
under Nevada law, holders of our common stock are entitled to receive ratably such dividends or other distributions, if any, as may be
declared by our Board out of funds legally available therefor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Liquidation Rights</span></i>. In the event
of the liquidation, dissolution or winding up of our business, the holders of our common stock are entitled to share ratably in the assets
available for distribution after the payment of all of our debts and other liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Other Matters</span></i>. The holders of our
common stock that did not obtain such common stock through the exercise of Class A or Class B Warrants are not entitled to subscription,
redemption, registration or preemptive rights, with the exception that the holders of our common stock that obtained such common stock
pursuant to the Merger Agreement are entitled to registration rights. All of the outstanding shares of our common stock are fully paid
and non-assessable. The holders of our common stock that obtained such common stock through the exercise of Class A and Class B Warrants
are waiving their registration rights in connection with this offering in consideration for extending the expiration date of the warrants
for one year to April 23, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Preferred Stock</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has the authority to issue up to 10,000,000
shares of preferred stock, 2,000,000 of which have been designated as &#8220;Series A Preferred Stock,&#8221; and 8,000,000 of which have
not been designated. Our Board may designate the undesignated preferred stock in one or more classes or series and fix the designations,
powers, preferences, and rights, and the qualifications, limitations or restrictions thereof including dividend rights, dividend rates,
conversion rights, voting rights, terms of redemption, redemption prices, liquidation preferences and the number of shares constituting
any class or series, without further vote or action by the stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 90 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of this prospectus, there
is an aggregate of 80,000 shares of Series A Preferred Stock issued and outstanding. The Series A Preferred Stock has the following features:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 92%; text-align: justify">the Series A Preferred Stock shall bear dividends, at 8% annually, cumulative, based upon a purchase price of $2.50 per share, computed as (0.08 x $2.50 =0.20 per share dividend per annum), payable in cash or common stock at market value, at the discretion of the Board, on or about December 31<sup>st</sup> of each year, from the date of issue;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">each holder of shares of the Series A Preferred Stock may, at any time and from time to time, convert
    each of its shares of Series A Preferred Stock into fully paid and nonassessable shares of common stock at a rate equal to one share
    of Series A Preferred Stock for .6667 share of common stock;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">automatic conversion of the Series A Preferred Stock shall occur 24 months after any approved stock exchange listing approval and the registration effectiveness of common stock underlying the conversion rights. The automatic conversion to common from Series A Preferred Stock shall be on a one-for-one basis, which shall be post-reverse split as may be necessary for any exchange listing;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">each holder of shares of the Series A Preferred Stock has liquidation rights, up to $2.50 per share, pro rata based on the number of shares held by each holder, plus any accrued unpaid dividends. The Company has redemption rights for the first year following the issuance date to redeem all or part of the principal amount of the Series A Preferred Stock between 115% and 140%; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">each holder of shares of the Series A Preferred Stock has registration rights for common stock underlying conversion rights in the event the Company files any other registration statement. The Company will file, and pursue to effectiveness, a registration statement or offering statement for common stock underlying the automatic conversion event triggered by an exchange listing impairing the liquidation rights of the common stock.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Warrants Issued in this Offering</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Overview</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following summary of certain terms and provisions
of the warrants offered hereby is not complete and is subject to, and qualified in its entirety by, the provisions of the Warrant Agent
Agreement and the form of warrant, both of which are filed as exhibits to the registration statement of which this prospectus is a part.
Prospective investors should carefully review the terms and provisions set forth in the Warrant Agent Agreement, including the annexes
thereto, and form of warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants issued in this offering entitle
the registered holder to purchase two shares of our common stock at an assumed exercise price of $4.13 per share, 110% of the
assumed public offering price of $3.75 per unit, the midpoint of the offering price per unit, subject to adjustment as discussed
below, immediately following the issuance of such warrant and terminating at 5:00 p.m., New York City time, on the fifth anniversary
of the date of issuance. We will not apply to have the warrants underlying the units listed on any exchange or market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price and number of shares of common
stock issuable upon exercise of the warrants may be adjusted in certain circumstances, including in the event of a stock dividend or
recapitalization, reorganization, merger or consolidation or applicable subsequent offerings. The warrants will be adjusted for issuances
of common stock at prices below its exercise price provided that the adjustment will not result in the exercise price being lower than
$1.88, which is 50% of the assumed public offering price of $3.75 per unit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 91 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Exercisability</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants are exercisable at any time after
their original issuance and at any time up to the date that is five years after their original issuance. The warrants may be exercised
upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, by utilizing the exercise
form on the reverse side of the warrant certificate completing and executing as indicated, accompanied by full payment of the exercise
price, by certified or official bank check payable to us, for the number of warrants being exercised. Under the terms of the Warrant Agent
Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to
common stock issuable upon exercise of the warrants until the expiration of the warrants. If we fail to maintain the effectiveness of
the registration statement and current prospectus relating to the common stock issuable upon exercise of the warrants, the holders of
the warrants shall have the right to exercise the warrants solely via a cashless exercise feature provided for in the warrants, until
such time as there is an effective registration statement and current prospectus relating to common stock issuable upon exercise of the
warrants.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Exercise Limitation</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A holder may not exercise any portion of a warrant
to the extent that the holder, together with its affiliates and any other person or entity acting as a group, would own more than 4.99%
of the outstanding common stock after exercise, as such percentage ownership is determined in accordance with the terms of the warrant,
except that upon prior notice from the holder to us, the holder may waive such limitation up to a percentage not in excess of 9.99%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Exercise Price</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price per whole share of common
stock purchasable upon exercise of the warrants is $4.13 per share (based on an assumed public offering price of $3.75
per unit) or 110% of the public offering price of the common stock. The exercise price is subject to appropriate adjustment in the event
of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting our common
stock and also upon any distributions of assets, including cash, stock or other property to our stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Reset Price</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If, on the date that is 90 calendar days immediately
following the initial exercise date, the reset price, which means the greater of (i) 50% of the exercise price and (ii) 100% of the last
volume weighted average price immediately preceding the 90<sup>th</sup>&#160;calendar day following the initial exercise date, is less
than the exercise price at such time, the exercise price shall be decreased to the reset price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Voluntary Adjustment</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the rules and regulations of the
trading market, the Company may at any time during the term of the warrants, subject to the prior written consent of the holder, reduce
the then current exercise price to any amount and for any period of time deemed appropriate by the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Fractional Shares</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No fractional warrant shares or scrip representing
fractional warrant shares shall be issued upon the exercise of the warrant. As to any fraction of a share which the holder would otherwise
be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final
fraction in an amount equal to such fraction multiplied by the exercise price or round up to the next whole warrant share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 92 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Transferability</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to applicable laws, the warrants may be
offered for sale, sold, transferred or assigned without our consent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Warrant Agent; Global Certificate</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants will be issued in registered form
under a Warrant Agent Agreement between the warrant agent and us. The warrants shall initially be represented only by one or more global
warrants deposited with the warrant agent, as custodian on behalf of The Depository Trust Company (DTC) and registered in the name of
CEDE, a nominee of DTC, or as otherwise directed by DTC. Our transfer agent, Mountain Share Transfer, LLC, will serve as the warrant agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Fundamental Transactions</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a fundamental transaction, as
described in the warrants and generally including any reorganization, recapitalization or reclassification of our common stock, the sale,
transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another
person, the acquisition of more than 50% of our outstanding common stock, or any person or group becoming the beneficial owner of 50%
of the voting power represented by our outstanding common stock, the holders of the warrants will be entitled to receive the kind and
amount of securities, cash or other property that the holders would have received had they exercised the warrants immediately prior to
such fundamental transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Callable</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reserves the right to redeem all
or a portion, on a pro rata basis, the outstanding warrants, at any time and from time to time prior to their exercise, with a notice
of redemption in writing to the holders (the &#8220;Redemption Notice&#8221;), giving not less than thirty (30) days&#8217; notice of
such redemption at any time during which the warrants are exercisable (the &#8220;Notice Period&#8221;) if the ten (10)-day average volume
weighted average price (&#8220;VWAP&#8221;) of the common stock is at or above 250% of the exercise price, as adjusted pursuant to the
terms of the warrant, and the shares of common stock issuable upon exercise of the warrant have been registered pursuant to an effective
registration statement with the SEC. The redemption price of the warrant shall be equal to 250% of the exercise price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Participation Rights</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither the Company nor any of its subsidiaries
shall, directly or indirectly, issue, offer, sell, grant any option or right to purchase, or otherwise dispose of (or announce any issuance,
offer, sale, grant of any option or right to purchase or other disposition of) any equity security or any equity-linked or related security
(including, without limitation, any &#8220;equity security&#8221; (as that term is defined under Rule 405 promulgated under the Securities
Act)), any convertible securities, any debt, any preferred shares or any purchase rights unless the Company shall have first delivered
to each holder that beneficially owns at least [&#8226;] warrants as of the time the Company engaged in a Subsequent Placement a written
notice notifying the holder of his, her or its rights to participate in the Subsequent Placement pursuant to the terms of the warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Rights as a Stockholder</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrant holders do not have the rights or
privileges of holders of common stock or any voting rights until they exercise their warrants and receive shares of common stock. After
the issuance of shares of common stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of
record on all matters to be voted on by stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Governing Law</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants and the Warrant Agent Agreement are
governed by New York law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 93 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Representative Warrants</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The registration statement of which this prospectus
is a part also registers for sale the Representative Warrants, as a portion of the underwriting compensation in connection with this
offering. The Representative Warrants will be exercisable for a five-year period commencing 180 days following the commencement of sales
pursuant to the registration statement of which this prospectus is a part at an exercise price of $4.13 (110% of the assumed public
offering price per unit). See &#8220;<i>Underwriting</i>&#8221; for a description of the Representative Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Series A Warrants and Class A Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series A Warrants and Class A Warrants
are exercisable into shares of the Company&#8217;s common stock at a price of $0.75 per share at any time and from time to time from
the date of grant until April 23, 2026. The exercise price and number of shares issuable upon exercise of the Series A Warrants and Class
A Warrants shall be subject to adjustment from time to time upon the occurrence of certain events, including, without limitation, subdividing
outstanding shares of common stock or being acquired by another person or entity. The Series A Warrants and Class A Warrants contain
either (i) &#8220;piggyback&#8221; and demand registration rights regarding the warrants and the shares of common stock issuable upon
the exercise of the warrants and redemption rights, or (ii) a combination of preemptive, &#8220;piggyback&#8221; registration and redemption
rights for shares underlying the warrants. The Series A Warrant and Class A Warrant holders have waived their preemptive and registration
rights in connection with this offering in exchange for the Company extending the expiration date of the Series A Warrants and Class
A Warrants for one year to April 23, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Class B Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Class B Warrants are exercisable into
shares of the Company&#8217;s common stock at a price of $1.50 per warrant at any time and from time to time from the date of grant until
April 23, 2026. The exercise price and number of shares issuable upon exercise of the Class B Warrants shall be subject to adjustment
from time to time upon the occurrence of certain events, including, without limitation, subdividing outstanding shares of common stock
or being acquired by another person or entity. The Class B Warrants contain &#8220;piggyback&#8221; registration rights regarding the
Class B Warrants and the shares of common stock issuable upon the exercise of the Class B Warrants. The Class B Warrant holders have
waived their registration rights in connection with this offering in exchange for the Company extending the expiration date of the Class
B Warrants for one year to April 23, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Class C Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Each
Class C Warrant is exercisable to purchase one share of common stock for $3.75 per share from the date of vesting in each installment
until the third anniversary date of the date of vesting.</span> The exercise price and number of shares issuable upon exercise of the
Class C Warrants shall be subject to adjustment from time to time upon the occurrence of certain events, including, without limitation,
subdividing outstanding shares of common stock or being acquired by another person or entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Class D Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Each
Class D Warrant is exercisable to purchase one share of common stock for $7.50 from the date of vesting in each installment until the
third anniversary date of the date of vesting.</span> The exercise price and number of shares issuable upon exercise of the Class D Warrants
shall be subject to adjustment from time to time upon the occurrence of certain events, including, without limitation, subdividing outstanding
shares of common stock or being acquired by another person or entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>2018 Award Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2018, the Board adopted the
2018 Nocera, Inc. Stock Option and Award Incentive Plan (the &#8220;2018 Plan&#8221;), pursuant to which 10,000,000 shares of our common
stock are reserved for issuance as awards to our employees, directors, consultants and other service providers. The number of shares
of common stock reserved under the 2018 Plan was subsequently reduced to 6,666,667 as a result of the Company&#8217;s 2-for-3 reverse
stock split on [&#8226;], 2022. Under the 2018 Plan, we are authorized to issue incentive stock options, non-qualified stock options,
stock appreciation rights, performance shares, restricted stock, and stock awards. The incentive stock options may only be granted to
employees. Non-statutory stock options, stock appreciation rights, performance shares, restricted stock, and stock awards may be granted
to employees, directors and consultants. The 2018 Plan is administered by the Compensation Committee. The 2018 Plan was ratified by our
stockholders in 2018. As of [&#8226;], 2022, the total amount of shares of common stock authorized and reserved for issuance under the
2018 Plan is 6,666,667. No awards have been granted to any of our officers or directors pursuant to the 2018 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 94 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Options</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2022, the Company had
not issued any stock options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nevada Business Combination Statutes</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The &#8220;business combination&#8221; provisions
of Sections 78.411 to 78.444, inclusive, of the Nevada Revised Statutes, (the &#8220;NRS&#8221;), generally prohibit a Nevada corporation
with at least 200 stockholders of record from engaging in various &#8220;combination&#8221; transactions with any interested stockholder
for a period of two years after the date of the transaction in which the person became an interested stockholder, unless the transaction
is approved by the Board prior to the date the interested stockholder obtained such status or the combination is approved by the Board
and thereafter is approved at a meeting of the stockholders by the affirmative vote of stockholders representing at least 60% of the outstanding
voting power held by disinterested stockholders, and extends beyond the expiration of the two-year period, unless:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 92%; text-align: justify">the combination was approved by the Board prior to the person becoming an interested stockholder or the transaction by which the person first became an interested stockholder was approved by the Board before the person became an interested stockholder or the combination is later approved by a majority of the voting power held by disinterested stockholders; or</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify">if the consideration to be paid by the interested stockholder is at least equal to the highest of: (a) the highest price per share paid by the interested stockholder within the two years immediately preceding the date of the announcement of the combination or in the transaction in which it became an interested stockholder, whichever is higher, (b) the market value per share of common stock on the date of announcement of the combination and the date the interested stockholder acquired the shares, whichever is higher, or (c) for holders of preferred stock, the highest liquidation value of the preferred stock, if it is higher.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A &#8220;combination&#8221; is generally defined
to include mergers or consolidations or any sale, lease exchange, mortgage, pledge, transfer, or other disposition, in one transaction
or a series of transactions, with an &#8220;interested stockholder&#8221; having: (a) an aggregate market value equal to 5% or more of
the aggregate market value of the assets of the corporation, (b) an aggregate market value equal to 5% or more of the aggregate market
value of all outstanding voting shares of the corporation, (c) more than 10% of the earning power or net income of the corporation, and
(d) certain other transactions with an interested stockholder or an affiliate or associate of an interested stockholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In general, an &#8220;interested stockholder&#8221;
is a person who, together with affiliates and associates, beneficially owns (or within two years, did own) 10% or more of the voting power
of the outstanding voting shares of a corporation. The statute could prohibit or delay mergers or other takeover or change in control
attempts and, accordingly, may discourage attempts to acquire us even though such a transaction may offer our stockholders the opportunity
to sell their stock at a price above the prevailing market price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nevada Control Share Acquisition Statutes</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The &#8220;control share&#8221; provisions of
Sections 78.378 to 78.3793, inclusive, of the NRS apply to &#8220;issuing corporations&#8221; that are Nevada corporations with at least
200 stockholders of record, including at least 100 stockholders of record who are Nevada residents, and that conduct business in Nevada
directly or through an affiliated corporation. The control share statute prohibits an acquirer, under certain circumstances, from voting
its shares of a target corporation&#8217;s stock after crossing certain ownership threshold percentages, unless the acquirer obtains approval
of the target corporation&#8217;s disinterested stockholders. The statute specifies three thresholds: one-fifth or more but less than
one-third, one-third or more but less than a majority, and a majority or more, of the outstanding voting power. Generally, once an acquirer
crosses one of the above thresholds, those shares in an offer or acquisition and acquired within 90 days thereof become &#8220;control
shares&#8221; and such control shares are deprived of the right to vote until disinterested stockholders restore the right. These provisions
also provide that if control shares are accorded full voting rights and the acquiring person has acquired a majority or more of all voting
power, all other stockholders who do not vote in favor of authorizing voting rights to the control shares are entitled to demand payment
for the fair value of their shares in accordance with statutory procedures established for dissenters&#8217; rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A corporation may elect to not be governed by,
or &#8220;opt out&#8221; of, the control share provisions by making an election in its articles of incorporation or bylaws, provided that
the opt-out election must be in place on the 10th day following the date an acquiring person has acquired a controlling interest, that
is, crossing any of the three thresholds described above. We have not opted out of the control share statutes, and will be subject to
these statutes if we are an &#8220;issuing corporation&#8221; as defined in such statutes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The effect of the Nevada control share statutes
is that the acquiring person, and those acting in association with the acquiring person, will obtain only such voting rights in the control
shares as are conferred by a resolution of the stockholders at an annual or special meeting. The Nevada control share law, if applicable,
could have the effect of discouraging takeovers of us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Transfer Agent and Registrar</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transfer agent and registrar for our common
stock will be Mountain Share Transfer, LLC located at 2030 Powers Ferry Rd SE Ste 212, Atlanta, GA 30339. Our transfer agent will also
be the warrant agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Nasdaq Capital Market Listing Application; Alternative Initial
Listing Standard</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have applied to have our common stock listed
on the Nasdaq Capital Market under the symbol &#8220;NCRA,&#8221; which listing is a condition for this offering. Given the price range
per unit in this offering and the required pricing methodology of Nasdaq for public offerings that contain a warrant, we have applied
to Nasdaq under the alternative initial listing standard pursuant to Nasdaq Rule 5550(a)(1)(B) r<span style="color: #3D3D3D; background-color: white">ather
than the $4.00 closing price listing standard. There can be no assurance Nasdaq will approve our listing application. We do not
intend to apply for listing of the warrants on any exchange or market. We will not proceed with this offering if the common stock is
not approved for listing on Nasdaq or another securities exchange.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A company that qualifies for initial listing
only under Nasdaq&#8217;s alternative listing standard could become a &#8220;penny stock&#8221; if it later fails the net tangible assets
and revenue tests after listing and does not satisfy any of the other exclusions from being a penny stock contained in Rule 3a51-1 under
the Act. In order to assist brokers&#8217; and dealers&#8217; compliance with the requirements of the penny stock rules, Nasdaq monitors
companies listed under the alternative requirement and publish on its website on a daily basis a list of any company that initially listed
under the alternative requirement, which no longer satisfies the net tangible assets or revenue test contained in Rule 5505(a)(1)(B),
and which does not satisfy any of the other exclusions from being a penny stock contained in Rule 3a51-1 under the Act. If a company
initially lists with a bid price below $4.00 under the alternative requirement contained in Rule 5505(a)(1)(B), but subsequently achieves
a $4.00 closing price for at least five consecutive business days and, at the same time, satisfies all other initial listing criteria,
it will no longer be considered as having listed under the alternative requirement and Nasdaq will notify the Company that it has qualified
for listing under the price requirement contained in Rule 5505(a)(1)(A). Although we the other listing requirements of Nasdaq, there
can be no assurances that our stock will achieve a $4.00 closing price for at least five consecutive business days.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Penny Stock Regulation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC has adopted regulations that generally
define &#8220;<i>penny stock</i>&#8221; to be any equity security that has a market price of less than Five Dollars ($5.00) per share
or an exercise price of less than Five Dollars ($5.00) per share. Such securities are subject to rules that impose additional sales practice
requirements on broker-dealers who sell them. For transactions covered by these rules, the broker-dealer must make a special suitability
determination for the purchaser of such securities and have received the purchaser&#8217;s written consent to the transaction prior to
the purchase. Additionally, for any transaction involving a penny stock, unless exempt, the rules require the delivery, prior to the transaction,
of a disclosure schedule prepared by the SEC relating to the penny stock market. The broker-dealer also must disclose the commissions
payable to both the broker-dealer and the registered representative, current quotations for the securities and, if the broker-dealer is
the sole market maker, the broker-dealer must disclose this fact and the broker-dealer&#8217;s presumed control over the market. Finally,
among other requirements, monthly statements must be sent disclosing recent price information for the penny stock held in the account
and information on the limited market in penny stocks. As our common stock immediately following this offering may be subject to such
penny stock rules, purchasers in this offering will in all likelihood find it more difficult to sell their common stock shares in the
secondary market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Dividend Policy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To date, we have never declared a dividend for
our common stock. We currently intend to retain future earnings, if any, to finance the expansion of our business and for general corporate
purposes. We cannot assure you that we will distribute any cash in the future. Our cash distribution policy is within the discretion of
our Board and will depend upon various factors, including our results of operations, financial condition, capital requirements and investment
opportunities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s22"></span>SHARES ELIGIBLE
FOR FUTURE SALE</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to this offering, only a limited public
market for our common stock existed on the OTC pink sheets. We cannot predict the effect, if any, that market sales of shares of our common
stock or the availability of shares of our common stock for sale will have on the market price of our common stock prevailing from time
to time. Sales of substantial amounts of our common stock, including shares issued upon exercise of outstanding warrants, in the public
market after this offering, could adversely affect market prices prevailing from time to time and could impair our ability to raise capital
through the sale of our equity securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon the closing of this offering, we will have
9,488,100 shares of our common stock outstanding pursuant to this offering (assuming no exercise of the underwriter&#8217;s option
to purchase additional shares of common stock and warrants).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All previously issued shares of common stock that
were not offered and sold as part of the units in this offering, are or will be upon issuance, &#8220;restricted securities,&#8221; as
that term is defined in Rule 144 under the Securities Act. These restricted securities are eligible for public sale only if such public
resale is registered under the Securities Act or if the resale qualifies for an exemption from registration under Rule 144 under the Securities
Act, which is summarized below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In general, a person who has beneficially owned
restricted shares of our common stock for at least six months in the event we have been a reporting company under the Exchange Act for
at least ninety (90) days before the sale, would be entitled to sell such securities, provided that such person is not deemed to be an
affiliate of ours at the time of sale or to have been an affiliate of ours at any time during the ninety (90) days preceding the sale.
A person who is an affiliate of ours at such time would be subject to additional restrictions, by which such person would be entitled
to sell within any three-month period only a number of shares that does not exceed the greater of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">1% of the number of shares of our common stock then outstanding; or</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">1% of the average weekly trading volume of our common stock during the four calendar weeks preceding the
filing by such person of a notice on Form 144 with respect to the sale;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">provided that, in each case, we are subject to
the periodic reporting requirements of the Exchange Act for at least 90 days before the sale. Rule 144 trades must also comply with the
manner of sale, notice and other provisions of Rule 144, to the extent applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Historically, the SEC has taken the position that
Rule 144 under the Securities Act is not available for the resale of securities initially issued by companies that are, or previously
were, blank check companies to their promoters or affiliates despite technical compliance with the requirements of Rule 144. The SEC has
codified and expanded this position in its amendments effective on February 15, 2008, which applies to securities acquired both before
and after that date by prohibiting the use of Rule 144 for the resale of securities issued by shell companies (other than business transaction
related shell companies) or issuers that have been at any time previously a shell company. The SEC has provided an important exception
to this prohibition, however, if the following conditions are met:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">the issuer of the securities that was formerly a shell company has ceased to be a shell company;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange
Act;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">the issuer of the securities has filed all Exchange Act reports and material required to be filed, as
applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other
than Form 8-K reports; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">at least one year has elapsed from the time that the issuer filed current Form 10 type information with
the SEC reflecting its status as an entity that is not a shell company.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In addition, for proposed
sales under Rule 144(i), there must be adequate current publicly available information about the issuing company before the sale can be
made. For reporting companies, this generally means that the companies have complied with the periodic reporting requirements of the Exchange
Act. As such, due to the fact that we were a shell company until the effective time of the reverse merger, holders of &#8220;restricted
securities&#8221; within the meaning of Rule 144 will be subject to the above conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s23"></span>UNDERWRITING</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the terms and conditions set forth
in the underwriting agreement between us and the underwriters named below, for which Spartan Capital Securities, LLC (&#8220;Spartan
Capital&#8221;) and Revere Securities LLC (&#8220;Revere Securities&#8221;) are acting as representatives (the &#8220;Representatives&#8221;),
each underwriter named below has severally agreed to purchase, and we have agreed to sell to the underwriters, the following respective
number of shares of common stock and warrants listed next to the underwriter&#8217;s name in the following table.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; width: 66%; font-weight: bold; text-align: left">Underwriters</td><td style="padding-bottom: 1pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 13%; font-weight: bold; text-align: center"><b>Number of<br /> Shares</b></td><td style="padding-bottom: 1pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 13%; font-weight: bold; text-align: center"><b>Number of<br /> Warrants</b></td><td style="padding-bottom: 1pt; width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Spartan Capital Securities, LLC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">[ <span style="font-family: Symbol">&#183;</span>]</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">[ <span style="font-family: Symbol">&#183;</span>]</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Revere Securities LLC</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">[ <span style="font-family: Symbol">&#183;</span>]</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">[ <span style="font-family: Symbol">&#183;</span>]</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-left: 17.95pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">[ <span style="font-family: Symbol">&#183;</span>]</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">[ <span style="font-family: Symbol">&#183;</span>]</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms of the underwriting agreement,
the underwriters are committed to purchasing all of the units offered by this prospectus if the underwriters buy any such units. The underwriters&#8217;
obligation to purchase the units is subject to satisfaction of certain conditions, including, among others, the continued accuracy of
representations and warranties made by us in the underwriting agreement, delivery of legal opinions and the absence of any material changes
in our assets, business or prospects after the date of this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The underwriters initially propose to offer our
units directly to the public at the public offering price set forth on the front cover page of this prospectus and to certain dealers
at such offering price less a concession not to exceed $[<span style="font-family: Symbol">&#183;</span>] per unit. After the initial public offering of the units, the offering
price and other selling terms may be changed by the underwriters. Sales of units made outside the United States may be made by affiliates
of certain of the underwriters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Over-Allotment Option</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have granted the underwriters an option <span style="background-color: white">exercisable
one or more times in whole or in part, not later than 45 days after the date of this prospectus, to purchase from us</span> up to an
aggregate of 352,500 additional shares of our common stock and 352,500 warrants, <span style="background-color: white">in each
case, less the underwriting discounts and commissions set forth on the cover of this prospectus in any combination thereof to cover over-allotments,
if any. To the extent that the Representatives exercise this option, each of the underwriters will become obligated, subject to conditions,
to purchase approximately the same percentage of these additional shares of common stock and warrants as the number of units to be purchased
by it in the above table bears to the total number of units offered by this prospectus. We will be obligated, pursuant to the option,
to sell these additional shares of common stock and warrants to the underwriters to the extent the option is exercised. If any additional
shares of common stock and warrants are purchased, the underwriters will offer the additional shares of common stock and warrants on
the same terms as those on which the other units are being offered hereunder. If this option is exercised in full, the total offering
price to the public will be approximately $1.3 million and the total net proceeds, before expenses and after the credit to the underwriting
commissions described below, to us will be approximately $1.2 million.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: normal"><span style="background-color: white"></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Underwriting Discount</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows the per unit and total
underwriting discount we will pay to the underwriters assuming both no exercise and full exercise of the underwriters&#8217; over-allotment
option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>No<br /> Exercise of Over-Allotment Option</b></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Full<br /> Exercise of Over-Allotment Option</b></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%">Public offering price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Underwriting discount to be paid by us (1)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Proceeds, before expenses, to us</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) Represents a blended underwriting discount
for all units. The underwriters will receive an underwriting discount equal to 8.0% on units sold in this offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have also agreed to reimburse the Representatives
for certain fees and expenses incurred by the Representatives in connection with the offering, and any amounts not actually incurred
will be reimbursed to us. We have paid an expense deposit of $10,000 to the Representatives, which will be applied against the actual
accountable expenses that will be payable by us to the Representatives in connection with this offering. We will pay a maximum of $150,000
for fees and expenses including &#8220;road show,&#8221; diligence, and legal fees and disbursements incurred by the Representatives
in connection with the offering, and other out-of-pocket expenses, plus the costs associated with the use of a third-party electronic
road show service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We estimate that the total expenses of the offering
payable by us, not including the underwriting discount, will be approximately $375,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stabilization</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with Regulation M under
the Exchange Act, the underwriters may engage in activities that stabilize, maintain or otherwise affect the price of our common
stock, including short sales and purchases to cover positions created by short positions, stabilizing transactions, syndicate
covering transactions, penalty bids and passive market making.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 92%; text-align: justify">Short positions involve sales by the underwriters of shares in excess of the number of shares the underwriters are obligated to purchase, which creates a syndicate short position. The short position may be either a covered short position or a naked short position. In a covered short position, the number of shares involved in the sales made by the underwriters in excess of the number of shares they are obligated to purchase is not greater than the number of shares that they may purchase by exercising their option to purchase additional shares. In a naked short position, the number of shares involved is greater than the number of shares in their option to purchase additional shares. The underwriters may close out any short position by either exercising their option to purchase additional shares or purchasing shares in the open market.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">Stabilizing transactions permit bids to purchase the underlying security as long as the stabilizing bids do not exceed a specific maximum price.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">Syndicate covering transactions involve purchases of our common stock in the open market after the distribution has been completed to cover syndicate short positions. In determining the source of shares to close out the short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the underwriters&#8217; option to purchase additional shares. If the underwriters sell more shares than could be covered by the underwriters&#8217; option to purchase additional shares, thereby creating a naked short position, the position can only be closed out by buying shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there could be downward pressure on the price of the shares in the open market after pricing that could adversely affect investors who purchase in the offering.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">Penalty bids permit the Representatives to reclaim a selling concession from a syndicate member when the common stock originally sold by the syndicate member is purchased in a stabilizing or syndicate covering transaction to cover syndicate short positions.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">In passive market making, market makers in our common stock who are underwriters or prospective underwriters may, subject to limitations, make bids for or purchase shares of our common stock until the time, if any, at which a stabilizing bid is made.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These activities may have the effect of raising
or maintaining the market price of our common stock or preventing or retarding a decline in the market price of our common stock. As a
result of these activities, the price of our common stock may be higher than the price that might otherwise exist in the open market.
These transactions may be effected on The Nasdaq Capital Market or otherwise and, if commenced, may be discontinued at any time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither we nor any of the underwriters make any
representation or prediction as to the direction or magnitude of any effect that the transactions described above may have on the price
of our common stock. In addition, neither we nor any of the underwriters make any representation that the Representatives will engage
in these stabilizing transactions or that any transaction, once commenced, will not be discontinued without notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Indemnification</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We and the underwriters have agreed to indemnify
each other against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the underwriters
may be required to make in respect of such liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 99 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Discretionary Accounts</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The underwriters have informed us that they do
not expect to make sales to accounts over which they exercise discretionary authority in excess of 5% of the units being offered in this
offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Determination of Offering Price</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to this offering, there has been a limited
public market for our common stock. Our common stock currently trades on the OTC, where it is quoted under the symbol &#8220;NCRA.&#8221;
The public offering price of the units, including the exercise price of the warrants, will be negotiated between us and the Representatives.
In determining the public offering price, the following factors to be considered included the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; width: 92%">the information set forth in this prospectus and otherwise available to the Representatives;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">the history and prospects for our Company and the industry in which we compete;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">our management, its past and present operations, and the prospects for, and timing of, our future revenues;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">our financial and operating information;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">our present state of development;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">valuation multiples of publicly traded companies that the Representatives believe comparable to ours; and</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">the above factors in relation to market values and various valuation measures of other companies engaged in activities similar to ours.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither we nor the Representatives can assure
investors that an active trading market will continue to exist for shares of our common stock or the warrants, or that the common
stock will trade in the public market at or above the public offering price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Representative Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, as additional compensation, we agreed
to issue warrants to Spartan Capital and Revere Securities or its designees to purchase a number of shares of our common stock equal
to a total of 5% of the aggregate number of shares of our common stock sold in this offering <span style="background-color: white">(including
shares of common stock and warrants sold to cover over-allotments, if any)</span>, at an exercise price equal to 110% of the public offering
price of the units sold in this offering exercisable after the 180<sup>th</sup> day after the commencement of sales of units in this
offering until the four and half year anniversary of initial exercise date. We are registering hereby the issuance of the Representative
Warrants and the shares of common stock issuable upon exercise of such warrants. The Representative Warrants cannot be exercised, sold,
transferred, assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that
would result in the effective economic disposition of the securities for a period of 180 days beginning on the commencement of such sales
in compliance with FINRA Rule 5110(g)(8)(A). The Representative Warrants will provide for unlimited &#8220;piggyback&#8221; registration
rights for a period of seven years following the commencement of sales pursuant to the registration statement of which this prospectus
is a part in compliance with FINRA Rule 5110(g)(8)(D), cashless exercise provisions, and customary anti-dilution provisions (for stock
dividends and splits and recapitalizations) and anti-dilution protection (adjustment in the number and price of such warrants and the
shares underlying such warrants) resulting from corporate events (which would include dividends, reorganizations, mergers, etc.) and
future issuance of common stock or common stock equivalents at prices (or with exercise and/or conversion prices) below the offering
price as permitted under FINRA Rule 5110(g)(8)(E).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tail Financing</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If, during the 12 month period following the closing
of this offering, we consummate a financing with investors with whom Spartan Capital had contacted or introduced to us during the period
in which we engaged Spartan Capital, we will pay Spartan Capital a fee equal to 8% of the proceeds of such financing and warrants to purchase
a number of shares of our common stock equal to 5% of the aggregate number of shares of our common stock sold in such offering at an exercise
price equal to 110% of the offering price of the shares of our common stock sold in such offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 100 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Right of First Refusal</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Until 12 months from the closing date of this
offering, if the Company or any of its subsidiaries (a) decides to dispose of or acquire business units or acquire any of its outstanding
securities or make any exchange or tender offer or enter into a merger, consolidation or other business combination or any recapitalization,
reorganization, restructuring or other similar transaction, including, without limitation, an extraordinary dividend or distributions
or a spin-off or split-off, and the Company decides to retain a financial advisor for such transaction, Spartan Capital shall have the
right to act as the Company&#8217;s exclusive financial advisors for any such transaction; or (b) decides to finance or refinance any
indebtedness using a manager or agent, Spartan Capital shall have the right to act as joint book-runners, joint managers, joint placement
agents or joint agents with respect to such financing or refinancing; or (c) decides to raise funds by means of a public offering (including
at-the-market facility) or a private placement or any other capital-raising financing of equity, equity-linked or debt securities using
an underwriter or placement agent, Spartan Capital shall have the right to act as joint book-running managers, joint underwriters or joint
placement agent for such financing, in any event on terms and conditions customary for such transactions of a similar size and nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lock-Up Agreements</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have agreed that for a period of 18 months
after the closing of this offering, we and any of our successors will not, without the prior written consent of Spartan Capital,
which may be withheld or delayed in Spartan Capital&#8217;s sole discretion:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 92%; text-align: justify">offer, issue, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 92%; text-align: justify">enter into any swap or other arrangement that transfers to another entity, in whole or in part, any of the economic consequences of ownership of any of our common stock or such other securities, whether any such transaction described above is to be settled by delivery of shares of our capital stock or such other securities, in cash or otherwise; </td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">complete any offering of debt securities of the Company, other than entering into a line of credit with a traditional bank; or</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">file with the SEC a registration statement under the Securities Act relating to, any shares of our common stock or any securities convertible into or exercisable or exchangeable for common stock.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing restrictions will not apply to
(1) the shares of common stock to be sold under this prospectus, (2) the issuance of common stock upon the exercise of warrants or the
conversion of outstanding preferred stock or other outstanding convertible securities disclosed as outstanding in the registration statement
of which this prospectus is a part, the time of sale disclosure package, and the final prospectus, (3) the issuance of employee stock
options not exercisable during the lock-up period and the grant of restricted stock awards or restricted stock units or shares of common
stock pursuant to equity incentive plans described in the registration statement (excluding exhibits thereto), or the time of sale disclosure
package and final prospectus, (4) the filing of a registration statement on Form S-8 or any successor form thereto, (5) the issuance
of unregistered securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors
of the Company, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising more
than $500,000 in capital or to an entity whose primary business is investing in securities, and (6) the issuance of unregistered securities
in payment or settlement of trade payables, contractor fees, or legal proceedings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each of our directors, executive officers and
substantially all holders of more than 5% of our outstanding common stock as of the effective date of this registration statement, has
entered into lock-up agreements with the Representatives prior to the commencement of this offering pursuant to which each of these persons
or entities has agreed that, for a period ending 18 months after the date of this prospectus (subject to the leak-out provisions,
as applicable), none of them will, without the prior written consent of the Representatives (which may be withheld or delayed in the
Representative sole discretion):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 92%; text-align: justify">offer, pledge, announce the intention to sell, sell, contract to sell, sell
any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise
transfer or dispose of, directly or indirectly, or file (or participate in the filing of) a registration statement with the SEC in respect
of, any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock (including
without limitation, shares of common stock which may be deemed to be beneficially owned by the undersigned in accordance with the rules
and regulations of the SEC and the securities which may be issued upon exercise of a stock option or warrant);</td></tr>
</table>

<p style="margin: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 5%">&#160;</td>
    <td style="text-align: justify; width: 3%"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; width: 92%">enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the shares of, whether any such transaction is to be settled by delivery of shares of common stock or such other securities, in cash or otherwise;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">make any demand for or exercise any right with respect to, the registration of any shares of common
    stock or any security convertible into or exercisable or exchangeable for shares of common stock; or</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">publicly announce an intention to effect any transaction specified above.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The restrictions described in the immediately
preceding paragraph and contained in the lock-up agreements do not apply, subject in certain cases to various conditions, to the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 92%; text-align: justify">transfers as a bona fide gift or gifts, provided that the donee or donees agree to be bound in writing by the above restrictions;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">transfers to any trust for the direct or indirect benefit of the locked-up person or the immediate
    family of the locked-up person, provided that the trustee of the trust agrees to be bound in writing by the above restrictions, and
    provided further that any such transfer will not involve a disposition for value; or</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">the acquisition or exercise of any stock option issued pursuant to the Company&#8217;s existing stock option plan, including any exercise effected by the delivery of shares of common stock of the Company held by the locked-up person, or (c) the purchase or sale of the Company&#8217;s securities pursuant to a plan, contract or instruction that satisfies all of the requirements of Rule 10b5-1(c)(1)(i)(B) of the Exchange Act.</td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indemnification</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have agreed to indemnify the underwriters against
certain liabilities, including certain liabilities under the Securities Act. If we are unable to provide this indemnification, we have
agreed to contribute to payments the underwriters may be required to make in respect of those liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other Relationships</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Some of the underwriters and their affiliates
have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business
with us or our affiliates. They have received, or may in the future receive, customary fees and commissions for these transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nasdaq Capital Market Listing Application</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have applied to have our common stock listed
on the Nasdaq Capital Market under the symbol &#8220;NCRA,&#8221; which listing is a condition to this offering. We do not intend to
apply for listing of the warrants on any exchange or market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Electronic Distribution</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A prospectus in electronic format may be made
available on websites maintained by one or more of the underwriters of this offering, or by their affiliates. A prospectus in electronic
format may be made available on the websites maintained by one or more of the underwriters or selling group members, if any, participating
in the offering. The Representatives may allocate a number of shares to the underwriters and selling group members, if any, for sale to
their online brokerage account holders. Any such allocations for online distributions will be made by the Representatives on the same
basis as other allocations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Selling
Restrictions</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No action has been taken in any jurisdiction (except
in the United States) that would permit a public offering of the units or the possession, circulation or distribution of this prospectus
or any other material relating to us or the units in any jurisdiction where action for that purpose is required. Accordingly, the units
may not be offered or sold, directly or indirectly, and neither this prospectus nor any other material or advertisements in connection
with the units may be distributed or published, in or from any country or jurisdiction except in compliance with any applicable laws,
rules and regulations of any such country or jurisdiction.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 102 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>People&#8217;s Republic of China</i></b><i>.</i>
This prospectus may not be circulated or distributed in the PRC and the units may not be offered or sold, and will not offer or sell to
any person for re-offering or resale directly or indirectly to any resident of the PRC except pursuant to applicable laws, rules and regulations
of the PRC. For the purpose of this paragraph only, the PRC does not include Taiwan and the special administrative regions of Hong Kong
and Macau.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Taiwan</i></b><i>.</i> The units have not
been and will not be registered with the Financial Supervisory Commission of Taiwan pursuant to relevant securities laws and regulations
and may not be sold, issued or offered within Taiwan through a public offering or in circumstances which constitutes an offer within the
meaning of the Securities and Exchange Act of Taiwan that requires a registration or approval of the Financial Supervisory Commission
of Taiwan. No person or entity in Taiwan has been authorized to offer, sell, give advice regarding or otherwise intermediate the offering
and sale of the units in Taiwan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Canada</i></b><i>.</i> The units may be
sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National
Instrument 45 106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in
National Instrument&#160;31 103&#160;Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the securities
must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities
laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities legislation in certain provinces or
territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus supplement (including any amendment
thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the
time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The purchaser should refer to any applicable provisions
of the securities legislation of the purchaser&#8217;s province or territory for particulars of these rights or consult with a legal advisor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to section 3A.3 of National Instrument
33 105 Underwriting Conflicts (NI 33 105), the underwriters are not required to comply with the disclosure requirements of NI 33 105 regarding
underwriter conflicts of interest in connection with this offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>European Economic Area</i></b><i>.</i> In
relation to each Member State of the European Economic Area which has implemented the Prospectus Directive, each, a Relevant Member State,
an offer to the public of any units may not be made in that Relevant Member State, except that an offer to the public in that Relevant
Member State of any units may be made at any time under the following exemptions under the Prospectus Directive, if they have been implemented
in that Relevant Member State:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 92%; text-align: justify">to any legal entity which is a qualified investor as defined in the Prospectus Directive;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">to fewer than 100 or, if the Relevant Member State has implemented the relevant provision of the 2010 PD Amending Directive, 150, natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted under the Prospectus Directive, subject to obtaining the prior consent of the Representatives for any such offer; or</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">in any other circumstances falling within Article&#160;3(2) of the Prospectus Directive, provided that no such offer of units shall result in a requirement for the publication by us or any underwriter of a prospectus pursuant to Article&#160;3 of the Prospectus Directive.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purposes of this provision, the expression
an &#8220;offer to the public&#8221; in relation to any units and the warrants in any Relevant Member State means the communication in
any form and by any means of sufficient information on the terms of the offer and any units to be offered so as to enable an investor
to decide to purchase any units, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in
that Member State, the expression &#8220;Prospectus Directive&#8221; means Directive 2003/71/EC (and amendments thereto, including the
2010 PD Amending Directive, to the extent implemented in the Relevant Member State), and includes any relevant implementing measure in
the Relevant Member State, and the expression &#8220;2010 PD Amending Directive&#8221; means Directive 2010/73/EU.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 103 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>United Kingdom. </i></b>Each underwriter
has represented and agreed that:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%; text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 92%; text-align: justify">it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section&#160;21 of the Financial Services and Markets Act 2000, or FSMA) received by it in connection with the issue or sale of the units in circumstances in which Section&#160;21(1) of the FSMA does not apply to us; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the units in, from or otherwise involving the United Kingdom.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Switzerland</i></b>. The units may not be
publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange, or the SIX, or on any other stock exchange or regulated
trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses
under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of
the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document
nor any other offering or marketing material relating to the units or the offering may be publicly distributed or otherwise made publicly
available in Switzerland.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither this document nor any other offering or
marketing material relating to the offering, or the units have been or will be filed with or approved by any Swiss regulatory authority.
In particular, this document will not be filed with, and the offer of units will not be supervised by, the Swiss Financial Market Supervisory
Authority FINMA, and the offer of units has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes,
or CISA. Accordingly, no public distribution, offering or advertising, as defined in CISA, its implementing ordinances and notices, and
no distribution to any non-qualified investor, as defined in CISA, its implementing ordinances and notices, shall be undertaken in or
from Switzerland, and the investor protection afforded to acquirers of interests in collective investment schemes under CISA does not
extend to acquirers of units.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Australia. </i></b>No placement document,
prospectus, product disclosure statement or other disclosure document has been lodged with the Australian Securities and Investments Commission,
or the ASIC, in relation to the offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus does not constitute a prospectus,
product disclosure statement or other disclosure document under the Corporations Act 2001, or the Corporations Act, and does not purport
to include the information required for a prospectus, product disclosure statement or other disclosure document under the Corporations
Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any offer in Australia of the units may only be made
to persons, the Exempt Investors, who are &#8220;sophisticated investors&#8221; (within the meaning of section 708(8) of the Corporations
Act), &#8220;professional investors&#8221; (within the meaning of section 708(11) of the Corporations Act) or otherwise pursuant to one
or more exemptions contained in section 708 of the Corporations Act so that it is lawful to offer the units without disclosure to investors
under Chapter 6D of the Corporations Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The  units applied for by Exempt Investors in
Australia must not be offered for sale in Australia in the period of 12&#160;months after the date of allotment under the offering, except
in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be required pursuant to an exemption
under section 708 of the Corporations Act or otherwise or where the offer is pursuant to a disclosure document which complies with Chapter
6D of the Corporations Act. Any person acquiring units must observe such Australian on-sale restrictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus contains general information only
and does not take account of the investment objectives, financial situation or particular needs of any particular person. It does not
contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether
the information in this prospectus is appropriate to their needs, objectives and circumstances, and, if necessary, seek expert advice
on those matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s24"></span>EXPERTS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements as of and
for the&#160;years ended December&#160;31, 2021 and December 31, 2020 included in this registration statement have been audited by Centurion
ZD CPA &amp; Co., as stated in their report appearing herein. Such financial statements are included in reliance upon the report of such
firm given upon their authority as experts in accounting and auditing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s25"></span>LEGAL MATTERS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain legal matters with respect to the validity
of the securities being offered by this prospectus will be passed upon by Carmel, Milazzo &amp; Feil LLP, New York, New York. Carmel,
Milazzo &amp; Feil LLP owns 66,667 shares of the Company&#8217;s common stock. Lucosky Brookman LLP, Woodbridge, New Jersey, is
acting as counsel for the representatives of the underwriters with respect to the offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="change"></span>CHANGE IN INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212121; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As previously reported by the Company on a Form
8-K filed with the SEC on June 1, 2020, on May 27, 2020, the Company dismissed its principal independent accountant, Marcum Bernstein
&amp; Pinchuk, LLP (&#8220;Marcum&#8221;) from its engagement with the Company, which dismissal was effective immediately. The decision
to dismiss Marcum as the Company&#8217;s principal independent accountant was approved by the Board of Directors of the Company on May
27, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no disagreements between the Company
and Marcum on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, from
the time of Marcum&#8217;s engagement up to the date of dismissal which disagreements that, if not resolved to Marcum&#8217;s satisfaction,
would have caused Marcum to make reference to the subject matter of the disagreement in connection with its report issued in connection
with the audit of the Company&#8217;s financial statements. None of the reportable events described under Item 304(a)(1)(v)(A)-(D) of
Regulation S-K occurred within the two fiscal years of the Company ended December 31, 2019 and 2018 and subsequently up to the date of
dismissal, and except for the material weaknesses in the Company&#8217;s internal control over financial reporting (the &#8220;Material
Weaknesses&#8221;) as disclosed in the Company&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2019
filed with the SEC on May 14, 2020. The Audit Committee and Board of Directors of the Company discussed the Material Weaknesses with
Marcum. The audit report of Marcum on the financial statements of the Company as of December 31, 2019 did not contain any adverse opinion
or disclaimer of opinion, and such audit report was not qualified or modified as to uncertainty, audit scope or accounting principles.
A letter from Marcum addressed to the SEC stating that it concurs with the statements made by the Company with respect to Marcum in the
Current Report on Form 8-K was filed as Exhibit 16.1 thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has engaged Centurion ZD CPA &amp; Co. (&#8220;CZD&#8221;) as
the auditor to serve as its independent auditor. The decision to engage CZD as the Company&#8217;s principal independent accountant was
approved by the Board of Directors of the Company on May 27, 2020. During the fiscal year of the Company ended December 31, 2019 and
through the date of CZD&#8217;s engagement, the Company did not consult CZD regarding either: (&#8560;) the application of accounting
principles to a specified transaction (either completed or proposed), or the type of audit opinion that might be rendered on the Company&#8217;s
financial statements; or (ii) any matter that was either the subject of a &#8220;disagreement&#8221; or &#8220;reportable event&#8221;
within the meaning set forth in Regulation S-K, Item 304 (a)(1)(iv) or (a)(1)(v).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s26"></span>WHERE YOU CAN FIND
MORE INFORMATION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have filed with the SEC a registration statement
on Form S-1/A under the Securities Act with respect to the units offered by this prospectus. This prospectus, which constitutes
a part of the registration statement, does not contain all of the information set forth in the registration statement, some of which
is contained in exhibits to the registration statement as permitted by the rules and regulations of the SEC. For further information
with respect to us and our units, we refer you to the registration statement, including the exhibits filed as a part of the registration
statement. Statements contained in this prospectus concerning the contents of any contract or any other document is not necessarily complete.
If a contract or document has been filed as an exhibit to the registration statement, please see the copy of the contract or document
that has been filed. Each statement in this prospectus relating to a contract or document filed as an exhibit is qualified in all respects
by the filed exhibit. You may obtain copies of this information by mail from the Public Reference Section of the SEC, 100 F Street, N.E.,
Room 1580, Washington, D.C. 20549, at prescribed rates. You may obtain information on the operation of the public reference rooms by
calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet website that contains reports, proxy statements and other information
about issuers, like us, that file electronically with the SEC. The address of that website is located at <i>www.sec.gov</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 105 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to the information and reporting
requirements of the Exchange Act and, in accordance with this law, are required to file periodic reports, proxy statements and other information
with the SEC. These periodic reports, proxy statements and other information are available for inspection and copying at the SEC&#8217;s
public reference facilities and the website of the SEC referred to above. We also maintain a website at <i>https://www.nocera.company/</i>.
You may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished
to, the SEC. Information contained on our website is not a part of this prospectus and the inclusion of our website address in this prospectus
is an inactive textual reference only.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s27"></span>INDEX TO FINANCIAL
STATEMENTS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">NOCERA, INC.</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONSOLIDATED FINANCIAL STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>AND FOR THE THREE MONTHS ENDED MARCH 31, 2022
AND 2021</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 80%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="text-align: right; width: 15%"><span style="text-decoration: underline">Pages</span></td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td><a href="#dec21fs">Reports of Independent Registered Public Accounting Firm</a></td>
    <td>&#160;</td>
    <td style="text-align: right">F-2-3</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td><a href="#dec31fs1">Consolidated Balance Sheets as of December 31, 2021 and 2020</a></td>
    <td>&#160;</td>
    <td style="text-align: right">F-4</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td><a href="#dec31fs2">Consolidated Statements of Operations and Comprehensive Loss for the Years ended December 31, 2021, and 2020</a></td>
    <td>&#160;</td>
    <td style="text-align: right">F-5</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td><a href="#dec31fs3">Consolidated Statements of Changes in Equity for the Years ended December 31, 2021, and 2020</a></td>
    <td>&#160;</td>
    <td style="text-align: right">F-6</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td><a href="#dec31fs4">Consolidated Statements of Cash Flows for the Years ended December 31, 2021, and 2020</a></td>
    <td>&#160;</td>
    <td style="text-align: right">F-7</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td><a href="#dec31fs5">Notes to the Consolidated Financial Statements for the Years ended December 31, 2021 and 2020</a></td>
    <td>&#160;</td>
    <td style="text-align: right">F-8</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#marbs">Consolidated Balance Sheets as of March 31, 2022 and 2021 (Unaudited)</a></td>
    <td>&#160;</td>
    <td style="text-align: right">F-27</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td><a href="#mar22fin2">Consolidated Statements of Operations and Comprehensive Loss for the Three Months ended March 31, 2022, and 2021 (Unaudited)</a></td>
    <td>&#160;</td>
    <td style="text-align: right">F-28</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td><a href="#mar22fin4">Consolidated Statements of Changes in Equity for the Three Months ended March 31, 2022, and 2021 (Unaudited)</a></td>
    <td>&#160;</td>
    <td style="text-align: right">F-29</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td><a href="#mar22fin3">Consolidated Statements of Cash Flows for the Three Months ended March 31, 2022, and 2021 (Unaudited)</a></td>
    <td>&#160;</td>
    <td style="text-align: right">F-30</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td><a href="#mar22fin5">Notes to the Consolidated Financial Statements for the Three Months ended March 31, 2022 and 2021 (Unaudited)</a></td>
    <td>&#160;</td>
    <td style="text-align: right">F-31</td>
    </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 107; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="dec21fs"></span>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the Shareholders and the Board of Directors of Nocera, Inc:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Opinion on the Financial Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
balance sheet of Nocera, Inc and its subsidiaries (the &#8220;Group&#8221;) as of December 31, 2021 and 2020, the related consolidated
statements of operations, comprehensive income (loss), changes in equity, and cash flows, for the year then ended, and the related notes
(collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements
present fairly, in all material respects, the financial position of the Group at December 31, 2021 and 2020, and the results of its operations
and its cash flows for the year then ended, in conformity with the U.S. generally accepted accounting principles.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis for Opinion</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements are the
responsibility of the Group's management. Our responsibility is to express an opinion on the Group's financial statements based on our
audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;)
and are required to be independent with respect to the Group in accordance with the U.S. federal securities laws and the applicable rules
and regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal
control over financial reporting. Accordingly, we express no such opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits included performing procedures to assess
the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures
that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the
financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management,
as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for
our opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Critical Audit Matter</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The critical audit matter communicated below is
a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the
audit committee and that (1)&#160;relates to accounts or disclosures that are material to the financial statements and (2)&#160;involved
our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our
opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate
opinion on the critical audit matter or on the accounts or disclosures to which it relates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Critical Audit Matter Description</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the </span>year ended December 31, 2021, the Company issued performance shares and warrants to employees including key management personnel
as well as to consultants which were accounted for as share-based compensation. The Company&#8217;s valuation of share-based compensation
is complex and subject to significant management estimates and judgement. The Company used black-scholes model to evaluate the fair value
of the warrants issued which requires management to make significant assumptions related to input of the pricing model.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>How the Critical Audit Matter Was Addressed in the Audit</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i></i>Our audit procedures included but were not limited to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="width: 0.25in"> <span style="font-family: Symbol">&#183;</span></td>
  <td>Evaluating management&#8217;s assessment of the valuation and recognition of the options.</td></tr>

<tr style="vertical-align: top">
  <td> <span style="font-family: Symbol">&#183;</span></td>
  <td>Obtaining an understanding of the key terms and conditions of the performance shares and options by inspecting relevant agreements.</td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify"> <span style="font-family: Symbol">&#183;</span></td>
  <td style="text-align: justify">Holding discussions with management to understand the share based payment arrangements in place</td></tr>

<tr style="vertical-align: top">
  <td> <span style="font-family: Symbol">&#183;</span></td>
  <td>Recalculating the estimated fair value of the performance shares and options using the valuation methodology selected, including assessing
the reasonableness of the methodology used and key inputs used in the Company&#8217;s valuation model.</td></tr>

<tr style="vertical-align: top">
  <td> <span style="font-family: Symbol">&#183;</span></td>
  <td>Reviewing the adequacy of the Company&#8217;s disclosures in respect of the accounting treatment of share-based payments in the financial
statements, including the significant judgments involved, and the accounting policy adopted.</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Centurion ZD CPA &amp; Co.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Centurion ZD CPA &amp; Co.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have served as the Group&#8217;s auditor since 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Hong Kong, China</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 23, 2022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ID 2769</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="dec31fs1"></span>CONSOLIDATED BALANCE SHEETS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Stated in US Dollars)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; width: 68%; text-align: left">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,444,009</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,023,531</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">699,555</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">432,309</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Inventories, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,488,681</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,723,674</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Advance to suppliers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,969</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,732</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Prepaid expenses and other assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">107,444</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,161</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Due from related parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,615,217</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">896,876</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Total current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,397,875</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,081,283</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Retention receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">458,392</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Deferred tax assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,300</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">71,245</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,926</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">332,040</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">332,040</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,870,649</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,924,941</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">92,112</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">187,447</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,442</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,798</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other payables and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">142,426</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,836</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Advance receipts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,051,121</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,285,777</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,341</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,681</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">312,320</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Dividend payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,312</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">387,319</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">285,186</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Bank borrowing</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">52,292</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">532,824</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,100,685</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,374,549</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Deferred tax liabilities, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,100,685</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,374,549</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Commitments and contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold">Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt">Common stock ($0.001 par value; authorized 200,000,000 shares; 10,607,150 shares and 9,131,786 shares issued and outstanding as of December 31, 2021 and 2020, respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,607</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,132</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Preferred stock ($0.001
    par value; authorized 10,000,000
    shares; Series A Preferred Stock, 2,000,000 authorized, 80,000
    shares and nil shares, issued and outstanding as of December 31, 2021 and 2020, respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,472,705</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,692,973</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Statutory and other reserves</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">191,219</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">191,219</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">(Accumulated losses) retained earnings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,918,553</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(293,162</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated other comprehensive loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">13,906</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(49,770</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Total Nocera, Inc.&#8217;s stockholders&#8217; equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,769,964</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,550,392</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Non-controlling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,769,964</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,550,392</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities and equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,870,649</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,924,941</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See notes to the consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="dec31fs2"></span>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE
(LOSS) INCOME</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Stated in US Dollars)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2020</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: left">Net sales</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">9,945,325</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,170,156</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Cost of sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9,000,733</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(526,343</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Gross profit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">944,592</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">643,813</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">General and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,419,684</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,325,696</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,419,684</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,325,696</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Loss from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,475,092</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(681,883</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other income (expense)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,055</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,479,147</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(681,847</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Income tax benefit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(139,932</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">42,777</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,619,079</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(639,070</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Less: Net loss attributable to non-controlling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6,705</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss attributable to the company</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(9,619,079</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(632,365</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,619,079</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(639,070</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Foreign currency translation loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">63,248</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">31,081</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Total comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,555,831</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(607,989</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Less: Net loss attributable to non-controlling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,705</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Less: Foreign currency translation loss attributable to non-controlling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(499</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Comprehensive loss attributable to the Company</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(9,555,831</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(600,785</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold">Loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.0500</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0538</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.0500</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0538</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Weighted average number of common shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,160,862</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,752,447</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,160,862</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,752,447</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See notes to the consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="dec31fs3"></span><b>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Stated in US Dollars)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center">Preferred stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Additional<br /> Paid-in</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Statutory<br /> and <br /> other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Retained</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated<br /> Other<br /> Comprehensive</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total <br /> Nocera Inc.&#8217;s<br /> Stockholders&#8217;<br /> Equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Non-<br /> controlling</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total<br /> Stockholders&#8217;<br /> Equity</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Capital</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Reserves</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Earnings</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(Deficit)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(Deficit)</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 12%; text-indent: -5pt; padding-left: 5pt">Balance, January 1, 2020</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">12,354,200</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">12,354</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 6%; font-weight: bold; text-align: right">&#8211;</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 6%; font-weight: bold; text-align: right">&#8211;</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">271,915</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">191,219</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">339,203</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(81,350</td><td style="width: 1%; text-align: left">)</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">733,341</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">29,072</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">762,413</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Termination of VIE agreements with GZWFH</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,750,000</td><td style="text-align: left">)</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,750</td><td style="text-align: left">)</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,750</td><td style="text-align: left">)</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,868</td><td style="text-align: left">)</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(26,618</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Foreign currency translation adjustments</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,580</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,580</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(499</td><td style="text-align: left">)</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,081</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Issuance of new shares</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,527,586</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,528</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,154,472</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,156,000</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,156,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Share-based compensation</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266,586</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266,586</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266,586</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -5pt; padding-left: 5pt">Net loss</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(632,365</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(632,365</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6,705</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(639,070</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-indent: -5pt; padding-left: 5pt">Balance, December 31, 2020</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,131,786</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,132</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,692,973</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">191,219</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(293,162</td><td style="padding-bottom: 2.5pt; text-align: left">)</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(49,770</td><td style="padding-bottom: 2.5pt; text-align: left">)</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,550,392</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,550,392</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right; text-indent: -5pt; padding-left: 5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Common stock and warrant issuance</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,000</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,832</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,880</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,880</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Preferred stock and warrant issuance</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,520</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,600</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,600</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Changes in fair value of warranty liabilities</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,800</td><td style="text-align: left">)</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,800</td><td style="text-align: left">)</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,800</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Issuance of new shares upon private placement</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">836,000</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">836</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,089,164</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,090,000</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,090,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Consultancy services settled by equities</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">505,000</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">505</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,044,645</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,045,150</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,045,150</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Share-based compensation</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">86,364</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">86</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,638,371</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,638,457</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,638,457</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Foreign currency translation Adjustments</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,676</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,676</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,676</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Preferred stock dividend</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,312</td><td style="text-align: left">)</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,312</td><td style="text-align: left">)</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,312</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -5pt; padding-left: 5pt">Net loss</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9,619,079</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9,619,079</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9,619,079</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-indent: -5pt; padding-left: 5pt">Balance, December 31, 2021</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,607,150</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,607</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">80,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">80</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,472,705</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">191,219</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(9,918,553</td><td style="padding-bottom: 2.5pt; text-align: left">)</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,906</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,769,964</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,769,964</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See notes to the consolidated financial statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="dec31fs4"></span>CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Stated in US Dollars)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December
31,<br />
2021</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br />
2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">$</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">$<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; width: 68%; text-align: left">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">(9,619,079</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">(639,070</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Adjustments to reconcile net loss to net cash provided by operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Depreciation expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,127</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74,958</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53,156</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt">Impairment of GZWFH</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">522,291</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Deferred income tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,258</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73,150</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Changes in fair value of warranty liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Consultancy services settled by equities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,045,150</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,638,371</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265,758</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(252,338</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,406,867</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">278,100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">268,285</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Advance to suppliers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(40,563</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">824</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Prepaid expenses and other assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(66,232</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,987</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Retention receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">395,579</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,894</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(99,106</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,180</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,092</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(236,137</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Advance from customers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(395,751</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Other payables and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,599</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(299,345</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">92,346</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(629,676</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(593,445</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Operating lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,563</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; padding-left: 20pt; text-align: left">Advance receipts</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(267,375</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(69,827</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net cash provided by (used in) operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">251,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(129,824</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash flows from investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Purchase of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(25,067</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(57,153</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Purchase of intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(25,360</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Disposal of GZ WFH</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,099</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Cash acquired from merger</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">857,555</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Net cash (used in) provided by investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(25,067</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">770,943</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Proceeds from related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(718,341</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">664,454</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Repayment to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(402,531</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Proceeds from common stock and warrant issuance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Proceeds from preferred stock and warrant issuance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Proceeds from issuance of common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,090,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Repayment of short-term bank loan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(487,826</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44,444</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,203,833</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">217,479</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Effect of exchange rate changes on cash and cash equivalents</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,017</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">136,394</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net increase in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,420,478</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">994,992</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,023,531</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28,539</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,444,009</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,023,531</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Supplemental disclosures of cash flow information</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Cash paid for interest expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Cash paid for Income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See notes to the consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="dec31fs5"></span>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1&#160;&#160;&#160;&#160;&#160;PRINCIPAL ACTIVITIES AND ORGANIZATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include
the financial statements of Nocera, Inc. (&#8220;Nocera&#8221; or the &#8220;Company&#8221;) and its subsidiaries, Grand Smooth Inc. Limited
(&#8220;GSI&#8221;) and Guizhou Grand Smooth Technology Ltd. (&#8220;GZ GST&#8221; or &#8220;WFOE&#8221;), and Xin Feng Construction Co.,
Ltd. (&#8220;XFC&#8221;) that is controlled through contractual arrangements. The Company, GSI, GZ GST and XFC are collectively referred
to as the &#8220;Company&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera was incorporated in the State of Nevada
on February 1, 2002 and is based in New Taipei City, Taiwan (R.O.C.). It did not engage in any operations and was dormant from its inception
until its reverse merger of GSI on December 31, 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Reverse merger</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective December 31, 2018, Nocera completed
a reverse merger transaction (the &#8220;Transaction&#8221;) pursuant to an Agreement and Plan of Merger (the &#8220;Agreement&#8221;),
with (i) GSI, (ii) GSI&#8217;s stockholders, Yin-Chieh Cheng and Zhang Bi, who together owned shares constituting 100% of the issued and
outstanding ordinary shares of GSI (the &#8220;GSI Shares&#8221;) and (iii) GSI Acquisition Corp. Under the terms of the Agreement, the
GSI Stockholders transferred to Nocera all of the GSI Shares in exchange for the issuance of 10,000,000 shares (the &#8220;Shares&#8221;)
of Nocera&#8217;s common stock (the &#8220;Share Exchange&#8221;). As a result of the reverse merger, GSI became Nocera&#8217;s wholly-owned
subsidiary and Yin-Chieh Cheng and Zhang Bi, the former stockholders of GSI, became Nocera&#8217;s controlling stockholders. The share
exchange transaction with GSI was treated as a reverse merger, with GSI as the accounting acquirer and Nocera as the acquired party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GSI is a limited company established under the
laws and regulations of Hong Kong on August 1, 2014, and is a holding company without any operation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GZ WFH was incorporated in Xingyi City, Guizhou
Province, People&#8217;s Republic of China (PRC) on October 25, 2017, and is engaged in providing fish farming containers service, which
integrates sales, installments, and maintenance of aquaculture equipment. The registered capital of GZ WFH is RMB$5,000,000 (equal to
US$733,138).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 13, 2018, GSI incorporated GZ GST
in PRC with registered capital of US$15,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Divestiture</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 21, 2020, the Company filed a Current
Report on Form 8-K outlining the lack of communication that led to the termination by Nocera, Inc. of its relationship with Guizhou
Wan Feng Hu Intelligent Aquatic Technology Co. Limited (&#8220;GZ WFH&#8221;) and its management, and termination of the Variable Interest
Entity agreements between the parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequently on October 8, 2020, Zhang Bi and
GZ WFH entered into a Settlement Agreement and Release with Nocera, Inc. wherein all claims as to GZ WFH&#8217;s debt (claim to shares
in Nocera, Inc. or GZ GST) were compromised, settled, and otherwise resolved as to any and all claims or causes of action whatsoever against
Nocera for any matter, action, or representation as to Nocera, and any debt to ownership of Nocera or GZ GST up to the date of the agreement.
The consideration for the agreement was mutual waiver of any and all claims against each other and GZ GST, and GZ WFH (including Zhang
Bi) waives any claims to Nocera stock, meaning the 4,750,000 shares of common stock of Nocera owned by Zhang Bi were cancelled as part
of the agreement. The Settlement Agreement and Release is attached hereto as Exhibit 10.8.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">The VIE Agreements</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2020, Nocera and XFC, a domestic
funded limited liability company registered in Taiwan (R.O.C), entered into a series of contractual agreements (&#8220;VIE Agreements&#8221;)
whereby Nocera, Inc. agreed to provide technical consulting and related services to XFC. As a result, Nocera has been determined to be
the primary beneficiary of XFC and XFC became a VIE (Variable Interest Entity) of Nocera.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2020, Nocera exchanged 700,000
shares of the Company&#8217;s restricted common stock to Shareholders of XFC in exchange for 100% controlling interest in XFC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The VIE structure was adopted mainly because we
engage in business in an industry that prohibits foreign investment (e.g., construction) and of which requires special licenses in Taiwan.
We are not currently planning to engage in business in mainland China or Hong Kong, and as a result, we are not currently required to
obtain any special licenses in mainland China or Hong Kong. The Company has entered into the following contractual arrangements with a
stockholders of XFC, that enable the Company to (1)&#160;have the power to direct the activities that most significantly affects the economic
performance of XFC, and (2)&#160;receive the economic benefits of XFC that could be significant to XFC. The Company is fully and exclusively
responsible for the management of XFC, assumes all of the risk of losses of XFC and has the exclusive right to exercise all voting rights
of XFC&#8217;s stockholders. Therefore, in accordance with ASC 810 &#8220;Consolidation&#8221;, the Company is considered the primary
beneficiary of XFC and has consolidated XFC&#8217;s assets, liabilities, results of operations, and cash flows in the accompanying consolidated
financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>(1) Voting Rights Proxy Agreement &amp; Power
of Attorney.</i> Mr. Tsai, Wen-Chih, Ms. Tu, Hui-Min, Mr. Tsai, Chin-Yao, and Mr. Tsai, Chin-Chao (Existing Stockholders) hereby irrevocably
undertake that they authorize Nocera or the individual then designated by Nocera (&#8220;Attorney&#8221;) to exercise, on his behalf,
the following rights available to them in their capacity as a stockholder of the XFC under the then effective articles of association
of the XFC (collectively, &#8220;Powers&#8221;): (a) to propose the convening of, and attend, stockholders&#8217; meetings in accordance
with the articles of association of the XFC on behalf of the Existing Stockholder; (b) to exercise voting rights on behalf of the Existing
Stockholder on all matters required to be deliberated and resolved by the stockholders&#8217; meeting, including without limitation the
appointment and election of the directors and other executives to be appointed and removed by the stockholders, of the XFC the sale or
transfer of all or part of the equity held by stockholders in the XFC; (c) to exercise other stockholders&#8217; voting rights under the
articles of association of the XFC (including any other stockholders&#8217; voting rights stipulated upon an amendment to such articles
of association); (d) other voting rights that stockholders shall enjoy under the Taiwan (R.O.C.) laws, as amended, revised, supplemented
and re-enacted, no matter whether they take effect before or after the conclusion of this Agreement. The Existing Stockholders shall not
revoke the authorization and entrustment accorded to the Attorney other than in the case where Nocera gives the Existing Stockholders
a written notice requesting the replacement of the Attorney, in which event the Existing Stockholders shall immediately appoint such other
person as then designated by Nocera to exercise the foregoing Powers and such new authorization and entrustment shall supersede, immediately
upon its grant, the original authorization, and entrustment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: -21pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>(2) Exclusive Business Cooperation Agreement.</i>
Nocera agrees to provide technical consulting and services including management consulting services, general and financial advisory service
and various general and administrative service, for the specific content thereof (hereinafter referred to as the &#8220;Target Business&#8221;)
to the XFC as the technical consulting and service provider of the XFC in accordance with the conditions set forth herein during the term
of this Agreement. XFC agrees to accept the technical consulting and services provided by Nocera. XFC further agrees that, without the
prior written consent of Nocera, during the term of this Agreement, it shall not accept any technical consulting and services identical
or similar to Target Business that are provided by any third party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>(3) Equity Pledge Agreement. </i>Under the
Equity Interest Pledge Agreement between Nocera and Mr. Tsai, Wen-Chih, Ms. Tu, Hui-Min, Mr. Tsai, Chin-Yao, and Mr. Tsai, Chin-Chao,
the stockholder of XFC, stockholder pledged all of his equity interests in XFC to Nocera to guarantee the performance of XFC&#8217;s obligations
under the Exclusive Business Cooperation Agreement. Under the terms of the agreement, in the event that XFC or stockholders breach their
respective contractual obligations under the Exclusive Business Cooperation Agreement, Nocera, as pledge, will be entitled to certain
rights, including, but not limited to, the right to collect dividends generated by the pledged equity interests. Zhang Bi also agreed
that upon the occurrence of any event of default, as set forth in the Equity Interest Pledge Agreement, Nocera is entitled to claim indemnity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>(4) Exclusive Call Option Agreement. </i>XFC
and its stockholders, Mr. Tsai, Wen-Chih, Ms. Tu, Hui-Min, Mr. Tsai, Chin-Yao, and Mr. Tsai, Chin-Chao, have entered into an Exclusive
Call Option Agreement with Nocera. Under the Exclusive Call Option Agreement, the XFC stockholders irrevocably granted Nocera (or its
designee) an exclusive option to purchase, to the extent permitted under Taiwan (R.O.C.) law, part or all of their equity interests in
XFC. According to the Exclusive Call Option Agreement, the purchase price shall be the minimum price permitted by applicable Taiwan (R.O.C.)
Law at the time when such share transfer occurs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 2&#160;&#160;&#160;&#160;&#160; GOING
CONCERN</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had net loss of $9.6 million for the
year ended December 31, 2021, which raise substantial doubt as to the Company&#8217;s ability to continue as a going concern. Management
believes that it has developed a liquidity plan, as summarized below, that, if executed successfully, would enable to meet presently anticipated
cash needs for at least the next 12 months after the date that the financial statements are issued and it has prepared the consolidated
financial statements on a going concern basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company started its business operation in 2018 and is continuing to focus on its business development and ultimately to attain profitable operations. XFC, the Company&#8217;s VIE in Taiwan, continuously receives orders from its customers. The Company expects XFC to generate $5 million of revenue in the coming twelve months. Moreover, NTB, the Company&#8217;s Taiwan branch, will keep engaged in the fish brokerage business, which is expected to generate $5 million of revenue in the coming twelve months.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company obtained a financial support letter from Mr. Yin-Chieh Cheng, the chief executive officer, also the Chairman of the Board and a principal shareholder of the Company.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, the Company continues to have ongoing
obligations and it expects that it will require additional capital in order to execute its longer-term business plan. If the Company encounters
unforeseen circumstances that place constraints on its capital resources, management will be required to take various measures to conserve
liquidity, which could include, but not necessarily be limited to, curtailing the Company&#8217;s business development activities, suspending
the pursuit of its business plan, controlling overhead expenses and seeking to further dispose of non-core assets. Management cannot provide
any assurance that the Company will raise additional capital if needed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 3&#160;&#160;&#160;&#160;&#160; SUMMARY
OF SIGNIFICANT ACCOUNTING POLICY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Change of Reporting Entity and Basis of
Presentation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the Share Exchange on December
31, 2018, GSI became a wholly owned subsidiary of Nocera, Inc. The former GSI&#8217;s stockholders owned a majority of the common stock
of the Company. The Transaction was regarded as a reverse merger whereby GSI was considered to be the accounting acquirer as its stockholders
retained control of the Company after the Share Exchange, although Nocera, Inc. is the legal parent company. The Share Exchange was treated
as a recapitalization of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result, the assets and liabilities and the
historical operations that will be reflected in the Nocera&#8217;s financial statements after consummation of the Transaction will be
those of GSI and will be recorded at the historical cost basis of GSI. Nocera&#8217;s assets, liabilities and results of operations will
be consolidated with the assets, liabilities and results of operations of GSI upon consummation of the Transaction. As such, GSI is the
continuing entity for financial reporting purpose. In a reverse merger, the historical stockholder&#8217;s equity of the accounting acquirer
prior to the merger is retroactively reclassified (a recapitalization) for the equivalent number of shares received in the merger after
giving effect to any difference in par value of the registrant&#8217;s and the accounting acquirer&#8217;s stock by an offset in paid-in-capital.
Therefore, the financial statements have been prepared as if GSI had always been the reporting company and then on the share exchange
date, had changed its name and reorganized its capital stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements
have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;)
and pursuant to the rules and regulations of the United States Securities and Exchange Commission (&#8220;SEC&#8221;) for interim financial
information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements included
the financial statements of all subsidiaries and the VIE of the Company. All transactions and balances between the Company and its subsidiary
and VIE have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reclassification </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior period amounts have been reclassified
to conform with current year presentation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity
with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during
the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the allowance for doubtful
receivables; the useful lives of property and equipment and intangible assets; impairment of long-lived assets; recoverability of the
carrying amount of inventory; fair value of financial instruments; provisional amounts based on reasonable estimates for certain income
tax effects of the Tax Act and the assessment of deferred tax assets or liabilities. These estimates are often based on complex judgments
and assumptions that management believes to be reasonable but are inherently uncertain and unpredictable. Actual results could differ
from these estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentrations of Credit Risk</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially expose
the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its
customers and suppliers, and generally does not require collateral or other security from them. The Company evaluates its collection experience
and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic reviews of the
financial condition and payment practices of its customers to minimize collection risk on accounts receivable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There was one customer who represented 58.22% of
the Company's total revenue during the years ended December 31, 2021. There were two customers who represented 96.44% of the Company's
total revenue during the years ended December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of single
customers who represent 10%
or more of the Company&#8217;s total accounts receivable, net:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Concentrations of credit risk</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Percentage of the Company&#8217;s accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: justify">Customer A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">16.37%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">26.33%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">59.53%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73.67%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Customer C</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">16.30%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">92.20%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100.00%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth a summary of single suppliers who represent
10% or more of the Company&#8217;s total purchase:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Percentage of the Company&#8217;s purchase</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: justify">Supplier A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">48.76%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">100%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Supplier B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15.14%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Supplier C</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14.26%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">78.16%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Fair Value Measurement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies ASC Topic 820, Fair Value
Measurements and Disclosures which defines fair value, establishes a framework for measuring fair value and expands financial statement
disclosure requirements for fair value measurements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 820 defines fair value as the price
that would be received from the sale of an asset or paid to transfer a liability (an exit price) on the measurement date in an orderly
transaction between market participants in the principal or most advantageous market for the asset or liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 820 specifies a hierarchy of valuation
techniques, which is based on whether the inputs into the valuation technique are observable or unobservable. The hierarchy is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1 inputs to the valuation methodology are
quoted prices (unadjusted) for identical assets or liabilities in active markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2 inputs to the valuation methodology include
quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either
directly or indirectly, for substantially the full term of the financial instruments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3 inputs to the valuation methodology are
unobservable and significant to the fair value. Unobservable inputs are valuation technique inputs that reflect the Company&#8217;s own
assumptions about the assumptions that market participants would use in pricing an asset or liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management of the Company is responsible for determining
the assets acquired, liabilities assumed and intangibles identified as of the acquisition date and considered a number of factors including
valuations from an independent appraiser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When available, the Company uses quoted market
prices to determine the fair value of an asset or liability. If quoted market prices are not available, the Company measures fair value
using valuation techniques that use, when possible, current market-based or independently sourced market parameters, such as interest
rates and currency rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December&#160;31, 2021 and 2020, there are
no assets or liabilities that are measured and reported at fair value on a recurring basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Cash and Cash Equivalents</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash and cash equivalents include all cash on
hand and cash in bank with no restrictions. The balance of cash as of December 31, 2021 and 2020 were $2,444,009 and $1,023,531, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Accounts Receivable, Net</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivable are stated at the original
amount less an allowance for doubtful accounts, if any, based on a review of all outstanding amounts at period end. An allowance is also
made when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of
the receivables. The Company analyzes the aging of the customer accounts, coverage of credit insurance, customer concentrations, customer
credit-worthiness, historical and current economic trends and changes in its customer payment patterns when evaluating the adequacy of
the allowance for doubtful accounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Prepaid Expenses and Other Assets, Net</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepaid expense and other assets, net consist
of receivable from investment, prepaid rent and etc. Management reviews its receivable balance each reporting period to determine if an
allowance for doubtful accounts is required. An allowance for doubtful account is recorded in the period in which loss is determined to
be probable based on an assessment of specific evidence indicating doubtful collection, historical experience, account balance aging,
and prevailing economic conditions. Bad debts are written off against the allowance after all collection efforts have ceased.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Inventories, net</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories are stated at lower of cost or net
realizable value. Cost is determined using the weighted average method. Inventories include raw materials, work in progress and finished
goods. The variable production overhead is allocated to each unit of product on the basis of the actual use of the production facilities.
The allocation of fixed production overhead to the costs of conversion is based on the normal capacity of the production facilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where there is evidence that the utility of inventories,
in their disposal in the ordinary course of business, will be less than cost, whether due to physical deterioration, obsolescence, changes
in price levels, or other causes, the inventories are written down to net realizable value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Property and Equipment, Net</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are stated at cost less
accumulated depreciation. Cost represents the purchase price of the asset and other costs incurred to bring the asset into its existing
use. Maintenance, repairs, and betterments, including replacement of minor items, are charged to expense; major additions to physical
properties are capitalized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation of property and equipment is provided
using the straight-line method over their estimated useful lives, which are shown as follows.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Property and Equipment Useful Lives</span></td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful life</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 38%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 52%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shorter of the remaining lease terms and estimated useful lives</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixture</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon sale or disposal, the applicable amounts
of asset cost and accumulated depreciation are removed from the accounts and the net amount less proceeds from disposal is charged or
credited to income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Goodwill and Intangible Assets</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize goodwill in accordance with ASC 350,&#160;<i>Intangibles&#8212;Goodwill
and Other</i>. Goodwill is the excess of cost of an acquired entity over the amounts assigned to assets acquired and liabilities assumed
in a business combination. Goodwill is not amortized. Goodwill is tested for impairment annually as of October 1st of each year, and is
tested for impairment between annual tests if an event occurs or circumstances change that would indicate the carrying amount may be impaired.
An impairment charge for goodwill is recognized only when the estimated fair value of a reporting unit, including goodwill, is less than
its carrying amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize intangibles assets in accordance
with ASC 350,&#160;<i>Intangibles&#8212;Goodwill and Other</i>. Acquired intangible assets subject to amortization are stated at cost
and are amortized using the straight-line method over the estimated useful lives of the assets. Intangible assets that are subject to
amortization are reviewed for potential impairment whenever events or circumstances indicate that carrying amounts may not be recoverable.
Assets not subject to amortization are tested for impairment at least annually.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimates of fair value are based on the best
information available as of the date of the assessment, which primarily incorporates management assumptions about expected future cash
flows. Although these assets are not currently impaired, there can be no assurance that future impairments will not occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Share-Based Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">We determine
our share-based compensation in accordance with ASC 718,&#160;</span><i>Compensation&#8212;Stock Compensation&#160;</i><span style="background-color: white">(ASC
718), which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees based
on the grant date fair value of the award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Determining the appropriate fair value model and
calculating the fair value of phantom award grants requires the input of subjective assumptions. We use the Black-Scholes pricing model
to value our phantom awards. Share-based compensation expense is calculated using our best estimates, which involve inherent uncertainties
and the application of management&#8217;s judgment. Significant estimates include our expected volatility. If different estimates and
assumptions had been used, our phantom unit valuations could be significantly different and related share-based compensation expense may
be materially impacted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Black-Scholes pricing model requires inputs
such as the risk-free interest rate, expected term, expected volatility and expected dividend yield. We base the risk-free interest rate
that we use in the Black-Scholes pricing model on zero coupon U.S. Treasury instruments with maturities similar to the expected term of
the award being valued. The expected term of phantom awards is estimated from the vesting period of the award and represents the weighted
average period that our phantom awards are expected to be outstanding. We estimated the volatility based on the historic volatility of
our guideline companies, which we feel best represent our Company. We have never paid and do not anticipate paying any cash dividends
in the foreseeable future and, therefore, we use an expected dividend yield of zero in the pricing model. We account for forfeitures as
they occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Impairment of Long-lived Assets</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews its long-lived assets for
impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no longer be recoverable. When
these events occur, the Company measures impairment by comparing the carrying value of the long-lived assets to the estimated undiscounted
future cash flows expected to result from the use of the assets and their eventual disposition. If the sum of the expected undiscounted
cash flow is less than the carrying amount of the assets, the Company would recognize an impairment loss, which is the excess of carrying
amount over the fair value of the assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Commitments and Contingencies</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the normal course of business, the Company
is subject to contingencies, including legal proceedings and claims arising out of its business that relate to a wide range of matters,
such as government investigations and tax matters. The Company recognizes a liability for such contingency if it determines it is probable
that a loss has occurred and a reasonable estimate of the loss can be made. The Company may consider many factors in making these assessments
including historical and the specific facts and circumstances of each matter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Revenue Recognition</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has early adopted ASU 2014-09, Revenue
from Contracts with Customers (Topic 606) and all subsequent ASUs that modified ASC 606 on January 1, 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The core principle of the guidance is that an
entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, the Company applies
the following steps:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 28px"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 1: Identify the contract (s) with a customer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 28px"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 2: Identify the performance obligations in the contract</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 28px"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 3: Determine the transaction price</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 28px"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 4: Allocate the transaction price to the performance obligation in the contract</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 28px"> <span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considered revenue is recognized when
(or as) the Company satisfies performance obligations by transferring a promised goods and provide maintenance service to a customer.
Revenue is measured at the transaction price which is based on the amount of consideration that the Company expects to receive in exchange
for transferring the promised goods and providing maintenance service to the customer. Contracts with customers are comprised of invoices
and written contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have arrangements for returns
from customers and does not have any future obligations directly or indirectly related to services resale by customers. The Company has
no sales incentive programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company provides goods, maintenance service
warranties for the goods sold with a period varying from 18 months to 72 months, which majority are 18 months, and exclusive sales agency
license to its customers. For performance obligation related to providing products, the Company expects to recognize the revenue according
to the delivery of products. For performance obligation related to maintenance service warranties, the Company expects to recognize the
revenue on a ratable basis using a time-based output method. The performance obligations are typically satisfied as services are rendered
on a straight-line basis over the contract term, which is generally for 18 months as majority of the maintenance service warranties periods
provided are 18 months. For performance obligation related to exclusive agency license, the Company recognizes the revenue ratably upon
the satisfaction over the estimated economic life of the license.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have amounts of contract
assets since revenue is recognized as control of goods is transferred. The contract liabilities consist of advance payments from customers
and deferred revenue. Advance payments from customer are expected to be recognized as revenue within 12 months. Deferred revenue is expected
to be recognized as revenue within 12 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Cost of Sales</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of sales consists primarily of material costs,
labor costs, depreciation, and related expenses, which are directly attributable to the production of the product. Write-down of inventories
to lower of cost or net realizable value is also recorded in cost of sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Income Taxes</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes deferred tax assets and
liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under
this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets
and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable
to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to
reduce deferred tax assets to the amount expected to be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i></i></b></p>

<!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Leases</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU 2016-12,
Leases (ASC Topic 842), which amends the leases requirements in ASC Topic 840, Leases. Under the new lease accounting standard, a lessee
will be required to recognize a right-of-use asset and lease liability for most leases on the balance sheet. The new standard also modifies
the classification criteria and accounting for sales-type and direct financing leases, and enhances the disclosure requirements. Leases
will continue to be classified as either finance or operating leases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company adopted ASC Topic 842 using the modified
retrospective transition method effective January 1, 2019. There was no cumulative effect of initially applying ASC Topic 842 that required
an adjustment to the opening retained earnings on the adoption date nor revision of the balances in comparative periods. As a result of
the adoption, The Company recognized a lease liability and right-of-use asset for each of our existing lease arrangement. The adoption
of the new lease standard does not have a material impact on our consolidated income statement or our consolidated statement of cash flow.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Uncertain Tax Positions</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for uncertainty in income
taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for
recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained
on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the
largest amount that is more than 50% likely of being realized upon settlement. Interest and penalties related to uncertain tax positions
are recognized and recorded as necessary in the provision for income taxes. According to the PRC Tax Administration and Collection Law,
the statute of limitations is three years if the underpayment of taxes is due to computational errors made by the taxpayer or the withholding
agent. The statute of limitations is extended to five years under special circumstances, where the underpayment of taxes is more than
RMB 100,000. In the case of transfer pricing issues, the statute of limitation is ten years. There is no statute of limitation in the
case of tax evasion. The Company records interest and penalties on uncertain tax provisions as income tax expense. There are no uncertain
tax positions as of December 31, 2021 and 2020, and the Company has no accrued interest or penalties related to uncertain tax positions.
The company does not believe that the unrecognized tax benefits will change over the next twelve months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Comprehensive (Loss) Income</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Comprehensive income or loss is comprised of the
Company&#8217;s net (loss) income and other comprehensive income or loss. The component of other comprehensive income or loss consists
solely of foreign currency translation adjustments, net of the income tax effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Foreign Currency Translation and Transactions</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s reporting currency is the
U.S. dollar (&#8220;US$&#8221;). The functional currency of the Company&#8217;s subsidiary and the consolidated VIE is RMB. In the consolidated
financial statements, the financial information of the Company&#8217;s subsidiary and the consolidated VIE has been translated into US$.
Assets and liabilities are translated at the exchange rates on the balance sheet date, equity amounts are translated at historical exchange
rates, except for changes in accumulated deficit during the year which is the result of income statement translation process, and revenue,
expense, gains or losses are translated using the average exchange rate during the year. Translation adjustments are reported as foreign
currency translation adjustments and are shown as a separate component of other comprehensive income or loss in the consolidated statements
of changes in equity and comprehensive (loss) income. The exchange rates as of December 31, 2021 and 2020 are 6.4854 and 6.5249, respectively.
The annual average exchange rates for the year ended December 31, 2021 and 2020 are 6.3700 and 6.8996, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>(Loss) Earnings per Share</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic (loss) earnings per share is computed by
dividing net (loss) income attributable to holders of common stock by the weighted average number of common shares outstanding during
the year. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common
shares were exercised or converted into common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Recent Accounting Pronouncements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Recently Adopted Accounting Standards</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Adoption of ASC Topic 606, &#8220;Revenue from Contracts with Customers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASU 2018-13. In August 2018, the FASB issued ASU
2018-13, &#8220;Fair Value Measurement (Topic 820): Disclosure Framework&#8212;Changes to the Disclosure Requirements for Fair Value Measurement&#8221;.
The amendments in this update is to improve the effectiveness of disclosures in the notes to the financial statements by facilitating
clear communication of the information required by GAAP that is most important to users of each entity&#8217;s financial statements. The
amendments in this update apply to all entities that are required, under existing GAAP, to make disclosures about recurring or nonrecurring
fair value measurements. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2019,
and interim periods within those fiscal years. There was no impact of the standard on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Accounting Pronouncements Issued But Not
Yet Adopted</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASU 2019-12. On December 18, 2019, the FASB issued
ASU No. 2019-12, Income taxes (Topic 740), Simplifying the Accounting for Income Taxes. This guidance amends ASC Topic 740 and addresses
several aspects including 1) evaluation of step-up tax basis of goodwill when there is not a business combination, 2) policy election
to not allocate consolidated taxes on a separate entity basis to entities not subject to income tax, 3) accounting for tax law changes
or rates during interim periods, 4) ownership changes from equity method investment to subsidiary or vice versa, 5) elimination of exception
to intraperiod allocation when there is gain in discontinued operations and a loss from continuing operations, 6) treatment of franchise
taxes that are partially based on income. The guidance is effective for calendar year-end public entities on January 1, 2021 and other
entities on January 1, 2022. The Company is evaluating the impact of this guidance on its consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not believe other recently issued
but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position,
statements of operations and cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 4&#160;&#160;&#160;&#160;&#160;ACCOUNTS RECEIVABLE, NET</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, accounts receivable
consisted of the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt"><span style="display: none">Schedule of accounts receivable</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Accounts receivable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">699,555</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">432,309</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Allowance for doubtful accounts</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">699,555</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">432,309</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020,
the Company has recorded provision for doubtful accounts of <span style="display: none">0</span> nil and <span style="display: none">0</span> nil, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 5&#160;&#160;&#160;&#160;&#160;INVENTORIES, NET</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, inventories
consisted of the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt"><span style="display: none">Schedule of inventory</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Raw materials</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">97,163</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">115,373</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Work in process</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,391,518</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,608,301</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,488,681</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,723,674</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The inventory write downs were $nil 0 and $nil
0 for the years ended December 31, 2021 and December 31, 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 6&#160;&#160;&#160;&#160;&#160;ADVANCE TO SUPPLIERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Balances of advances to suppliers were $42,969
and $1,732 as of December 31, 2021 and 2020, respectively, which represented prepayments to suppliers for raw materials.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note
7&#160;&#160;&#160;&#160;&#160;PREPAID EXPENSES AND OTHER ASSETS, NET</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="display: none">Schedule of prepaid expenses and other assets</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Other receivables from third party</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">107,444</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">3,161</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Others</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">107,444</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,161</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Allowance for doubtful accounts</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Prepaid expenses and other assets, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">107,444</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,161</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 8&#160;&#160;&#160;&#160;&#160;PROPERTY AND EQUIPMENT, NET</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and December&#160;31,
2020, property and equipment consisted of the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Schedule of property and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: justify">Equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">78,802</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">51,287</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Leasehold improvement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Vehicle</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">78,802</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,287</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(7,557</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(361</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">71,245</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">50,926</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation expenses for the years ended December
31, 2021 and 2020 were $6,127 and $74,958, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 9 &#160;&#160;&#160;&#160;Goodwill</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and December 31, 2020,
goodwill consisted of the followings:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="display: none">&#160;Schedule of goodwill</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Goodwill - XFC</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">332,040</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">332,040</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Balance at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">332,040</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">332,040</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 10 &#160;&#160;&#160;&#160;WARRANTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On April
1, 2021, the Company entered in a securities purchase agreement with certain investors for an aggregate of 80,000 shares of its preferred
stock at a per share purchase price of $2.50. As part of the transaction, the investors received one Class C warrant and one Class D warrant
for the subscription of each preferred share. The Class C warrants consist of the right to purchase up to 80,000 shares of the Company&#8217;s
common stock at an exercise price of $2.50 per share exercisable for 36 months from the date of inception. The Class D warrants consist
of the right to purchase up to 80,000 shares of the Company&#8217;s common stock at an exercise price of $5.00 per share exercisable for
36 months from the date of inception. The subscription was completed on August 10, 2021.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September
27, 2021 the Company entered into another securities purchase agreement with the same investors, pursuant to which the Company issued
in a registered direct offering, an aggregate of 48,000 shares of common stock of the Company at a per share purchase price of $2.50.
In addition, the investors also received one Class C warrant and one Class D warrant for the subscription of each preferred share. The
Class C warrants consist of the right to purchase up to 80,000 shares of the Company&#8217;s common stock at an exercise price of $2.50
per share exercisable for 36 months from the date of inception. The Class D warrants consist of the right to purchase up to 80,000 shares
of the Company&#8217;s common stock at an exercise price of $5.00 per share exercisable for 36 months from the date of inception.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td colspan="6"><span style="display: none">Schedule Assumption used</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="6" style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Appraisal Date (Inception Date)</b></span></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1.5pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>C Warrant<br />
    August 10, </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>D Warrant<br />
    August 10, </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b></p></td>
    <td>&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><b>(Unaudited)</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td colspan="4" style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><b>(Unaudited)</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td colspan="5">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="6">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center"><span style="font-size: 10pt"><b>$</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>$</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td colspan="6"><span style="font-size: 10pt">Market price per share (USD/share)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="font-size: 10pt">1.47</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">0.66</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td colspan="6"><span style="font-size: 10pt">Exercise price (USD/price)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="font-size: 10pt">2.50</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">5.00</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td colspan="6"><span style="font-size: 10pt">Risk free rate</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="font-size: 10pt">0.14</span></td>
    <td><span style="font-size: 10pt">%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">0.14</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td colspan="6"><span style="font-size: 10pt">Dividend yield</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="font-size: 10pt">0.00</span></td>
    <td><span style="font-size: 10pt">%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">0.00</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td colspan="6"><span style="font-size: 10pt">Expected term/ Contractual life (years)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="font-size: 10pt">1.39</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1.39</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td colspan="6"><span style="font-size: 10pt">Expected volatility</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="font-size: 10pt">56.36</span></td>
    <td><span style="font-size: 10pt">%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">56.36</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 31%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 16%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 21%">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td colspan="5" style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Appraisal Date (Inception Date)</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>C Warrant<br />
September 27,<br />
2021</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>D Warrant<br />
September 27,<br />
2021</b></span></td>
    <td>&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><b>(Unaudited)</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td colspan="5">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="5">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>$</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>$</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td colspan="5"><span style="font-size: 10pt">Market price per share (USD/share)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1.71</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">0.73</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td colspan="5"><span style="font-size: 10pt">Exercise price (USD/price)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">2.50</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">5.00</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td colspan="5"><span style="font-size: 10pt">Risk free rate</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">0.15</span></td>
    <td><span style="font-size: 10pt">%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">0.15</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td colspan="5"><span style="font-size: 10pt">Dividend yield</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">0.00</span></td>
    <td><span style="font-size: 10pt">%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">0.00</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td colspan="5"><span style="font-size: 10pt">Expected term/ Contractual life (years)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1.26</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1.26</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td colspan="5"><span style="font-size: 10pt">Expected volatility</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">52.93</span></td>
    <td><span style="font-size: 10pt">%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">52.93</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 34%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 25%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 23%">&#160;</td>
    <td style="width: 2%">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The following
is a reconciliation of the beginning and ending balances of warrants liability measured at fair value on a recurring basis using Level
3 inputs:</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="display: none">Schedule of Warranty Liability</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>December 31, <br />
2021</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>December 31, <br />
2020</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-size: 10pt">$</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-size: 10pt">$</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt">Balance at the beginning of period</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 68%"><span style="font-size: 10pt">Warrants issued to investors</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><span style="font-size: 10pt">287,520</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt">Warrants redeemed</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Fair value change of warrants included in earnings</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">24,800</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt"><b>Total</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">312,320</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The following
is a summary of the warrant activity:</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td><span style="display: none">&#160;Schedule of warrant activity</span></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number of</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Warrants</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise Price</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Remaining</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contractual</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Term in</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Years</b></p></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt">Outstanding at January 1, 2021</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Exercisable at January 1, 2021</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 52%"><span style="font-size: 10pt">Granted</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><span style="font-size: 10pt">256,000</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><span style="font-size: 10pt">3.75</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><span style="font-size: 10pt">3.00</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Exercised / surrendered</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt">Expired</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Outstanding at December 31, 2021</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">256,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">3.75</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">2.66</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt">Exercisable at December 31, 2021</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">256,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">3.75</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">2.66</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 11&#160;&#160;&#160;&#160;&#160;LEASES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has two non-cancelable lease agreements
for certain office and accommodation as well as fish farming containers for research and develop advanced technology for water circulation
applying in fishery with original lease periods expiring between 2022 and 2023. The lease terms may include options to extend or terminate
the lease when it is reasonably certain the Company will exercise that option. The Company recognizes rental expense on a straight-line
basis over the lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The components of lease expenses for the year ended December 31, 2021
and December 31, 2020 were as follows:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="display: none">Components of lease expenses</span></td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statement of Income Location</b></span></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended December 31, 2021</b></span></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended December 31, 2020</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td colspan="3">&#160;</td>
    <td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease Costs</b></span></td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 37%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease expense</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 29%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative expenses</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,424</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,224</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total net lease costs</span></td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,424</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,224</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Maturity of lease liabilities under our non-cancelable operating leases
as of December 31, 2021 and December 31, 2020 are US$ nil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note
12&#160;&#160;&#160;&#160;&#160;OTHER PAYABLES AND ACCRUED LIABILITIES</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Schedule of payables</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">VAT payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">40,023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">12,235</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Salary payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">89,775</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">920</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Others</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,628</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">43,681</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">142,426</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">56,836</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 13&#160;&#160;&#160;&#160;&#160;TAXATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and its subsidiary, and the consolidated
VIE file tax returns separately.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1) Value-added tax (&#8220;VAT&#8221;)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">PRC</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Provisional Regulation of the
PRC on VAT and the related implementing rules, all entities and individuals (&#8220;taxpayers&#8221;) that are engaged in the sale of
products in the PRC are generally required to pay VAT, at a rate of which was changed from 16% to 13% on April 1, 2019 of the gross sales
proceeds received, less any deductible VAT already paid or borne by the taxpayers. GZ WFH also subjected to 10% for the installment service
provided.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Taiwan</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Value-added and Non-value-added
Business Tax Act and the related implementing rules, all entities and individuals (&#34;taxpayers&#34;) that are engaged in the sale
of products in the Taiwan are generally required to pay VAT, at a rate of 5%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2) Income tax</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">United States</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, the Tax Cuts and Jobs Act
(the &#8220;Tax Act&#8221;) was signed into legislation. The 2017 Tax Act significantly revises the U.S. corporate income tax by, among
other things, lowering the statutory corporate tax rate from 34% to 21%, imposing a mandatory one-time tax on accumulated earnings of
foreign subsidiaries, introducing new tax regimes, and changing how foreign earnings are subject to U.S. tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, Staff Accounting Bulletin
No. 118 (&#8220;SAB 118&#8221;) was issued to provide guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement
period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740.
The Company has completed the assessment of the income tax effect of the Tax Act and there were no adjustments recorded to the provisional
amounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Coronavirus Aid, Relief and Economy Security
(CARES) Act (the &#8220;CARES Act, H.R. 748&#8221;) was signed into law on 27 March 2020. The CARES Act temporarily eliminates the 80%
taxable income limitation (as enacted under the Tax Cuts and Jobs Act of 2017) for NOL deductions for 2018-2020 tax years and reinstated
NOL carrybacks for the 2018-2020 tax years. Moreover, the CARES Act also temporarily increases the business interest deduction limitations
from 30% to 50% of adjusted taxable income for the 2019 and 2020 taxable year. Lastly, the Tax Act technical correction classifies qualified
improvement property as 15-year recovery period, allowing the bonus depreciation deduction to be claimed for such property retroactively
as if it was included in the Tax Act at the time of enactment. The Company does not anticipate a significant tax impact on its financial
statements and will continue to examine the impact the CARES Act may have on its business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluated the Global Intangible Low
Taxed Income (&#8220;GILTI&#8221;) inclusion on current earnings and profits of greater than 10% owned foreign controlled corporations.
The Company has evaluated whether it has additional provision amount resulted by the GILTI inclusion on current earnings and profits of
its foreign controlled corporations. The law also provides that corporate taxpayers may benefit from a 50% reduction in the GILTI inclusion,
which effectively reduces the 21% U.S. corporate tax rate on the foreign income to an effective rate of 10.5%. The GILTI inclusion further
provides for a foreign tax credit in connection with the foreign taxes paid. In 2019, the Company recorded a GILTI inclusion of $152,829.
The Company has elected to treat the financial statement impact of GILTI as current period expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reverse merger was completed on December 31,
2018 and the tax losses of US subsidiary was not in the scope as of December 31, 2018. As of December 31, 2019, net operating loss carried
forward which was available to offset future taxable income for the Company in the United States was $99,817. There is a full valuation
allowance applied against these loss carry forward as management determined it was not more likely than not that&#9;these net operating
losses would be utilized in the foreseeable future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Taiwan</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company&#8217;s loss
before income taxes is primarily derived from the operations in Taiwan and income tax expense is primarily incurred in Taiwan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As a result of amendments
to the &#8220;Taiwan Income Tax Act&#8221; enacted by the Office of the President of Taiwan on February 7, 2018, the statutory income
tax rate increased from&#160;17% to&#160;20% and the undistributed earning tax, or a surtax, decreased from&#160;10% to&#160;5% effective
from January 1, 2018. As a result, the statutory income tax rate in Taiwan is 20%&#160;for the years ended August 31, 2021 and 2020. An
additional surtax, of which rate was reduced from&#160;10% to&#160;5% being applied to the Company starting from September 1, 2018, is
assessed on undistributed income for the entities in Taiwan, but only to the extent such income is not distributed or set aside as a legal
reserve before the end of the following year. The&#160;5% surtax is recorded in the period the income is earned, and the reduction in
the surtax liability is recognized in the period the distribution to stockholders or the setting aside of legal reserve is finalized in
the following year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Hong Kong</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The HK tax reform has introduced two-tiered profits
tax rates for corporations. Under the two-tiered profits tax rates regime, the profits tax rate for the first HK$2 million (approximately
$257,931) of assessable profits will be lowered to 8.25% (half of the rate specified in Schedule 8 to the Inland Revenue Ordinance (IRO))
for corporations. Assessable profits above HK$2 million (approximately $257,931) will continue to be subject to the rate of 16.5% for
corporations. The Company assessed that the HK entity will not earn a profit greater than HK$2 million (approximately $257,931), it is
subject to a corporate income tax rate of 8.25%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, The Company&#8217;s subsidiary
in Hong Kong had net operating loss carry forwards available to offset future taxable income. The net operating losses will be carryforward
indefinitely under Hong Kong Profits Tax regulation. There is a full valuation allowance applied against these loss carry forward as management
determined it was not more likely than not that these net operating losses would be utilized in the foreseeable future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">PRC </span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WFOE and the consolidated VIE established in the
PRC are subject to the PRC statutory income tax rate of 25%, according to the PRC Enterprise Income Tax (&#8220;EIT&#8221;) law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the relevant tax laws and regulations
of the PRC, a company registered in the PRC is subject to income taxes within the PRC at the applicable tax rate on taxable income. All
the PRC subsidiaries were subject to income tax at a rate of 25% for the year ended December 31, 2021 and 2020. According to PRC tax regulations,
the PRC net operating loss can generally carry forward for no longer than five years starting from the year subsequent to the year in
which the loss was incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The components of the income tax (benefit) expense
are:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="display: none">Income tax components</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">139,932</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Deferred</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(42,777</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total income tax expense (benefit)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">139,932</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(42,777</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reconciliation of income taxes expenses computed
at the TW statutory tax rate (2020: at PRC statutory tax rate) applicable to income tax expense is as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Reconciliation of income tax expense</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Taiwan (2020 - PRC) income tax statutory rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">20.00%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">25.00%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Tax effect of non-deductible expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6.78</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Tax effect of stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14.71</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Tax effect of non-taxable income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Tax effect of different tax rates in other jurisdictions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.07</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">GILTI Tax impact</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Changes in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1.01%</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18.73%</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.43%</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">6.27%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3) Deferred tax assets (liabilities), net</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The tax effects of temporary differences representing
deferred income tax assets and liabilities result principally from the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Schedule of deferred income taxes</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: justify">Tax loss carried forward</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">2,300</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Allowance for doubtful receivables</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: White; text-align: justify">Total deferred tax assets&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,300</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total deferred tax assets, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,300</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Property and equipment, difference in depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Deferred tax liabilities, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The valuation allowance as of December 31, 2021
and 2020 was primarily provided for the deferred income tax assets if it is more likely than not that these items will expire before
the Company is able to realize its benefits, or that the future deductibility is uncertain. The ultimate realization of deferred income
tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible
or utilizable. Management considers projected future taxable income and tax planning strategies in making this assessment. The movement
for the valuation allowance is as following.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Movement in valuation allowance</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; font-weight: bold; text-align: justify">Balance at beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">(304,418</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Additions of valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95,844</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Reductions of valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">304,418</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Balance at the end of the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">95,844</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>PRC Withholding Tax on Dividends</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current PRC Enterprise Income Tax Law imposes
a 10% withholding income tax for dividends distributed by foreign-invested enterprises to their immediate holding companies outside the
PRC. A lower withholding tax rate will be applied if there is a tax treaty arrangement between the PRC and the jurisdiction of the foreign
holding company. Distributions to holding companies in Hong Kong that satisfy certain requirements specified by PRC tax authorities, for
example, will be subject to a 5% withholding tax rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December&#160;31, 2021 and 2020, the Company
had not recorded any withholding tax on the retained earnings of its foreign-invested enterprises in the PRC, since the Company intends
to reinvest its earnings to potentially continue its business in mainland China, namely the manufacturing of the RASs through GZ GST,
and its foreign-invested enterprises do not intend to declare dividends to their immediate foreign holding companies.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 14&#160;&#160;&#160;&#160;&#160;RELATED PARTY BALANCES AND
TRANSACTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due to related parties</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The balance due to related parties was as following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="display: none">Schedule of related party transactions</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Mountain Share Transfer, LLC (2)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">39,341</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">7,681</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due from a related party</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The balance due from a related party was as following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Mr. Yin-Chieh Cheng (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">19,067</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Taisi Electrical &amp; Plumbing Co. Pte Ltd. (3)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,615,217</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">877,809</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,615,217</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">896,876</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Yin-Chieh Cheng (&#8220;Mr. Cheng&#8221;) is the chairman the Company, and he holds 42.5% shares of the Company. The balance due to Mr. Cheng as of December 31, 2020 mainly represented the amount paid by Mr. Cheng on behalf of the Company. In September 2019, Mr. Cheng took over the receivable amount of the concert the Company invested in November 2018, and assumed the liability of $551,457 related to such receivable to the Company. In September 2019, Mr. Cheng collected the payment of $1,000,000 from JCD, our exclusive sales agent in Asia Pacific, on behalf of the Company. As agreed between Mr. Cheng and the Company, the due from balance was netted off by due to balances.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mountain Share Transfer, LLC is company 100% controlled by Erik S. Nelson, the corporate secretary and director of the Company. The balances represented the amount paid on behalf of the Company for its daily operation purpose.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Tsai Wen-Chih is the director of XFC and has control power over Taisi Electrical &amp; Plumbing Co. Pte Ltd. The Company took over the receivable amount of $877,809 from acquisition of XFC in December 2020. None of the receivables have been impaired and it is expected that the full contractual amounts can be collected.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Related party transactions</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The details of the related party transactions
were as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify">Paid on behalf of the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: justify">Mr. Zhang Bi (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">3,455</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Mr. Yin-Chieh Cheng (1)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">86,320</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Mountain Share Transfer, LLC (1)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Repayment to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Mr. Yin-Chieh Cheng</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">665,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The transactions represent the amount paid by Mr. Zhang Bi, Mr. Yin-Chieh Cheng, and Mountain Share Transfer, LLC on behalf of the Company for its daily operation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 15&#160;&#160;&#160;&#160;&#160;COMMON STOCK</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s authorized number of common
stock is 200,000,000 shares with par value of $0.001 each, and issued ordinary shares were 10,607,150 and 9,131,786 as of December 31,
2021 and 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All number of shares, share amounts and per share
data presented in the accompanying consolidated financial statements and related notes have been retroactively restated to reflect the
reverse merger transaction and subsequent issuance of shares stated above, except for authorized common shares, which were not affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 16&#160;&#160;&#160;&#160;&#160;SHARE-BASED COMPENSATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 27, 2018, Nocera granted Mr. Yin-Chieh
Cheng quarterly option awards of 250,000 Series &#8220;A&#8221; Warrants for 20 quarters (5 years) for a total of 5,000,000 Series &#8220;A&#8221;
Warrants with exercise price of $0.50 per share, subject to continued employment for services as Chairman of the Board and a Director.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2020, Nocera granted Mr. Shun-Chih
Chuang and Mr. Hsien-Wen Yu 50,000 shares of Class A warrants and 60,000 shares of Class A warrants separately,
each with exercise price of $0.50 per share, for serving as the Company&#8217;s Chief Financial Officer and Chief Operating Officer. The
Company also granted 2 employees 50,000 shares of Class A warrants with exercise price of $0.50 per share. The Class A warrants
consist of the right to purchase one share for $0.50 per share from the date of issuance until April 23, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2020, Nocera granted Mr. Michael A.
Littman 50,000 shares of Class A warrants with exercise price of $0.50 per share and 50,000 shares of Class B
warrants with exercise price of $1.00 per share. Mr. Littman exercised 50,000 shares of Class A warrants and 50,000 shares
of Class B warrants on August 11, 2021. The Class B warrants consist of the right to purchase one share for
$1.00 per share separately from the date of issuance until April 23, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 1, 2021, Nocera granted Mr. Shun-Chih
Chuang and Mr. Hsien-Wen Yu 75,000 shares of Class A warrants and 60,000 shares of Class A warrants separately,
each with exercise price of $0.50 per share, for serving as the Company&#8217;s Chief Financial Officer and Chief Operating Officer. The
Company also granted 2 employees 70,000 shares of Class A warrants with exercise price of $0.50 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2021, the Company issued an aggregate
of 505,000 shares of common stock to Mr. Shun-Chih Chuang and a total of five consultants in consideration for services rendered.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated fair value of share-based compensation
for employees is recognized as a charge against income on a ratable basis over the requisite service period, which is generally the vesting
period of the award. The fair value of stock option grant was estimated on the date of grant using the Black-Scholes option pricing model
under the following assumptions:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Assumptions used</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, <br />
2021</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, <br />
2020</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend yield</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.20%</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (in years)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.31</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.88</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48.15%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">407.00%</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company estimated the grant date fair value
of time-based stock option awards using the Black-Scholes option valuation model, which requires assumptions involving an estimate of
the fair value of the underlying common stock on the date of grant, the expected term of the options, volatility, discount rate and dividend
yield. The Company calculated expected option terms based on the &#8220;simplified&#8221; method for &#8220;plain vanilla&#8221; options
due to the limited exercise information. The &#8220;simplified method&#8221; calculates the expected term as the average of the vesting
term and the original contractual term of the options. The Company calculated volatility using the average adjusted volatility of quick
companies feature of Capital IQ for a period of time reflective of the expected option term, while the discount rate was estimated using
the interest rate for a treasury note with the same contractual term as the options granted. Dividend yield is estimated at our current
dividend rate, which adjustments for any known future changes in the rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and December
31, 2020, $6,638,371 and $266,586 share-based compensation expenses was recognized into additional paid-in capital of the Company, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, total unrecognized compensation
cost related to unvested share-based compensation awards was $11,114,097. This amount is expected to be recognized as stock-based compensation
expense in the Company&#8217;s consolidated statements of operations and comprehensive income over the remaining vesting period of 1.99
years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 17&#160;&#160;&#160;&#160;&#160;PREFERRED STOCK</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2021, the Company issued 80,000 shares
of preferred shares of $1.00 each at an issue price of $2.50 per share to certain investors credited as fully paid. The preferred shares
are non-voting and non-redeemable. The holder of the preferred shares will have priority over the holders of ordinary shares of the Company
on the assets and funds of the Company available for distribution in a distribution of assets on liquidation, winding up or dissolution
of the Company. The holder of the preferred shares shall not have the right to attend or vote at any general meeting of the Company (except
a general meeting for winding up of the Company or a resolution is to be proposed which if passed would vary or abrogate the rights or
privileges of such holder).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 18&#160;&#160;&#160;&#160;&#160;(LOSS) EARNINGS PER SHARE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the computation
of basic and diluted (loss) earnings per common share for the years ended December 31, 2021 and 2020.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Schedule of earnings (loss) per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: justify; padding-bottom: 2.5pt">Net loss attributable to the Company</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">(9,619,079</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">(632,365</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Weighted-average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">- Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">9,160,862</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,752,447</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,160,862</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,752,447</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Earnings (loss) per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.0500</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0538</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.0500</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0538</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic net (loss) income per common share is computed
using the weighted average number of the common shares outstanding during the period. Diluted (loss) income per share is computed using
the weighted average number of ordinary shares and ordinary equivalent shares outstanding which include 5,473,636 warrants outstanding
as of December 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 19&#160;&#160;&#160;&#160;&#160;COMMITMENTS AND CONTINGENCIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Capital commitments</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, the Company&#8217;s
capital commitments contracted but not yet reflected in the consolidated financial statements amounted to $nil. <span style="display: none">0</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Contingencies</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the ordinary course of business, the Company
may be subject to legal proceeding regarding contractual and employment relationships and a variety of other matters. The Company records
contingent liabilities resulting from such claims when a loss is assessed to be probable and the amount of the loss is reasonably estimable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has no significant pending litigation
for the year ended December 31, 2021 and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 20 &#160;&#160;&#160;&#160;&#160;&#160;BUSINESS COMBINATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Xin Feng Construction Co., Ltd.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2020, the Company acquired substantially
all of the assets of XFC. The fair values of assets acquired and liabilities assumed were as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="display: none">Schedule of assets acquired and liabilities assumed</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 84%; text-align: left">Cash and bank balance</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">857,555</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">318,487</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,608,301</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">877,809</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Plant and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,567</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other non-current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">458,392</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(187,447</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Bank borrowing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(532,824</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Other payables and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(55,917</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(285,186</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Advance receipts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,285,777</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">332,040</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net assets acquired</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,156,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Guizhou Wan Feng Hu Intelligent Aquatic Technology
Co. Limited.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 8, 2020, the Company terminated the
VIE agreements with and settled all debt claims as to GZ WFH. The fair values of assets and liabilities of GZ WFH were as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="display: none">Schedule of assets acquired and liabilities assumed</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 84%; text-align: left">Cash and bank balance</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">3,974</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,534,961</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">295,960</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">143,819</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Plant and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">703,412</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Advance to suppliers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,996</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Deferred tax assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">121,675</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(264,622</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Other payables and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(312,562</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Advance from customers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(637,455</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(629,666</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Due to related parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(414,583</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net assets acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">548,909</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Consideration received</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,750</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Non-controlling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,868</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cumulative exchange difference from translation of foreign operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(62,174</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Loss on disposal of subsidiary</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">460,117</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 21&#160;&#160;&#160;&#160;&#160;SUBSEQUENT EVENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Consulting Agreements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; background-color: white">On January 3, 2022, the
Company entered&#160;into a consulting agreement with a consultant. The term the consulting agreement is from January 3, 2022 to
January 2, 2025. In consideration for services rendered under the consulting agreement, the Company agreed to issue the consultant 60,000
Class A warrants, vesting in three equal installments commencing on the first anniversary date of the consulting agreement. Each
Class A warrant is exercisable to purchase one share of common stock for $0.50 per share from the date of vesting until April 23, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; background-color: white">On January 3, 2022, the
Company entered&#160;into two consulting agreements with two consultants. The term of each consulting agreement is from January 3,
2022 to January 2, 2025. In consideration for services rendered under the consulting agreements, the Company agreed to issue the consultants
an aggregate of 90,000 Class C Warrants, vesting in three equal installments commencing on the first anniversary date of the consulting
agreements. Each Class C Warrant is exercisable to purchase one share of common stock for $2.50 per share from the date of vesting in
each installment until the third anniversary date of the date of vesting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; background-color: white">The foregoing securities
were issued in reliance on the exclusion from registration provided by Rule 903 of Regulation S under the Securities Act due
to the fact that such persons was a non-U.S. Person (as defined under Rule 902 Section (k)(2)(i)&#160;of&#160;Regulation S).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Gerald H. Lindberg&#8217;s Employment
Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; background-color: white">On
January 3, 2022, the Company agreed to issue 60,000 Class C Warrants to Gerald H. Lindberg in connection with the Employment Agreement,
dated January 3, 2022, between the Company and Mr. Lindberg, as more fully described under Item 5.02 of the Current Report on Form 8-K
filed by the Company with the Securities and Exchange Commission (the &#8220;SEC&#8221;)&#160;on January 5, 2022. The Class C Warrants
issued to Mr. Lindberg vest in three equal installments over a three-year period, commencing on the first-year anniversary date of Mr.
Lindberg&#8217;s employment agreement. Each Class C Warrant will be exercisable to purchase one share of common stock for $2.50 per share
from the vesting date until the third anniversary of such vesting date. The Company agreed to issue the foregoing Class C Warrants to
Mr. Lindberg pursuant to the exemption from the registration requirements of the Securities Act of 1933 available under Section 4(a)(2)&#160;promulgated
thereunder due to the fact that the issuance did not involve a public offering of securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Issuance of Common Stock to CARMEL,
MILAZZO &amp; FEIL LLP</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; background-color: white">On January 28, 2022,
the Company issued 100,000 common shares as consideration to CARMEL, MILAZZO &amp; FEIL LLP, which has served as the Company&#8217;s legal
counsel since November 2021, according to the engagement letter signed by mutual parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 132; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="marbs"></span>INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Stated in US Dollars except for Number of
Shares)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_111_z3YbnXcinbD2" summary="xdx: Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20220331" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20211231" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br />2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br />2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsAbstract_iB_z3LEWVe8dCxk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zCfCXJdImcSc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left">Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maCz7NV_zdZJZBL0mLCk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; width: 66%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,961,777</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,444,009</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AccountsReceivableNetCurrent_i02I_maCz7NV_zugNtdT2wOVj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">531,522</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">699,555</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--InventoryNet_i02I_maCz7NV_zA5cfgaKvLt8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,618,264</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,488,681</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--AdvanceToSuppliers_i02I_maCz7NV_z2kKO8AwVcWc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Advances to suppliers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,917</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,969</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maCz7NV_z4WJL3MKPST6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Prepaid expenses and other assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,015</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107,444</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DueFromRelatedPartiesCurrent_i02I_maCz7NV_zalSmOUciZm9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Due from a related party</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DueFromRelatedPartiesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,073,362</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DueFromRelatedPartiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,615,217</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrent_i01TI_mtCz7NV_maAzB8S_zQoBVMhytTvc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,225,857</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,397,875</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsNoncurrentAbstract_i01B_zmY0ZcfKWnak" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left">Non-current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--RetentionReceivables_i01I_maCzs7p_zJuArEC3zTQf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Retention receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NCRA:RetentionReceivables" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,946</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NCRA:RetentionReceivables" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,489</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredIncomeTaxAssetsNet_i01I_d0_maCzs7p_zb0ZIELYZcK1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Deferred tax asset, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2021-12-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCzs7p_zSqM4oE7Anma" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,444</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,245</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--Goodwill_i01I_maCzs7p_z6By7phR0jcd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">332,040</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">332,040</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsNoncurrent_i01TI_mtCzs7p_maAzB8S_zd6N2DlkTdD1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total non-current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">448,430</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">472,774</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--Assets_iTI_mtAzB8S_zvVk1Zwsv8Vd" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,674,287</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,870,649</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zsP2lkkIlhX6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS' EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesAbstract_i01B_zri2VPDAAJs4" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesCurrentAbstract_i02B_zTdVCuiYGKod" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NotesPayableCurrent_i03I_d0_maCzz3U_zC9agJwHn8c9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,112</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccountsPayableCurrent_i03I_d0_maCzz3U_zwXnz7xMyln5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,442</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_i03I_maCzz3U_z0Jlce1Jb5k3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other payables and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,387</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">142,426</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--AdvanceReceipts_i03I_maCzz3U_zMIVLBPehmK3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Advance receipts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,407,854</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,051,121</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DueToRelatedPartiesCurrent_i03I_maCzz3U_zqfo3KA3QgY6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,334</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,341</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ExtendedProductWarrantyAccrual_i03I_maCzz3U_zUPcoFFeEABc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ExtendedProductWarrantyAccrual" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">312,320</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ExtendedProductWarrantyAccrual" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">312,320</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DividendsPayableCurrent_i03I_maCzz3U_zD1i9uLYwJta" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Dividend payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DividendsPayableCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,312</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DividendsPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,312</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccruedIncomeTaxesCurrent_i03I_maCzz3U_zd7i69Xf4ZMl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">112,885</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">387,319</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LoansPayableToBankCurrent_i03I_maCzz3U_zEUieRDRLtGb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Bank borrowing</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LoansPayableToBankCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,565</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LoansPayableToBankCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,292</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesCurrent_i02TI_mtCzz3U_maCzdh2_zjf5RpW99fwb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,974,657</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,100,685</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--Liabilities_i01TI_mtCzdh2_maCzGbi_zbBBeGb15SEj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">TOTAL LIABILITIES</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,974,657</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,100,685</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--CommitmentsAndContingencies_i01I_maCzGbi_zGnQVeJLHyye" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Commitments and contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0118">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0119">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockholdersEquityAbstract_i01B_zGI0TEqBBxz9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold">EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CommonStockValue_i02I_maCzjIz_zBglwviEtJr2" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt">Common stock ($<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_c20220331_pdd" title="Common stock par value"><span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_c20211231_pdd" title="Common stock par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value; authorized <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_c20220331_pdd" title="Common stock, shares authorized"><span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_c20211231_pdd" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></ix:nonFraction></span></span> shares;
    <span id="xdx_906_eus-gaap--CommonStockSharesIssued_c20220331_pdd" title="Common stock, shares issued"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_c20220331_pdd" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,707,150</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of March 31, 2022 and <span id="xdx_901_eus-gaap--CommonStockSharesIssued_c20211231_pdd" title="Common stock, shares issued"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_c20211231_pdd" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,607,150</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of December 31, 2021,
    respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,707</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,607</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PreferredStockValue_i02I_maCzjIz_zzgOCXiZg0V6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt">Preferred stock ($<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_c20220331_pdd" title="Preferred Stock, Par or Stated Value Per Share"><span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_c20211231_pdd" title="Preferred Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value; authorized <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_c20220331_pdd" title="Preferred Stock, Shares Authorized"><span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_c20211231_pdd" title="Preferred Stock, Shares Authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></ix:nonFraction></span></span>
    shares; Series A Preferred Stock, <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred Stock, Shares Authorized"><span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred Stock, Shares Authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-03-31_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></ix:nonFraction></span></span> authorized, <span id="xdx_903_eus-gaap--PreferredStockSharesIssued_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred Stock, Shares Issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred Stock, Shares Outstanding"><span id="xdx_900_eus-gaap--PreferredStockSharesIssued_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred Stock, Shares Issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred Stock, Shares Outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-03-31_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">80,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding as of March 31, 2022 and December 31,
    2021)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AdditionalPaidInCapital_i02I_maCzjIz_zCN7E9FKYmR9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,078,760</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,472,705</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StatutoryAndOtherReserves_i02I_maCzjIz_zyxmN64GGjL" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Statutory and other reserves</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">191,219</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">191,219</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCzjIz_zlY7RqUnHXNf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">(Accumulated losses) Retained earnings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,724,273</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,918,553</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maCzjIz_zxbLfpN45BX6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated other comprehensive loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">143,137</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,906</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockholdersEquity_i02TI_mtCzjIz_maCz6wm_zMqEHq2uursb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">TOTAL NOCERA, INC.&#8217;S STOCKHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,699,630</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,769,964</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--MinorityInterest_i02I_d0_maCz6wm_zeSJ3jphN426" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Non-controlling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2021-12-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_i01TI_mtCz6wm_maCzGbi_z4yMu2mFrPbc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">TOTAL STOCKHOLDER EQUITY</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,699,630</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,769,964</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtCzGbi_zBmywQxgXKT8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES AND STOCKHOLDER EQUITY</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,674,287</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,870,649</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See notes to the condensed consolidated financial
statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 133; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="mar22fin2"></span>INTERIM CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS AND COMPREHENSIVE LOSS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Stated in US Dollars except for Number of
Shares)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(UNAUDITED)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_113_znw8kmeXZICk" summary="xdx: Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20220101_20220331" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20210101_20210331" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended March 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maCz4dn_zM99rrM7ofFc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left">Net sales</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,919,045</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,579,486</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CostOfGoodsAndServicesSold_iN_di_msCz4dn_zBJJIflJcK7b" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Cost of sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,863,803</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,230,842</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--GrossProfit_iT_mtCz4dn_maCzxPS_zyXRa8HCYcg7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Gross profit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,242</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">348,644</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingExpensesAbstract_iB_zYarb90njmn2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--GeneralAndAdministrativeExpense_i01N_di_maCzQ77_zLsCIJOwZR3g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">General and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">860,953</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">235,235</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingExpenses_iNT_di_mtCzQ77_msCzxPS_zEvNuRYBTae8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.5in">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">860,953</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">235,235</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingIncomeLoss_iT_mtCzxPS_maCzBHm_zDJI8NmyqVve" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">(Loss) Income from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">805,711</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">113,409</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NonoperatingIncomeExpense_d0_maCzBHm_zLELZ3tIOaA6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Other expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,759</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCzBHm_maCzkpI_zKlda9YLKShd" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">(Loss) Income before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">805,711</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">111,650</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msCzkpI_z939LwbSpowe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,160</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--ProfitLoss_iT_mtCzkpI_maCzmaF_zGlkZ8Y9xv3g" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Net (loss) income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">805,720</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,490</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_d0_msCzmaF_zs5UflAub9V6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Less: Net loss attributable to non-controlling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-01-012021-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_iT_mtCzmaF_zHDzeJPysOA5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net (loss) income attributable to the company</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">805,720</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,490</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ComprehensiveIncomeNetOfTaxAbstract_iB_zYsIs24yOIQ2" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Comprehensive Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ProfitLoss_maCzRlV_z58aqaCyDDjg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net (loss) income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">805,720</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,490</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_maCzRlV_zywwzDqXUBpd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Foreign currency translation (loss) gain</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">129,231</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,669</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_iT_mtCzRlV_maCz43p_zBJNCT7jujo5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Total comprehensive (loss) income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">934,951</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,159</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--LessForeignCurrencyTranslationLossAttributableToNoncontrollingInterest_d0_maCz43p_zawtaqN1dqW5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Less: comprehensive loss attributable to non-controlling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ComprehensiveIncomeNetOfTax_iT_mtCz43p_z9HQbbrQ6mdb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Comprehensive (loss) income attributable to the Company</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">934,951</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,159</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--LossIncomePerShareAbstract_iB_zgpAruJXKzSl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">(Loss) Income per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--EarningsPerShareBasic_zBFbqvBlykok" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.0755</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0054</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--EarningsPerShareDiluted_zV8easykTm38" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.0755</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0036</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_z5FFWvRkXQ9l" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Weighted average number of common shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,677,150</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,131,786</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i_pdd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,677,150</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,821,506</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See notes to the condensed consolidated financial
statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 134; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="mar22fin4"></span>INTERIM CONDENSED CONSOLIDATED STATEMENTS OF
CHANGES IN STOCKHOLDERS&#8217; EQUITY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Stated in US Dollars except Number of Shares)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(UNAUDITED)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30E_114_zl93mumGgFOi" summary="xdx: Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; EQUITY (Unaudited)" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zODefNs2ByLl" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_zjGdQDjcS8Sd" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BD_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zgLXsOh64sU1" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_custom--StatutoryAndOtherReservesMember_zLfLje6F2uO2" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zZ51HtWsM1S7" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zw6rrozoRq0c" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_custom--TotalNoceraStockholdersEquityMember_zBHGWxZSKY92" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zPXOs8aEOxT8" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BE_zzAyGX92Nuol" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td>&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center">Preferred stock</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Additional<br /> Paid-in</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Statutory<br /> and <br /> other</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Retained</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Accumulated<br /> Other<br /> Comprehensive</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Total <br /> Nocera Inc.&#8217;s<br /> Stockholders&#8217;<br /> Equity</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Non-<br /> controlling</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Total<br /> Stockholders&#8217;<br /> Equity</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Capital</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Reserves</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Earnings</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(Deficit)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(Deficit)</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; text-align: center">$</td><td style="font-size: 10pt; text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_437_c20210101__20210331_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_d0_zyarPdn1NkNd" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt; width: 33%">Balance, January 1, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFsTB1hSSSq2" title="Beginning balance, shares" style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,131,786</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,132</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zBM2wCajZyMj" title="Beginning balance, shares" style="width: 4%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0277">&#8211;</span></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,692,973</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_custom_StatutoryAndOtherReservesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191,219</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">293,162</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">49,770</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_custom_TotalNoceraStockholdersEquityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,550,392</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,550,392</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">Foreign currency translation adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0279">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0280">&#8211;</span></td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0281">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0282">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0283">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2021-01-012021-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,669</ix:nonFraction></td><td style="text-align: left">)</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2021-01-012021-03-31_custom_TotalNoceraStockholdersEquityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,669</ix:nonFraction></td><td style="text-align: left">)</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0286">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,669</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0289">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0290">&#8211;</span></td><td style="font-weight: bold; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,155</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0292">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0293">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0294">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-03-31_custom_TotalNoceraStockholdersEquityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,155</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0296">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,155</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-indent: -5pt; padding-left: 5pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0299">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0300">&#8211;</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0301">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0302">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,490</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0304">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31_custom_TotalNoceraStockholdersEquityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,490</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0306">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,490</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43F_c20210101__20210331_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_d0_zUExjDxxCAg2" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-indent: -5pt; padding-left: 5pt">Balance, March 31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iE_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z7CgJUTwpgrj" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,131,786</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,132</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zrU60pIgMO67" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0321">&#8211;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,796,128</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31_custom_StatutoryAndOtherReservesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191,219</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">243,672</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">51,439</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31_custom_TotalNoceraStockholdersEquityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,701,368</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,701,368</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_434_c20220101__20220331_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_d0_zAwgWuFY21sf" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Balance, January 1, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zonAvtbTvfuk" title="Beginning balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,607,150</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,607</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z8weG6NymIYh" title="Beginning balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">80,000</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,472,705</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_custom_StatutoryAndOtherReservesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191,219</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,918,553</ix:nonFraction></td><td style="text-align: left">)</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,906</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_custom_TotalNoceraStockholdersEquityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,769,964</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,769,964</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueOther_iP3us-gaap--SharesOutstanding_zZeyugO6IqOi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt"><p style="text-indent: -5pt; padding-left: 5pt">Consultancy services settled by equities</p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesOther_iP3us-gaap--StockIssuedDuringPeriodValueOther_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOuQ2O2Ga3x7" title="Common stock issuance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0338">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">502,900</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0340">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0341">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0342">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-01-012022-03-31_custom_TotalNoceraStockholdersEquityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">503,000</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0344">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">503,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_zZZIpAajF3sl" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Foreign currency translation Adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0349">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0350">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0351">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0352">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0353">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,231</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-01-012022-03-31_custom_TotalNoceraStockholdersEquityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,231</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0356">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,231</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_z6shDAylWiH2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0359">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0360">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,155</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0362">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0363">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0364">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-01-012022-03-31_custom_TotalNoceraStockholdersEquityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,155</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0366">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,155</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ProfitLoss_zjpIpQZXAdRd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: -5pt; padding-left: 5pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0369">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0370">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0371">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0372">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">805,720</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0374">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-03-31_custom_TotalNoceraStockholdersEquityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">805,720</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0376">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">805,720</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_436_c20220101__20220331_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_d0_zHTFiBzCw4U7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-indent: -5pt; padding-left: 5pt">Balance, March 31, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iE_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGXxAfYhEnta" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,707,150</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,707</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zkXrR3cWJEB2" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">80,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,078,760</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_custom_StatutoryAndOtherReservesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191,219</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,724,273</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">143,137</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_custom_TotalNoceraStockholdersEquityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,699,630</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,699,630</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See notes to the condensed consolidated financial
statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 135; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="mar22fin3"></span><b>INTERIM CONDENSED CONSOLIDATED STATEMENTS OF
CASH FLOWS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Stated in US Dollars except for Number of
Shares)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(UNAUDITED)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_112_z5HX7AuDB6E5" summary="xdx: Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220101__20220331_zdHlb2SeM1L9" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20210101__20210331_zllJHibKN8Ia" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Three months ended March 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zNolQNJB0vC8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ProfitLoss_i01_maCzalN_zYnNobe5YhPl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; width: 66%; text-align: left">Net (loss) income</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">805,720</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,490</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zU0lSrW3CsQ1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Adjustments to reconcile net income to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--Depreciation_i01_maCzalN_z7tGfsxPwHb7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Depreciation expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">787</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,218</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInDeferredIncomeTaxes_i01N_di0_msCzalN_zD17nc3LZYub" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Deferred income tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,332</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--ConsultancyServicesSettledByEquities_i01_maCzalN_zWsQigC2Bie" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Consultancy services settled by equities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">503,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ShareBasedCompensation_i01_maCzalN_zLHrfsTICVii" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,155</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,155</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_iB_zoGzyLMtK2z7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msCzalN_zhqIN1ry8Yj6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 20pt">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">181,547</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">303,302</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInInventories_i01N_di_msCzalN_zlBO8JAMicI5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">81,931</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,374</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInDueToRelatedPartiesCurrent_i01_maCzalN_ztxXLwAW0awc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Advance to suppliers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,892</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">89,647</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i01N_di_msCzalN_zCj7IEUIhCMg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Prepaid expenses and other assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">149,262</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,683</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingLeaseCost_i01_d0_maCzalN_zRkLRHWmh6ff" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Operating lease right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2021-01-012021-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IncreaseDecreaseInGoodwill_i01N_di0_msCzalN_zb1qbAGvvO1f" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt">Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,950</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i01N_di_msCzalN_zleNgddQuf3k" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Other non-current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">23,414</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,901</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInNotesPayableCurrent_i01_maCzalN_zF5uJbTCIXNf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInNotesPayableCurrent" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">93,194</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInNotesPayableCurrent" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">51,688</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInOtherAccountsPayable_i01_maCzalN_zq26tyIqptGk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">34,887</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,129</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--IncreaseDecreaseInAdvanceFromCustomers_i01N_di0_msCzalN_zRdpUvK5Pjpg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Advance from customers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">272,511</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_i01_maCzalN_z1gV6Dr4moG9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; text-indent: 10pt">Other payables and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">98,670</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,133</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedTaxesPayable_i01_maCzalN_zKTAEjTODh9k" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">281,200</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,743</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInDeferredRevenue_i01_d0_maCzalN_zFlKoSA1sQod" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,332</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_ecustom--IncreaseDecreaseInAdvanceReceipt_i01N_di0_msCzalN_zZ9kldOgk0xa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Advance Receipts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">313,423</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseDueFromOtherRelatedParties_i01N_di_msCzalN_z7MTZEktH7Ec" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Amount due from a related party</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseDueFromOtherRelatedParties" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">458,145</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseDueFromOtherRelatedParties" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">261,209</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iT_mtCzalN_maCznrU_zoicvGHV947i" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">553,267</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">258,573</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zr0faLrhv0Q5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PaymentsToAcquireOilAndGasPropertyAndEquipment_i01N_di0_msCzOkF_zvosUoR7spMd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Purchase of property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireOilAndGasPropertyAndEquipment" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireOilAndGasPropertyAndEquipment" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInInvestingActivities_iT_d0_mtCzOkF_maCznrU_z66ekO106oj6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zhwtwUAhVST5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RepaymentsOfBankDebt_i01N_di_msCzyCs_zFmMW2uNPqTk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Bank borrowing</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfBankDebt" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,453</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfBankDebt" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">144,233</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInFinancingActivities_iT_mtCzyCs_maCznrU_zCgz0BrNPDx1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Net cash used in financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,453</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">144,233</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_maCznrU_zAmzGH0VTtlk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Effect of exchange rate changes on cash and cash equivalents</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,488</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,727</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCznrU_zEHrnyZWUEPg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net increase in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">482,232</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">416,079</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zsxZFuO1p3M9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,444,009</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,023,531</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_zOaoValFLFz1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,961,777</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">607,452</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zo4S9F3hQlUc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Supplemental disclosures of cash flow information</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--InterestPaidNet_i01_d0_zXSiemKxiVtc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Cash paid for interest expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-01-012021-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxesPaidNet_i01_d0_zlxznfKfR9Dk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Cash paid for Income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2021-01-012021-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See notes to the condensed consolidated financial
statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 136; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="mar22fin5"></span><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_805_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zrEb8tFfPdJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1 &#160;&#160;&#160;&#160;&#160;<span id="xdx_826_zoHQe5OKUshe">PRINCIPAL ACTIVITIES AND ORGANIZATION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include
the financial statements of Nocera, Inc., a Nevada corporation (&#8220;Nocera&#8221;), and its subsidiaries, Grand Smooth Inc Limited
(&#8220;GSI&#8221;) and Guizhou Grand Smooth Technology Ltd. (&#8220;GZ GST&#8221; or &#8220;WFOE&#8221;), and Xin Feng Construction
Co., Ltd. (&#8220;XFC&#8221;) that is controlled through contractual arrangements. Nocera, GSI, GZ GST and XFC are collectively referred
to as the &#8220;Company.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera was incorporated in the State of Nevada
on February 1, 2002 and is based in New Taipei City, Taiwan (R.O.C). It did not engage in any operations and was dormant from its inception
until its reverse merger of GSI on December 31, 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Reverse Merger</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective December 31, 2018, Nocera completed
a reverse merger transaction (the &#8220;Transaction&#8221;) pursuant to an Agreement and Plan of Merger (the &#8220;Agreement&#8221;),
with (i) GSI, (ii) GSI&#8217;s shareholders, Yin-Chieh Cheng and Bi Zhang, who together owned shares constituting 100% of the issued
and outstanding ordinary shares of GSI (the &#8220;GSI Shares&#8221;) and (iii) GSI Acquisition Corp. Under the terms of the Agreement,
the GSI Shareholders transferred to Nocera all of the GSI Shares in exchange for the issuance of 10,000,000 shares (the &#8220;Shares&#8221;)
of Nocera&#8217;s common stock (the &#8220;Share Exchange&#8221;). As a result of the reverse merger, GSI became Nocera&#8217;s wholly-owned
subsidiary and Yin-Chieh Cheng and Bi Zhang, the former shareholders of GSI, became Nocera&#8217;s controlling shareholders. The share
exchange transaction with GSI was treated as a reverse merger, with GSI as the accounting acquirer and Nocera as the acquired party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GSI is a limited company established under the
laws and regulations of Hong Kong on August 1, 2014, and is a holding company without any operation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GZ WFH was incorporated in Xingyi City, Guizhou
Province, People&#8217;s Republic of China (&#8220;PRC&#8221;) on October 25, 2017, and is engaged in providing fish farming containers
service, which integrates sales, installments, and maintenance of aquaculture equipment. The registered capital of GZ WFH is RMB$5,000,000
(equal to US$733,138).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 13, 2018, GSI incorporated GZ GST
in PRC with registered capital of US$15,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Divestiture</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 21, 2020, the Company filed a Current
Report on Form 8-K outlining the lack of communication that led to the termination by Nocera of its relationship with its former variable
interest entity, Guizhou Wan Feng Hu Intelligent Aquatic Technology Co. Limited (&#8220;GZ WFH&#8221;) and its management, and termination
of the variable interest entity agreements between the parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequently on October 8, 2020, Zhang Bi and
GZ WFH entered into a Settlement Agreement and Release with Nocera wherein all claims as to GZ WFH&#8217;s debt (claim to shares in Nocera
or GZ GST) were compromised, settled, and otherwise resolved as to any and all claims or causes of action whatsoever against Nocera for
any matter, action, or representation as to Nocera, and any debt to ownership of Nocera or GZ GST up to the date of the agreement. The
consideration for the agreement was mutual waiver of any and all claims against each other and GZ GST, and GZ WFH (including Zhang Bi)
waived any claims to Nocera stock, meaning the 4,750,000 shares of common stock of Nocera owned by Zhang Bi were cancelled as part of
the agreement. The Settlement Agreement and Release is attached hereto as Exhibit 10.8.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_233_zn6yC1S3AKV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zCqZXurotwbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zBGmqSAOhxZh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 137; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zqrr5qpTz15a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">The VIE Agreements</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2020, Nocera and XFC, a domestic
funded limited liability company registered in Taiwan (R.O.C), entered into a series of contractual agreements (&#8220;VIE Agreements&#8221;)
whereby Nocera agreed to provide technical consulting and related services to XFC. As a result, Nocera has been determined to be the
primary beneficiary of XFC and XFC became a variable interest entity (&#8220;VIE&#8221;) of Nocera.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2020, Nocera exchanged <span id="xdx_902_ecustom--SharesExchanged_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShareholdersMember_zuhq4bZLDds5" title="Shares exchanged">700,000</span>
shares of the Company&#8217;s restricted common stock to shareholders of XFC in exchange for 100% controlling interest in XFC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The VIE structure was adopted mainly because
the China and Taiwan (R.O.C.) operating company may in the future engage in business that may require special licenses in China and which
can be in an industry that prohibits foreign investment. WFOE has entered into the following contractual arrangements with a stockholder
of XFC, that enables the Company to (1) have the power to direct the activities that most significantly affects the economic performance
of XFC, and (2) receive the economic benefits of XFC that could be significant to XFC. The Company is fully and exclusively responsible
for the management of XFC, assumes all of the risk of losses of XFC and has the exclusive right to exercise all voting rights of XFC&#8217;s
stockholder. Therefore, in accordance with ASC 810 &#8220;Consolidation,&#8221; the Company is considered the primary beneficiary of
XFC and has consolidated XFC&#8217;s assets, liabilities, results of operations, and cash flows in the accompanying consolidated financial
statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) Voting Rights Proxy Agreement &amp; Power
of Attorney. Mr. Tsai, Wen-Chih, Ms. Tu, Hui-Min, Mr. Tsai, Chin-Yao, and Mr. Tsai, Chin-Chao (&#8220;Existing Stockholders&#8221;) hereby
irrevocably undertake that they authorize Nocera or the individual then designated by Nocera (&#8220;Attorney&#8221;) to exercise, on
his or her behalf, the following rights available to them in their capacity as a stockholder of XFC under the then effective articles
of association of XFC (collectively, &#8220;Powers&#8221;): (a) to propose the convening of, and attend, stockholders&#8217; meetings
in accordance with the articles of association of XFC on behalf of the Existing Stockholders; (b) to exercise voting rights on behalf
of the Existing Stockholders on all matters required to be deliberated and resolved by the stockholders&#8217; meeting, including without
limitation the appointment and election of the directors and other executives to be appointed and removed by the stockholders of XFC
and the sale or transfer of all or part of the equity held by stockholders of XFC; (c) to exercise other stockholders&#8217; voting rights
under the articles of association of XFC (including any other stockholders&#8217; voting rights stipulated upon an amendment to such
articles of association); (d) other voting rights that stockholders shall enjoy under Taiwan (R.O.C.) laws, as amended, revised, supplemented
and re-enacted, no matter whether they take effect before or after the conclusion of the Voting Rights Proxy Agreement. The Existing
Stockholders shall not revoke the authorization and entrustment accorded to the Attorney other than in the case where Nocera gives the
Existing Stockholders a written notice requesting the replacement of the Attorney, in which event the Existing Stockholders shall immediately
appoint such other person as then designated by Nocera to exercise the foregoing Powers and such new authorization and entrustment shall
supersede, immediately upon its grant, the original authorization, and entrustment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2) Exclusive Business Cooperation Agreement.
Nocera agrees to provide technical consulting and services including management consulting services, general and financial advisory service
and various general and administrative service, for the specific content thereof (hereinafter referred to as the &#8220;Target Business&#8221;)
to XFC as the technical consulting and service provider of XFC in accordance with the conditions set forth herein during the term of
this Agreement. XFC agrees to accept the technical consulting and services provided by Nocera. XFC further agrees that, without the prior
written consent of Nocera, during the term of the Exclusive Business Cooperation Agreement, it shall not accept any technical consulting
and services identical or similar to the Target Business that are provided by any third party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3) Equity Pledge Agreement. Under the Equity
Interest Pledge Agreement between Nocera and the Existing Stockholders, the Existing Stockholders pledged all of their equity interests
in XFC to Nocera to guarantee the performance of XFC&#8217;s obligations under the Exclusive Business Cooperation Agreement. Under the
terms of the Equity Pledge Agreement, in the event that XFC or the Existing Stockholders breach their respective contractual obligations
under the Exclusive Business Cooperation Agreement, Nocera, as pledgor, will be entitled to certain rights, including, but not limited
to, the right to collect dividends generated by the pledged equity interests. Zhang Bi also agreed that upon the occurrence of any event
of default, as set forth in the Equity Pledge Agreement, Nocera is entitled to claim indemnity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(4) Exclusive Call Option Agreement. XFC and
the Existing Stockholders have entered into an Exclusive Call Option Agreement with Nocera. Under the Exclusive Call Option Agreement,
the Existing Stockholders irrevocably granted Nocera (or its designee) an exclusive option to purchase, to the extent permitted under
Taiwan (R.O.C.) law, part or all of their equity interests in XFC. According to the Exclusive Call Option Agreement, the purchase price
shall be the minimum price permitted by applicable Taiwan (R.O.C.) law at the time when such share transfer occurs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_232_zYswgqyajuPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zR9C4Ev93zv4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zpQsYpHDhGM7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 138; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zilVsKbKjoUd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zsA4Hz2pvhTg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 2&#160;&#160;&#160;&#160;&#160; <span id="xdx_822_zG378H6snXKi">SUMMARY
OF SIGNIFICANT ACCOUNTING POLICY</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zOPDEjzSSOw3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_865_zzthcj81O9vb">Basis of Presentation</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated
financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;)
and pursuant to the rules and regulations of the United States Securities and Exchange Commission (&#8220;SEC&#8221;) for interim financial
information. Accordingly, these financial statements do not include all of the information and footnotes required for complete financial
statements and should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the
Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 23, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of management, all adjustments
(which include normal recurring adjustments) necessary to present a fair presentation of the Company&#8217;s unaudited condensed consolidated
financial position as of March 31, 2022, its consolidated results of operations for the three months ended March 31, 2022, cash flows
for the three months ended March 31, 2022 and change in equity for the three months ended March 31, 2022, as applicable, have been made.
Operating results for the three months ended March 31, 2022 are not necessarily indicative of the operating results that may be expected
for the year ending December 31, 2021 or any future periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zyWbWqZ1EcTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86A_zotZqIi3DkM7">Concentrations of Credit Risk</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially expose
the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its
customers and suppliers, and generally does not require collateral or other security from them. The Company evaluates its collection
experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic
reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were two customers who represent <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zqiCWblCaVS1" title="Concentration risk"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-03-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">98</ix:nonFraction></span>% of
the Company&#8217;s total revenue for the three months ended March 31, 2021. There were three customers who represent <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zy6rnYyOTYbh" title="Concentration risk"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-03-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">97</ix:nonFraction></span>% of the Company&#8217;s
total revenue for the three months ended March 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of single
customers who represent 10% or more of the Company&#8217;s total accounts receivable, net:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zm25Fxx0Zcgc" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B0_zW4Z3tOGIYKf" style="display: none">Concentrations of credit risk</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br /> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">Percentage of the Company&#8217;s accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Customer A</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zK5sbpyPlAUj" title="Concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22.01</ix:nonFraction></span>%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zuYJNPFVAu05" title="Concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16.37</ix:nonFraction></span>%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zB2k6gUomz9a" title="Concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">56.98</ix:nonFraction></span>%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zkaoD6BhLDdi" title="Concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">59.53</ix:nonFraction></span>%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Customer C</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zUxiX7ZeoRw6" title="Concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20.75</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zXgLgH7ZWUI9" title="Concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16.30</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_zWKMciXuphs9" title="Concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AllCustomersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">99.74</ix:nonFraction></span>%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_z3ZENt2V02q3" title="Concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AllCustomersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">92.20</ix:nonFraction></span>%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_235_zOzanXCxZa8h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zyq77TAfW4S1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_z5L7qCogiKzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 139; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zCSSs5EuiNoa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_84F_eus-gaap--RevenueRecognitionPolicyTextBlock_zTX5IXSAHa7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_860_zqVyQTKrSymi">Revenue Recognition</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes revenue in accordance
with Accounting Standards Codification (&#8220;ASC&#8221;) 606, &#8220;Revenue from Contracts with Customers.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The core principle of the guidance is that an
entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, the Company applies
the following steps:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 1: Identify the contract(s)
    with a customer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 2: Identify the performance
    obligations in the contract</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 3: Determine the transaction
    price</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 4: Allocate the transaction
    price to the performance obligation in the contract</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Wingdings; font-size: 10pt">&#376;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 5: Recognize revenue
    when (or as) the entity satisfies a performance obligation</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considered revenue is recognized
when (or as) the Company satisfies performance obligations by transferring promised goods or services to its customers. Revenue is measured
at the transaction price which is based on the amount of consideration that the Company expects to receive in exchange for transferring
the promised goods or services to its customers. Contracts with customers are comprised of invoices and written contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have arrangements for returns
from customers and does not have any future obligations directly or indirectly related to services resale by customers. The Company has
no sales incentive programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company provides goods, maintenance service
warranties for the goods sold with a period varying from 18 months to 72 months, a majority of which are 18 months, and exclusive sales
agency license to its customers. For performance obligation related to providing products, the Company expects to recognize the revenue
according to the delivery of products. For performance obligation related to maintenance service warranties, the Company expects to recognize
the revenue on a ratable basis using a time-based output method. The performance obligations are typically satisfied as services are
rendered on a straight-line basis over the contract term, which is generally for 18 months as a majority of the maintenance service warranties
periods provided are 18 months. For performance obligation related to exclusive agency license, the Company recognizes the revenue ratably
upon the satisfaction over the estimated economic life of the license.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have amounts of contract
assets since revenue is recognized as control of goods is transferred. The contract liabilities consist of advance payments from customers
and deferred revenue. Advance payments from customers are expected to be recognized as revenue within 12 months. Deferred revenue is
expected to be recognized as revenue within 12 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zdmRuBtRXOTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_866_zvQxyYzc7Cef">Recent Accounting Pronouncements</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The FASB issued several updates during the period, none of these standards
are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the consolidated
financial statements upon adoption.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:exclude><p id="xdx_230_zGPcu5LtJKol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_zPkhLKDQxgGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zYcwKc6d08M2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 140; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zFvsYybc3Ds4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:AccountsAndNontradeReceivableTextBlock"><p id="xdx_802_eus-gaap--AccountsAndNontradeReceivableTextBlock_zrDK24Rj4eBe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 3&#160;&#160;&#160;&#160;&#160;<span id="xdx_82A_zfn0f5ca1M7g">ACCOUNTS RECEIVABLE, NET</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2022 and December 31, 2021, accounts
receivable consisted of the following:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zvxUkk75SMQi" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, NET (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B0_zJOWVgbUJQQ3" style="display: none">Schedule of accounts receivable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20220331_z7fGBYydQXwk" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20211231_zjxfyEkfbM67" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br /> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccountsReceivableGross_iI_pp0p0_maARNCzmYm_zlyj2389ocuc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableGross" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">531,522</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">699,555</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_d0_msARNCzmYm_zZWOE0xJQT2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Allowance for doubtful accounts</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-03-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-12-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNCzmYm_zBmCxAALEk64" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">531,522</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">699,555</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended March 31, 2022 and
for the year ended December 31, 2021, the Company has recorded provision for doubtful accounts of nil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_zcpph4ZtWiag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 4 &#160;&#160;&#160;&#160;&#160;<span id="xdx_828_ztHWsNYJQdGd">INVENTORIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2022 and December 31, 2021, inventories
consisted of the following:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zJrBbyeFxJgc" summary="xdx: Disclosure - INVENTORIES (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B8_zXcJN3HrTLAj" style="display: none">Schedule of inventory</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20220331_zNPx1lrMRR8c" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20211231_zVoRi9ywFbPj" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br /> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_pp0p0_maINz9VL_z7cGHFufja82" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Raw materials</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterialsNetOfReserves" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">99,263</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterialsNetOfReserves" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">97,163</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InventoryWorkInProcessAndRawMaterialsNetOfReserves_iI_pp0p0_maINz9VL_zyokTyy9ldvf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Work in process</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcessAndRawMaterialsNetOfReserves" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,519,001</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcessAndRawMaterialsNetOfReserves" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,391,518</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InventoryNet_iTI_pp0p0_mtINz9VL_zvBBf6UE8Fa2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,618,264</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,488,681</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:OtherCurrentAssetsTextBlock"><p id="xdx_80A_eus-gaap--OtherCurrentAssetsTextBlock_zFjDzJzPWLWk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note
5&#160;&#160;&#160;&#160;&#160; <span id="xdx_822_zautqDbUIBY3">PREPAID EXPENSES AND OTHER ASSETS, NET</span></b></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zjkbDhSBANY7" summary="xdx: Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B9_zUkeBYARoimj" style="display: none">Schedule of prepaid expenses and other assets</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220331_z2F8Zb8a3fQg" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20211231_z3i9deZN8Tb5" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br /> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Other receivables from third party</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_pp0p0_c20220331_zrpuL1g7L8e5" title="Other receivables from third party" style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:AccountsAndOtherReceivablesNetCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,015</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccountsAndOtherReceivablesNetCurrent_c20211231_pp0p0" title="Other receivables from third party" style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:AccountsAndOtherReceivablesNetCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">107,444</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Others</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PrepaidExpenseAndOtherAssets_iI_d0_c20220331_zX3sRGRhkpui" title="Others" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssets" contextRef="AsOf2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PrepaidExpenseAndOtherAssets_iI_d0_c20211231_zMGPGfSQlPZd" title="Others" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssets" contextRef="AsOf2021-12-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Prepaid expenses and other assets, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_c20220331_pp0p0" title="Prepaid expenses" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,015</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_c20211231_pp0p0" title="Prepaid expenses" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">107,444</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23A_zOYvjsIVxzHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zL6uzffStMue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zuIsj9dRZx3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 141; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_z8P4qWP7hQT8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_801_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zC586Wb8FNe3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 6 &#160;&#160;&#160;&#160;&#160;<span id="xdx_826_zcGIlgcP6bV5">PROPERTY AND EQUIPMENT, NET</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2022 and December&#160;31, 2021,
property and equipment consisted of the following:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--PropertyPlantAndEquipmentTextBlock_z1BtwQ7P3Be2" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT, NET (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BA_zKf5UCVa7U4i" style="display: none">Schedule of property and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br /> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zDmnQElPvyQl" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-03-31_us-gaap_FurnitureAndFixturesMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zAe1uhhejWe3" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; text-align: justify">Equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" title="Property and equipment, gross" style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-03-31_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">77,031</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" title="Property and equipment, gross" style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">78,802</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Leasehold improvement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zrD9YVR9xcda" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-03-31_us-gaap_LeaseholdImprovementsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zoXPFdeCGeR2" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Vehicle</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zcB14m3JzGK6" title="Property and equipment, gross" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-03-31_us-gaap_VehiclesMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z9kM2c4BzIik" title="Property and equipment, gross" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_VehiclesMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20220331_pp0p0" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">77,031</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">78,802</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20220331_z9WTzKKTHvvk" title="Accumulated depreciation" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,587</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zZjPEa8Z3yTf" title="Accumulated depreciation" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,557</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20220331_pp0p0" title="Property and equipment, net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">68,444</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" title="Property and equipment, net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">71,245</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation expenses for the three months ended
March 31, 2022 and 2021 were $<span id="xdx_90B_eus-gaap--Depreciation_pp0p0_c20220101__20220331_zEDa8u4Y7rFa" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">787</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--Depreciation_pp0p0_c20210101__20210331_zqyyx2RRKFx7" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,218</ix:nonFraction></span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:GoodwillDisclosureTextBlock"><p id="xdx_809_eus-gaap--GoodwillDisclosureTextBlock_zf7qKeMb0QC7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 7 &#160;&#160;&#160;&#160;<span id="xdx_827_zRYZyYqc1xv9">GOODWILL</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2022 and December&#160;31, 2021,
goodwill consisted of the following:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfGoodwillTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfGoodwillTextBlock_zKCaKhtLz8ba" summary="xdx: Disclosure - GOODWILL (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BF_zpSt53H8uXib" style="display: none">Schedule of goodwill</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br /> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Goodwill - XFC</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Goodwill_c20220331__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_pp0p0" title="Goodwill" style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-03-31_custom_XinFengConstructionCoLtdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">332,040</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Goodwill_c20211231__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_pp0p0" title="Goodwill" style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-12-31_custom_XinFengConstructionCoLtdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">332,040</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20220331__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_zZhMHr3F27N" title="Accumulated amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-03-31_custom_XinFengConstructionCoLtdMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20211231__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_zrnytFwnc8oj" title="Accumulated amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_custom_XinFengConstructionCoLtdMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Goodwill, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Goodwill_c20220331_pp0p0" title="Goodwill" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">332,040</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Goodwill_c20211231_pp0p0" title="Goodwill" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">332,040</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:GuaranteesTextBlock"><p id="xdx_800_eus-gaap--GuaranteesTextBlock_zxUz9CGYXmxa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note </b><b>8
</b><b>&#160;&#160;&#160;&#160;<span id="xdx_82D_zgJB3DLrWrLj">WARRANTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April
1, 2021, the Company entered into a securities purchase agreement with certain investors for an aggregate of 80,000 shares of its preferred
stock at a per share purchase price of $2.50. As part of the transaction, the investors received one Class C warrant and one Class D
warrant for the subscription of each preferred share. The Class C warrants consist of the right to purchase up to 80,000 shares of the
Company&#8217;s common stock at an exercise price of $2.50 per share exercisable for 36 months from the date of inception. The Class
D warrants consist of the right to purchase up to 80,000 shares of the Company&#8217;s common stock at an exercise price of $5.00 per
share exercisable for 36 months from the date of inception. The subscription was completed on August 10, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23B_zccoaOpAbvAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zhbfdCj65Y3j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 142; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zeWbJU53AL4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September
27, 2021, the Company entered into another securities purchase agreement with the same investors, pursuant to which the Company issued
in a registered direct offering, an aggregate of 48,000 shares of common stock of the Company at a per share purchase price of $2.50.
In addition, the investors also received one Class C warrant and one Class D warrant for the subscription of each preferred share. The
Class C warrants consist of the right to purchase up to 80,000 shares of the Company&#8217;s common stock at an exercise price of $2.50
per share exercisable for 36 months from the date of inception. The Class D warrants consist of the right to purchase up to 80,000 shares
of the Company&#8217;s common stock at an exercise price of $5.00 per share exercisable for 36 months from the date
of inception.</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_zZNzhkd1ivsb" summary="xdx: Disclosure - WARRANT (Details - Assumptions used)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B3_zolyDeAvVSP1" style="display: none">Schedule Assumption used</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Appraisal Date (Inception Date)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>C
                                            Warrant<br /> August 10, </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>D
                                            Warrant<br /> August 10, </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 70pt"><b>(Unaudited)</b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; padding-bottom: 1pt">Market price per share (USD/share)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharePrice_c20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" title="Market price per share (USD/share)" style="padding-bottom: 1pt; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-08-10_custom_CWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.47</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharePrice_c20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" title="Market price per share (USD/share)" style="padding-bottom: 1pt; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-08-10_custom_DWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.66</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Exercise price (USD/price)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" title="Exercise price (USD/price)" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-08-10_custom_CWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.50</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" title="Exercise price (USD/price)" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-08-10_custom_DWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Risk free rate</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zJtleOeWH7x5" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-012021-08-10_custom_CWarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.14</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zVFfXxfSE29g" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-012021-08-10_custom_DWarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.14</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Dividend yield</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zDeljX4piFi5" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-01-012021-08-10_custom_CWarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.00</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zphHp84WtXFb" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-01-012021-08-10_custom_DWarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.00</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Expected term/ Contractual life (years)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zYIzg7iLiKB3" title="Expected term/ Contractual life (years)"><ix:nonNumeric contextRef="From2021-01-012021-08-10_custom_CWarrantMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">1.39</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zxdp9jeBwaYb" title="Expected term/ Contractual life (years)"><ix:nonNumeric contextRef="From2021-01-012021-08-10_custom_DWarrantMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">1.39</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Expected volatility</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zcNQumQ3wbUh" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-012021-08-10_custom_CWarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">56.36</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zSN0k9tl3Cn4" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-012021-08-10_custom_DWarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">56.36</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Appraisal Date (Inception Date)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">C Warrant<br /> September 27,<br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">D Warrant<br /> September 27,<br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 70pt"><b>(Unaudited)</b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; padding-bottom: 1pt">Market price per share (USD/share)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharePrice_iI_c20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zQ0OvoIHBHq8" title="Market price per share (USD/share)" style="padding-bottom: 1pt; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-09-27_custom_CWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.71</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharePrice_c20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" title="Market price per share (USD/share)" style="padding-bottom: 1pt; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-09-27_custom_DWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.73</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Exercise price (USD/price)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" title="Exercise price (USD/price)" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-09-27_custom_CWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.50</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" title="Exercise price (USD/price)" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-09-27_custom_DWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Risk free rate</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zHuA0VWtRLg5" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-012021-09-27_custom_CWarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.15</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zZ62Z2LHUAKb" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-012021-09-27_custom_DWarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.15</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Dividend yield</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zmshSCeRiq89" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-01-012021-09-27_custom_CWarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.00</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zsqMuDZuGT9h" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-01-012021-09-27_custom_DWarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.00</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Expected term/ Contractual life (years)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zA066G7UQiv5" title="Expected term/ Contractual life (years)"><ix:nonNumeric contextRef="From2021-01-012021-09-27_custom_CWarrantMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">1.26</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zlViy1eBJLhi" title="Expected term/ Contractual life (years)"><ix:nonNumeric contextRef="From2021-01-012021-09-27_custom_DWarrantMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">1.26</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Expected volatility</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zRsOtfaKSvWc" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-012021-09-27_custom_CWarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">52.93</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zjlhNqiuyjSj" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-012021-09-27_custom_DWarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">52.93</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zgww6eMBcEw8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23B_zsJQY4kJmhBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zs2q93adbLc8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zO9JSRjRrl0d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 143; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zKfRG5l2Z0Kc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following
is a reconciliation of the beginning and ending balances of warrants liability measured at fair value on a recurring basis using Level
3 inputs:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zRBbX1KQWYJi" summary="xdx: Disclosure - WARRANT (Details - Warrant Liability)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8BF_zEsJTGJAr8X9" style="display: none">Schedule of Warranty Liability</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br /> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left; padding-bottom: 1pt">Balance at the beginning of period</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_c20220101__20220331_zb0FgH8HVBn2" title="Balance at the beginning of period" style="padding-bottom: 1pt; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">312,320</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_d0_c20210101__20211231_zdfF0NYdyda8" title="Balance at the beginning of period" style="padding-bottom: 1pt; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" contextRef="AsOf2020-12-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Warrants issued to investors</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_d0_c20220101__20220331_z3hoiL8ruSBl" title="Warrants issued to investors" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20210101__20211231_zv5ZxRxu2TWl" title="Warrants issued to investors" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">287,520</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Warrants redeemed</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_ecustom--WarrantsRedeemed_pp0p0_d0_c20220101__20220331_zh3tOl2AGX5j" title="Warrants redeemed" style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_988_ecustom--WarrantsRedeemed_pp0p0_d0_c20210101__20211231_z1ihNezgdBFj" title="Warrants redeemed" style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Fair value change of warrants included in earnings</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_pp0p0_d0_c20220101__20220331_zUhCxqG5iC59" title="Fair value change of warrants included in earnings" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProductWarrantyAccrualPeriodIncreaseDecrease" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_pp0p0_c20210101__20211231_zsGpfdw9VAof" title="Fair value change of warrants included in earnings" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProductWarrantyAccrualPeriodIncreaseDecrease" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,800</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20220101__20220331_z6J3cmCtUIzl" title="Balance at the end of period" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">312,320</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20210101__20211231_zbozojyq2qs3" title="Balance at the end of period" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">312,320</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following
is a summary of the warrant activity:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock_zdRW7EME5sqj" summary="xdx: Disclosure - WARRANT (Details - Warrant Activity)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B3_zuMpDTHKvy61" style="display: none">Schedule of warrant activity</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number
                                            of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Warrants</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise
                                            Price</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Remaining</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contractual</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Term
                                            in</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Years</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; padding-bottom: 1pt">Outstanding at January 1, 2022</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zZg4p29h3n1i" title="Warrants outstanding, beginning balance" style="padding-bottom: 1pt; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">256,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zs74PakyxSi4" title="Average exercise price, outstanding beginning" style="padding-bottom: 1pt; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.75</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 1pt; width: 11%; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_zBEPjacYxVe8" title="Weighted average remaining contractual term"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.66</ix:nonNumeric></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Exercisable at January 1, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_986_ecustom--WarrantsExercisable_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z15yeeroRkRg" title="Warrants exercisable beginning" style="padding-bottom: 1pt; text-align: right">256,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_ecustom--AverageExercisePriceExerciasable_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zhAgzTReyVCg" title="Average exercise price, exerciasable beginning" style="padding-bottom: 1pt; text-align: right">3.75</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_zlzBpKCdBSdl" title="Weighted average remaining contractual term"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.66</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Granted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z3E0O5QkUjpf" title="Warrants Granted" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="From2022-01-012022-03-31_us-gaap_WarrantMember" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_986_ecustom--AverageExercisePriceGranted_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z6gEqiS9i7Ie" title="Average exercise price, granted" style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised / surrendered</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_980_ecustom--WarrantsExercisedSurrendered_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zK5E6F6fRhpj" title="Warrants Exercised / surrendered" style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_982_ecustom--AverageExercisePriceExercisedSurrendered_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zXfaY0ifyBf2" title="Average exercise price, exercised / surrendered" style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zzc0c0qavmZd" title="Warrants expired" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2022-01-012022-03-31_us-gaap_WarrantMember" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_982_ecustom--WarrantWeightedAverageExercisePriceExpired_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zDZP7SIzuO22" title="Average exercise price, expired" style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Outstanding at March 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zKfnjL9vFa27" title="Warrants outstanding, ending balance" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-03-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">256,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zjRsP5UP5Jg6" title="Average exercise price, outstanding ending" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-03-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.75</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_905_ecustom--WeightedAverageRemainingContractualTermOutsanding_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zazAkIfoMZe8" title="Weighted Average Remaining Contractual Term, outsanding">2.66</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Exercisable at March 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98B_ecustom--WarrantsExercisable_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zXlwjtrWVvug" title="Warrants exercisable at ending" style="padding-bottom: 1pt; text-align: right">256,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_ecustom--AverageExercisePriceExerciasable_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zS9dqwVk5Po8" title="Average exercise price, exerciasable ending" style="padding-bottom: 1pt; text-align: right">3.75</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_905_ecustom--WeightedAverageRemainingContractualTermExercisable_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z8BZmieWyzSi" title="Weighted Average Remaining Contractual Term, exercisable">2.66</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_231_z9hCXSBeqj27" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zyoBNNgDVEcj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zcT84fLfQOmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 144; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zUyzOxw5hzKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:LeasesOfLesseeDisclosureTextBlock"><p id="xdx_802_eus-gaap--LeasesOfLesseeDisclosureTextBlock_ztCPw4fOw6ae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 9 &#160;&#160;&#160;&#160;&#160;<span id="xdx_826_zxWDTRzOgcCd">LEASES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has two non-cancelable lease agreements
for certain of the office and accommodation as well as fish farming containers for research and develop advanced technology for water
circulation applying in fishery with original lease periods expiring between 2022 and 2023. The lease terms may include options to extend
or terminate the lease when it is reasonably certain the Company will exercise that option. The Company recognizes rental expense on
a straight-line basis over the lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The components of lease expense for the three months ended March 31,
2022 and March 31, 2021 were as follows:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:LeaseCostTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--LeaseCostTableTextBlock_zsAAkdKcnPF7" summary="xdx: Disclosure - LEASES (Details - Lease costs)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BE_zVB7hE2UFac" style="display: none">Components of lease expenses</span></td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Statement of Income Location</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended <br /> March 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended <br /> March 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Lease Costs</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: justify; padding-bottom: 1pt">Operating lease expense</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 24%; text-align: center; padding-bottom: 1pt">General and administrative expenses</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OperatingLeaseExpense_pp0p0_c20220101__20220331_zUgL9JhLDzbb" title="Operating lease expense" style="border-bottom: Black 1pt solid; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,788</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--OperatingLeaseExpense_c20210101__20210331_pp0p0" title="Operating lease expense" style="border-bottom: Black 1pt solid; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,218</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total net lease costs</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LeaseCost_c20220101__20220331_pp0p0" title="Total net lease costs" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,788</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LeaseCost_c20210101__20210331_pp0p0" title="Total net lease costs" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,218</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Maturity of lease liabilities under our non-cancelable operating leases
as of December 31, 2021 and March 31, 2022 are US$ nil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"><p id="xdx_80C_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zurhctaYBSth" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note
10&#160;&#160;&#160;&#160;&#160;<span id="xdx_822_z0xzanoc8udg">OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zWMjxoS4liwg" summary="xdx: Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B0_z2kcpJ0g7eOe" style="display: none">Schedule of payables</span></td>
    <td>&#160;</td>
    <td id="xdx_496_20220331_zn44z4h1Zp3c" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_498_20211231_zV4mvrnmUm4d" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March
    31, <br />
    2022</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, <br />
    2021</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0_maOAPAAzlpa_z0mZVfeq3Wn6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VAT payable</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,742</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,023</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maOAPAAzlpa_z6Y8UvO3JUae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary payable</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31,255</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">89,775</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOAPAAzlpa_zSqCaOvLFhQk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,390</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,628</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzlpa_zskZ7Bea6exa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">69,387</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">142,426</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_236_zA1gvnVb3pfg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zayFeUqJlQTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 145; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zVXMo54tkcFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80B_eus-gaap--IncomeTaxDisclosureTextBlock_zBCMoWHPAHp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Note 11
&#160;&#160;&#160;&#160;&#160;<span id="xdx_82C_zoZ35SQXaG3h">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and its subsidiary, and the consolidated
VIE file tax returns separately.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1) Value-added tax (&#8220;VAT&#8221;)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">PRC</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Provisional Regulation of the
PRC on VAT and the related implementing rules, all entities and individuals (&#8220;taxpayers&#8221;) that are engaged in the sale of
products in the PRC are generally required to pay VAT, at a rate of which was changed from <span id="xdx_905_ecustom--ValueAddedTaxRate_iI_dp_c20211231_zWMfCmiNFeU8" title="Value added tax rate">16</span>% to <span id="xdx_90C_ecustom--ValueAddedTaxRate_c20220331_pdd" title="Value added tax rate">13</span>% on April 1, 2019 of the gross sales
proceeds received, less any deductible VAT already paid or borne by the taxpayers. GZ WFH also subjected to 10% for the installment service
provided.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Taiwan</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Value-added and Non-value-added
Business Tax Act and the related implementing rules, all entities and individuals (&#8220;taxpayers&#8221;) that are engaged in the sale
of products in the Taiwan are generally required to pay VAT, at a rate of 5%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2) Income tax</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">United States </span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, the Tax Cuts and Jobs Act
(the &#8220;Tax Act&#8221;) was signed into legislation. The Tax Act significantly revises the U.S. corporate income tax by, among other
things, lowering the statutory corporate tax rate from 34% to 21%, imposing a mandatory one-time tax on accumulated earnings of foreign
subsidiaries, introducing new tax regimes, and changing how foreign earnings are subject to U.S. tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, Staff Accounting Bulletin
No. 118 (&#8220;SAB 118&#8221;) was issued to provide guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement
period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740.
The Company has completed the assessment of the income tax effect of the Tax Act and there were no adjustments recorded to the provisional
amounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Coronavirus Aid, Relief and Economy Security
Act (the &#8220;CARES Act&#8221;) was signed into law on 27 March 2020. The CARES Act temporarily eliminates the 80% taxable income limitation
(as enacted under the Tax Cuts and Jobs Act of 2017) for NOL deductions for 2018-2020 tax years and reinstated NOL carrybacks for the
2018-2020 tax years. Moreover, the CARES Act also temporarily increases the business interest deduction limitations from 30% to 50% of
adjusted taxable income for the 2019 and 2020 taxable year. Lastly, the Tax Act technical correction classifies qualified improvement
property as 15-year recovery period, allowing the bonus depreciation deduction to be claimed for such property retroactively as if it
was included in the Tax Act at the time of enactment. The Company does not anticipate a significant tax impact on its financial statements
and will continue to examine the impact the CARES Act may have on its business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluated the Global Intangible Low
Taxed Income (&#8220;GILTI&#8221;) inclusion on current earnings and profits of greater than 10% owned foreign controlled corporations.
The Company has evaluated whether it has additional provision amount resulted by the GILTI inclusion on current earnings and profits
of its foreign controlled corporations. The law also provides that corporate taxpayers may benefit from a 50% reduction in the GILTI
inclusion, which effectively reduces the <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20220331__us-gaap--IncomeTaxAuthorityAxis__country--US_zV4VYhboKQfg" title="Effective income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-01-012022-03-31_country_US" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span>% U.S. corporate tax rate on the foreign income to an effective rate of <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20210331__us-gaap--IncomeTaxAuthorityAxis__country--US_zvjahn1hx6fe" title="Effective income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-01-012021-03-31_country_US" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.5</ix:nonFraction></span>%. The GILTI inclusion
further provides for a foreign tax credit in connection with the foreign taxes paid. In 2019, the Company recorded a GILTI inclusion
of $<span id="xdx_90D_ecustom--GlobalIntangibleLowTaxedIncome_c20220101__20220331_pp0p0" title="Global Intangible Low Taxed Income">152,829</span>. The Company has elected to treat the financial statement impact of GILTI as current period expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_239_zNoRmMM1fxF4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_znc6mWtQ5o2g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zhcxOmxrxzec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 146; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zDDvqPYbE4xl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reverse merger was completed on December
31, 2018 and the tax losses of US subsidiary was not in the scope as of December 31, 2018. As of December 31, 2019, net operating loss
carried forward which was available to offset future taxable income for the Company in the United States was $<span id="xdx_90D_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20191231__us-gaap--IncomeTaxAuthorityAxis__country--US_ziwTIVA27cwk" title="Net operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2019-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">99,817</ix:nonFraction></span>. There is a full
valuation allowance applied against these loss carry forward as management determined it was not more likely than not that these net
operating losses would be utilized in the foreseeable future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Hong Kong</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The HK tax reform has introduced two-tiered profits
tax rates for corporations. Under the two-tiered profits tax rates regime, the profits tax rate for the first HK$2 million (approximately
$257,931) of assessable profits will be lowered to <span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20220331__us-gaap--IncomeTaxAuthorityAxis__country--HK_zSgDuT1sqNi1" title="Effective income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-01-012022-03-31_country_HK" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.25</ix:nonFraction></span>% (half of the rate specified in Schedule 8 to the Inland Revenue Ordinance (IRO))
for corporations. Assessable profits above HK$2 million (approximately $257,931) will continue to be subject to the rate of 16.5% for
corporations. The Company assessed that the HK entity will not earn a profit greater than HK$2 million (approximately $257,931), it is
subject to a corporate income tax rate of 8.25%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, the Company&#8217;s
subsidiary in Hong Kong had net operating loss carry forwards available to offset future taxable income. The net operating losses will
be carryforward indefinitely under Hong Kong Profits Tax regulation. There is a full valuation allowance applied against these loss carry
forward as management determined it was not more likely than not that these net operating losses would be utilized in the foreseeable
future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">PRC</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WFOE and the consolidated VIE established in
the PRC are subject to the PRC statutory income tax rate of <span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20220331__us-gaap--IncomeTaxAuthorityAxis__custom--PrcMember_z9fCgaCJArC6" title="Effective income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-01-012022-03-31_custom_PrcMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></span>%, according to the PRC Enterprise Income Tax (&#8220;EIT&#8221;) law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance
with the relevant tax laws and regulations of the PRC, a company registered in the PRC is subject to income taxes within the PRC at the
applicable tax rate on taxable income. All the PRC subsidiaries were subject to income tax at a rate of 25% for the year ended December
31, 2021. According to PRC tax regulations, the PRC net operating loss can generally carry forward for no longer than five years starting
from the year subsequent to the year in which the loss was incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Taiwan</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The
Company&#8217;s loss before income taxes is primarily derived from the operations in Taiwan and income tax expense is primarily incurred
in Taiwan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As
a result of amendments to the &#8220;Taiwan Income Tax Act&#8221; enacted by the Office of the President of Taiwan on February 7, 2018,
the statutory income tax rate increased from&#160;17% to&#160;20% and the undistributed earning tax, or a surtax, decreased from&#160;10%
to&#160;5% effective from January 1, 2018. As a result, the statutory income tax rate in Taiwan is 20%&#160;for the years ended August
31, 2021 and 2020. An additional surtax, of which rate was reduced from&#160;10% to&#160;5% being applied to the Company starting from
September 1, 2018, is assessed on undistributed income for the entities in Taiwan, but only to the extent such income is not distributed
or set aside as a legal reserve before the end of the following year. The&#160;5% surtax is recorded in the period the income is earned,
and the reduction in the surtax liability is recognized in the period the distribution to stockholders or the setting aside of legal
reserve is finalized in the following year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:exclude><p id="xdx_23B_zruemaLPF6J2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zh6DlngPHlql" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zcZiCcGs3Fo9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 147; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zc7ruRdmQR8k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The components of the income tax (benefit) expense
are:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zNBlCeB3s3Fj" summary="xdx: Disclosure - TAXATION (Details - Income tax expense)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BA_zWIYPtJ5eEq2" style="display: none">Income tax components</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20220101__20220331_z22ivmCU75wb" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20210101__20210331_zg7NLvQLywSh" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three
                                            months ended </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March
                                            31,</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CurrentIncomeTaxExpenseBenefit_maITEBzz8A_zFcIrk11lfEl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Current</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,845</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredIncomeTaxExpenseBenefit_d0_maITEBzz8A_zAY8oAF2jPAh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Deferred</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,315</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzz8A_zqkoR6pJjKW8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total income tax expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">62,160</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reconciliation of income taxes expenses computed
at the Taiwan statutory tax rate (2021: at PRC statutory rate) applicable to income tax expense is as follows:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zIhHDT4qwibj" summary="xdx: Disclosure - TAXATION (Details - Reconcilation of income tax)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BF_zgAKvp0kzcGc" style="display: none">Reconciliation of income tax expense</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three
                                            months ended</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,</b></p>

</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Taiwan (2021-PRC) income tax statutory rate</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20220101__20220331_zrN7nGv33YV8" title="PRC income tax statutory rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20.00</ix:nonFraction></span>%</td><td style="text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20210101__20210331_ztPAilGbJTO8" title="PRC income tax statutory rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25.00</ix:nonFraction></span>%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Impact of different tax rates in other jurisdictions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20220101__20220331_z0vYRtCjweX8" title="Impact of different tax rates in other jurisdictions"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.20</ix:nonFraction></span>%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(<span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20210101__20210331_zAqgeGCddJ52" title="Impact of different tax rates in other jurisdictions"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.93</ix:nonFraction></span>%)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Tax effect of non-deductible expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20220101__20220331_zC4vbbbjpPF8" title="Tax effect of non-deductible expense"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15.85</ix:nonFraction></span>%</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20210101__20210331_zigsnhYgJ0ij" title="Tax effect of non-deductible expense"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.00</ix:nonFraction></span>%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Utilization of tax losses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_ecustom--TaxEffectOfNontaxableIncomeLoss_dp0_c20220101__20220331_z0jLXLkNfC39" title="Tax effect of utilization of tax losses previously recognized">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(<span id="xdx_907_ecustom--TaxEffectOfNontaxableIncomeLoss_dp_c20210101__20210331_zJwFVApCWW65" title="Tax effect of utilization of tax losses previously recognized">2.07</span>%)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsOther_dp_c20220101__20220331_zYqrjFjLQnn1" title="Others"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.00</ix:nonFraction></span>%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsOther_dp0_c20210101__20210331_z0TDxFcxKeng" title="Others"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther" contextRef="From2021-01-012021-03-31" format="ixt:zerodash" decimals="INF" scale="-2" sign="-" unitRef="Pure">-</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Changes in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20220331_zNWp2yL6lI06" title="Changes in valuation allowance"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.35</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210101__20210331_zI01XUU8de11" title="Changes in valuation allowance"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">36.6</ix:nonFraction></span>%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20220331_zfTk65wv4xnj" title="Effective tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.00</ix:nonFraction></span>%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20210331_zcGWOudRGmB6" title="Effective tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">53.60</ix:nonFraction></span>%</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3) Deferred tax assets (liabilities), net</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The tax effects of temporary differences representing
deferred income tax assets and liabilities result principally from the following:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zOpb9kfrk5Sc" summary="xdx: Disclosure - TAXATION (Details - Deferred taxes)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify"><span id="xdx_8B8_zzI2HQsnYHV4" style="display: none">Schedule of deferred income taxes</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20220331_zeov4IFQyBO5" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20211231_zPfQc6vrLjB8" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">March 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGrossAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_d0_maDTAGzr6G_z0UxfON8Cqfa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Tax loss carried forward</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2022-03-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2021-12-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_i01I_pp0p0_d0_maDTAGzr6G_zyd46Wka0yk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Allowance for doubtful receivables</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" contextRef="AsOf2022-03-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" contextRef="AsOf2021-12-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_d0_mtDTAGzr6G_maDTANzRmV_zWDL49L0RdAj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><b style="display: none">Total deferred tax assets</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2022-03-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2021-12-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetsValuationAllowanceCurrents_i01NI_pp0p0_di0_msDTANzRmV_z2SBASl55znj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_d0_mtDTANzRmV_zFqyAMJYNsRh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total deferred tax assets, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2022-03-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2021-12-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">March 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_i01NI_pp0p0_di0_maDITLzGX1_z91AKMAQgoF6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Property and equipment, difference in depreciation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="AsOf2022-03-31" format="ixt:zerodash" decimals="0" scale="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="AsOf2021-12-31" format="ixt:zerodash" decimals="0" scale="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredIncomeTaxLiabilities_i01NTI_pp0p0_di0_mtDITLzGX1_zbzCUzarUte7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Deferred tax liabilities, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="AsOf2022-03-31" format="ixt:zerodash" decimals="0" scale="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="AsOf2021-12-31" format="ixt:zerodash" decimals="0" scale="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zcUl80h0jStd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:exclude><p id="xdx_230_zddrpioyiOY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zDCuRH9uqSLh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 148; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zBg83fZGAxh7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The valuation allowance as of March 31, 2022
and December 31, 2021 was primarily provided for the deferred income tax assets if it is more likely than not that these items will expire
before the Company is able to realize its benefits, or that the future deductibility is uncertain. The ultimate realization of deferred
income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become
deductible or utilizable. Management considers projected future taxable income and tax planning strategies in making this assessment.
The movement for the valuation allowance is as following.</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:SummaryOfValuationAllowanceTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--SummaryOfValuationAllowanceTextBlock_z2d2NOuYyQSb" summary="xdx: Disclosure - TAXATION (Details - Valuation Allowance)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BD_zoHuHUzAQc8" style="display: none">Movement in valuation allowance</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">March 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; font-weight: bold; text-align: justify">Balance at beginning of the year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pp0p0_c20220101__20220331_zatVc5YIS4Hd" title="Valuation allowance, beginning" style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">95,844</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pp0p0_d0_c20210101__20211231_zWTTI0X5EAp3" title="Valuation allowance, beginning" style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-12-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Additions of valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20220101__20220331_pp0p0" title="Additions to valuation allowance" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,102</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pp0p0_c20210101__20211231_zBe1D7KEGk98" title="Additions to valuation allowance" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">95,844</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Reductions of valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20220101__20220331_zHtO5OuCig0l" title="Reductions in valuation allowance" style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20210101__20211231_zKAN78REQQAk" title="Reductions in valuation allowance" style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Balance at the end of the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20220101__20220331_zltgf9v29d6c" title="Valuation allowance, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">138,946</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20210101__20211231_zpCa8Roa4Wzd" title="Valuation allowance, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">95,844</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>PRC Withholding
Tax on Dividends</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current PRC Enterprise Income Tax Law imposes
a 10% withholding income tax for dividends distributed by foreign-invested enterprises to their immediate holding companies outside the
PRC. A lower withholding tax rate will be applied if there is a tax treaty arrangement between the PRC and the jurisdiction of the foreign
holding company. Distributions to holding companies in Hong Kong that satisfy certain requirements specified by PRC tax authorities,
for example, will be subject to a 5% withholding tax rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of
December&#160;31, 2021, the Company had not recorded any withholding tax on the retained earnings
of its foreign-invested enterprises in the PRC, since the Company intended to reinvest its earnings to potentially continue its business
in mainland China, namely the manufacturing of the RASs through GZ GST, and its foreign-invested enterprises do not intend to declare
dividends to their immediate foreign holding companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March
31, 2022, the Company had not recorded any withholding tax on the retained earnings of its foreign-invested enterprises in the PRC, and
the Company decided not to reinvest its earnings since it is not continuing its business in mainland China, and its foreign-invested
enterprises do not intend to declare dividends to their immediate foreign holding companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zvtXanx0xRj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 12&#160;&#160;&#160;&#160;&#160; <span id="xdx_825_zLrNTLLxqjUa">RELATED PARTY BALANCES AND
TRANSACTIONS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due to related parties</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The balance due to related parties was as following:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zPZQSQoiiX9e" summary="xdx: Disclosure -  RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_z5aIQXWUmNp" style="display: none">Schedule of related party transactions</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br /> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Mr. Yin-Chieh Cheng (1)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_fKDEp_zYGNXSMd5e27" title="Due from related parties" style="padding-bottom: 1pt; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2022-03-31_custom_YinChiehChengMember" id="Fact000929" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,653</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_d0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_fKDEp_zqCqxQ9us1v7" title="Due from related parties" style="padding-bottom: 1pt; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2021-12-31_custom_YinChiehChengMember" id="Fact000931" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Mountain Share Transfer, LLC (2)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferMember_fKDIp_z8kOPGm38MAf" title="Due to related parties" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2022-03-31_custom_MountainShareTransferMember" id="Fact000933" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,681</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferMember_fKDIp_zmlC1mm3w1Ta" title="Due to related parties" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-12-31_custom_MountainShareTransferMember" id="Fact000935" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,341</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_c20220331_pp0p0" title="Due from related parties" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,334</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_c20211231_pp0p0" title="Due from related parties" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,341</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_230_z0vSk5IO0KO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zAi03lbTpFNh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zvEnvkDhEPud" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 149; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zlEDZyzPp51b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due from a related party</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The balance due from a related party was as following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br /> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Taisi Electrical &amp; Plumbing Co. Pte Ltd. (3)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TaisiElectricMember_fKDMp_zh2O3aSAwF3h" title="Due from related parties" style="padding-bottom: 1pt; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2022-03-31_custom_TaisiElectricMember" id="Fact000945" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,073,362</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TaisiElectricMember_fKDMp_zMEU1ccVhgm9" title="Due from related parties" style="padding-bottom: 1pt; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2021-12-31_custom_TaisiElectricMember" id="Fact000947" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,615,217</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span id="xdx_F05_z9Yq5JGix94k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F1C_zKpw4KlepWn5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000948" xml:lang="en-US">Mr. Yin-Chieh Cheng (&#8220;Mr.
    Cheng&#8221;) is the chairman the Company, and he holds 42.5% shares of the Company. The balance due to Mr. Cheng as of March 31,
    2022 mainly represented the amount paid by Mr. Cheng on behalf of the Company. </ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span id="xdx_F05_zZ7CsgsUqw3d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td><p id="xdx_F1F_z2rkY9MMOZ69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><ix:footnote id="Footnote000949" xml:lang="en-US">Mountain Share Transfer, LLC is company 100%
    controlled by Erik S. Nelson, a greater than 5% stockholder of the Company. The balances represented the amount paid on behalf of
    the Company for its daily operation purpose.</ix:footnote></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td><span id="xdx_F08_zkGiWhWHfv07" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span id="xdx_F18_zZVheyzozH05" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000950" xml:lang="en-US">Mr. Tsai Wen-Chih is the
    director of XFC and has control power over Taisi Electrical &amp; Plumbing Co. Pte Ltd. The Company took over the receivable amount
    of $877,809 from acquisition of XFC in December 2020. None of the receivables have been impaired and it is expected that the full
    contractual amounts can be collected.</ix:footnote></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A1_zJU7RnjrkcH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zcAmT7Si6RCf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1</b><b>3</b><b>&#160;&#160;&#160;&#160;&#160;<span id="xdx_827_zyw1oTG59h34">COMMON
STOCK</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s
authorized number of common stock is <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_c20220331_zSZdU6cplEMd" title="Common stock, shares authorized"><span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20211231_zuoQRaVUFu2j" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></ix:nonFraction></span></span> shares with par value of $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220331_zg8eSKwPrUc4" title="Common stock par value"><span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231_zIOOnQPTblda" title="Common stock par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> each, and issued ordinary shares were <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_c20220331_zDQnqSfhN78e" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,707,150</ix:nonFraction></span>
shares and 9,131,786 as of March
31, 2022 and December 31, 2021, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All number
of shares, share amounts and per share data presented in the accompanying consolidated financial statements and related notes have been
retroactively restated to reflect the reverse merger transaction and subsequent issuance of shares stated above, except for authorized
common shares, which were not affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p id="xdx_800_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zjMIYiYkiqz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1</b><b>4</b><b>&#160;&#160;&#160;&#160;<span id="xdx_82B_zFHLijvWP3Ql">SHARE-BASED
COMPENSATION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December
27, 2018, Nocera granted Mr. Yin-Chieh Cheng quarterly option awards of <span id="xdx_904_ecustom--WarrantsGranted_c20181201__20181227__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember_pdd" title="Warrants granted">250,000</span> Series A warrants for 20 quarters (5 years) for a total
of <span id="xdx_90E_ecustom--WarrantsGranted_c20181201__20181227__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember_pdd" title="Warrants granted">5,000,000</span> Series A warrants with an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20181227__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember_pdd" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2018-12-27_custom_SeriesAWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.50</ix:nonFraction></span> per share, subject to continued employment for services as Chairman of
the Board of Directors (&#8220;Board&#8221;) and a Director.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1,
2020, Nocera granted Mr. Shun-Chih Chuang and Mr. Hsien-Wen Yu <span id="xdx_90F_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShunChihChuangMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zWovoEZYipZ2" title="Warrants granted">50,000</span> shares of Class A warrants and <span id="xdx_902_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HsienWenYuMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zQOrbiZU3579" title="Warrants granted">60,000</span> shares of Class A warrants
separately, each with an exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200601_pdd" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-06-01" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.50</ix:nonFraction></span> per share, for serving as the Company&#8217;s Chief Financial Officer and Chief Operating
Officer, respectively. The Company also granted 2 employees <span id="xdx_903_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted">50,000</span> shares of Class A warrants with an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200601__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-06-01_custom_ClassAWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.50</ix:nonFraction></span> per share.
The Class A warrants consist of the right to purchase one share for $0.50 per share from the date of issuance until April 23, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23C_zdKi7rXh1ywk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zRr1tcfd67ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 150; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zhfMJdEm2ix1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1,
2020, Nocera granted Mr. Michael A. Littman <span id="xdx_906_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted">50,000</span> shares of Class A warrants with an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-06-01_custom_MichaelALittmanMember_custom_ClassAWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.50</ix:nonFraction></span> per share and <span id="xdx_907_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_pdd" title="Warrants granted">50,000</span> shares
of Class B warrants with exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_pdd" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-06-01_custom_MichaelALittmanMember_custom_ClassBWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span> per share. Mr. Littman exercised <span id="xdx_905_ecustom--WarrantsGranted_c20210802__20210811__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted">50,000</span> shares of Class A warrants and <span id="xdx_906_ecustom--WarrantsGranted_c20210802__20210811__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_pdd" title="Warrants granted">50,000</span> shares
of Class B warrants on August 11, 2021. The Class B warrants consist of the right to purchase one share for $1.00 per share separately
from the date of issuance until April 23, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December
1, 2021, Nocera granted Mr. Shun-Chih Chuang and Mr. Hsien-Wen Yu <span id="xdx_90D_ecustom--WarrantsGranted_c20211129__20211202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShunChihChuangMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zvtHH6Oz1MHd" title="Warrants granted">75,000</span> shares of Class A warrants and <span id="xdx_901_ecustom--WarrantsGranted_c20211129__20211202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HsienWenYuMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted">60,000</span> shares of Class A warrants
separately, each with an exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20211202_pdd" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-12-02" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.50</ix:nonFraction></span> per share, for serving as the Company&#8217;s Chief Financial Officer and Chief Operating
Officer, respectively. The Company also granted 2 employees <span id="xdx_904_ecustom--WarrantsGranted_c20211129__20211202__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted">70,000</span> shares of Class A warrant with an exercise price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20211202__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-12-02_custom_ClassAWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.50</ix:nonFraction></span> per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December
31, 2021, the Company issued an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20211201__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShunChihChuangMember_zCmbkNb21aSa" title="Issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2021-12-012021-12-31_custom_ShunChihChuangMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">505,000</ix:nonFraction></span> shares of common stock to Mr. Shun-Chih Chuang and a total of five consultants in
consideration for services rendered.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated fair value of share-based compensation
for employees is recognized as a charge against income on a ratable basis over the requisite service period, which is generally the vesting
period of the award. The fair value of stock option grant was estimated on the date of grant using the Black-Scholes option pricing model
under the following assumptions:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zvCyXL0fZQO4" summary="xdx: Disclosure - SHARE-BASED COMPENSATION (Details - assumptions)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B1_zPZHyVmdkp69" style="display: none">Assumptions used</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br /> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br /> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: justify">Dividend yield</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: right">N/A</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: right">N/A</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Risk-free interest rate</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 1pt; width: 13%; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220331_z6HPq8IQRbGj" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.16</ix:nonFraction></span>%</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 1pt; width: 13%; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231_zde4z729rsl2" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.16</ix:nonFraction></span>%</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Expected term (in years)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220331_z5gLUDDuzWkh" title="Expected term (in years)"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">4.31</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zG3Es5HDzOcj" title="Expected term (in years)"><ix:nonNumeric contextRef="From2021-01-012021-12-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">4.31</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Volatility</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220331_zGRaIVOagcLk" title="Volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48.15</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231_zfLeAlsy2i36" title="Volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48.15</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company
estimated the grant date fair value of time-based stock option awards using the Black-Scholes option valuation model, which requires
assumptions involving an estimate of the fair value of the underlying common stock on the date of grant, the expected term of the options,
volatility, discount rate and dividend yield. The Company calculated expected option terms based on the &#8220;simplified&#8221; method
for &#8220;plain vanilla&#8221; options due to the limited exercise information. The &#8220;simplified method&#8221; calculates the expected
term as the average of the vesting term and the original contractual term of the options. The Company calculated volatility using the
average adjusted volatility of quick companies feature of Capital IQ for a period of time reflective of the expected option term, while
the discount rate was estimated using the interest rate for a treasury note with the same contractual term as the options granted. Dividend
yield is estimated at our current dividend rate, which adjusts for any known future changes in the rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three
months ended March 31, 2022
and year ended December 31, 2021,
$<span id="xdx_90E_ecustom--ReverseMergerRecapitalization_pp0p0_c20220101__20220331_zStVeRRfoNHi" title="Reverse merger recapitalization">606,055</span>
and $<span id="xdx_904_ecustom--ReverseMergerRecapitalization_pp0p0_c20210101__20211231_ztu7eiXz3zFa" title="Reverse merger recapitalization">6,638,371</span>
share-based compensation expenses was recognized into additional paid-in capital of the Company,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December
31, 2021, total unrecognized compensation cost related to unvested share-based compensation awards was $<span id="xdx_904_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pp0p0_c20211231_zsHVYDOe32r8" title="Unrecognized compensation costs"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,114,097</ix:nonFraction></span>. This amount is expected
to be recognized as stock-based compensation expense in the Company&#8217;s consolidated statements of operations and comprehensive income
over the remaining vesting period of <span id="xdx_909_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20220101__20220331_zFEYpVW4MX8b" title="Unrecognized compensation cost amortization period"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">1.99</ix:nonNumeric></span> years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_232_ziIez3tSyvjk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_z9Kls2KDVRT6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 151; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zhBloyknfyp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:PreferredStockTextBlock"><p id="xdx_803_eus-gaap--PreferredStockTextBlock_z7iRHUZ7yJHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1</b><b>5</b><b>&#160;&#160;&#160;&#160;&#160;<span id="xdx_82C_zOfazsI0vUPb">PREFERRED
STOCK</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August
2021, the Company issued <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zMyvMIdakyYd" title="Preferred Stock, Shares Issued"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-03-31_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">80,000</ix:nonFraction></span> shares of preferred shares of $<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_c20210801_zm4X2T5IVjK2" title="Sale of stock, price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2021-08-01" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span> each at an issue price of $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20210801_zfuyGsrpHU28" title="Share price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-01" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.50</ix:nonFraction></span> per share to certain investors credited
as fully paid. The preferred shares are non-voting and non-redeemable. The holder of the preferred shares will have priority over the
holders of ordinary shares of the Company on the assets and funds of the Company available for distribution in a distribution of assets
on liquidation, winding up or dissolution of the Company. The holder of the preferred shares shall not have the right to attend or vote
at any general meeting of the Company (except a general meeting for winding up of the Company or a resolution is to be proposed which
if passed would vary or abrogate the rights or privileges of such holder).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:EarningsPerShareTextBlock"><p id="xdx_808_eus-gaap--EarningsPerShareTextBlock_zISuPgiiRhI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 16 &#160;&#160;&#160;&#160;&#160;<span id="xdx_82C_zxWhvspfwHol">(LOSS) INCOME PER SHARE</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the computation
of basic and diluted income (loss) per common share for the quarters ended March 31, 2022 and 2021.</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXyGPZVIU9b9" summary="xdx: Disclosure - (LOSS) EARNINGS PER SHARE (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B1_z9yq6RhnB7C7" style="display: none">Schedule of earnings (loss) per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220101__20220331_z8URAQdjdX9h" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20210101__20210331_z3Owc1yVkrE4" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For
                                            three months ended </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March
                                            31,</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_ecustom--NumeratorAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify; padding-bottom: 2.5pt">Net (loss) income attributable to the Company</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">805,720</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">49,490</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--DenominatorAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Weighted-average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,677,150</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,131,786</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,677,150</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,821,506</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--LossIncomePerShareAbstract_i01B_z4vQx9r7V4o7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">(Loss) income per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.0755</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0054</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.0755</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0036</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic net income per common share is computed
using the weighted average number of the common shares outstanding during the period ended March 31, 2021. Diluted income per share is
computed using the weighted average number of ordinary shares and ordinary equivalent shares outstanding which include <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210331_zALCEbez29gl" title="Antidilutive shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,560,000</ix:nonFraction></span> warrants
outstanding as of March 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zUnnlm6OjxNc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 17 &#160;&#160;&#160;&#160;&#160;<span id="xdx_826_zz1D3GFem5l6">SUBSEQUENT EVENT</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has evaluated subsequent events through
the issuance of the unaudited condensed consolidated financial statements and except for the event discloses blow, no other subsequent
event is identified that would have required adjustment or disclosure in the consolidated financial statements.&#160;</p>

</ix:nonNumeric><p id="xdx_815_zlEkdbExmwYj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 152; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2,350,000 Units</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Each Consisting of</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>One Share of Common Stock and </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>One Warrant to Purchase Two Shares of
Common Stock</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="image_017.jpg" alt="" style="height: 40.5pt; width: 168.75pt" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PRELIMINARY PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Through
and including </span>__________________, <span style="background-color: white">2022, (the 25<sup>th</sup> day after the date of this prospectus),
all dealers effecting transactions in the units whether or not participating in this offering, may be required to deliver a prospectus.
This delivery requirement is in addition to a dealer&#8217;s obligation to deliver a prospectus when acting as an underwriter and with
respect to an unsold allotment or subscription.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 153; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">Part II</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">INFORMATION NOT
REQUIRED IN PROSPECTUS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 13. Other Expenses
of Issuance and Distribution.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table indicates the expenses to
be incurred in connection with the offering described in this registration statement, other than underwriting discounts and commissions,
all of which will be paid by us. All amounts are estimated except the Securities and Exchange Commission (&#8220;SEC&#8221;) registration
fee and the Financial Industry Regulatory Authority, Inc., or FINRA filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; text-align: justify">SEC registration fee</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">3,262</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">FINRA filing fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,280</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">NASDAQ listing fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Fees of transfer agent and warrant agent</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Accountants&#8217; fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Legal fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">215,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Printing and engraving expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: justify">Miscellaneous</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28,458</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: justify">Total expenses</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">375,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 14. Indemnification
of Directors and Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s Articles of Incorporation
and Bylaws provide that, to the fullest extent permitted by the laws of the State of Nevada, any officer or director of the Company, who
was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil,
criminal, administrative or investigative, by reason of the fact that he or she is or was or has agreed to serve at the request of the
Company as a director, officer, employee or agent of the Company, or while serving as a director or officer of the Company, is or was
serving or has agreed to serve at the request of the Company as a director, officer, employee or agent (which, for purposes hereof, shall
include a trustee, partner or manager or similar capacity) of another corporation, partnership, joint venture, trust, employee benefit
plan or other enterprise, or by reason of any action alleged to have been taken or omitted in such capacity. For the avoidance of doubt,
the foregoing indemnification obligation includes, without limitation, claims for monetary damages against Indemnitee to the fullest extent
permitted under Section 78.7502 of the Nevada Revised Statutes as in existence on the date hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The indemnification provided shall be from and
against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by
the indemnitee or on the indemnitee&#8217;s behalf in connection with such action, suit or proceeding and any appeal therefrom, but shall
only be provided if the indemnitee acted in good faith and in a manner the indemnitee reasonably believed to be in or not opposed to the
best interests of the Company, and, with respect to any criminal action, suit or proceeding, had no reasonable cause to believe the indemnitee&#8217;s
conduct was unlawful.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the case of any threatened, pending or completed
action or suit by or in the right of the Company to procure a judgment in its favor by reason of the fact that he or she is or was a director,
officer, employee or agent of the Company, or while serving as a director or officer of the Company, is or was serving or has agreed to
serve at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust,
employee benefit plan or other enterprise, no indemnification shall be made in respect of any claim, issue or matter as to which the indemnitee
shall have been adjudged to be liable to the Company unless, and only to the extent that, the Nevada courts or the court in which such
action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances
of the case, the indemnitee is fairly and reasonably entitled to indemnity for such expenses which the Nevada courts or such other court
shall deem proper.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 154; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The termination of any action, suit or proceeding
by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption
that he or she did not act in good faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the best interests
of the Company, and, with respect to any criminal action or proceeding, had reasonable cause to believe that the indemnitee&#8217;s conduct
was unlawful.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that indemnification for liabilities
arising under the Securities Act may be permitted to directors, officers or persons controlling our company pursuant to the foregoing
provisions, we have been informed that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities
Act and is therefore unenforceable. If a claim for indemnification against such liabilities (other than the payment by us of expenses
incurred or paid by a director, officer or controlling person of our company in the successful defense of any action, suit or proceeding)
is asserted by any of our directors, officers or controlling persons in connection with the securities being registered, we will, unless
in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by us is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of that issue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In any underwriting agreement we enter into in
connection with the sale of common stock or warrants being registered hereby, the underwriters will agree to indemnify, under certain
conditions, us, our directors, our officers and persons who control us within the meaning of the Securities Act of 1933, as amended, or
the Securities Act, against certain liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Item 15. Recent Sales of Unregistered Securities.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Set forth below is information regarding shares
of capital stock issued by us within the past three years which were not registered under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-style: normal">(a)</span>
<span style="text-decoration: underline">Issuance of Capital Stock</span>.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">On
                                            May 29, 2020, the Company issued 666,667 shares of common stock of the Company to
                                            Yin-Chieh Cheng.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">On
                                            December 31, 2020, pursuant to the VIE Interest Merger Agreement, the Company issued a total
                                            of 466,667 shares of common stock of the Company to four individuals and a total of
                                            200,000 shares of common stock of the Company to six individuals in exchange for all of the
                                            equity in XFC and SFC, respectively. Thereafter, the Company received no communication or
                                            information from SFC regarding its financial conditions or operations for the purpose of
                                            the annual audit and the closing of the acquisition of SFC. Therefore, on March 18, 2021,
                                            the Company rescinded the acquisition of SFC and as a result of the rescission, the 200,000
                                            common shares previously issued to the stockholders of SFC per the SFC VIE Agreements have
                                            been cancelled by action of the Board.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">On August 10, 2021, the Company issued 80,000 shares of preferred stock of the Company to a foreign investor.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">On
                                            September 27, 2021, the Company issued an aggregate of 32,000 shares of common stock
                                            of the Company to a total of two foreign investors.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">On
                                            December 31, 2021, the Company issued an aggregate of 336,667 shares of common stock
                                            to a total of six consultants in consideration for services rendered.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"></td><td style="width: 3%"> <span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 92%">On
                                            December 31, 2021, the Company consummated a private offering of 418,000 units at a purchase
                                            price of $5.00 per unit to 28 investors for gross proceeds of $2,090,000. Each unit consisted
                                            of one share of the Company&#8217;s common stock and an &#8220;equity kicker&#8221; of one
                                            share of the Company&#8217;s common stock, for a total of 557,334 shares of common
                                            stock.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td style="width: 92%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 28, 2022, the Company issued 66,667
    shares of common stock of the Company to Carmel, Milazzo &amp; Feil LLP in consideration for legal services rendered.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 155; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing securities were issued in reliance
on the exclusion from registration provided by either (i) Rule 903 of&#160;Regulation S&#160;under the Securities Act of the Securities
Act because the recipient was a non-U.S. Person (as defined under Rule 902 Section (k)(2)(i) of Regulation S), or (ii) Section 4(a)(2)
of the Securities Act due to the fact the issuance did not involve a public offering of securities to a U.S. Person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-style: normal">(b)</span> <span style="text-decoration: underline">Warrants</span>.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td style="width: 92%; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 1, 2020, the Company issued an aggregate of 210,000 Class A warrants to a total of two executive officers of the Company, two foreign investors and a defined benefit plan. The Class A warrants consist of the right to purchase one share for $0.50 per share from the date of issuance until April 23, 2026.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td style="width: 92%; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 1, 2020, the Company issued 50,000 Class B warrants to a defined benefit plan. The Class B warrants consist of the right to purchase one share for $1.00 per share from the date of issuance until April 23, 2026.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td style="width: 92%; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 10, 2021, the Company issued 80,000 Class C warrants and 80,000 Class D warrants to a foreign investor. The Class C warrants consist of the right to purchase one share of common stock of the Company for $2.50 per share for three years from the date of issuance and the Class D warrants consist of the right to purchase one share of common stock of the Company for $5.00 for a period of three years from the date of issuance.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td style="width: 92%; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 27, 2021, the Company issued an aggregate of 48,000 Class C warrants and 48,000 Class D warrants to a total of two foreign investors. The Class C warrants consist of the right to purchase one share of common stock of the Company for $2.50 per share for three years from the date of issuance and the Class D warrants consist of the right to purchase one share of common stock of the Company for $5.00 for a period of three years from the date of issuance.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td style="width: 92%; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    December 1, 2021, the Company issued 205,000 Class A warrants to a total of two executive officers of the Company and two foreign
    investors. The Class A warrants consist of the right to purchase one share for $0.50 per share from the date of issuance until April
    23, 2026.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td style="width: 92%; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2021, the Company issued an aggregate of 812,000 Class C warrants and 812,000 Class D warrants to a total of two contractors. The Class C warrants consist of the right to purchase one share of common stock of the Company for $2.50 per share from the date of issuance until December 31, 2024 and the Class D warrants consist of the right to purchase one share of common stock of the Company for $5.00 per share from the date of issuance until December 31, 2024.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td style="width: 92%; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2022, <span style="background-color: white">the Company agreed to issue 60,000 </span>Class A Warrants, vesting in three equal&#160;installments commencing on the first anniversary date of the consulting agreement. Each Class A Warrant is exercisable to purchase one share of common stock for $0.50 per share from the date of vesting until April 23, 2026.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="font-family: Symbol">&#183;</span></span></td>
    <td style="width: 92%; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2022, the Company agreed to issue two consultants an aggregate of 90,000 Class C Warrants, vesting in three equal installments commencing on the first anniversary date of the consulting agreements. Each Class C Warrant is exercisable to purchase one share of common stock for $2.50 per share from the date of vesting in each installment until the third anniversary date of the date of vesting.</span></td></tr>
  </table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing securities were issued in reliance
on the exclusion from registration provided by either (i) Rule 903 of&#160;Regulation S&#160;under the Securities Act of the Securities
Act because the recipient was a non-U.S. Person (as defined under Rule 902 Section (k)(2)(i) of Regulation S), or (ii) Section 4(a)(2)
of the Securities Act due to the fact the issuance did not involve a public offering of securities to a U.S. Person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 156; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-style: normal">(c)</span> <span style="text-decoration: underline">Option Grants</span>.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 16. Exhibits and Financial Statement Schedules.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a) <b><i>Exhibits</i></b>: Reference is made
to the Exhibit Index following the signature pages hereto, which Exhibit Index is hereby incorporated into this Item.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b) <b><i>Financial Statement Schedules</i></b>:
All schedules are omitted because the required information is inapplicable or the information is presented in the financial statements
and the related notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 17. Undertakings.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned registrant hereby undertakes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) To file, during any period in which offers
or sales are being made, a post-effective amendment to this registration statement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(i) To include any prospectus required by section
10(a)(3) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(ii) To reflect in the prospectus any facts or
events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually
or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which
was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent
no more than a 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221;
table in the effective registration statement; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(iii) To include any material information with
respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information
in the registration statement; provided, however, that paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if the information required
to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and
Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated
by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the
registration statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2) That, for the purpose of determining any liability
under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3) To remove from registration by means of a
post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(4) That, for the purpose of determining liability
under the Securities Act to any purchaser:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(A) Each prospectus filed by the registrant pursuant
to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and
included in the registration statement; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 157; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(B) Each prospectus filed pursuant to Rule 424(b)
as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses
filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used
after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is
part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify
any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such
document immediately prior to such date of first use.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(5) That for the purpose of determining liability
of the registrant under the Securities Act to any purchaser in the initial distribution of securities, the undersigned registrant undertakes
that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting
method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following
communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to
such purchaser:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(i) Any preliminary prospectus or prospectus of
the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(ii) Any free writing prospectus relating to the
offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(iii) The portion of any other free writing prospectus
relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of
the undersigned registrant; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(iv) Any other communication that is an offer
in the offering made by the undersigned registrant to the purchaser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to any charter provision,
by law or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification
is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than payment by the registrant of expenses incurred or paid by a director, officer or controlling person
of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person
in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned registrant hereby undertakes that:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) For purposes of determining any liability
under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance
upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities
Act shall be deemed to be part of this registration statement as of the time it was declared effective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2) For the purpose of determining any liability
under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide
offering thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 158; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">EXHIBIT INDEX</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: left"><b>Exhibit No.</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><b>Description</b></td>
    <td>&#160;</td>
    <td><b>Previously Filed and Incorporated by Reference Herein</b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="width: 5%; text-align: left">1.1</td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="width: 49%; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822003812/nocera_ex0101.htm" style="-sec-extract: exhibit">Form of Underwriting Agreement</a></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 44%; text-align: justify">Filed as Exhibit 1.1 to Form S-1/A filed on May 19, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">3.1</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822001860/nocera_ex0302.htm">Amended and Restated Articles of Incorporation of the Registrant</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 3.2 to Form 10-K filed on March 23, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">3.2</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822001860/nocera_ex0306.htm">Certificate of Amendment of Amended and Restated Articles of Incorporation of the Registrant</a></p></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 3.6 to Form 10-K filed on March 23, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">3.3</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822001860/nocera_ex0307.htm">Certificate of Amendment of Articles of Incorporation of the Registrant</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as  Exhibit 3.7 to Form 10-K filed on March 23, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">3.4</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594918000149/ex3_3.htm" style="-sec-extract: exhibit">Certificate of Change of the Registrant</a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 3.3 to Form 10-12G filed on October 19, 2018.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">3.5</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822001304/nocera_ex0301.htm">Amended and Restated Bylaws of the Registrant</a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 3.1 to Form 8-K filed on February 28, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">3.6</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000015/ex3_3.htm" style="-sec-extract: exhibit">Articles of Incorporation of GSI Acquisition Corp.</a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 3.3 to Form 8-K12G3 filed on January 31, 2019.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">3.7</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000015/ex3_4.htm" style="-sec-extract: exhibit">Articles of Association of Grand Smooth Inc Limited</a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 3.4 to Form 8-K12G3 filed on January 31, 2019.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">3.8</td>
    <td>&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594918000203/ex10_1.htm" style="-sec-extract: exhibit">Agreement and Plan of Merger, dated as of December 27, 2018, by and among the Registrant, Grand Smooth Inc Limited and GSI Acquisition Corp.</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.1 to Form 8-K filed on December 31, 2018.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">3.9</td>
    <td>&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000015/ex2_1.htm" style="-sec-extract: exhibit">Amended Agreement and Plan of Merger, dated as of December 27, 2018, and effective as of December 31, 2018, by and among the Registrant, Grand Smooth Inc Limited and GSI Acquisition Corp.</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 2.1 to Form 8-K12G3 filed on January 31, 2019.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">3.10</td>
    <td>&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000015/ex3_5.htm" style="-sec-extract: exhibit">Statement of Merger &#8211; GSI Acquisition Corp. and Grand Smooth Inc Limited</a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 3.5 to Form 8-K12G3 filed on January 31, 2019.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">4.1*</td>
    <td>&#160;</td>
    <td>Specimen of Common Stock</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">4.2&#8224;</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822002274/nocera_ex0402.htm" style="-sec-extract: exhibit">Form of Class A Warrant</a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 4.2 to Form S-1 filed on April 1, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">4.3&#8224;</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822002274/nocera_ex0403.htm" style="-sec-extract: exhibit">Form of Class B Warrant</a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 4.3 to Form S-1 filed on April 1, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">4.4&#8224;</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822002274/nocera_ex0404.htm" style="-sec-extract: exhibit">Form of Class C Warrant</a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 4.4 to Form S-1 filed on April 1, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">4.5&#8224;</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822002274/nocera_ex0405.htm" style="-sec-extract: exhibit">Form of Class D Warrant</a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 4.5 to Form S-1 filed on April 1, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">4.6</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822003812/nocera_ex0406.htm" style="-sec-extract: exhibit">Form of Warrant Underlying the Units</a></td>
    <td>&#160;</td>
        <td>Filed as Exhibit 4.6 to Form S-1/A filed on May 19, 2022.</td>
</tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">4.7*</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Form of Warrant Agency Agreement</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">4.8</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822002274/nocera_ex0408.htm" style="-sec-extract: exhibit">Form of Representative Warrant</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 4.8 to Form S-1 filed on April 1, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">5.1*</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="nocera_ex0501.htm">Opinion of Carmel, Milazzo &amp; Feil LLP</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">10.1&#8224;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000015/ex10_2.htm" style="-sec-extract: exhibit">2018 Nocera, Inc. Stock Option and Award Incentive Plan</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.2 to Form 8-K12G3 filed on January 31, 2019.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">10.2</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000015/ex10_1.htm" style="-sec-extract: exhibit">Share Exchange Agreement</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.1 to Form 8-K12G3 filed on January 31, 2019.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">10.3&#8224;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000015/ex2_1.htm" style="-sec-extract: exhibit">Consulting Agreement dated as of December 27, 2018, between the Registrant and Yin-Chieh Cheng</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 2.1 to Form 8-K12G3 filed on January 31, 2019.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">10.4</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000148/ex10_1.htm" style="-sec-extract: exhibit">Regional Agency Cooperation Agreement dated as of September 2019, by and between Grand Smooth Inc Ltd and Jie Hao Development Co., Ltd.</a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 10.1 to Form 8-K filed on October 30, 2019.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">10.5</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594920000002/ex10_1.htm" style="-sec-extract: exhibit">Procare International Co., Limited Project Contract</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.1 to Form 8-K filed on January 10, 2020.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">10.6</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594920000088/ex10_1.htm" style="-sec-extract: exhibit">Regional Agency Cooperation Supplementary Agreement dated as of May 31, 2020, by and between Grand Smooth Inc Ltd and JC Development Co., Ltd.</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.1 to Form 8-K filed on June 19, 2020.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">10.7</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594920000088/ex10_2.htm" style="-sec-extract: exhibit">Consulting Agreement dated as of May 15, 2020, between the Registrant and Atlanta Capital Partners, LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.2 to Form 8-K filed on June 19, 2020.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">10.8</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316820003919/nocera_10q-ex1004.htm" style="-sec-extract: exhibit">Settlement Agreement and Release dated as of October 8, 2020, by and between Guizhou Wan Feng Hu Zhi Shui Chan Company, Ltd. and the Registrant</a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 10.4 to Form 10-Q filed on November 16, 2020.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">10.9</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594921000001/ex2_1.htm" style="-sec-extract: exhibit">Exchange Agreement, Consent, and Representations dated as of December 31, 2020 of the Registrant and Agreement and Plan of Share Exchange for VIE Interest dated as of December 31, 2020, by and between Nocera, Inc., Xin Feng Construction Co. Ltd., and Shunda Feed Co. Ltd</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 2.1 to Form 8-K filed on January 4, 2021.</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 159; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left; width: 5%">10.10</td>
    <td style="text-align: justify; width: 1%">&#160;</td>
    <td style="text-align: left; width: 49%"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594921000001/ex10_1.htm" style="-sec-extract: exhibit">Voting Rights Proxy Agreement dated as of December 31, 2020, by and among Hui-Min Tu, Wen-Chih Tsai, Ching-Yao Tsai, Ching-Chao Tsai, the Registrant and Xin Feng Construction Co. Ltd.</a></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 44%">Filed as Exhibit 10.1 to Form 8-K filed on January 4, 2021.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">10.11</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594921000001/ex10_2.htm" style="-sec-extract: exhibit">Exclusive Business Cooperation Agreement dated as of December 31, 2020, by and among the Registrant and Xin Feng Construction Co. Ltd.</a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 10.2 to Form 8-K filed on January 4, 2021.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">10.12</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594921000001/ex10_3.htm" style="-sec-extract: exhibit">Equity Pledge Agreement dated as of December 31, 2020, by and among Hui-Min Tu, Wen-Chih Tsai, Ching-Yao Tsai, Ching-Chao Tsai, the Registrant and Xin Feng Construction Co. Ltd.</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.3 to Form 8-K filed on January 4, 2021.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">10.13</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594921000001/ex10_4.htm" style="-sec-extract: exhibit">Exclusive Call Option Agreement dated as of December 31, 2020, by and among the Registrant, Hui-Min Tu, Wen-Chih Tsai, Ching-Yao Tsai, Ching-Chao Tsai and Xin Feng Construction Co. Ltd.</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.4 to Form 8-K filed on January 4, 2021.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">10.14</td>
    <td>&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316821002002/nocera_10q-ex1004.htm" style="-sec-extract: exhibit">Subscription Agreement dated as of April 1, 2021, by and between the Registrant and Han-Chieh Shih</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.4 to Form 10-Q filed on May 12, 2021.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">10.15</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822001860/nocera_ex1015.htm">Consulting Agreement dated as of November 15, 2021, by and between the Registrant and Shih-Chung Lin</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.15 to Form 10-K filed on March 23, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">10.16</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822001860/nocera_ex1016.htm">Consulting Agreement dated as of November 15, 2021, by and between the Registrant and Han-Chieh Shih</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.16 to Form 10-K filed on March 23, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">10.17&#8224;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822001860/nocera_ex1017.htm">Employment Agreement dated as of August 16, 2019, by and between the Registrant and Hsien-Wen Yu</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed
as Exhibit 10.17 to Form 10-K filed on March 23, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">10.18&#8224;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822001860/nocera_ex1018.htm">Employment Agreement dated as of August 16, 2019, by and between the Registrant and Shun-Chih Chuang</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.18 to Form 10-K filed on March 23, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">10.19&#8224;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822000131/nocera_ex1001.htm">Employment Agreement dated as of January 3, 2022, by and between the Registrant and Gerald H. Lindberg</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.11 to Form 8-K filed on January 6, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">10.20&#8224;</td>
    <td style="text-align: justify">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822000131/nocera_ex1002.htm" style="-sec-extract: exhibit">Addendum, dated December 31, 2021, to that certain
Employment Agreement, dated August 16, 2019, between Nocera, Inc. and Shun-Chih Chuang</a></p></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.2 to Form 8-K filed on January 6, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">10.21&#8224;</td>
    <td style="text-align: justify">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822001860/nocera_ex2101.htm">Addendum, dated December 31, 2021, to that certain Employment Agreement, dated August 16, 2019, between Nocera, Inc. and Hsien-Wen Yu</a></p></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 10.3 to Form 8-K filed on January 6, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">14.1</td>
    <td style="text-align: justify">&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822002274/nocera_ex1401.htm" style="-sec-extract: exhibit">Code of Conduct</a></td>
    <td>&#160;</td>
    <td style="text-align: justify">Filed as Exhibit 14.1 to Form S-1 filed on April 1, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">21.1</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822001860/nocera_ex2101.htm">List of Subsidiaries of the Registrant</a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 21.1 to Form 10-K filed on March 23, 2022</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">23.1*</td>
    <td>&#160;</td>
    <td><a href="nocera_ex2301.htm">Consent of Centurion ZD CPA &amp; Co.</a></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left">23.2*</td>
    <td>&#160;</td>
    <td>Consent of Carmel, Milazzo &amp; Feil LLP (included in Exhibit 5.1)</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left">24.1</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822002274/nocera_s1.htm" style="-sec-extract: exhibit">Power of Attorney </a></td>
    <td>&#160;</td>
    <td>Included on the Signature Page to the Form S-1 filed on April 1, 2022.</td></tr>

<tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822002274/nocera_ex9901.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Committee Charter</span></a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 99.1 to Form S-1 filed on April 1, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822002274/nocera_ex9902.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation Committee Charter</span></a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 99.2 to Form S-1 filed on April 1, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3</span></td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822002274/nocera_ex9903.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating and Corporate Governance Committee Charter</span></a></td>
    <td>&#160;</td>
    <td>Filed as Exhibit 99.3 to Form S-1 filed on April 1, 2022.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td>107</td>
    <td>&#160;</td>
    <td><a href="nocera_ex107.htm">Filing Fee Table</a></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">______________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Filed herewith.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8224; Management contract or compensatory plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 160; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">SIGNATURES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act of 1933, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly
authorized in the City of New York, State of New York, on July 20, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOCERA,
    INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 52%">&#160;</td>
    <td style="white-space: nowrap; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </span></td>
    <td style="border-bottom: black 1pt solid; width: 46%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Yin-Chieh Cheng</i></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yin-Chieh Cheng</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer
    (Principal Executive Officer)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 28%; text-align: justify"><b>Name</b></td>
    <td style="width: 2%">&#160;</td>
    <td style="vertical-align: bottom; width: 45%; text-align: justify"><b>Position</b></td>
    <td style="vertical-align: top; width: 25%; text-align: center"><b>Date</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom"><i>/s/ Yin-Chieh Cheng</i></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">Chief Executive Officer, President, Chairman of the Board and Director</td>
    <td style="vertical-align: top; text-align: center">July 20, 2022</td></tr>
  <tr>
    <td style="vertical-align: bottom">Yin-Chieh Cheng</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">(Principal Executive Officer)</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom"><i>/s/ Shun-Chih Chuang</i></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">Chief Financial Officer</td>
    <td style="vertical-align: top; text-align: center">July 20, 2022</td></tr>
  <tr>
    <td style="vertical-align: bottom">Shun-Chih Chuang</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">(Principal Financial and Accounting Officer)</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom">*</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">Director</td>
    <td style="vertical-align: top; text-align: center">July 20, 2022</td></tr>
  <tr>
    <td style="vertical-align: bottom">Gerald H. Lindberg</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom"><i>&#8239;*</i></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">Director</td>
    <td style="vertical-align: top; text-align: center">July 20, 2022</td></tr>
  <tr>
    <td style="vertical-align: bottom">David Yu-Lung Kou</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom"><i>*</i></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">Director</td>
    <td style="vertical-align: top; text-align: center">July 20, 2022</td></tr>
  <tr>
    <td style="vertical-align: bottom">Thomas A. Steele</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom">*</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">Director</td>
    <td style="vertical-align: top; text-align: center">July 20, 2022</td></tr>
  <tr>
    <td style="vertical-align: bottom">Hui-Ying Zhuang</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*By: <i>/s/ Yin-Chieh Cheng</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Yin-Chieh Cheng</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attorney-in-Fact</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></p>

<!-- Field: Page; Sequence: 161; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>



</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxVj+FqwyAUhZ8g73Dxd2nVrmP4s2EtY9koUsb+2uR2SI03qM3WR9pbzhjG2EW4yDmf58jYgu1pZx0GeN/qBo7YD84kBI1nDOhbzI766VlB3ho/bEzB+FSuv2BNmcHMbJZifcpCsY42YqeAb1biYSUlcKnW93B4YdWk1+TPtkOfrHFgfAeHQEOwmEy4zS8czRd56m8l6g1DtOQViCWf5W+QXEh4pdF8UrhEaJqaVYsyFdsHug5TzDUm6uHRYZ+z4oz+nVKlLR6l8w9yHfIaW7SjOTmc/EKIHMTv/nM/JO5Yuw== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>nocera_ex0401.htm
<DESCRIPTION>STOCK CERTIFICATE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;<IMG SRC="stockcert.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.7
<SEQUENCE>3
<FILENAME>nocera_ex0407.htm
<DESCRIPTION>WARRANT AGENCY AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 4.7</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>WARRANT AGENCY AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This WARRANT AGENCY AGREEMENT
(this &ldquo;<U>Warrant Agreement</U>&rdquo;) is dated as of July ___, 2022 between Nocera, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;),
and Mountain Share Transfer, Inc., a Georgia corporation (the &ldquo;<U>Warrant Agent</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, pursuant to the terms
of that certain Underwriting Agreement (&ldquo;Underwriting Agreement&rdquo;), dated July ____, 2022, by and between the Company and Spartan
Capital Securities, LLC and Revere Securities, LLC, as the representatives of the underwriters set forth on Schedule I thereto (the &ldquo;Underwriters&rdquo;),
the Company is engaged in a public offering (the &ldquo;<U>Offering</U>&rdquo;) of up to 2,702,500 units (&ldquo;<U>Units</U>&rdquo;),
each Unit consisting of (i) one share (&ldquo;Share&rdquo;) of common stock, par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;)
and (ii) one warrant (&ldquo;<U>Warrant</U>&rdquo;) exercisable for two (2) shares of Common Stock of the Company (the &ldquo;<U>Warrant
Shares</U>&rdquo;), including 325,500 Units issuable upon the over-allotment option granted to the underwriters to any cover over-allotments,
if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company filed
with the Securities and Exchange (the &ldquo;<U>Commission</U>&rdquo;) a Registration Statement on Form S-1 (File No. 333-264059), as
amended (the &ldquo;Registration Statement&rdquo;), for the registration under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;), of the Shares, Warrants and Warrant Shares and the Registration Statement was declared effective by the Commission on
July___, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company desires
the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in accordance with the terms set forth
in this Warrant Agreement in connection with the issuance, registration, transfer, exchange, and exercise of the Warrants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company desires
to provide for the provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation
of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, all acts and things
have been done and performed which are necessary to make the Warrants the valid, binding, and legal obligations of the Company, and to
authorize the execution and delivery of this Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the mutual agreements herein contained, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><U>Appointment of Warrant Agent</U>. The Company hereby appoints the Warrant Agent to act as agent for
the Company with respect to the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance
with the express terms and conditions set forth in this Warrant Agreement (and no duties or obligations shall be inferred or implied).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><U>Warrants</U>. The Warrant Agent shall serve as warrant agent for all existing classes of warrants,
and any classes of warrants that may be created in the future.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.1</TD><TD STYLE="text-align: justify"><U>Form of Warrants</U>. The Warrants shall be registered securities and shall be initially evidenced
by a global Warrant certificate (&ldquo;<U>Global Certificate</U>&rdquo;) in the form of <U>Annexes A through D </U>to this Warrant Agreement.
The Warrants and Warrant Shares may, at the election of the holder of the Warrant, be deposited on behalf of the Company with a custodian
for The Depository Trust Company (&ldquo;<U>DTC</U>&rdquo;) and registered in the name of Cede &amp; Co., a nominee of DTC. If DTC subsequently
ceases to make its settlement system available for the Warrants, the Company may instruct the Warrant Agent regarding making arrangements
for book-entry settlement. In the event that the Warrants are not eligible for, or it is no longer necessary to have the Warrants available
in, registration in the name of Cede &amp; Co., a nominee of DTC, the Company may instruct the Warrant Agent to provide written instructions
to DTC to deliver to the Warrant Agent for cancellation the Global Certificate, and the Company shall instruct the Warrant Agent to deliver
to each Holder (as defined below) separate certificates evidencing Warrants (&ldquo;<U>Definitive Certificates</U>&rdquo; and, together
with the Global Certificate, &ldquo;<U>Warrant Certificates</U>&rdquo;), in the form of <U>Annex C</U> to this Warrant Agreement. The
Warrants represented by the Global Certificate are referred to as &ldquo;<U>Global Warrants</U>.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Warrant Agency Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.2.</TD><TD STYLE="text-align: justify"><U>Issuance and Registration of Warrants</U>.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                       <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>2.2.1.</TD><TD STYLE="text-align: justify"><U>Warrant Register</U>. The Warrant Agent shall maintain books (&ldquo;<U>Warrant
                              Register</U>&rdquo;) for the registration of original issuance and the registration of transfer of the
                              Warrants. Any Person in whose name ownership of a beneficial interest in the Warrants evidenced by a Global
                              Certificate is recorded in the records maintained by DTC or its nominee shall be deemed the &ldquo;beneficial
                              owner&rdquo; thereof, provided that all such beneficial interests shall be held through a Participant (as
                              defined below), which shall be the registered holder of such Warrants.</TD></TR>
                                                                                                                                                       <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                       <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>2.2.2.</TD><TD STYLE="text-align: justify"><U>Issuance of Warrants</U>. Upon the initial issuance of the Warrants,
                              the Warrant Agent shall issue the Global Certificate and deliver the Warrants in the DTC settlement system
                              in accordance with written instructions delivered to the Warrant Agent by the Company. Ownership of beneficial
                              interests in the Warrants shall be shown on, and the transfer of such ownership shall be effected through,
                              records maintained by (i) DTC and (ii) institutions that have accounts with DTC (each, a &ldquo;<U>Participant</U>&rdquo;),
                              subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form in the form of <U>Annex
                              C</U> to this Warrant Agreement. Any Holder desiring to elect to receive a Warrant in certificated form
                              shall make such request in writing delivered to the Warrant Agent pursuant to Section 2.2.8, and shall
                              surrender to the Warrant Agent the interest of the Holder on the books of the Participant evidencing the
                              Warrants which are to be represented by a Definitive Certificate through the DTC settlement system. Thereupon,
                              the Warrant Agent shall countersign and deliver to the person entitled thereto a Warrant Certificate or
                              Warrant Certificates, as the case may be, as so requested.</TD></TR>
                                                                                                                                                       <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                       <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>2.2.3.</TD><TD STYLE="text-align: justify"><U>Beneficial Owner; Holder</U>. Prior to due presentment for registration
                              of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person in whose name
                              that Warrant shall be registered on the Warrant Register (the &ldquo;<U>Holder,</U>&rdquo; which term shall
                              include a Holder&rsquo;s transferees, successors and assigns and a &ldquo;Holder&rdquo; shall include,
                              if the Warrants are held in &ldquo;street name,&rdquo; a Participant or a designee appointed by such Participant)
                              as the absolute owner of such Warrant for purposes of any exercise thereof, and for all other purposes,
                              and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Notwithstanding
                              the foregoing, nothing herein shall prevent the Company, the Warrant Agent, or any agent of the Company
                              or the Warrant Agent from giving effect to any written certification, proxy, or other authorization furnished
                              by DTC governing the exercise of the rights of a holder of a beneficial interest in any Warrant. The rights
                              of beneficial owners in a Warrant evidenced by the Global Certificate shall be exercised by the Holder
                              or a Participant through the DTC system, except to the extent set forth herein or in the Global Certificate.</TD></TR>
                                                                                                                                                       <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                       <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>2.2.4.</TD><TD STYLE="text-align: justify"><U>Execution</U>. The Warrant Certificates shall be executed on behalf
                              of the Company by any authorized officer of the Company (an &ldquo;<U>Authorized Officer</U>&rdquo;), which
                              need not be the same authorized signatory for all of the Warrant Certificates, either manually or by facsimile
                              signature. The Warrant Certificates shall be countersigned by an authorized signatory of the Warrant Agent,
                              which need not be the same signatory for all of the Warrant Certificates, and no Warrant Certificate shall
                              be valid for any purpose unless so countersigned. In case any Authorized Officer of the Company that signed
                              any of the Warrant Certificates ceases to be an Authorized Officer of the Company before countersignature
                              by the Warrant Agent and issuance and delivery by the Company, such Warrant Certificates, nevertheless,
                              may be countersigned by the Warrant Agent, issued and delivered with the same force and effect as though
                              the person who signed such Warrant Certificates had not ceased to be such officer of the Company; and any
                              Warrant Certificate may be signed on behalf of the Company by any person who, at the actual date of the
                              execution of such Warrant Certificate, shall be an Authorized Officer of the Company authorized to sign
                              such Warrant Certificate, although at the date of the execution of this Warrant Agreement any such person
                              was not such an Authorized Officer.</TD></TR>
                                                                                                                                                       </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.2.5.</TD><TD STYLE="text-align: justify"><U>Registration of Transfer</U>. At any time at or prior to the Expiration Date (as defined below), a transfer of any Warrants may be registered and any
Warrant Certificate or Warrant Certificates may be split up, combined or exchanged for another Warrant Certificate or Warrant Certificates
evidencing the same number of Warrants as the Warrant Certificate or Warrant Certificates surrendered. Any Holder desiring to register
the transfer of Warrants or to split up, combine or exchange any Warrant Certificate shall make such request in writing delivered to the
Warrant Agent, and shall surrender to the Warrant Agent the Warrant Certificate or Warrant Certificates evidencing the Warrants the transfer
of which is to be registered or that is or are to be split up, combined or exchanged. Thereupon, the Warrant Agent shall countersign and
deliver to the person entitled thereto a Warrant Certificate or Warrant Certificates, as the case may be, as so requested. The Warrant
Agent may require reasonable and customary payment, with respect to a registration of transfer of Warrants or a split-up, combination
or exchange of a Warrant Certificate (but, for purposes of clarity, not upon the exercise of the Warrants and issuance of Warrant Shares
to the Holder), of a sum sufficient to cover any tax or governmental charge that may be imposed in connection with such registration of
transfer, split-up, combination or exchange, together with reimbursement to the Warrant Agent of all reasonable expenses incidental thereto.
All such fees and expenses shall be paid by the Company, and not by the Holder.</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.2.6.</TD><TD STYLE="text-align: justify"><U>Loss,
Theft, and Mutilation of Warrant Certificates</U>. Upon receipt by the Company and the Warrant Agent of evidence reasonably satisfactory
to them of the loss, theft, destruction, or mutilation of a Warrant Certificate, and, in case of loss, theft or destruction, of indemnity
or security in customary form and amount, and reimbursement to the Company and the Warrant Agent of all reasonable expenses incidental
thereto, and upon surrender to the Warrant Agent and cancellation of the Warrant Certificate if mutilated, the Warrant Agent shall, on
behalf of the Company, countersign and deliver a new Warrant Certificate of like tenor to the Holder in lieu of the Warrant Certificate
so lost, stolen, destroyed, or mutilated. The Warrant Agent may charge the Holder an administrative fee for processing the replacement
of lost Warrant Certificates, which shall be charged only once in instances where a single surety bond obtained covers multiple certificates.
The Warrant Agent may receive compensation from the surety companies or surety bond agents for administrative services provided to them.</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.2.7.</TD><TD STYLE="text-align: justify"><U>Proxies</U>. The Holder of a Warrant may grant proxies or otherwise authorize any person, including
the Participants and beneficial holders that may own interests through the Participants, to take any action that a Holder is entitled
to take under this Agreement or the Warrants;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that at all times that Warrants are evidenced
by a Global Certificate, exercise of those Warrants shall be effected on their behalf by Participants through DTC in accordance the procedures
administered by DTC.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.2.8.</TD><TD STYLE="text-align: justify"><U>Warrant Certificate Request</U>. A Holder has the right to elect at any time or from time to time a
Warrant Exchange (as defined below) pursuant to a Warrant Certificate Request Notice (as defined below). Upon written notice by a Holder
to the Warrant Agent for the exchange of some or all of such Holder&rsquo;s Global Warrants for a Definitive Certificate evidencing the
same number of Warrants, which request shall be in the form attached hereto as <U>Annex E</U> (a &ldquo;<U>Warrant Certificate Request
Notice</U>&rdquo; and the date of delivery of such Warrant Certificate Request Notice by the Holder, the &ldquo;<U>Warrant Certificate
Request Notice Date</U>&rdquo; and the deemed surrender upon delivery by the Holder of a number of Global Warrants for the same number
of Warrants evidenced by a Definitive Certificate, a &ldquo;<U>Warrant Exchange</U>&rdquo;), the Warrant Agent shall promptly effect the
Warrant Exchange and shall promptly issue and deliver to the Holder a Definitive Certificate for such number of Warrants in the name set
forth in the Warrant Certificate Request Notice. Such Definitive Certificate shall be dated the original issue date of the Warrants, shall
be manually executed by an authorized signatory of the Company, shall be in the form attached hereto as <U>Annex C,</U> and shall be reasonably
acceptable in all respects to such Holder. In connection with a Warrant Exchange, the Company agrees to deliver, or to direct the Warrant
Agent to deliver, the Definitive Certificate to the Holder within the earlier of (i) two Trading Days and (ii) the number of Trading Days
comprising the Standard Settlement Period of the Warrant Certificate Request Notice pursuant to the delivery instructions in the Warrant
Certificate Request Notice (&ldquo;<U>Warrant Certificate Delivery Date</U>&rdquo;). If the Company fails for any reason to deliver to
the Holder the Definitive Certificate subject to the Warrant Certificate Request Notice by the Warrant Certificate Delivery Date, the
Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares evidenced by such
Definitive Certificate (based on the VWAP (as defined in the Warrants) of the Common Stock on the Warrant Certificate Request Notice Date),
$10 per Business Day for each Business Day after such Warrant Certificate Delivery Date until such Definitive Certificate is delivered
or, prior to delivery of such Warrant Certificate, the Holder rescinds such Warrant Exchange. The Company covenants and agrees that, upon
the date of delivery of the Warrant Certificate Request Notice, the Holder shall be deemed to be the holder of the Definitive Certificate
and, notwithstanding anything to the contrary set forth herein, the Definitive Certificate shall be deemed for all purposes to contain
all of the terms and conditions of the Warrants evidenced by such Warrant Certificate and the terms of this Agreement, other than Sections
2.2.8 and 7.8 herein, shall not apply to the Warrants evidenced by the Definitive Certificate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Warrant Agency Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">For purposes of clarity,
if there is a conflict between the express terms of this Warrant Agreement and the Warrant certificate in the form of <U>Annex C</U> hereto
with respect to terms of the Warrants, the terms of the Warrant certificate shall govern and control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><U>Terms and Exercise of Warrants</U>.</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.1.</TD><TD STYLE="text-align: justify"><U>Exercise
Price</U>. Each Warrant shall entitle the Holder, subject to the provisions of the applicable Warrant Certificate and of this Warrant
Agreement, to purchase from the Company the number of Common Stock stated therein, at the price state within the warrant certificate per
whole share, subject to the subsequent adjustments provided in Section 4 hereof. The term &ldquo;<I><U>Exercise Price</U></I>&rdquo; as
used in this Warrant Agreement refers to the price per share at which Common Stock may be purchased at the time a Warrant is exercised.</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.2.</TD><TD STYLE="text-align: justify"><U>Duration of Warrants</U>. Warrants may be exercised only during the period (&ldquo;<I><U>Exercise Period</U></I>&rdquo;)
commencing on the Issuance Date and terminating at 5:00 P.M., New York City time (the &ldquo;<I><U>close of business</U></I>&rdquo;) on
the expiration date stated within the warrant certificate (the &ldquo;<U>Expiration Date</U>&rdquo;). Each Warrant not exercised on or
before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Warrant Agreement
shall cease at the close of business on the Expiration Date.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                      <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>3.3.</TD><TD STYLE="text-align: justify"><U>Exercise of Warrants</U>.</TD></TR>
                                                                      <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                      <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>3.3.1.</TD><TD STYLE="text-align: justify"><U>Exercise and Payment</U>.</TD></TR>
                                                                      </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Exercise of the purchase rights represented by a Warrant may be made, in whole or in part, at any time
or times during the Exercise Period by delivery to the Warrant Agent of the Notice of Exercise in the form annexed as <U>Annex B</U> hereto
(the &ldquo;<U>Notice of Exercise&rdquo;)</U>. Within the earlier of (i) two Trading Days and (ii) the number of Trading Days comprising
the Standard Settlement Period following the date the Holder delivers the Notice of Exercise as aforesaid, the Holder shall deliver, in
accordance with the payment instructions in the Notice of Exercise, the aggregate Exercise Price for the shares specified in the applicable
Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified
in Section 3.3.6 below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender a Warrant Certificate to the Company until the Holder
has purchased all of the Warrant Shares available thereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender such Warrant to the Company for cancellation within three Trading Days of the date the final Notice of Exercise is delivered
to the Company. Partial exercises of a Warrant resulting in purchases of a portion of the total number of Warrant Shares available thereunder
shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable
number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and
the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one Business Day of receipt of such
notice. The Holder and any assignee, by acceptance of a Warrant, acknowledge and agree that, by reason of the provisions of this paragraph,
following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at
any given time may be less than the amount stated on the face thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Warrant Agency Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Notwithstanding the&nbsp;foregoing in
this Section 3.3.1 a holder whose interest in a Warrant is a beneficial interest in certificate(s) representing such Warrant held in
registered form through DTC (or another established clearing corporation performing similar functions), shall effect exercises made pursuant
to this Section 3.3.1 by delivering to DTC (or such other clearing corporation, as applicable) the appropriate instruction form for exercise,
complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable), subject
to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in
which case this sentence shall not apply. Upon giving irrevocable instructions to its Participant to exercise Warrants, solely for purposes
of Regulation SHO, the holder whose interest in the Warrant is a beneficial interest shall be deemed to have exercised such Warrant,
notwithstanding when the applicable Warrant Shares are delivered to such holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.3.2.</TD><TD STYLE="text-align: justify"><U>Issuance of Warrant Shares</U>. (a) The Warrant Agent shall, on the Trading Day following the date
of exercise of any Warrant, advise the Company, the transfer agent and registrar for the Company&rsquo;s Common Stock, in respect of (i)
the number of Warrant Shares indicated on the Notice of Exercise as issuable upon such exercise with respect to such exercised Warrants;
(ii) the instructions of the Holder or Participant, as the case may be, provided to the Warrant Agent with respect to the delivery of
the Warrant Shares and the number of Warrants that remain outstanding after such exercise; and (iii) such other information as the Company
or such transfer agent and registrar shall reasonably request.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the transfer agent
to the Holder by (1) crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit
or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there
is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B)
this Warrant is being exercised via cashless exercise; or (2) if the Warrant Shares cannot be transmitted to the Holder via DWAC pursuant
to clause (1) above, or if specifically requested by the Holder in the applicable Notice of Exercise, by delivery of a book-entry position,
registered in the Company&rsquo;s share register in the name of the Holder or its designee, in each case for the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earlier of (i) two Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two Trading Days of and (ii) the
number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading
Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date
until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant
in the FAST program so long as the Warrants remain outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Warrant Agency Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.3.3.</TD><TD STYLE="text-align: justify"><U>Valid
Issuance</U>. All Warrant Shares issued by the Company upon the proper exercise of a Warrant in conformity with this Warrant Agreement
shall be validly issued, fully paid, and non-assessable.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                  <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>3.3.4.</TD><TD STYLE="text-align: justify"><U>No Fractional Exercise</U>. No fractional Warrant Shares will be issued
                              upon the exercise of the Warrant. If, by reason of any adjustment made pursuant to Section 4, a Holder
                              would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the
                              Company shall, upon such exercise, round up to the nearest whole number of Warrant Shares to be issued
                              to such Holder.</TD></TR>
                                                                  <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                  <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>3.3.5.</TD><TD STYLE="text-align: justify"><U>No Transfer Taxes</U>. Issuance of Warrant Shares shall be made without
                              charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance
                              of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
                              Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
                              <U>provided</U>, <U>however</U>, that in the event Warrant Shares are to be issued in a name other than
                              the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment
                              Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the
                              payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall
                              pay all transfer agent fees required for same-day processing of any Notice of Exercise and all fees to
                              the Depository Trust Company (or another established clearing corporation performing similar functions)
                              required for same-day electronic delivery of the Warrant Shares.</TD></TR>
                                                                  <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                  <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>3.3.6.</TD><TD STYLE="text-align: justify"><U>Restrictive Legend Events; Cashless Exercise Under Certain Circumstances</U>.</TD></TR>
                                                                  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">The Company shall use its commercially reasonable efforts to maintain the effectiveness of the Registration
Statement and the current status of the prospectus included therein or to file and maintain the effectiveness of another registration
statement and another current prospectus covering the Warrants and the Warrant Shares at any time that the Warrants are exercisable. The
Company shall provide to the Warrant Agent and each Holder prompt written notice of any time that the Company is unable to deliver the
Warrant Shares via DTC transfer or otherwise without restrictive legend because (A) the Commission has issued a stop order with respect
to the Registration Statement; (B) the Commission otherwise has suspended or withdrawn the effectiveness of the Registration Statement,
either temporarily or permanently; (C) the Company has suspended or withdrawn the effectiveness of the Registration Statement, either
temporarily or permanently; (D) the prospectus contained in the Registration Statement is not available for the issuance of the Warrant
Shares to the Holder; or (E) otherwise (each a &ldquo;<U>Restrictive Legend Event</U>&rdquo;). To the extent that the Warrants cannot
be exercised as a result of a Restrictive Legend Event, the Company shall, at the election of the Holder, which shall be given within
five days of receipt of such notice of the Restrictive Legend Event, either (A) rescind the previously submitted Election to Purchase
and the Company shall return all consideration paid by registered holder for such shares upon such rescission or (B) treat the attempted
exercise as a cashless exercise as described in paragraph (ii) below and refund the cash portion of the exercise price to the Holder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">If a Restrictive Legend Event has occurred, the Warrant may also be exercisable on a cashless basis. Notwithstanding
anything herein to the contrary, but without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to this Section 3.3.6(b) or to receive cash payments pursuant to Section 3.3.2(b) and Section 3.3.8 herein, the Company shall
not be required to make any cash payments or net cash settlement to the Holder in lieu of delivery of the Warrant Shares. Upon a &ldquo;cashless
exercise,&rdquo; the Holder shall be entitled to receive the number of Warrant Shares equal to the quotient (if such quotient would be
a positive number) obtained by dividing (A-B) (X) by (A), where:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Warrant Agency Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 108pt"></TD><TD STYLE="width: 27pt">(A) =</TD><TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 3.3.1(a) hereof on a day that is not a Trading
Day or (2) both executed and delivered pursuant to Section 3.3.1(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii)
at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise
or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s
execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a
Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section 3.3.1(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise
if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section
3.3.1(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                     <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>(B) =</TD><TD STYLE="text-align: justify">the Exercise Price of the Warrant,
as adjusted as set forth herein; and</TD></TR>
                                                                                                     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 108pt"></TD><TD STYLE="width: 27pt">(X) =</TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise of the Warrant in accordance with the
terms of the Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">If the Warrant Shares are issued in such
a cashless exercise, the Company acknowledges and agrees that, in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares
shall take on the registered characteristics of the Warrants being exercised and the Company agrees not to take any position contrary
thereto. Upon receipt of an Election to Purchase for a cashless exercise, the Warrant Agent will promptly deliver a copy of the Election
to Purchase to the Company to confirm the number of Warrant Shares issuable in connection with the cashless exercise. The Company shall
calculate and transmit to the Warrant Agent in a written notice, and the Warrant Agent shall have no duty, responsibility, or obligation
under this section to calculate, the number of Warrant Shares issuable in connection with any cashless exercise. The Warrant Agent shall
be entitled to rely conclusively on any such written notice provided by the Company, and the Warrant Agent shall not be liable for any
action taken, suffered, or omitted to be taken by it in accordance with such written instructions or pursuant to this Warrant Agreement.
Notwithstanding anything herein to the contrary, on the Termination Date (as defined below), this Warrant shall be automatically exercised
via cashless exercise pursuant to this Section 3.3.6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.3.7.</TD><TD STYLE="text-align: justify"><U>Disputes</U>.
In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant Shares issuable
in connection with any exercise, the Company shall promptly deliver to the Holder the number of Warrant Shares that are not disputed.</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Warrant Agency Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">3.3.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise.</U> In addition to any other rights available to the Holder, if
the Company fails to cause the transfer agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
3.3.2(b) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
(a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the Common Stock so purchased exceeds (y) the amount obtained by multiplying
(1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times
(2) the price at which the sell order giving rise to such purchase obligation was executed; <I>provided</I>, <I>however</I>, that such
Holder provides reasonable evidence of the date and time of such sell order and such sell order occurred after the missed Warrant Share
Delivery Date and prior to the delivery of the related Warrant Shares, and (B) at the option of the Holder, either reinstate the portion
of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be
deemed rescinded) or deliver to the Holder the number of Common Stock that would have been issued had the Company timely complied with
its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted exercise of Common Stock with an aggregate sale price giving rise to such purchase obligation
of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder
shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the
Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Company&rsquo;s failure to timely deliver Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.
For the avoidance of doubt, except in the event of gross negligence or willful misconduct on its part, the Warrant Agent shall not be
liable for any failure of the Company to timely deliver Warrant Shares pursuant to this Section 3.3.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Warrant Agency Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">3.3.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Beneficial
Ownership Limitation</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of a Warrant, pursuant to Section 3 or otherwise, to the extent that after giving effect to such issuance after exercise as
set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Common
Stock issuable upon exercise of such Warrant with respect to which such determination is being made, but shall exclude the number of Common
Stock which would be issuable upon (i) exercise of the remaining, non-exercised portion of such Warrant beneficially owned by the Holder
or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or non-converted portion of any other
securities of the Company (including, without limitation, any other securities of the Company which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock
(&ldquo;<U>Common Share Equivalents</U>&rdquo;)) subject to a limitation on conversion or exercise analogous to the limitation contained
herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence,
for purposes of this Section 3.3.9, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange
Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;) and the rules and regulations promulgated thereunder, it being acknowledged
by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange
Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation
contained in this Section 3.3.9 applies, the determination of whether a Warrant is exercisable (in relation to other securities owned
by the Holder together with any Affiliates and Attribution Parties) and of which portion of a Warrant is exercisable shall be in the sole
discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether
a Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and
of which portion of a Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have
no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For
purposes of this Section 3.3.9, in determining the number of outstanding Common Stock, a Holder may rely on the number of outstanding
Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may
be; (B) a more recent public announcement by the Company; or (C) a more recent written notice by the Company or the transfer agent setting
forth the number of Common Stock outstanding.&nbsp; Upon the written request of a Holder, the Company shall within two Trading Days confirm
in writing (including by e-mail) to the Holder the number of Common Stock then outstanding.&nbsp; In any case, the number of outstanding
Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including such Warrant,
by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding Common Stock was reported.
The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants,
9.99%) of the number of Common Stock outstanding immediately after giving effect to the issuance of Common Stock issuable upon exercise
of a Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this
Section 3.3.9, provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of Common Stock outstanding immediately
after giving effect to the issuance of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section
3.3.9 shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day
after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this Section 3.3.9 to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Warrant Agency
Agreement</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><U>Adjustments</U>.
</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                               <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>4.1.</TD><TD STYLE="text-align: justify"><U>Adjustment upon Subdivisions or Combinations</U>. If the Company, at any
                            time while the Warrants are outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions
                            on its Common Stock or any other equity or equity equivalent securities payable in Common Stock (which, for
                            avoidance of doubt, shall not include any Common Stock issued by the Company upon exercise of the Warrants);
                            (ii) subdivides outstanding Common Stock into a larger number of shares; (iii) combines (including by way
                            of reverse stock split) outstanding Common Stock into a smaller number of shares; or (iv) issues by reclassification
                            of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall
                            be multiplied by a fraction of which the numerator shall be the number of Common Stock and such other capital
                            stock of the Company (excluding treasury shares, if any) outstanding immediately before such event and of
                            which the denominator shall be the number of Common Stock and such other capital stock of the Company (excluding
                            treasury shares, if any) outstanding immediately after such event, and the number of shares issuable upon
                            exercise of each Warrant shall be proportionately adjusted such that the aggregate Exercise Price of such
                            Warrant shall remain unchanged. Any adjustment made pursuant to this Section 4.1 shall become effective immediately
                            after the record date for the determination of stockholders entitled to receive such dividend or distribution
                            and shall become effective immediately after the effective date in the case of a subdivision, combination,
                            or re-classification.</TD></TR>
                                                                                                                                               <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                               <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>4.2.</TD><TD STYLE="text-align: justify"><U>Adjustment for Other Distributions</U>.</TD></TR>
                                                                                                                                               </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 4.1 above, if at
any time the Company grants, issues or sells any Common Share Equivalents or rights to purchase stock, warrants, securities, or other
property pro rata to the record holders of any class of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will
be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired
if the Holder had held the number of Common Stock acquirable upon complete exercise of a Warrant (without regard to any limitations on
exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken
for the grant, issuance, or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common
Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such Common Stock as a result of
such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if
ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Extraordinary Dividends</U>. If the Company, at any time during the Exercise Period, shall pay a dividend
in cash, securities or other assets to all holders of Common Stock (or other shares of the Company&rsquo;s capital stock into which the
Warrants are convertible), other than (i) as described in Sections 4.1, 4.2(a) or 4.3, or (ii) regular quarterly or other periodic dividends
(any such non-excluded event being referred to herein as an &ldquo;<U>Extraordinary Dividend</U>&rdquo;), then the Exercise Price shall
be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the quotient of (1) the gross amount of
cash and/or fair market value (as determined by the Company&rsquo;s Board of Directors, in good faith) of all securities or other assets
paid to the holders of Common Stock (or other shares of the Company&rsquo;s capital stock into which the Warrants are convertible) in
respect of such Extraordinary Dividend divided by (2) the sum of the number of Common Stock (or other shares of the Company&rsquo;s capital
stock into which the Warrants are exercisable) outstanding at the time of the Extraordinary Dividend plus the number of Common Stock then
issuable upon exercise of all outstanding Warrants, provided, that the Exercise Price shall not be reduced below zero.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Warrant Agency Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">4.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fundamental
Transaction</U>. If, at any time while the Warrants are outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any
sale, lease, license, assignment, transfer, conveyance, or other disposition of all or substantially all of its assets in one or a series
of related transactions, (iii) any, direct or indirect, purchase offer, tender offer, or exchange offer (whether by the Company or another
Person) is completed pursuant to which all holders of Common Stock are permitted to sell, tender, or exchange their shares for other securities,
cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization, or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which all outstanding Common Stock are effectively converted into or exchanged for other securities, cash or
property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement
or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, or scheme of arrangement)
with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding Common Stock (not
including any Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;),
then, upon any subsequent exercise of a Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been
issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in Section
3.3.9 on the exercise of a Warrant), the number of Common Stock of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and such amount of cash or any other consideration (collectively, the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of Common Stock for which a Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 3.3.9 on the exercise of a Warrant). For purposes of
any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based
on the amount of Alternate Consideration issuable in respect of one Common Share in such Fundamental Transaction, and the Company shall
apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components
of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash, or property to be received
in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise
of a Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which
the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company
under the Warrants in accordance with the provisions of this Section 4.3 pursuant to written agreements prior to or during such Fundamental
Transaction. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of the Warrants referring to the &ldquo;Company&rdquo; shall
refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under the Warrants with the same effect as if such Successor Entity had been named as the Company therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company shall instruct the Warrant
Agent in writing (including by e-mail) to send by e-mail or by first class mail, postage prepaid, to each Holder, written notice of the
execution of any such amendment, supplement, or agreement with the Successor Entity. Any supplemented or amended agreement entered into
by the successor corporation or transferee shall provide for adjustments, which shall be as nearly equivalent as may be practicable to
the adjustments provided for in this Section 4.3. The Warrant Agent shall have no duty, responsibility or obligation to determine the
correctness of any provisions contained in such agreement or such notice, including but not limited to any provisions relating either
to the kind or amount of securities or other property receivable upon exercise of warrants or with respect to the method employed and
provided therein for any adjustments, and shall be entitled to rely conclusively for all purposes upon the provisions contained in any
such agreement. The provisions of this Section 4.3 shall similarly apply to successive reclassifications, changes, consolidations, mergers,
sales, and conveyances of the kind described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Warrant Agency Agreement</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.4.</TD><TD STYLE="text-align: justify"><U>Notices to Holder</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision
of this Section 4, the Company shall promptly deliver to the Holder by facsimile or e-mail a notice setting forth the Exercise Price after
such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring
such adjustment. Provided, however, that the Company may satisfy this notice requirement in this Section 4.4(a) by filing such notice
with the Commission pursuant to a Current Report on Form 8-K, or, to the extent that the Company is no longer subject to the reporting
requirements of Section 13 or 15(d) of the Exchange Act, by posting such notice on the Company&rsquo;s website.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution
in whatever form) on the Common Stock; (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common
Stock; (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase
any shares of capital stock of any class or of any rights; (D) the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all
or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock are converted into other
securities, cash, or property; or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation, or winding up
of the affairs of the Company, then, in each case, the Company shall cause to be delivered by mail, facsimile, or e-mail to the Holder
at its last mailing address, facsimile number, or e-mail address as it shall appear upon the Warrant Register of the Company, at least
five calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record
is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the
date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants
are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected
to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to
exchange their Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale,
transfer, or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not
affect the validity of the corporate action required to be specified in such notice. To the extent that any notice required to be provided
in this Warrant Agreement constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. Provided such notice occurs
within the Exercise Period, the Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.5.</TD><TD STYLE="text-align: justify"><U>Other Events</U>. If any event occurs
                                            of the type contemplated by the provisions of Section 4.1 or 4.2 but not expressly provided
                                            for by such provisions (including, without limitation, the granting of stock appreciation
                                            rights, Adjustment Rights, phantom stock rights, or other rights with equity features to
                                            all holders of Common Stock for no consideration), then the Company's Board of Directors
                                            will, at its discretion and in good faith, make an adjustment in the Exercise Price and the
                                            number of Warrant Shares or designate such additional consideration to be deemed issuable
                                            upon exercise of a Warrant, so as to protect the rights of the registered Holder. No adjustment
                                            to the Exercise Price will be made pursuant to more than one sub-section of this Section
                                            4 in connection with a single issuance.</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Warrant Agency Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">4.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices
of Changes in Warrant</U>. Upon every adjustment of the Exercise Price or the number of Warrant Shares issuable upon exercise of a Warrant,
the Company shall give written notice thereof (including by e-mail) to the Warrant Agent, which notice shall state the Exercise Price
resulting from such adjustment and the increase or decrease, if any, in the number of Warrant Shares purchasable at such price upon the
exercise of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based.
Upon the occurrence of any event specified in Sections 4.1 or 4.2, then, in any such event, the Company shall give written notice by mail,
e-mail or facsimile to each Holder, at the last address set forth for such holder in the Warrant Register, as of the record date or the
effective date of the event. Provided, however, that the Company may satisfy the notice requirement to Holders in this Section 4.6 by
filing such notice with the Commission pursuant to a Current Report on Form 8-K, or, to the extent that the Company is no longer subject
to the reporting requirements of Section 13 or 15(d) of the Exchange Act, by posting such notice on the Company&rsquo;s website. Failure
to give such notice, or any defect therein, shall not affect the legality or validity of such event. The Warrant Agent shall be entitled
to rely conclusively on, and shall be fully protected in relying on, any certificate, notice or instructions provided by the Company with
respect to any adjustment of the Exercise Price or the number of shares issuable upon exercise of a Warrant, or any related matter, and
the Warrant Agent shall not be liable for any action taken, suffered or omitted to be taken by it in accordance with any such certificate,
notice or instructions or pursuant to this Warrant Agreement. The Warrant Agent shall not be deemed to have knowledge of any such adjustment
unless and until it shall have received written notice thereof (including by e-mail) from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictive
Legends; Fractional Warrants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">In the event that
a Warrant Certificate surrendered for transfer bears a restrictive legend, the Warrant Agent shall not register that transfer until the
Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the Warrants
must also bear a restrictive legend upon that transfer. The Warrant Agent shall not be required to effect any registration of transfer
or exchange which will result in the transfer of or delivery of a Warrant Certificate for a fraction of a Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&nbsp;&#9;<U>Other Provisions
Relating to Rights of Holders of Warrants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">6.1.&nbsp;&#9;<U>No
Rights as Stockholder</U>. Except as otherwise specifically provided herein, a Holder, solely in its capacity as a holder of Warrants,
shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall
anything contained in this Warrant Agreement be construed to confer upon a Holder, solely in its capacity as the registered holder of
Warrants, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether
any reorganization, issue of stock, reclassification of share capital, consolidation, merger, conveyance or otherwise), receive notice
of meetings, receive dividends or subscription rights or rights to participate in new issues of shares, or otherwise, prior to the issuance
to the Holder of the Warrant Shares which it is then entitled to receive upon the due exercise of Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">6.2.&nbsp;&#9;<U>Reservation
of Common Stock</U>. The Company shall at all times reserve and keep available a number of its authorized but unissued Common Stock that
will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Warrant Agency
Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Concerning
the Warrant Agent and Other Matters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.1.</TD><TD STYLE="text-align: justify">Any instructions given to the Warrant Agent orally, as permitted by any provision of this Warrant Agreement,
shall be confirmed in writing (including by e-mail) by the Company as soon as practicable. The Warrant Agent shall not be liable or responsible
and shall be fully authorized and protected for acting, or failing to act, in accordance with any oral instructions which do not conform
with the written confirmation received in accordance with this Section 7.1.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.2.</TD><TD STYLE="text-align: justify">(a) Whether or not any Warrants are exercised, for the Warrant Agent&rsquo;s services as agent for the
Company hereunder, the Company shall pay to the Warrant Agent such fees as may be separately agreed between the Company and Warrant Agent
and the Warrant Agent&rsquo;s out of pocket expenses in connection with this Warrant Agreement, including the reasonable fees and expenses
of the Warrant Agent&rsquo;s counsel. While the Warrant Agent endeavors to maintain out-of-pocket charges (both internal and external)
at competitive rates, these charges may not reflect actual out-of-pocket costs, and may include handling charges to cover internal processing
and use of the Warrant Agent&rsquo;s billing systems.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">No provision of this Warrant Agreement shall require Warrant Agent to expend or risk its own funds or
otherwise incur any financial liability in the performance of any of its duties under this Warrant Agreement or in the exercise of its
rights.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">7.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As agent
for the Company hereunder, the Warrant Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">shall have no duties or obligations other than those specifically set forth herein or as may subsequently
be agreed to in writing by the Warrant Agent and the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">shall be regarded as making no representations and having no responsibilities as to the validity, sufficiency,
value, or genuineness of the Warrants or any Warrant Shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 20pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">shall not be obligated to take any legal action hereunder; if, however, the Warrant Agent determines to
take any legal action hereunder, and where the taking of such action might, in its judgment, subject or expose it to any expense or liability
it shall not be required to act unless it has been furnished with an indemnity reasonably satisfactory to it;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 20pt">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">may rely on and shall be fully authorized and protected in acting or failing to act upon any certificate,
instrument, opinion, notice, letter, telegram, telex, facsimile transmission, or other document or security delivered to the Warrant Agent
and believed by it to be genuine and to have been signed by the proper party or parties;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">shall not be liable or responsible for any recital or statement contained in the Registration Statement
or any other documents relating thereto;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">shall not be liable or responsible for any failure on the part of the Company to comply with any of its
covenants and obligations relating to the Warrants, including without limitation obligations under applicable securities laws;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Warrant Agency
Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">may rely on and shall be fully authorized and protected in acting or failing to act upon the written,
telephonic, or oral instructions with respect to any matter relating to its duties as Warrant Agent covered by this Warrant Agreement
(or supplementing or qualifying any such actions) of officers of the Company, and is hereby authorized and directed to accept instructions
with respect to the performance of its duties hereunder from the Company or counsel to the Company, and may apply to the Company, for
advice or instructions in connection with the Warrant Agent&rsquo;s duties hereunder, and the Warrant Agent shall not be liable for any
delay in acting while waiting for those instructions; any applications by the Warrant Agent for written instructions from the Company
may, at the option of the Warrant Agent, set forth in writing any action proposed to be taken or omitted by the Warrant Agent under this
Warrant Agreement and the date on or after which such action shall be taken or such omission shall be effective; the Warrant Agent shall
not be liable for any action taken by, or omission of, the Warrant Agent in accordance with a proposal included in such application on
or after the date specified in such application (which date shall not be less than five Business Days after the date such application
is sent to the Company, unless the Company shall have consented in writing to any earlier date) unless prior to taking any such action,
the Warrant Agent shall have received written instructions in response to such application specifying the action to be taken or omitted;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">may consult with counsel satisfactory to the Warrant Agent, including its in-house counsel, if any, and
the advice of such counsel shall be full and complete authorization and protection in respect of any action taken, suffered, or omitted
by it hereunder in good faith and in accordance with the advice of such counsel;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">may perform any of its duties hereunder either directly or by or through nominees, correspondents, designees,
or subagents, and it shall not be liable or responsible for any misconduct or negligence on the part of any nominee, correspondent, designee,
or subagent appointed with reasonable care by it in connection with this Warrant Agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">is not authorized, and shall have no obligation, to pay any brokers, dealers, or soliciting fees to any
person; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify">shall not be required hereunder to comply with the laws or regulations of any country other than the United
States of America or any political subdivision thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.4.</TD><TD STYLE="text-align: justify">(a) In the absence of gross negligence or willful or illegal misconduct on its part, the Warrant Agent
shall not be liable for any action taken, suffered, or omitted by it or for any error of judgment made by it in the performance of its
duties under this Warrant Agreement. Anything in this Warrant Agreement to the contrary notwithstanding, in no event shall the Warrant
Agent be liable for special, indirect, incidental, consequential, or punitive losses or damages of any kind whatsoever (including but
not limited to lost profits), even if the Warrant Agent has been advised of the possibility of such losses or damages and regardless of
the form of action. Any liability of the Warrant Agent will be limited in the aggregate to the amount of fees paid by the Company hereunder.
The Warrant Agent shall not be liable for any failures, delays or losses, arising directly or indirectly out of conditions beyond its
reasonable control including, but not limited to, acts of government, exchange or market ruling, suspension of trading, work stoppages
or labor disputes, fires, civil disobedience, riots, rebellions, storms, electrical or mechanical failure, computer hardware or software
failure, communications facilities failures including telephone failure, war, terrorism, insurrection, earthquakes, floods, acts of God,
or similar occurrences.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Warrant Agency Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">In the event any question or dispute arises with respect to the proper interpretation of the Warrants
or the Warrant Agent&rsquo;s duties under this Warrant Agreement or the rights of the Company or of any Holder, the Warrant Agent shall
not be required to act and shall not be held liable or responsible for its refusal to act until the question or dispute has been judicially
settled (and, if appropriate, it may file a suit in interpleader or for a declaratory judgment for such purpose) by final judgment rendered
by a court of competent jurisdiction, binding on all persons interested in the matter which is no longer subject to review or appeal,
or settled by a written document in form and substance satisfactory to Warrant Agent and executed by the Company and each such Holder.
In addition, the Warrant Agent may require for such purpose, but shall not be obligated to require, the execution of such written settlement
by all the Holders and all other persons that may have an interest in the settlement.&nbsp;&nbsp;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.5.</TD><TD STYLE="text-align: justify">The Company covenants to indemnify the Warrant Agent and hold it harmless from and against any loss, liability,
claim or expense (&ldquo;<U>Loss</U>&rdquo;) arising out of or in connection with the Warrant Agent&rsquo;s duties under this Warrant
Agreement, including the costs and expenses of defending itself against any Loss, unless such Loss shall have been determined by a court
of competent jurisdiction to be a result of the Warrant Agent&rsquo;s gross negligence or willful misconduct.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.6.</TD><TD STYLE="text-align: justify">Unless terminated earlier by the parties hereto, this Warrant Agreement shall terminate 90 days after
the earlier of the Expiration Date and the date on which no Warrants remain outstanding (the &ldquo;<U>Termination Date</U>&rdquo;). On
the Business Day following the Termination Date, the Warrant Agent shall deliver to the Company any entitlements, if any, held by the
Warrant Agent under this Warrant Agreement. The Warrant Agent&rsquo;s right to be reimbursed for fees, charges and out-of-pocket expenses
as provided in this Section 7 shall survive the termination of this Warrant Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.7.</TD><TD STYLE="text-align: justify">If any provision of this Warrant Agreement shall be held illegal, invalid, or unenforceable by any court,
this Warrant Agreement shall be construed and enforced as if such provision had not been contained herein and shall be deemed an Agreement
among the parties to it to the full extent permitted by applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.8.</TD><TD STYLE="text-align: justify">The Company represents and warrants that (a) it is duly incorporated and validly existing under the laws
of its jurisdiction of incorporation; (b) the offer and sale of the Warrants and the execution, delivery and performance of all transactions
contemplated thereby (including this Warrant Agreement) have been duly authorized by all necessary corporate action and will not result
in a breach of or constitute a default under the articles of incorporation, bylaws or any similar document of the Company or any indenture,
agreement or instrument to which it is a party or is bound; (c) this Warrant Agreement has been duly executed and delivered by the Company
and constitutes the legal, valid, binding and enforceable obligation of the Company; (d) the Warrants will comply in all material respects
with all applicable requirements of law; and (e) to the best of its knowledge, there is no litigation pending or threatened as of the
date hereof in connection with the offering of the Warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.9.</TD><TD STYLE="text-align: justify">In the event of inconsistency between this Warrant Agreement and the descriptions in the Registration
Statement, as they may from time to time be amended, the terms of this Warrant Agreement shall control.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.10.</TD><TD STYLE="text-align: justify">Set forth in&nbsp;<U>Annex D</U>&nbsp;hereto is a list of the names and specimen signatures of the persons
authorized to act for the Company under this Warrant Agreement (the &ldquo;<U>Authorized Representatives</U>&rdquo;). The Company shall,
from time to time, certify to you the names and signatures of any other persons authorized to act for the Company under this Warrant Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Warrant Agency
Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.11.</TD><TD STYLE="text-align: justify">Any notice, statement or demand authorized by this Warrant Agreement to be given or made by the Warrant
Agent or by the holder of any Warrant to or on the Company including, without limitation, any Notice of Exercise, shall be in writing
and delivered by e-mail, hand or sent by registered or certified mail or a nationally recognized overnight courier service, addressed
(until another address is filed in writing by the Company with the Warrant Agent) as set forth below and if to any holder any notice,
statement or demand shall be given to the last address set forth for such holder (if any) in the Warrant Register:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Nocera, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">3F (Building B), No. 185, Sec 1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Datong Rd., Xizhi District</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Taiwan, CN. 00000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Att.: Jeff Cheng</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">E-mail: jeffcheng@nocera.company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0">with a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Carmel, Milazzo &amp; Feil, LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">55 West 39<SUP>th</SUP> Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">18<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">New York, NY. 10018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Attention: Ross Carmel, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Facsimile No.: (646) 838-1314</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">E-mail: rcarmel@cmfllp.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any notice, statement or demand
authorized by this Warrant Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent including,
without limitation, any Notice of Exercise, shall be in writing and delivered by e-mail, facsimile, hand or sent by registered or certified
mail a nationally recognized overnight courier service, addressed (until another address is filed in writing by the Warrant Agent with
the Company), as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">Mountain Share Transfer, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">2030 Powers Ferry Rd. SE, Suite # 212</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">Atlanta, GA 30339</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">Facsimile No.: (404) 816-8830</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">Attention: Erik Nelson</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">E-mail: esn@mountainsharetransfer.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Warrant Agency Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Any notice or other communication
or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication
is delivered via facsimile at the facsimile number or e-mail at the e-mail address set forth above in this Section 7.11 prior to 5:30
p.m. (New York City time) on any Trading Day, (ii) the next Trading Day after the date of transmission, if such notice or communication
is delivered via facsimile at the facsimile number or e-mail at the e-mail address set forth in this Section 7.11 on a day that is not
a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing,
if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required
to be given. Notwithstanding any other provision of this Warrant, where this Warrant provides for notice of any event to the Holder, if
this Warrant is held in global form by DTC (or any successor depositary), such notice shall be sufficiently given if given to DTC (or
any successor depositary) pursuant to the procedures of DTC (or such successor depositary), subject to a Holder&rsquo;s right to elect
to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case this sentence shall not
apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.12.</TD><TD STYLE="text-align: justify">(a) This Warrant Agreement shall be governed by and construed in accordance with the laws of the State
of Nevada. All actions and proceedings relating to or arising from, directly or indirectly, this Warrant Agreement may be litigated in
courts located in the United States District Court for the Western District of Nevada. The Company hereby submits to the personal jurisdiction
of such courts and consents that any service of process may be made by certified or registered mail, return receipt requested, directed
to the Company at its address last specified for notices hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 20pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">This Warrant Agreement shall inure to the benefit of and be binding upon the successors and assigns of
the parties hereto. This Warrant Agreement may not be assigned, or otherwise transferred, in whole or in part, by either party without
the prior written consent of the other party, which the other party will not unreasonably withhold, condition or delay; except that (i)
consent is not required for an assignment or delegation of duties by Warrant Agent to any affiliate of Warrant Agent and (ii) any reorganization,
merger, consolidation, sale of assets or other form of business combination by Warrant Agent or the Company shall not be deemed to constitute
an assignment of this Warrant Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">No provision of this Warrant Agreement may be amended, modified, or waived, except in a written document
signed by both parties. The Company and the Warrant Agent may amend or supplement this Warrant Agreement without the consent of any Holder
for the purpose of curing any ambiguity, or curing, correcting or supplementing any defective provision contained herein or adding or
changing any other provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable,
so long as such amendment or supplement shall not materially and adversely affect the interests of the Holders.&nbsp;&nbsp;All other amendments
and supplements shall require the vote or written consent of Holders of at least 50.1% of the then outstanding Warrants; provided that
if any such amendment or supplement disproportionately and adversely affect the rights of a Holder compared to other Holders, the prior
written consent of such Holder shall also be required.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.13</TD><TD STYLE="text-align: justify"><U>Payment of Taxes</U>. The Company will from time to time promptly pay all taxes and charges that may
be imposed upon the Company or the Warrant Agent in respect of the issuance or delivery of Warrant Shares upon the exercise of Warrants,
but the Company may require the Holders to pay any transfer taxes in respect of the Warrants or such shares. The Warrant Agent may refrain
from registering any transfer of Warrants or any delivery of any Warrant Shares unless or until the persons requesting the registration
or issuance shall have paid to the Warrant Agent for the account of the Company the amount of such tax or charge, if any, or shall have
established to the reasonable satisfaction of the Company and the Warrant Agent that such tax or charge, if any, has been paid.&nbsp;</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                               <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>7.14</TD><TD STYLE="text-align: justify"><U>Resignation of Warrant Agent</U>.</TD></TR>
                                                                                                                                               </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Warrant Agency Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.14.1.</TD><TD STYLE="text-align: justify"><U>Appointment of Successor Warrant Agent</U>. The Warrant Agent, or any successor to it hereafter appointed,
may resign its duties, and be discharged from all further duties and liabilities hereunder after giving 30 days&rsquo; notice in writing
to the Company, or such shorter period of time agreed to by the Company. The Company may terminate the services of the Warrant Agent,
or any successor Warrant Agent, after giving 30 days&rsquo; notice in writing to the Warrant Agent or successor Warrant Agent, or such
shorter period of time as agreed to by the parties. If the office of the Warrant Agent becomes vacant by resignation, termination, or
incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent. If the Company
shall fail to make such appointment within a period of 30 days after it has been notified in writing of such resignation or incapacity
by the Warrant Agent, then the Warrant Agent or any Holder may apply to any court of competent jurisdiction for the appointment of a successor
Warrant Agent at the Company&rsquo;s cost. Pending appointment of a successor to such Warrant Agent, either by the Company or by such
a court, the duties of the Warrant Agent shall be carried out by the Company. Any successor Warrant Agent (but not including the initial
Warrant Agent), whether appointed by the Company or by such court, shall be a person organized and existing under the laws of any state
of the United States of America, in good standing, and authorized under such laws to exercise corporate trust powers and subject to supervision
or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers,
rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent
hereunder, without any further act or deed, and except for executing and delivering documents as provided in the sentence that follows,
the predecessor Warrant Agent shall have no further duties, obligations, responsibilities, or liabilities hereunder, but shall be entitled
to all rights that survive the termination of this Warrant Agreement and the resignation or removal of the Warrant Agent, including but
not limited to its right to indemnity hereunder. If for any reason it becomes necessary or appropriate or at the request of the Company,
the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Warrant
Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent
the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in
and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">7.14.2.&nbsp;<U>Notice
of Successor Warrant Agent</U>. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the
predecessor Warrant Agent and the transfer agent for the Common Stock not later than the effective date of any such appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">7.14.3.&nbsp;<U>Merger
or Consolidation of Warrant Agent</U>. Any person into which the Warrant Agent may be merged or converted or with which it may be consolidated
or any person resulting from any merger, conversion or consolidation to which the Warrant Agent shall be a party or any person succeeding
to the shareowner services business of the Warrant Agent or any successor Warrant Agent shall be the successor Warrant Agent under this
Warrant Agreement, without any further act or deed. For purposes of this Warrant Agreement, &ldquo;person&rdquo; shall mean any individual,
firm, corporation, partnership, limited liability company, joint venture, association, trust, or other entity, and shall include any successor
(by merger or otherwise) thereof or thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous
Provisions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">8.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Persons
Having Rights under this Warrant Agreement</U>. Nothing in this Warrant Agreement expressed and nothing that may be implied from any
of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties
hereto and the Holders any right, remedy, or claim under or by reason of this Warrant Agreement or of any covenant, condition, stipulation,
promise, or agreement hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Warrant Agency
Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">8.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Examination
of the Warrant Agreement</U>. A copy of this Warrant Agreement shall be available at all reasonable times at the office of the Warrant
Agent designated for such purpose for inspection by any Holder. Prior to such inspection, the Warrant Agent may require any such holder
to provide reasonable evidence of its interest in the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">8.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U>.
This Warrant Agreement may be executed in any number of original, facsimile, or electronic counterparts and each of such counterparts
shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">8.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect
of Headings</U>. The Section headings herein are for convenience only and are not part of this Warrant Agreement and shall not affect
the interpretation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">8.5</TD><TD STYLE="text-align: justify">If a Warrant is held in global form through DTC (or any successor depositary), such Warrant is issued
subject to this Warrant Agent Agreement. To the extent any provision of a Warrant conflicts with the express provisions of this Warrant
Agent Agreement, the provisions of such Warrant shall govern and be controlling.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Definitions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">As used herein,
the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">&ldquo;<U>Adjustment Right</U>&rdquo; means any right granted with respect to any securities issued in
connection with, or with respect to, any issuance, sale or delivery (or deemed issuance, sale or delivery in accordance with Section 4)
of Common Stock (other than rights of the type described in Section 4.2 and 4.3 hereof) that could result in a decrease in the net consideration
received by the Company in connection with, or with respect to, such securities (including, without limitation, any cash settlement rights,
cash adjustment or other similar rights) but excluding anti-dilution and other similar rights (including pursuant to Section 4.4 of this
Agreement).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">&ldquo;<U>Bid Price</U>&rdquo; means, for any date, the price determined by the first of the following
clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the
time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported
by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is
not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or
OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock
are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock
as determined by an independent appraiser selected in good faith by the Holders of a majority of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">&ldquo;<U>Business Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal
legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law
or other governmental action to close.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Warrant Agency Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">&ldquo;<U>Trading Day</U>&rdquo; means any day on which the Common Stock are traded on the Trading Market,
or, if the Trading Market is not the principal trading market for the Common Stock, then on the principal securities exchange or securities
market in the United States on which the Common Stock are then traded, provided that &ldquo;Trading Day&rdquo; shall not include any day
on which the Common Stock are scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock are
suspended from trading during the final hour of trading on such exchange or market (or if such exchange or market does not designate in
advance the closing time of trading on such exchange or market, then during the hour ending at 4:00 P.M., New York City time).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">&ldquo;<U>Trading Market</U>&rdquo; means the NYSE American, the Nasdaq Capital Market, the Nasdaq Global
Market, the Nasdaq Global Select Market, or the New York Stock Exchange (or any successors to any of the foregoing).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">&ldquo;<U>VWAP</U>&rdquo; means, for any date, the price determined by the first of the following clauses
that applies: (a) if the Common Stock are then listed or quoted on a Trading Market, the daily volume weighted average price of the Common
Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock are then listed or quoted as reported
by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or
OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on
OTCQB or OTCQX as applicable, (c) if the Common Stock are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the
Common Stock are then reported in the &ldquo;Pink Open Market&rdquo; published by OTC Markets Group, Inc. (or a similar organization or
agency succeeding to its functions of reporting prices), the most recent bid price per Common Share so reported, or (d)&nbsp;in all other
cases, the fair market value of a Common Share as determined by an independent appraiser selected in good faith by the holders of a majority
in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by
the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Warrant Agency Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, this Warrant Agency Agreement
has been duly executed by the parties hereto as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Nocera, Inc.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Yin-Chieh Cheng,</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">President &amp; CEO</P></TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Mountain Share Transfer, LLC, as warrant agent.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Erik Nelson,</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">President</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Annex A</U>: &#9;Class A Form of Warrant Certificate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Annex B</U>: &#9;Class B Form of Warrant Certificate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Annex C</U>: &#9;Class C Form of Warrant Certificate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Annex
D</U>: &#9;Class D Form of Warrant Certificate</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Annex E</U>: &#9;Authorized Representatives</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Annex F</U>:&#9;Form of Warrant Certificate
Request Notice</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>nocera_ex0501.htm
<DESCRIPTION>OPINION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<IMG SRC="cmflogo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 20, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nocera, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3F (Building B), No. 185, Sec. 1, Datong Rd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Xizhi Dist., New Taipei City 221, Taiwan</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Re: <U>Registration Statement on Form S-1 (File
No. 333-264059)</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have examined the Registration Statement on
Form S-1 (File No. 333-264059), as amended (the &ldquo;<U>Registration Statement</U>&rdquo;), of Nocera, Inc., a Nevada corporation (the
&ldquo;<U>Company</U>&rdquo;), originally filed pursuant to the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;)
on April 1, 2022, in connection with the offering by the Company of: (i) an aggregate of 2,702,500 shares (the &ldquo;<U>Shares</U>&rdquo;)
of the Company&rsquo;s common stock, $0.001 par value per share (the &ldquo;<U>Common Stock</U>&rdquo;), including up to 352,500 shares
that may be sold pursuant to the underwriters&rsquo; over-allotment option; (ii) 2,702,500 warrants (the &ldquo;<U>Warrants</U>&rdquo;)
to purchase an aggregate of 5,405,000 shares of Common Stock (the &ldquo;<U>Warrants Shares</U>&rdquo;). The Company is also offering
up to an aggregate of 135,125 warrants (the &ldquo;<U>Representative Warrants</U>&rdquo;) to purchase an aggregate of 135,125 shares of
Common Stock (the &ldquo;<U>Warrant Shares</U>&rdquo;) to Spartan Capital Securities, LLC and Revere Securities LLC, the representatives
of the underwriters named on Schedule I to that certain underwriting agreement to be entered into by and between the Company and the underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In arriving at the opinions expressed below, we
have examined originals, or copies certified or otherwise identified to our satisfaction as being true and complete copies of the originals,
of specimen Common Stock certificates, and such other documents, corporate records, certificates of officers of the Company and of public
officials and other instruments as we have deemed necessary or advisable to enable us to render the opinions set forth below. In our examination,
we have assumed without independent investigation the genuineness of all signatures, the legal capacity and competency of all natural
persons, the authenticity of all documents submitted to us as originals and the conformity to original documents of all documents submitted
to us as copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based upon the foregoing, and subject to the assumptions,
exceptions, qualifications and limitations set forth herein, we are of the opinion that: (i) the Shares, when issued against payment therefor
as set forth in the Registration Statement, will be validly issued, fully paid and non-assessable shares of Common Stock of the Company;
(ii) the Warrant Shares and the Representative Warrant Shares, when issued against payment therefor in accordance with the terms set forth
in the Warrants and the Representative Warrants, respectively, will be validly issued, fully paid and non-assessable shares of Common
Stock of the Company; and (iii) the Warrants and the Representative Warrants, when issued as set forth in the Registration Statement,
will be legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, except that
(a) such enforceability may be limited by bankruptcy, insolvency or other similar laws affecting the enforcement of creditors' rights
in general and (b) the remedies of specific performance and injunctive and other forms of injunctive relief may be subject to equitable
defenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our opinions expressed herein are limited to the
laws of the State of New York and the Nevada Revised Statutes. The opinions expressed herein are based upon the laws of the State of New
York and the Nevada Revised Statutes in effect on the date hereof and as of the effective date of the Registration Statement. We assume
no obligation to revise or supplement this opinion in the event of future changes in such laws or the interpretations thereof or such
facts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We consent to the filing of this opinion as an
exhibit to the Registration Statement, and we further consent to the use of our name under the caption &ldquo;Legal Matters&rdquo; in
the Registration Statement and the prospectus that forms a part thereof. In giving these consents, we do not thereby admit that we are
within the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations of the Securities
Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>/s/ Carmel, Milazzo &amp; Feil LLP</U></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carmel, Milazzo &amp; Feil LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>nocera_ex2301.htm
<DESCRIPTION>CONSENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<IMG SRC="czd.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the inclusion in this Registration
Statement of Nocera, Inc. on Form S-1/A of our report dated March 23, 2022, with respect to our audit of the consolidated financial statements
of Nocera, Inc. and its subsidiaries for the years ended December 31, 2021 and December 31, 2020. We also consent to the reference of
our firm under the heading &ldquo;Experts&rdquo; in this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>/s/ Centurion ZD CPA &amp; Co.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Centurion ZD CPA &amp; Co.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Hong Kong, China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 20, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>6
<FILENAME>nocera_ex107.htm
<DESCRIPTION>CALCULATION OF FILING FEE TABLE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 107</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Calculation of Filing Fee Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Form S-1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Form Type)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>NOCERA, INC.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Table 1: Newly Registered Securities</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 29%; border: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 8%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security<BR>
Type</B></FONT></TD>
    <TD STYLE="width: 10%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security<BR>
Class<BR>
Title</B></FONT></TD>
    <TD STYLE="width: 9%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee<BR>
Calculation</B></FONT></TD>
    <TD STYLE="width: 8%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount<BR>
Registered</B></FONT></TD>
    <TD STYLE="width: 8%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed<BR>
Maximum<BR>
Offering<BR>
Price Per<BR>
Unit</B></FONT></TD>
    <TD STYLE="width: 10%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum<BR>
Aggregate<BR>
Offering<BR>
Price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="width: 8%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee<BR>
Rate</B></FONT></TD>
    <TD STYLE="width: 10%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount of<BR>
Registration<BR>
Fee</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees to Be Paid</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, each consisting of one share of common stock, $0.001 par value, and one Warrant to purchase two shares of common stock</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">457(o)</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,702,500</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,810,000.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0000927</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,002.09</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees to Be Paid</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of common stock, $0.001 par value <SUP>(2)(3)</SUP></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">457(g)</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--<SUP>(8)</SUP></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees to Be Paid</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants <SUP>(4)</SUP></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">457(g)</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--<SUP>(8)</SUP></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees to Be Paid</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of common stock, par value $0.001 per share <SUP>(2)(5)</SUP></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">457(o)</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,405,000</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.40</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$23,782,000.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0000927</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,204.59</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees to Be Paid</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representative Warrants<SUP>(6)</SUP></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">457(g)</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--<SUP>(8)</SUP></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees to Be Paid</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of common stock, par value $0.001 per share <SUP>(2)(7)</SUP></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">457(o)</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,125</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.40</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$594,550.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0000927</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$55.11</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Offering Amounts</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,261.79</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Fees Previously Paid</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,116.12</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Net Fee Due</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$145.67</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="width: 96%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Rule 416, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of common stock included in the Units.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants included in the Units. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of common stock issuable upon the exercise of the Warrants included in the Units.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents warrants issuable to the representatives of the underwriters, or their designees, to purchase a number of shares of common stock equal to 5% of the aggregate number of shares of common stock sold in the offering (including the number of shares of common stock issuable upon the exercise of the over-allotment option) at an exercise price equal to 110% of the public offering price per Unit. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Shares of common stock issuable upon the exercise of the Representative Warrants.&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">No&nbsp;separate registration fee is required pursuant to Rule 457(g) under the Securities Act. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>ncra-20220331.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaaDSaPty552WYkxvmRwfWn67yksQyBJOCDvwq3GkfcK -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:NCRA="http://nocera.company/20220331" elementFormDefault="qualified" targetNamespace="http://nocera.company/20220331">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://nocera.company/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets" id="InterimCondensedConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" id="InterimCondensedConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss">
	  <link:definition>00000004 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" id="InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity">
	  <link:definition>00000005 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows" id="InterimCondensedConsolidatedStatementsOfCashFlows">
	  <link:definition>00000006 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/PrincipalActivitiesAndOrganization" id="PrincipalActivitiesAndOrganization">
	  <link:definition>00000007 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicy" id="SummaryOfSignificantAccountingPolicy">
	  <link:definition>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/AccountsReceivableNet" id="AccountsReceivableNet">
	  <link:definition>00000009 - Disclosure - ACCOUNTS RECEIVABLE, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/Inventories" id="Inventories">
	  <link:definition>00000010 - Disclosure - INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNet" id="PrepaidExpensesAndOtherAssetsNet">
	  <link:definition>00000011 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
	  <link:definition>00000012 - Disclosure - PROPERTY AND EQUIPMENT, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/Goodwill" id="Goodwill">
	  <link:definition>00000013 - Disclosure - GOODWILL</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/Warrants" id="Warrants">
	  <link:definition>00000014 - Disclosure - WARRANTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/Leases" id="Leases">
	  <link:definition>00000015 - Disclosure - LEASES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/OtherPayablesAndAccruedLiabilities" id="OtherPayablesAndAccruedLiabilities">
	  <link:definition>00000016 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000017 - Disclosure - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/RelatedPartyBalancesAndTransactions" id="RelatedPartyBalancesAndTransactions">
	  <link:definition>00000018 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/CommonStock" id="CommonStock">
	  <link:definition>00000019 - Disclosure - COMMON STOCK</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/Share-basedCompensation" id="Share-basedCompensation">
	  <link:definition>00000020 - Disclosure - SHARE-BASED COMPENSATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/PreferredStock" id="PreferredStock">
	  <link:definition>00000021 - Disclosure - PREFERRED STOCK</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/LossIncomePerShare" id="LossIncomePerShare">
	  <link:definition>00000022 - Disclosure - (LOSS) INCOME PER SHARE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/SubsequentEvent" id="SubsequentEvent">
	  <link:definition>00000023 - Disclosure - SUBSEQUENT EVENT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyPolicies" id="SummaryOfSignificantAccountingPolicyPolicies">
	  <link:definition>00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyTables" id="SummaryOfSignificantAccountingPolicyTables">
	  <link:definition>00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/AccountsReceivableNetTables" id="AccountsReceivableNetTables">
	  <link:definition>00000026 - Disclosure - ACCOUNTS RECEIVABLE, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/InventoriesTables" id="InventoriesTables">
	  <link:definition>00000027 - Disclosure - INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetTables" id="PrepaidExpensesAndOtherAssetsNetTables">
	  <link:definition>00000028 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
	  <link:definition>00000029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/GoodwillTables" id="GoodwillTables">
	  <link:definition>00000030 - Disclosure - GOODWILL (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/WarrantsTables" id="WarrantsTables">
	  <link:definition>00000031 - Disclosure - WARRANTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/LeasesTables" id="LeasesTables">
	  <link:definition>00000032 - Disclosure - LEASES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesTables" id="OtherPayablesAndAccruedLiabilitiesTables">
	  <link:definition>00000033 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000034 - Disclosure - INCOME TAXES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/RelatedPartyBalancesAndTransactionsTables" id="RelatedPartyBalancesAndTransactionsTables">
	  <link:definition>00000035 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/Share-basedCompensationTables" id="Share-basedCompensationTables">
	  <link:definition>00000036 - Disclosure - SHARE-BASED COMPENSATION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/LossIncomePerShareTables" id="LossIncomePerShareTables">
	  <link:definition>00000037 - Disclosure - (LOSS) INCOME PER SHARE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/PrincipalActivitiesAndOrganizationDetailsNarrative" id="PrincipalActivitiesAndOrganizationDetailsNarrative">
	  <link:definition>00000038 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" id="SummaryOfSignificantAccountingPolicyDetails-Concentrations">
	  <link:definition>00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" id="SummaryOfSignificantAccountingPolicyDetailsNarrative">
	  <link:definition>00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/AccountsReceivableNetDetails" id="AccountsReceivableNetDetails">
	  <link:definition>00000041 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/InventoriesDetails" id="InventoriesDetails">
	  <link:definition>00000042 - Disclosure - INVENTORIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetDetails" id="PrepaidExpensesAndOtherAssetsNetDetails">
	  <link:definition>00000043 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/PropertyAndEquipmentNetDetails" id="PropertyAndEquipmentNetDetails">
	  <link:definition>00000044 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/PropertyAndEquipmentNetDetailsNarrative" id="PropertyAndEquipmentNetDetailsNarrative">
	  <link:definition>00000045 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/GoodwillDetails" id="GoodwillDetails">
	  <link:definition>00000046 - Disclosure - GOODWILL (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/WarrantDetails-AssumptionsUsed" id="WarrantDetails-AssumptionsUsed">
	  <link:definition>00000047 - Disclosure - WARRANT (Details - Assumptions used)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/WarrantDetails-WarrantLiability" id="WarrantDetails-WarrantLiability">
	  <link:definition>00000048 - Disclosure - WARRANT (Details - Warrant Liability)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/WarrantDetails-WarrantActivity" id="WarrantDetails-WarrantActivity">
	  <link:definition>00000049 - Disclosure - WARRANT (Details - Warrant Activity)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/LeasesDetails-LeaseCosts" id="LeasesDetails-LeaseCosts">
	  <link:definition>00000050 - Disclosure - LEASES (Details - Lease costs)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails" id="OtherPayablesAndAccruedLiabilitiesDetails">
	  <link:definition>00000051 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/TaxationDetails-IncomeTaxExpense" id="TaxationDetails-IncomeTaxExpense">
	  <link:definition>00000052 - Disclosure - TAXATION (Details - Income tax expense)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax" id="TaxationDetails-ReconcilationOfIncomeTax">
	  <link:definition>00000053 - Disclosure - TAXATION (Details - Reconcilation of income tax)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/TaxationDetails-DeferredTaxes" id="TaxationDetails-DeferredTaxes">
	  <link:definition>00000054 - Disclosure - TAXATION (Details - Deferred taxes)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/TaxationDetails-ValuationAllowance" id="TaxationDetails-ValuationAllowance">
	  <link:definition>00000055 - Disclosure - TAXATION (Details - Valuation Allowance)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000056 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" id="RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties">
	  <link:definition>00000057 - Disclosure -  RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/CommonStockDetailsNarrative" id="CommonStockDetailsNarrative">
	  <link:definition>00000058 - Disclosure - COMMON STOCK (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/Share-basedCompensationDetails-Assumptions" id="Share-basedCompensationDetails-Assumptions">
	  <link:definition>00000059 - Disclosure - SHARE-BASED COMPENSATION (Details - assumptions)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/Share-basedCompensationDetailsNarrative" id="Share-basedCompensationDetailsNarrative">
	  <link:definition>00000060 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/PreferredStockDetailsNarrative" id="PreferredStockDetailsNarrative">
	  <link:definition>00000061 - Disclosure - PREFERRED STOCK (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/LossEarningsPerShareDetails" id="LossEarningsPerShareDetails">
	  <link:definition>00000062 - Disclosure - (LOSS) EARNINGS PER SHARE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nocera.company/role/LossIncomePerShareDetailsNarrative" id="LossIncomePerShareDetailsNarrative">
	  <link:definition>00000063 - Disclosure - (LOSS) INCOME PER SHARE (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="ncra-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ncra-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ncra-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ncra-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="NCRA_StatutoryAndOtherReservesMember" name="StatutoryAndOtherReservesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_TotalNoceraStockholdersEquityMember" name="TotalNoceraStockholdersEquityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_ShareholdersMember" name="ShareholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_TwoCustomersMember" name="TwoCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_ThreeCustomersMember" name="ThreeCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_CustomerAMember" name="CustomerAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_CustomerBMember" name="CustomerBMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_CustomerCMember" name="CustomerCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_AllCustomersMember" name="AllCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_XinFengConstructionCoLtdMember" name="XinFengConstructionCoLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_CWarrantMember" name="CWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_DWarrantMember" name="DWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_PrcMember" name="PrcMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_YinChiehChengMember" name="YinChiehChengMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_MountainShareTransferMember" name="MountainShareTransferMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_TaisiElectricMember" name="TaisiElectricMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_SeriesAWarrantMember" name="SeriesAWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_ShunChihChuangMember" name="ShunChihChuangMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_ClassAWarrantMember" name="ClassAWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_HsienWenYuMember" name="HsienWenYuMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_MichaelALittmanMember" name="MichaelALittmanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_ClassBWarrantMember" name="ClassBWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NCRA_RetentionReceivables" name="RetentionReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>ncra-20220331_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nocera.company/role/Cover" xlink:href="ncra-20220331.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrincipalActivitiesAndOrganization" xlink:href="ncra-20220331.xsd#PrincipalActivitiesAndOrganization" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicy" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicy" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/AccountsReceivableNet" xlink:href="ncra-20220331.xsd#AccountsReceivableNet" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Inventories" xlink:href="ncra-20220331.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNet" xlink:href="ncra-20220331.xsd#PrepaidExpensesAndOtherAssetsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PropertyAndEquipmentNet" xlink:href="ncra-20220331.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Goodwill" xlink:href="ncra-20220331.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Warrants" xlink:href="ncra-20220331.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Leases" xlink:href="ncra-20220331.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/OtherPayablesAndAccruedLiabilities" xlink:href="ncra-20220331.xsd#OtherPayablesAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/IncomeTaxes" xlink:href="ncra-20220331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/RelatedPartyBalancesAndTransactions" xlink:href="ncra-20220331.xsd#RelatedPartyBalancesAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/CommonStock" xlink:href="ncra-20220331.xsd#CommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Share-basedCompensation" xlink:href="ncra-20220331.xsd#Share-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PreferredStock" xlink:href="ncra-20220331.xsd#PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LossIncomePerShare" xlink:href="ncra-20220331.xsd#LossIncomePerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SubsequentEvent" xlink:href="ncra-20220331.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyPolicies" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicyPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyTables" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/AccountsReceivableNetTables" xlink:href="ncra-20220331.xsd#AccountsReceivableNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InventoriesTables" xlink:href="ncra-20220331.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetTables" xlink:href="ncra-20220331.xsd#PrepaidExpensesAndOtherAssetsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PropertyAndEquipmentNetTables" xlink:href="ncra-20220331.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/GoodwillTables" xlink:href="ncra-20220331.xsd#GoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/WarrantsTables" xlink:href="ncra-20220331.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LeasesTables" xlink:href="ncra-20220331.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:href="ncra-20220331.xsd#OtherPayablesAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/IncomeTaxesTables" xlink:href="ncra-20220331.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/RelatedPartyBalancesAndTransactionsTables" xlink:href="ncra-20220331.xsd#RelatedPartyBalancesAndTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Share-basedCompensationTables" xlink:href="ncra-20220331.xsd#Share-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LossIncomePerShareTables" xlink:href="ncra-20220331.xsd#LossIncomePerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrincipalActivitiesAndOrganizationDetailsNarrative" xlink:href="ncra-20220331.xsd#PrincipalActivitiesAndOrganizationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicyDetails-Concentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/AccountsReceivableNetDetails" xlink:href="ncra-20220331.xsd#AccountsReceivableNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InventoriesDetails" xlink:href="ncra-20220331.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetDetails" xlink:href="ncra-20220331.xsd#PrepaidExpensesAndOtherAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PropertyAndEquipmentNetDetails" xlink:href="ncra-20220331.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="ncra-20220331.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/GoodwillDetails" xlink:href="ncra-20220331.xsd#GoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/WarrantDetails-AssumptionsUsed" xlink:href="ncra-20220331.xsd#WarrantDetails-AssumptionsUsed" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/WarrantDetails-WarrantLiability" xlink:href="ncra-20220331.xsd#WarrantDetails-WarrantLiability" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/WarrantDetails-WarrantActivity" xlink:href="ncra-20220331.xsd#WarrantDetails-WarrantActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LeasesDetails-LeaseCosts" xlink:href="ncra-20220331.xsd#LeasesDetails-LeaseCosts" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails" xlink:href="ncra-20220331.xsd#OtherPayablesAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/TaxationDetails-IncomeTaxExpense" xlink:href="ncra-20220331.xsd#TaxationDetails-IncomeTaxExpense" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax" xlink:href="ncra-20220331.xsd#TaxationDetails-ReconcilationOfIncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/TaxationDetails-DeferredTaxes" xlink:href="ncra-20220331.xsd#TaxationDetails-DeferredTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/TaxationDetails-ValuationAllowance" xlink:href="ncra-20220331.xsd#TaxationDetails-ValuationAllowance" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/IncomeTaxesDetailsNarrative" xlink:href="ncra-20220331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" xlink:href="ncra-20220331.xsd#RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/CommonStockDetailsNarrative" xlink:href="ncra-20220331.xsd#CommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Share-basedCompensationDetails-Assumptions" xlink:href="ncra-20220331.xsd#Share-basedCompensationDetails-Assumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Share-basedCompensationDetailsNarrative" xlink:href="ncra-20220331.xsd#Share-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PreferredStockDetailsNarrative" xlink:href="ncra-20220331.xsd#PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LossEarningsPerShareDetails" xlink:href="ncra-20220331.xsd#LossEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LossIncomePerShareDetailsNarrative" xlink:href="ncra-20220331.xsd#LossIncomePerShareDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="loc_us-gaapDueFromRelatedPartiesCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapDueFromRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_RetentionReceivables" xlink:label="loc_NCRARetentionReceivables" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_NCRARetentionReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyAccrual" xlink:label="loc_us-gaapExtendedProductWarrantyAccrual" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapExtendedProductWarrantyAccrual" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent" xlink:label="loc_us-gaapDividendsPayableCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDividendsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableToBankCurrent" xlink:label="loc_us-gaapLoansPayableToBankCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLoansPayableToBankCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; EQUITY (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredIncomeTaxes" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInNotesPayableCurrent" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseDueFromOtherRelatedParties" />
      <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseDueFromOtherRelatedParties" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOilAndGasPropertyAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquireOilAndGasPropertyAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireOilAndGasPropertyAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfBankDebt" xlink:label="loc_us-gaapRepaymentsOfBankDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfBankDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/PrincipalActivitiesAndOrganization" xlink:title="00000007 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicy" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/AccountsReceivableNet" xlink:title="00000009 - Disclosure - ACCOUNTS RECEIVABLE, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/Inventories" xlink:title="00000010 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNet" xlink:title="00000011 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/PropertyAndEquipmentNet" xlink:title="00000012 - Disclosure - PROPERTY AND EQUIPMENT, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/Goodwill" xlink:title="00000013 - Disclosure - GOODWILL" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/Warrants" xlink:title="00000014 - Disclosure - WARRANTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/Leases" xlink:title="00000015 - Disclosure - LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/OtherPayablesAndAccruedLiabilities" xlink:title="00000016 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/IncomeTaxes" xlink:title="00000017 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/RelatedPartyBalancesAndTransactions" xlink:title="00000018 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/CommonStock" xlink:title="00000019 - Disclosure - COMMON STOCK" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/Share-basedCompensation" xlink:title="00000020 - Disclosure - SHARE-BASED COMPENSATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/PreferredStock" xlink:title="00000021 - Disclosure - PREFERRED STOCK" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/LossIncomePerShare" xlink:title="00000022 - Disclosure - (LOSS) INCOME PER SHARE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/SubsequentEvent" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicyPolicies" xlink:title="00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicyTables" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/AccountsReceivableNetTables" xlink:title="00000026 - Disclosure - ACCOUNTS RECEIVABLE, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/InventoriesTables" xlink:title="00000027 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetTables" xlink:title="00000028 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/PropertyAndEquipmentNetTables" xlink:title="00000029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/GoodwillTables" xlink:title="00000030 - Disclosure - GOODWILL (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/WarrantsTables" xlink:title="00000031 - Disclosure - WARRANTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/LeasesTables" xlink:title="00000032 - Disclosure - LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:title="00000033 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/IncomeTaxesTables" xlink:title="00000034 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/RelatedPartyBalancesAndTransactionsTables" xlink:title="00000035 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/Share-basedCompensationTables" xlink:title="00000036 - Disclosure - SHARE-BASED COMPENSATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/LossIncomePerShareTables" xlink:title="00000037 - Disclosure - (LOSS) INCOME PER SHARE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/PrincipalActivitiesAndOrganizationDetailsNarrative" xlink:title="00000038 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" xlink:title="00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/AccountsReceivableNetDetails" xlink:title="00000041 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGross" xlink:label="loc_us-gaapAccountsReceivableGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsReceivableNetCurrent" xlink:to="loc_us-gaapAccountsReceivableGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsReceivableNetCurrent" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/InventoriesDetails" xlink:title="00000042 - Disclosure - INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaapInventoryRawMaterialsNetOfReserves" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterialsNetOfReserves" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessAndRawMaterialsNetOfReserves" xlink:label="loc_us-gaapInventoryWorkInProcessAndRawMaterialsNetOfReserves" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryWorkInProcessAndRawMaterialsNetOfReserves" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetDetails" xlink:title="00000043 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/PropertyAndEquipmentNetDetails" xlink:title="00000044 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000045 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/GoodwillDetails" xlink:title="00000046 - Disclosure - GOODWILL (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/WarrantDetails-AssumptionsUsed" xlink:title="00000047 - Disclosure - WARRANT (Details - Assumptions used)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/WarrantDetails-WarrantLiability" xlink:title="00000048 - Disclosure - WARRANT (Details - Warrant Liability)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/WarrantDetails-WarrantActivity" xlink:title="00000049 - Disclosure - WARRANT (Details - Warrant Activity)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/LeasesDetails-LeaseCosts" xlink:title="00000050 - Disclosure - LEASES (Details - Lease costs)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails" xlink:title="00000051 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/TaxationDetails-IncomeTaxExpense" xlink:title="00000052 - Disclosure - TAXATION (Details - Income tax expense)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax" xlink:title="00000053 - Disclosure - TAXATION (Details - Reconcilation of income tax)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/TaxationDetails-DeferredTaxes" xlink:title="00000054 - Disclosure - TAXATION (Details - Deferred taxes)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/TaxationDetails-ValuationAllowance" xlink:title="00000055 - Disclosure - TAXATION (Details - Valuation Allowance)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/IncomeTaxesDetailsNarrative" xlink:title="00000056 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" xlink:title="00000057 - Disclosure -  RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/CommonStockDetailsNarrative" xlink:title="00000058 - Disclosure - COMMON STOCK (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/Share-basedCompensationDetails-Assumptions" xlink:title="00000059 - Disclosure - SHARE-BASED COMPENSATION (Details - assumptions)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/Share-basedCompensationDetailsNarrative" xlink:title="00000060 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/PreferredStockDetailsNarrative" xlink:title="00000061 - Disclosure - PREFERRED STOCK (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/LossEarningsPerShareDetails" xlink:title="00000062 - Disclosure - (LOSS) EARNINGS PER SHARE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nocera.company/role/LossIncomePerShareDetailsNarrative" xlink:title="00000063 - Disclosure - (LOSS) INCOME PER SHARE (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>ncra-20220331_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nocera.company/role/Cover" xlink:href="ncra-20220331.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrincipalActivitiesAndOrganization" xlink:href="ncra-20220331.xsd#PrincipalActivitiesAndOrganization" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicy" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicy" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/AccountsReceivableNet" xlink:href="ncra-20220331.xsd#AccountsReceivableNet" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Inventories" xlink:href="ncra-20220331.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNet" xlink:href="ncra-20220331.xsd#PrepaidExpensesAndOtherAssetsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PropertyAndEquipmentNet" xlink:href="ncra-20220331.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Goodwill" xlink:href="ncra-20220331.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Warrants" xlink:href="ncra-20220331.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Leases" xlink:href="ncra-20220331.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/OtherPayablesAndAccruedLiabilities" xlink:href="ncra-20220331.xsd#OtherPayablesAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/IncomeTaxes" xlink:href="ncra-20220331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/RelatedPartyBalancesAndTransactions" xlink:href="ncra-20220331.xsd#RelatedPartyBalancesAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/CommonStock" xlink:href="ncra-20220331.xsd#CommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Share-basedCompensation" xlink:href="ncra-20220331.xsd#Share-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PreferredStock" xlink:href="ncra-20220331.xsd#PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LossIncomePerShare" xlink:href="ncra-20220331.xsd#LossIncomePerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SubsequentEvent" xlink:href="ncra-20220331.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyPolicies" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicyPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyTables" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/AccountsReceivableNetTables" xlink:href="ncra-20220331.xsd#AccountsReceivableNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InventoriesTables" xlink:href="ncra-20220331.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetTables" xlink:href="ncra-20220331.xsd#PrepaidExpensesAndOtherAssetsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PropertyAndEquipmentNetTables" xlink:href="ncra-20220331.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/GoodwillTables" xlink:href="ncra-20220331.xsd#GoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/WarrantsTables" xlink:href="ncra-20220331.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LeasesTables" xlink:href="ncra-20220331.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:href="ncra-20220331.xsd#OtherPayablesAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/IncomeTaxesTables" xlink:href="ncra-20220331.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/RelatedPartyBalancesAndTransactionsTables" xlink:href="ncra-20220331.xsd#RelatedPartyBalancesAndTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Share-basedCompensationTables" xlink:href="ncra-20220331.xsd#Share-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LossIncomePerShareTables" xlink:href="ncra-20220331.xsd#LossIncomePerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrincipalActivitiesAndOrganizationDetailsNarrative" xlink:href="ncra-20220331.xsd#PrincipalActivitiesAndOrganizationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicyDetails-Concentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/AccountsReceivableNetDetails" xlink:href="ncra-20220331.xsd#AccountsReceivableNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InventoriesDetails" xlink:href="ncra-20220331.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetDetails" xlink:href="ncra-20220331.xsd#PrepaidExpensesAndOtherAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PropertyAndEquipmentNetDetails" xlink:href="ncra-20220331.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="ncra-20220331.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/GoodwillDetails" xlink:href="ncra-20220331.xsd#GoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/WarrantDetails-AssumptionsUsed" xlink:href="ncra-20220331.xsd#WarrantDetails-AssumptionsUsed" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/WarrantDetails-WarrantLiability" xlink:href="ncra-20220331.xsd#WarrantDetails-WarrantLiability" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/WarrantDetails-WarrantActivity" xlink:href="ncra-20220331.xsd#WarrantDetails-WarrantActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LeasesDetails-LeaseCosts" xlink:href="ncra-20220331.xsd#LeasesDetails-LeaseCosts" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails" xlink:href="ncra-20220331.xsd#OtherPayablesAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/TaxationDetails-IncomeTaxExpense" xlink:href="ncra-20220331.xsd#TaxationDetails-IncomeTaxExpense" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax" xlink:href="ncra-20220331.xsd#TaxationDetails-ReconcilationOfIncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/TaxationDetails-DeferredTaxes" xlink:href="ncra-20220331.xsd#TaxationDetails-DeferredTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/TaxationDetails-ValuationAllowance" xlink:href="ncra-20220331.xsd#TaxationDetails-ValuationAllowance" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/IncomeTaxesDetailsNarrative" xlink:href="ncra-20220331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" xlink:href="ncra-20220331.xsd#RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/CommonStockDetailsNarrative" xlink:href="ncra-20220331.xsd#CommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Share-basedCompensationDetails-Assumptions" xlink:href="ncra-20220331.xsd#Share-basedCompensationDetails-Assumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Share-basedCompensationDetailsNarrative" xlink:href="ncra-20220331.xsd#Share-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PreferredStockDetailsNarrative" xlink:href="ncra-20220331.xsd#PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LossEarningsPerShareDetails" xlink:href="ncra-20220331.xsd#LossEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LossIncomePerShareDetailsNarrative" xlink:href="ncra-20220331.xsd#LossIncomePerShareDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_50" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; EQUITY (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_StatutoryAndOtherReservesMember" xlink:label="loc_NCRAStatutoryAndOtherReservesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NCRAStatutoryAndOtherReservesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_TotalNoceraStockholdersEquityMember" xlink:label="loc_NCRATotalNoceraStockholdersEquityMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NCRATotalNoceraStockholdersEquityMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_100" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/PrincipalActivitiesAndOrganization" xlink:title="00000007 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicy" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/AccountsReceivableNet" xlink:title="00000009 - Disclosure - ACCOUNTS RECEIVABLE, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/Inventories" xlink:title="00000010 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNet" xlink:title="00000011 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/PropertyAndEquipmentNet" xlink:title="00000012 - Disclosure - PROPERTY AND EQUIPMENT, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/Goodwill" xlink:title="00000013 - Disclosure - GOODWILL" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/Warrants" xlink:title="00000014 - Disclosure - WARRANTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/Leases" xlink:title="00000015 - Disclosure - LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/OtherPayablesAndAccruedLiabilities" xlink:title="00000016 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/IncomeTaxes" xlink:title="00000017 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/RelatedPartyBalancesAndTransactions" xlink:title="00000018 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/CommonStock" xlink:title="00000019 - Disclosure - COMMON STOCK" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/Share-basedCompensation" xlink:title="00000020 - Disclosure - SHARE-BASED COMPENSATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/PreferredStock" xlink:title="00000021 - Disclosure - PREFERRED STOCK" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/LossIncomePerShare" xlink:title="00000022 - Disclosure - (LOSS) INCOME PER SHARE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/SubsequentEvent" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicyPolicies" xlink:title="00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicyTables" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/AccountsReceivableNetTables" xlink:title="00000026 - Disclosure - ACCOUNTS RECEIVABLE, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/InventoriesTables" xlink:title="00000027 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetTables" xlink:title="00000028 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/PropertyAndEquipmentNetTables" xlink:title="00000029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/GoodwillTables" xlink:title="00000030 - Disclosure - GOODWILL (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/WarrantsTables" xlink:title="00000031 - Disclosure - WARRANTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/LeasesTables" xlink:title="00000032 - Disclosure - LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:title="00000033 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/IncomeTaxesTables" xlink:title="00000034 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/RelatedPartyBalancesAndTransactionsTables" xlink:title="00000035 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/Share-basedCompensationTables" xlink:title="00000036 - Disclosure - SHARE-BASED COMPENSATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/LossIncomePerShareTables" xlink:title="00000037 - Disclosure - (LOSS) INCOME PER SHARE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/PrincipalActivitiesAndOrganizationDetailsNarrative" xlink:title="00000038 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_ShareholdersMember" xlink:label="loc_NCRAShareholdersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRAShareholdersMember_0" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" xlink:title="00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_CustomerAMember" xlink:label="loc_NCRACustomerAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NCRACustomerAMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_CustomerBMember" xlink:label="loc_NCRACustomerBMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NCRACustomerBMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_CustomerCMember" xlink:label="loc_NCRACustomerCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NCRACustomerCMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_AllCustomersMember" xlink:label="loc_NCRAAllCustomersMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NCRAAllCustomersMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_TwoCustomersMember" xlink:label="loc_NCRATwoCustomersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NCRATwoCustomersMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_ThreeCustomersMember" xlink:label="loc_NCRAThreeCustomersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NCRAThreeCustomersMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/AccountsReceivableNetDetails" xlink:title="00000041 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/InventoriesDetails" xlink:title="00000042 - Disclosure - INVENTORIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetDetails" xlink:title="00000043 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/PropertyAndEquipmentNetDetails" xlink:title="00000044 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000045 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/GoodwillDetails" xlink:title="00000046 - Disclosure - GOODWILL (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_XinFengConstructionCoLtdMember" xlink:label="loc_NCRAXinFengConstructionCoLtdMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NCRAXinFengConstructionCoLtdMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/WarrantDetails-AssumptionsUsed" xlink:title="00000047 - Disclosure - WARRANT (Details - Assumptions used)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_CWarrantMember" xlink:label="loc_NCRACWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NCRACWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_DWarrantMember" xlink:label="loc_NCRADWarrantMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NCRADWarrantMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharePrice_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_90" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/WarrantDetails-WarrantLiability" xlink:title="00000048 - Disclosure - WARRANT (Details - Warrant Liability)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/WarrantDetails-WarrantActivity" xlink:title="00000049 - Disclosure - WARRANT (Details - Warrant Activity)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/LeasesDetails-LeaseCosts" xlink:title="00000050 - Disclosure - LEASES (Details - Lease costs)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails" xlink:title="00000051 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/TaxationDetails-IncomeTaxExpense" xlink:title="00000052 - Disclosure - TAXATION (Details - Income tax expense)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax" xlink:title="00000053 - Disclosure - TAXATION (Details - Reconcilation of income tax)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/TaxationDetails-DeferredTaxes" xlink:title="00000054 - Disclosure - TAXATION (Details - Deferred taxes)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/TaxationDetails-ValuationAllowance" xlink:title="00000055 - Disclosure - TAXATION (Details - Valuation Allowance)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/IncomeTaxesDetailsNarrative" xlink:title="00000056 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_countryUS_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_countryUS_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_HK" xlink:label="loc_countryHK_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_countryHK_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_PrcMember" xlink:label="loc_NCRAPrcMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_NCRAPrcMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_90" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" xlink:title="00000057 - Disclosure -  RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_YinChiehChengMember" xlink:label="loc_NCRAYinChiehChengMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRAYinChiehChengMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_MountainShareTransferMember" xlink:label="loc_NCRAMountainShareTransferMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRAMountainShareTransferMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_TaisiElectricMember" xlink:label="loc_NCRATaisiElectricMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRATaisiElectricMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOtherRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToOtherRelatedPartiesCurrentAndNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToOtherRelatedPartiesCurrentAndNoncurrent_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent_90" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/CommonStockDetailsNarrative" xlink:title="00000058 - Disclosure - COMMON STOCK (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/Share-basedCompensationDetails-Assumptions" xlink:title="00000059 - Disclosure - SHARE-BASED COMPENSATION (Details - assumptions)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/Share-basedCompensationDetailsNarrative" xlink:title="00000060 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_YinChiehChengMember" xlink:label="loc_NCRAYinChiehChengMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRAYinChiehChengMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_ShunChihChuangMember" xlink:label="loc_NCRAShunChihChuangMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRAShunChihChuangMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_HsienWenYuMember" xlink:label="loc_NCRAHsienWenYuMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRAHsienWenYuMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_MichaelALittmanMember" xlink:label="loc_NCRAMichaelALittmanMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRAMichaelALittmanMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_SeriesAWarrantMember" xlink:label="loc_NCRASeriesAWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NCRASeriesAWarrantMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_ClassAWarrantMember" xlink:label="loc_NCRAClassAWarrantMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NCRAClassAWarrantMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_ClassBWarrantMember" xlink:label="loc_NCRAClassBWarrantMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NCRAClassBWarrantMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_240" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_240" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_240" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_240" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/PreferredStockDetailsNarrative" xlink:title="00000061 - Disclosure - PREFERRED STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/LossEarningsPerShareDetails" xlink:title="00000062 - Disclosure - (LOSS) EARNINGS PER SHARE (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nocera.company/role/LossIncomePerShareDetailsNarrative" xlink:title="00000063 - Disclosure - (LOSS) INCOME PER SHARE (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>ncra-20220331_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_StatutoryAndOtherReservesMember" xlink:label="NCRA_StatutoryAndOtherReservesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_StatutoryAndOtherReservesMember" xlink:to="NCRA_StatutoryAndOtherReservesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_StatutoryAndOtherReservesMember_lbl" xml:lang="en-US">Statutory And Other Reserves [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_TotalNoceraStockholdersEquityMember" xlink:label="NCRA_TotalNoceraStockholdersEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_TotalNoceraStockholdersEquityMember" xlink:to="NCRA_TotalNoceraStockholdersEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_TotalNoceraStockholdersEquityMember_lbl" xml:lang="en-US">Total Nocera Stockholders Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_TwoCustomersMember" xlink:label="NCRA_TwoCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_TwoCustomersMember" xlink:to="NCRA_TwoCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_TwoCustomersMember_lbl" xml:lang="en-US">Two Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_ThreeCustomersMember" xlink:label="NCRA_ThreeCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_ThreeCustomersMember" xlink:to="NCRA_ThreeCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_ThreeCustomersMember_lbl" xml:lang="en-US">Three Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_CustomerAMember" xlink:label="NCRA_CustomerAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_CustomerAMember" xlink:to="NCRA_CustomerAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_CustomerAMember_lbl" xml:lang="en-US">Customer A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_CustomerBMember" xlink:label="NCRA_CustomerBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_CustomerBMember" xlink:to="NCRA_CustomerBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_CustomerBMember_lbl" xml:lang="en-US">Customer B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_CustomerCMember" xlink:label="NCRA_CustomerCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_CustomerCMember" xlink:to="NCRA_CustomerCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_CustomerCMember_lbl" xml:lang="en-US">Customer C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_AllCustomersMember" xlink:label="NCRA_AllCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_AllCustomersMember" xlink:to="NCRA_AllCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_AllCustomersMember_lbl" xml:lang="en-US">All Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_XinFengConstructionCoLtdMember" xlink:label="NCRA_XinFengConstructionCoLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_XinFengConstructionCoLtdMember" xlink:to="NCRA_XinFengConstructionCoLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_XinFengConstructionCoLtdMember_lbl" xml:lang="en-US">Xin Feng Construction Co Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_CWarrantMember" xlink:label="NCRA_CWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_CWarrantMember" xlink:to="NCRA_CWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_CWarrantMember_lbl" xml:lang="en-US">C Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_DWarrantMember" xlink:label="NCRA_DWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_DWarrantMember" xlink:to="NCRA_DWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_DWarrantMember_lbl" xml:lang="en-US">D Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">UNITED STATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_HK" xlink:label="country_HK" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_HK" xlink:to="country_HK_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_HK_lbl" xml:lang="en-US">HONG KONG</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_PrcMember" xlink:label="NCRA_PrcMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_PrcMember" xlink:to="NCRA_PrcMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_PrcMember_lbl" xml:lang="en-US">Prc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_YinChiehChengMember" xlink:label="NCRA_YinChiehChengMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_YinChiehChengMember" xlink:to="NCRA_YinChiehChengMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_YinChiehChengMember_lbl" xml:lang="en-US">Yin Chieh Cheng [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_MountainShareTransferMember" xlink:label="NCRA_MountainShareTransferMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_MountainShareTransferMember" xlink:to="NCRA_MountainShareTransferMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_MountainShareTransferMember_lbl" xml:lang="en-US">Mountain Share Transfer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_TaisiElectricMember" xlink:label="NCRA_TaisiElectricMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_TaisiElectricMember" xlink:to="NCRA_TaisiElectricMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_TaisiElectricMember_lbl" xml:lang="en-US">Taisi Electric [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_SeriesAWarrantMember" xlink:label="NCRA_SeriesAWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_SeriesAWarrantMember" xlink:to="NCRA_SeriesAWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_SeriesAWarrantMember_lbl" xml:lang="en-US">Series A Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_ClassAWarrantMember" xlink:label="NCRA_ClassAWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_ClassAWarrantMember" xlink:to="NCRA_ClassAWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_ClassAWarrantMember_lbl" xml:lang="en-US">Class A Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_MichaelALittmanMember" xlink:label="NCRA_MichaelALittmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_MichaelALittmanMember" xlink:to="NCRA_MichaelALittmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_MichaelALittmanMember_lbl" xml:lang="en-US">Michael A Littman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_ClassBWarrantMember" xlink:label="NCRA_ClassBWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_ClassBWarrantMember" xlink:to="NCRA_ClassBWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_ClassBWarrantMember_lbl" xml:lang="en-US">Class B Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_ShunChihChuangMember" xlink:label="NCRA_ShunChihChuangMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_ShunChihChuangMember" xlink:to="NCRA_ShunChihChuangMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_ShunChihChuangMember_lbl" xml:lang="en-US">Shun Chih Chuang [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedPartiesCurrent" xlink:to="us-gaap_DueFromRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_lbl" xml:lang="en-US">Due from a related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_RetentionReceivables" xlink:label="NCRA_RetentionReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_RetentionReceivables" xlink:to="NCRA_RetentionReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_RetentionReceivables_lbl" xml:lang="en-US">Retention receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax asset, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_OtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_OtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Other payables and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Due to related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyAccrual" xlink:label="us-gaap_ExtendedProductWarrantyAccrual" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtendedProductWarrantyAccrual" xlink:to="us-gaap_ExtendedProductWarrantyAccrual_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtendedProductWarrantyAccrual_lbl" xml:lang="en-US">Warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableCurrent" xlink:to="us-gaap_DividendsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableCurrent_lbl" xml:lang="en-US">Dividend payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US">Income tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableToBankCurrent" xlink:label="us-gaap_LoansPayableToBankCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableToBankCurrent" xlink:to="us-gaap_LoansPayableToBankCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayableToBankCurrent_lbl" xml:lang="en-US">Bank borrowing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock ($0.001 par value; authorized 200,000,000 shares; 10,707,150 shares issued and outstanding as of March 31, 2022 and 10,607,150 shares issued and outstanding as of December 31, 2021, respectively)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock ($0.001 par value; authorized 10,000,000 shares; Series A Preferred Stock, 2,000,000 authorized, 80,000 shares issued and outstanding as of March 31, 2022 and December 31, 2021)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">(Accumulated losses) Retained earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">TOTAL NOCERA, INC.&#8217;S STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">TOTAL STOCKHOLDER EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDER EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Net sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">(Loss) Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Other expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">(Loss) Income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net (loss) income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Less: Net loss attributable to non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net (loss) income attributable to the company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xml:lang="en-US">Comprehensive Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net (loss) income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Foreign currency translation (loss) gain</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Total comprehensive (loss) income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive (loss) income attributable to the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted average number of common shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Consultancy services settled by equities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Common stock issuance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Foreign currency translation Adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_3_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl" xml:lang="en-US">Deferred income tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Advance to suppliers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease right-of-use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInNotesPayableCurrent" xlink:to="us-gaap_IncreaseDecreaseInNotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableCurrent_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Other payables and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_lbl" xml:lang="en-US">Income tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:to="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties_lbl" xml:lang="en-US">Amount due from a related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOilAndGasPropertyAndEquipment" xlink:label="us-gaap_PaymentsToAcquireOilAndGasPropertyAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireOilAndGasPropertyAndEquipment" xlink:to="us-gaap_PaymentsToAcquireOilAndGasPropertyAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireOilAndGasPropertyAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfBankDebt" xlink:label="us-gaap_RepaymentsOfBankDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfBankDebt" xlink:to="us-gaap_RepaymentsOfBankDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfBankDebt_lbl" xml:lang="en-US">Bank borrowing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash used in financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosures of cash flow information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid for interest expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Cash paid for Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">PRINCIPAL ACTIVITIES AND ORGANIZATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditLossAbstract" xlink:label="us-gaap_CreditLossAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditLossAbstract" xlink:to="us-gaap_CreditLossAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreditLossAbstract_lbl" xml:lang="en-US">Credit Loss [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:label="us-gaap_AccountsAndNontradeReceivableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:to="us-gaap_AccountsAndNontradeReceivableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsAndNontradeReceivableTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl" xml:lang="en-US">PREPAID EXPENSES AND OTHER ASSETS, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="us-gaap_GoodwillDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl" xml:lang="en-US">GOODWILL</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAndProductWarrantiesAbstract" xlink:label="us-gaap_GuaranteesAndProductWarrantiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GuaranteesAndProductWarrantiesAbstract" xlink:to="us-gaap_GuaranteesAndProductWarrantiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GuaranteesAndProductWarrantiesAbstract_lbl" xml:lang="en-US">Guarantees and Product Warranties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesTextBlock" xlink:label="us-gaap_GuaranteesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GuaranteesTextBlock" xlink:to="us-gaap_GuaranteesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GuaranteesTextBlock_lbl" xml:lang="en-US">WARRANTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:label="us-gaap_LeasesOfLesseeDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_LeasesOfLesseeDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesOfLesseeDisclosureTextBlock_lbl" xml:lang="en-US">LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">OTHER PAYABLES AND ACCRUED LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY BALANCES AND TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">COMMON STOCK</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">SHARE-BASED COMPENSATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockTextBlock" xlink:label="us-gaap_PreferredStockTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xml:lang="en-US">PREFERRED STOCK</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">(LOSS) INCOME PER SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xml:lang="en-US">Concentrations of credit risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xml:lang="en-US">Schedule of accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of prepaid expenses and other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US">Schedule of goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule Assumption used</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:label="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_lbl" xml:lang="en-US">Schedule of Warranty Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock" xlink:label="us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock" xlink:to="us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock_lbl" xml:lang="en-US">Schedule of warrant activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Components of lease expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Income tax components</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Reconciliation of income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xml:lang="en-US">Movement in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xml:lang="en-US">Schedule of related party transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Assumptions used</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of earnings (loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_2_lbl" xml:lang="en-US">Concentration risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGross" xlink:label="us-gaap_AccountsReceivableGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableGross" xlink:to="us-gaap_AccountsReceivableGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableGross_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Less: Allowance for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xml:lang="en-US">Raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessAndRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryWorkInProcessAndRawMaterialsNetOfReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessAndRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryWorkInProcessAndRawMaterialsNetOfReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcessAndRawMaterialsNetOfReserves_lbl" xml:lang="en-US">Work in process</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xml:lang="en-US">Other receivables from third party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Others</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Depreciation_2_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Market price per share (USD/share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Exercise price (USD/price)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term/ Contractual life (years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="us-gaap_ProductWarrantyAccrualClassifiedCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="us-gaap_ProductWarrantyAccrualClassifiedCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ProductWarrantyAccrualClassifiedCurrent_lbl" xml:lang="en-US">Balance at the beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:label="us-gaap_ProductWarrantyAccrualWarrantiesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:to="us-gaap_ProductWarrantyAccrualWarrantiesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductWarrantyAccrualWarrantiesIssued_lbl" xml:lang="en-US">Warrants issued to investors</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualPeriodIncreaseDecrease" xlink:label="us-gaap_ProductWarrantyAccrualPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductWarrantyAccrualPeriodIncreaseDecrease" xlink:to="us-gaap_ProductWarrantyAccrualPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductWarrantyAccrualPeriodIncreaseDecrease_lbl" xml:lang="en-US">Fair value change of warrants included in earnings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="us-gaap_ProductWarrantyAccrualClassifiedCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ProductWarrantyAccrualClassifiedCurrent_2_lbl" xml:lang="en-US">Balance at the end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants outstanding, beginning balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Average exercise price, outstanding beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining contractual term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Warrants Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xml:lang="en-US">Warrants expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Warrants outstanding, ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xml:lang="en-US">Average exercise price, outstanding ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Operating lease expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">Total net lease costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">VAT payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Salary payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Others</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_OtherAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Total income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_lbl" xml:lang="en-US">PRC income tax statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Impact of different tax rates in other jurisdictions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Tax effect of non-deductible expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_lbl" xml:lang="en-US">Others</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Changes in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Tax loss carried forward</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_lbl" xml:lang="en-US">Allowance for doubtful receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment, difference in depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Deferred tax liabilities, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US">Additions to valuation allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Valuation allowance, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Effective income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOtherRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToOtherRelatedPartiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToOtherRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToOtherRelatedPartiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToOtherRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Due from related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xml:lang="en-US">Expected term (in years)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_lbl" xml:lang="en-US">Volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_HsienWenYuMember" xlink:label="NCRA_HsienWenYuMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NCRA_HsienWenYuMember" xlink:to="NCRA_HsienWenYuMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NCRA_HsienWenYuMember_lbl" xml:lang="en-US">Hsien Wen Yu [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4_lbl" xml:lang="en-US">Warrants exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized compensation costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Unrecognized compensation cost amortization period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sale of stock, price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net (loss) income attributable to the Company</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2_lbl" xml:lang="en-US">Weighted-average shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">- Basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">- Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">- Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_lbl" xml:lang="en-US">- Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">General and Administrative Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInNotesPayableCurrent" xlink:to="us-gaap_IncreaseDecreaseInNotesPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableCurrent_2_lbl" xml:lang="en-US">Increase (Decrease) in Notes Payable, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:to="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties_2_lbl" xml:lang="en-US">Increase (Decrease) Due from Other Related Parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireOilAndGasPropertyAndEquipment" xlink:to="us-gaap_PaymentsToAcquireOilAndGasPropertyAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireOilAndGasPropertyAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Oil and Gas Property and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfBankDebt" xlink:to="us-gaap_RepaymentsOfBankDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfBankDebt_2_lbl" xml:lang="en-US">Repayments of Bank Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="us-gaap_ProductWarrantyAccrualClassifiedCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductWarrantyAccrualClassifiedCurrent_3_lbl" xml:lang="en-US">Product Warranty Accrual, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Other, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_3_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2_lbl" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>ncra-20220331_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nocera.company/role/Cover" xlink:href="ncra-20220331.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows" xlink:href="ncra-20220331.xsd#InterimCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrincipalActivitiesAndOrganization" xlink:href="ncra-20220331.xsd#PrincipalActivitiesAndOrganization" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicy" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicy" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/AccountsReceivableNet" xlink:href="ncra-20220331.xsd#AccountsReceivableNet" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Inventories" xlink:href="ncra-20220331.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNet" xlink:href="ncra-20220331.xsd#PrepaidExpensesAndOtherAssetsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PropertyAndEquipmentNet" xlink:href="ncra-20220331.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Goodwill" xlink:href="ncra-20220331.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Warrants" xlink:href="ncra-20220331.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Leases" xlink:href="ncra-20220331.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/OtherPayablesAndAccruedLiabilities" xlink:href="ncra-20220331.xsd#OtherPayablesAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/IncomeTaxes" xlink:href="ncra-20220331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/RelatedPartyBalancesAndTransactions" xlink:href="ncra-20220331.xsd#RelatedPartyBalancesAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/CommonStock" xlink:href="ncra-20220331.xsd#CommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Share-basedCompensation" xlink:href="ncra-20220331.xsd#Share-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PreferredStock" xlink:href="ncra-20220331.xsd#PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LossIncomePerShare" xlink:href="ncra-20220331.xsd#LossIncomePerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SubsequentEvent" xlink:href="ncra-20220331.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyPolicies" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicyPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyTables" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/AccountsReceivableNetTables" xlink:href="ncra-20220331.xsd#AccountsReceivableNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InventoriesTables" xlink:href="ncra-20220331.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetTables" xlink:href="ncra-20220331.xsd#PrepaidExpensesAndOtherAssetsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PropertyAndEquipmentNetTables" xlink:href="ncra-20220331.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/GoodwillTables" xlink:href="ncra-20220331.xsd#GoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/WarrantsTables" xlink:href="ncra-20220331.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LeasesTables" xlink:href="ncra-20220331.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:href="ncra-20220331.xsd#OtherPayablesAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/IncomeTaxesTables" xlink:href="ncra-20220331.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/RelatedPartyBalancesAndTransactionsTables" xlink:href="ncra-20220331.xsd#RelatedPartyBalancesAndTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Share-basedCompensationTables" xlink:href="ncra-20220331.xsd#Share-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LossIncomePerShareTables" xlink:href="ncra-20220331.xsd#LossIncomePerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrincipalActivitiesAndOrganizationDetailsNarrative" xlink:href="ncra-20220331.xsd#PrincipalActivitiesAndOrganizationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicyDetails-Concentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" xlink:href="ncra-20220331.xsd#SummaryOfSignificantAccountingPolicyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/AccountsReceivableNetDetails" xlink:href="ncra-20220331.xsd#AccountsReceivableNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/InventoriesDetails" xlink:href="ncra-20220331.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetDetails" xlink:href="ncra-20220331.xsd#PrepaidExpensesAndOtherAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PropertyAndEquipmentNetDetails" xlink:href="ncra-20220331.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="ncra-20220331.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/GoodwillDetails" xlink:href="ncra-20220331.xsd#GoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/WarrantDetails-AssumptionsUsed" xlink:href="ncra-20220331.xsd#WarrantDetails-AssumptionsUsed" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/WarrantDetails-WarrantLiability" xlink:href="ncra-20220331.xsd#WarrantDetails-WarrantLiability" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/WarrantDetails-WarrantActivity" xlink:href="ncra-20220331.xsd#WarrantDetails-WarrantActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LeasesDetails-LeaseCosts" xlink:href="ncra-20220331.xsd#LeasesDetails-LeaseCosts" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails" xlink:href="ncra-20220331.xsd#OtherPayablesAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/TaxationDetails-IncomeTaxExpense" xlink:href="ncra-20220331.xsd#TaxationDetails-IncomeTaxExpense" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax" xlink:href="ncra-20220331.xsd#TaxationDetails-ReconcilationOfIncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/TaxationDetails-DeferredTaxes" xlink:href="ncra-20220331.xsd#TaxationDetails-DeferredTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/TaxationDetails-ValuationAllowance" xlink:href="ncra-20220331.xsd#TaxationDetails-ValuationAllowance" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/IncomeTaxesDetailsNarrative" xlink:href="ncra-20220331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" xlink:href="ncra-20220331.xsd#RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/CommonStockDetailsNarrative" xlink:href="ncra-20220331.xsd#CommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Share-basedCompensationDetails-Assumptions" xlink:href="ncra-20220331.xsd#Share-basedCompensationDetails-Assumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/Share-basedCompensationDetailsNarrative" xlink:href="ncra-20220331.xsd#Share-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/PreferredStockDetailsNarrative" xlink:href="ncra-20220331.xsd#PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LossEarningsPerShareDetails" xlink:href="ncra-20220331.xsd#LossEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nocera.company/role/LossIncomePerShareDetailsNarrative" xlink:href="ncra-20220331.xsd#LossIncomePerShareDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="loc_us-gaapDueFromRelatedPartiesCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDueFromRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_RetentionReceivables" xlink:label="loc_NCRARetentionReceivables" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_NCRARetentionReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyAccrual" xlink:label="loc_us-gaapExtendedProductWarrantyAccrual" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapExtendedProductWarrantyAccrual" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent" xlink:label="loc_us-gaapDividendsPayableCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDividendsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableToBankCurrent" xlink:label="loc_us-gaapLoansPayableToBankCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLoansPayableToBankCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfitLoss_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; EQUITY (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="90" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_StatutoryAndOtherReservesMember" xlink:label="loc_NCRAStatutoryAndOtherReservesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_NCRAStatutoryAndOtherReservesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_TotalNoceraStockholdersEquityMember" xlink:label="loc_NCRATotalNoceraStockholdersEquityMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_NCRATotalNoceraStockholdersEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredIncomeTaxes" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInNotesPayableCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInNotesPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseDueFromOtherRelatedParties" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseDueFromOtherRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOilAndGasPropertyAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquireOilAndGasPropertyAndEquipment" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireOilAndGasPropertyAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfBankDebt" xlink:label="loc_us-gaapRepaymentsOfBankDebt" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfBankDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/PrincipalActivitiesAndOrganization" xlink:title="00000007 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicy" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/AccountsReceivableNet" xlink:title="00000009 - Disclosure - ACCOUNTS RECEIVABLE, NET">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditLossAbstract" xlink:label="loc_us-gaapCreditLossAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:label="loc_us-gaapAccountsAndNontradeReceivableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditLossAbstract" xlink:to="loc_us-gaapAccountsAndNontradeReceivableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/Inventories" xlink:title="00000010 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNet" xlink:title="00000011 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="loc_us-gaapOtherCurrentAssetsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherCurrentAssetsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/PropertyAndEquipmentNet" xlink:title="00000012 - Disclosure - PROPERTY AND EQUIPMENT, NET">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/Goodwill" xlink:title="00000013 - Disclosure - GOODWILL">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="loc_us-gaapGoodwillDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwillDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/Warrants" xlink:title="00000014 - Disclosure - WARRANTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAndProductWarrantiesAbstract" xlink:label="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesTextBlock" xlink:label="loc_us-gaapGuaranteesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" xlink:to="loc_us-gaapGuaranteesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/Leases" xlink:title="00000015 - Disclosure - LEASES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaapLeasesOfLesseeDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLeasesOfLesseeDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/OtherPayablesAndAccruedLiabilities" xlink:title="00000016 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/IncomeTaxes" xlink:title="00000017 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/RelatedPartyBalancesAndTransactions" xlink:title="00000018 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/CommonStock" xlink:title="00000019 - Disclosure - COMMON STOCK">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/Share-basedCompensation" xlink:title="00000020 - Disclosure - SHARE-BASED COMPENSATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/PreferredStock" xlink:title="00000021 - Disclosure - PREFERRED STOCK">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockTextBlock" xlink:label="loc_us-gaapPreferredStockTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapPreferredStockTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/LossIncomePerShare" xlink:title="00000022 - Disclosure - (LOSS) INCOME PER SHARE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/SubsequentEvent" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicyPolicies" xlink:title="00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicyTables" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/AccountsReceivableNetTables" xlink:title="00000026 - Disclosure - ACCOUNTS RECEIVABLE, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditLossAbstract" xlink:label="loc_us-gaapCreditLossAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditLossAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/InventoriesTables" xlink:title="00000027 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetTables" xlink:title="00000028 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/PropertyAndEquipmentNetTables" xlink:title="00000029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/GoodwillTables" xlink:title="00000030 - Disclosure - GOODWILL (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaapScheduleOfGoodwillTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfGoodwillTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/WarrantsTables" xlink:title="00000031 - Disclosure - WARRANTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAndProductWarrantiesAbstract" xlink:label="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:label="loc_us-gaapScheduleOfProductWarrantyLiabilityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" xlink:to="loc_us-gaapScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock" xlink:label="loc_us-gaapScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" xlink:to="loc_us-gaapScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/LeasesTables" xlink:title="00000032 - Disclosure - LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:title="00000033 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/IncomeTaxesTables" xlink:title="00000034 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="loc_us-gaapSummaryOfValuationAllowanceTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapSummaryOfValuationAllowanceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/RelatedPartyBalancesAndTransactionsTables" xlink:title="00000035 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/Share-basedCompensationTables" xlink:title="00000036 - Disclosure - SHARE-BASED COMPENSATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/LossIncomePerShareTables" xlink:title="00000037 - Disclosure - (LOSS) INCOME PER SHARE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/PrincipalActivitiesAndOrganizationDetailsNarrative" xlink:title="00000038 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION (Details Narrative)" />
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" xlink:title="00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_CustomerAMember" xlink:label="loc_NCRACustomerAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NCRACustomerAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_CustomerBMember" xlink:label="loc_NCRACustomerBMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NCRACustomerBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_CustomerCMember" xlink:label="loc_NCRACustomerCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NCRACustomerCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_AllCustomersMember" xlink:label="loc_NCRAAllCustomersMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NCRAAllCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_TwoCustomersMember" xlink:label="loc_NCRATwoCustomersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NCRATwoCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_ThreeCustomersMember" xlink:label="loc_NCRAThreeCustomersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NCRAThreeCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/AccountsReceivableNetDetails" xlink:title="00000041 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditLossAbstract" xlink:label="loc_us-gaapCreditLossAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGross" xlink:label="loc_us-gaapAccountsReceivableGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditLossAbstract" xlink:to="loc_us-gaapAccountsReceivableGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditLossAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditLossAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/InventoriesDetails" xlink:title="00000042 - Disclosure - INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaapInventoryRawMaterialsNetOfReserves" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterialsNetOfReserves" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessAndRawMaterialsNetOfReserves" xlink:label="loc_us-gaapInventoryWorkInProcessAndRawMaterialsNetOfReserves" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcessAndRawMaterialsNetOfReserves" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetDetails" xlink:title="00000043 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/PropertyAndEquipmentNetDetails" xlink:title="00000044 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000045 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/GoodwillDetails" xlink:title="00000046 - Disclosure - GOODWILL (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_XinFengConstructionCoLtdMember" xlink:label="loc_NCRAXinFengConstructionCoLtdMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NCRAXinFengConstructionCoLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/WarrantDetails-AssumptionsUsed" xlink:title="00000047 - Disclosure - WARRANT (Details - Assumptions used)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAndProductWarrantiesAbstract" xlink:label="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_CWarrantMember" xlink:label="loc_NCRACWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NCRACWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_DWarrantMember" xlink:label="loc_NCRADWarrantMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NCRADWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/WarrantDetails-WarrantLiability" xlink:title="00000048 - Disclosure - WARRANT (Details - Warrant Liability)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAndProductWarrantiesAbstract" xlink:label="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" xlink:to="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:label="loc_us-gaapProductWarrantyAccrualWarrantiesIssued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" xlink:to="loc_us-gaapProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualPeriodIncreaseDecrease" xlink:label="loc_us-gaapProductWarrantyAccrualPeriodIncreaseDecrease" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" xlink:to="loc_us-gaapProductWarrantyAccrualPeriodIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="loc_us-gaapProductWarrantyAccrualClassifiedCurrent_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" xlink:to="loc_us-gaapProductWarrantyAccrualClassifiedCurrent_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/WarrantDetails-WarrantActivity" xlink:title="00000049 - Disclosure - WARRANT (Details - Warrant Activity)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAndProductWarrantiesAbstract" xlink:label="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGuaranteesAndProductWarrantiesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/LeasesDetails-LeaseCosts" xlink:title="00000050 - Disclosure - LEASES (Details - Lease costs)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaapLeaseCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLeaseCost" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails" xlink:title="00000051 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/TaxationDetails-IncomeTaxExpense" xlink:title="00000052 - Disclosure - TAXATION (Details - Income tax expense)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax" xlink:title="00000053 - Disclosure - TAXATION (Details - Reconcilation of income tax)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationDeductionsOther" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/TaxationDetails-DeferredTaxes" xlink:title="00000054 - Disclosure - TAXATION (Details - Deferred taxes)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="loc_us-gaapDeferredTaxAssetsGrossAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGrossAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsGrossAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsGrossAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsGrossAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsGrossAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaapDeferredTaxLiabilitiesAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/TaxationDetails-ValuationAllowance" xlink:title="00000055 - Disclosure - TAXATION (Details - Valuation Allowance)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/IncomeTaxesDetailsNarrative" xlink:title="00000056 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_HK" xlink:label="loc_countryHK" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_countryHK" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_PrcMember" xlink:label="loc_NCRAPrcMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_NCRAPrcMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" xlink:title="00000057 - Disclosure -  RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_YinChiehChengMember" xlink:label="loc_NCRAYinChiehChengMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRAYinChiehChengMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_MountainShareTransferMember" xlink:label="loc_NCRAMountainShareTransferMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRAMountainShareTransferMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_TaisiElectricMember" xlink:label="loc_NCRATaisiElectricMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRATaisiElectricMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOtherRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToOtherRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToOtherRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/CommonStockDetailsNarrative" xlink:title="00000058 - Disclosure - COMMON STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/Share-basedCompensationDetails-Assumptions" xlink:title="00000059 - Disclosure - SHARE-BASED COMPENSATION (Details - assumptions)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/Share-basedCompensationDetailsNarrative" xlink:title="00000060 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_YinChiehChengMember" xlink:label="loc_NCRAYinChiehChengMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRAYinChiehChengMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_ShunChihChuangMember" xlink:label="loc_NCRAShunChihChuangMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRAShunChihChuangMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_HsienWenYuMember" xlink:label="loc_NCRAHsienWenYuMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRAHsienWenYuMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_MichaelALittmanMember" xlink:label="loc_NCRAMichaelALittmanMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NCRAMichaelALittmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_SeriesAWarrantMember" xlink:label="loc_NCRASeriesAWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NCRASeriesAWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_ClassAWarrantMember" xlink:label="loc_NCRAClassAWarrantMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NCRAClassAWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ncra-20220331.xsd#NCRA_ClassBWarrantMember" xlink:label="loc_NCRAClassBWarrantMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NCRAClassBWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/PreferredStockDetailsNarrative" xlink:title="00000061 - Disclosure - PREFERRED STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/LossEarningsPerShareDetails" xlink:title="00000062 - Disclosure - (LOSS) EARNINGS PER SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nocera.company/role/LossIncomePerShareDetailsNarrative" xlink:title="00000063 - Disclosure - (LOSS) INCOME PER SHARE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !_ A0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BH;N\MK"V>YO+B*W@3&Z69PBKDX&2>.M):7EK?VRW-G<Q7$#_=D
MA<.I^A'%%NH$]%%% !16=?Z_H^E3K!J&J65I,R[PD\ZHQ7)&<$],@_E26/B#
M1M4N#!8:K974P4L8X)U=L>N >G(I\KM>PKHTJ***0PHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **@N[RUL+=KB\N8;>%>#),X11^)XK+_X3'PR#_P C
M#I?_ (%I_C346]D*Z-NBL3_A,?#/_0PZ7_X%I_C2KXO\-.<+X@TLG_K[C_QI
M\DNP71M44BL&4,I!4C((Z&EJ1A1110 4451O]:TK2F5=0U*SM&<959YU0L/8
M$\TTF]@+U%8G_"8^&?\ H8=+_P# M/\ &C_A,?#/_0PZ7_X%I_C3Y)=A71MT
M5B?\)CX9_P"AATO_ ,"T_P :GM/$NA7]REM9ZS87$[YVQ17",S8&> #1RR[!
M=&I1114C"BBLFY\4:!9W$EO<ZWIT,\9VO')<HK*?0@GBFDWL%S6HK$_X3'PS
M_P!##I?_ (%I_C1_PF/AG_H8=+_\"T_QI\DNPKHVZ*Q/^$Q\,_\ 0PZ7_P"!
M:?XU>L-8TS5=_P#9^HVEWLQN^SS+)MSZX/%)Q:W071=HHHI#"BBB@ HHHH *
M*KWE]::=;FXOKJ"V@!P9)I BY],FEL[ZTU&V6YLKJ&Y@;@20R!U/XBG9[@3T
M444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YR^.FO75YXO71M[+9V
M,2,(\\-(PW%OR('X'UK-^$?C&?PYXJ@T^:5CIFH.(I(R?E20\*X'KG /L>^!
M4?QF_P"2G:C_ -<X?_1:UP<<CQ2+)&Q1U(964X((Z$5[-.G&5%1[HX92:J-G
MV_16-X3UP>)/"NFZMA0]Q"K2JO19!PP'MN!Q[5LUX[33LSN3OJ?.7Q^_Y'NQ
M_P"P9'_Z-EJ+X#_\E F_Z\)/_0DJ7X_?\CW8_P#8,C_]&RU%\!_^2@3?]>$G
M_H25ZB_W7Y''_P OOF?25%%%>4=@445P?Q#^)=EX*@%M J76KR#*0$\1K_>?
M'Z#J:J$)3?+$4I**NSJM:U_2O#ME]KU:]BM8<X4N>6/H .2?I7D&O_'\AVB\
M/:4I4<">]SS[A%/U[_X5X_K.N:EXAU%[_5;N2YN&XW.>%&<X Z <]!5[P;X<
M_P"$L\4V>C&Z6V6?<6D(R0%4L<#N>*]*&$A!<U34Y95I2=HEZ_\ B9XRU%F,
MVO72AAC;#B(8^B@?GUK)_P"$H\0?]!W4_P#P+D_QKZ 3X&>$%L#;M]O>8_\
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M#X2BC6-?#VG[5&!F$$_F>37K5:T:"2L<<(.I=W/D&BOL#_A!?"G_ $+VG?\
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M%?8'_""^%/\ H7M._P"_"T?\(+X4_P"A>T[_ +\+4_7H]A_5WW/C^NW^$/\
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M-/%)\5^#+6ZF.;RW_P!'N3_>=0/F_$8/U)KGQE&S]HOF:T)W]UG85YW\;?\
MDFUQ_P!?$7_H5>B5YW\;?^2;7'_7Q%_Z%7+0_B1]36I\#/F:W_X^8O\ ?'\Z
M^W:^(K?_ (^8O]\?SK[=KKQ_V?F8X?J%<?\ %3_DF>N?]<E_]#6NPHZUPQER
MR3['0U=6/AZOM'0O^1>TS_KTB_\ 0!5_:OH/RI:WKXCVJ2M:QG3I\G4****Y
MC4^=_C]_R-VG?]>0_P#0VJG\"?\ DH,G_7C)_P"A)5SX_?\ (W:=_P!>0_\
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M;Q1J5]AMMO:"/(Z9=AP?^^3^53_M Z5Y.MZ3JRGBXMVMV4+T,;9!)]2),?\
M :[?:?[3R^7_  3GY?W5RY^SWJ;[M;TIW8IB.YC7L#RKGZGY/RKW*OF'X*ZB
M+'XC6L+'"7D,D&2V #MWCZ\KC\:^GJX\9&U6_<WH.\ HHHKE-@HHHH ****
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M_P#7.'_T6M=+^SY_R'=9_P"O9/\ T*N:^,W_ "4[4?\ KG#_ .BUKI?V?/\
MD.ZS_P!>R?\ H5>K/_=?DCCC_%+_ .T!H8*:5KT:_,";25O4<LG_ +/^?M7G
M_P +=>/A_P ?Z?*Q @N6^RS9_NOP#^#;3^%?1?C[0QXB\$:IIX0-,83)#QR)
M$^9<<'KC'T)KY$1VC=71BKJ<A@<$'UI85JI1<&.LN6?,CU+X_?\ (]V/_8,C
M_P#1LM1? ?\ Y*!-_P!>$G_H25E_%'6QXCU#P_JORA[C1HC*%Z"022A@/;<#
M^%:GP'_Y*!-_UX2?^A)5--8:S["O>K<^DJ\M^/,._P #6TN?N7J#'KE6KU*N
M-^*FD'6/AUJL4:!IH$%S'GML(8X]RNX?C7G4':I%^9TU%>+/EW2+D6>M6-R7
MV"&XCD+>@# YK[.GABO;.6!^8IHRC8[J1C^M?$E?6GPU\0CQ)X%T^Z>3?<PH
M+:X.<G>@ R?<C#?C7;CHNRDC##O='S/XL\,7OA+7[C3+Q&VJQ,$I7 FCSPP_
MSP<BL.OM#6="TSQ!8M9:K9174!S@..5)&,J>H/N*\?U[]G]B[2>']60*2,07
MP/ [_.H/Y;?QJJ6,BU:>C%.@U\)R'@'X72^.=)N=0&K)9)#/Y(4P&0L=H8G[
MPQ]X5W<'[/FG"-?M&O73R?Q&.%5!^F2:T/AO\/O%O@K4IS/J>EMIUP 9H8_,
MD+,.A&0NTX)YY^AXQZK6%;$S4WR2T-*=*/+[RU.2\"^ ;#P+;7D=K/)<RW3@
MO-(,':H^5<#C@EC^/M76T45R2DY.\MS9))604455U+4(-*TRZU"Y<)!;1-*Y
M)[ 9J4KC/F;XRW@N_B7?HI!6WCBAR#G/R!C^K$?A5+X5)O\ B;H@_P"FKG\H
MV-<QJ=])JFJWFH3?ZVZG>9_JS$G^=>A_ S36O/'C7>S,=E;.Y8CHS84<^O)_
M(U[4UR4&NR.&/O5+^9]*5YW\;?\ DFUQ_P!?$7_H5>B5YW\;?^2;7'_7Q%_Z
M%7E4/XD?4ZZGP,^9K?\ X^8O]\?SK[=KXBM_^/F+_?'\Z^W:Z\?]GYF.'ZA1
M117GG2%%%% !1110!\[_ !^_Y&[3O^O(?^AM7(_#WPE!XS\2MI=Q=26R"W>;
M?&H)R"HQS]:Z[X_?\C=IW_7D/_0VJG\"?^2@R?\ 7C)_Z$E>M"3CAKKL<<DG
M5LSLO^&?-*_Z#E[_ -^EH_X9\TK_ *#E[_WZ6O8J*X/K-7^8Z/90['D$'P!T
MN"XCE&MWA*,& ,2\X.:]?HHK.=6<_B=RHP4=@HHHJ"@KY'^)'_)1M>_Z^F_I
M7UQ7R/\ $C_DHVO?]?3?TKMP/QOT.?$?"C/T3PIKGB1)GT?3I;M82!(4(&TG
M..I'H:U?^%7^-?\ H7[G_OI/\:]*_9Z_X\->_P"NL/\ )Z]IK6MBYPFXI$PH
MJ44V?#[*R.4=2K*<$$8(-=UX*^%FL>,(8;]98+;2V<JT[.&?@X("#G/UP*S?
MB1IQTOXAZU!@@/<&89.>'^?_ -FKU#]GW5-VG:QI+$?NYDN4&.?F&UN?^ +6
M]:I)4N>!G""<^5GJGAW0+'PSHEOI6GIMAB'+'[SMW9O4FM2BBO';;=V=R5@H
MHHI >=_&O4S8?#JXMU^_>SQP9W8( .\GW^YC\:^8J]P_:#U-<Z+I2LI<>9<2
M+W X53]#\_Y5Y)X?\.ZGXHU3^SM*@$USL,A!<* HZDD_4?G7K81*-&[.*MK.
MR/2X_C_J<421IH5B%10H D;@"A_C_J<D;1OH-BR,"&4R-@@]JY__ (4OXW_Z
M!\'_ (%1_P"-'_"E_&__ $#X/_ J/_&ER87R^\?-5. 8[F)QC)S@5]+_  /O
MS>?#U826)M+J2'D]CAQCV^:OGSQ#X<U/POJ?]G:M (;C8)  P8%3T((X/0_E
M7J/[/FH&/5=9TXGB:&.903T*$@X'OO\ T%5BDIT;H5%VG9GO=%%%>0=H4444
M %%%% !1110 4444 %%%% !1110!\N?&;_DIVH_]<X?_ $6M=+^SY_R'=9_Z
M]D_]"KFOC-_R4[4?^N</_HM:Z7]GS_D.ZS_U[)_Z%7JS_P!U^2../\4]^KY%
M^(>B+X?\=:K8Q1B.#S3+"B@ *C_, !Z#./PKZZKQ']H#0U,>EZ]''\X)M)F]
M1RR?^S_G["N7!SY:ENYM7C>-^QXA)-)*D2.Y98EV1@_PKDM@?BQ/XUZ7\!_^
M2@3?]>$G_H25YA7I_P !_P#DH$W_ %X2?^A)7H8C^%+T.:G\:/I*F31)/#)#
M*H:.12K*>X/!%/HKQ#O/CGQ=X?E\+^*+_29<E89#Y3'^.,\J?RQ^.:Z/X5>.
M%\(>(##>NW]EWV$FP?\ 5-_"^/09P?8]\ 5ZK\8O S>(]&75]/A5M2L%)8#A
MI8>I'N1U ]SZU\V5[%.4:]*S^9PS3ISNC[@5@ZAE(*D9!'<4M?./PW^+4WAM
M(='UH/<:4#B.8<R6X],=T]NHYQG@5]!Z;JECK%C'>Z==Q75M(,K)$V1]#Z'V
M/(KS:M&5)V>QUPJ*:T+=%%%8EA1139)$BC:21U1%&69C@ >I- #J\0^._BR>
M/R/"]NC)%(JW%Q)_?&3M4>V1D_A7MRLKJ&4AE(R"#D$5\W?'>&6/QY%(Y_=R
M6:%/H"P/ZUTX2*=57,JS:AH>85],?!3PV^B^#/M]Q%LN-3<3<]?* PF?KDL/
M9J\:^&W@F;QEXB1)$8:9:D27<@].R#W;'Y9-?5B(L<:HBA44 *HZ "NC&U=/
M9HRH0^TQU>=_&W_DFUQ_U\1?^A5Z)7G?QM_Y)M<?]?$7_H5<=#^)'U-ZGP,^
M9K?_ (^8O]\?SK[=KXBM_P#CYB_WQ_.OMVNO'_9^9CA^H4$@#).!17'_ !4_
MY)GKG_7)?_0UKAC'FDEW.ANRN==O3^^OYTZOAZOM'0O^1>TS_KTB_P#0!6]?
M#^R2=[W,Z=3GZ&A1117,:GSO\?O^1NT[_KR'_H;53^!/_)09/^O&3_T)*N?'
M[_D;M._Z\A_Z&U4_@3_R4&3_ *\9/_0DKU5_NOR.-_QCZ4HHHKRCL"BBB@ H
MHHH *^1_B1_R4;7O^OIOZ5]<5\C_ !(_Y*-KW_7TW]*[<#\;]#GQ'PH]/_9Z
M_P"/#7O^NL/\GKVFO%OV>O\ CPU[_KK#_)Z]IK+%?Q6:4?@1\^_'_2A!XATS
M547 N;<POA<?,AR"3W)# ?\  :Q/@KJ_]F_$."V;'E7\+VY); 4XWJ?<Y7;_
M ,"KT_XZ:2;[P(E^@&_3[E'8D_P/\A _X$R?E7S[H&I'1_$.G:D"1]FN$E)
MR<!AGCZ9KMH?O,/R^J.>I[M2Y]H4445Y1V!1102 ,DX% 'R]\9]1-_\ $B\C
MWEEM(H[=01C&!N(_-C^==%^S[8"77-7U H#Y%ND0;/(+L3_[)7E_B'5#K7B3
M4M3PP%U<R2JK')52Q('X# _"OH'X%:<MIX">[VKYEY=NY8+@[5 4 GOR&/\
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MI0=Z:U[FT*<Y+WWH4_#GAW3O"VC0Z9ID/EPQC+,>6D;NS'N3^G08 Q6M117
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M_P#\!D_PI\?AW1(FW1Z18*?46Z#^E:5%',^XK(0 *H50 !P .U+112&%%%%
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6G\ZM444KW **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !D 7<# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9@00" >#TSS5[P[I;:+H5M8,5)CW'"$E4W,6VKGLN<#V K6=K&4+W%\1AO\
MA&M39))8G2VD='BD9&5E4D$$$'J*XRSN7_X1[0KS2-9N;G7)4M3/:/>M.)MX
M7S-Z,QV  LVX8QBNUU^.>?P]J$%K;M<3S6[Q1QJRJ264@<L0 .<_XU!X6ANK
M7POIMG>VKVUQ:VT<#H[JV2BA<@J2,''UIQERP^?Z"E&\_E^IL5G:YJ?]E:8\
MR()+F1EAMHO^>DK'"K],\GT )[5HUS\M@=:UVXCU?1EETVWC M3<B*2-W)^=
MMN20<;0,C@;O7%9Q2O=FDF[617\&W=Y&NHZ'J=PUQJ&FW!!F8<RQ2?.C_J1[
M;:ZBN-E\/MH/C"RU/P_HN+6:!X+^*V,428X*,%++\P(YQV]^O9552S?,NI-.
MZ7*^AQ_CR<6G]A3M?3VD,FJ16]P\=T\*F)E<L&(8#^$<]1ZU+X<E9_$.HII^
MH2W^AB&,I+).9PD^6W(DA)+#;M)Y.":D\7V>H7LNAFQL);H6FI1W<Q22-<(@
M8$#<PR3NX^AY%":;?Z-XFDO]-M6GT[4L->VRNJM#-_SU7) ((X8 YR,\U::]
MG;KK^?\ 5B&G[2_33\OZN=/7">.=-FTOPMK&L0:OJBWBGS$*7LBH@+@ ! V
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MVBWZ!45Y)>IOZ<]U)I=H]\BI=M"AG1>BOM&X#\<US_Q$FGM? VHW=K<3V]Q
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
B4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P@ 1" #( ,@# 2(  A$! Q$!_\0
M'  !  ,! 0$! 0            0%!@<# 0@"_\0 &0$!  ,! 0
M      $" P0%_]H # ,!  (0 Q    ']4@
M                                  /+S1)1DI*,)*,./7U!9>EY?G>U
M5KGIF]CC^C1;EW;L'[TODM#F-EKCBMKB^E1;F>@SUEIE]M(DO/2EU^1Z)6U%
MS7NO%NGDKZS21>OEBQ[FKI?^7?7E>ORKK4.XK;C&FTWW3.@U&;F4OJ/S/^F:
MB8C5.VA9Z8K89R5IGA.KQKBMN-7VJ_O3*FT6;G4TT_$NVU=L^0W/1_??'B?;
M);GZ0YNH "DJ]+&UQQMY/G6K6UU[X1.9^[),4E7L43GXVI\2+EMM!+L8[@
M
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M*=E038%9P$\V)"K12*!,KVH+(_C#\DBHBG.L-KIM #W IB ($958G^T?_\0
M*Q$  00 ! 0$!P           0 " Q$2$R%!!"(Q<10C46$@4&"AL='P_]H
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M]:_H#AII:Q8*U#E9!1"#Z*:\"D'C?\&__\0 /A   @$# 00$"@<( P
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MZE(8J0?NIHU#%&YAV+]]1NB-F/J!G9@GL!/#^=/_Q  H$ $  0,#! $$ P$
M       !$0 A,4%181!Q@9&AL<'P\3!PT>'_V@ ( 0$  3\A_O-B&N(K]"K]
M"K]"K]"K]"K](H4Z<9&EAX2;5$"ZN.!\0-MRK/S[:*VCF">*7V+@,#XJ87P1
M*/6'ETEU1'S:?R]4:D>&*2UTL4R&W%#*  +<1M3^![R&$&@#M)L-%36N@P>-
MFD4X_"S0-T=P2R8HY:$0$*.W%#8-EL!>+/=%O3) ]9QCC2AT0SW<*H^*1E-E
M(>":S^L'/N?%3D)SKY*2\Y1L@LZL%30(AJP4ZFN#$.DTDAG?(4B>(+1WF]?C
M]M#''1B.\5Q_X:%_K7N!4ACZ^A0.1>E1R]&F830T*?XE/B5Q9MV65I4 0C"]
MZ9JJ&Q,@/-2TU-VA(1HZ5&?5HK\%S1RX$Y81"HA QGP,O?JL_JGLZ/NI,8*Y
M&TC5PY(I1CGNFNWM^Z!=Y2(-Y(GPE+*G+D[M'II7H$TD_(>8J ,9/DV Z>O^
MDA=WJ-_@;=CQ0Q0N?;T( X6G)-9.FE/ T (DCD::2DQT<B/"^-0O+\-5?_'B
MOB5X.&A3B6D5G"$>">DKOG;#9.3-&#DV^[3M]4E.8[_]J#L^>J%DFL[<"'@>
MFA6;#HW>_NC;F!M=[W9Y[T=BHO7-:/I0M>I'"A>?CFB3G 0]'0;CYV(='@Z.
MR*$P)[B@,0= AG,SGGH2,HY9B+1AY=(8_JJ6,F&&^_2RV=X3#)<ODZ$CNW2D
M/F@]ESJS.CN= !HRH&UQ1 HULB,7F>A(MLO$)$;,,+TUKN]$3G#Q4KQYBTD.
M9HB"^'Z/X$>8;TLG8A))O3*>;#"%TWEAQI:HVY""HEGO2E%-6*AHF!1%HIV,
M0O%-MJ$(H!+9[;5Y*OYDYFKP-T:1&MA$F=2U8>_EP1O45- 88I8LOM1%63#E
MC$77S4ZT#49X@FTYTI#^49*C45M<U!]B<K[<R3A8[_R"4^\11EW]R45#BF 8
M,[P@D P4N(\,ED3".1YH!DB[!@E6.*$ % (+6@66O3BTI:6Q%L4\+.2B+)R6
M,T'B2YN+,1C+6H+]<4?"HY.Y$AI5&S6VN42*'#4S1+G20W;;BF@I2;*UX+-O
M[I__V@ , P$  @ #    $///////////////////////////////////////
M///////////////////////_ #SQGUCQV@DK];J@T52ZGVF7WFV3[SSRDY$Y
MFE[SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSS
MSSSSSSSSSSSS_\0 )A$!  $# P,%  ,          1$ (3%!46%QD;&!H<'1
M\"!08/_:  @! P$!/Q#^]D-:AO4-ZAO3"S1&BZ<8H%90Y,V6HJT@7D7ZQ%7;
ML/DH2NA#H&.]01@&99C>(I"=7-%TXQ0&^B\3G9-26(&9'O%.":=-S)VABTW)
MF*0$,L*2O4A.&>M#"E;H^?-61E>\2<4T/2/L1>@E10ZI)T;8-Z"% @R_5")0
M->&S[5+8K0=HI,$"#+IZ4T%2/B+T%-%"*\G#;3>B8H$:OU15881V2I]$&*4Z
MIB-^*14K\_OOG^#@/V>/GK0]<KY6&VUM:3( A;2Q<>/BLZP!VS^UPTJ+EZ2/
MBB0.8]FDK(M]G'B.W^&__\0 )A$!  $$  4$ P$          1$ (3%!46%Q
MH=&!L<'P(%"18/_:  @! @$!/Q#][)U4N%2X5+A0909V&^>:3LI+HQQ4AN&T
M'M5I9N?#2CMA>JD_RE)9&T,3PS0806=AOGFE=I-IC$[HD))8@]IHF6W9QWDF
M\68B:&,DF08'HR',CI0BADU$_%3E8M:8ZT%G,^[-J5 0)I#&R^Z:BR9<'FF4
M)6N9<J 7;R_V: +)EP>:*2C/WFU*QDD0M'4ONFJ),Z/-.PE")5L7B$(:G,_-
M#"%N7WQR_ C?W'W'2E]8#V"<^NJ%62R%XO9/N:PC*]\?=9*$$X1ZQ'O2,C$]
MZ %F_CKY_P -_\0 )1 ! 0 " @(!! ,! 0       1$ (3%!46$0<8'!\)&A
ML3!P_]H " $!  $_$/\ W,XC%!5/NY^T_G/VG\Y^T_G/VG\Y^T_G!W]W^<MH
MJD8;/<<.T&<T?299'E3$]BJ(BE )JU*A1Z<#F$!5&X5#[X!->,@70=Z\Y;S4
M/B17[GZCX<0&5H4E'05/ L8=YGH*OMY7RN'<YCR&@M-#O)7!L9W0/2]X"X2\
M1@^8N)0(VYZG"C6L1 )56ER6H-8R!1Z?K@O4V%- J%?./:;UF&@[I[\X.1XX
M@BC< O,&QD?ID[Y4]O2TZN.*T4#^&"3WBU ].9O_ )S)KP2;^H,8HCW L^QG
M]Y)4)B/"NZ-APN*0;Q$F*ZKK[X[J%H48 ?'DQ="1.]9%(4VI:?#(^-2RYJW%
MP9*)1LA9QM$]9M"+$T7]ML[<EHOQR-^Y0^5\9S4WYK@'R/P*!<'6@KK7$5/M
M@6!4-)6CB.L.J2T.!8R@+.\CW4*T*"!\.J<9.GKY,4E!"$+"UO'[GSC0V:C0
M\"D9[PE13&-"'E1,35AEV']$/VQ([ %3KP)H]#:$J#!IY+.+WL'"%J%RA'3:
M O21YW@=&<WZT /5;>7"WFA.,**/Z=.<&J]P+T 0XL+S"PSH<)A',> ]!B/2
M#@"WV]FT+H XN@G:X[@D4:. >B^(-B4/IQ7;(H(*Q"Z%UXP6QH"B>,H\N6L
M'=:\OIDQQ/>4O<6/0^* EV41I$":1WYSTD69$%+]/C+9=1'+RKI #Y#*XD%=
MV N@-A==QPFH#%/K@"\KF$HH1Z<H;_3:*Q"P%^@_ 5RA<*WT"$^CCCI*J,3.
M!H.#TT3,^(Z?ZU57(/ UJ9-;V/X6O#C*+_CGRA#_ %\J[^&6$==5&$.^:\?
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G.*6.XZ\F$+:1 2#FPY[Q"C)LD!3H.TYUMP*A!(BO )H0T:_]I__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_029.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_029.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #7 98# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WZBBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHI* "BBDH #332FF$TP FF$TI-,)IB$)IA-*33":  FF$T$TTFF I--)I
M":::8AVZC=3<T9H ?NI0:92B@"0&G U&*<*0Q^:7-,%.H =FES3:6@!V:*;1
M2 OT445(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBF22QPQF25U1!U9C@#\: 'TE<]?^.?#MAN#:BDSC^"W!E/Z<?K7
M.7?Q6@4D66DS2#LT\H3]!FG9L#T,TAKR&Z^)NO3Y$$=G;#_9C+G\R<?I63/X
MS\27#$MK$ZY[1A4 _(4^1BN>YX/H:8P(ZBOGZ?5M3N5VSZG>R@]0T[?XU7\Z
M9AAIYB#ZR,?ZU7(%SZ$:1%ZN@^K"F[E/1E/T-?//EH>JY^M."*#P,?2CE%<^
M@L$]!FF-D=>*\&$DN !-*![2$?UJY%JVIP@"+4[U .F)V_QI\H7/:R:::\DA
M\5Z_"V1J<CC^[*BN/Y5IV_C_ %6/B>VM)QGJ T9Q^!(HY0/1C337)6GQ LI"
M!>6=Q;G^\F)%_H?TK<L]?TF_P+;4(&<_P,VUOR.#18#1HI.:6@!13A3:44@'
MBEIHIU #A2TT4M(8ZEI!10 X44E% &@.E%%%0,**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ***Y?6_'.F:47@@/VV[7(\N(_*I_VFZ#Z#
M)H2N!U%<WJ_CC1=)+1>>;JX7@Q6^&P?=N@_.O-M8\3:MK9875RT<!X^SPDJF
M/?NWXUC8"C   ]!6BAW%<Z[4OB/K%UE;**&Q0]_]8_YG@?E7)7MY=:C)YE]=
M37+^LKEL?0=!^%,-,-6HI"N1D #&.*::>:8:!#324II* "EI*44 **<*:*<*
M '"G"FBG"F X4HI!2B@!W>@JK## $>XH%.% %^PUO5-- %K>R*@_Y9R?.GY'
MI^%=/IWCQ"0FIVI3MYUN"R_BO4?AFN)Q3J5AGL-G>VM_")K2XCGC/\2-G'U]
M/QJR*\9MYIK2<7%M,\$P_CC.#^/J/8UV6D>.5.V'5T"'H+F,?*?]Y>WU''TI
M- =L*45''(DL:R1NKHPRK*<@CU!IXJ0'4ZFT4ACZ6F4M #J*2B@#2'2B@=**
M@84444 %%%% !145S=06=N]Q<RI%$@RSN< 5QNH^.)78QZ9;A$_Y[3CD_1/\
M3^%-)O8#MZ*\HN=5U.\S]HU&Y<-U57V+^2XJDZ+*VZ3+MTRS$FK]FQ<Q[)17
MC\4LUN5,%Q/$5X7RY67'Y&M:R\5:O9$!IUNXQU2<<X]F'/YYH=-A<]*HK*T;
M7[36HV\K='.@S) _WE]QZCW%:M9C"BC-)F@!:*3-&: %JIJ.I6FE6;W=[,L4
M2\9/5CV '<^U5=<UVTT&Q^T7)+.QVQ0K]Z1O0>WJ>U>2ZMJUYK5[]JO9 2.(
MXU^Y$/11_,]3^E5&-Q-FMXA\:7VLA[>VWV=B>"H;]Y(/]HCH/8?B:Y? 48
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M!1110 4444 %%%% "4444P"BBB@ HHHH 9+#',NV6-77T89JA+I"];:5H_\
M8?YE_P 16E12L,Y^6.6V_P"/B/8O9P<J?Q[?C170$ C!&0:SI]+0@M:D1/\
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MQJ[9(D=E"J,&78#N'\6>2?UJGJ-SYUW&I(SSCGFFZ;-Y$QM&/[M\M#['NO\
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G $ZQ 4_;113$+BEVFBB@ VTM%%(!,48HHH ,48HHH&&****!'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_013.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" (# \X# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS3D/%("1.E21G!Q4<9YQ3U.#4 /[U(#D9J/.:=&<C% QZG!I]1Y'K3U/RY-
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M%?M7_MQ_M0_MK))H7Q,\2KX0\%R,X;X=^"]2F6"ZC*J-FH7NV.:_P0QV*MO
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M6!(K=J=C-1^^*>K9X-(!5<CY<5(1WJ/\*5& SF@8X-M.0&IX8,*;@$=*!Q0
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MIKRZ6-4'J2Q '7O63H'Q5\#^,;FXL_ .JS>)IK2$2W,/A.QGU5XT/1B+1)"
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M:)G?P4Q?(BD(SG2N6P<?Z" !S:X^R?IA:7=K?6T=W9W"2PS1AX98V#*ZD9#
MCJ".AK\9=BNFUER.X(ZU[+^Q%^W#JG['M];_  L^*^IW%Y\);B1(M/OYI#))
MX)8G !)^9M+)QQDFTSD?Z."+?DJ4;>]$TC+N?IR"0<U(#GI533M1L=4L8=2T
MV]BN+>XB66WN(9 Z2QL,JRL.&!!!!'!!J<$CI7,42JQ%/!SVJ)6S2@X.:0$F
M2.0:<&R,XJ,.#UIV<\YI 24;MIS31)C@BG<'F@9("#THJ/)'0TJOV:@8\-@Y
M!J2"0%^!VJ(8/2GP##_A2 ],C_U:_P"[3J;'_JU_W:=7 ;!1110 4444 %%%
M% !1110 4444 %%%% !1020,@5\P_P#!0C]NO4_V=18_!+X*V]E>?$KQ%IK7
MD,VH1&2T\.Z=N:/^T;E 092TBM'!!N4S/'(<A(92*C&522C%7;!NVK.N_:U_
M;T^#?[)R0^%]5DD\1>.=2M/M&B>!-$D5KV>(N4%S.3\MG:!P0UQ+A?E98Q+)
MMC;X"^.OQ]_:-_:V*0_'SQQ_9OAUF5_^%;^#;J6WTEOD96CO9OEFU9?G962;
M9;/M1C:JRAJY+0?#SZ1/?:OJFN7^LZSK%VUYX@\1:Q.)K[5;M@%:>=P "V%5
M0JA8XT54C1$15&E7N8? TZ>L]7^!RSJREL5=*T;2="TV#1M#TVWLK.UC6.VM
M;2%8XXD'1550 H'H!BK5%%=QB%%%% !1110 4444 %%%% &3XC\%Z-XEEM=0
MGDO;'4M/9FTG7M%U&:QU+37;&Y[:[MV2:W8X )C==R_*V5)!^EOV</\ @JA\
M0/A%?)X0_;3OUUWPL[$P?%2SL8X+C2@23C5K:%5C\A .;Z!5" CS8%5)+D_/
M](ZAUVD?G7/7PU/$+WEKW+C4E#8_86VN8+NWCNK6=)(Y%#1R1L&5U(R"".H(
MJ3..M?F__P $Z/VJ;S]FWXA:+^RWXUOXU^'/BB]^Q^";FXDVCPQJTF!#I@=W
M"K8W+ QV\07,-RZP)N2XAC@_1P-NKP*U&5&IRR.N,N:-T/W+ZTF\=J;1FLBA
MV\]A3<D]:3</6D+^E #L=\T4W>:;D^M.P$FX>M-WBFT;AZT .\ST%(6)II8=
MC2;S0 ZC('4TS<?6O/\ ]IW]I3X7_LE?!?6/CG\7=0N(]+TF$".SL(?.O-2N
M7.V&SM8L@S7$KD(D8/)/) !(8&5^V%^V/\(_V*?A6OQ-^*4MY>37MZEAX=\-
MZ/&LNHZW?."5M[:-F4,0H:1W8JD<:.[LJJ37Y&_&+XQ?&#]J7XGM\;OVA=6@
MN-652NA>'=.FD;2_#$#(%,%FLARTC#/FW3 23,6XCC\N".]\=?CQ\3/VM/C#
M-\?/C!9#3KC[*UGX7\*QW7G0^'-.9@Q@#CY9;B1@K3S ?,RJB_NXDKFQGO7L
M83"^S7-/?\CEJ5.;1$9X.,5&>M2O]ZHFX:NXS(V^]3'^]3V^]BF/]Z@"-_O5
M$?OFI)/OU&_WS4@1G[QXICC!IYX)J.3D]32 C8Y:HVY-/(YZM43\9.6I -/2
MH7]*FQQC-0MUR*"AC_=J&7!'6L[Q-X\\)^%&CM-;UF..ZN%8VFGPJTUU=8&2
ML,$8:69L#[J*Q]JT/#GP^^/'Q)MQ<>&O 4?AFQFMXY(-7\9[DE(=20RV$1\X
ME1@-'.]JX)QU!I=; ,8^U87BCQ_X,\'W%O:>)?$]E9W%Y,(K&TEF'GW4A( 2
M*,?/*V2/E4$\]*]:\/?L<:0US'J/Q)^*'B+7I%@4-I]C=?V38K+\N9$6UVW&
M"5/R27$BX8@@]:]"^'?P@^%WPET]M,^&GP_TC0X9&W3_ -FV*1O.^ "\C@;I
M'( RS$L<<DU7)-^0N9'SCI'A_P",_C22:'P+\$]7VK'^YU+Q3_Q)[4OQ\C+,
M#=C@_>6V9<C&:Z_P[^R/\3M9%I>_$?XPP:4!&KW6E^#M*1BLG&8S=W@D\V/K
MR+>%CGM7T'15JE'J+F/*_#?[&'[.^@W5U?:EX*F\12WR;;E?%^K7.KPXW[QL
MM[N22&'G_GFB_E7HOAWPMX:\(:5'H7A+P]8Z78Q9\JSTVT2"%,]<(@"C\JOT
M52C&.R)NP QTHHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "D/7[M+33C/
MWC5(F08_V*,?[%&5_O&C*_WC02&/]BC'^Q1E?[QHRO\ >- !C_8HQ_L497^\
M:,K_ 'C0 8_V*,?[%&5_O&C*_P!XT &/]B@C/&RC*_WC1E?[QH -G.=OZUS_
M (P^$_PO^(=Q#=_$#X:Z#KLMLNVWDUG1X+IHAG=A3(A*\\\=ZZ#*_P!XT97^
M\:- /&]7_8V\*V,5P_PM^(7B;PO-/<&?R&U$ZG:%S_#Y5]YK11<_ZN!X0.V,
M5S.N?"7]H[P?>2>3X<T+QAI\=OO%QHEX=/OI)/\ GFMI=,T./]LW8S_=' /T
M5E?[QH)'8M6?LX]-"N>1\GW_ ,3_  YX7EMK;XC0WWA*XNG$4,?BK3Y+%'F(
MSY,<\@$$SCTBD<'L2.:Z2*6.9!)&ZLK<AE;.:^A[BWANH6MYXEDC;AHY%# _
M@:\RUS]D#X)WD5Q)X.T2X\'7EQ,9C>>#;HV*B8D9E:V7-M,YQ@F6)\@GOS4>
MRFMC12.'!YJ2F^(O@W\?_ +2W&DPV'CS35D7R8[5H]-U5(^F"LK?9KA_XBXD
MMAU CZ"N?TGXE^%]1UL^%+^6ZT?6EFDC_L/7K.2QO)#']YHXYE4SQC/$L6^,
M]0Q%0_=T8'14Z.HQ@\@M4B'YJ '44W'NU&/=J!CJ<IR>E1X]VIT8PW4]*KH(
MDJ0=*C%/']*78.I(OW>E*0"-K#@\'/>FJ<\4ZG]D.A] ?\$P?VHC\!_']O\
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MU'NSU:DW+ZUY)TDFY?6D+^@J/>*"Y[46 DWFFECZU&7]6I"X]:=A$NX>M(6
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M1ZDGH*I^&C\2?BN\B?";P/(MBK21_P#"4>)(Y+.PWKQF&,CS[L<A@R(L,@!
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M1EP.E'F>U $GF>U'F>U1^9[4>9[4 2>9[4;SZ5'O/84;S0!)O-&\U'O-&\T
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M4 @T50!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,+_=-&%_NFC/^W1G_;H ,+_=-&%_NFC/^W1G_;H ,+_=-&%_NFC/^W1G_;H
M,+_=-&%_NFC/^W1G_;H ,+_=-&%_NFC/^W1G_;H ,+_=-&%_NFC/^W1G_;H
M!@=%-*"?3]*3/^W1G_;I .!HI 1W:EW#UI6+N%%%%(84444 %%%% !1110 4
M444 %%%% !1110 4T\GD4ZD/^]5(F0F%_NFC"_W31G_;HS_MTR0PO]TT87^Z
M:,_[=&?]N@ PO]TT87^Z:,_[=&?]N@ PO]TTF<?P_2E)R.6IM!204444R@HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBIY@"BBBE< KP;]HG
MP9!\(_%/_#0/A\+;Z+J-Q'!\0[;<JQ("JQ0:MST:(K'%,00#"_F,?]' /O-5
M]5TO3];TVXT?5K&&ZM+J%X;JVN(PT<L;*59&4\$$$@@\$5$H\R \93[@Q7D_
M[9IUG4?A!!X+\,W<UOJOB+Q-IEEIEQ;W'E/'*ERESD-D;3MMW .1@G.1@UVO
MAFQU#X9^+;[X%>([VXN)M+@^U>'=0O)FDDU+26;;&[.P^>6!L02\LQQ%*V//
M45@?%F&WU[XM?#OPL0OF6]_JFN,LF/GBM].FM>!ZB6_@8>FWZ5C+WJ=N^GZ%
MQ/V&\,:W]OTRVO/,SYT*/^8S7007!D&:\E^"_BZW\0?#3P[K=M+NCO-#LYXV
M'=7A1A_.O0M*ORQY;OZUY_F:G1P2?+@__KJS!)@[<]:S()]RYJU!(<XS5 7Z
M<),#)J*-P5&*>.1S0+<M(Q89J2,D'BJ]O)CY<5/&<G(J6+8ZM)#M QVIWF>U
M5UD^4<GI1Y@KG-BQYH'6CS1_DU7\SVH\SVH L>:/\FD\WW%0;SZ4;S0!/YON
M*/-]Q4&]J3<WK0(G\WWH\W_:J#<WK2>9_M4 6/-_VJ#+[FJ_F?[5'F?[5 R?
MS?<TADJ'?_M4%\?QT 3&3CI7X9^!@R^!]'1A@KI-NK#T(C4&OW$:< ??K\2U
ML1I&K:YX> Q_9/BC6--V^GV;4)X,?AY==F$OSLRJ/0CN <<+5=\[>E6+CCG%
M5V V]*[#,AE)YXJK..,X[U:E YXJK,V!0,IS 8SBJ=P.,8J[-UJG<?TH H3@
M55DSGBK4]4Y.3R*S 3Y_:LSQ9*\=AI[1]6\3:.O'OJ-L#^AK2PO]TUC_ !!N
MYM+\$WFM6[!9--,5\C-_"8)4F!^@V4OL@=!XAE%OJ6A1K&NY_%DD9DVC(4Z?
M>,1GT)1?R%=59D'!-<WKMK'-K&G^9+M:W\1>;&NW.XFRNEQ[<,3^%=%:>F/\
MXJX@:UH3BM.V/(K+LL'G;6G:\'(%:1)-&W_I78?LV?Z/^VI\$]:[6/CBZ);L
M/.T'5;7^=P!]2*XZW)KKO@=*EK\>OA_?DX:'QMI8C/H9+J.$_P#CLA'XU-;6
MF_0(_$?K!YW'7\A32XS53SY/X32_:B/O&O+-BR93G'%,DG"C[U0FY7KUJ%I&
M8T 2/+N.XTADQP*C+-ZU%+<;.^:=@))KC:< U^)_Q/\ #J^%?^"FGBS0'*1M
M"_C:\6(L S_;M?L[TN%],2KD^XZY-?M%-<X^5?\ OJOQG_X*'>(=/\&?\%HM
M-M68D^);'4+"/8P$<)&CZ5<OO[[V:*+&>N_W&=:7NU%_75"9VU% .:0D@UZ1
MD8WCSQG:>!] ;5YK&XOKB29+;3=+L8]]Q?W4AVQ6\8Z;G8@;F(1!EW945F'9
M? ?X37WP[TN\\3>,;JWO/%OB)HYO$5[;Y\J,(&\FSA) /D0*[*N0"[-)*0&E
M85QWP!T-OB?\1=0^.U_(DVB:6)M'\$PM"A5I%D9+_45;[WSN@MHSQB.WD="4
MN<GVT#%53CS>\_E_F2^P[<?449;U6FT9K8GE'_/[4?/[4S/J*,^U+45F/^?V
MH^?VI!M/:C"_W32$+\_M1\_M287^Z:,+_=-,!?G]J/G]J3"_W31A?[IH 7Y_
M:CY_:DPO]TT87^Z: %^?VH^?VI,+_=-&%_NF@!?G]J/G]J3"_P!TT87^Z: %
M^?VH^?VI,+_=-&%_NF@!?G]J/G]J3"_W31A?[IH =D]Q13<+_=-*#V"FE8I2
M%HHHJ2@HHHH **** "BBB@ HHHH **** "@[NU!Z4W"_W351)D+\_M1\_M28
M7^Z:,+_=-,D7Y_:CY_:DPO\ =-&%_NF@!26'7%(684AP/X:2@8$D]:***984
M444 %%%% !1110 4444 %%%% !1110 4444K@%%%%+F ****D HHHH ****
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M9X9L_L^FZ1I\-EI]ON+>5#$@1%R<DX50,DYXKYL^,?G^%9?#OQTTO2?MEYX
MUI=3FB52S/ISQO;Z@J@ L["UEEE1%Y:2&, '[I^G-(U?2]?TJUUS1-0AN[.]
MMTGL[JWD#QS1.H975APRD$$$<$&O2HJTF8RZ%BBBBN@D**** "BBB@ HHHH
M**** "BBB@ HHHH **** "@?2BB@!<K_ ':7Y>PIM%!/*.X_N_\ CU&/]C]:
M;1N/K0'*.Q_L?K1C_8_6F[OK^=*&^OYTB1<?['ZT8_V/UHX[M1E?[QI &/\
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MXUO_ *FS15VV]A#ZQ01_(&X,CF24@&0@95-?=^\:[G7111Q1JD2!55<*JC
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M,V!NP<9SBOGGP/\ M!? KP+%:Z1<_%G3-:U=-4O;^X6UEB\[SKJ:2Z:(J,+
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MG3^R3XAU#PQ^WGJ&AVJPK9^(/A.]U<%;EO,\ZRU*&-28]VW!6^(#;0?EQDX
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MI42XZ'F%G&!D$CFO4(I(IHUFB.Y67*LIR"/6M8RC+9D--;C_ )_:C+#KBD(
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M429Q4@SQBJ78"=/O4^($'\34:$AOFJ2+.?QJ@)E( Y-2)TJ-=VWBI(ONT 3
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M ?+5]X+F5SNA/Y53D\&2Y_U+?E7T=?\ P=G1L?93_P!\U1?X/S[O^/0_]\T
M?/Z>#9B?]2?RJ]9^!Y68'RC^5>Z0_!R9CS:_^.UJ:=\%9R5S:'_OF@#Q/2O
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M\??#\1^9B _E7C7C/P>Z%AY1_*OMKXB_#D@R,+?_ ,=KPKX@?#UE,A-N?RH
M^3_$?AIHV8[&KBM;T,899(]P88*D=:^@_&'@AHV?]S^E>:^)?"K(6Q'^E '4
M?L^?MZ_$KX(6UKX4\86LOB;P[%/L^SRR!;JRA9]S&"3'S[=SXBD)!&Q%>%4P
M?M?X-_'_ .%'QYT-M9^&WBN&\:%%-]I\@\NZLRV0!+$?F7)5@&Y1MIVLP&:_
M,S5]#,;'Y/TK,TK5?$W@G7+?Q1X0UZ\TO4K)BUK?6,S1RQ$C#88=B.".C#((
M()%=E#&5*6CU1G*G&6J/UY!STHKXQ_9\_P""G;VRP^&?VC+!L*J1Q^)=*LBS
M,0N"]Q G<D9+0KU8 1  FOK[P[XH\.>+M+37/"GB"QU2RD8B.\TZ[2:)R.N'
M0D'\Z]2G6IUE>+,)1<=R\QXP335Z4XX*YQ48R!P*T(ZCJC/WS3\M_=J,D[CQ
M^M "TU_6ERW]VFR<8P*!B&F,<GK3^HZ5')][ % P)]ZCP <BI#_NU&3@X- "
M,>.M,)]Z<W^[4><GIF@!K<#K36.1U%/?GJ*8W ^[0!&"?6FGK3R/]FF'K0 V
M2FD^].?/I3#_ +M2P&$^]1MUSFI#_NU&_P#NT=0&N>.M1N>.M/?I]VF-T^[4
M@,)[9IA.#U%./7[M,;K]R@!A/O3&^]3\9ZBF-]Z@!*3/^T*4_2FX_P!B@!<_
M[0HS_M"DQ_L48_V* %S_ +0HS_M"DQ_L48_V* %S_M"C/^T*3'^Q1C_8H D2
MI(SS4:=:D3([4 3+S4B?PU&I[5(GTH F2I(ZC0\<U(E4!(IZ9J9.N:A7^&ID
M^E-!U)$/7FI8C][ZU$G':IHNE,"1#GD5(I^2HHC\@^M2I]V@"8=*DXZU""=M
M9OB_QYX+\ :3_;?CGQ7INCVG3[1J5ZD*D@9P"Q&3[#FC;<1N+P?QKGOB=\8/
MAI\&= _X2?XF>,+72;,DK$;AB9)V SLCC4%Y&P"=J@G ST%?)O[0'_!4^-[:
M;P_^SII+>8S%/^$BU:UZ+M^_# W?)!#2]U(,9!!KY(\5^,?&_P 1M=G\3>.?
M%-]JM_=,#-<WMPSL0.B\\*H[*  ,\ 5Q5L=3AI#5_@:QIR>Y].?M ?\ !4?Q
MIXJ:?PW\ =*DT*P("_VYJ$:27LO'S;4^:.$ Y .9&(P04/%?,FL:UXG\8WXU
M;Q7K]_JET(PGVK4+IYI"H).-SDGJ2>O)8D\DFH;'2V8C"UOZ5H+2$?)^E>94
MK5*KO)FT8QCL4=+T9G(.PUU6@^&7E*XC;\JTO#WA%Y@O[K_QVO1/"7@*24J%
MA_2LRC(\)^"3(RCRCS[5ZSX&^'4DC(6@/Y5L> OADS,G[C]*]N^'WPJ9FCW6
M_P"E.P&-\.OAB28\P-V_AKWOX<?"X'RR;8]OX:U/AU\*AF,M;=A_#7NW@#X:
M+&(_]']/X:8&=\/?ANL2H?(].U>U^"O!"(L?[KCCM5KP7X!6-(RT6.G\->G>
M'/"D<>T",?E5"*_AKPTL2*!%7<:+HZP@$J:=I.@I"BYQ6[:604X(% F+96C*
M, ?2M*"W5%RQH@@"+D"K$4.>7Z?SJB1T<9/+?=["I"0.M-+!1@4WDMUZTP'!
MBY"CBIE&!@"F11[>6.32LV.!3 =G'6A'P>*C))ZFI+=59CN]* .C1OEX/:G;
MF]:@1QC@T_>?6L;&A+O:CS/:H][4;S0!)O'I2[UJ+?ZBE# U($H(/2C(Z9J/
M.>E&<4[ 24<]JCW-ZT[>U #@2*=O:H]Y]*4.#UI *Y+C:14(<=ZFSGI4,BD-
MN]: '9'K4$T8#8(XI]-EW,/IS0!7G@&W@UFWED&X'^?>M9F##!%0RQ(%YY%
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M/7-'8!K#@\FHSP<9J5NE1-][KVJ0(V^\#36[T]_O=:8_?F@",TUQSFG&FO\
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MX,D'6,_E2#P6[<^2?^^: .&&FR=P:7^S'_NFNY_X0J4_\LC^5/7P1*.?)/\
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<N/K1N/K110 ;CZT;CZT44 &X^M&2>IHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_023.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (( G # 2(  A$! Q$!_\0
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M[]V[/7T[42>%=/EA\MYY#_IOVT-N&0^<X^E>$_:KG_GXF_[[-'VJY_Y^)O\
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MN:)9:/9P,MU+-<3,V $ 7:#C/UK/N-8O[B^>[-U,LC$XPY^4$YP/:JDD\LP
MEE=]N<;CG&:<833NV34K4&FH0U.ML_!MG=_9I!J1$-T-T'RC<0!EP?<'BIT\
M#V32@?;;IUE?;&8X@=G&?G]*Y>[U>>Y-H(A]G6TC"1+&QX]3GU-1+JE^C.RW
MMP&D^^1(?F^M+DJ/[12K8=:.%R]KVE6FD/!!#/-+.Z"23<H"@'IBL:GR2R3,
M&E=G8#&6.>*96L4TM3EJ24I7BK(****HS"BBB@ HHHH **** "BBB@ HHHH
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M_OV*/[*T_P#Y\;?_ +]BKE%'-+N'LX=D4_[*T[_GQM_^_8H_LK3_ /GQM_\
MOV*N44<TNX>SAV13_LK3_P#GQM_^_8H_LK3_ /GQM_\ OV*N44<TNX>SAV13
M_LK3_P#GQM_^_8H_LK3_ /GQM_\ OV*N44<TNX>SAV13_LK3_P#GQM_^_8H_
MLK3_ /GQM_\ OV*N44<TNX>SAV13_LK3_P#GQM_^_8H_LK3_ /GQM_\ OV*N
M44<TNX>SAV13_LK3_P#GQM_^_8H_LK3_ /GQM_\ OV*N44<TNX>SAV13_LK3
M_P#GQM_^_8H_LK3_ /GQM_\ OV*N44<TNX>SAV13_LK3_P#GQM_^_8H_LK3_
M /GQM_\ OV*N44<TNX>SAV13_LK3_P#GQM_^_8H_LK3_ /GQM_\ OV*N44<T
MNX>SAV13_LK3_P#GQM_^_8H_LK3_ /GQM_\ OV*N44<TNX>SAV13_LK3_P#G
MQM_^_8H_LG3O^?&W_P"_8JY11S2[A[.'9%/^R=._Y\;?_OV*/[*T[_GQM_\
MOV*N44<TNX>SAV13_LK3O^?&W_[]BC^RM/\ ^?*W_P"_8JY11S2[A[.'9%/^
MRM/_ .?&W_[]BC^RM._Y\;?_ +]BKE%'-+N'LX=D4_[*T[_GQM_^_8H_LK3_
M /GQM_\ OV*N44<TNX>SAV13_LK3_P#GQM_^_8H_LK3O^?&W_P"_8JY11S2[
MA[.'9%/^RM._Y\;?_OV*/[*T[_GQM_\ OV*N44<TNX>SAV13_LK3O^?&W_[]
MBC^RM._Y\;?_ +]BKE%'-+N'LX=D4_[*T_\ Y\;?_OV*/[*T[_GQM_\ OV*N
M44<TNX>SAV13_LK3_P#GQM_^_8H_LK3_ /GQM_\ OV*N44<TNX>SAV13_LK3
M_P#GQM_^_8H_LK3O^?&W_P"_8JY11S2[A[.'9%/^RM/_ .?&W_[]BC^RM/\
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MH*,#T%','(96#Z&C!]#6K@>@HP/04<P<AE8/H:,'T-:I  Z5DCQ%I9TV>_\
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M6A65_9^I_P#08;_OPM']GZG_ -!AO^_"T#-6BLK^S]3_ .@PW_?A:/[/U/\
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M/_H,-_WX6@#G_#6@Z[I_BN\U'4TM)/M47[VXAD8DMN^50IZ "NUK*_L_4_\
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MJ0U*UEO;/[*EC9BT!WAO.;/WACMQ^M;']GZG_P!!AO\ OPM']GZG_P!!AO\
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MA1_PD-I_SQO/_ =O\* -:BLG_A(;3_GC>?\ @.W^%'_"0VG_ #QO/_ =O\*
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MLID55P",,>OK[5;;4]*8,&L9R'3RV!M&P5].G2EM-4TNQ@$%I97$,0Y"1VK
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M3Z5M0^#53P3>^')+MBMR93YRK@KO8MT]LT^C U'\3:'';17+ZO9K!*2(Y#,
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M3$*BXG1-D9/ 9L ?AS4NB:C=W,][97XB-U9NJL\0(5PPR" :?,PY46OLDO\
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M7_OH_P"-'_"/:5_SZ+_WT?\ &@#1\Q/[Z_G1YB?WE_.L[_A'M*_Y]%_[Z/\
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MG^4!CEMHSQGOB@2(Y/B98V]]8V5SIMY%<7,:3-&0"8D<X4G'K7;CFN4N]/\
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MYI5BUW;6T,R1J6D\R79CTQZDUK5F:II0U2:S$LQ%M!+YLD('^M(^Z#[ \XH
M;'JLT?AH:K>VAAE$'FO;@[BO&<?6F>'-9?7=*6]=(H]QQLC?=M]CQP?:K-[;
MW\R2K:W<<&5'EDQ[MK \Y]0:@T329=,2Y>XG$]U=2^;*R)L7.,8 ^@H UJ**
M* "BBB@ JAJUU=V5DT]K#%+LRS^;)L 4#DYJ_6;K.EG6+2.T>=H[<RJTZKUE
M0<[,]@3BD!'HFJ7.HZ''J%Y:?97=2XB#;OE['\15;PQXB;Q##<3&&.%8WVA
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MVDTC 1+' 98U@XD+L0QR>1@8.* >ATG_  CNF_W)O^_S?XT?\(YIO]R;_O\
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MW)O^_P W^-:U% &3_P (WIW]R;_O\W^-'_"-Z=_<F_[_ #?XUK44 8DNB:/
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MD%O"NU(U P./4CDT :'_  C>G?W)O^_S?XT?\(WIW]R;_O\ -_C6M10!D_\
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M/[03^XU']H)_<:L^B@#0_M!/[C4?V@G]QJSZ* -#[?'_ '&I/MT8X\LU0HH
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M*^.+.5HWAM)WM3(D4TXP!$[#A2.IZC-0OXON9QILMIIDODW=PZY<C<T:@EF
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MM0EU#3S)<70FN.-Z 8V#''Y]<UO5@6%]H.FHRVLFP,<D[6)/I5O_ (2'3/\
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M<:K]CF:.%77[.)(L-M&W)!].32Z!8[?^R;O_ *#-Y^2_X4?V1=_]!F\_)?\
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M?+5J;XB7LMG*(-*6&Y^Q?:5,DP(5B-P&,<C'>FPL=18>%M/T^:.2,S.4MS;
M.^1M)R?Q-8ES\.;!+>,:?-/',DZ2%I)20RA@2I]L#BJUK\0&AOA9SVDDK%CY
MDA< (Q7(51W'!^E3S>.))O!\^H_V>8[EIQ:I#YHQN<<'=^-#3Z@GT+K?#W1&
M.<W()E\PD2]1_=_W>!Q5H>#-*6ZAN4\])HG$B.LG(()/]37*_P#">7MMIZV=
MM:!IHH8S]HDD!W$,H?C_ (%Q6H_BJ?6_#6O-;6AMY;:/$1\W[X.<'(^[THZ7
M V;[PEI>HWDEU<+*9)&#-A\#(&W^55(? .BPQO&HN"C/NP92=O&,#VK*M/',
MEMY.G#3&=PT=O$QG!WG(5B?3!_.I/%=[JEAXAA>RU)QFU=VM% VHBCEV]3DC
M'TI C3;P'HK*5*3X))_UA[DY_F:6/P+I$5\UVAN!)NWJ/,^5#[#M6!H^MW\0
MLWGOY[I(9[F-CP3,JJ&&<=2"<5=\'^+%D\.^?JUY)+<-<S#<(F. &X' [#BB
MX&W9^&+:UTBYTAI))-/EC\M8RW*@YR<^I)S4%QX)TNZLOLTSW+ L&,GF_.<+
MMQGT(X-<OJVH:O'K=_';ZW,;29XD9P !;;SD*OH=HY^M4I_$>M-X>N[A;Z?S
MY+*U=%0@-O9RIV^A('6G:ZN%M3LV\"Z.TT3D7&V.0R+'YAV]<[<?W<C.*CA^
M'VAP&4J+AO,))W2DX!(.![<"L^3QK+HWA;1+J> WT]S;^9*^\)@# )]SS4]K
MX]-QK.G:<^F.AO"2'#[MB[BJD\=\'Z46Z 7%\$:;;H?LCSQNLYN(\OPLF./P
M&>E6=1\*V6KO92WTL[S6R;=Z/M\SO\P[\\UD2>/F359[!=,+,LXAC;S1\_S8
M)/IBHE^(H97SIC@^<(8\2 [BPRO;@G!X]J V+.I^ ;&6PN18@B[=0$,LAV@@
M #ITX%)IWP\T^&UM#>23274<"QR%)"$8C^+'KVS5!?',B*D<T,R>4R-O+C=.
M#DG Q]T8QFI$^)/,/F:4R@L1-B8'9SQCCG/% -FW;>#-)M=0-[&)Q+YOFJ#)
MPAYX ],DFEF\&Z7/HS:6[7 B:=K@NLF'WMG)![=:QM'\52Z[KUM(T#6J0I,K
MQ"0,'PH8'CV-5_\ A9$MUI<EQ;::8G*S>7),_P A*J2O;DGTH6H=3:E\ Z++
M&RXN%)& RRX*].1^56I_".F3VMI;-YZQVUN;9=LF-T9&,-Z],US"?$"\MB(F
MT\W-R^TN/-"JA*KP..F327?Q(NY;"X:QTU8Y4@657EE! ;(W#'X]: V-R/X?
MZ)&H&+EF"E=S2Y)SG.?S-+)X T662-_])79GY1*<-]?6J>G>/_[0N(HQIS11
M/=_9C-(^$''!Z=21TKM001QTH YG_A"[*W6)K"::&:%B\3%\A6( )_*K>K>%
MK#6Y5DOC,Y6$PJ ^  >I^M;E% '+)X"T59GD*SL'A,+(TGRD$8)QZX[T)X T
M&**VBC@D2.W9V50_WM_4'U%=310!RL?@#1HDME1KD?9W+H?-Z\Y /J!VJ:;P
M3I,VCP:8YN!##*TJL),-EB2V3Z'/2NDHH Y6Z\ :+=AM_P!I1F8MN24@@GK5
MVY\*:9=W=G<2++NM8A$@#X! &!GU(K=HH Y9O .B-;&#RYMAC\L?O.@XY^O
MK0M_#6GVUE=6BK(T5U&(Y=S9) &*V:* .*N?AW8;;$6DTX\B0>9YDA/F1YY!
M]_2K"_#O1%%OS=%H"<,9CEP3G#>H!KK:* .>M?!NEV5[%=V_GI-&ZL&$G7"[
M<'VQ5.+P-9RZGJ%]J#/,]Q<>;&JN0J+QQCUR.:ZVB@#E8/ .C0-D&Y=M^\%Y
M2<8Q@?3@5<M?"=A9S1RV\ERC1*43$G0%MQ_,UNTM &)JWA;3]9DEEN?.620(
M-\;[2NTY!'OS5&7P#HDIC^6X01LK820C.,8!]N!74T4 8=EX5TZQDD:'SOGM
MS;X9\@(22<?B:H2?#[1)(V7%PI*[=RRD$<@Y'OQ75T4!<YW2O"T&FZO=WBXV
M26L=I$,Y81KG.3ZDFJ__  K_ $,-&P6<&-@PQ*>0!C!]JZFEH Q)?"NFS:9!
MI[++Y$#%D ?G)SGG\:H_\(#HWVE)Q]I#*&4J)3ALYZC\374T4 <S)X&TB195
M/V@1R!0R"7C(7;GZXJ:^\(:7J%]!=SB;?#%Y(59,*RX(Y'<X)KH**0',:=X$
MTC3;RUNX/M!GMV+*SR9W$^OKBIKKP;I-YJ(OI5F\TSB=@'P&88P"/3(!Q70T
M4P,'4?"6FZGYQG\Y6EG6=F23!W 8X]B.M55\ Z*KS,%GQ*X?;YG"8SP/0<UU
M%% '*)\/M$CDE91<XD &TRG"X.>/3FJ&H_#Z-KZPDTR011Q2 SL[DL5&, >O
M3O7=4E $=O#Y$*Q;W?;_ !.<DU+110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 A^M9;>'=(:]GO&L8C/.09'/\ $001_(?E3M4L[BYO
M-.D@P%@FWR'?CY<=,=ZXFX\2W7A;4-7BN"U[>O/YR>9-B(0') ']U@!C'<TA
MVOL=D_AC19$D1M/A*R9W<=<YS_,_G35\*Z(C!AI\6X1>3DY^YZ5S\?CR>YOH
MK2VL8S)),(AODQM!/4_A1IWCRYO=:TVQ.GH([W>V]'R8U#%1GWXYI[D^9T3>
M'-&%RMR;"$2KG#D>HP:?)X>TF73WL'L8C;.P=H\<%AT/Z5Q.O^)+K5KYM(CM
MXXTAU&!=WFD%U#X(;'3FM/7/'4^D:S>6*V4,B11YC8RX)?C[P[+SUI7'UL;X
M\+Z()FF&GP^8R!"<=5&,#]!4MOH6EVL=U%!:1HMT<S*/X_K7&O\ $FXCNTB;
M3H?+,?)$O(?;D_\  ?>J;>.+BVU>YOX[=)#<K!$D;RX1<;R3GWQ3 [Q/#FD)
M=O=+8Q"9V5V?'4KT-27&B:==:A]OFM5>Y\LQ%SGE/[OTKA/^$YU&S$ES<11S
M2LSK$@?;&!O &[Z>M;&B^,[G6M0EMC91PPF%VC?>2VY0"<CTYI7T Z.RT73+
M&*".TM8XTMV9HMO\)/4_6K-K96UE&T=O"D:,YD(4=6/)->7Z9XLO/#^D:?&(
M$N)9X!(WF3$+RS$GG^*MU?']Q-<QV\-A$9&F\L@R?=&2,G\!0'4Z27PSH\SW
MC262,;P@SY)^<^I]Z?-X?TJXMI+>2QB:)XUB9<8RJ_='X5S&C^/+O5C:YT^*
MWCN)9(UED<[<@94?4U%XRU:^L[^T5+LP&2TW%8WX+^8HX]>":8'5W7AW2+VU
MMK:XL(I(+88A0CA!_D4]="TQ+FVN%LXQ+; B)@/N@\UPWA?6=4N/%.L6EU=R
M/%#!,\0)XQOX_+I6/8ZIJ+VME;+J%U=QR7T!;_2-K?,"67?Z<9Q1?81Z-8>%
M--L[JYNGA6:XGN#.9''(/8#Z59A\/Z3 &$=C$H:;SSQ_RT_O5Y[J>NW6AZ1>
MVLE]/_:2:DI>3S-X:/[PV^@VC!%=OXCN(I_"-U<_;WM(O)$AFB/S =< ]B>G
MXTN@WN6?^$:T?S1(;"(L  ,\X ]*;%X7T6&-(TTZ$*F2HQTYS7G,.H:NMZT-
MSJ5QYJ6ZQ",2?P&$OO\ <@]ZT[2[UH>-M!+W$[65Q8HV?,&S:$^?</[VXCFF
MD%M#N+'P]I6F-NL[**%LL<J.YZU$OA;15B$0L(O+#,P3G&6&#6Q10!E'PYI!
MDWFPAW<<X],?X"F#PKH:R.XTZ'<\?EMQU7KBMBB@#)7PUI"'*V48_>^=@9QO
M]:TH88[>%8HQA%& *DHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K-ET#2IS,9=/@<SN'D+)
MG<1T)HHH DCT?3HKI[E+*%9W<.T@3DL.AIL6B:9!<)/%8P)+&69'"\J3UQ]:
M** '?V1IXN)+@64/G2.'=]O+,.AJK_PC>FOJ-]>SVZ3RWBA)/,7.% QM'M11
M0!'#X4TF+4KF]-K&[31+#L91A$ Q@?6K)\/:0UNL!TVW,2[<+L&!MZ?EFBB@
M!\FB:9+&T<EA R,,$%!SSFI8M,LH)?,AM8D?!&Y5QUZ_RHHH R=<\(:=K5G#
M;%?LRQ,IS$@R5'\/TK1AT338)FFCL85E9@S/MY)'0_6BB@!J:#I<0 CL(% 9
MF "]VZFI+C1]/NS;FXLX93;$&'<N=F/2BB@!\>G6<,K2QVL22,"K,%Y()R15
M=?#VD+;"W73K=81)YH0)@;_7ZT44 /31-,C9F6P@!9BS'8#DD8/Z4U-$L%L)
M;&2!9;:5BSQR#(/M]*** 'IHNFI*LJV,(D6+R0^WD)_=^E2'3;-MN;:/Y4$8
M^7HHYQ]*** +8X&**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
D@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )U >D# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#>\:?$[7]
M\77^EV:69MX"@0R1$MRBL<G/J36!_P +F\4?\\]/_P"_+?\ Q59?Q/\ ^2BZ
MO_O1_P#HI*Y&O0A3@XIV/"JXBJJDDI/=GH7_  N;Q1_SST__ +\M_P#%4?\
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M[:&7[CS0L@;Z$BF7>E:A80PS7=C<V\4XS$\L3*''L2.:7LZ?9#]O7_F9V_\
MPN;Q1_SST_\ [\M_\51_PN;Q1_SST_\ [\M_\57%76D:E9& 76GW4!N!F$20
MLOF?[N1S3;_2]0TN1$U"QN+5W&Y5GB*%AZC(H]G3[(/;U_YF=O\ \+F\4?\
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MU?\ WH__ $4E<C7?#X4>'6_B2]6%%%%49A1110 4444 %%%% !1110 4444
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M_$C0Y+V[OX'N+"U,OV1L&2;/RB0=U]>]21F^T\>,9XW5-4_M6V5GM\CY&D!
M'?!SS7GUKXY\1V=_=WT6HG[3=D&:1XD8DC@8R.,9/3%5]-\5ZYI&H7-]9:A(
MES<Y\YV ?S#G.2&!&<]ZE4W_ %ZW_P"!^AHZ\?/^HVOOOU_4T?B0D2?$#5A#
M@*9%)Q_>*@G]<URM2W%Q-=W,EQ<2-+-*Q=W8Y+$]2:BK2$>6*CV.>K-3FY+J
MPHHHJC,]I^!O_(.UC_KK'_)J]9KR;X&_\@[6/^NL?\FKUFO/K?Q&>]@_X,3C
M-;N9H]8N$21E4$8 ^@K/^VW/_/9JM:]_R&KGZK_Z"*SJTBE8RFWS,G^VW/\
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MND:.Z)!7E+61Q]T=PI!K+_M*'_GC>_\ @%-_\36T9*QS2C+F>A<HJG_:4/\
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MPWVED7ZM\H_G4_@R.ZTWQ#<Z?=PI"\ME#*JHVX$(-N?J>]=A_:4/_/&]_P#
M*;_XFC^TH?\ GC>_^ 4W_P 31&R:=_(4G)IJV_\ P/\ (N453_M*'_GC>_\
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MO?\ J]PO*UK?U:QY3<6LL,7VZ(9BGU-[>8>A64,I_P#0A7L54_[2A_YXWO\
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M X'';O6GXMU.SU?P#=W=C-YL#.@#;2O(<9X(KIO[2A_YXWO_ (!3?_$T#48
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M_-6;S/,;[X0H#C./NDC_ .O57=XJ_P">>C?]]R_X4;O%7_//1O\ ON7_  H
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MZ)6MRN+TP^(_[>USRTTKS?-A\W<\FW/E+C;QZ8ZUL;O%7_//1O\ ON7_  H
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M\YV_CS78T=$+J%%%% &'I'_(R>(?^NT'_HE:W*P](_Y&3Q#_ -=H/_1*UN4
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ME?W]3_\ !K=?_'*/^$2TK^_J?_@UNO\ XY0!N45A_P#"):5_?U/_ ,&MU_\
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MDX  %;] !1112 **** "BBB@ K#\+?\ 'E?_ /83N_\ T<U;E8?A;_CRO_\
ML)W?_HYJ -RF2B1H7$3JDA4A69=P![$C(S^=/J&[^T_8YOL8B-UL/E"8D)NQ
MQN(!.,^E)[#6YQL_BJ_T6+5K>]N+:[GMKF"VMK@Q^4C/*H.' )^[U..2,#K2
MR^*;F%K-HM3M+J )$\LJP[!<;Y_+8*,_+L'/<YZTEMX:UP:-!'/#IPU"UO4O
MUE6Z>074O._>3&NS(.!@-CCTJ[;>%I?[,2WO([5YI[V6YN64;O*61BS)&2 >
M>%)XR"337]?U]_W>8G_7]?UN:F@ZO'J\,\@NH9'\PL($8%H8S]P,!R"0,\]R
M1VK7KG-!T"[TS4I9IW@,*(\4)C8EG#2M)EP0,$;@, GN:Z.@.H4444 8>D?\
MC)XA_P"NT'_HE:W*P](_Y&3Q#_UV@_\ 1*UN4 %%%% '.^(+W5-+OK"ZM[N%
MK6:[AMC9F#YGWM@L'SU YZ= :YZ'QEJQFU7)@=[6&=IK?RB/L3K(%CW'/S!E
MRW_ >.*W=0T[7+CQ;;WZP:=/IULF($ENGC>-VX>3:(V!;' Y'&?7BIH7A2^L
M-2M9+S[&8K2&>$RQ,6>\$KALR J ,8Z9;))Z4+S_ *_K]=!O^OZ_KS'V'BAG
MO(;&\O[5&BN98Y9V*H)@&*QJH)^\QST_N'UKKJXJ[\'74MNIMELXI9XYH;A,
ME4B20IC9A>=BH !QGDY%=H!@ 4=!=1:*** "BBB@##TW_D;==_ZYVW_H+UN5
MAZ;_ ,C;KO\ USMO_07K<H **** .=\37NJ:4;:_M+N$V_GPP-9M!EI2\@4X
M?/!P<CCL<YK*3QFUTVLW-O=VNVSBG^S66PF27R^#(S9Z9'W0,X()/-:.KZ=K
MEUXELKN"WTZXTZT7=%%/=/&PE/!<@1L#A<A1D=2?I5TKPM?6>J62SM:G3].E
MN9+=D9C)+YQ/RNI7  #'N<\=*2_K^OZW&Q+/Q2PN5L;S4;16BNF22Z;:BR1A
M05 !.-Q9BO'9&/:NQKB[[PA=2V[/:1V44\PGB>(Y2..*1=B[=JGE1SC R6;D
M9KL8D\J)(\D[5"Y/?%/H+J/HHHH **** ,.S_P"1WUC_ *\+/_T.XK<K#L_^
M1WUC_KPL_P#T.XK<H **** .=\37NJ:4;:_M+N$V_GPP-9M!EI2\@4X?/!P<
MCCL<YK-UGQ=>VFOW-O911O:6MC<.Q89+SQJK8SZ ,,^Y/I5[5].URZ\2V5W!
M;Z=<:=:+NBBGNGC82G@N0(V!PN0HR.I/TC3P7;VWB>RU.UEN%@B%PTT3WDK!
MGD*GA22N"=V1P#QP>R7^8V06?BEA<K8WFHVBM%=,DETVU%DC"@J "<;BS%>.
MR,>U=C7%WWA"ZEMV>TCLHIYA/$\1RD<<4B[%V[5/*CG&!DLW(S78Q)Y421Y)
MVJ%R>^*?074?1110 4444 %%%% &5=^(].L;I[:<7GF)C/EV,\B\C/#*A!Z]
MC4'_  END^FH?^"RY_\ C=;E5FU"R2^2R>[MUNW&Y8#(!(P]0N<D4 9G_"6Z
M3Z:A_P""RY_^-T?\);I/IJ'_ (++G_XW6O/<P6P0SS1Q"1Q&A=@-S$X"CW/I
M4M &'_PEND^FH?\ @LN?_C='_"6Z3Z:A_P""RY_^-UN44 8?_"6Z3Z:A_P""
MRY_^-T?\);I/IJ'_ (++G_XW6Y10!A_\);I/IJ'_ (++G_XW1_PEND^FH?\
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MGMV>-'=Q^]922^=^2""0V3D'@UJ@   # %'0770**** "BBB@ HHHH RKO\
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M (UN44 8>/%7KHWY2_XT8\5>NC?E+_C6Y10!AX\5>NC?E+_C1CQ5ZZ-^4O\
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M[2L/PM_QY7__ &$[O_T<U !_PB.D?W;W_P &-Q_\71_PB.D?W;W_ ,&-Q_\
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MQ_PB.D?W;W_P8W'_ ,719_\ ([ZQ_P!>%G_Z'<5N4 8?_"(Z1_=O?_!C<?\
MQ='_  B.D?W;W_P8W'_Q=;E% &'_ ,(CI']V]_\ !C<?_%T?\(CI']V]_P#!
MC<?_ !=;E<-K:ZI9Z].-*U34)I(K&>\E@=E= 2"L2JNW/7<0/]BE<:5S=_X1
M'2/[M[_X,;C_ .+H_P"$1TC^[>_^#&X_^+KG;'Q2D4ZV]QJ-Q)90W#RBYV,[
M2Q!05!VC[N[>2W0!!GK7>@@@$'(/0TQ7,3_A$=(_NWO_ (,;C_XNC_A$=(_N
MWO\ X,;C_P"+K<HH P_^$1TC^[>_^#&X_P#BZ/\ A$=(_NWO_@QN/_BZW**
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METRWD@D#2KI:7UULB5F422C!4="5C$F!W([U<UC5V@C&HP3?;ETG2VO$ED
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MW2A:@]$>BT444 %8?A;_ (\K_P#["=W_ .CFK<K#\+?\>5__ -A.[_\ 1S4
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MI$\>_P XR!<1L^P# 9AW 7 3/2O1XM_DIYF-^T;L>O>GTN+K8?1110 4444
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M,3N<@ GGIP!69_PB&B_\\+C_ ,#)O_BZ/^$0T7_GA<?^!DW_ ,70!N45A_\
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M0T7_ )X7'_@9-_\ %T ;E%8?_"(:+_SPN/\ P,F_^+H_X1#1?^>%Q_X&3?\
MQ= !I'_(R>(?^NT'_HE:W*XO3/#&DRZ_KD30S[(I80@%U*,9B4G)W<\GO6Q_
MPB&B_P#/"X_\#)O_ (N@#<HK#_X1#1?^>%Q_X&3?_%T?\(AHO_/"X_\  R;_
M .+H W**P_\ A$-%_P">%Q_X&3?_ !='_"(:+_SPN/\ P,F_^+H W**P_P#A
M$-%_YX7'_@9-_P#%T?\ "(:+_P \+C_P,F_^+H W**P_^$0T7_GA<?\ @9-_
M\71_PB&B_P#/"X_\#)O_ (N@#<HK#_X1#1?^>%Q_X&3?_%T?\(AHO_/"X_\
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MZ_KLAMM6*R2PE0NE7)(Q$HY CROXX]:V/^$KT_\ Y]=9_P#!-=__ !NC2/\
MD9/$/_7:#_T2M;E &'_PE>G_ //KK/\ X)KO_P"-T?\ "5Z?_P ^NL_^":[_
M /C=;E% &'_PE>G_ //KK/\ X)KO_P"-T?\ "5Z?_P ^NL_^":[_ /C=;E%
M&'_PE>G_ //KK/\ X)KO_P"-T?\ "5Z?_P ^NL_^":[_ /C=;E% &'_PE>G_
M //KK/\ X)KO_P"-T?\ "5Z?_P ^NL_^":[_ /C=;E% &'_PE>G_ //KK/\
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MEF*(54&,C;NZ N23@>]=A26P/<**** "BBB@ HHHH **** "L/PM_P >5_\
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M^/*__P"PG=_^CFH /*\5?\_FC?\ @)+_ /'*/*\5?\_FC?\ @)+_ /'*W**
M,/RO%7_/YHW_ ("2_P#QRCRO%7_/YHW_ ("2_P#QRM'4;FZM;;S+.Q:]EW >
M4LBH<>N6XKG[/QO'=1V[OIL\2R.%E)D5A$&E,2-P?F!8'IV&:%KH'F7_ "O%
M7_/YHW_@)+_\<H\KQ5_S^:-_X"2__'*T;"^6_CEEC0B)96CC<G_6!>"P]LY'
MOC/>K= &'Y7BK_G\T;_P$E_^.4>5XJ_Y_-&_\!)?_CE;E% '%Z9'XD.OZX([
MK2A()8?,+6TA!/E+C W\<8]:V/*\5?\ /YHW_@)+_P#'*-(_Y&3Q#_UV@_\
M1*UN4 8?E>*O^?S1O_ 27_XY1Y7BK_G\T;_P$E_^.5N44 8?E>*O^?S1O_ 2
M7_XY1Y7BK_G\T;_P$E_^.5N5@MXGA\K4+F.SG>QL@RFY!4++(IP409R>>,G
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M79IU5T,XR@"=6ZC)'3(ZT@>AI_\ "(:'_P ^;_\ @1)_\51_PB&A_P#/F_\
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MW&J:9K&IV]AJ-Y=J-->YE64*YMW+@(4 48^7?\O/W10,W?\ A$-#_P"?-_\
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MJN/_ (BL?PYXDM8;2]#6>K-NU"Z<;--G;@RL<'"<'U'44 =I16'_ ,)59_\
M/CK/_@JN/_B*/^$JL_\ GQUG_P %5Q_\10!-XDTJZUO1I+"UODLS*P$CM"9
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M'6?_  57'_Q% &Y16'_PE5G_ ,^.L_\ @JN/_B*/^$JL_P#GQUG_ ,%5Q_\
M$4 ;E<]H.A:II-]>3W>J6MXMW(TLA6R:.0MT4;_,8;5' &W^N9?^$JL_^?'6
M?_!5<?\ Q%'_  E5G_SXZS_X*KC_ .(H#R*=[X1>\A7-\$GE69+N0Q;O-64J
M6"\C:0$4 \X Z&NH P !VK#_ .$JL_\ GQUG_P %5Q_\11_PE5G_ ,^.L_\
M@JN/_B*/(#<HK#_X2JS_ .?'6?\ P57'_P 11_PE5G_SXZS_ ."JX_\ B* -
MRBL/_A*K/_GQUG_P57'_ ,11_P )59_\^.L_^"JX_P#B* #3?^1MUW_KG;?^
M@O6Y7%V'B2U3Q/K,IL]5*R);@ :;.6& W4;,CKWZUL?\)59_\^.L_P#@JN/_
M (B@#<HK#_X2JS_Y\=9_\%5Q_P#$4?\ "56?_/CK/_@JN/\ XB@#<KGM'T+5
M--UB]O;C5;6ZCO)"\@^Q,DF,810_F$;5';;Z]S4O_"56?_/CK/\ X*KC_P"(
MH_X2JS_Y\=9_\%5Q_P#$4=;AY%6_\)R7T3,+Y8[N5IA/*8=P9)5VE0,C!"A0
M#S]WH<UTD:+%&D:_=4!1]!6+_P )59_\^.L_^"JX_P#B*/\ A*K/_GQUG_P5
M7'_Q%'D!N45A_P#"56?_ #XZS_X*KC_XBC_A*K/_ )\=9_\ !5<?_$4 ;E%8
M?_"56?\ SXZS_P""JX_^(H_X2JS_ .?'6?\ P57'_P 10 6?_([ZQ_UX6?\
MZ'<5N5Q=IXDM5\7ZI.;/52KV=JH4:;.6!#3YRNS('S#!/!P<=#6Q_P )59_\
M^.L_^"JX_P#B* -RBL/_ (2JS_Y\=9_\%5Q_\11_PE5G_P ^.L_^"JX_^(H
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MB;5=!M[FXGN[6WN9K&6.=8HDPSR@-&N"<H 5(+<GG.1Q7J<:LD:JSEV  +$
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MI)?._)!!(;)R#P:U0   !@"L/S?%7_/GHW_@7+_\;H\WQ5_SYZ-_X%R__&Z
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MX5RL6C^;X<U$W5M>).FHWCP)&"CR"21E Y'W6#=?0YR,9I-&TW4-+\216O\
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M6?\ P<W?_P =H W**P_^$3T__GZUG_P<W?\ \=H_X1/3_P#GZUG_ ,'-W_\
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M .#F[_\ CM'_  B>G_\ /UK/_@YN_P#X[0!N45A_\(GI_P#S]:S_ .#F[_\
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M/_\ $5N44 8?_"7Z-_SUNO\ P!G_ /B*/^$OT;_GK=?^ ,__ ,16Y10!A_\
M"7Z-_P ];K_P!G_^(H_X2_1O^>MU_P" ,_\ \16Y10!A_P#"7Z-_SUNO_ &?
M_P"(H_X2_1O^>MU_X S_ /Q%;E% &'_PE^C?\];K_P  9_\ XBL?PYXHTJ"T
MO5DEN 6U"Z<8M)CP96(Z+Z=J[2L/PM_QY7__ &$[O_T<U !_PE^C?\];K_P!
MG_\ B*/^$OT;_GK=?^ ,_P#\16Y10!A_\)?HW_/6Z_\  &?_ .(H_P"$OT;_
M )ZW7_@#/_\ $5MDA022 !R2:9]HAS$/.CS+_J_F'S\9X]>* ,?_ (2_1O\
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M7_@#/_\ $4?\)?HW_/6Z_P# &?\ ^(K<HH P_P#A+]&_YZW7_@#/_P#$4?\
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MD CO65-X<TNXM[>":V+);EBG[Q@3N.6#$'Y@3R0<@]ZU:?2PNH4444 %%%%
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MTF-Q+$DB_=8!A]#69<>'-+N[6.VGMV>-'=Q^]922^=^2""0V3D'@UJ@   #
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ML;"Z@*RH9(R)!AU')8>HY'/O0!E;O%7_ #ST;_OY+_A1N\5?\\]&_P"_DO\
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MY;KQ]T<GL*31=;AUBS67"0S%YAY'F!FVQRM'N['!*^G?% [&7%8>)XM8NM1
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M8PS+(6O;C[/'L (#;6;GGIA33>K$C"T32HX;V.:?1KQII6,S7=^UN7B=5"*
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M*)97('"AB0!GU.TU4G\/:9<ZB+Z>!Y9@ZR //(8PR]&\O=LR,=<4+2W]=O\
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MMZ;.AW<\U:NO$$C^-+7[+<O 1J8LYK:6^=G=-IR?(QM1<X(;J3]<5Z,0"02
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MLKK/<FW4"4D8">4QRA!XW<\#DYKI(M.L81 (K.W3[.ACAVQ*/+4XRJ\< X'
M]*J0^&M"MQ((=&L(Q*P9PMN@W$'<">.QY^M"T$S4HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
ABB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_024.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_024.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #7 @<# 2(  A$! Q$!_\0
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MH_\ WP://7T?_O@T 2T5%YZ^C_\ ?!H\]?1_^^#0!+147GKZ/_WP://7T?\
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M!IU'&$;R=B5+N>H^0/[\G_?1H\@?WY/^^C63_P );H__ #\G_O@TG_"6Z/\
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ME^_^R:N8'H*K:B!_9EWP/]2__H)IQ^) ?#U%%%??K8Y3K_AW_P AFZ_Z]_\
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MG_7%/YUY.%_BHZL;_ D>N^?%_P ]%_.CSXO^>B_G3\#T%&!Z"O:/G1GGQ?\
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MH\^+_GHOYT_ ]!1@>@H 9Y\7_/1?SH\^+_GHOYT_ ]!1@>@H 6BBB@ HHHH
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MG_/8_P#?(H\N3_GL?^^10!+147ER?\]C_P!\BCRY/^>Q_P"^10!+147ER?\
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MN_"? _4YJWQ!6[H/^HF_WA6%6[H/^HF_WA6.9_[L_E^9SS^$UJ!UHH'6OF#
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M?ZU_]XTVOFGN?2K9%34_^0;/_NURM=5J?_(-G_W:Y6N_"? _4YJWQ!6[H/\
MJ)O]X5A5NZ#_ *B;_>%8YG_NS^7YG//X36H'6B@=17S!@>$^*_\ D:M3_P"N
MYK'K8\5_\C5J?_7<UCU^IX;^##T7Y(Z2_HO_ "%[?_>KMZXC1?\ D+V_^]7;
MU\UG_P#'CZ?J>_E/\)^H5Z;\&O\ D*:I_P!<4_G7F5>F_!K_ )"FJ?\ 7%/Y
MUY.%_BHZL;_ D>P44F1ZBC(]17M'SHM%)D>HHR/44 +6)KGB[0?#<L,6L:G#
M9O,I:,29^8#KT%;61ZBOG_\ :)YU;1/^N$G_ *$*ZL%0CB*RIR=DR9.RN>H_
M\+3\#_\ 0Q6GY-_A1_PM3P/_ -#%:?DW^%?(E!KW/[#H_P S_ S]HSW_ %"Y
MAO=2NKJVD$D$TA>-QT93T-5JJ:5_R"+/_KBO\JMU^4XA<M::\W^;/TJA_"CZ
M+\D7-)_Y"MO_ +Q_E755RNE?\A6W_P!X_P JZJOI<A_@2]?T/A^+/]ZA_A_4
M*SM6^Y%]36C6=JWW(OJ:]/&?P9'S^#_C1,RBBBO"/=.8UC_D*2_0?RJC5[6/
M^0I+]!_*J->O3^!'#+XF26__ !]0_P"^/YUV!ZFN/M_^/J'_ 'Q_.NP/4UXF
M<_'#T?YF-02N,^)O_(LP_P#7RO\ (UV=<9\3?^19A_Z^5_D:Y\H_WZGZ_P"9
M$/B/)****_2#<[;0O^0%;?5__0JT*S]"_P"0%;?5_P#T*M"O@L?_ +U4]6?5
MX3^!#T$;[M?4UE_QX6__ %R7^5?++?=KZFLB/L%OS_RR7^0K7 ?:^1Q9IM'Y
MEBBDR/449'J*]$\@6BBB@ HHHH **** "L#4]"N-6O,SR6\=N@;RWC0^:25Q
MACTP.OO6_10!S0T'4/.2_:XMCJ$141X5O+**I&#WR<DULZ79'3]/CMV?>XRS
ML!@%B<G]35RB@ J/[/%_SS7\JDHH C^SQ?\ /-?RJMJ$,0TR[Q&O^I?M_LFK
MM5=1_P"09=_]<7_]!-./Q(#X>HHHK[];'*=?\._^0S=_]>__ +,*]'KSGX=_
M\AF[_P"O?_V85Z-7YAQ;_P C%_X5^I]QP_\ [G\V%=)H7_(./_70US=='H7_
M "#C_P!=#7!DG^]?)F'$_P#N'_;R_4TZ***^O/SM'.R?ZU_]XTVG2?ZU_P#>
M--KYI[GTJV*FI_\ (-G_ -VN5KJM3_Y!L_\ NURM=^$^!G-6^(*W=!_U$W^\
M*PJW=!_U$W^\*QS/_=G\OS.>?PFM0.M% ZU\P8'A/BK_ )&K4_\ KN:QZV/%
M?_(U:G_UW-8]?J>&_@P]%^2.DOZ+_P A>W_WJ[>N(T;_ )"]O_O5V]?-9_\
MQX^GZGOY3_"?J%>E_!Q%?4]4W*#^Y3K]:\TKTWX-?\A35/\ KBG\Z\G"_P 5
M'5C?X$CUS[/%_P \U_*C[/%_SS7\JDHKVCYTC^SQ?\\U_*C[/%_SS7\JDHH
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M'28(6LF5G/V.,QQ GU &3[X%: IB"BBB@84444 %%%% !1110 4444 %%)7
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M %VK_='Y4%$92K*I!Z@C@T44 -$4:A0(T 4Y "CCZ4[:#G('/!HHH %54&%
M '0#H*=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
&444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_017.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !_ A0# 2(  A$! Q$!_\0
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MVO72AAC;#B(8^B@?GUK)_P"$H\0?]!W4_P#P+D_QKZ 3X&>$%L#;M]O>8_\
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M#X2BC6-?#VG[5&!F$$_F>37K5:T:"2L<<(.I=W/D&BOL#_A!?"G_ $+VG?\
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M%?8'_""^%/\ H7M._P"_"T?\(+X4_P"A>T[_ +\+4_7H]A_5WW/C^NW^$/\
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M-/%)\5^#+6ZF.;RW_P!'N3_>=0/F_$8/U)KGQE&S]HOF:T)W]UG85YW\;?\
MDFUQ_P!?$7_H5>B5YW\;?^2;7'_7Q%_Z%7+0_B1]36I\#/F:W_X^8O\ ?'\Z
M^W:^(K?_ (^8O]\?SK[=KKQ_V?F8X?J%<?\ %3_DF>N?]<E_]#6NPHZUPQER
MR3['0U=6/AZOM'0O^1>TS_KTB_\ 0!5_:OH/RI:WKXCVJ2M:QG3I\G4****Y
MC4^=_C]_R-VG?]>0_P#0VJG\"?\ DH,G_7C)_P"A)5SX_?\ (W:=_P!>0_\
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M;Q1J5]AMMO:"/(Z9=AP?^^3^53_M Z5Y.MZ3JRGBXMVMV4+T,;9!)]2),?\
M :[?:?[3R^7_  3GY?W5RY^SWJ;[M;TIW8IB.YC7L#RKGZGY/RKW*OF'X*ZB
M+'XC6L+'"7D,D&2V #MWCZ\KC\:^GJX\9&U6_<WH.\ HHHKE-@HHHH ****
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M_P#7.'_T6M=+^SY_R'=9_P"O9/\ T*N:^,W_ "4[4?\ KG#_ .BUKI?V?/\
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M ,"KT_XZ:2;[P(E^@&_3[E'8D_P/\A _X$R?E7S[H&I'1_$.G:D"1]FN$E)
MR<!AGCZ9KMH?O,/R^J.>I[M2Y]H4445Y1V!1102 ,DX% 'R]\9]1-_\ $B\C
MWEEM(H[=01C&!N(_-C^==%^S[8"77-7U H#Y%ND0;/(+L3_[)7E_B'5#K7B3
M4M3PP%U<R2JK')52Q('X# _"OH'X%:<MIX">[VKYEY=NY8+@[5 4 GOR&/\
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MI0=Z:U[FT*<Y+WWH4_#GAW3O"VC0Z9ID/EPQC+,>6D;NS'N3^G08 Q6M117
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M_P#\!D_PI\?AW1(FW1Z18*?46Z#^E:5%',^XK(0 *H50 !P .U+112&%%%%
M!5:ZTZQOCF[L[><XQF6)6X].15FB@#*_X1G0?^@+I_\ X#)_A1_PC.@_] 73
M_P#P&3_"M6BJYI=Q61E?\(SH/_0%T_\ \!D_PJ6VT+2+.=9[;2[.&9?NR1P*
MK#Z$"M"BES/N%D%%%%(85G3Z!HUS.\T^E64LKG+.\"EF/N2*T:*:;6P%6STV
MQTX.+*SM[8/@L(8PF['KBK5%%*]P"J%SH>DWL[3W6F6<\S8W220*S'\2*OT4
MTVM@*EGI6GZ<S-96-M;%QAC#$J9^N!5NBBDW< JM>:=9:BBI>VD%RJG*B:,.
M ?;-6:*-@,V'P_HUO,DT.DV,<J'<KI;J"I]0<5I444VV]P"BBBD 5GW&@Z1=
MSO/<Z7933/\ >DD@5F/U)%:%%--K8"K9:98:=O\ L-E;VWF8W^3$$W8Z9QUZ
6G\ZM444KW **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>czd.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 czd.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "> 94# 2(  A$! Q$!_\0
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M)?-5OO(G\+*VVO0?'WQ4\*?#'^Q5\4:[;Z,^LWR:?8K<;]T\[_P#;_Z%]U:
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M$>]RGAOA^#Q=!_P3\\47$VJ:/)X;7P]K@6UAL94NA+]JN/G\WS67;][Y-G_
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MN'++]C9EVMM"_+]T#AO[JUVU)2T@"BBB@ HHHH **** "BBB@ HHHH ****
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M5U-% ' ?\*+^&;7GVO\ X5YX5^U_;_[3^T?V+;;_ +9_S\;MG^M_V_O4NI?
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M8M+^ OPUT-M(?3OAUX4L7TJ=KK3FM]$M8OL4[;=TL6U/W;ML3++S\J^E)??
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M5S4?P%U%?#UCI:_%+QI_H=V;U+HV^CF61C_"ZFP\MOFW/NV[][;MW"[?8Z*
M//?B)\'M!^*7]BP>(]^HZ=I<S3_V?+!;RI<,4V[G=HFD3'S?ZIX]P9E?>IVU
M#X=^#.C^&O&U[XAMKW4=\OVE[;3&:/[)827+J]U+ JINW2NBLV]VV\[-F]]W
MI%% 'CWBW]F_1/%^B>'],?Q!K^EVVDVDFGO_ &?<Q!KZ"0Q-*D^^)_F=H4;S
M8O*E7^!TKU]4VKBG44<P!1110 4444 %%%% !1110 4444 %%%% !1110 44
)44 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>cmflogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cmflogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !F 0L# 2(  A$! Q$!_\0
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MC_F9G_"<>)?^@O<?I_A6[X-\6:[J'BW3[6[U*:6"1V#HV,'Y2:J_\*O\2?\
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MY>A[A1117S1]2%%%% !1110!\C?&G_DJ^L?]L?\ T4E8OP\_Y*-X=_["$/\
MZ$*VOC3_ ,E7UC_MC_Z*2L7X>?\ )1O#O_80A_\ 0A3$?:=?-_QO^&_]DWC^
M*=)@Q87#_P"F1(.(9#_&!_=8_D?K7TA4%Y9V^H64UG=PI-;3H8Y(W&0RD8(-
M(9\'5J>'= O_ !/KMMI&FQ;[B=L9/W47NS'L .:Z/XA?#N_\'^*/L5M!-<V-
MTVZQD52Q8$_<./X@2![\'O7O_P */AW'X(T+S[M%;6;Q0;A^OE+U$8/MW]3]
M!3$=+X1\*V'@[P];Z18+E4&Z64CYI9#U8_YX&!6/\4_^1._[>$_D:[6N*^*?
M_(G?]O"?R-;X3^/#U.?&?[O/T/$*,FBO3_!?@31M=\-0W]Y]H\YW<'9( .#@
M=J^BK5XT8\T]CYJA0G7ER0W/,,GUHR?6O;_^%6>'/2[_ ._H_P */^%6>'/2
M[_[^C_"N7^TZ'G]QU_V5B/+[_P#@'B&3ZUZ=\'O^/K5O]R/^;5T/_"K/#GI=
M_P#?T?X5L^'_  GIOAIYWL/.S. '\Q\],X[>]88K'4JM)PC>[\CHPF7UJ5:,
MY6LO,W****\8]L**** "BBB@ HHHH **** "BBB@#QWXH^''LM4&LVZ'[-='
M$N!]R3_ZXY^N:\^!(((."*^F[ZRM]1LI;.[B$L$J[64_YZUXCXL\!W_A^5[B
MW5[G3\Y$JC)0>C#M]>G\J]W 8N,HJG-ZK;S/ S#!2C)U8+1[^1U'A+XF0F".
MQUUBDB@*EWC(8?[?O[_G7H]K>VM]$);2YBGC/.Z-PP_2OF*I;>YGM9DF@E>.
M1""K*<$$4Z^6PF^:#M^1-#-*E-<LU?\ ,^GZY7Q+\1O"_A6%SJ&J0M.HXMK=
MA)*Q]-HZ?C@5Y-\28KCQ7X#@\6V5Q/'=V)%OJ4$<C!'7L^W..I'X,?[M>%5X
MDX.$G&6Z/>A-3BI1V9[G8?M#W3^+_,OK!(O#[_N_*0;I8N?]9G^(^J],=.>O
MOUE>VNI6,-[93I/;3H'CE0Y#*>XKX8T[3;[5[Z.RTZTFNKF0X6*)"S'_ .M[
MU]5_"3P3K'@OP_+#J^H-(]PPD6R4[H[;UP?[Q[XXX[]:@L\)^-/_ "5?6/\
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MAMX2\.ZFFHZ5I M[M%95D\^1L!A@\,Q'0U17X/> TE$BZ"H<-N!^TS=?^^Z
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4"\?_ !=%%'M9=E]R#V,>[^]G_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>stockcert.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 stockcert.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &\ G # 2(  A$! Q$!_\0
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M3P0>U>$6_P 5_'-]<>%['78KCPK_ &AXD.D>(KI9<I#Y4 *>0^3Y44[X(?\
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MPD"1 3]W;U52HR0V2W&2*Z7P[J6C?"'P+J^K6NG,^M7BK:Z=<W3AI%9AB28
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MOXJTNVUE+OPUJT%Y<6V+"]LI+</!,I!C<KOZ<;2.F#^%<YI7PZ\=Z3'/>_\
M"*WU[KES*9;F^N)("Y!_NN9./?CG/M6\:E)R:J33BNG,M?GV7WD>\M;"QO9>
M.M!_M4W4;7$;I%,;EBLJ,3Q',R@Y!YVN!ST//30L19>!]0N!!;7%_J:VDCS"
M%,EMZ/Y:8S@8P3Z@'GG@1:3\-_&UCXNT[5K70=7T=)\1ZL-+>W3S8BP+*B^;
MR<9'..0#6UXA\-^.+SQ-J-[HW@+4-/LI7S%;L]NVY1T#CS"/Q&2?:LJE2E_#
MC-<K_O+3R-$I;V/:_!_B1-<L8))(UM)I85E\EG$@92.JLO!P>#W!'.*Z6.=5
M1@D<1 '5@/YUX/8^!/&,<UO<P:1);1!2XM;YE+12,<O\NUEW''+9R<5K?\(Y
MXUCX?2K<QY'"[ <9&>?+] ?SKYFIA*;FW&HOO.Z-:5K-'KTC6S*7D$#L1NW+
M(JD?457#0.\#O]AW)DH[;25SQD9]:\@;POX[9<6^EVH;'SEG3GT./+Z]3^52
MS>&_'(G(2TMX8OER"R<==W\'N,?2H6#C_P _%]Y7MI?RGLGFQ!@%-NWR_?0@
M$_KS5A95CD 4#<0.C@_H3UKRGPOIWC#0[>ZAGCWPEFFAVOOV9/1<D<\^F._;
M!Q8_"/CBV:8I;0R%V+\3LV&+,<Y*DGC:.O8^M3]5IMM>T7WC]M+L>U;XY-A#
MV[R%O3D>YP:GBW"1G^42@\8[?I7B<GAOQLSYBTJV=N@9GS@Y'7Y/0'\_:G+H
M?CZ-8E;1X6(P'V2;03E<](O0-_WT/2CZG'I47WH7MI=8GKFM:U;:1IMSJ5[/
M%;VULN^6:7>  /3CG\*\BU+QUI'Q(T_5;G3V:WM9+-K=0ZNLC $DR<K@#!XY
M)X[56U3P'XOU[3VL[[P_'<02KAX\@_W?F!\G(_BQCU%<OJOP_P#'%C/(FE^%
M=4,'E+$TT**JM&3DPJ6(9(USQ@8)SD 8KT<-A:$-?:+F]58QJ5)R7PZ&)%X%
MM-.U*[>YN$DBL0[^5,6VPX.3)..P7 P%)W'&*QX_BQ9W^I?89+J\CL9_W7GW
MC![=NPWP@?(N?[O*_A7>_$#P3XM\51:-;V'AGQ+INC^5&=3TXI&4DF3CS(\/
MSN&#@G@\]:Y;4/ OC*\86-YX N_[*4%8_)M4WIUY0%_E8\9))^[[FOH*52C.
M/-6DF_5:?YLX7&2>D3&;X;P0^()V:<1Z;%$;B:S+$O$H7) (X*D8PP/(/'-0
M^-=83QII_P!B2,6UM;Q_Z#9O($VJ .6X^<X[G&!Q73:/H/BGPU\/]5LO$6B:
M]-(98;/2_.1?LUNC..7.20S,54=0.<57U;P+K>C:HT%[:6^GFW0+)Y^!(%)!
M( Y))]#V4]LU4:RY[N2;6SOZ:ARM*QP_P]L=<T_Q!_8=Y$PTA0T\B #"OM.T
MHW9B=O0\XYKI+Z^G\2Z_):Z7YVH-(5CVVZF:60A0K'RP5;E@3D9K2NO$D5UY
M.B6\RVVB.ZBYFD8.\R$Y;><<CK@\&NF\*NFG:1-I]BD=A>+<-%J.S(FBC(^1
M4/+%2H'.[!)SZ45\0W/VKCJ_ZN_,<8*W+<Z#2?!=E\,Y- U+X@ZC&DUM))=V
MNDP2F>:/Y2JEF(R$']S.03@=Z]T_9GEBN/!<$D0PAL[7;]-C'^M?$WQ0UJ]3
MQ)<)>'S/(!$&6&?+ P,=CT.3TW CDU]I?LL_/\.]-)&"-.LB>,9)B)KYO-J,
MHX3VLY7<K>GW?,]#"3O6Y5T/*/VX+=]4NK&Q$2OYUYIL>'/RL6:< 'VKQFQN
MHM$OKSP]IIMYY=+@DN3). 8YS&K-YF_//*[4;)PI*,0<9]M_;.U"#3]2TRZG
M^9;;4=,E9=N20#<' '<XSQ7AMCH$5UXSU">695TW4;&XMK:92V0K1L59L#L=
MH88&TD+@L<UZ.7-?4H)[?KH85_XTF8EOKVO:AHZ:K>-9O+XB;[254LT@MU;;
MY6#T4$'ODA1UK9T'P^+W3XK[4;AOL4;ND=OYVQ) F"S,<?+&N>2.O0 &N:0P
MV/AOP_<R02_:H8I=.GMV!4QRK(6!]B5?.WD\'(&*ZO07LO$'A>+1)VD2=(Y[
M?8N/,GA=@VZ,$_,R-D[?XAP,GBO7GI"ZT5_P.5:O4IZOXVN_$&I+)X5OI=%L
M-*EDEFUO<8I999L @*.D?R@!3]6Y-?7'[..DV&O>%[>;4[2"^D&DZ:J>?&'*
M9A8G&>F37Q'>:>W@>SD\/Z\^_2]0<W%CK%LNZ&1!PWN"< 8;E3U%?='[*\0'
MA-<@#_B5Z4>#W^S9_K7BY[&-/"?NMNC[ZKKZ].FQWX'WJFJ/4QX)\/LW_($L
M2PXW?9US_*HS\/\ P]\V-$T_+=3]G6MN23RV-21L6&:_.U5G?=GO**:V,*/P
M#X>C7']AZ?N]?LR_X4Y? N@J<KH]@#_U[)_A6]0:?M)]Q\L>Q@?\(/H+-^\T
M/39!_M6J'^E*W@/PX>!H.FC_ +=(_P#"J?BCXE:-X0N#!?R.TB@,_E;=L0/W
M=[,P4$\X&<G!.,5SDG[0?A9#Q*^/^NUO_P#':7M)=PY%V.N7P)X>7IH6FC_M
MTC_PIW_"#Z ?^8+IW_@)'_A7%M^T+X0VY>Z93Z">W_\ CM0']I#PBF"ER7!]
M;BW!_P#1M/VDNX^1=COE\$^'XU(70].7/I:I_A2+X+T-.FCV/_@.O^%>??\
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M+ZD97*I_9)WD'!5?MEOD_EFOCZQT&;XE36[P>=;>&=+)A::1?GNI3R5C7NY
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MA3Q0H96+*%TJ3GO_ 'NU:/\ PSS##:LS^)O[HYTE^#@<_>[XKUJ%4NIV/SD
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M21@X! ]V%94?[*.CS> ]:\)WVIW5_;ZA>_VBMT85CGM+GC,D9"X_#%=3X?\
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M/_74Q'I=]>3RR0OAM@R1M5_SJ,7%S-)YDDDK2$8Y\S_&O-5^,7AGR$E%]?\
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MAH2XSG 1\_SKSNX^,?A:-FC;4=1C93@C^P@?_;FF)\:O"UNT(75-07S#E2-
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M>LS@K8L&_=LQ]6#'U]JSY&=& $C%?[S/_P#6KS:;X[Z(RG+:LA& 6_L^#/\
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MH?VJR)*T*%[4)"3'U$9=>.,!N>,U\:>RCZ/##@9Y^M*R[AC%?).H:+XU\/\
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MWMY8-<D;);713)YBQ*&(+W;A%&<@G9G)(]!@WEWO4:<5V1G77[QMFGJ5Y/\
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M.M"--4KI<JV.2E&$I2Y][G4?"#X3Z+\%? .F>$/#[3MI6G!Q";E@TAW,6.2
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MO:7_ &LD\UZA\.[?5UU/Q,UQ]L3P^UU$=(CU'=YZIY2^=][YMGF9VAN>O;%
MF=Y1357%/6@E"T4&D5J"P)VU^<GPXTF#7/\ @J!\0M.O(?.L[RTU""=&&0T;
MV\:L#]02*_1C/4U^>GP?;=_P5.\<D%C^YO1UZ?NXQ7I832-5_P!UG'7UE!>9
M\H>)M4NOA'X'^-/P4U5MK0:[;75DK# +0RLK,OLT1C;\*_5#]DFQ-]^RK\.X
M"WEK-X?2+/IN##/ZU\&?\%6/AE)X;^,FD^+[:+9:>(=.5)I!T-Q =I'XH4/X
M5]\_L<[?^&8?AH@Z?V+#_6M\5+GPT)KJ_P ;&-"/+5<.Q^=_['_QVT']DSXT
M>,=#\<Z:8[>XN6L)-42W#SV,D4C#D8W>6P/('/ -?9G[2O[9MEX$^%-GXL^&
M6J^&_%LLERL5S#+>!FAB93\XC#!B=VT8]Z\7_P""AW[&.I:]K=S\4? NGM?7
M,R[M;TJV3,C%1C[3&!]XX'S#KP#ZU^<QA:&1T>/9(IPRLN"#[BNZEAZ.,M6O
MKU1A.I*BG!H]L^/?[87CS]I#0]/TCQ+]AMM-L;DW4<%A"8P[E=HWY)SCG'UK
MPV0GBI=X6NF^%_AVS\6_%+PAH>J[H].U+5+:VN.=I,3R -@]L@]:];EC1A:*
MLD<5W4=V?K5_P3C\*W/A/]ECPXURC1R:K<SZDJ,"#Y<CX0_BJ@_C7@/_  3K
M.?VIOCNV=Y5YOF'0_P"GO7Z&Z'I-GH&DV6G:?"EO8VD206\,8PL<:@!5 ]
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MK?QQKWP5M=#BTS6K?Q1ITNE1SS37T7GW>QH7N'$J,%;@.K<C<<^M- >7:]\
M_BY]H^(5S:7+21:X=0_LR&'4RCVS27D,L)<DX91$CJN-I3YAR&XZ'7/@U\0M
M4\3^=HHN-!B^R:7%::A)J&!:307SRW4IB#'/F0G;LY!W;2<"NYUN+XB7?CGQ
M5J^CZ-?:>NH>'H]/TL75Y$8;:\$TW[YTWD [&C8X!/&*Z+X5V&J>';'2[.ZT
M'5K>YN+.--3O+_4%G1;B-/F8*78GS&9OF7 .!Q2V);/-_P!L25D\/:K(BLX&
MG6P ''S'4(<<]J^/KK9J5O):702[CDD9]O8$Y560 #;DEFP.RBOM#]K); ^&
M[I-4E:#3F@M#=21J681_;H]Q ').!7S##I_AK5K-=8\/V,UY9-)+#;-J#XDA
MFB 9-R(=JM)T13G@$CG&/T;)I^SP<='OO]W4^>Q:YJCN9FE>"]*\ ,/$/F2^
M;<Q26VGZ1TN9/,RC<GHQ5APW9C[58\-^!9]>6XUWQ1J,EA9R2L/L=@/-NI2,
M;E6)LQX'*[@>,8 .*S(]4GFUT:Q>MYFHV\R\R,R\JO(9<9P >_.>?>NQ\.W%
MO#>&T@F#)8Q&XT^3>-SVY^\ISQO5BV#W/2O6JRJ_$WJ^OZ')&S>A>^(?QDL/
MAJ%T/X>V46@Q6,+6\ETPWS2NREGR^<,!N;Y3QN'3@5]0?LRR#_A XG/WFMK
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M3FE4UBJDE+G3U-.2-N7H8VM:"GB+0=3TF\_X]M0MY;:;']R12I_0UYO^S?\
MLVZ1^S3X=U/1-$U>_P!5L;ZZ%V1?[<Q,%"X7:!P0!^5>P=Z5J7/)1<$]&'*K
MW/$_VD/V6M%_:8@\/V^NZYJ6F6NCS/.D-B$Q,S!0=^X'LN./4UZ_I.EQZ/I]
MO9P#;!!&L4:@=%4  ?D*N"EW4.<G%1;T0U&*=^IXS^TC^R]X=_::T72]-\0Z
MCJ&F)IUPUQ#-IQ0/EEVL#N!&,8_*O3?#6@CP[H&FZ4EU->)8VT=JL]QCS) B
MA0S8&,D"MKJ*;0YRE%1;T0<JO="CA:2CMBBLR@HHHH$.[5P7QOM]5N_AGK4&
MB0ZK<:K)&%MDT6817(<G 96) PO4C/(&.]=[7.^/IM4A\+7XT)6.LS(8;1MN
M1'(W"NW^RIY/TH+/FJ;P_P#&B:X\30W#Z\T5W$L>F7$,ZYAF$BM"S .-JB-6
M20KD;FY!K?T[0?B]#\,?B.-2FOIO$4\*?V;';W W_:?,<N8&R,1[/+ Z9P:=
M>>//C)?:?X>E_L"\LGCLK)[^WBM 6>[2X=+D%@?]6T:JP [/Q38?BY\;[Z&U
M_P"+>Q6K21W"S+) Y9'!E$3#Y\ $+&2#G[U(9I00_&GPHLFD:3+#XBMH[)[J
M'4M309,Q!<6Y)?/!Q&,YX.XGC%5IO%'[0\=G$CZ!HPO/[.N)&:VC$J&Z5RL:
M9,@VY&UQG@Y(.,5T7PZ^*7CB\\3?V7XM\)WEGIDEO:Q6^J0V+Q^9=.O[T."Q
MVH#GGC%/\>:EXVTWQUJIAT[7=1T@1V*Z-#H<BQ1EFD(NI)W*D97Y3M?@KG;S
M0!#JDWQ1O/!_Q&TZZCDDOX;)4T&^TV$6TD\QC^;:-YP0_?.,&LT2?&?PO'#I
M>F6EO?PC3X)C?7*M.3=22@2CYI 0(UYVGKS@UUGPQ^(WBSQ!I>KMXQ\)ZAH]
MY;R7$ENEK9N%DMT *@%B<R')P.^*\MTC5OC%:ZM#)J0UNX\.A9U62&V)G>W8
MS[9&3 <2J3;X4_-A3UR:!'<7'B/XH6>O:78W-UIQ;4-:GLTM39['^P(N1=A@
MQS@\E3C[PKD?%FE_&'3/C=K6NZ%!>W_AE686=HUU^ZD;[%A 8RV/*\X<X ;=
MCL34"'XQZAI=A%#<:M:ZE;Z(L.HM/&0L]TLJLK0MMQNEC)4D8VD'=7T#X%36
M++PGH\/B.=)M<6TB%[)']UIMHWD?C2&>(KX^^/'VB!#X1@: V+M(X@4$3>8-
MI'S_ 'C'D[>F<#-67TGXE1^ _ H1]0N-=M/,?4[>ZD(%T#*,+(ZL"CA#N5N5
MX((Y%?0X;/.[BFR'*\-@T6 \)^",GBOPRTT'BK2]>NKO4-1GCAN)I#)#;P>9
M(\6_+G^$ ;E'0J#S7/VNH?&KPC=/'IFE3>(K*YU)=UW?K^_2%FR0T9DVC8"P
MWIPP"_*"#7TI'MA5F)ZGFG9#]&]Z!'S5X=U?X[6&J003:;_H$]]$CM>0B=;>
MWW3%VR)-Y)^0$DG:"N!CBNRLM'\?W'C[QE>:NUPWA-;29-+L["54N)&PH78?
MX6^5B&)'+@U[+P.II/,7_(JD)7/FS1M/^(=OX;T:*[M_%\Z)X:U!+F#[5%]K
M^V-<(;93(&/[P1[P')^Z,G!->X_#F#4(? ^@QZNUV^J)8Q+=-?[?M#2!0&,F
MTD;B>N#70JR+D 8_"E:544MVH*9\W?MB.+3PM>3&'[1MM;9A&<D$B]C/..HK
MXFOKZY\':Y83Z8&$>KPJ;O34_P!5< GJ5!P V?EQR".QXK[9_:SAGU+2Y;:V
M:.*YFMK189)SMC5C?(!N;L,XKYETKP7/X'DN;WQ':O<>(Y&F1I=XDB@B4#R_
M*(^4F3D*_1<''-?I61UH4\&N;5MO3OHOR/F<;%NJVMBIXITN-=,M+LL+B=KV
M2RE+8!FC 4B3G^(9VD]^I]:3PYJDEGK'AV2UT\-]BUE[:,QJ29HW5-Z9YYY;
MGGKP:Q;S4KG7)HXT"Q;/W4<$"F2-(VY'4<G/4\Y/)YYKL_".CW<>N62R2B>'
MPYND0"/<7NY ,KQ]Y@-HSU&.XKUJC5.%I:[G'#WGH8]O)'(/&%E<6SSVYMYH
M8HY ,P>6A9&P!]Y>@)P "<'DU]L?LU*O_"$YW$EK>P;'I_H4-?$?CC55\(0:
MG96H_?ZG R73&$+((2"?F4]V.-W4H1QP:^U_V9) W@,#!_=VU@N??['%D5\_
MGB;PG.MG_P  ]# /]]8^>_V^H/M-X KJC)<P-TZY@:O'/V>OAOXJOM!UO5K7
M3YI=*G"P+(^%B!5LF1F)  0$G!(!)'7%?4WQ^BTB3XN:$VMV:ZA8"^1FLV.!
M*PLI61<^NX#'OBOFGQY\3/%7CC0;6"&Z2'PI"VR;0[2$+':R%SMCG0[&<X ^
M?)R2:[LOK59X*GAZ:LM&V_T\]##$1BJTIR+^K:IH=CX@T?3]*U%M?U6T@E@D
M^QQ^8'+*5$9!VY5>6)PV<@ \9J2/11X/TN9O[0AU;7);?<3$XECM#@8)^7#,
M=P^4@'GKZT_A_ILEO]IO9;5;JZB6-X+4N0-H?,JQY)()4 <'H37+^)O!/B2/
M5+G6K.[%TUQ-)*R13;;I.=Q#Q'D@>V1Q7J4Z493]FYV7GU?8YG+J6M7U76+S
M2[UCJD]U(\<@EF53P5&SC P,\J..BL?2OT#^!"8\-W;!L[C:G'I_HD/2OS_C
MO&UWP?!<7$D N#!+$WG(XW;=W(V\#@GG'<U^@GP)5%\-7&S/_+KG_P !(:^?
MX@7+04-K-_H>A@7[[/25/S8I6^]2A1NS2,/FK\_/?6PM%.HI#L(%H:EHZT@&
MUSGB/P:-<U;3=7MK^?2]6T])(H;F%5<&*3;O1E8$$$HI!Z@BNCHH)//[SX-Z
M???:(I+^[:QN+X:I+:-M*F\ QYN[&>H#;>F1^%92_L]:':W37-E<75I<.\LC
MNI# M)&(WPI&%!P6P.-S,>]>JY-*M!5SRB+]G70+6>&6TFNK1X"TD!1P?*D,
MRS*RDCHK* %Z!215S4/@3HNLKJ?]I/+?R:H)6O)6"H[ROL"RH0/W;((UV[>F
M*],-)N- [G$^)/A;9>)ET2.[GE:'2A"85VH65XR"LBOC<C'&"5(R"147_"J;
M,74]Y%>W46H'5Y-:@NL*3!,Z>6R@$89"O&#Z]:[O)I#UH%<X#PU\'K/PAJMS
MJ&D:I?6=Q?/YNI?ZMQ>R;F;S&ROR-EB/DP,<8J7X>_"'2?AC-+_8EU>16TZ'
M[39LRF&:8N6\\KCB0YVDKC< ,@D9KNJ*"0I>M)2K0-!MHVTM% [#<44XTV@0
M48HI0: &E#3E7%+FDW4%",I-*HQ2YI&H 6F%32BG4 (HI:3=1NH"XE%!-%!(
M4444"$'%+11F@8[%':DW&DS0,2EHHH)%6EIM+NH*0C=:*5J2@04"BE6F M<I
M\2+_ %S3?"&J3^'+1KS6%@;[/&N"0V#R >I'I75UQWQ;N-6L?ASXAO="NIK7
M6+6REGM#;Q"21Y50E$"D'.3@8Q4M75C>E-4ZD9M7L]GLSRBX\3_%Z#1]8E@T
MJZN+SR%V1[4S"Q=<&,'[QV9SUY/M79Z]KGCN^\0>'[&WT>\TG29Q*M]>VTD,
MTB?NB5/?;\V,<<DUY?J7Q ^+&A^.?#%O&FJ:CX?FL-+NM4NCIRN+=Y7?[0I5
M4W-@!5^4Y3.370R>.OBCK]OXBTVPMAH>NV^K076CS7%B6MKO3WC+BWE;!VME
M"C-D%=ZFL53:^TSUYYE"336'@K7Z/JK=^FZ.CT/4_B#I7B;2+.[L;S5M)&FR
MRS7,KQ*\LY=2H<X 4JI(VX&<&IK#6O%L^K6!9K[^RYM<?YI+?:PLC 2%<%05
M"R<9/7U(KSK6OBA\7H--N[B'1KM)KC1WG@M8[8--I]Z$+>7(IC*RH3@*Z-G(
MP5/6M>U\3?$6V^(EEIVJ7&H)I3:#'>.T-L)5^VL[CR=XA ;Y=N1\I YJN1]V
M82QT97_<QNU;;UU]=?ZTML>&M4^)%SX@\,_;8KDV4C-]L+Q!5VB28,7X&"%$
M.WIUKK/$OBKQQ8^-HM-TS0+6[T65%_XF#NW[IB&SN&>@('3LPKSOX$_$;XB3
M^'_$4_CNROS>6MK;3V,$UGL:;>AW$,JJ,F3 ,9&Y,<D@U2A^+WCZ71]-'B#3
MM2T9[&'4(]6FTNQ$DES>0L/(CAW KL=&W ]&*XS25-VMS,JICH5)\[H1V:MJ
MEJ[WTZH[*+Q_\3+C0;B[3PG:+=Q3H@MF=LR(RGYE.>S#!SV(JWXD^(?C*TL[
M#^S/#+7%WM_TU9H7VHQV85"#S@,<GU4UQ.F>+_B+K5_XTM6U"]TIX9$BT26;
M3@W#)$2[J%QA69L_,<G([5;L=:^)]]JWA%=4EOM'FN=6N;#5;>UA22!(HHB4
MF5BIPCN 02>C8H]F]N9A]<HN2D\/'TU[>IN7_P 4/'5NPDC\&R/$L,4AQ&Y*
ME@NX?[1R2,=MO- ^(7Q NI[F,>&Q;PH\)$ODNYVED$@QW.&;ITVT_P 8_$3Q
M5I?Q'ATVSTVX'AJ>QN+4ZA#;&1H=0$?FQOT^YCY>F"U><:_XW^,.GIIME>O>
M0W<%S);RW^EV DBO4^R220SA-IV[I/+5E/0@CO1[/^\RXXV@E_NT?Q_S.T;X
ME_$2ZA:ZMO"4S3(7002P.J,-Z[6*]<[2>_:K-Y\0?B$VJ6$EOX9D2VAE/VB!
M(F998V1/XCR&5BWMQWKD/BI\1_BWX?U#P!_9]E<(]UHZW6NPV=D)XX+@2PJY
M/!+ *TOR*03C(Z5-I/Q&^(]Q#J!E-^N[Q*UF7_L__CUTGSROVE5,8^8+M Y;
M();'%+V?]YE_7Z%[_5H]>_7^M#L-/^)WCV^CN67PEL^S)<2[;B*1#<! OEHG
MHS;CU_NU/I?CKX@W6I!+G1+9()_+;:8)0D2>2SN0W!)+ +@@8)KA]:^)7Q)N
M]0W>'XM1%A_9_G0C6M/$)FF6\=&0RI&PC+1+\K%2,%6(YJ/QOXJ^)[+J\^CW
MFM6KQ^%%U:TL9--AD;^T#)C[-E4.6"\E0>^>G%-1?\Q#QE'6V'CKZG76?Q6\
M?W4-B6\'FW$GFK+YD,PV8.$/3C(P3D&J=KX[^)#:]%</H4QM[D0QFWFB80P?
M)N<\<DEL@-T'0CFL7P[\5OBQ%X.BGO/#MY<ZS9:YNU*QFL_WHTO<BXB=0%E<
MABX*#.%((R":N_!;Q[\1]:^+'B'3O%%M>1>&_,OO[.GFLPJ3!+C;$%8*"F(^
MSYWYR#P:GV?]YE_7J*O;#1U]?4\R_:N\5>*IO -E)<:&[:C>6UJ]RD2,BVT9
MNLJN3SORH!]-PKY'7QAXTAEM[@:=>+&?,+PQ+)MDVE6((Z$8.<=.#BOOK]KZ
M);CP_/&S!=UM:@%E+ $WBCD?TKXX\3W5_:QV.E:>'CN+V:0;XXC"&*\;><8Z
MDG\/2OTS),/*IA(P4[:O]#XO'8NE&NW[)?CY_P!?([&"%=3^S:]HD$5OK]OY
M<E[H&3E=PP=@XSP#DMW]^O1?#^XTWQ!I,%IIEPC:Q9EE&FW$@072D]3(?W9;
M!QC=DXXK@?!7@_4/"MY'JKW=OJ#W$+PF"VW,HWC&9';"_*?FZGI3]>L4DUFY
MN+5A+%O_ ';1J9%4X&?+4MM&6W8^6O9E1C*].,[]G^C\OZN>0IM^\U8G^-7@
M?5/#NOWUOJ=O();A&N4\Y3PK#CZ$'C(/0#.:^W_V:X%C\ QYY+0V>?7BTB%?
M/'@?QMJ#066A^+@?$%HEI<>;'>CS'L%\LM$[RD!6R3MV9(!('45]&?LXR+)X
M&7&05CM00>W^BQ5\WF]6<L*J<UMU6S_JQW8**5;F1X)^V9=31^+M+CLXVDNI
M-4ME3: 2#Y#=,\#K7C\NQM0:]TQKBTUVW=HA;SCS_P"T/563.&+)GGV]<5Z?
M^W?>2Z?K%E<VCF&Z6_@(EY^7_1W!''J#7D?@_6-+\4V<5M'"NGZJ"\D*[FE@
MD;<,[6*?+A8V.TYZ\&O9P$6L!2GTM_5_(Y*[_?R1:\21^=!::M&-FF2!@+?)
M#6TRD;HF..<=CW^8=J=X#U9KJ*>.>:6Y$=Q!/ LS,X4^:H;:<< AL$'@UK^)
M%T^&222+:NGZP&M[D[28HIU.(Y,]%W8#=1U;%<9I<DNA7UV;I]DA#V\]J!R!
MT/S'^(;00>:]"$?:TK&,O=8_P/;ZEK^GZ[X>L](O+B='N)2T/$44><OYA.-H
MP#WYST-?H%\#I!_PC=\<87S;<#\+2"O@ZQ\9ZUXDMK_PWX>@N%-[',GEJX+R
M?(6+.PQ]TQ;OSK[P^"BLV@7Z] L\*_\ DI!BOG>(.9PNU:^MON_,]# 6YM#T
MA6!I6ZU&J[7J7N*_/T>\A,FG TFVEH*&YI5HVTN*"@I"*6FYH)844 9I=M A
M**7;2[13"PVBG;132,4@"BBB@04JTE.% T%%%%!04VG4TT"84444$A1113 *
M**4K2&)111TH$%%%%, HI=M(10,****8@HHHJ0"BBBF 4444@"BBB@!=U)11
M0,*=2+2T#05P'QR\3:OX+^&FKZUH(9]6M_*$"K%YN2TJJ?EP>Q//;K7?US_C
MO7+CP]X6U"^L8%N]22,K9VS D33GB-/H6Q^% SQCP+\3_B-J>K>#AJMO_P 2
M[7H+Q+AOLAC>REMYB1)TY26+ !..>0.<5[?X8ULZYH-E>SF&*2X3>T4;L5')
MZ;@K?F!7C'@_X[:[XSU;P^18QZ99ZIX;^UR07$!$D>I1W2PS6X)Z[06.WKC!
MZ5S&J^)-;_MC7Y;W2M)U>:T\8VGAY6?3A%)+;R+&SR[RV,@,P!Z<4#/J7S%Q
MPZX_WA3"T0ZNF?\ >%?&>A?$K5-2TB2Z?P?I0O(8[9[73A8DOJK27TD$L:$G
MY?+C16)7N<GY:R]%^,>I:AI>KS7/@_1K.>VN[*.V$VG,OVB.74WM96CPQ#HL
M:J2V0P8\C;BE<+'V_P";%U#H??<*5;A2?O ?C7QQ=>/':POK^QT3P_J5G+XE
M@TC38#IYCGDM/-,4]TPW@(I<$)N[*6/6NDTWQ/O^+">'H?#NC:QI7V^QM=UM
M9.DAAFMI))KD-N(VQNBCIC#8SG% 6/J7S4'_ "T4?\"%-\Z'IYL9_P"!BOD3
MQ!X]UC3XM5GM?!.F_:K>;6HY-->R9FL8;2,M;3N<Y<2G:,=#O&WH:WM+OM;N
MO%_A[2YO"VEV\&I>&I-<N6_LY=UJZNH$;'?@@@]!S\P/8T7#E/IT7$(Z2I_W
MT*0W$ &3+'C_ 'A7RW\+]6F\<:+)<ZMH6B^'[^/2[2]AAETXLMX9$=Y"F3D!
M2NS Z$$GJ*XS4OB1J=O\-?"?B"W\*:3>ZSJJSR76GV^DK(T"I;/*N5#<*67)
M_B"D\9Q1<+'VJ+F$\[U)'3YAFI5EC;HZ_F*XCPYX#\+ZQX?TZ^?0M+9KJVBG
M9K>(B,ED!)7.#C)XSS6J/AOX75<?V%9$?]<Z8C>:XC7HZGU(8<4R.Z@8Y62-
MN_RL*PO^%:^%-V[_ (1^PS_UQ%1GX9^$5'_(O6'_ 'ZYHL2=$UU".=Z\>A%*
M+RW;CSHP?0N*YS_A6?A*3_F7[$_6*HIOA7X/7!'AO3R<_P#/$4;%'D'[5=@G
MB#2YM/AN(!-<6]K#&))E1=QO% RQX'U-?)-Q=7:_$UK._M9]..GVEU%)!>ON
M=#Y3Y8<\#D8P3U')KZ>_::^$NFZEIMS8:'H5C]LNH;6&&(H '=KM>_;@$5\E
MQ/ID?B F_P!($U[#(R;C(4(*NSA6QU49 ^@K]'R7G^J^[9K7U5TM3YK&J/M+
M]3>\47D8\2&WDDDEM(1Y*0@D1QJHQM5>W(-=%X;TN[T^Q2*U8I>7*M*)74;K
M.WSS+S_$1^(&,=:XNRLSJ6O27=S=9@@#75WYG!V;LX!^IQU'6O4-!4:I!>!K
M?_3[XB[N&FC)$4:Y(B7C@!,-QZ#VKV*[]G!17S.6"YFVR%K6S_LW4-,TJVDE
M,-JTWVLR(7E^49/()/R[B!VSUS7U3^SG&/\ A"Y>>/\ 1<?3[)#7Q[XA\46]
MK9RRZ+;AA'9R!IV21)'C#8;8C)M7Y'4\U]@_LXDMX)D;D<6HQ_VZ0U\WG$6L
M+S/O_D>C@?XI\]?MUL(]6AD#[3#=1R+SCYA:R$ >^:^;O#NL0Z+.KI=>2UFL
M:(#>RA#M9$)"*O7_ %A&>W%?2W[;,,B^);:2V)%PESY\:[5<-)'9ED!##&#S
M7@TVK7VI7#V<<TK2(5D/_$K@R<N&4C81C*7'7V]:]W*]<!3B]K'GXK^/)G5R
M1QZTLL3SRKI>HL2I8!]V[;(HX52#^\!'T;%8FM;&F_L>:U?[9;J$2^MD+1R@
M!E0RYP5PPQN]^>E;>FQP:;.+6-3#+:X::XD8$.T<2(P'+8Y5SUQT K+\0:I-
M>7E\\D:C1=2B6.:ZF;RV=$+2'RU!ZY8 9!7)&>:Z8\U[1(>JU/9? WAG3_@O
M\)_$GCNXB,NIWMM/8V,<SH6P23-PO!"L'PPR=I.>*^F?@VH70;UAT:6 _7_1
M(*\"\2R_\+2_9GN['35\R^\,H^RW5TEW1*C* "O+,BL QX^8<U[]\'V7^P=1
M4?=6YB7.,?\ +I;\?A7Q&92E.G*53XN9I^BM8]K#)*22VL=YCYLTM%%?*H]4
M<#10*3=0,4G%)NH!#>YIK2*A(/&/:@8I-%+]*8S8Q[TR1ZTM-7/>ACMI%(=F
MD+4E"X:@8H;-(>M.VX[8IN#02PHHP?2CF@0NVEI%]*&!H&)DT4NVC;3$(*<U
M(1BDI %%%% @HHQ3L8H& %%-=@H))P!ZT<\\=*!A0311WQWH$ &:=30>^1CZ
MTNX=B"?K0- 30.>#2>O-)_%C/.,X[T%"T4A.*-V2!U.,]:9 M.J(R(O5U'U8
M4HE4L%#J6Z;=PS^5(8ZBE)7C) )X&3UIK,%XR,TQ"TJTS=Z\4N?0T@'FFTQI
MHUSND08ZY84Y6##(((]0: %HIN]=VS<N_&[;GG'KCTH6169U5E9D.& .2IQG
M!]."*!#UZ4E%% PI-H8C(SCUI:*8AOV>/CY%R#D?*.#ZBF_9ES]T?E4FZA6S
M2+(_LZ9!*9(I^T<?*/;BGTC8Z'@T ,\M.?D7\J41+_= .,9 YI=H7O2LVWZT
M -\E"22H)(P<CJ*3R8_[H].E*K;NM.VCUH C^S1-C**<<#@<4+:PJV5B13[*
M!3PM.H CV[< # [ 4_/K0W2HBQ!IB)*-@:FJ2>HQ3QWH$"H%H90PI12;O6D4
M>!_M'>)+CPK'#J=M&)9;5]/F5&&<D7J\8KQ;]H;X8Z7)>1>,--+0:?KT9O&:
M"52 [%//P#U;A54*<'FO6?VK+";6-/DT^UA$\]RNG0I$3PS/?!17GO[0GB+2
MK/PQH7P^N;J*<:';Q&>1YLA9QA=X55RPB/!4XR&'UK[;+92C&BZ>[;O_ (;+
M]3P<3:\D]M+>IXMHEHFK,89;>2QL[=TDF$N?.ED &-^.FT$#';/K6W<:J=#T
M:_N;F95:XD"1N9'4,A99&SL&>5B./J*S=$N;FUNKV[U)H?*U0*5N;;F*23Y#
MCU'W!QC].:6ZM6OM-N_L4!@OK61%+Q%&,L;?N@0K-U!D4GWS7U35W9['FI=C
M-66V6!H3J%MY7F,DF+Z8#8VZ%@=PQC/EG'TK[J_9UC"^"G!15(%J" /^G."O
MB74-4U"2VN(9-0O5MGQ!\SVZ_N,M,XXSSLB3WYK[9_9Q<R>!V.TJI^RD9][&
MW/\ 6OG\]3^K+U_R/0P'\0^>?VY)6L_$FEW2QK*8=0CD*M&) 5%L,Y4]1C/'
MO7B?A'PG_P (U>6NM:M:6UO!;18BCN;3%Q*4+*@(63Y1AHF(89.,"O>?VOM5
M;3?'FF,8%G0ZC''M9PHP;49Y/0X)P?7%>336"^%[5KZ[96DBN&,.GM)DW3DH
M =X&XY*J=W^R!U->AE]22P-*'='-65Z\B;7=-^QN-**Q1)*DL][<(NUX;59&
M8\<C]YC.,=U&17(S7TGBR9C:1_NW(6WM6&/+C4G"YS@8[MGD\FMW7GG:WO+.
MX??K.HKY^IS/R8R#E;?'.-F!N X^48I/ >EB1;Q'DCB$AM[>41C&Y7F3< .J
MY"D?B:]&$N6#DSGEO8@\&^--9^$NH:GJ*0-<6MQ87-G<V7 \V%DD8E6Y&0\B
M-^'/6OO'X,!UT?5"P/\ Q^*?Q^RP5\$>$_%4VH:!XB.NZ)9:CH$T,]LH!^SS
M0.2I#1,O7#"/.[J!C-??7P27;HNMK_"-1XSZ?9X:^;S^/+'WHZ]7WV_(]+ O
M4]%!Y!I6-"]J&4YKX,]WH+NHVTE*M(#YW_:HCEUS5/!'A9]>U;1;/7KBZC)T
MF]>S.8(&G8M(A#,S! BKG W,W) KQ;X9V.K:-^RCXB\>WWCSQ9)XB@\/SW.E
MPZCK$CPP7!M1*)8XSRSC/&XD =J^OOBE\(_#?QB\.'1/$]DUW9B030RP2M#/
M;2@$"2*13N1L$C(Z@X-<?9_LM^%+?0]?T^^N];\0R:O8/ILEUK&IO)+' R!"
MD1 "QY55!95R0H!R.*5C1/2QY-X=_:,UNXT_1/!]]HH6]BU[P_HCW::K(99(
MKNT6Y\]Y-N2^4(9>A#8S72^ /VH-4^)'QLC\'M8V7ARQ2]O(XTN6D:]N/LN4
MDA92@16;*RC:Q(0<]:ZO0?V6O#UI'<7&J2W%UJ4VJV.K"2UG>,026D(AMXT;
M[Q54&"2<L23QTK?\+_L]^&/#/CG_ (2[=J6I:XLDT\<VHW\DZ0RS#$LD:'Y4
M9UPIP.@ HU#0\^^('[0.H^ ?$WQ3U!M%^W1>%8=*L+55NW$;F[+,99DVX14/
MWG&3M7%6_!?QS\1>-O@7X^\<Q-I2ZII,5XEOI\)=X;2:WAR=[%59MY'F $<!
ME%=SXJ^ /AOQ9J7B:_N)=2M+CQ'';PZF;&]:(3QP9V+@=/<CDXQZU9\+_ _P
MSX5\$ZWX5MH;JXTW6S,^IR7=R\D]Y)*H61WDZ[BH R,=* T/!4_:T\7>%/"/
MAC^T-"L==O(?#6F^(=;O5NFA+V]W.((O*7;S+N(9@?EZ@5VO[6'Q:\0?#^/2
M-"\-SO8ZMJUE?75M<1IN>:>!$,-J@/\ %(\@XZD*0.M;]U^R3\/;R#18YK+4
M)AI=G#IR[]0E_P!)M8GWQ0S\_O$5\,!V(%=O\3/A/X?^+6APZ;XAMI)?LTRW
M5I=6TK0W-I.OW98I%Y1A[4*X[H\/T?4E_9_^!]]\4;R]\0>(M7N+2-KS3M4U
M>22W^T/<+&SHCY$?S,"VT=%( %:4?[0WQ#NK[P+H\'@'3X->\26]_(8;[47B
MA!M63]Y&=A/ER(Q9=P#=,@=^L@_99\'R^$+[P[JMSKFO6MW$(&N-2U262>-!
M() L;9 0;P&X') SFNCD^"/AVXU7PIJMQ)J=UJOAD2"QOIM1E:5Q( )!,<_O
M V!D'T';B@6AX=I/QR\<W\VK0:W#87MG=?$Z/PE:K93RVTMM ,,?F ^880>A
M;<X/!%<]X/\ C1XX\)>(/%FNZ@(O$9UGXBR^$H(+K4Y8H+&&-'\ORHRI1%!'
M+=2,DYXKZ#_X9S\%,]V?L=[&+G7X_$[K'?S*%OTZ2)\WR@Y.0.N:PM<_9A\.
M3ZDTUA9I<65UK3:_=Z;J=W,]LUZPP9E4'L"YV9 )89X&* NCD?B%\?/&<W[,
M7@OQSH-C9Z%X@U[5=-LYX+K=)'$DUT(F*'&2K8&&(^Z^1SBN1T'X_:[X$^,O
MB73]6,5_HVI>,Y-":[NKY\:<(].%SMB0C"Q"3S"6/9AZ5]->/OA;X?\ B5X7
MC\/ZW;2'38;B"Z@2TE,#0R0L&B9"N,;2!QTKS?4/V2?">N>+KO4[^%WTZXOI
M]4FL3/(YN;N:V^S/([,?E C)PJ]SDGM0.ZL>5>+OVMO'4G@'Q_)I^CZ=HVKZ
M&VCFWNB\KJ\-_*H4[74?,JGKT.<BOL#3YKIK. 7PA6]V+YXMR3'OQ\VW/.,]
M,\UXXW['_P /&TG5M.:VU.2WU2TLK.Z9]3E9V6T(-NVXGAE('/H *]$U/PKK
M<TD TOQ3/I-K%"L7DFTCN&8CC<7?DD\4"=NAU+4E<;_PB?BM6!_X3R<^QTNW
MP?TI?^$4\5>9N/CNYQ_=73+;'_H-,S?J=C17'?\ ")^*RQ(\>7 &.!_95M_\
M33&\'^+3T\?W(_[A-K_\304CD['X4^+;;X\7WC"3Q3+)X=FMV1-+\V3;RKA4
MQNX",=X_ARYPH(S4GP'^&/C#X>ZAXGF\4>)&UR'4+GS+:,R,PC]7Y)R6& 2?
MF^6NH;PCXNR"OCZ?&03NTFV/'ITIO_"'^,=S'_A8,V">!_8]MQ^E(9S7Q^T?
MQ)JL?AFY\+&QU34--O);Q_"VHSF&+6HA$5:,/_"Z;PZE@5SUKR_PUXNM_$OC
M;X(7WAS3+^V@>W\0Q3Z/JET4EAFA9 T<C9*OY4AD"GG@\&O7M:^%&M^(I+5]
M2\9/>2VK,]O(^D0*T+,-K%67!!(XX/2J-K\$=2L[S2[F/Q-:QSZ6KQV$D6AP
M*ULK?>"<\;N_KWIB.5^'?BF[\,Z3\7;V.T9M:D\8S6&GV/FF;,S6]OY<:_[(
M9G<@=MU<5<:YJ>F_LS?&OP'KU_J%YK_A'3KQ[;4+_,5U=6<T;S6MR><AE;>F
M>QBKV2W^!MS:WGVN'Q%#%=&[-^98]'A!-P1M,O7[Y'&[KCBEU+X&R:UJ%_?:
MEKL5]=W]L+.ZFFT>W)GA!R(WX^90?X3QR:0SR#PK)+<7_P 8A<EO#+VOA&.
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MS4KM*Q_W1CCCMQTI8_@UJ$&JG4H?$EO#>^<;A95T*V^60]9 .F\\Y8#)SUI
M9GP2DMM(U[XP7ETZVT:^+)-\LS_+&OV6W.T$]%W,>!W;WKS6;2=(B^&/Q\UJ
M^O)M.O=-\1ZH^G:G;7#QW%I+'#$8$B8'_GIC"#@[L8.:]17X R)>7%VNN6$=
MQ<7 NYI%\/VH,LP((D?^\V0.3SP/2BW_ &?VM[U[N/7;-;I[@W;RC0+3+3'K
M*<CE^/O'FF!Y7X+B\0>*OBAXJEU?1+'4-2F\%^'[F_M]1N6A6WN9$G\\JH!
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M'_N&V8_]ITY?"7B9>OCO4&_[AUJ/_9*0'945Q3>#/%#-G_A8&H 8Z?V=:_\
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MM#>%;GQ;\7M&TVUC:>=KF29(5?:9&CL ZKGL"P _&OF'4O$EUX=OX9]0C/\
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ML(KXX^,/QFU#5+R;1=+*Z+HUC"UO':Z=B.,D AB/<G*]?QK[$_9Z_>>#GD&
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ML\\DI541%/JS 9/UKSWQM\=+V2U_X1?2X+>P\8ZC=MIPD%QYT&GQB,-+<.P
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MY;HY$C8/!2WWY+<G.0*TOC7?>-X_AW::1X+CSXMUB:/3UOY$+1V",/WURY'
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M8_V2>H[U\^>-OB/\1_A+;^&O[0@.I7G]FL@T^V"LM[>NPCAA&T<["=[;1PJ
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M"&M7_A?Q#!=VEOI>FZ?%)=3:OJ9\I%[>6H/WV9@%7 ZGK7Z+_!U GAS4<?\
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M[&SFL[:TC L[:".50HV *(U&>JX QVKP=OV13;>$[3P[;>);B2&\FC;6]4G
M%W-&"7=82!A=TA(7/$:LVT9.:O:;^R^^DZ]=SC5/MVG 0-8QS$QM:F(;MJA1
MU>7]XTF<DG)!(&)U$>\)JME)(J)>6[2,YC55E4DN!DJ!GJ!VK@_BM\0'TG1E
MT;PQ>VL_C+6+D:7IT2N)#!*P)>>10<A8D#2'/]T#O7F.F_LK:[8S6NH?\)6J
M:V8;VYGOH8V AU&9/+22!#PJ11_(H//)8Y8\$G[+NN&&Z$&MV>E2#1X-*M)K
M%&\^*/>'NU,IY+3L,O+][G XZO4#WS2]2LK/2K.%M8AU QA;9KQYD)FE50"3
M@XW'&<#UJ_'J5I-8_;4NH7LBOF?:%D4QE?[V[.,>]?/^N_LSG7I--LY=7.E:
M%'<-?WD5E(5EEF 588E8X C& 6Z%MJJ, 5W'C#X3W6N:1X.TZPN85T[0KP3R
MZ9< I;7BK&RQ+(B#!5'*N$Z':!3 W?B)\2;+P9X=M;JWE2\U#5)DL]*@A_>F
MXF?H5"Y+*HRQQV%<I?>/+[X9QZ39:C!?^(/$'B*^+6^GK*'>TMD5?/GD;HJH
MH+D#C<X0>M</\#? NK>(/B%J'B^74H[WP[HS3:-H=XT6V6X DS=RHGW$1YMR
M CDJAQP:U_B+^S?K7CO7_&%XOB,:?'XD>UL9[F-G-S!I,:CS;2'M'O?<Q(^]
MN&>F"#*^E0Q_'K4M4\2ZSJ5FGPYAD6'3M/N& :>)&^>YER<(LSC"D\^6G&-Y
M->V:-KB36DL%V;6VU*UC$EU9V\XE$"$MY9) & 57/2O ;?\ 9-GMYH+6+5K.
M'1X]9COAI6U_)FMK="MG#(O\8A^5BG1V#%CSQZA\+_AUXA\)ZYKVJZ[K-M>O
MJ?D_Z'91%8PZ)M:9W;YF=SSCA5& ,XH!V.&\6?'+_A+/%5_X=\/374>@:.L9
MUS6K8B']](,QV<<DF C%2&9QD@$!1DY':^!O#NEV&I:?K<DFEV331.NGVEC+
MO+[\;V>9CNG<X^@Y[\UA6?P<EL?'6MWMA?:9<BYUB372EP2\MK<20)"&>,?>
MV!&*9(QN/I6?#^SS=VGB34]0.K?VCO,<NFK?2MN@,<> @ '"F4O(S#^^>,@&
M@-#UW6_'&B:!H][J-WJEJEK9P27,S+*K%8T^^V >QX^I KD?"_Q:D\0>%5\1
M:AI/_".V$:R7-XNJ3B.:VL]K-%.4_P!L ';QC/<BO-+7]C\06VCM/XA;5KS^
MT%U'6EO(L0WKC<_EJ!RL E*,(LX.P9KD_$WPZO=/\?'PE=^([34'UC4CXC\0
MW=Z68FTCD LX' QGYEVI".,(YH"R/7/ _C+7O&GB&P\2RR?V9X=\J6::WN;D
M0F.W=/W#F(C/.-Q9L<G X7GU/_A(=)CMH)Y-4LUAF4M%,UP@60#J5.>1]*^>
M/#GP-U#5))[U?$,.N71\1-JFJ6]\LD:Z@55A!'<9&=D2M$5B V_+[U;O/V7=
M2N+NZC;4]/N=)NM5@O);:2!E M8@'6S1<X2)9LR%1]_/S&D&AZ=JWQ@M+'XC
M6GA.UL9M0V6OV[5-0B8>1ID+<0F5O60@X']U2W2NKU7Q1I.AZ'<ZU?7\$&DV
M\#7,EX7!C$:C);/<8_.O"M/_ &8M7ACB:Y\0_:99=8N-7U-6+*-3D=66%YFP
M2?*'EA(P-HV<<\TOC;P#9_$B\T+X/VTLDF@>'%AU/Q#-"2BLH):VL^#U=QO9
M2<A$'=@:!:'LOA#QU;>*?"]CK4T7]E)> %;>YF4O'N/R*^.%<KM.SJ,XZBM;
M^WM.:2W1;^V:2YR(%6929<'!V\\X/I7@?_#+>IZAX4TS0+[Q$L-I)J$NHZQ<
MV(9)[F0G<HB)&$W,$W'LD:HO4D\]XZ^%=Y\)[%QHE[%=:]K6IP6WA^*.,"X\
MP1[8X%XVPV\7[V=V7DXR>>H![5/XZMOB%>^,?"6@ZBVGW>GP_8I=:C*N(KIU
M^=(TSEFB4J2>@9@.H-;G@^S\/>#/"NEZ'I%S;IIMC&MI#^^5MS#KDYY<G)/<
MDFO M'_8WOO#.F7-AI'BB2V!TQ;5;X,PN99Y)?,OI&;L9VP-PR548 ZFNAU3
M]EU]:ETRT;53I>BI<-?7L-BQ$LDRJJP(C8 "# +' +;5 P,TP.O^(_CV>XO]
M(\)^%M3BM]6U4?:[G4XRKIIVGH?WMP3]W<Q_=IG^)B?X37HBZE;744<%O?0_
M:)H3)!\ZNS* !Y@&?F )'(XYKYUUCX)K\._"OC/S=?BM;K6G<6=Q%%F18D3$
M,80<*D,>XA5^4,2YK:_9K^'>L6<K>,-;S:BZM([+2--D&9+/38P!#&V?NEL&
M1L<DL,G@"D%CTWX>^%](^&>B?V&FJ+>:E(\NH7UW=2*+B[FD8M).ZYX!/'H
M .U=-%JUC.&,5[;R!8Q,2DJG"'HYY^[P>>G%>#R_LZZQ]GUUH/$<%SXCN9[F
M1-3O&:5T6XDSN=/]B,*JIR"4'.,@YW_#)<FEK);6OB!7TAKJPB-E>.^;VQ@&
M?LL[CDAI2TC;?ODA3@#%,5CT+Q%X^?Q!\0=%\.^'=8A@TVQ0:QX@U6&2-HX[
M8$K#;;R2 TKY)[A(V]17HLFL6$,:227UM'&Z&5':90&0#)8$GE0._2O!]+_9
MKUNQNK.[N=8TV]G_ +8N=6OK;[.T=K=S.I2WE>,?>\A0@2(_(-O7/-&I?LKW
M&M:O8/J/B,W6F:-8"+3;>6$-Y]T<[Y+I?NM$!@+$O&2S')-(5D>Z+XBTN3[9
MC4;;%FRK<-YR[868 @,<X!((/XBL?QU\1='\!^';_4KJXCN)[>#S8=/AD4SW
M+,0L:(N<DNY51]:\>7]FSQ'JFI0W6M^(;2XL&GN)WT&U5X[.)Y(XXQ+N(+S.
M%1^6V\R$@CK4GAG]F35M$U?0KB\UVSU"/3=3N=3DNY8"UU/(WR6KG(V@01$Q
MI&/E4X;D\4#LCV#X>:?KUCX1L!XFO/MNO3!KB[(QLA=R6\E,#[J A >^W/>N
MG_E6?I<NH%KL:B+8#SV^S&WW?ZGC;OW?Q]<XXZ5?W4Q'G^B_#,Q^+O\ A(]=
MN(M5U2"65K.0*<0AR0",]"$P@ X'S'DM7H'WA2=:<.E Q-M4]6M;BXTV[CLI
MQ:WDD3)#.R[A&Y!"L1WP<''M5VJ\FH6L-Y%9O<PI=RJ7CMV<"1U'4A>I% '(
M^ ?AK;>$)KK4)BMUK=Y&D5Q><DE%YVAF^8Y8EB2>2>P  [78!VHW4;J N&T"
MEIGVB+SEA,B"9E+B/<-Q4'!./3D<^])<7,-K$99Y4AB7 +R,%49.!R?>@"3/
MO11MHH #\W6DV@4M1S7$=O'OED2),A=SL ,DX R>Y/% #SBF[12T4$AM#=10
M(U5LJ,&C::!0,=2<+[4V&XBN-_E2))L8HVQ@=K#J#CH1Z4VYN(;6%Y9I%BB1
M=S.YPJ@=R:!B.S'D&N'\4?#4>-O$"S:S.MWHD:QE+!@?O*26![$,=N3UPN.
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M, 8X+8)KZ>\<?#S2OB%:VL&JO?(EL[21-8WLMJZLR%"=T9!SM8@<]S7.Z?\
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M[^7M.%&-VX9^6O2_B;\0K3X=>$;C598S=WDCK:Z?8)_K+R[D.V*%1ZLQ&3V
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MWJ.Y\S_MC*/^%F:9O$?E1WZ&5I[K[*N#;1X.\>^/KTKY5FTYK>*\@G-N\A?
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M I7Q>91E3PRH5%K%O[G9IGL4)*55RCU1WJ'Y:4FE4<4UJ^4/5%I1ZTS=3UH
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MPQDH7'YU])?DESGG[JQQ$XLH+;5)C:Z)A;)_D\^X)SY<<>%YY.XCKW6OT0^
M>Z/P=<*__/RI'_?B*OS_ +RZ6:SNFFNPR-F:16U%&!1%>7;\J]V=!BOT"^!"
MEO!CL1@^>O\ Z)CKY_/VWAXOS_R/0P*]]GS!^V3H<_B'XI6=E:[O.>Y65649
MVLEJ'R1WQMZ5YOH]O8Z?-#%I,/VG4YI6A:6:!?-*APQ"HJ_*NUV]3A>O%>G_
M +6EG=77Q<TE+)Y8KJ2_78T.0^1:KT(Z'C'XUY1K%Q!<2SV5C)#:0%R;W6+F
M7(MB<9CC8$[G."O')Y'3FN_!-_5*4/)&%;6K)^9=UZ6WECEU.T^73=++Q65T
MRA3=73L3NYYVC\OE Q7)>#X9KNZN#>6\ET(SF18"/,N79P%4>YW Y]JO7NJ?
MVU>6UA:6\EQID,&RW@1,,">2SX&-[=6/N>V*VO"=O+H\,,-U&EH\T@E9B5:1
M$C#.[MMSL4?*.>]>DG[.%NIRNW,9EOX"N9-"U36?#UU+=R6",UTEC.LDT"$H
MA5MI^[CS,^@]:_0?X.QF'PW?*1Q]OEP?^ I7YH>'HHM!\$ZAJMJ[QZO<HY-P
MEP5;R=VUEV C<""<YR..E?I?\'L?\(UJ/;_B93']$KYOB+F5-)NZ3?3T/4P-
MG)G>U')R:3S.V*7D]J^#1[8*N:D'%-SBBF*Z%9O2HUS3Z*+"W#)I,\XSS535
M[RXT_3;FXM;*34;B)"R6L3!6E(_A!/ )]Z\A\0?M0:#9P7%CHFD:OXD\:1/Y
M3^%[*S?[7 _'^NXVQKS]XG!'3-%@U/:E:E/K7!^"?&'BOQ%?QKK/@J7PY8&W
M\PW-Q?1R2&3(^3RER0.O)/:JOBSXR1^'_&6D^&;#0-4UO4K^Y6 F"/RXH5ZO
M(7;A@B\G;G''.30/4]$W;:-V[OFO//B%\8+#P'XNT309[>2\N=6AED@BM^7+
M1LH((Z*NUBQ=B  IK \1?&>_N-:\/CPS:6__  BMU?"QOO$E\CF!9&'[M8 "
M-X+#:9#\H)'6D+4]B5@W0YHS3(5&W(&/K7-?$[QM;?#?P'K?B.Y^SXT^W:9(
M[F<0I*P'"[CT)]@3[4!J=32@UR7PO\:7GQ \&V>MWNBS:%+<9*6\S;MZ?PR*
M2 =K#D;@#[5U2[L\B@$24444%AP*3=2T;:8#2: N:4K0,T@$Z44ZDVT$B448
MHJ78!&;:*X?XM?$2/X>^&P\<D*ZI>-Y5FLS!45N\CD]$4<DUVDS"&-I&("J-
MS%N@ ZFODSXM6WBOXA6NL^,-%UO3;)62>PTC1=6TL7D%["O#LQ)_=@G^+'4U
MW8>GS/G:NE^+Z+^NAA4ERH\C^.7[0$_A7X<^+=+L/#UQX@V:K'!K'B*UOPIN
MGCD1Y(Y% #)"X)4%2>#SUKP3QY:^$?'^@:-KW@6VG%HDRB^T>SN")F_BV ?P
MF,[F1>@3@]:Y[2-5\90^,#ILC6^A7<Z"WOM+;+;U08020R<2H,';@\$_05ZS
MX7^$,GPUM(-8TJQM[BZBB,%X5B!$JE\G;R<IG*CD[MC<8&:^KPV#DVY2T;ZL
M\ZK6ML<%\'?A+?76IZIIVHW4OA=I[K[0UK"RJ]W 6# /N^12" P;DCE<'(KU
MSX6_#6Q\)?$C7K*%)+:XDBN/+BD9@K*^&SM88 X;@;.O)[5T&H/:^.-'A\1Z
M#/\ 9O$&G-N,#OAGP1QN/)(/<Y8DYP M)J6O+J=SHOBNV80ZC;8BNH]NQG/=
MB!CD''0=L\DUZRHQ5U%;_A+_ "9QNI*6XWP78I#\./%5K,5EGT_SMK! =JDG
M'.P[>HY#(/>LO7O#^CZE\$-%CO=/M;ZYN@L44DMJCLH&T$*YCW=\<2'_ '1V
MNR3>1?:YC;$VI)E\X&XX.0-Q)'0=\^_JVT1[C3]*AE,;Q695UC&W+$#@=5)Y
MYPQ)XX(Y WMK=]T_P_S)\C!^)GPLTJ\G\/:9I4]QIVMW2@2S:?(,21R*H=7!
M+9!VJ/E8#MA36_K,=SX772_#MA,UWKA1;<2+$%= O!<J #DD< H'4@#)'-3_
M -O>7XAU7Q+=YN+S9Y5HK9?:3QN.YR3[9!R!@^M26'V7PGI]UXCUL-=^(;[_
M %-L1N8+T"X/\)! Y R&W!@140I\K3MK^;?Z(&R[X?UJ'X5V*2EHWM&3]\\G
M2Y8YY4Y)R"&PP *G@UZC\/?%EWXZ\#37&H6,FG7L5V]UIFJV[_O(& !<D$88
M$_,RCG!)Q7C]EX<N-2=?$/B.6,2#YH;6;F.%2 0S \,VW#<_?"M@Y%6-)^(F
MH:?<RV7AT+="9XV>20DV\3  ##>W(!]&P<5A7H*LFX_%WZ?U_P ,:0J<I]O_
M  Q\<-XQT=XKI5AUFQ80WD(/&['#C_98<BNT]N]?.=IXK'A/6/#GB":'[+/;
MP1Z7K$<?W)X00@EQU5D;:"#V9>2#7T/'^\;S%8%&'%?!XJC[.7,MF>Y1ES+S
M)=M)C;3J3!K@-V)2@4;:6F(3;1MI?QHY]:"A-M&VEI#]: #;28H!SWIPH ;3
MJ*3</6@!:BD8YXITC';Q^=87A'QE9^,K;4;FQCF%I9W<MD+F4 +.T9P[)ZJ&
MR,^H-,#>#!E]?6DXW<5YIXJ^,=BL=OIW@SR?%'B?5 XLK.W<F) I*M-,X^Y$
MK Y/<C R:ZWP3INJ:-X=LK;7=5_MG5U3-U>",(K2$DD*HZ*,X'? &: .AJ/<
M2U#_ #C(:O.M'^..B:[\6KKX?Z9%/J.H6-LUQ?WT #6UHP( B=O[YST[8H ]
M)II8YZ4FT^9G/%9FM^)--T'2]1U#4+R.ULK",RW,S,,1J!DY]_:D!J=:*S?#
M'B"#Q3X?L=7MHYX;:\B$T2741BE"GIN4\J<=C6H1FF VEQ24"I)%6F^M*W%&
M!@F@;1\H_MK6]Y?:7+9Z=&TE[))IH@CC)WNYGD"@>^>E?-$WA72_#?BQ],O+
MJ+4-5@#/+:6MQ\T:*6)Y&1N"L<\_PGBOI+]MB\EM=+O)HV93$VF%#&V&W>=+
MT/K7RE%'86OC[1[ZV$,1NH[FVVP-N)E\ME7@]V)'MS7Z=D\92P:2??\ ),^:
MQ;7M6Q+K4I])\73%9%9;><HRJ<">/.,'^]E<^HYKU+1U;2M/N=.T\[3"GVRR
MNX\?O;4MN*X& "I'/&<9KCM9T>?4-66\C@62.:*,K Q"RJVP!E*GG.0<$9SQ
M6CHZ13:<;.]N%TV6VE:6TF;D02=UD_V3S]"3ZUZ%1J44<\=&6-8M;7Q/IMY]
ME\RWDGM)"?) 6(\EV# +\H*HHR#CVK[?^ :O'X)8,./M Q[#R8N*^)M0N+75
MM'U:.[LH[#5UMI#+;QR8WIC=YBA6^8'G(' #<9%?;_P,/_%%D]VG&?\ OS%7
MS.=7^KI>?^1Z>"7OL\)_: U#P]I?QJL)/$TLD&E7(GM"T+8?=)8E!@_PGGKV
MKP'XA?!G7K/PGIVN>&YH_$G@BT3RTDT]'=[216P6D@0+N?& SDD#'7&*[G]O
MZ<VOB.V(C\UUOD"$?PYM1_GUKS'X)ZQKJZ+>O!?7EOI\31RP30SL%$HXV\'[
MA'7IR5#"O7P-.<<'3Q$)=%H]O^ ]3DKR3K2@T6?A?J2:_=7NB74K)+<B+:L;
MJ'DA7/F)A6;!P0W4?=/I7(7LGC+Q!)<Z2)6M=/MYF@:V7;!"ASP,C[V01R2<
M@@UZ9XPBT[Q)KR"&PALK^"P:XO9K7;&EM,06A=O*V@LY*@J1D\'UJ/\ X29_
M'MBD6IJJ>(;2,+!<L%6.X('23:O&T*,;1P,'IG'I4:SC+VJA]^MGW.:4>C.%
MN(4T?PO%9PO#*$M65I%MA+N9OF;#YX&#C_@)K] /AOXZMM$TW4K"6!WDCU"7
MYMW!^5*^(_$/P_\ $4GA_5]0&@DVUD")Y;<!XD7=G<KK\NT'D8X()'<5]4>'
M?+:XUDF'?*-2D'F8&/NI[YZ5X6<JGB*,+N^^WR.W"R<),]?;XF0(58VAV=\N
M,_E4X^)UENV-;3*_I@?XUYI;R/'<$-#E!DY?D''IS5IKB*3:XB9-Q/9B?Y<5
M\C]7I]CU%69W\GQ,LOX(9&/<8'Z<\TD/Q)MY63%C= ,#U"@@^_.*\Z:0OU5S
M'C<"L9SC/7I47F*Q>0-(SOC<"&//M\M'U>'87M&>G?\ "RK5&*M97(([#::1
MOB5:ABIL;M6'9AC^E>9321QJ2PP<_>8MC\!MI5N(OW(>5<$$'\#D 97U]:7U
M> _;,D\?_';P[K 71+'4=8N-268I-I7AR1?MDFWADD;&8E&1ELKQWKS#P3<^
M+-)UMX=2\KP/X6GCNY);31KF,7DH$FY))YF!RVPX+ID\<D5OZU\,_"VH:C-J
M/]G0V^I3.7?4+%_LURYX^9I$(+=!P<]*\*^+^H:CK%U;6]BUUK.BV=];Z<MQ
M!;FY1"S 2"3O<N,?=!"+C+9/%6L/3>B0_;,]HT[Q-HFHZS:ZIX'T_5+?3M,6
M6>Z\1W%Y-,;\^4RB"/><2*20Q?&!M&.:DT_Q'XN\;^!/#%MJ.FPP:Y:VL;P^
M-O[0V2>6X4ETB3YBY& 58["1WIVA^*M'\3^'[BRTC4Q<2Q6C0-"=D;HP0CYX
M^"I]L 4SP;J5I>?"?0[J>6.SM#IL:R7'F>6J )M8[LC&"#S5?5J?87MF:_CK
MQE\/-/UP75WIEWKGBGB66WM<W,]TOE&/RY%'"Q$=5.!GGFN>\6?M)W/BKX4P
M1R>'-*\/Z;J]MY5O8W%WY]R<<9CC3:L84C.YF 7&37B>N-XG\/Z7>S_"RYU
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M+V]Q]G?;C:2\0.X'OO&<^@K!^('P]T'3V;Q0FFV<FKZB^^^>; $K&)9"P!.
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M371*HK>[_2?5&25MR"X\,ZCX>9;CP]JT>HZ3*N5L)FSO5LIM4]>C.@QUVO@
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MFO8]J6^2V&9WSR""H##))&,5#8Z79WFOVHM+.YO(;Q?LB&=M\2# R%#89AP
M<\ $XS6F)HT\73C=V:15&;ISNCD]*NH?BM##?VD-AX'\+Z#$ EU N^!>[,X'
M^NN'PJ%5X7))R:]"TWXJ0WDTNG16-UH^MQ%8HK6]VAHU=?DDW+QDICY<YZY%
M<IX;^"\FDR0^*?"-^-1TPZC+;V7A"ZAECC.I! R?9#G'J SCY2,<US7BUH?
M?A?7;/QC9WNI_$:XE%]-:0@&/3I'D"R.^[&V<C 1ER/EX')-?)J4\'4:LVEN
MOZ_0]1QC55^I]"Z:5\"Z'/<HY-PD3//.&!9Y"/NC!SC/4?,K #('%3^'2/#7
M@35M0E5&U2_A,MQ*PW?.Q^5<[2 ?Q5OJ*\O\)6_C#Q)9^#+VYF@NO"6L:V]H
M)YG'FRS*"S"-0V/*C"[03RVWL,5N^*/BMI%Q(^BSV][%/<:BMC#<26K!)T$A
M0-&V"=NY".3QCGIFO1CBJ-=1;EJ]_D<\J,XZG9SI_8OP=?3?,_XF$BK/*RNO
M4@CD!^OU0'GJ:O>*M0BNO"6D/]H N='6)G52I958CHOF,0.3_"H_2N;U_P ;
M:#>>$M2D;5[5].:2/3O,DD.%ER,1\D@'TP2,=*ZBZ\.ZO/H^H3)%(^E26R)'
M*I++(R@$, 7YZ=@3[#K6\)PDU)R7Q7^\Q<7M8@\9WJK?6VM6\A2]L K-@",O
M&0"",!,@9'W%"Y Y).:R_$44FO>3-!*L=U&?.LY$ !8GHF0><DXY+,2>3Q76
M^&_"">,-%CU2:Z%K;-;>2\.UB7/]]F"JJC/]YCZX)P*V[;]G%KWX:R67BXV-
MII[2>;;WUQ=_9I;=%^:*0':6!!.[:.3T-<]3$T\/'1^\M+#C2E-Z['S3KWC[
M6/B--)8^'(&LK+38XKK66LX/.N#%O*GR[<X\R-2#O  ('(-4?$,TOPWTG^R+
M_0](U6"Y,E[I>NZ4B76FK'-\W]GCJRHPP5W<Q/D@XK:M1K?@GXA:AH<.MW@U
M@RRZGH_CRQ&))RWRSQ2P$!4B==N5?Y?DW*034MIX-\/?"_5K/5KO68_%%W=3
M/<SZ9!;LNEP,Z@L8X,Y()(W'<,MG& *\^EAZV+K)U8M1?3T.J52-&/N;G7^&
M])7X*^!\:=I.ER7_ (F2&?4;B?4O/ETT.I>&U1<[EC3.=S<;B>.E>;Z'9PS^
M)KNYMM5CMXH0KB5T=S)+D': .=H(^\>U=)J@T36Y[BZBM1%<[6CN+"WW(802
M6"J<'<!U'?& >E5_!-Y;>#]8>:]E@TQ19PR1WLS!EE)?AE/!PWW< 9XQ7U6'
MIQPU&5OBZ_UK^!YE23J31M:W9Z-\5[Z&/4);JR\0V\1AG%BJMY^TXWX8A3N(
M/W3P!T-1:]'/I-E:64[-;<(WDJ=WE(B;8D8CO]YN_)JU\5- 6\L=.\:Z/%(-
M,U%%6Y>*(K''-@QQ%#C&& 9B.H.0:S--VWUB+Z\B:YM9F,5E:QCFY<$\MCD)
MQU[]*FG)3A&49>ZNG9]@E&496:*=AX<O-42:YAEB@MK<@M=W3!( V.A/(8\?
M= -7](TU6M1=Z1MN70F*;5[K$42;ATB0\EB".?<_=KI9OL^E/9W/B.-=0N8G
M$4%ND9^P6N[:JG XW G!SQD9P3FK.K>*-$L[Z[LI[F6^U57A,]K:RCR8@P<J
MOG+&PZ+C: ,=Z4L2Y/D6H^3JS+M]%T33;9X+2!)IKE!$;A4!#9P&$F.%'.>H
MQ@>E;7]AZ1>:.8KJ,2BS_=>=&!Y2@9 9&.0<YW9R<YKA=6\57]U&(;%DTNTV
MH@AAF,CD/E2,JX/<9P@-)X;\:RQPW-LMW'J=K;M+8R+++Y93RD^XI9\@!L_P
M'VJ)4YZ>]KZCO'L;UY9BYMU.JAW1?W*:E9KO:/'W1+'_ !8 Z]MO4]*YV^\(
MSPVZWD<J7FF/\HO+>3*Y'0.",H>O4= *ZW2_'F@0ZC'$]U)I^I7,P6%6DS$)
M#$7"M)L7:.#UX-7]4CDO+Z26Q1M*U>1%/F19-I.,D,7!&.<CIP2<D=ZF-:=-
M\K5A\K>MCA/#-D6M+^PMW+1S,S%=P E5EVR(A/0G@_A6C8W&A?"^[\S2O-U'
MQ%<*;=5N'5EMP?E+90[593SU/![5BZU<0MIUS/!;BRN;)UMM1LF^Y#(3PZ$]
M4P1G^[74?"3P3]@\(ZY\0-2M?-TS2LPVXF*CS)V7;+UX*HH##U;%==2<%3<I
MRT[=WT,E&3E9(XB]\._;HKBXL]174M6),UQ;O$4D;<"<JAQO7W'ITJKHOC;4
M]%M5MK>1$MB26AO(EF17S@L%<'!^G]*]!U77_#WB"&RU*_NTUMIBKVD]A*$N
MD4J6)7OM0#DM\H)[USFL^*-,M=+MY?\ A,='U)=IE6VU72&EFMT&1N+!3E0>
MYYZD@41Q,&N6HK^O3\/T0W3ENC!-QJ/C35V%P6O+QDP\D@ 14 (SGA44#UZ
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MG[Z3_P"*J*F<PG'E47KZ L$^:]S\U/&-GXP\3:LVHSZ+K=U=,V]I)K&8DC/
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MNG:;H^OW7AO2H%MK&-],G1&7'7:5Z],YZX.!7W1_PJ_PHK;_ .Q+4/\ WEW
M_P Z&^'/AC;@:5&?]D._\MU1#.XPJ*IRMVV6F@Y8%N-KGYC>&/#/C;0M0N9(
M/#NL-')&R.DFF&5),\C<KKC[P!'<8%>D:M#JD?B[2-4L-&URX%K"B0?:-&EV
MVJA.$D"@>8V_N!@ #K7WDOPU\,L ?['C0@Y&UW'_ +-22?#OPX&&-.7'IYC_
M /Q5=-3B*%67,Z?D9++YI6YC\[-)'C*UUI+Z?PYX@)L+LW^FQQZ?(4\W=NV.
MI&%7=\V1R#D=ZQ/%WPXOOB;K-UK^O^%/$5IXFN9))H]2L;"0)#+_  >8N#YB
M\L>@VG%?IG'\/O#NW']E0D'U9C_6B3X<^&F4 Z/;D#W8?UJ9Y[1J*SH_U_PX
M+ 5([3/R \3_  R^*EN-)$7AS7+RRT>.2TM8-)M);5I(RA7>XQRS<9QVSZU9
M\5P>*TO-)TP^'[W3HM!TEK>WC?2987N$6+>]Q(Y!W.'D<CTVYK];E^%_A?<6
M.D0#VRW^-.D^%OA.=2LFB6TBL,$,6(_G7D5L;0JNZA;^O4[:=&I#>1^<4OC;
MX97'B3Q3=ZQH4VI:))X932]->-U-NTT<+>:RLB*KLH:/GEA7NOP:\3>3\,O"
M::GX4\1WFJQZ?"MW'=)Y*3,$'WW\G>RD8X+^QKZ/E_9Y^&<]O!;R^"=&EMX&
M+Q0O; I&Q.257H"3Z5MQ_##PM&,)H\0'3 D?_P"*J%BJ*6S_ *^93HS?4^;_
M !I\9=?C8R:;\/XX;F+"I-;:0T\R =,,RA>.Q ->.ZSXD^(7BS6HKG5]%U^2
MU#?OY)+5Y)]I_P">>5VJ>G05]ZGX<>&@,?V5"!_OO_\ %4QOAGX:88.E0[<Y
M'SO_ /%5WT,TPV'^&CKW.>6$J2WF?GNFF^*=)T6;2(?">J7$UPP>]O5L7+W9
MYVHS$;BG/(]1[5EZYX?\2W&J0M:^%]66W:19)5N-/D?:PQD# PRYY'3TK]'O
M^%;^&U);^QX68\$EG_QIB?#WPZN -'MPBG(&6_QKMCQ"D[JF9/+F_M'Y[6/A
M&^TC7KO4/[&U[49XDD57BTF6-;MG3 )_N;&]<Y KA?B9X)\;_$"^FENO#.N7
M,4IC&+JV<21A!\H1D0;<'., 5^H__"O?##==(M__ ![_ !IO_"L?"^[<=&@)
M[9+?XU7^L4;MRIW;5A?V?+I(_,7PGH?Q T_1KS0]8L/$;:-?FU#QK97#(C1>
M:2Q54."2Z<@<E>:AA^%_C&QM+F]L].UN35Y76*WG_LZXC"6PA\KR]NW@Y^;(
M_#!K]/?^%;>%]V?[%M\_5O\ &AOAKX67@:+;C_OK_&O/EFE)S<N1V?0V6&G;
MXC\S;CX;^-X#9W%AX<UC[3N1WCN;2YE2)EF63=&VT9! 88(&,=3FJU]\*O%V
MJ>(O[0OO"&O-$IMOWQTV6X8B-G+X4JCY<,!USQ7Z>+\-?"K==%MS_P!]?XTW
M_A5OA,G+:#:-CD9#'^M:+.*4$X^SW_KN#PDY?:/S9T7X4^)M+\(S6P\,Z_?Z
MA-&J12OIT\;*JN0H=)8V (0]FYK"C^!GBNUFNK>RT;58].\V*ZB6]L9U+R+P
M3L@C7AUP#EN,'UK]16^&_A<MDZ':Y_W3_C2K\-_#'_0#M0.G (_K3_MN-E'D
M>G]=S-8*W4_)J'X*>-K&(Q3^%-0O"SHTC+921*V%D4<X9S@.IZ\[>:Z/4OA7
MXYUC1TM[_2==N[[H;R.UECWIL5!&V>=GRAN.?I7ZA_\ "M/"QQG1+4XZ94G'
MZTO_  K3PL.?["L_^^*3SBB]Z3^__@FGU.7\Q^9FJ_"?Q!K]]<1KX7U+0[6>
M^6;SH;*:4B%4V^7M]SSGKQBJOCGX;^/;C3+?1='T34M0TRV4H_G65S&+WA@L
MCQL#B12Q.1D'\!7Z>)\-/"R\KH-D&'\7ETC?#;PRW_,$LP?^N?\ ]>DLVHQD
MIJGL#PDK?$?E+I?PC^(V@ZAX?U2U\-:H;_3;?[,K&TD "E0#M^4] !@'CVJU
M/\'O$>I0.EWX*UJ2\N+6\2XF^QR2*TDLH=-B;,*J]3D\DFOU.;X7^%&Y?0+-
MCG.=AZ_G3#\,?"ZXV:#9J?9#_C734SRE5WI?U]_D9+!3C]L_++4/A'\1+&^N
M4\.^"]2M-)N9"9+6ZLY69T,:K_"!MPRD@#D;NM<O9_LZ_$.&^LKB;PCK#K:S
M%Y9VM9RTG!VM@\!LD9P/X0:_7H_#CPL5*MH-DV1@_NJ:/AAX412$T&S3)R<*
M1_6E'/*4?^77]?>/ZE)_:/SY\4^#]9^(6AQW^J'Q58>)(XQ <://<.81"T30
MEB NUB=VX'N00>*R-:\+:[+\'8?"=IX.UI66"*,,;*6-0XSO.=I)R<?>]>U?
MH]_PK7PQC!T6VV^@##^M(/AGX5P!_8EN #D?>_QK".;T(W2@[:Z=KE_59:>\
M?F#XT^'7BG6+R6YTWPQK;QLMNL<+64\+DJA$@'#)UQU&#BJN@?"/Q@J%KO0]
M0C?(7,EA<([I]G,3+OBY^\0>5/2OU,_X5OX8P,:-;C'3&[C]:8?AMX8_BT:
M_BW^-#SBB_\ EVQ?4Y+J?EA=_"'Q5'%+*?"VJ7%XB6B0R"P<^8(YBTBEC'D
MH0">I(_"M[1_A7K^@G6KD>&[]I[I2;:V&G75P8>!A2TFU<<=E-?I?_PK7PMN
M9O[%@RW7EO\ &EC^&GA=<8T:!?IN_P :TAG5&&T&0\'*6[/R_M? OCK29M2O
M8?"^NN=2TU[:]C6SF+22-(&21%B10 ASP<D@D5'I/@7Q)Y<A;PGKD44L90Q3
M65RFR0%F\U4"#Y6WX*MR-O?I7ZDGX<^'&7:=+CQVPS#'ZU"?AEX97[VEJ_\
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M=)6\&WZ/\F^+=R,N5;''.T -[@\5I+XPUUHQ(-!*)N9")&;<,2JF>G3:Q/\
MP&NV"BG4Y58/:'Y@HON<Y?>(-1M-0>"/2I)X5N(XA(N>4899^F..GX<UT*;6
M4$=#R.,4ZD8UA*2=K*QHE81E'I1DTAIRU(Q-O>DP#3S3:!"4M%*M*]P$Q36S
M4E(U,&AJYI3FBD)IB$YI1F@4HH"P<T[:*1J;N-38H?M%%-W&D9CZT[#'TG!Z
M4B\]:4\4 &TTM,W&ER:+"$S2JU.VCTHVB@8GTI:C8TY*+ .Z4F:4TBT +113
F: $P:<O2EII)I)"M87%(R^E-W'UHW'UJ@%$?KS2L*,FBD+1'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350782682528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">Revising for shares and pricing<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Nocera,
Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001756180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-1626611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3F (Building B)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">No. 185, Sec. 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Datong Rd., Xizhi Dist.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New Taipei City<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">163-358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350784100592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,961,777<span></span>
</td>
<td class="nump">$ 2,444,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">531,522<span></span>
</td>
<td class="nump">699,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,618,264<span></span>
</td>
<td class="nump">1,488,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other assets, net</a></td>
<td class="nump">23,015<span></span>
</td>
<td class="nump">107,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from a related party</a></td>
<td class="nump">2,073,362<span></span>
</td>
<td class="nump">1,615,217<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">6,225,857<span></span>
</td>
<td class="nump">6,397,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_NCRA_RetentionReceivables', window );">Retention receivables</a></td>
<td class="nump">47,946<span></span>
</td>
<td class="nump">69,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax asset, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">68,444<span></span>
</td>
<td class="nump">71,245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">332,040<span></span>
</td>
<td class="nump">332,040<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">448,430<span></span>
</td>
<td class="nump">472,774<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">6,674,287<span></span>
</td>
<td class="nump">6,870,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">92,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities', window );">Other payables and accrued liabilities</a></td>
<td class="nump">69,387<span></span>
</td>
<td class="nump">142,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="nump">15,334<span></span>
</td>
<td class="nump">39,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyAccrual', window );">Warrant liability</a></td>
<td class="nump">312,320<span></span>
</td>
<td class="nump">312,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividend payable</a></td>
<td class="nump">6,312<span></span>
</td>
<td class="nump">6,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="nump">112,885<span></span>
</td>
<td class="nump">387,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayableToBankCurrent', window );">Bank borrowing</a></td>
<td class="nump">50,565<span></span>
</td>
<td class="nump">52,292<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,974,657<span></span>
</td>
<td class="nump">2,100,685<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">1,974,657<span></span>
</td>
<td class="nump">2,100,685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock ($0.001 par value; authorized 200,000,000 shares; 10,707,150 shares issued and outstanding as of March 31, 2022 and 10,607,150 shares issued and outstanding as of December 31, 2021, respectively)</a></td>
<td class="nump">10,707<span></span>
</td>
<td class="nump">10,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock ($0.001 par value; authorized 10,000,000 shares; Series A Preferred Stock, 2,000,000 authorized, 80,000 shares issued and outstanding as of March 31, 2022 and December 31, 2021)</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">15,078,760<span></span>
</td>
<td class="nump">14,472,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">(Accumulated losses) Retained earnings</a></td>
<td class="num">(10,724,273)<span></span>
</td>
<td class="num">(9,918,553)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">143,137<span></span>
</td>
<td class="nump">13,906<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL NOCERA, INC.&#8217;S STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">4,699,630<span></span>
</td>
<td class="nump">4,769,964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">TOTAL STOCKHOLDER EQUITY</a></td>
<td class="nump">4,699,630<span></span>
</td>
<td class="nump">4,769,964<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDER EQUITY</a></td>
<td class="nump">$ 6,674,287<span></span>
</td>
<td class="nump">$ 6,870,649<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NCRA_RetentionReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NCRA_RetentionReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NCRA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate extended product warranty liability. Does not include the ending balance for the standard product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableToBankCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of current portion of long-term loans payable to bank due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableToBankCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350780313952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">10,707,150<span></span>
</td>
<td class="nump">10,607,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">10,707,150<span></span>
</td>
<td class="nump">10,607,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">80,000<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">80,000<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350780187040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 2,919,045<span></span>
</td>
<td class="nump">$ 1,579,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(2,863,803)<span></span>
</td>
<td class="num">(1,230,842)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">55,242<span></span>
</td>
<td class="nump">348,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="num">(860,953)<span></span>
</td>
<td class="num">(235,235)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="num">(860,953)<span></span>
</td>
<td class="num">(235,235)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">(Loss) Income from operations</a></td>
<td class="num">(805,711)<span></span>
</td>
<td class="nump">113,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,759)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) Income before income taxes</a></td>
<td class="num">(805,711)<span></span>
</td>
<td class="nump">111,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(62,160)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">(805,720)<span></span>
</td>
<td class="nump">49,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net loss attributable to non-controlling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income attributable to the company</a></td>
<td class="num">(805,720)<span></span>
</td>
<td class="nump">49,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">(805,720)<span></span>
</td>
<td class="nump">49,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation (loss) gain</a></td>
<td class="num">(129,231)<span></span>
</td>
<td class="nump">1,669<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total comprehensive (loss) income</a></td>
<td class="num">(934,951)<span></span>
</td>
<td class="nump">51,159<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive (loss) income attributable to the Company</a></td>
<td class="num">$ (934,951)<span></span>
</td>
<td class="nump">$ 51,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="num">$ (0.0755)<span></span>
</td>
<td class="nump">$ 0.0054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="num">$ (0.0755)<span></span>
</td>
<td class="nump">$ 0.0036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">10,677,150<span></span>
</td>
<td class="nump">9,131,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">10,677,150<span></span>
</td>
<td class="nump">13,821,506<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350777994416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Statutory And Other Reserves [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Total Nocera Stockholders Equity [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 9,132<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,692,973<span></span>
</td>
<td class="nump">$ 191,219<span></span>
</td>
<td class="num">$ (293,162)<span></span>
</td>
<td class="num">$ (49,770)<span></span>
</td>
<td class="nump">$ 2,550,392<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,550,392<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="nump">9,131,786<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation Adjustments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,669)<span></span>
</td>
<td class="num">(1,669)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,669)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">103,155<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">103,155<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">103,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">49,490<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">49,490<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">49,490<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Mar. 31, 2021</a></td>
<td class="nump">$ 9,132<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,796,128<span></span>
</td>
<td class="nump">191,219<span></span>
</td>
<td class="num">(243,672)<span></span>
</td>
<td class="num">(51,439)<span></span>
</td>
<td class="nump">2,701,368<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,701,368<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Mar. 31, 2021</a></td>
<td class="nump">9,131,786<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2021</a></td>
<td class="nump">$ 10,607<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">14,472,705<span></span>
</td>
<td class="nump">191,219<span></span>
</td>
<td class="num">(9,918,553)<span></span>
</td>
<td class="nump">13,906<span></span>
</td>
<td class="nump">4,769,964<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,769,964<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2021</a></td>
<td class="nump">10,607,150<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Consultancy services settled by equities</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">502,900<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">503,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">503,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Common stock issuance, shares</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation Adjustments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">129,231<span></span>
</td>
<td class="nump">129,231<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">129,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">103,155<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">103,155<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">103,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(805,720)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(805,720)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(805,720)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Mar. 31, 2022</a></td>
<td class="nump">$ 10,707<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 15,078,760<span></span>
</td>
<td class="nump">$ 191,219<span></span>
</td>
<td class="num">$ (10,724,273)<span></span>
</td>
<td class="nump">$ 143,137<span></span>
</td>
<td class="nump">$ 4,699,630<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,699,630<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Mar. 31, 2022</a></td>
<td class="nump">10,707,150<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350777800848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (805,720)<span></span>
</td>
<td class="nump">$ 49,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expenses</a></td>
<td class="nump">787<span></span>
</td>
<td class="nump">1,218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">103,155<span></span>
</td>
<td class="nump">103,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">181,547<span></span>
</td>
<td class="num">(303,302)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(81,931)<span></span>
</td>
<td class="num">(47,374)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent', window );">Advance to suppliers</a></td>
<td class="nump">25,892<span></span>
</td>
<td class="num">(89,647)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets, net</a></td>
<td class="nump">149,262<span></span>
</td>
<td class="num">(21,683)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease right-of-use asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">23,414<span></span>
</td>
<td class="nump">6,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInNotesPayableCurrent', window );">Notes payable</a></td>
<td class="num">(93,194)<span></span>
</td>
<td class="num">(51,688)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(34,887)<span></span>
</td>
<td class="nump">8,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Other payables and accrued liabilities</a></td>
<td class="num">(98,670)<span></span>
</td>
<td class="nump">26,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Income tax payable</a></td>
<td class="num">(281,200)<span></span>
</td>
<td class="nump">59,743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,332)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseDueFromOtherRelatedParties', window );">Amount due from a related party</a></td>
<td class="num">(458,145)<span></span>
</td>
<td class="num">(261,209)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(553,267)<span></span>
</td>
<td class="num">(258,573)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOilAndGasPropertyAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(24,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(24,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfBankDebt', window );">Bank borrowing</a></td>
<td class="num">(3,453)<span></span>
</td>
<td class="num">(144,233)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(3,453)<span></span>
</td>
<td class="num">(144,233)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">74,488<span></span>
</td>
<td class="nump">10,727<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="num">(482,232)<span></span>
</td>
<td class="num">(416,079)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">2,444,009<span></span>
</td>
<td class="nump">1,023,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">1,961,777<span></span>
</td>
<td class="nump">607,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for Income taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseDueFromOtherRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables due from related parties classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseDueFromOtherRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOilAndGasPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to purchase long lived physical asset for use in the normal oil and gas operations and to purchase mineral interests in oil and gas properties not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOilAndGasPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfBankDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle a bank borrowing during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfBankDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350785084544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRINCIPAL ACTIVITIES AND ORGANIZATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">PRINCIPAL ACTIVITIES AND ORGANIZATION</a></td>
<td class="text"><p id="xdx_805_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zrEb8tFfPdJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1 &#160;&#160;&#160;&#160;&#160;<span id="xdx_826_zoHQe5OKUshe">PRINCIPAL ACTIVITIES AND ORGANIZATION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include
the financial statements of Nocera, Inc., a Nevada corporation (&#8220;Nocera&#8221;), and its subsidiaries, Grand Smooth Inc Limited
(&#8220;GSI&#8221;) and Guizhou Grand Smooth Technology Ltd. (&#8220;GZ GST&#8221; or &#8220;WFOE&#8221;), and Xin Feng Construction
Co., Ltd. (&#8220;XFC&#8221;) that is controlled through contractual arrangements. Nocera, GSI, GZ GST and XFC are collectively referred
to as the &#8220;Company.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera was incorporated in the State of Nevada
on February 1, 2002 and is based in New Taipei City, Taiwan (R.O.C). It did not engage in any operations and was dormant from its inception
until its reverse merger of GSI on December 31, 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Reverse Merger</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective December 31, 2018, Nocera completed
a reverse merger transaction (the &#8220;Transaction&#8221;) pursuant to an Agreement and Plan of Merger (the &#8220;Agreement&#8221;),
with (i) GSI, (ii) GSI&#8217;s shareholders, Yin-Chieh Cheng and Bi Zhang, who together owned shares constituting 100% of the issued
and outstanding ordinary shares of GSI (the &#8220;GSI Shares&#8221;) and (iii) GSI Acquisition Corp. Under the terms of the Agreement,
the GSI Shareholders transferred to Nocera all of the GSI Shares in exchange for the issuance of 10,000,000 shares (the &#8220;Shares&#8221;)
of Nocera&#8217;s common stock (the &#8220;Share Exchange&#8221;). As a result of the reverse merger, GSI became Nocera&#8217;s wholly-owned
subsidiary and Yin-Chieh Cheng and Bi Zhang, the former shareholders of GSI, became Nocera&#8217;s controlling shareholders. The share
exchange transaction with GSI was treated as a reverse merger, with GSI as the accounting acquirer and Nocera as the acquired party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GSI is a limited company established under the
laws and regulations of Hong Kong on August 1, 2014, and is a holding company without any operation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GZ WFH was incorporated in Xingyi City, Guizhou
Province, People&#8217;s Republic of China (&#8220;PRC&#8221;) on October 25, 2017, and is engaged in providing fish farming containers
service, which integrates sales, installments, and maintenance of aquaculture equipment. The registered capital of GZ WFH is RMB$5,000,000
(equal to US$733,138).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 13, 2018, GSI incorporated GZ GST
in PRC with registered capital of US$15,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Divestiture</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 21, 2020, the Company filed a Current
Report on Form 8-K outlining the lack of communication that led to the termination by Nocera of its relationship with its former variable
interest entity, Guizhou Wan Feng Hu Intelligent Aquatic Technology Co. Limited (&#8220;GZ WFH&#8221;) and its management, and termination
of the variable interest entity agreements between the parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequently on October 8, 2020, Zhang Bi and
GZ WFH entered into a Settlement Agreement and Release with Nocera wherein all claims as to GZ WFH&#8217;s debt (claim to shares in Nocera
or GZ GST) were compromised, settled, and otherwise resolved as to any and all claims or causes of action whatsoever against Nocera for
any matter, action, or representation as to Nocera, and any debt to ownership of Nocera or GZ GST up to the date of the agreement. The
consideration for the agreement was mutual waiver of any and all claims against each other and GZ GST, and GZ WFH (including Zhang Bi)
waived any claims to Nocera stock, meaning the 4,750,000 shares of common stock of Nocera owned by Zhang Bi were cancelled as part of
the agreement. The Settlement Agreement and Release is attached hereto as Exhibit 10.8.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">The VIE Agreements</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2020, Nocera and XFC, a domestic
funded limited liability company registered in Taiwan (R.O.C), entered into a series of contractual agreements (&#8220;VIE Agreements&#8221;)
whereby Nocera agreed to provide technical consulting and related services to XFC. As a result, Nocera has been determined to be the
primary beneficiary of XFC and XFC became a variable interest entity (&#8220;VIE&#8221;) of Nocera.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2020, Nocera exchanged <span id="xdx_902_ecustom--SharesExchanged_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShareholdersMember_zuhq4bZLDds5" title="Shares exchanged">700,000</span>
shares of the Company&#8217;s restricted common stock to shareholders of XFC in exchange for 100% controlling interest in XFC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The VIE structure was adopted mainly because
the China and Taiwan (R.O.C.) operating company may in the future engage in business that may require special licenses in China and which
can be in an industry that prohibits foreign investment. WFOE has entered into the following contractual arrangements with a stockholder
of XFC, that enables the Company to (1) have the power to direct the activities that most significantly affects the economic performance
of XFC, and (2) receive the economic benefits of XFC that could be significant to XFC. The Company is fully and exclusively responsible
for the management of XFC, assumes all of the risk of losses of XFC and has the exclusive right to exercise all voting rights of XFC&#8217;s
stockholder. Therefore, in accordance with ASC 810 &#8220;Consolidation,&#8221; the Company is considered the primary beneficiary of
XFC and has consolidated XFC&#8217;s assets, liabilities, results of operations, and cash flows in the accompanying consolidated financial
statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) Voting Rights Proxy Agreement &amp; Power
of Attorney. Mr. Tsai, Wen-Chih, Ms. Tu, Hui-Min, Mr. Tsai, Chin-Yao, and Mr. Tsai, Chin-Chao (&#8220;Existing Stockholders&#8221;) hereby
irrevocably undertake that they authorize Nocera or the individual then designated by Nocera (&#8220;Attorney&#8221;) to exercise, on
his or her behalf, the following rights available to them in their capacity as a stockholder of XFC under the then effective articles
of association of XFC (collectively, &#8220;Powers&#8221;): (a) to propose the convening of, and attend, stockholders&#8217; meetings
in accordance with the articles of association of XFC on behalf of the Existing Stockholders; (b) to exercise voting rights on behalf
of the Existing Stockholders on all matters required to be deliberated and resolved by the stockholders&#8217; meeting, including without
limitation the appointment and election of the directors and other executives to be appointed and removed by the stockholders of XFC
and the sale or transfer of all or part of the equity held by stockholders of XFC; (c) to exercise other stockholders&#8217; voting rights
under the articles of association of XFC (including any other stockholders&#8217; voting rights stipulated upon an amendment to such
articles of association); (d) other voting rights that stockholders shall enjoy under Taiwan (R.O.C.) laws, as amended, revised, supplemented
and re-enacted, no matter whether they take effect before or after the conclusion of the Voting Rights Proxy Agreement. The Existing
Stockholders shall not revoke the authorization and entrustment accorded to the Attorney other than in the case where Nocera gives the
Existing Stockholders a written notice requesting the replacement of the Attorney, in which event the Existing Stockholders shall immediately
appoint such other person as then designated by Nocera to exercise the foregoing Powers and such new authorization and entrustment shall
supersede, immediately upon its grant, the original authorization, and entrustment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2) Exclusive Business Cooperation Agreement.
Nocera agrees to provide technical consulting and services including management consulting services, general and financial advisory service
and various general and administrative service, for the specific content thereof (hereinafter referred to as the &#8220;Target Business&#8221;)
to XFC as the technical consulting and service provider of XFC in accordance with the conditions set forth herein during the term of
this Agreement. XFC agrees to accept the technical consulting and services provided by Nocera. XFC further agrees that, without the prior
written consent of Nocera, during the term of the Exclusive Business Cooperation Agreement, it shall not accept any technical consulting
and services identical or similar to the Target Business that are provided by any third party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3) Equity Pledge Agreement. Under the Equity
Interest Pledge Agreement between Nocera and the Existing Stockholders, the Existing Stockholders pledged all of their equity interests
in XFC to Nocera to guarantee the performance of XFC&#8217;s obligations under the Exclusive Business Cooperation Agreement. Under the
terms of the Equity Pledge Agreement, in the event that XFC or the Existing Stockholders breach their respective contractual obligations
under the Exclusive Business Cooperation Agreement, Nocera, as pledgor, will be entitled to certain rights, including, but not limited
to, the right to collect dividends generated by the pledged equity interests. Zhang Bi also agreed that upon the occurrence of any event
of default, as set forth in the Equity Pledge Agreement, Nocera is entitled to claim indemnity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(4) Exclusive Call Option Agreement. XFC and
the Existing Stockholders have entered into an Exclusive Call Option Agreement with Nocera. Under the Exclusive Call Option Agreement,
the Existing Stockholders irrevocably granted Nocera (or its designee) an exclusive option to purchase, to the extent permitted under
Taiwan (R.O.C.) law, part or all of their equity interests in XFC. According to the Exclusive Call Option Agreement, the purchase price
shall be the minimum price permitted by applicable Taiwan (R.O.C.) law at the time when such share transfer occurs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350786057808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICY</a></td>
<td class="text"><p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zsA4Hz2pvhTg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 2&#160;&#160;&#160;&#160;&#160; <span id="xdx_822_zG378H6snXKi">SUMMARY
OF SIGNIFICANT ACCOUNTING POLICY</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zOPDEjzSSOw3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_865_zzthcj81O9vb">Basis of Presentation</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated
financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;)
and pursuant to the rules and regulations of the United States Securities and Exchange Commission (&#8220;SEC&#8221;) for interim financial
information. Accordingly, these financial statements do not include all of the information and footnotes required for complete financial
statements and should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the
Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 23, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of management, all adjustments
(which include normal recurring adjustments) necessary to present a fair presentation of the Company&#8217;s unaudited condensed consolidated
financial position as of March 31, 2022, its consolidated results of operations for the three months ended March 31, 2022, cash flows
for the three months ended March 31, 2022 and change in equity for the three months ended March 31, 2022, as applicable, have been made.
Operating results for the three months ended March 31, 2022 are not necessarily indicative of the operating results that may be expected
for the year ending December 31, 2021 or any future periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zyWbWqZ1EcTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86A_zotZqIi3DkM7">Concentrations of Credit Risk</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially expose
the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its
customers and suppliers, and generally does not require collateral or other security from them. The Company evaluates its collection
experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic
reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were two customers who represent <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zqiCWblCaVS1" title="Concentration risk">98</span>% of
the Company&#8217;s total revenue for the three months ended March 31, 2021. There were three customers who represent <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zy6rnYyOTYbh" title="Concentration risk">97</span>% of the Company&#8217;s
total revenue for the three months ended March 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of single
customers who represent 10% or more of the Company&#8217;s total accounts receivable, net:</p>

<table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zm25Fxx0Zcgc" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B0_zW4Z3tOGIYKf" style="display: none">Concentrations of credit risk</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">Percentage of the Company&#8217;s accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Customer A</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zK5sbpyPlAUj" title="Concentration percentage">22.01</span>%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zuYJNPFVAu05" title="Concentration percentage">16.37</span>%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zB2k6gUomz9a" title="Concentration percentage">56.98</span>%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zkaoD6BhLDdi" title="Concentration percentage">59.53</span>%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Customer C</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zUxiX7ZeoRw6" title="Concentration percentage">20.75</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zXgLgH7ZWUI9" title="Concentration percentage">16.30</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_zWKMciXuphs9" title="Concentration percentage">99.74</span>%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_z3ZENt2V02q3" title="Concentration percentage">92.20</span>%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<p id="xdx_84F_eus-gaap--RevenueRecognitionPolicyTextBlock_zTX5IXSAHa7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_860_zqVyQTKrSymi">Revenue Recognition</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes revenue in accordance
with Accounting Standards Codification (&#8220;ASC&#8221;) 606, &#8220;Revenue from Contracts with Customers.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The core principle of the guidance is that an
entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, the Company applies
the following steps:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 1: Identify the contract(s)
    with a customer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 2: Identify the performance
    obligations in the contract</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 3: Determine the transaction
    price</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 4: Allocate the transaction
    price to the performance obligation in the contract</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Wingdings; font-size: 10pt">&#376;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 5: Recognize revenue
    when (or as) the entity satisfies a performance obligation</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considered revenue is recognized
when (or as) the Company satisfies performance obligations by transferring promised goods or services to its customers. Revenue is measured
at the transaction price which is based on the amount of consideration that the Company expects to receive in exchange for transferring
the promised goods or services to its customers. Contracts with customers are comprised of invoices and written contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have arrangements for returns
from customers and does not have any future obligations directly or indirectly related to services resale by customers. The Company has
no sales incentive programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company provides goods, maintenance service
warranties for the goods sold with a period varying from 18 months to 72 months, a majority of which are 18 months, and exclusive sales
agency license to its customers. For performance obligation related to providing products, the Company expects to recognize the revenue
according to the delivery of products. For performance obligation related to maintenance service warranties, the Company expects to recognize
the revenue on a ratable basis using a time-based output method. The performance obligations are typically satisfied as services are
rendered on a straight-line basis over the contract term, which is generally for 18 months as a majority of the maintenance service warranties
periods provided are 18 months. For performance obligation related to exclusive agency license, the Company recognizes the revenue ratably
upon the satisfaction over the estimated economic life of the license.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have amounts of contract
assets since revenue is recognized as control of goods is transferred. The contract liabilities consist of advance payments from customers
and deferred revenue. Advance payments from customers are expected to be recognized as revenue within 12 months. Deferred revenue is
expected to be recognized as revenue within 12 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zdmRuBtRXOTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_866_zvQxyYzc7Cef">Recent Accounting Pronouncements</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The FASB issued several updates during the period, none of these standards
are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the consolidated
financial statements upon adoption.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350786047936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, NET<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditLossAbstract', window );"><strong>Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndNontradeReceivableTextBlock', window );">ACCOUNTS RECEIVABLE, NET</a></td>
<td class="text"><p id="xdx_802_eus-gaap--AccountsAndNontradeReceivableTextBlock_zrDK24Rj4eBe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 3&#160;&#160;&#160;&#160;&#160;<span id="xdx_82A_zfn0f5ca1M7g">ACCOUNTS RECEIVABLE, NET</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2022 and December 31, 2021, accounts
receivable consisted of the following:</p>

<table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zvxUkk75SMQi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, NET (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B0_zJOWVgbUJQQ3" style="display: none">Schedule of accounts receivable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20220331_z7fGBYydQXwk" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20211231_zjxfyEkfbM67" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccountsReceivableGross_iI_pp0p0_maARNCzmYm_zlyj2389ocuc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">531,522</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">699,555</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_d0_msARNCzmYm_zZWOE0xJQT2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Allowance for doubtful accounts</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNCzmYm_zBmCxAALEk64" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">531,522</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">699,555</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended March 31, 2022 and
for the year ended December 31, 2021, the Company has recorded provision for doubtful accounts of nil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndNontradeReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -URI https://asc.fasb.org/topic&amp;trid=2196771<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -URI https://asc.fasb.org/topic&amp;trid=82887179<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndNontradeReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781602368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_zcpph4ZtWiag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 4 &#160;&#160;&#160;&#160;&#160;<span id="xdx_828_ztHWsNYJQdGd">INVENTORIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2022 and December 31, 2021, inventories
consisted of the following:</p>

<table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zJrBbyeFxJgc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B8_zXcJN3HrTLAj" style="display: none">Schedule of inventory</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20220331_zNPx1lrMRR8c" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20211231_zVoRi9ywFbPj" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_pp0p0_maINz9VL_z7cGHFufja82" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Raw materials</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">99,263</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">97,163</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InventoryWorkInProcessAndRawMaterialsNetOfReserves_iI_pp0p0_maINz9VL_zyokTyy9ldvf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Work in process</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,519,001</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,391,518</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InventoryNet_iTI_pp0p0_mtINz9VL_zvBBf6UE8Fa2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,618,264</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,488,681</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350866172208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER ASSETS, NET<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">PREPAID EXPENSES AND OTHER ASSETS, NET</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--OtherCurrentAssetsTextBlock_zFjDzJzPWLWk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note
5&#160;&#160;&#160;&#160;&#160; <span id="xdx_822_zautqDbUIBY3">PREPAID EXPENSES AND OTHER ASSETS, NET</span></b></p>

<table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zjkbDhSBANY7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B9_zUkeBYARoimj" style="display: none">Schedule of prepaid expenses and other assets</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220331_z2F8Zb8a3fQg" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20211231_z3i9deZN8Tb5" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Other receivables from third party</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_pp0p0_c20220331_zrpuL1g7L8e5" style="width: 13%; text-align: right" title="Other receivables from third party">23,015</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccountsAndOtherReceivablesNetCurrent_c20211231_pp0p0" style="width: 13%; text-align: right" title="Other receivables from third party">107,444</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Others</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PrepaidExpenseAndOtherAssets_iI_d0_c20220331_zX3sRGRhkpui" style="border-bottom: Black 1pt solid; text-align: right" title="Others">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PrepaidExpenseAndOtherAssets_iI_d0_c20211231_zMGPGfSQlPZd" style="border-bottom: Black 1pt solid; text-align: right" title="Others">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Prepaid expenses and other assets, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_c20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Prepaid expenses">23,015</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Prepaid expenses">107,444</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781495824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, NET</a></td>
<td class="text"><p id="xdx_801_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zC586Wb8FNe3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 6 &#160;&#160;&#160;&#160;&#160;<span id="xdx_826_zcGIlgcP6bV5">PROPERTY AND EQUIPMENT, NET</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2022 and December&#160;31, 2021,
property and equipment consisted of the following:</p>

<table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--PropertyPlantAndEquipmentTextBlock_z1BtwQ7P3Be2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT, NET (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BA_zKf5UCVa7U4i" style="display: none">Schedule of property and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zDmnQElPvyQl" style="text-align: right" title="Property and equipment, gross">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zAe1uhhejWe3" style="text-align: right" title="Property and equipment, gross">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; text-align: justify">Equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 13%; text-align: right" title="Property and equipment, gross">77,031</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 13%; text-align: right" title="Property and equipment, gross">78,802</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Leasehold improvement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zrD9YVR9xcda" style="text-align: right" title="Property and equipment, gross">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zoXPFdeCGeR2" style="text-align: right" title="Property and equipment, gross">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Vehicle</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zcB14m3JzGK6" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z9kM2c4BzIik" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20220331_pp0p0" style="text-align: right" title="Property and equipment, gross">77,031</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" style="text-align: right" title="Property and equipment, gross">78,802</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20220331_z9WTzKKTHvvk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(8,587</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zZjPEa8Z3yTf" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(7,557</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">68,444</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">71,245</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation expenses for the three months ended
March 31, 2022 and 2021 were $<span id="xdx_90B_eus-gaap--Depreciation_pp0p0_c20220101__20220331_zEDa8u4Y7rFa" title="Depreciation expense">787</span> and $<span id="xdx_904_eus-gaap--Depreciation_pp0p0_c20210101__20210331_zqyyx2RRKFx7" title="Depreciation expense">1,218</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781504112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">GOODWILL</a></td>
<td class="text"><p id="xdx_809_eus-gaap--GoodwillDisclosureTextBlock_zf7qKeMb0QC7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 7 &#160;&#160;&#160;&#160;<span id="xdx_827_zRYZyYqc1xv9">GOODWILL</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2022 and December&#160;31, 2021,
goodwill consisted of the following:</p>

<table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfGoodwillTextBlock_zKCaKhtLz8ba" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BF_zpSt53H8uXib" style="display: none">Schedule of goodwill</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Goodwill - XFC</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Goodwill_c20220331__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="width: 13%; text-align: right" title="Goodwill">332,040</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Goodwill_c20211231__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="width: 13%; text-align: right" title="Goodwill">332,040</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20220331__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_zZhMHr3F27N" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20211231__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_zrnytFwnc8oj" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Goodwill, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Goodwill_c20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill">332,040</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Goodwill_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill">332,040</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781585264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAndProductWarrantiesAbstract', window );"><strong>Guarantees and Product Warranties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesTextBlock', window );">WARRANTS</a></td>
<td class="text"><p id="xdx_800_eus-gaap--GuaranteesTextBlock_zxUz9CGYXmxa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note </b><b>8
</b><b>&#160;&#160;&#160;&#160;<span id="xdx_82D_zgJB3DLrWrLj">WARRANTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April
1, 2021, the Company entered into a securities purchase agreement with certain investors for an aggregate of 80,000 shares of its preferred
stock at a per share purchase price of $2.50. As part of the transaction, the investors received one Class C warrant and one Class D
warrant for the subscription of each preferred share. The Class C warrants consist of the right to purchase up to 80,000 shares of the
Company&#8217;s common stock at an exercise price of $2.50 per share exercisable for 36 months from the date of inception. The Class
D warrants consist of the right to purchase up to 80,000 shares of the Company&#8217;s common stock at an exercise price of $5.00 per
share exercisable for 36 months from the date of inception. The subscription was completed on August 10, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>









<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September
27, 2021, the Company entered into another securities purchase agreement with the same investors, pursuant to which the Company issued
in a registered direct offering, an aggregate of 48,000 shares of common stock of the Company at a per share purchase price of $2.50.
In addition, the investors also received one Class C warrant and one Class D warrant for the subscription of each preferred share. The
Class C warrants consist of the right to purchase up to 80,000 shares of the Company&#8217;s common stock at an exercise price of $2.50
per share exercisable for 36 months from the date of inception. The Class D warrants consist of the right to purchase up to 80,000 shares
of the Company&#8217;s common stock at an exercise price of $5.00 per share exercisable for 36 months from the date
of inception.</p>

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_zZNzhkd1ivsb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANT (Details - Assumptions used)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B3_zolyDeAvVSP1" style="display: none">Schedule Assumption used</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Appraisal Date (Inception Date)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>C
                                            Warrant<br/> August 10, </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>D
                                            Warrant<br/> August 10, </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 70pt"><b>(Unaudited)</b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; padding-bottom: 1pt">Market price per share (USD/share)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharePrice_c20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)">1.47</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharePrice_c20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)">0.66</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Exercise price (USD/price)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)">2.50</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)">5.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Risk free rate</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zJtleOeWH7x5" title="Risk free rate">0.14</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zVFfXxfSE29g" title="Risk free rate">0.14</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Dividend yield</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zDeljX4piFi5" title="Dividend yield">0.00</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zphHp84WtXFb" title="Dividend yield">0.00</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Expected term/ Contractual life (years)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zYIzg7iLiKB3" title="Expected term/ Contractual life (years)">1.39</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zxdp9jeBwaYb" title="Expected term/ Contractual life (years)">1.39</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Expected volatility</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zcNQumQ3wbUh" title="Expected volatility">56.36</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zSN0k9tl3Cn4" title="Expected volatility">56.36</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Appraisal Date (Inception Date)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">C Warrant<br/> September 27,<br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">D Warrant<br/> September 27,<br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 70pt"><b>(Unaudited)</b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; padding-bottom: 1pt">Market price per share (USD/share)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharePrice_iI_c20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zQ0OvoIHBHq8" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)">1.71</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharePrice_c20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)">0.73</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Exercise price (USD/price)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)">2.50</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)">5.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Risk free rate</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zHuA0VWtRLg5" title="Risk free rate">0.15</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zZ62Z2LHUAKb" title="Risk free rate">0.15</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Dividend yield</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zmshSCeRiq89" title="Dividend yield">0.00</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zsqMuDZuGT9h" title="Dividend yield">0.00</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Expected term/ Contractual life (years)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zA066G7UQiv5" title="Expected term/ Contractual life (years)">1.26</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zlViy1eBJLhi" title="Expected term/ Contractual life (years)">1.26</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Expected volatility</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zRsOtfaKSvWc" title="Expected volatility">52.93</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zjlhNqiuyjSj" title="Expected volatility">52.93</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zgww6eMBcEw8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following
is a reconciliation of the beginning and ending balances of warrants liability measured at fair value on a recurring basis using Level
3 inputs:</p>

<table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zRBbX1KQWYJi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANT (Details - Warrant Liability)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8BF_zEsJTGJAr8X9" style="display: none">Schedule of Warranty Liability</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left; padding-bottom: 1pt">Balance at the beginning of period</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_c20220101__20220331_zb0FgH8HVBn2" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Balance at the beginning of period">312,320</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_d0_c20210101__20211231_zdfF0NYdyda8" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Balance at the beginning of period">&#8211;</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Warrants issued to investors</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_d0_c20220101__20220331_z3hoiL8ruSBl" style="padding-bottom: 1pt; text-align: right" title="Warrants issued to investors">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20210101__20211231_zv5ZxRxu2TWl" style="padding-bottom: 1pt; text-align: right" title="Warrants issued to investors">287,520</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Warrants redeemed</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_ecustom--WarrantsRedeemed_pp0p0_d0_c20220101__20220331_zh3tOl2AGX5j" style="padding-bottom: 1pt; text-align: right" title="Warrants redeemed">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_988_ecustom--WarrantsRedeemed_pp0p0_d0_c20210101__20211231_z1ihNezgdBFj" style="padding-bottom: 1pt; text-align: right" title="Warrants redeemed">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Fair value change of warrants included in earnings</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_pp0p0_d0_c20220101__20220331_zUhCxqG5iC59" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value change of warrants included in earnings">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_pp0p0_c20210101__20211231_zsGpfdw9VAof" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value change of warrants included in earnings">24,800</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20220101__20220331_z6J3cmCtUIzl" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end of period">312,320</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20210101__20211231_zbozojyq2qs3" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end of period">312,320</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following
is a summary of the warrant activity:</p>

<table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock_zdRW7EME5sqj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANT (Details - Warrant Activity)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B3_zuMpDTHKvy61" style="display: none">Schedule of warrant activity</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number
                                            of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Warrants</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise
                                            Price</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Remaining</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contractual</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Term
                                            in</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Years</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; padding-bottom: 1pt">Outstanding at January 1, 2022</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zZg4p29h3n1i" style="padding-bottom: 1pt; width: 11%; text-align: right" title="Warrants outstanding, beginning balance">256,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zs74PakyxSi4" style="padding-bottom: 1pt; width: 11%; text-align: right" title="Average exercise price, outstanding beginning">3.75</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 1pt; width: 11%; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_zBEPjacYxVe8" title="Weighted average remaining contractual term">2.66</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Exercisable at January 1, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_986_ecustom--WarrantsExercisable_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z15yeeroRkRg" style="padding-bottom: 1pt; text-align: right" title="Warrants exercisable beginning">256,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_ecustom--AverageExercisePriceExerciasable_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zhAgzTReyVCg" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, exerciasable beginning">3.75</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_zlzBpKCdBSdl" title="Weighted average remaining contractual term">2.66</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Granted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z3E0O5QkUjpf" style="padding-bottom: 1pt; text-align: right" title="Warrants Granted">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_986_ecustom--AverageExercisePriceGranted_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z6gEqiS9i7Ie" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, granted">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised / surrendered</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_980_ecustom--WarrantsExercisedSurrendered_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zK5E6F6fRhpj" style="padding-bottom: 1pt; text-align: right" title="Warrants Exercised / surrendered">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_982_ecustom--AverageExercisePriceExercisedSurrendered_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zXfaY0ifyBf2" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, exercised / surrendered">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zzc0c0qavmZd" style="padding-bottom: 1pt; text-align: right" title="Warrants expired">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_982_ecustom--WarrantWeightedAverageExercisePriceExpired_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zDZP7SIzuO22" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, expired">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Outstanding at March 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zKfnjL9vFa27" style="padding-bottom: 1pt; text-align: right" title="Warrants outstanding, ending balance">256,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zjRsP5UP5Jg6" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, outstanding ending">3.75</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_905_ecustom--WeightedAverageRemainingContractualTermOutsanding_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zazAkIfoMZe8" title="Weighted Average Remaining Contractual Term, outsanding">2.66</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Exercisable at March 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98B_ecustom--WarrantsExercisable_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zXlwjtrWVvug" style="padding-bottom: 1pt; text-align: right" title="Warrants exercisable at ending">256,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_ecustom--AverageExercisePriceExerciasable_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zS9dqwVk5Po8" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, exerciasable ending">3.75</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_905_ecustom--WeightedAverageRemainingContractualTermExercisable_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z8BZmieWyzSi" title="Weighted Average Remaining Contractual Term, exercisable">2.66</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAndProductWarrantiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAndProductWarrantiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for each guarantee obligation, or each group of similar guarantee obligations, including (a) the nature of the guarantee, including its term, how it arose, and the events or circumstances that would require the guarantor to perform under the guarantee; (b) the maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee; (c) the current carrying amount of the liability, if any, for the guarantor's obligations under the guarantee; and (d) the nature of any recourse provisions under the guarantee, and any assets held either as collateral or by third parties, and any relevant related party disclosure. Excludes disclosures about product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI https://asc.fasb.org/topic&amp;trid=2155896<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350780246368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOfLesseeDisclosureTextBlock', window );">LEASES</a></td>
<td class="text"><p id="xdx_802_eus-gaap--LeasesOfLesseeDisclosureTextBlock_ztCPw4fOw6ae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 9 &#160;&#160;&#160;&#160;&#160;<span id="xdx_826_zxWDTRzOgcCd">LEASES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has two non-cancelable lease agreements
for certain of the office and accommodation as well as fish farming containers for research and develop advanced technology for water
circulation applying in fishery with original lease periods expiring between 2022 and 2023. The lease terms may include options to extend
or terminate the lease when it is reasonably certain the Company will exercise that option. The Company recognizes rental expense on
a straight-line basis over the lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The components of lease expense for the three months ended March 31,
2022 and March 31, 2021 were as follows:</p>

<table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--LeaseCostTableTextBlock_zsAAkdKcnPF7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details - Lease costs)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BE_zVB7hE2UFac" style="display: none">Components of lease expenses</span></td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Statement of Income Location</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended <br/> March 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended <br/> March 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Lease Costs</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: justify; padding-bottom: 1pt">Operating lease expense</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 24%; text-align: center; padding-bottom: 1pt">General and administrative expenses</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OperatingLeaseExpense_pp0p0_c20220101__20220331_zUgL9JhLDzbb" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Operating lease expense">11,788</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--OperatingLeaseExpense_c20210101__20210331_pp0p0" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Operating lease expense">1,218</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total net lease costs</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LeaseCost_c20220101__20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total net lease costs">11,788</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LeaseCost_c20210101__20210331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total net lease costs">1,218</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Maturity of lease liabilities under our non-cancelable operating leases
as of December 31, 2021 and March 31, 2022 are US$ nil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -URI https://asc.fasb.org/topic&amp;trid=2208923<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781595056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER PAYABLES AND ACCRUED LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">OTHER PAYABLES AND ACCRUED LIABILITIES</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zurhctaYBSth" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note
10&#160;&#160;&#160;&#160;&#160;<span id="xdx_822_z0xzanoc8udg">OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></p>

<table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zWMjxoS4liwg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B0_z2kcpJ0g7eOe" style="display: none">Schedule of payables</span></td>
    <td>&#160;</td>
    <td id="xdx_496_20220331_zn44z4h1Zp3c" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_498_20211231_zV4mvrnmUm4d" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March
    31, <br/>
    2022</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, <br/>
    2021</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0_maOAPAAzlpa_z0mZVfeq3Wn6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VAT payable</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,742</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,023</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maOAPAAzlpa_z6Y8UvO3JUae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary payable</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,255</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89,775</span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOAPAAzlpa_zSqCaOvLFhQk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,390</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,628</span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzlpa_zskZ7Bea6exa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69,387</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">142,426</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>









<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781530672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--IncomeTaxDisclosureTextBlock_zBCMoWHPAHp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Note 11
&#160;&#160;&#160;&#160;&#160;<span id="xdx_82C_zoZ35SQXaG3h">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and its subsidiary, and the consolidated
VIE file tax returns separately.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1) Value-added tax (&#8220;VAT&#8221;)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">PRC</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Provisional Regulation of the
PRC on VAT and the related implementing rules, all entities and individuals (&#8220;taxpayers&#8221;) that are engaged in the sale of
products in the PRC are generally required to pay VAT, at a rate of which was changed from <span id="xdx_905_ecustom--ValueAddedTaxRate_iI_dp_c20211231_zWMfCmiNFeU8" title="Value added tax rate">16</span>% to <span id="xdx_90C_ecustom--ValueAddedTaxRate_c20220331_pdd" title="Value added tax rate">13</span>% on April 1, 2019 of the gross sales
proceeds received, less any deductible VAT already paid or borne by the taxpayers. GZ WFH also subjected to 10% for the installment service
provided.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Taiwan</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Value-added and Non-value-added
Business Tax Act and the related implementing rules, all entities and individuals (&#8220;taxpayers&#8221;) that are engaged in the sale
of products in the Taiwan are generally required to pay VAT, at a rate of 5%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2) Income tax</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">United States </span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, the Tax Cuts and Jobs Act
(the &#8220;Tax Act&#8221;) was signed into legislation. The Tax Act significantly revises the U.S. corporate income tax by, among other
things, lowering the statutory corporate tax rate from 34% to 21%, imposing a mandatory one-time tax on accumulated earnings of foreign
subsidiaries, introducing new tax regimes, and changing how foreign earnings are subject to U.S. tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, Staff Accounting Bulletin
No. 118 (&#8220;SAB 118&#8221;) was issued to provide guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement
period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740.
The Company has completed the assessment of the income tax effect of the Tax Act and there were no adjustments recorded to the provisional
amounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Coronavirus Aid, Relief and Economy Security
Act (the &#8220;CARES Act&#8221;) was signed into law on 27 March 2020. The CARES Act temporarily eliminates the 80% taxable income limitation
(as enacted under the Tax Cuts and Jobs Act of 2017) for NOL deductions for 2018-2020 tax years and reinstated NOL carrybacks for the
2018-2020 tax years. Moreover, the CARES Act also temporarily increases the business interest deduction limitations from 30% to 50% of
adjusted taxable income for the 2019 and 2020 taxable year. Lastly, the Tax Act technical correction classifies qualified improvement
property as 15-year recovery period, allowing the bonus depreciation deduction to be claimed for such property retroactively as if it
was included in the Tax Act at the time of enactment. The Company does not anticipate a significant tax impact on its financial statements
and will continue to examine the impact the CARES Act may have on its business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluated the Global Intangible Low
Taxed Income (&#8220;GILTI&#8221;) inclusion on current earnings and profits of greater than 10% owned foreign controlled corporations.
The Company has evaluated whether it has additional provision amount resulted by the GILTI inclusion on current earnings and profits
of its foreign controlled corporations. The law also provides that corporate taxpayers may benefit from a 50% reduction in the GILTI
inclusion, which effectively reduces the <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20220331__us-gaap--IncomeTaxAuthorityAxis__country--US_zV4VYhboKQfg" title="Effective income tax rate">21</span>% U.S. corporate tax rate on the foreign income to an effective rate of <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20210331__us-gaap--IncomeTaxAuthorityAxis__country--US_zvjahn1hx6fe" title="Effective income tax rate">10.5</span>%. The GILTI inclusion
further provides for a foreign tax credit in connection with the foreign taxes paid. In 2019, the Company recorded a GILTI inclusion
of $<span id="xdx_90D_ecustom--GlobalIntangibleLowTaxedIncome_c20220101__20220331_pp0p0" title="Global Intangible Low Taxed Income">152,829</span>. The Company has elected to treat the financial statement impact of GILTI as current period expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reverse merger was completed on December
31, 2018 and the tax losses of US subsidiary was not in the scope as of December 31, 2018. As of December 31, 2019, net operating loss
carried forward which was available to offset future taxable income for the Company in the United States was $<span id="xdx_90D_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20191231__us-gaap--IncomeTaxAuthorityAxis__country--US_ziwTIVA27cwk" title="Net operating loss carryforwards">99,817</span>. There is a full
valuation allowance applied against these loss carry forward as management determined it was not more likely than not that these net
operating losses would be utilized in the foreseeable future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Hong Kong</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The HK tax reform has introduced two-tiered profits
tax rates for corporations. Under the two-tiered profits tax rates regime, the profits tax rate for the first HK$2 million (approximately
$257,931) of assessable profits will be lowered to <span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20220331__us-gaap--IncomeTaxAuthorityAxis__country--HK_zSgDuT1sqNi1" title="Effective income tax rate">8.25</span>% (half of the rate specified in Schedule 8 to the Inland Revenue Ordinance (IRO))
for corporations. Assessable profits above HK$2 million (approximately $257,931) will continue to be subject to the rate of 16.5% for
corporations. The Company assessed that the HK entity will not earn a profit greater than HK$2 million (approximately $257,931), it is
subject to a corporate income tax rate of 8.25%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, the Company&#8217;s
subsidiary in Hong Kong had net operating loss carry forwards available to offset future taxable income. The net operating losses will
be carryforward indefinitely under Hong Kong Profits Tax regulation. There is a full valuation allowance applied against these loss carry
forward as management determined it was not more likely than not that these net operating losses would be utilized in the foreseeable
future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">PRC</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WFOE and the consolidated VIE established in
the PRC are subject to the PRC statutory income tax rate of <span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20220331__us-gaap--IncomeTaxAuthorityAxis__custom--PrcMember_z9fCgaCJArC6" title="Effective income tax rate">25</span>%, according to the PRC Enterprise Income Tax (&#8220;EIT&#8221;) law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance
with the relevant tax laws and regulations of the PRC, a company registered in the PRC is subject to income taxes within the PRC at the
applicable tax rate on taxable income. All the PRC subsidiaries were subject to income tax at a rate of 25% for the year ended December
31, 2021. According to PRC tax regulations, the PRC net operating loss can generally carry forward for no longer than five years starting
from the year subsequent to the year in which the loss was incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Taiwan</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The
Company&#8217;s loss before income taxes is primarily derived from the operations in Taiwan and income tax expense is primarily incurred
in Taiwan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As
a result of amendments to the &#8220;Taiwan Income Tax Act&#8221; enacted by the Office of the President of Taiwan on February 7, 2018,
the statutory income tax rate increased from&#160;17% to&#160;20% and the undistributed earning tax, or a surtax, decreased from&#160;10%
to&#160;5% effective from January 1, 2018. As a result, the statutory income tax rate in Taiwan is 20%&#160;for the years ended August
31, 2021 and 2020. An additional surtax, of which rate was reduced from&#160;10% to&#160;5% being applied to the Company starting from
September 1, 2018, is assessed on undistributed income for the entities in Taiwan, but only to the extent such income is not distributed
or set aside as a legal reserve before the end of the following year. The&#160;5% surtax is recorded in the period the income is earned,
and the reduction in the surtax liability is recognized in the period the distribution to stockholders or the setting aside of legal
reserve is finalized in the following year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The components of the income tax (benefit) expense
are:</p>

<table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zNBlCeB3s3Fj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Income tax expense)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BA_zWIYPtJ5eEq2" style="display: none">Income tax components</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20220101__20220331_z22ivmCU75wb" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20210101__20210331_zg7NLvQLywSh" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three
                                            months ended </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March
                                            31,</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CurrentIncomeTaxExpenseBenefit_maITEBzz8A_zFcIrk11lfEl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Current</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">59,845</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredIncomeTaxExpenseBenefit_d0_maITEBzz8A_zAY8oAF2jPAh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Deferred</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,315</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzz8A_zqkoR6pJjKW8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total income tax expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">62,160</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reconciliation of income taxes expenses computed
at the Taiwan statutory tax rate (2021: at PRC statutory rate) applicable to income tax expense is as follows:</p>

<table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zIhHDT4qwibj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Reconcilation of income tax)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BF_zgAKvp0kzcGc" style="display: none">Reconciliation of income tax expense</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three
                                            months ended</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,</b></p>

</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Taiwan (2021-PRC) income tax statutory rate</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20220101__20220331_zrN7nGv33YV8" title="PRC income tax statutory rate">20.00</span>%</td><td style="text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20210101__20210331_ztPAilGbJTO8" title="PRC income tax statutory rate">25.00</span>%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Impact of different tax rates in other jurisdictions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20220101__20220331_z0vYRtCjweX8" title="Impact of different tax rates in other jurisdictions">1.20</span>%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(<span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20210101__20210331_zAqgeGCddJ52" title="Impact of different tax rates in other jurisdictions">5.93</span>%)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Tax effect of non-deductible expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20220101__20220331_zC4vbbbjpPF8" title="Tax effect of non-deductible expense">15.85</span>%</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20210101__20210331_zigsnhYgJ0ij" title="Tax effect of non-deductible expense">0.00</span>%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Utilization of tax losses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_ecustom--TaxEffectOfNontaxableIncomeLoss_dp0_c20220101__20220331_z0jLXLkNfC39" title="Tax effect of utilization of tax losses previously recognized">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(<span id="xdx_907_ecustom--TaxEffectOfNontaxableIncomeLoss_dp_c20210101__20210331_zJwFVApCWW65" title="Tax effect of utilization of tax losses previously recognized">2.07</span>%)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsOther_dp_c20220101__20220331_zYqrjFjLQnn1" title="Others">1.00</span>%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsOther_dp0_c20210101__20210331_z0TDxFcxKeng" title="Others">-</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Changes in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20220331_zNWp2yL6lI06" title="Changes in valuation allowance">5.35</span>%</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210101__20210331_zI01XUU8de11" title="Changes in valuation allowance">36.6</span>%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20220331_zfTk65wv4xnj" title="Effective tax rate">1.00</span>%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20210331_zcGWOudRGmB6" title="Effective tax rate">53.60</span>%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3) Deferred tax assets (liabilities), net</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The tax effects of temporary differences representing
deferred income tax assets and liabilities result principally from the following:</p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zOpb9kfrk5Sc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Deferred taxes)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify"><span id="xdx_8B8_zzI2HQsnYHV4" style="display: none">Schedule of deferred income taxes</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20220331_zeov4IFQyBO5" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20211231_zPfQc6vrLjB8" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">March 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGrossAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_d0_maDTAGzr6G_z0UxfON8Cqfa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Tax loss carried forward</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_i01I_pp0p0_d0_maDTAGzr6G_zyd46Wka0yk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Allowance for doubtful receivables</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_d0_mtDTAGzr6G_maDTANzRmV_zWDL49L0RdAj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><b style="display: none">Total deferred tax assets</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetsValuationAllowanceCurrents_i01NI_pp0p0_di0_msDTANzRmV_z2SBASl55znj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_d0_mtDTANzRmV_zFqyAMJYNsRh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total deferred tax assets, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">March 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_i01NI_pp0p0_di0_maDITLzGX1_z91AKMAQgoF6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Property and equipment, difference in depreciation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredIncomeTaxLiabilities_i01NTI_pp0p0_di0_mtDITLzGX1_zbzCUzarUte7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Deferred tax liabilities, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zcUl80h0jStd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>









<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The valuation allowance as of March 31, 2022
and December 31, 2021 was primarily provided for the deferred income tax assets if it is more likely than not that these items will expire
before the Company is able to realize its benefits, or that the future deductibility is uncertain. The ultimate realization of deferred
income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become
deductible or utilizable. Management considers projected future taxable income and tax planning strategies in making this assessment.
The movement for the valuation allowance is as following.</p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--SummaryOfValuationAllowanceTextBlock_z2d2NOuYyQSb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Valuation Allowance)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BD_zoHuHUzAQc8" style="display: none">Movement in valuation allowance</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">March 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; font-weight: bold; text-align: justify">Balance at beginning of the year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pp0p0_c20220101__20220331_zatVc5YIS4Hd" style="width: 13%; text-align: right" title="Valuation allowance, beginning">95,844</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pp0p0_d0_c20210101__20211231_zWTTI0X5EAp3" style="width: 13%; text-align: right" title="Valuation allowance, beginning">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Additions of valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20220101__20220331_pp0p0" style="text-align: right" title="Additions to valuation allowance">43,102</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pp0p0_c20210101__20211231_zBe1D7KEGk98" style="text-align: right" title="Additions to valuation allowance">95,844</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Reductions of valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20220101__20220331_zHtO5OuCig0l" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions in valuation allowance">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20210101__20211231_zKAN78REQQAk" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions in valuation allowance">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Balance at the end of the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20220101__20220331_zltgf9v29d6c" style="border-bottom: Black 2.5pt double; text-align: right" title="Valuation allowance, ending balance">138,946</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20210101__20211231_zpCa8Roa4Wzd" style="border-bottom: Black 2.5pt double; text-align: right" title="Valuation allowance, ending balance">95,844</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>PRC Withholding
Tax on Dividends</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current PRC Enterprise Income Tax Law imposes
a 10% withholding income tax for dividends distributed by foreign-invested enterprises to their immediate holding companies outside the
PRC. A lower withholding tax rate will be applied if there is a tax treaty arrangement between the PRC and the jurisdiction of the foreign
holding company. Distributions to holding companies in Hong Kong that satisfy certain requirements specified by PRC tax authorities,
for example, will be subject to a 5% withholding tax rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of
December&#160;31, 2021, the Company had not recorded any withholding tax on the retained earnings
of its foreign-invested enterprises in the PRC, since the Company intended to reinvest its earnings to potentially continue its business
in mainland China, namely the manufacturing of the RASs through GZ GST, and its foreign-invested enterprises do not intend to declare
dividends to their immediate foreign holding companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March
31, 2022, the Company had not recorded any withholding tax on the retained earnings of its foreign-invested enterprises in the PRC, and
the Company decided not to reinvest its earnings since it is not continuing its business in mainland China, and its foreign-invested
enterprises do not intend to declare dividends to their immediate foreign holding companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781579664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY BALANCES AND TRANSACTIONS</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zvtXanx0xRj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 12&#160;&#160;&#160;&#160;&#160; <span id="xdx_825_zLrNTLLxqjUa">RELATED PARTY BALANCES AND
TRANSACTIONS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due to related parties</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The balance due to related parties was as following:</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zPZQSQoiiX9e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_z5aIQXWUmNp" style="display: none">Schedule of related party transactions</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Mr. Yin-Chieh Cheng (1)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_fKDEp_zYGNXSMd5e27" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties">7,653</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_d0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_fKDEp_zqCqxQ9us1v7" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties">&#8211;</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Mountain Share Transfer, LLC (2)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferMember_fKDIp_z8kOPGm38MAf" style="padding-bottom: 1pt; text-align: right" title="Due to related parties">7,681</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferMember_fKDIp_zmlC1mm3w1Ta" style="padding-bottom: 1pt; text-align: right" title="Due to related parties">39,341</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_c20220331_pp0p0" style="padding-bottom: 2.5pt; text-align: right" title="Due from related parties">15,334</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_c20211231_pp0p0" style="padding-bottom: 2.5pt; text-align: right" title="Due from related parties">39,341</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due from a related party</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The balance due from a related party was as following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Taisi Electrical &amp; Plumbing Co. Pte Ltd. (3)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TaisiElectricMember_fKDMp_zh2O3aSAwF3h" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties">2,073,362</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TaisiElectricMember_fKDMp_zMEU1ccVhgm9" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties">1,615,217</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span id="xdx_F05_z9Yq5JGix94k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F1C_zKpw4KlepWn5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Yin-Chieh Cheng (&#8220;Mr.
    Cheng&#8221;) is the chairman the Company, and he holds 42.5% shares of the Company. The balance due to Mr. Cheng as of March 31,
    2022 mainly represented the amount paid by Mr. Cheng on behalf of the Company. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span id="xdx_F05_zZ7CsgsUqw3d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td><p id="xdx_F1F_z2rkY9MMOZ69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mountain Share Transfer, LLC is company 100%
    controlled by Erik S. Nelson, a greater than 5% stockholder of the Company. The balances represented the amount paid on behalf of
    the Company for its daily operation purpose.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td><span id="xdx_F08_zkGiWhWHfv07" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span id="xdx_F18_zZVheyzozH05" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Tsai Wen-Chih is the
    director of XFC and has control power over Taisi Electrical &amp; Plumbing Co. Pte Ltd. The Company took over the receivable amount
    of $877,809 from acquisition of XFC in December 2020. None of the receivables have been impaired and it is expected that the full
    contractual amounts can be collected.</span></td></tr>
  </table>
<p id="xdx_8A1_zJU7RnjrkcH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781595056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON STOCK<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">COMMON STOCK</a></td>
<td class="text"><p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zcAmT7Si6RCf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1</b><b>3</b><b>&#160;&#160;&#160;&#160;&#160;<span id="xdx_827_zyw1oTG59h34">COMMON
STOCK</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s
authorized number of common stock is <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_c20220331_zSZdU6cplEMd" title="Common stock, shares authorized"><span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20211231_zuoQRaVUFu2j" title="Common stock, shares authorized">200,000,000</span></span> shares with par value of $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220331_zg8eSKwPrUc4" title="Common stock par value"><span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231_zIOOnQPTblda" title="Common stock par value">0.001</span></span> each, and issued ordinary shares were <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_c20220331_zDQnqSfhN78e" title="Common stock, shares issued">10,707,150</span>
shares and 9,131,786 as of March
31, 2022 and December 31, 2021, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All number
of shares, share amounts and per share data presented in the accompanying consolidated financial statements and related notes have been
retroactively restated to reflect the reverse merger transaction and subsequent issuance of shares stated above, except for authorized
common shares, which were not affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781498256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">SHARE-BASED COMPENSATION</a></td>
<td class="text"><p id="xdx_800_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zjMIYiYkiqz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1</b><b>4</b><b>&#160;&#160;&#160;&#160;<span id="xdx_82B_zFHLijvWP3Ql">SHARE-BASED
COMPENSATION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December
27, 2018, Nocera granted Mr. Yin-Chieh Cheng quarterly option awards of <span id="xdx_904_ecustom--WarrantsGranted_c20181201__20181227__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember_pdd" title="Warrants granted">250,000</span> Series A warrants for 20 quarters (5 years) for a total
of <span id="xdx_90E_ecustom--WarrantsGranted_c20181201__20181227__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember_pdd" title="Warrants granted">5,000,000</span> Series A warrants with an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20181227__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember_pdd" title="Warrants exercise price">0.50</span> per share, subject to continued employment for services as Chairman of
the Board of Directors (&#8220;Board&#8221;) and a Director.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1,
2020, Nocera granted Mr. Shun-Chih Chuang and Mr. Hsien-Wen Yu <span id="xdx_90F_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShunChihChuangMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zWovoEZYipZ2" title="Warrants granted">50,000</span> shares of Class A warrants and <span id="xdx_902_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HsienWenYuMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zQOrbiZU3579" title="Warrants granted">60,000</span> shares of Class A warrants
separately, each with an exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200601_pdd" title="Warrants exercise price">0.50</span> per share, for serving as the Company&#8217;s Chief Financial Officer and Chief Operating
Officer, respectively. The Company also granted 2 employees <span id="xdx_903_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted">50,000</span> shares of Class A warrants with an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200601__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants exercise price">0.50</span> per share.
The Class A warrants consist of the right to purchase one share for $0.50 per share from the date of issuance until April 23, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>









<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1,
2020, Nocera granted Mr. Michael A. Littman <span id="xdx_906_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted">50,000</span> shares of Class A warrants with an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants exercise price">0.50</span> per share and <span id="xdx_907_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_pdd" title="Warrants granted">50,000</span> shares
of Class B warrants with exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_pdd" title="Warrants exercise price">1.00</span> per share. Mr. Littman exercised <span id="xdx_905_ecustom--WarrantsGranted_c20210802__20210811__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted">50,000</span> shares of Class A warrants and <span id="xdx_906_ecustom--WarrantsGranted_c20210802__20210811__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_pdd" title="Warrants granted">50,000</span> shares
of Class B warrants on August 11, 2021. The Class B warrants consist of the right to purchase one share for $1.00 per share separately
from the date of issuance until April 23, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December
1, 2021, Nocera granted Mr. Shun-Chih Chuang and Mr. Hsien-Wen Yu <span id="xdx_90D_ecustom--WarrantsGranted_c20211129__20211202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShunChihChuangMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zvtHH6Oz1MHd" title="Warrants granted">75,000</span> shares of Class A warrants and <span id="xdx_901_ecustom--WarrantsGranted_c20211129__20211202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HsienWenYuMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted">60,000</span> shares of Class A warrants
separately, each with an exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20211202_pdd" title="Warrants exercise price">0.50</span> per share, for serving as the Company&#8217;s Chief Financial Officer and Chief Operating
Officer, respectively. The Company also granted 2 employees <span id="xdx_904_ecustom--WarrantsGranted_c20211129__20211202__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted">70,000</span> shares of Class A warrant with an exercise price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20211202__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants exercise price">0.50</span> per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December
31, 2021, the Company issued an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20211201__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShunChihChuangMember_zCmbkNb21aSa" title="Issued for services">505,000</span> shares of common stock to Mr. Shun-Chih Chuang and a total of five consultants in
consideration for services rendered.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated fair value of share-based compensation
for employees is recognized as a charge against income on a ratable basis over the requisite service period, which is generally the vesting
period of the award. The fair value of stock option grant was estimated on the date of grant using the Black-Scholes option pricing model
under the following assumptions:</p>

<table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zvCyXL0fZQO4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHARE-BASED COMPENSATION (Details - assumptions)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B1_zPZHyVmdkp69" style="display: none">Assumptions used</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: justify">Dividend yield</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: right">N/A</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: right">N/A</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Risk-free interest rate</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 1pt; width: 13%; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220331_z6HPq8IQRbGj" title="Risk-free interest rate">1.16</span>%</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 1pt; width: 13%; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231_zde4z729rsl2" title="Risk-free interest rate">1.16</span>%</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Expected term (in years)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220331_z5gLUDDuzWkh" title="Expected term (in years)">4.31</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zG3Es5HDzOcj" title="Expected term (in years)">4.31</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Volatility</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220331_zGRaIVOagcLk" title="Volatility">48.15</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231_zfLeAlsy2i36" title="Volatility">48.15</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company
estimated the grant date fair value of time-based stock option awards using the Black-Scholes option valuation model, which requires
assumptions involving an estimate of the fair value of the underlying common stock on the date of grant, the expected term of the options,
volatility, discount rate and dividend yield. The Company calculated expected option terms based on the &#8220;simplified&#8221; method
for &#8220;plain vanilla&#8221; options due to the limited exercise information. The &#8220;simplified method&#8221; calculates the expected
term as the average of the vesting term and the original contractual term of the options. The Company calculated volatility using the
average adjusted volatility of quick companies feature of Capital IQ for a period of time reflective of the expected option term, while
the discount rate was estimated using the interest rate for a treasury note with the same contractual term as the options granted. Dividend
yield is estimated at our current dividend rate, which adjusts for any known future changes in the rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three
months ended March 31, 2022
and year ended December 31, 2021,
$<span id="xdx_90E_ecustom--ReverseMergerRecapitalization_pp0p0_c20220101__20220331_zStVeRRfoNHi" title="Reverse merger recapitalization">606,055</span>
and $<span id="xdx_904_ecustom--ReverseMergerRecapitalization_pp0p0_c20210101__20211231_ztu7eiXz3zFa" title="Reverse merger recapitalization">6,638,371</span>
share-based compensation expenses was recognized into additional paid-in capital of the Company,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December
31, 2021, total unrecognized compensation cost related to unvested share-based compensation awards was $<span id="xdx_904_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pp0p0_c20211231_zsHVYDOe32r8" title="Unrecognized compensation costs">11,114,097</span>. This amount is expected
to be recognized as stock-based compensation expense in the Company&#8217;s consolidated statements of operations and comprehensive income
over the remaining vesting period of <span id="xdx_909_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20220101__20220331_zFEYpVW4MX8b" title="Unrecognized compensation cost amortization period">1.99</span> years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>









<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781504112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREFERRED STOCK<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">PREFERRED STOCK</a></td>
<td class="text"><p id="xdx_803_eus-gaap--PreferredStockTextBlock_z7iRHUZ7yJHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1</b><b>5</b><b>&#160;&#160;&#160;&#160;&#160;<span id="xdx_82C_zOfazsI0vUPb">PREFERRED
STOCK</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August
2021, the Company issued <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zMyvMIdakyYd" title="Preferred Stock, Shares Issued">80,000</span> shares of preferred shares of $<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_c20210801_zm4X2T5IVjK2" title="Sale of stock, price">1.00</span> each at an issue price of $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20210801_zfuyGsrpHU28" title="Share price">2.50</span> per share to certain investors credited
as fully paid. The preferred shares are non-voting and non-redeemable. The holder of the preferred shares will have priority over the
holders of ordinary shares of the Company on the assets and funds of the Company available for distribution in a distribution of assets
on liquidation, winding up or dissolution of the Company. The holder of the preferred shares shall not have the right to attend or vote
at any general meeting of the Company (except a general meeting for winding up of the Company or a resolution is to be proposed which
if passed would vary or abrogate the rights or privileges of such holder).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781530672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(LOSS) INCOME PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">(LOSS) INCOME PER SHARE</a></td>
<td class="text"><p id="xdx_808_eus-gaap--EarningsPerShareTextBlock_zISuPgiiRhI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 16 &#160;&#160;&#160;&#160;&#160;<span id="xdx_82C_zxWhvspfwHol">(LOSS) INCOME PER SHARE</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the computation
of basic and diluted income (loss) per common share for the quarters ended March 31, 2022 and 2021.</p>

<table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXyGPZVIU9b9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - (LOSS) EARNINGS PER SHARE (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B1_z9yq6RhnB7C7" style="display: none">Schedule of earnings (loss) per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220101__20220331_z8URAQdjdX9h" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20210101__20210331_z3Owc1yVkrE4" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For
                                            three months ended </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March
                                            31,</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_ecustom--NumeratorAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify; padding-bottom: 2.5pt">Net (loss) income attributable to the Company</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">(805,720</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">49,490</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--DenominatorAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Weighted-average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,677,150</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,131,786</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,677,150</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,821,506</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--LossIncomePerShareAbstract_i01B_z4vQx9r7V4o7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">(Loss) income per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0755</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0054</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0755</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0036</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic net income per common share is computed
using the weighted average number of the common shares outstanding during the period ended March 31, 2021. Diluted income per share is
computed using the weighted average number of ordinary shares and ordinary equivalent shares outstanding which include <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210331_zALCEbez29gl" title="Antidilutive shares">5,560,000</span> warrants
outstanding as of March 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781439440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENT</a></td>
<td class="text"><p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zUnnlm6OjxNc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 17 &#160;&#160;&#160;&#160;&#160;<span id="xdx_826_zz1D3GFem5l6">SUBSEQUENT EVENT</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has evaluated subsequent events through
the issuance of the unaudited condensed consolidated financial statements and except for the event discloses blow, no other subsequent
event is identified that would have required adjustment or disclosure in the consolidated financial statements.&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350780837472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zOPDEjzSSOw3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_865_zzthcj81O9vb">Basis of Presentation</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated
financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;)
and pursuant to the rules and regulations of the United States Securities and Exchange Commission (&#8220;SEC&#8221;) for interim financial
information. Accordingly, these financial statements do not include all of the information and footnotes required for complete financial
statements and should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the
Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 23, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of management, all adjustments
(which include normal recurring adjustments) necessary to present a fair presentation of the Company&#8217;s unaudited condensed consolidated
financial position as of March 31, 2022, its consolidated results of operations for the three months ended March 31, 2022, cash flows
for the three months ended March 31, 2022 and change in equity for the three months ended March 31, 2022, as applicable, have been made.
Operating results for the three months ended March 31, 2022 are not necessarily indicative of the operating results that may be expected
for the year ending December 31, 2021 or any future periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zyWbWqZ1EcTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86A_zotZqIi3DkM7">Concentrations of Credit Risk</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially expose
the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its
customers and suppliers, and generally does not require collateral or other security from them. The Company evaluates its collection
experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic
reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were two customers who represent <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zqiCWblCaVS1" title="Concentration risk">98</span>% of
the Company&#8217;s total revenue for the three months ended March 31, 2021. There were three customers who represent <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zy6rnYyOTYbh" title="Concentration risk">97</span>% of the Company&#8217;s
total revenue for the three months ended March 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of single
customers who represent 10% or more of the Company&#8217;s total accounts receivable, net:</p>

<table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zm25Fxx0Zcgc" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B0_zW4Z3tOGIYKf" style="display: none">Concentrations of credit risk</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">Percentage of the Company&#8217;s accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Customer A</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zK5sbpyPlAUj" title="Concentration percentage">22.01</span>%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zuYJNPFVAu05" title="Concentration percentage">16.37</span>%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zB2k6gUomz9a" title="Concentration percentage">56.98</span>%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zkaoD6BhLDdi" title="Concentration percentage">59.53</span>%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Customer C</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zUxiX7ZeoRw6" title="Concentration percentage">20.75</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zXgLgH7ZWUI9" title="Concentration percentage">16.30</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_zWKMciXuphs9" title="Concentration percentage">99.74</span>%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_z3ZENt2V02q3" title="Concentration percentage">92.20</span>%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--RevenueRecognitionPolicyTextBlock_zTX5IXSAHa7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_860_zqVyQTKrSymi">Revenue Recognition</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes revenue in accordance
with Accounting Standards Codification (&#8220;ASC&#8221;) 606, &#8220;Revenue from Contracts with Customers.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The core principle of the guidance is that an
entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, the Company applies
the following steps:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 1: Identify the contract(s)
    with a customer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 2: Identify the performance
    obligations in the contract</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 3: Determine the transaction
    price</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 4: Allocate the transaction
    price to the performance obligation in the contract</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Wingdings; font-size: 10pt">&#376;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 5: Recognize revenue
    when (or as) the entity satisfies a performance obligation</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considered revenue is recognized
when (or as) the Company satisfies performance obligations by transferring promised goods or services to its customers. Revenue is measured
at the transaction price which is based on the amount of consideration that the Company expects to receive in exchange for transferring
the promised goods or services to its customers. Contracts with customers are comprised of invoices and written contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have arrangements for returns
from customers and does not have any future obligations directly or indirectly related to services resale by customers. The Company has
no sales incentive programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company provides goods, maintenance service
warranties for the goods sold with a period varying from 18 months to 72 months, a majority of which are 18 months, and exclusive sales
agency license to its customers. For performance obligation related to providing products, the Company expects to recognize the revenue
according to the delivery of products. For performance obligation related to maintenance service warranties, the Company expects to recognize
the revenue on a ratable basis using a time-based output method. The performance obligations are typically satisfied as services are
rendered on a straight-line basis over the contract term, which is generally for 18 months as a majority of the maintenance service warranties
periods provided are 18 months. For performance obligation related to exclusive agency license, the Company recognizes the revenue ratably
upon the satisfaction over the estimated economic life of the license.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have amounts of contract
assets since revenue is recognized as control of goods is transferred. The contract liabilities consist of advance payments from customers
and deferred revenue. Advance payments from customers are expected to be recognized as revenue within 12 months. Deferred revenue is
expected to be recognized as revenue within 12 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zdmRuBtRXOTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_866_zvQxyYzc7Cef">Recent Accounting Pronouncements</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The FASB issued several updates during the period, none of these standards
are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the consolidated
financial statements upon adoption.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781579664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Concentrations of credit risk</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zm25Fxx0Zcgc" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B0_zW4Z3tOGIYKf" style="display: none">Concentrations of credit risk</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">Percentage of the Company&#8217;s accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Customer A</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zK5sbpyPlAUj" title="Concentration percentage">22.01</span>%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zuYJNPFVAu05" title="Concentration percentage">16.37</span>%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zB2k6gUomz9a" title="Concentration percentage">56.98</span>%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zkaoD6BhLDdi" title="Concentration percentage">59.53</span>%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Customer C</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zUxiX7ZeoRw6" title="Concentration percentage">20.75</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zXgLgH7ZWUI9" title="Concentration percentage">16.30</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_zWKMciXuphs9" title="Concentration percentage">99.74</span>%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_z3ZENt2V02q3" title="Concentration percentage">92.20</span>%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781530672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditLossAbstract', window );"><strong>Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of accounts receivable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zvxUkk75SMQi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, NET (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B0_zJOWVgbUJQQ3" style="display: none">Schedule of accounts receivable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20220331_z7fGBYydQXwk" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20211231_zjxfyEkfbM67" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccountsReceivableGross_iI_pp0p0_maARNCzmYm_zlyj2389ocuc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">531,522</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">699,555</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_d0_msARNCzmYm_zZWOE0xJQT2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Allowance for doubtful accounts</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNCzmYm_zBmCxAALEk64" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">531,522</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">699,555</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350782380688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventory</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zJrBbyeFxJgc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B8_zXcJN3HrTLAj" style="display: none">Schedule of inventory</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20220331_zNPx1lrMRR8c" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20211231_zVoRi9ywFbPj" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_pp0p0_maINz9VL_z7cGHFufja82" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Raw materials</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">99,263</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">97,163</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InventoryWorkInProcessAndRawMaterialsNetOfReserves_iI_pp0p0_maINz9VL_zyokTyy9ldvf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Work in process</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,519,001</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,391,518</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InventoryNet_iTI_pp0p0_mtINz9VL_zvBBf6UE8Fa2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,618,264</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,488,681</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781439440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER ASSETS, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of prepaid expenses and other assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zjkbDhSBANY7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B9_zUkeBYARoimj" style="display: none">Schedule of prepaid expenses and other assets</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220331_z2F8Zb8a3fQg" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20211231_z3i9deZN8Tb5" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Other receivables from third party</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_pp0p0_c20220331_zrpuL1g7L8e5" style="width: 13%; text-align: right" title="Other receivables from third party">23,015</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccountsAndOtherReceivablesNetCurrent_c20211231_pp0p0" style="width: 13%; text-align: right" title="Other receivables from third party">107,444</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Others</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PrepaidExpenseAndOtherAssets_iI_d0_c20220331_zX3sRGRhkpui" style="border-bottom: Black 1pt solid; text-align: right" title="Others">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PrepaidExpenseAndOtherAssets_iI_d0_c20211231_zMGPGfSQlPZd" style="border-bottom: Black 1pt solid; text-align: right" title="Others">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Prepaid expenses and other assets, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_c20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Prepaid expenses">23,015</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Prepaid expenses">107,444</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350784877072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--PropertyPlantAndEquipmentTextBlock_z1BtwQ7P3Be2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT, NET (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BA_zKf5UCVa7U4i" style="display: none">Schedule of property and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zDmnQElPvyQl" style="text-align: right" title="Property and equipment, gross">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zAe1uhhejWe3" style="text-align: right" title="Property and equipment, gross">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; text-align: justify">Equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 13%; text-align: right" title="Property and equipment, gross">77,031</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 13%; text-align: right" title="Property and equipment, gross">78,802</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Leasehold improvement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zrD9YVR9xcda" style="text-align: right" title="Property and equipment, gross">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zoXPFdeCGeR2" style="text-align: right" title="Property and equipment, gross">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Vehicle</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zcB14m3JzGK6" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z9kM2c4BzIik" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20220331_pp0p0" style="text-align: right" title="Property and equipment, gross">77,031</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" style="text-align: right" title="Property and equipment, gross">78,802</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20220331_z9WTzKKTHvvk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(8,587</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zZjPEa8Z3yTf" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(7,557</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">68,444</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">71,245</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350780246368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of goodwill</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfGoodwillTextBlock_zKCaKhtLz8ba" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BF_zpSt53H8uXib" style="display: none">Schedule of goodwill</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Goodwill - XFC</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Goodwill_c20220331__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="width: 13%; text-align: right" title="Goodwill">332,040</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Goodwill_c20211231__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="width: 13%; text-align: right" title="Goodwill">332,040</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20220331__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_zZhMHr3F27N" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20211231__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_zrnytFwnc8oj" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Goodwill, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Goodwill_c20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill">332,040</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Goodwill_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill">332,040</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350780265248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAndProductWarrantiesAbstract', window );"><strong>Guarantees and Product Warranties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule Assumption used</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_zZNzhkd1ivsb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANT (Details - Assumptions used)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B3_zolyDeAvVSP1" style="display: none">Schedule Assumption used</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Appraisal Date (Inception Date)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>C
                                            Warrant<br/> August 10, </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>D
                                            Warrant<br/> August 10, </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 70pt"><b>(Unaudited)</b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; padding-bottom: 1pt">Market price per share (USD/share)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharePrice_c20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)">1.47</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharePrice_c20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)">0.66</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Exercise price (USD/price)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)">2.50</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)">5.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Risk free rate</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zJtleOeWH7x5" title="Risk free rate">0.14</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zVFfXxfSE29g" title="Risk free rate">0.14</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Dividend yield</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zDeljX4piFi5" title="Dividend yield">0.00</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zphHp84WtXFb" title="Dividend yield">0.00</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Expected term/ Contractual life (years)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zYIzg7iLiKB3" title="Expected term/ Contractual life (years)">1.39</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zxdp9jeBwaYb" title="Expected term/ Contractual life (years)">1.39</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Expected volatility</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zcNQumQ3wbUh" title="Expected volatility">56.36</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zSN0k9tl3Cn4" title="Expected volatility">56.36</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Appraisal Date (Inception Date)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">C Warrant<br/> September 27,<br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">D Warrant<br/> September 27,<br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 70pt"><b>(Unaudited)</b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; padding-bottom: 1pt">Market price per share (USD/share)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharePrice_iI_c20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zQ0OvoIHBHq8" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)">1.71</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharePrice_c20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)">0.73</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Exercise price (USD/price)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)">2.50</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)">5.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Risk free rate</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zHuA0VWtRLg5" title="Risk free rate">0.15</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zZ62Z2LHUAKb" title="Risk free rate">0.15</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Dividend yield</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zmshSCeRiq89" title="Dividend yield">0.00</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zsqMuDZuGT9h" title="Dividend yield">0.00</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Expected term/ Contractual life (years)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zA066G7UQiv5" title="Expected term/ Contractual life (years)">1.26</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zlViy1eBJLhi" title="Expected term/ Contractual life (years)">1.26</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Expected volatility</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zRsOtfaKSvWc" title="Expected volatility">52.93</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zjlhNqiuyjSj" title="Expected volatility">52.93</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of Warranty Liability</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zRBbX1KQWYJi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANT (Details - Warrant Liability)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8BF_zEsJTGJAr8X9" style="display: none">Schedule of Warranty Liability</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left; padding-bottom: 1pt">Balance at the beginning of period</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_c20220101__20220331_zb0FgH8HVBn2" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Balance at the beginning of period">312,320</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_d0_c20210101__20211231_zdfF0NYdyda8" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Balance at the beginning of period">&#8211;</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Warrants issued to investors</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_d0_c20220101__20220331_z3hoiL8ruSBl" style="padding-bottom: 1pt; text-align: right" title="Warrants issued to investors">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20210101__20211231_zv5ZxRxu2TWl" style="padding-bottom: 1pt; text-align: right" title="Warrants issued to investors">287,520</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Warrants redeemed</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_ecustom--WarrantsRedeemed_pp0p0_d0_c20220101__20220331_zh3tOl2AGX5j" style="padding-bottom: 1pt; text-align: right" title="Warrants redeemed">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_988_ecustom--WarrantsRedeemed_pp0p0_d0_c20210101__20211231_z1ihNezgdBFj" style="padding-bottom: 1pt; text-align: right" title="Warrants redeemed">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Fair value change of warrants included in earnings</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_pp0p0_d0_c20220101__20220331_zUhCxqG5iC59" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value change of warrants included in earnings">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_pp0p0_c20210101__20211231_zsGpfdw9VAof" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value change of warrants included in earnings">24,800</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20220101__20220331_z6J3cmCtUIzl" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end of period">312,320</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20210101__20211231_zbozojyq2qs3" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end of period">312,320</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock', window );">Schedule of warrant activity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock_zdRW7EME5sqj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANT (Details - Warrant Activity)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B3_zuMpDTHKvy61" style="display: none">Schedule of warrant activity</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number
                                            of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Warrants</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise
                                            Price</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Remaining</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contractual</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Term
                                            in</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Years</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; padding-bottom: 1pt">Outstanding at January 1, 2022</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zZg4p29h3n1i" style="padding-bottom: 1pt; width: 11%; text-align: right" title="Warrants outstanding, beginning balance">256,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zs74PakyxSi4" style="padding-bottom: 1pt; width: 11%; text-align: right" title="Average exercise price, outstanding beginning">3.75</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 1pt; width: 11%; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_zBEPjacYxVe8" title="Weighted average remaining contractual term">2.66</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Exercisable at January 1, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_986_ecustom--WarrantsExercisable_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z15yeeroRkRg" style="padding-bottom: 1pt; text-align: right" title="Warrants exercisable beginning">256,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_ecustom--AverageExercisePriceExerciasable_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zhAgzTReyVCg" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, exerciasable beginning">3.75</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_zlzBpKCdBSdl" title="Weighted average remaining contractual term">2.66</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Granted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z3E0O5QkUjpf" style="padding-bottom: 1pt; text-align: right" title="Warrants Granted">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_986_ecustom--AverageExercisePriceGranted_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z6gEqiS9i7Ie" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, granted">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised / surrendered</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_980_ecustom--WarrantsExercisedSurrendered_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zK5E6F6fRhpj" style="padding-bottom: 1pt; text-align: right" title="Warrants Exercised / surrendered">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_982_ecustom--AverageExercisePriceExercisedSurrendered_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zXfaY0ifyBf2" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, exercised / surrendered">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zzc0c0qavmZd" style="padding-bottom: 1pt; text-align: right" title="Warrants expired">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_982_ecustom--WarrantWeightedAverageExercisePriceExpired_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zDZP7SIzuO22" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, expired">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Outstanding at March 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zKfnjL9vFa27" style="padding-bottom: 1pt; text-align: right" title="Warrants outstanding, ending balance">256,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zjRsP5UP5Jg6" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, outstanding ending">3.75</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_905_ecustom--WeightedAverageRemainingContractualTermOutsanding_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zazAkIfoMZe8" title="Weighted Average Remaining Contractual Term, outsanding">2.66</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Exercisable at March 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98B_ecustom--WarrantsExercisable_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zXlwjtrWVvug" style="padding-bottom: 1pt; text-align: right" title="Warrants exercisable at ending">256,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_ecustom--AverageExercisePriceExerciasable_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zS9dqwVk5Po8" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, exerciasable ending">3.75</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_905_ecustom--WeightedAverageRemainingContractualTermExercisable_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z8BZmieWyzSi" title="Weighted Average Remaining Contractual Term, exercisable">2.66</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAndProductWarrantiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAndProductWarrantiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of acquisition of assets or a business through noncash (or part noncash) transactions. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Disclosure may include the equity interest acquired, value of assets acquired, value of liabilities acquired, net monetary assets acquired, number of shares, warrants or options issued as consideration for a business or asset acquired and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781439440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of lease expenses</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--LeaseCostTableTextBlock_zsAAkdKcnPF7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details - Lease costs)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BE_zVB7hE2UFac" style="display: none">Components of lease expenses</span></td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Statement of Income Location</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended <br/> March 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended <br/> March 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Lease Costs</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: justify; padding-bottom: 1pt">Operating lease expense</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 24%; text-align: center; padding-bottom: 1pt">General and administrative expenses</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OperatingLeaseExpense_pp0p0_c20220101__20220331_zUgL9JhLDzbb" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Operating lease expense">11,788</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--OperatingLeaseExpense_c20210101__20210331_pp0p0" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Operating lease expense">1,218</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total net lease costs</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LeaseCost_c20220101__20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total net lease costs">11,788</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LeaseCost_c20210101__20210331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total net lease costs">1,218</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781545168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of payables</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zWMjxoS4liwg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B0_z2kcpJ0g7eOe" style="display: none">Schedule of payables</span></td>
    <td>&#160;</td>
    <td id="xdx_496_20220331_zn44z4h1Zp3c" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_498_20211231_zV4mvrnmUm4d" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March
    31, <br/>
    2022</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, <br/>
    2021</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0_maOAPAAzlpa_z0mZVfeq3Wn6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VAT payable</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,742</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,023</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maOAPAAzlpa_z6Y8UvO3JUae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary payable</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,255</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89,775</span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOAPAAzlpa_zSqCaOvLFhQk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,390</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,628</span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzlpa_zskZ7Bea6exa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69,387</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">142,426</span></td>
    <td>&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350784020256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Income tax components</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zNBlCeB3s3Fj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Income tax expense)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BA_zWIYPtJ5eEq2" style="display: none">Income tax components</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20220101__20220331_z22ivmCU75wb" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20210101__20210331_zg7NLvQLywSh" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three
                                            months ended </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March
                                            31,</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CurrentIncomeTaxExpenseBenefit_maITEBzz8A_zFcIrk11lfEl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Current</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">59,845</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredIncomeTaxExpenseBenefit_d0_maITEBzz8A_zAY8oAF2jPAh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Deferred</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,315</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzz8A_zqkoR6pJjKW8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total income tax expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">62,160</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of income tax expense</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zIhHDT4qwibj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Reconcilation of income tax)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BF_zgAKvp0kzcGc" style="display: none">Reconciliation of income tax expense</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three
                                            months ended</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,</b></p>

</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Taiwan (2021-PRC) income tax statutory rate</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20220101__20220331_zrN7nGv33YV8" title="PRC income tax statutory rate">20.00</span>%</td><td style="text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20210101__20210331_ztPAilGbJTO8" title="PRC income tax statutory rate">25.00</span>%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Impact of different tax rates in other jurisdictions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20220101__20220331_z0vYRtCjweX8" title="Impact of different tax rates in other jurisdictions">1.20</span>%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(<span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20210101__20210331_zAqgeGCddJ52" title="Impact of different tax rates in other jurisdictions">5.93</span>%)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Tax effect of non-deductible expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20220101__20220331_zC4vbbbjpPF8" title="Tax effect of non-deductible expense">15.85</span>%</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20210101__20210331_zigsnhYgJ0ij" title="Tax effect of non-deductible expense">0.00</span>%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Utilization of tax losses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_ecustom--TaxEffectOfNontaxableIncomeLoss_dp0_c20220101__20220331_z0jLXLkNfC39" title="Tax effect of utilization of tax losses previously recognized">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">(<span id="xdx_907_ecustom--TaxEffectOfNontaxableIncomeLoss_dp_c20210101__20210331_zJwFVApCWW65" title="Tax effect of utilization of tax losses previously recognized">2.07</span>%)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsOther_dp_c20220101__20220331_zYqrjFjLQnn1" title="Others">1.00</span>%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsOther_dp0_c20210101__20210331_z0TDxFcxKeng" title="Others">-</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Changes in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20220331_zNWp2yL6lI06" title="Changes in valuation allowance">5.35</span>%</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210101__20210331_zI01XUU8de11" title="Changes in valuation allowance">36.6</span>%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20220331_zfTk65wv4xnj" title="Effective tax rate">1.00</span>%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20210331_zcGWOudRGmB6" title="Effective tax rate">53.60</span>%</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred income taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zOpb9kfrk5Sc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Deferred taxes)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify"><span id="xdx_8B8_zzI2HQsnYHV4" style="display: none">Schedule of deferred income taxes</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20220331_zeov4IFQyBO5" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20211231_zPfQc6vrLjB8" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">March 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGrossAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_d0_maDTAGzr6G_z0UxfON8Cqfa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Tax loss carried forward</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_i01I_pp0p0_d0_maDTAGzr6G_zyd46Wka0yk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Allowance for doubtful receivables</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_d0_mtDTAGzr6G_maDTANzRmV_zWDL49L0RdAj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><b style="display: none">Total deferred tax assets</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetsValuationAllowanceCurrents_i01NI_pp0p0_di0_msDTANzRmV_z2SBASl55znj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_d0_mtDTANzRmV_zFqyAMJYNsRh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total deferred tax assets, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">March 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_i01NI_pp0p0_di0_maDITLzGX1_z91AKMAQgoF6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Property and equipment, difference in depreciation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredIncomeTaxLiabilities_i01NTI_pp0p0_di0_mtDITLzGX1_zbzCUzarUte7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Deferred tax liabilities, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Movement in valuation allowance</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--SummaryOfValuationAllowanceTextBlock_z2d2NOuYyQSb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Valuation Allowance)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8BD_zoHuHUzAQc8" style="display: none">Movement in valuation allowance</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">March 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; font-weight: bold; text-align: justify">Balance at beginning of the year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pp0p0_c20220101__20220331_zatVc5YIS4Hd" style="width: 13%; text-align: right" title="Valuation allowance, beginning">95,844</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pp0p0_d0_c20210101__20211231_zWTTI0X5EAp3" style="width: 13%; text-align: right" title="Valuation allowance, beginning">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Additions of valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20220101__20220331_pp0p0" style="text-align: right" title="Additions to valuation allowance">43,102</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pp0p0_c20210101__20211231_zBe1D7KEGk98" style="text-align: right" title="Additions to valuation allowance">95,844</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Reductions of valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20220101__20220331_zHtO5OuCig0l" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions in valuation allowance">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20210101__20211231_zKAN78REQQAk" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions in valuation allowance">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Balance at the end of the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20220101__20220331_zltgf9v29d6c" style="border-bottom: Black 2.5pt double; text-align: right" title="Valuation allowance, ending balance">138,946</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20210101__20211231_zpCa8Roa4Wzd" style="border-bottom: Black 2.5pt double; text-align: right" title="Valuation allowance, ending balance">95,844</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781524560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of related party transactions</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zPZQSQoiiX9e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_z5aIQXWUmNp" style="display: none">Schedule of related party transactions</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Mr. Yin-Chieh Cheng (1)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_fKDEp_zYGNXSMd5e27" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties">7,653</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_d0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_fKDEp_zqCqxQ9us1v7" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties">&#8211;</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Mountain Share Transfer, LLC (2)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferMember_fKDIp_z8kOPGm38MAf" style="padding-bottom: 1pt; text-align: right" title="Due to related parties">7,681</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferMember_fKDIp_zmlC1mm3w1Ta" style="padding-bottom: 1pt; text-align: right" title="Due to related parties">39,341</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_c20220331_pp0p0" style="padding-bottom: 2.5pt; text-align: right" title="Due from related parties">15,334</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_c20211231_pp0p0" style="padding-bottom: 2.5pt; text-align: right" title="Due from related parties">39,341</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due from a related party</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The balance due from a related party was as following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Taisi Electrical &amp; Plumbing Co. Pte Ltd. (3)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TaisiElectricMember_fKDMp_zh2O3aSAwF3h" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties">2,073,362</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TaisiElectricMember_fKDMp_zMEU1ccVhgm9" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties">1,615,217</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span id="xdx_F05_z9Yq5JGix94k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F1C_zKpw4KlepWn5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Yin-Chieh Cheng (&#8220;Mr.
    Cheng&#8221;) is the chairman the Company, and he holds 42.5% shares of the Company. The balance due to Mr. Cheng as of March 31,
    2022 mainly represented the amount paid by Mr. Cheng on behalf of the Company. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span id="xdx_F05_zZ7CsgsUqw3d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td><p id="xdx_F1F_z2rkY9MMOZ69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mountain Share Transfer, LLC is company 100%
    controlled by Erik S. Nelson, a greater than 5% stockholder of the Company. The balances represented the amount paid on behalf of
    the Company for its daily operation purpose.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td><span id="xdx_F08_zkGiWhWHfv07" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span id="xdx_F18_zZVheyzozH05" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Tsai Wen-Chih is the
    director of XFC and has control power over Taisi Electrical &amp; Plumbing Co. Pte Ltd. The Company took over the receivable amount
    of $877,809 from acquisition of XFC in December 2020. None of the receivables have been impaired and it is expected that the full
    contractual amounts can be collected.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781520080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Assumptions used</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zvCyXL0fZQO4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHARE-BASED COMPENSATION (Details - assumptions)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B1_zPZHyVmdkp69" style="display: none">Assumptions used</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: justify">Dividend yield</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: right">N/A</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: right">N/A</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Risk-free interest rate</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 1pt; width: 13%; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220331_z6HPq8IQRbGj" title="Risk-free interest rate">1.16</span>%</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 1pt; width: 13%; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231_zde4z729rsl2" title="Risk-free interest rate">1.16</span>%</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Expected term (in years)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220331_z5gLUDDuzWkh" title="Expected term (in years)">4.31</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zG3Es5HDzOcj" title="Expected term (in years)">4.31</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Volatility</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220331_zGRaIVOagcLk" title="Volatility">48.15</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231_zfLeAlsy2i36" title="Volatility">48.15</span>%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350780117792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(LOSS) INCOME PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of earnings (loss) per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXyGPZVIU9b9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - (LOSS) EARNINGS PER SHARE (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B1_z9yq6RhnB7C7" style="display: none">Schedule of earnings (loss) per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220101__20220331_z8URAQdjdX9h" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20210101__20210331_z3Owc1yVkrE4" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For
                                            three months ended </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March
                                            31,</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_ecustom--NumeratorAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify; padding-bottom: 2.5pt">Net (loss) income attributable to the Company</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">(805,720</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">49,490</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--DenominatorAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Weighted-average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,677,150</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,131,786</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,677,150</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,821,506</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--LossIncomePerShareAbstract_i01B_z4vQx9r7V4o7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">(Loss) income per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0755</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0054</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">- Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0755</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0036</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350778025120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations) - Accounts Receivable [Member] - Customer Concentration Risk [Member]<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Customer A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">22.01%<span></span>
</td>
<td class="nump">16.37%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Customer B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">56.98%<span></span>
</td>
<td class="nump">59.53%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Customer C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">20.75%<span></span>
</td>
<td class="nump">16.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">All Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">99.74%<span></span>
</td>
<td class="nump">92.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=NCRA_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=NCRA_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=NCRA_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=NCRA_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=NCRA_CustomerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=NCRA_CustomerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=NCRA_AllCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=NCRA_AllCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350782765200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative) - Revenue Benchmark [Member] - Customer Concentration Risk [Member]<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Two Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Three Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=NCRA_TwoCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=NCRA_TwoCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=NCRA_ThreeCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=NCRA_ThreeCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350780837440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, NET (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditLossAbstract', window );"><strong>Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts receivable</a></td>
<td class="nump">$ 531,522<span></span>
</td>
<td class="nump">$ 699,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Less: Allowance for doubtful accounts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total</a></td>
<td class="nump">$ 531,522<span></span>
</td>
<td class="nump">$ 699,555<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350780359520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 99,263<span></span>
</td>
<td class="nump">$ 97,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessAndRawMaterialsNetOfReserves', window );">Work in process</a></td>
<td class="nump">1,519,001<span></span>
</td>
<td class="nump">1,391,518<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 1,618,264<span></span>
</td>
<td class="nump">$ 1,488,681<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessAndRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of items which are partially completed at the time of measurement and unprocessed items that will go through the production process and become part of the final product. This element may be used when the reporting entity combines work in process and raw materials into an aggregate amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessAndRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350783998416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER ASSETS, NET (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Other receivables from third party</a></td>
<td class="nump">$ 23,015<span></span>
</td>
<td class="nump">$ 107,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Others</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses</a></td>
<td class="nump">$ 23,015<span></span>
</td>
<td class="nump">$ 107,444<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350777953952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 77,031<span></span>
</td>
<td class="nump">$ 78,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(8,587)<span></span>
</td>
<td class="num">(7,557)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">68,444<span></span>
</td>
<td class="nump">71,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">77,031<span></span>
</td>
<td class="nump">78,802<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350782241952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 787<span></span>
</td>
<td class="nump">$ 1,218<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350785136624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 332,040<span></span>
</td>
<td class="nump">$ 332,040<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=NCRA_XinFengConstructionCoLtdMember', window );">Xin Feng Construction Co Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">332,040<span></span>
</td>
<td class="nump">332,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NCRA_XinFengConstructionCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NCRA_XinFengConstructionCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350775900448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANT (Details - Assumptions used) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Aug. 10, 2021</div></th>
<th class="th"><div>Sep. 27, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 02, 2021</div></th>
<th class="th"><div>Jun. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (USD/price)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free rate</a></td>
<td class="nump">1.16%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.16%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term/ Contractual life (years)</a></td>
<td class="text">4 years 3 months 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 3 months 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">48.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=NCRA_CWarrantMember', window );">C Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Market price per share (USD/share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.47<span></span>
</td>
<td class="nump">$ 1.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (USD/price)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.14%<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term/ Contractual life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 4 months 20 days<span></span>
</td>
<td class="text">1 year 3 months 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.36%<span></span>
</td>
<td class="nump">52.93%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=NCRA_DWarrantMember', window );">D Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Market price per share (USD/share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="nump">$ 0.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (USD/price)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.14%<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term/ Contractual life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 4 months 20 days<span></span>
</td>
<td class="text">1 year 3 months 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.36%<span></span>
</td>
<td class="nump">52.93%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=NCRA_CWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=NCRA_CWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=NCRA_DWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=NCRA_DWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350782218432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANT (Details - Warrant Liability) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAndProductWarrantiesAbstract', window );"><strong>Guarantees and Product Warranties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Balance at the beginning of period</a></td>
<td class="nump">$ 312,320<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued', window );">Warrants issued to investors</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">287,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPeriodIncreaseDecrease', window );">Fair value change of warrants included in earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Balance at the end of period</a></td>
<td class="nump">$ 312,320<span></span>
</td>
<td class="nump">$ 312,320<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAndProductWarrantiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAndProductWarrantiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12524-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126907644&amp;loc=d3e11281-110244<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the standard and extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from warranties issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350782762544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANT (Details - Warrant Activity)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual term</a></td>
<td class="text">2 years 7 months 28 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding, beginning balance</a></td>
<td class="nump">256,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Average exercise price, outstanding beginning | $ / shares</a></td>
<td class="nump">$ 3.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Warrants Granted</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations', window );">Warrants expired</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding, ending balance</a></td>
<td class="nump">256,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Average exercise price, outstanding ending | $ / shares</a></td>
<td class="nump">$ 3.75<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350777868672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details - Lease costs) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 11,788<span></span>
</td>
<td class="nump">$ 1,218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total net lease costs</a></td>
<td class="nump">$ 11,788<span></span>
</td>
<td class="nump">$ 1,218<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350782715968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER PAYABLES AND ACCRUED LIABILITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">VAT payable</a></td>
<td class="nump">$ 7,742<span></span>
</td>
<td class="nump">$ 40,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Salary payable</a></td>
<td class="nump">31,255<span></span>
</td>
<td class="nump">89,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Others</a></td>
<td class="nump">30,390<span></span>
</td>
<td class="nump">12,628<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities', window );">Total</a></td>
<td class="nump">$ 69,387<span></span>
</td>
<td class="nump">$ 142,426<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350784020000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXATION (Details - Income tax expense) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 59,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,315<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 62,160<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350784201264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXATION (Details - Reconcilation of income tax)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings', window );">PRC income tax statutory rate</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Impact of different tax rates in other jurisdictions</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">5.93%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Tax effect of non-deductible expense</a></td>
<td class="nump">15.85%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther', window );">Others</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">(0.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Changes in valuation allowance</a></td>
<td class="nump">5.35%<span></span>
</td>
<td class="nump">36.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">53.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350780532208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>TAXATION (Details - Deferred taxes) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Tax loss carried forward</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances', window );">Allowance for doubtful receivables</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment, difference in depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated returns and sales allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350777981680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXATION (Details - Valuation Allowance) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance, beginning</a></td>
<td class="nump">$ 95,844<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Additions to valuation allowance</a></td>
<td class="nump">43,102<span></span>
</td>
<td class="nump">95,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance, ending balance</a></td>
<td class="nump">$ 138,946<span></span>
</td>
<td class="nump">$ 95,844<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350780570464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,817<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=country_HK', window );">HONG KONG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective income tax rate</a></td>
<td class="nump">8.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=NCRA_PrcMember', window );">Prc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective income tax rate</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=country_HK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=country_HK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=NCRA_PrcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=NCRA_PrcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350780233824">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToOtherRelatedPartiesCurrentAndNoncurrent', window );">Due from related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 15,334<span></span>
</td>
<td class="nump">$ 39,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,334<span></span>
</td>
<td class="nump">39,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_YinChiehChengMember', window );">Yin Chieh Cheng [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToOtherRelatedPartiesCurrentAndNoncurrent', window );">Due from related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">7,653<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_MountainShareTransferMember', window );">Mountain Share Transfer [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">7,681<span></span>
</td>
<td class="nump">39,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_TaisiElectricMember', window );">Taisi Electric [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToOtherRelatedPartiesCurrentAndNoncurrent', window );">Due from related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 2,073,362<span></span>
</td>
<td class="nump">$ 1,615,217<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Mr. Yin-Chieh Cheng (&#8220;Mr.
    Cheng&#8221;) is the chairman the Company, and he holds 42.5% shares of the Company. The balance due to Mr. Cheng as of March 31,
    2022 mainly represented the amount paid by Mr. Cheng on behalf of the Company.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Mountain Share Transfer, LLC is company 100%
    controlled by Erik S. Nelson, a greater than 5% stockholder of the Company. The balances represented the amount paid on behalf of
    the Company for its daily operation purpose.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Mr. Tsai Wen-Chih is the
    director of XFC and has control power over Taisi Electrical &amp; Plumbing Co. Pte Ltd. The Company took over the receivable amount
    of $877,809 from acquisition of XFC in December 2020. None of the receivables have been impaired and it is expected that the full
    contractual amounts can be collected.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToOtherRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount payable to related parties classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToOtherRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_YinChiehChengMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_YinChiehChengMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_MountainShareTransferMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_MountainShareTransferMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_TaisiElectricMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_TaisiElectricMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350780305872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMON STOCK (Details Narrative) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">10,707,150<span></span>
</td>
<td class="nump">10,607,150<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350780305872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Details - assumptions)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.16%<span></span>
</td>
<td class="nump">1.16%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">4 years 3 months 21 days<span></span>
</td>
<td class="text">4 years 3 months 21 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">48.15%<span></span>
</td>
<td class="nump">48.15%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350776105456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 02, 2021</div></th>
<th class="th"><div>Jun. 01, 2020</div></th>
<th class="th"><div>Dec. 27, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation costs</a></td>
<td class="nump">$ 11,114,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 11 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=NCRA_SeriesAWarrantMember', window );">Series A Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=NCRA_ClassAWarrantMember', window );">Class A Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_ShunChihChuangMember', window );">Shun Chih Chuang [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issued for services</a></td>
<td class="nump">505,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_MichaelALittmanMember', window );">Michael A Littman [Member] | Class A Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_MichaelALittmanMember', window );">Michael A Littman [Member] | Class B Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=NCRA_SeriesAWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=NCRA_SeriesAWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=NCRA_ClassAWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=NCRA_ClassAWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_ShunChihChuangMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_ShunChihChuangMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_MichaelALittmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NCRA_MichaelALittmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=NCRA_ClassBWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=NCRA_ClassBWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350775794112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PREFERRED STOCK (Details Narrative) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">80,000<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350775844080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(LOSS) EARNINGS PER SHARE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net (loss) income attributable to the Company</a></td>
<td class="num">$ (805,720)<span></span>
</td>
<td class="nump">$ 49,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">- Basic</a></td>
<td class="nump">10,677,150<span></span>
</td>
<td class="nump">9,131,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">- Diluted</a></td>
<td class="nump">10,677,150<span></span>
</td>
<td class="nump">13,821,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">- Basic</a></td>
<td class="num">$ (0.0755)<span></span>
</td>
<td class="nump">$ 0.0054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">- Diluted</a></td>
<td class="num">$ (0.0755)<span></span>
</td>
<td class="nump">$ 0.0036<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140350781590336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(LOSS) INCOME PER SHARE (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">5,560,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>nocera_s1a2_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:NCRA="http://nocera.company/20220331"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ncra-20220331.xsd" xlink:type="simple"/>
    <context id="From2022-01-01to2022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_StatutoryAndOtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TotalNoceraStockholdersEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_StatutoryAndOtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TotalNoceraStockholdersEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_custom_StatutoryAndOtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_custom_TotalNoceraStockholdersEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_StatutoryAndOtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_TotalNoceraStockholdersEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_custom_StatutoryAndOtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_custom_TotalNoceraStockholdersEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_StatutoryAndOtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_TotalNoceraStockholdersEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:TwoCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:ThreeCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AllCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:AllCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AllCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:AllCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_XinFengConstructionCoLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NCRA:XinFengConstructionCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_XinFengConstructionCoLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NCRA:XinFengConstructionCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-08-10_custom_CWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:CWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-10</instant>
        </period>
    </context>
    <context id="AsOf2021-08-10_custom_DWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:DWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-10</instant>
        </period>
    </context>
    <context id="From2021-01-012021-08-10_custom_CWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:CWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-08-10</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-08-10_custom_DWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:DWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-08-10</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-27_custom_CWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:CWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-27</instant>
        </period>
    </context>
    <context id="AsOf2021-09-27_custom_DWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:DWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-27</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-27_custom_CWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:CWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-27</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-27_custom_DWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:DWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-27</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_country_HK">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PrcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">NCRA:PrcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_YinChiehChengMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:YinChiehChengMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_YinChiehChengMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:YinChiehChengMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_MountainShareTransferMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MountainShareTransferMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_MountainShareTransferMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MountainShareTransferMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_TaisiElectricMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:TaisiElectricMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TaisiElectricMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:TaisiElectricMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-27_custom_SeriesAWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:SeriesAWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-27</instant>
        </period>
    </context>
    <context id="AsOf2020-06-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
        </entity>
        <period>
            <instant>2020-06-01</instant>
        </period>
    </context>
    <context id="AsOf2020-06-01_custom_ClassAWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-01</instant>
        </period>
    </context>
    <context id="AsOf2020-06-01_custom_MichaelALittmanMember_custom_ClassAWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MichaelALittmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-01</instant>
        </period>
    </context>
    <context id="AsOf2020-06-01_custom_MichaelALittmanMember_custom_ClassBWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassBWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MichaelALittmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-01</instant>
        </period>
    </context>
    <context id="AsOf2021-12-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
        </entity>
        <period>
            <instant>2021-12-02</instant>
        </period>
    </context>
    <context id="AsOf2021-12-02_custom_ClassAWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-02</instant>
        </period>
    </context>
    <context id="From2021-12-012021-12-31_custom_ShunChihChuangMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:ShunChihChuangMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001756180</identifier>
        </entity>
        <period>
            <instant>2021-08-01</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-01-01to2022-03-31">0001756180</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-01-01to2022-03-31">true</dei:AmendmentFlag>
    <dei:AmendmentDescription contextRef="From2022-01-01to2022-03-31">Revising for shares and pricing</dei:AmendmentDescription>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2022-03-31"
      id="xdx2ixbrl0118"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0119"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0277"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0279"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0280"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0281"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2021-01-012021-03-31_custom_StatutoryAndOtherReservesMember"
      id="xdx2ixbrl0282"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0283"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2021-01-012021-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0286"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0289"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0290"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-03-31_custom_StatutoryAndOtherReservesMember"
      id="xdx2ixbrl0292"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0293"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0294"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0296"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0299"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0300"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0301"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31_custom_StatutoryAndOtherReservesMember"
      id="xdx2ixbrl0302"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0304"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0306"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0321"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0338"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-01-012022-03-31_custom_StatutoryAndOtherReservesMember"
      id="xdx2ixbrl0340"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0341"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0342"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0344"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0349"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0351"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-01-012022-03-31_custom_StatutoryAndOtherReservesMember"
      id="xdx2ixbrl0352"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0353"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0356"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0359"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0360"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-01-012022-03-31_custom_StatutoryAndOtherReservesMember"
      id="xdx2ixbrl0362"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0363"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0364"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0366"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0370"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0371"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-03-31_custom_StatutoryAndOtherReservesMember"
      id="xdx2ixbrl0372"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0374"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0376"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2022-01-01to2022-03-31">S-1/A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2022-01-01to2022-03-31">Nocera, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-01-01to2022-03-31">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-01-01to2022-03-31">16-1626611</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-01-01to2022-03-31">3F (Building B)</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-01-01to2022-03-31">No. 185, Sec. 1</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="From2022-01-01to2022-03-31">Datong Rd., Xizhi Dist.</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="From2022-01-01to2022-03-31">New Taipei City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="From2022-01-01to2022-03-31">221</dei:EntityAddressPostalZipCode>
    <dei:CountryRegion contextRef="From2022-01-01to2022-03-31">886</dei:CountryRegion>
    <dei:CityAreaCode contextRef="From2022-01-01to2022-03-31">910</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-01-01to2022-03-31">163-358</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2022-01-01to2022-03-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-01-01to2022-03-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-01-01to2022-03-31">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2022-01-01to2022-03-31">false</dei:EntityExTransitionPeriod>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">1961777</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2444009</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">531522</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">699555</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">1618264</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1488681</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">23015</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">107444</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">2073362</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1615217</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">6225857</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">6397875</us-gaap:AssetsCurrent>
    <NCRA:RetentionReceivables contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">47946</NCRA:RetentionReceivables>
    <NCRA:RetentionReceivables contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">69489</NCRA:RetentionReceivables>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">0</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">68444</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">71245</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">332040</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">332040</us-gaap:Goodwill>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">448430</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">472774</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">6674287</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">6870649</us-gaap:Assets>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">0</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">92112</us-gaap:NotesPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">17442</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">69387</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">142426</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">15334</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">39341</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:ExtendedProductWarrantyAccrual contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">312320</us-gaap:ExtendedProductWarrantyAccrual>
    <us-gaap:ExtendedProductWarrantyAccrual contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">312320</us-gaap:ExtendedProductWarrantyAccrual>
    <us-gaap:DividendsPayableCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">6312</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">6312</us-gaap:DividendsPayableCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">112885</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">387319</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LoansPayableToBankCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">50565</us-gaap:LoansPayableToBankCurrent>
    <us-gaap:LoansPayableToBankCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">52292</us-gaap:LoansPayableToBankCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">1974657</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2100685</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">1974657</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2100685</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-03-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-03-31" decimals="INF" unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2022-03-31" decimals="INF" unitRef="Shares">10707150</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-03-31" decimals="INF" unitRef="Shares">10707150</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">10607150</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">10607150</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">10707</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">10607</us-gaap:CommonStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-03-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-03-31" decimals="INF" unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">80000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">80000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">80000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">80000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">80</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">80</us-gaap:PreferredStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">15078760</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">14472705</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">-10724273</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-9918553</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">143137</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">13906</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">4699630</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4769964</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">0</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">4699630</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4769964</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">6674287</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">6870649</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">2919045</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">1579486</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">2863803</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">1230842</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">55242</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">348644</us-gaap:GrossProfit>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">860953</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">235235</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">860953</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">235235</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-805711</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">113409</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-1759</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-805711</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">111650</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">9</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">62160</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-805720</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">49490</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-805720</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">49490</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-805720</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">49490</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-129231</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">1669</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-934951</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">51159</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-934951</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">51159</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="USDPShares">-0.0755</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="USDPShares">0.0054</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="USDPShares">-0.0755</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="USDPShares">0.0036</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Shares">10677150</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Shares">9131786</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Shares">10677150</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Shares">13821506</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">9131786</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">9132</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">2692973</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_custom_StatutoryAndOtherReservesMember"
      decimals="0"
      unitRef="USD">191219</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-293162</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">-49770</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_custom_TotalNoceraStockholdersEquityMember"
      decimals="0"
      unitRef="USD">2550392</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2550392</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2021-01-012021-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">-1669</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2021-01-012021-03-31_custom_TotalNoceraStockholdersEquityMember"
      decimals="0"
      unitRef="USD">-1669</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-1669</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">103155</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-03-31_custom_TotalNoceraStockholdersEquityMember"
      decimals="0"
      unitRef="USD">103155</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">103155</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">49490</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31_custom_TotalNoceraStockholdersEquityMember"
      decimals="0"
      unitRef="USD">49490</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">49490</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">9131786</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">9132</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">2796128</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-03-31_custom_StatutoryAndOtherReservesMember"
      decimals="0"
      unitRef="USD">191219</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-243672</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">-51439</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-03-31_custom_TotalNoceraStockholdersEquityMember"
      decimals="0"
      unitRef="USD">2701368</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-03-31" decimals="0" unitRef="USD">2701368</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">10607150</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">10607</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">80000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">80</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">14472705</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_custom_StatutoryAndOtherReservesMember"
      decimals="0"
      unitRef="USD">191219</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-9918553</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">13906</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_custom_TotalNoceraStockholdersEquityMember"
      decimals="0"
      unitRef="USD">4769964</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4769964</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">100000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">100</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">502900</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-01-012022-03-31_custom_TotalNoceraStockholdersEquityMember"
      decimals="0"
      unitRef="USD">503000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">503000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">129231</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-01-012022-03-31_custom_TotalNoceraStockholdersEquityMember"
      decimals="0"
      unitRef="USD">129231</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">129231</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">103155</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-01-012022-03-31_custom_TotalNoceraStockholdersEquityMember"
      decimals="0"
      unitRef="USD">103155</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">103155</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-805720</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-03-31_custom_TotalNoceraStockholdersEquityMember"
      decimals="0"
      unitRef="USD">-805720</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-805720</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">10707150</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">10707</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">80000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">80</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">15078760</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_custom_StatutoryAndOtherReservesMember"
      decimals="0"
      unitRef="USD">191219</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-10724273</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">143137</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_custom_TotalNoceraStockholdersEquityMember"
      decimals="0"
      unitRef="USD">4699630</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">4699630</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-805720</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">49490</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">787</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">1218</us-gaap:Depreciation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-0</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-2332</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">103155</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">103155</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-181547</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">303302</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">81931</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">47374</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">25892</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-89647</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-149262</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">21683</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:OperatingLeaseCost
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:OperatingLeaseCost>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-23414</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-6901</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInNotesPayableCurrent
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-93194</us-gaap:IncreaseDecreaseInNotesPayableCurrent>
    <us-gaap:IncreaseDecreaseInNotesPayableCurrent
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-51688</us-gaap:IncreaseDecreaseInNotesPayableCurrent>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-34887</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">8129</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-98670</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">26133</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-281200</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">59743</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-8332</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseDueFromOtherRelatedParties
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">458145</us-gaap:IncreaseDecreaseDueFromOtherRelatedParties>
    <us-gaap:IncreaseDecreaseDueFromOtherRelatedParties
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">261209</us-gaap:IncreaseDecreaseDueFromOtherRelatedParties>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-553267</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-258573</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireOilAndGasPropertyAndEquipment
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-0</us-gaap:PaymentsToAcquireOilAndGasPropertyAndEquipment>
    <us-gaap:PaymentsToAcquireOilAndGasPropertyAndEquipment
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">24000</us-gaap:PaymentsToAcquireOilAndGasPropertyAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-24000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfBankDebt
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">3453</us-gaap:RepaymentsOfBankDebt>
    <us-gaap:RepaymentsOfBankDebt
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">144233</us-gaap:RepaymentsOfBankDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-3453</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-144233</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">74488</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">10727</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-482232</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-416079</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2444009</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1023531</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">1961777</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-03-31" decimals="0" unitRef="USD">607452</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_805_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zrEb8tFfPdJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 1 &#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_826_zoHQe5OKUshe"&gt;PRINCIPAL ACTIVITIES AND ORGANIZATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements include
the financial statements of Nocera, Inc., a Nevada corporation (&#x201c;Nocera&#x201d;), and its subsidiaries, Grand Smooth Inc Limited
(&#x201c;GSI&#x201d;) and Guizhou Grand Smooth Technology Ltd. (&#x201c;GZ GST&#x201d; or &#x201c;WFOE&#x201d;), and Xin Feng Construction
Co., Ltd. (&#x201c;XFC&#x201d;) that is controlled through contractual arrangements. Nocera, GSI, GZ GST and XFC are collectively referred
to as the &#x201c;Company.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Nocera was incorporated in the State of Nevada
on February 1, 2002 and is based in New Taipei City, Taiwan (R.O.C). It did not engage in any operations and was dormant from its inception
until its reverse merger of GSI on December 31, 2018.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Reverse Merger&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Effective December 31, 2018, Nocera completed
a reverse merger transaction (the &#x201c;Transaction&#x201d;) pursuant to an Agreement and Plan of Merger (the &#x201c;Agreement&#x201d;),
with (i) GSI, (ii) GSI&#x2019;s shareholders, Yin-Chieh Cheng and Bi Zhang, who together owned shares constituting 100% of the issued
and outstanding ordinary shares of GSI (the &#x201c;GSI Shares&#x201d;) and (iii) GSI Acquisition Corp. Under the terms of the Agreement,
the GSI Shareholders transferred to Nocera all of the GSI Shares in exchange for the issuance of 10,000,000 shares (the &#x201c;Shares&#x201d;)
of Nocera&#x2019;s common stock (the &#x201c;Share Exchange&#x201d;). As a result of the reverse merger, GSI became Nocera&#x2019;s wholly-owned
subsidiary and Yin-Chieh Cheng and Bi Zhang, the former shareholders of GSI, became Nocera&#x2019;s controlling shareholders. The share
exchange transaction with GSI was treated as a reverse merger, with GSI as the accounting acquirer and Nocera as the acquired party.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;GSI is a limited company established under the
laws and regulations of Hong Kong on August 1, 2014, and is a holding company without any operation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;GZ WFH was incorporated in Xingyi City, Guizhou
Province, People&#x2019;s Republic of China (&#x201c;PRC&#x201d;) on October 25, 2017, and is engaged in providing fish farming containers
service, which integrates sales, installments, and maintenance of aquaculture equipment. The registered capital of GZ WFH is RMB$5,000,000
(equal to US$733,138).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On November 13, 2018, GSI incorporated GZ GST
in PRC with registered capital of US$15,000.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Divestiture&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On September 21, 2020, the Company filed a Current
Report on Form 8-K outlining the lack of communication that led to the termination by Nocera of its relationship with its former variable
interest entity, Guizhou Wan Feng Hu Intelligent Aquatic Technology Co. Limited (&#x201c;GZ WFH&#x201d;) and its management, and termination
of the variable interest entity agreements between the parties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsequently on October 8, 2020, Zhang Bi and
GZ WFH entered into a Settlement Agreement and Release with Nocera wherein all claims as to GZ WFH&#x2019;s debt (claim to shares in Nocera
or GZ GST) were compromised, settled, and otherwise resolved as to any and all claims or causes of action whatsoever against Nocera for
any matter, action, or representation as to Nocera, and any debt to ownership of Nocera or GZ GST up to the date of the agreement. The
consideration for the agreement was mutual waiver of any and all claims against each other and GZ GST, and GZ WFH (including Zhang Bi)
waived any claims to Nocera stock, meaning the 4,750,000 shares of common stock of Nocera owned by Zhang Bi were cancelled as part of
the agreement. The Settlement Agreement and Release is attached hereto as Exhibit 10.8.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;The VIE Agreements&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December 31, 2020, Nocera and XFC, a domestic
funded limited liability company registered in Taiwan (R.O.C), entered into a series of contractual agreements (&#x201c;VIE Agreements&#x201d;)
whereby Nocera agreed to provide technical consulting and related services to XFC. As a result, Nocera has been determined to be the
primary beneficiary of XFC and XFC became a variable interest entity (&#x201c;VIE&#x201d;) of Nocera.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December 31, 2020, Nocera exchanged &lt;span id="xdx_902_ecustom--SharesExchanged_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShareholdersMember_zuhq4bZLDds5" title="Shares exchanged"&gt;700,000&lt;/span&gt;
shares of the Company&#x2019;s restricted common stock to shareholders of XFC in exchange for 100% controlling interest in XFC.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The VIE structure was adopted mainly because
the China and Taiwan (R.O.C.) operating company may in the future engage in business that may require special licenses in China and which
can be in an industry that prohibits foreign investment. WFOE has entered into the following contractual arrangements with a stockholder
of XFC, that enables the Company to (1) have the power to direct the activities that most significantly affects the economic performance
of XFC, and (2) receive the economic benefits of XFC that could be significant to XFC. The Company is fully and exclusively responsible
for the management of XFC, assumes all of the risk of losses of XFC and has the exclusive right to exercise all voting rights of XFC&#x2019;s
stockholder. Therefore, in accordance with ASC 810 &#x201c;Consolidation,&#x201d; the Company is considered the primary beneficiary of
XFC and has consolidated XFC&#x2019;s assets, liabilities, results of operations, and cash flows in the accompanying consolidated financial
statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;(1) Voting Rights Proxy Agreement &amp;amp; Power
of Attorney. Mr. Tsai, Wen-Chih, Ms. Tu, Hui-Min, Mr. Tsai, Chin-Yao, and Mr. Tsai, Chin-Chao (&#x201c;Existing Stockholders&#x201d;) hereby
irrevocably undertake that they authorize Nocera or the individual then designated by Nocera (&#x201c;Attorney&#x201d;) to exercise, on
his or her behalf, the following rights available to them in their capacity as a stockholder of XFC under the then effective articles
of association of XFC (collectively, &#x201c;Powers&#x201d;): (a) to propose the convening of, and attend, stockholders&#x2019; meetings
in accordance with the articles of association of XFC on behalf of the Existing Stockholders; (b) to exercise voting rights on behalf
of the Existing Stockholders on all matters required to be deliberated and resolved by the stockholders&#x2019; meeting, including without
limitation the appointment and election of the directors and other executives to be appointed and removed by the stockholders of XFC
and the sale or transfer of all or part of the equity held by stockholders of XFC; (c) to exercise other stockholders&#x2019; voting rights
under the articles of association of XFC (including any other stockholders&#x2019; voting rights stipulated upon an amendment to such
articles of association); (d) other voting rights that stockholders shall enjoy under Taiwan (R.O.C.) laws, as amended, revised, supplemented
and re-enacted, no matter whether they take effect before or after the conclusion of the Voting Rights Proxy Agreement. The Existing
Stockholders shall not revoke the authorization and entrustment accorded to the Attorney other than in the case where Nocera gives the
Existing Stockholders a written notice requesting the replacement of the Attorney, in which event the Existing Stockholders shall immediately
appoint such other person as then designated by Nocera to exercise the foregoing Powers and such new authorization and entrustment shall
supersede, immediately upon its grant, the original authorization, and entrustment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;(2) Exclusive Business Cooperation Agreement.
Nocera agrees to provide technical consulting and services including management consulting services, general and financial advisory service
and various general and administrative service, for the specific content thereof (hereinafter referred to as the &#x201c;Target Business&#x201d;)
to XFC as the technical consulting and service provider of XFC in accordance with the conditions set forth herein during the term of
this Agreement. XFC agrees to accept the technical consulting and services provided by Nocera. XFC further agrees that, without the prior
written consent of Nocera, during the term of the Exclusive Business Cooperation Agreement, it shall not accept any technical consulting
and services identical or similar to the Target Business that are provided by any third party.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;(3) Equity Pledge Agreement. Under the Equity
Interest Pledge Agreement between Nocera and the Existing Stockholders, the Existing Stockholders pledged all of their equity interests
in XFC to Nocera to guarantee the performance of XFC&#x2019;s obligations under the Exclusive Business Cooperation Agreement. Under the
terms of the Equity Pledge Agreement, in the event that XFC or the Existing Stockholders breach their respective contractual obligations
under the Exclusive Business Cooperation Agreement, Nocera, as pledgor, will be entitled to certain rights, including, but not limited
to, the right to collect dividends generated by the pledged equity interests. Zhang Bi also agreed that upon the occurrence of any event
of default, as set forth in the Equity Pledge Agreement, Nocera is entitled to claim indemnity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;(4) Exclusive Call Option Agreement. XFC and
the Existing Stockholders have entered into an Exclusive Call Option Agreement with Nocera. Under the Exclusive Call Option Agreement,
the Existing Stockholders irrevocably granted Nocera (or its designee) an exclusive option to purchase, to the extent permitted under
Taiwan (R.O.C.) law, part or all of their equity interests in XFC. According to the Exclusive Call Option Agreement, the purchase price
shall be the minimum price permitted by applicable Taiwan (R.O.C.) law at the time when such share transfer occurs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zsA4Hz2pvhTg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 2&#160;&#160;&#160;&#160;&#160; &lt;span id="xdx_822_zG378H6snXKi"&gt;SUMMARY
OF SIGNIFICANT ACCOUNTING POLICY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zOPDEjzSSOw3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zzthcj81O9vb"&gt;Basis of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed consolidated
financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;)
and pursuant to the rules and regulations of the United States Securities and Exchange Commission (&#x201c;SEC&#x201d;) for interim financial
information. Accordingly, these financial statements do not include all of the information and footnotes required for complete financial
statements and should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the
Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 23, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In the opinion of management, all adjustments
(which include normal recurring adjustments) necessary to present a fair presentation of the Company&#x2019;s unaudited condensed consolidated
financial position as of March 31, 2022, its consolidated results of operations for the three months ended March 31, 2022, cash flows
for the three months ended March 31, 2022 and change in equity for the three months ended March 31, 2022, as applicable, have been made.
Operating results for the three months ended March 31, 2022 are not necessarily indicative of the operating results that may be expected
for the year ending December 31, 2021 or any future periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zyWbWqZ1EcTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zotZqIi3DkM7"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial instruments that potentially expose
the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its
customers and suppliers, and generally does not require collateral or other security from them. The Company evaluates its collection
experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic
reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There were two customers who represent &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zqiCWblCaVS1" title="Concentration risk"&gt;98&lt;/span&gt;% of
the Company&#x2019;s total revenue for the three months ended March 31, 2021. There were three customers who represent &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zy6rnYyOTYbh" title="Concentration risk"&gt;97&lt;/span&gt;% of the Company&#x2019;s
total revenue for the three months ended March 31, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table sets forth a summary of single
customers who represent 10% or more of the Company&#x2019;s total accounts receivable, net:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zm25Fxx0Zcgc" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B0_zW4Z3tOGIYKf" style="display: none"&gt;Concentrations of credit risk&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;Percentage of the Company&#x2019;s accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Customer A&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zK5sbpyPlAUj" title="Concentration percentage"&gt;22.01&lt;/span&gt;%&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zuYJNPFVAu05" title="Concentration percentage"&gt;16.37&lt;/span&gt;%&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Customer B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zB2k6gUomz9a" title="Concentration percentage"&gt;56.98&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zkaoD6BhLDdi" title="Concentration percentage"&gt;59.53&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Customer C&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zUxiX7ZeoRw6" title="Concentration percentage"&gt;20.75&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zXgLgH7ZWUI9" title="Concentration percentage"&gt;16.30&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_zWKMciXuphs9" title="Concentration percentage"&gt;99.74&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_z3ZENt2V02q3" title="Concentration percentage"&gt;92.20&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











&lt;p id="xdx_84F_eus-gaap--RevenueRecognitionPolicyTextBlock_zTX5IXSAHa7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zqVyQTKrSymi"&gt;Revenue Recognition&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company recognizes revenue in accordance
with Accounting Standards Codification (&#x201c;ASC&#x201d;) 606, &#x201c;Revenue from Contracts with Customers.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The core principle of the guidance is that an
entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, the Company applies
the following steps:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step 1: Identify the contract(s)
    with a customer&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step 2: Identify the performance
    obligations in the contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step 3: Determine the transaction
    price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step 4: Allocate the transaction
    price to the performance obligation in the contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Wingdings; font-size: 10pt"&gt;&#x178;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step 5: Recognize revenue
    when (or as) the entity satisfies a performance obligation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company considered revenue is recognized
when (or as) the Company satisfies performance obligations by transferring promised goods or services to its customers. Revenue is measured
at the transaction price which is based on the amount of consideration that the Company expects to receive in exchange for transferring
the promised goods or services to its customers. Contracts with customers are comprised of invoices and written contracts.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company does not have arrangements for returns
from customers and does not have any future obligations directly or indirectly related to services resale by customers. The Company has
no sales incentive programs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company provides goods, maintenance service
warranties for the goods sold with a period varying from 18 months to 72 months, a majority of which are 18 months, and exclusive sales
agency license to its customers. For performance obligation related to providing products, the Company expects to recognize the revenue
according to the delivery of products. For performance obligation related to maintenance service warranties, the Company expects to recognize
the revenue on a ratable basis using a time-based output method. The performance obligations are typically satisfied as services are
rendered on a straight-line basis over the contract term, which is generally for 18 months as a majority of the maintenance service warranties
periods provided are 18 months. For performance obligation related to exclusive agency license, the Company recognizes the revenue ratably
upon the satisfaction over the estimated economic life of the license.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company does not have amounts of contract
assets since revenue is recognized as control of goods is transferred. The contract liabilities consist of advance payments from customers
and deferred revenue. Advance payments from customers are expected to be recognized as revenue within 12 months. Deferred revenue is
expected to be recognized as revenue within 12 months.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zdmRuBtRXOTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zvQxyYzc7Cef"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The FASB issued several updates during the period, none of these standards
are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the consolidated
financial statements upon adoption.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;











</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zOPDEjzSSOw3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zzthcj81O9vb"&gt;Basis of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed consolidated
financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;)
and pursuant to the rules and regulations of the United States Securities and Exchange Commission (&#x201c;SEC&#x201d;) for interim financial
information. Accordingly, these financial statements do not include all of the information and footnotes required for complete financial
statements and should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the
Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 23, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In the opinion of management, all adjustments
(which include normal recurring adjustments) necessary to present a fair presentation of the Company&#x2019;s unaudited condensed consolidated
financial position as of March 31, 2022, its consolidated results of operations for the three months ended March 31, 2022, cash flows
for the three months ended March 31, 2022 and change in equity for the three months ended March 31, 2022, as applicable, have been made.
Operating results for the three months ended March 31, 2022 are not necessarily indicative of the operating results that may be expected
for the year ending December 31, 2021 or any future periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zyWbWqZ1EcTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zotZqIi3DkM7"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial instruments that potentially expose
the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its
customers and suppliers, and generally does not require collateral or other security from them. The Company evaluates its collection
experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic
reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There were two customers who represent &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zqiCWblCaVS1" title="Concentration risk"&gt;98&lt;/span&gt;% of
the Company&#x2019;s total revenue for the three months ended March 31, 2021. There were three customers who represent &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zy6rnYyOTYbh" title="Concentration risk"&gt;97&lt;/span&gt;% of the Company&#x2019;s
total revenue for the three months ended March 31, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table sets forth a summary of single
customers who represent 10% or more of the Company&#x2019;s total accounts receivable, net:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zm25Fxx0Zcgc" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B0_zW4Z3tOGIYKf" style="display: none"&gt;Concentrations of credit risk&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;Percentage of the Company&#x2019;s accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Customer A&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zK5sbpyPlAUj" title="Concentration percentage"&gt;22.01&lt;/span&gt;%&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zuYJNPFVAu05" title="Concentration percentage"&gt;16.37&lt;/span&gt;%&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Customer B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zB2k6gUomz9a" title="Concentration percentage"&gt;56.98&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zkaoD6BhLDdi" title="Concentration percentage"&gt;59.53&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Customer C&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zUxiX7ZeoRw6" title="Concentration percentage"&gt;20.75&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zXgLgH7ZWUI9" title="Concentration percentage"&gt;16.30&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_zWKMciXuphs9" title="Concentration percentage"&gt;99.74&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_z3ZENt2V02q3" title="Concentration percentage"&gt;92.20&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-03-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember"
      decimals="INF"
      unitRef="Pure">0.98</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-03-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember"
      decimals="INF"
      unitRef="Pure">0.97</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zm25Fxx0Zcgc" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B0_zW4Z3tOGIYKf" style="display: none"&gt;Concentrations of credit risk&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;Percentage of the Company&#x2019;s accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Customer A&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zK5sbpyPlAUj" title="Concentration percentage"&gt;22.01&lt;/span&gt;%&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zuYJNPFVAu05" title="Concentration percentage"&gt;16.37&lt;/span&gt;%&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Customer B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zB2k6gUomz9a" title="Concentration percentage"&gt;56.98&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zkaoD6BhLDdi" title="Concentration percentage"&gt;59.53&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Customer C&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zUxiX7ZeoRw6" title="Concentration percentage"&gt;20.75&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zXgLgH7ZWUI9" title="Concentration percentage"&gt;16.30&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_zWKMciXuphs9" title="Concentration percentage"&gt;99.74&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_z3ZENt2V02q3" title="Concentration percentage"&gt;92.20&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember"
      decimals="INF"
      unitRef="Pure">0.2201</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember"
      decimals="INF"
      unitRef="Pure">0.1637</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember"
      decimals="INF"
      unitRef="Pure">0.5698</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember"
      decimals="INF"
      unitRef="Pure">0.5953</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember"
      decimals="INF"
      unitRef="Pure">0.2075</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember"
      decimals="INF"
      unitRef="Pure">0.1630</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AllCustomersMember"
      decimals="INF"
      unitRef="Pure">0.9974</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AllCustomersMember"
      decimals="INF"
      unitRef="Pure">0.9220</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_84F_eus-gaap--RevenueRecognitionPolicyTextBlock_zTX5IXSAHa7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zqVyQTKrSymi"&gt;Revenue Recognition&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company recognizes revenue in accordance
with Accounting Standards Codification (&#x201c;ASC&#x201d;) 606, &#x201c;Revenue from Contracts with Customers.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The core principle of the guidance is that an
entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, the Company applies
the following steps:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step 1: Identify the contract(s)
    with a customer&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step 2: Identify the performance
    obligations in the contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step 3: Determine the transaction
    price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step 4: Allocate the transaction
    price to the performance obligation in the contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Wingdings; font-size: 10pt"&gt;&#x178;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step 5: Recognize revenue
    when (or as) the entity satisfies a performance obligation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company considered revenue is recognized
when (or as) the Company satisfies performance obligations by transferring promised goods or services to its customers. Revenue is measured
at the transaction price which is based on the amount of consideration that the Company expects to receive in exchange for transferring
the promised goods or services to its customers. Contracts with customers are comprised of invoices and written contracts.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company does not have arrangements for returns
from customers and does not have any future obligations directly or indirectly related to services resale by customers. The Company has
no sales incentive programs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company provides goods, maintenance service
warranties for the goods sold with a period varying from 18 months to 72 months, a majority of which are 18 months, and exclusive sales
agency license to its customers. For performance obligation related to providing products, the Company expects to recognize the revenue
according to the delivery of products. For performance obligation related to maintenance service warranties, the Company expects to recognize
the revenue on a ratable basis using a time-based output method. The performance obligations are typically satisfied as services are
rendered on a straight-line basis over the contract term, which is generally for 18 months as a majority of the maintenance service warranties
periods provided are 18 months. For performance obligation related to exclusive agency license, the Company recognizes the revenue ratably
upon the satisfaction over the estimated economic life of the license.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company does not have amounts of contract
assets since revenue is recognized as control of goods is transferred. The contract liabilities consist of advance payments from customers
and deferred revenue. Advance payments from customers are expected to be recognized as revenue within 12 months. Deferred revenue is
expected to be recognized as revenue within 12 months.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zdmRuBtRXOTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zvQxyYzc7Cef"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The FASB issued several updates during the period, none of these standards
are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the consolidated
financial statements upon adoption.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;











</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:AccountsAndNontradeReceivableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_802_eus-gaap--AccountsAndNontradeReceivableTextBlock_zrDK24Rj4eBe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 3&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_82A_zfn0f5ca1M7g"&gt;ACCOUNTS RECEIVABLE, NET&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of March 31, 2022 and December 31, 2021, accounts
receivable consisted of the following:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zvxUkk75SMQi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, NET (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B0_zJOWVgbUJQQ3" style="display: none"&gt;Schedule of accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20220331_z7fGBYydQXwk" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20211231_zjxfyEkfbM67" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AccountsReceivableGross_iI_pp0p0_maARNCzmYm_zlyj2389ocuc" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;531,522&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;699,555&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_d0_msARNCzmYm_zZWOE0xJQT2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Less: Allowance for doubtful accounts&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNCzmYm_zBmCxAALEk64" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;531,522&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;699,555&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the three months ended March 31, 2022 and
for the year ended December 31, 2021, the Company has recorded provision for doubtful accounts of nil.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:AccountsAndNontradeReceivableTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zvxUkk75SMQi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, NET (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B0_zJOWVgbUJQQ3" style="display: none"&gt;Schedule of accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20220331_z7fGBYydQXwk" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20211231_zjxfyEkfbM67" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AccountsReceivableGross_iI_pp0p0_maARNCzmYm_zlyj2389ocuc" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;531,522&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;699,555&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_d0_msARNCzmYm_zZWOE0xJQT2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Less: Allowance for doubtful accounts&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNCzmYm_zBmCxAALEk64" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;531,522&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;699,555&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGross contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">531522</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">699555</us-gaap:AccountsReceivableGross>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">531522</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">699555</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_zcpph4ZtWiag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 4 &#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_828_ztHWsNYJQdGd"&gt;INVENTORIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of March 31, 2022 and December 31, 2021, inventories
consisted of the following:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zJrBbyeFxJgc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B8_zXcJN3HrTLAj" style="display: none"&gt;Schedule of inventory&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20220331_zNPx1lrMRR8c" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20211231_zVoRi9ywFbPj" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_pp0p0_maINz9VL_z7cGHFufja82" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Raw materials&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;99,263&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;97,163&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--InventoryWorkInProcessAndRawMaterialsNetOfReserves_iI_pp0p0_maINz9VL_zyokTyy9ldvf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Work in process&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,519,001&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,391,518&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--InventoryNet_iTI_pp0p0_mtINz9VL_zvBBf6UE8Fa2" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,618,264&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,488,681&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zJrBbyeFxJgc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B8_zXcJN3HrTLAj" style="display: none"&gt;Schedule of inventory&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20220331_zNPx1lrMRR8c" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20211231_zVoRi9ywFbPj" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_pp0p0_maINz9VL_z7cGHFufja82" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Raw materials&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;99,263&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;97,163&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--InventoryWorkInProcessAndRawMaterialsNetOfReserves_iI_pp0p0_maINz9VL_zyokTyy9ldvf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Work in process&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,519,001&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,391,518&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--InventoryNet_iTI_pp0p0_mtINz9VL_zvBBf6UE8Fa2" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,618,264&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,488,681&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">99263</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">97163</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessAndRawMaterialsNetOfReserves contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">1519001</us-gaap:InventoryWorkInProcessAndRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessAndRawMaterialsNetOfReserves contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1391518</us-gaap:InventoryWorkInProcessAndRawMaterialsNetOfReserves>
    <us-gaap:InventoryNet contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">1618264</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1488681</us-gaap:InventoryNet>
    <us-gaap:OtherCurrentAssetsTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_80A_eus-gaap--OtherCurrentAssetsTextBlock_zFjDzJzPWLWk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note
5&#160;&#160;&#160;&#160;&#160; &lt;span id="xdx_822_zautqDbUIBY3"&gt;PREPAID EXPENSES AND OTHER ASSETS, NET&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zjkbDhSBANY7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B9_zUkeBYARoimj" style="display: none"&gt;Schedule of prepaid expenses and other assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20220331_z2F8Zb8a3fQg" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20211231_z3i9deZN8Tb5" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Other receivables from third party&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_pp0p0_c20220331_zrpuL1g7L8e5" style="width: 13%; text-align: right" title="Other receivables from third party"&gt;23,015&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccountsAndOtherReceivablesNetCurrent_c20211231_pp0p0" style="width: 13%; text-align: right" title="Other receivables from third party"&gt;107,444&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PrepaidExpenseAndOtherAssets_iI_d0_c20220331_zX3sRGRhkpui" style="border-bottom: Black 1pt solid; text-align: right" title="Others"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PrepaidExpenseAndOtherAssets_iI_d0_c20211231_zMGPGfSQlPZd" style="border-bottom: Black 1pt solid; text-align: right" title="Others"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Prepaid expenses and other assets, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_c20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Prepaid expenses"&gt;23,015&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Prepaid expenses"&gt;107,444&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zjkbDhSBANY7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B9_zUkeBYARoimj" style="display: none"&gt;Schedule of prepaid expenses and other assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20220331_z2F8Zb8a3fQg" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20211231_z3i9deZN8Tb5" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Other receivables from third party&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_pp0p0_c20220331_zrpuL1g7L8e5" style="width: 13%; text-align: right" title="Other receivables from third party"&gt;23,015&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccountsAndOtherReceivablesNetCurrent_c20211231_pp0p0" style="width: 13%; text-align: right" title="Other receivables from third party"&gt;107,444&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PrepaidExpenseAndOtherAssets_iI_d0_c20220331_zX3sRGRhkpui" style="border-bottom: Black 1pt solid; text-align: right" title="Others"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PrepaidExpenseAndOtherAssets_iI_d0_c20211231_zMGPGfSQlPZd" style="border-bottom: Black 1pt solid; text-align: right" title="Others"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Prepaid expenses and other assets, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_c20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Prepaid expenses"&gt;23,015&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Prepaid expenses"&gt;107,444&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">23015</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">107444</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssets contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">0</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">23015</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">107444</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_801_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zC586Wb8FNe3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 6 &#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_826_zcGIlgcP6bV5"&gt;PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of March 31, 2022 and December&#160;31, 2021,
property and equipment consisted of the following:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--PropertyPlantAndEquipmentTextBlock_z1BtwQ7P3Be2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT, NET (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BA_zKf5UCVa7U4i" style="display: none"&gt;Schedule of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zDmnQElPvyQl" style="text-align: right" title="Property and equipment, gross"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zAe1uhhejWe3" style="text-align: right" title="Property and equipment, gross"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 13%; text-align: right" title="Property and equipment, gross"&gt;77,031&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 13%; text-align: right" title="Property and equipment, gross"&gt;78,802&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Leasehold improvement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zrD9YVR9xcda" style="text-align: right" title="Property and equipment, gross"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zoXPFdeCGeR2" style="text-align: right" title="Property and equipment, gross"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Vehicle&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zcB14m3JzGK6" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z9kM2c4BzIik" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20220331_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;77,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;78,802&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20220331_z9WTzKKTHvvk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;(8,587&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zZjPEa8Z3yTf" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;(7,557&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"&gt;68,444&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"&gt;71,245&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Depreciation expenses for the three months ended
March 31, 2022 and 2021 were $&lt;span id="xdx_90B_eus-gaap--Depreciation_pp0p0_c20220101__20220331_zEDa8u4Y7rFa" title="Depreciation expense"&gt;787&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--Depreciation_pp0p0_c20210101__20210331_zqyyx2RRKFx7" title="Depreciation expense"&gt;1,218&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--PropertyPlantAndEquipmentTextBlock_z1BtwQ7P3Be2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT, NET (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BA_zKf5UCVa7U4i" style="display: none"&gt;Schedule of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zDmnQElPvyQl" style="text-align: right" title="Property and equipment, gross"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zAe1uhhejWe3" style="text-align: right" title="Property and equipment, gross"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 13%; text-align: right" title="Property and equipment, gross"&gt;77,031&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 13%; text-align: right" title="Property and equipment, gross"&gt;78,802&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Leasehold improvement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zrD9YVR9xcda" style="text-align: right" title="Property and equipment, gross"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zoXPFdeCGeR2" style="text-align: right" title="Property and equipment, gross"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Vehicle&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zcB14m3JzGK6" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z9kM2c4BzIik" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20220331_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;77,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;78,802&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20220331_z9WTzKKTHvvk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;(8,587&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zZjPEa8Z3yTf" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;(7,557&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"&gt;68,444&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"&gt;71,245&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-03-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-03-31_us-gaap_EquipmentMember"
      decimals="0"
      unitRef="USD">77031</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_EquipmentMember"
      decimals="0"
      unitRef="USD">78802</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-03-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-03-31_us-gaap_VehiclesMember"
      decimals="0"
      unitRef="USD">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_VehiclesMember"
      decimals="0"
      unitRef="USD">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">77031</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">78802</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">8587</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">7557</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">68444</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">71245</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">787</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">1218</us-gaap:Depreciation>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_809_eus-gaap--GoodwillDisclosureTextBlock_zf7qKeMb0QC7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 7 &#160;&#160;&#160;&#160;&lt;span id="xdx_827_zRYZyYqc1xv9"&gt;GOODWILL&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of March 31, 2022 and December&#160;31, 2021,
goodwill consisted of the following:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfGoodwillTextBlock_zKCaKhtLz8ba" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BF_zpSt53H8uXib" style="display: none"&gt;Schedule of goodwill&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Goodwill - XFC&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Goodwill_c20220331__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="width: 13%; text-align: right" title="Goodwill"&gt;332,040&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Goodwill_c20211231__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="width: 13%; text-align: right" title="Goodwill"&gt;332,040&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Less: Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20220331__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_zZhMHr3F27N" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20211231__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_zrnytFwnc8oj" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Goodwill, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Goodwill_c20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill"&gt;332,040&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Goodwill_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill"&gt;332,040&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfGoodwillTextBlock_zKCaKhtLz8ba" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BF_zpSt53H8uXib" style="display: none"&gt;Schedule of goodwill&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Goodwill - XFC&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Goodwill_c20220331__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="width: 13%; text-align: right" title="Goodwill"&gt;332,040&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Goodwill_c20211231__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="width: 13%; text-align: right" title="Goodwill"&gt;332,040&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Less: Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20220331__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_zZhMHr3F27N" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20211231__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_zrnytFwnc8oj" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Goodwill, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Goodwill_c20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill"&gt;332,040&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Goodwill_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill"&gt;332,040&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="AsOf2022-03-31_custom_XinFengConstructionCoLtdMember"
      decimals="0"
      unitRef="USD">332040</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2021-12-31_custom_XinFengConstructionCoLtdMember"
      decimals="0"
      unitRef="USD">332040</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-03-31_custom_XinFengConstructionCoLtdMember"
      decimals="0"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_custom_XinFengConstructionCoLtdMember"
      decimals="0"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:Goodwill contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">332040</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">332040</us-gaap:Goodwill>
    <us-gaap:GuaranteesTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_800_eus-gaap--GuaranteesTextBlock_zxUz9CGYXmxa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note &lt;/b&gt;&lt;b&gt;8
&lt;/b&gt;&lt;b&gt;&#160;&#160;&#160;&#160;&lt;span id="xdx_82D_zgJB3DLrWrLj"&gt;WARRANTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On April
1, 2021, the Company entered into a securities purchase agreement with certain investors for an aggregate of 80,000 shares of its preferred
stock at a per share purchase price of $2.50. As part of the transaction, the investors received one Class C warrant and one Class D
warrant for the subscription of each preferred share. The Class C warrants consist of the right to purchase up to 80,000 shares of the
Company&#x2019;s common stock at an exercise price of $2.50 per share exercisable for 36 months from the date of inception. The Class
D warrants consist of the right to purchase up to 80,000 shares of the Company&#x2019;s common stock at an exercise price of $5.00 per
share exercisable for 36 months from the date of inception. The subscription was completed on August 10, 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On September
27, 2021, the Company entered into another securities purchase agreement with the same investors, pursuant to which the Company issued
in a registered direct offering, an aggregate of 48,000 shares of common stock of the Company at a per share purchase price of $2.50.
In addition, the investors also received one Class C warrant and one Class D warrant for the subscription of each preferred share. The
Class C warrants consist of the right to purchase up to 80,000 shares of the Company&#x2019;s common stock at an exercise price of $2.50
per share exercisable for 36 months from the date of inception. The Class D warrants consist of the right to purchase up to 80,000 shares
of the Company&#x2019;s common stock at an exercise price of $5.00 per share exercisable for 36 months from the date
of inception.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_zZNzhkd1ivsb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANT (Details - Assumptions used)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B3_zolyDeAvVSP1" style="display: none"&gt;Schedule Assumption used&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Appraisal Date (Inception Date)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;C
                                            Warrant&lt;br/&gt; August 10, &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;D
                                            Warrant&lt;br/&gt; August 10, &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 70pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; padding-bottom: 1pt"&gt;Market price per share (USD/share)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharePrice_c20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)"&gt;1.47&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharePrice_c20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)"&gt;0.66&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Exercise price (USD/price)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)"&gt;2.50&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)"&gt;5.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Risk free rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zJtleOeWH7x5" title="Risk free rate"&gt;0.14&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zVFfXxfSE29g" title="Risk free rate"&gt;0.14&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Dividend yield&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zDeljX4piFi5" title="Dividend yield"&gt;0.00&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zphHp84WtXFb" title="Dividend yield"&gt;0.00&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Expected term/ Contractual life (years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zYIzg7iLiKB3" title="Expected term/ Contractual life (years)"&gt;1.39&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zxdp9jeBwaYb" title="Expected term/ Contractual life (years)"&gt;1.39&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Expected volatility&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zcNQumQ3wbUh" title="Expected volatility"&gt;56.36&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zSN0k9tl3Cn4" title="Expected volatility"&gt;56.36&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Appraisal Date (Inception Date)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;C Warrant&lt;br/&gt; September 27,&lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;D Warrant&lt;br/&gt; September 27,&lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 70pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; padding-bottom: 1pt"&gt;Market price per share (USD/share)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharePrice_iI_c20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zQ0OvoIHBHq8" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)"&gt;1.71&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharePrice_c20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)"&gt;0.73&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Exercise price (USD/price)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)"&gt;2.50&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)"&gt;5.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Risk free rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zHuA0VWtRLg5" title="Risk free rate"&gt;0.15&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zZ62Z2LHUAKb" title="Risk free rate"&gt;0.15&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Dividend yield&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zmshSCeRiq89" title="Dividend yield"&gt;0.00&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zsqMuDZuGT9h" title="Dividend yield"&gt;0.00&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Expected term/ Contractual life (years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zA066G7UQiv5" title="Expected term/ Contractual life (years)"&gt;1.26&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zlViy1eBJLhi" title="Expected term/ Contractual life (years)"&gt;1.26&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Expected volatility&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zRsOtfaKSvWc" title="Expected volatility"&gt;52.93&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zjlhNqiuyjSj" title="Expected volatility"&gt;52.93&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zgww6eMBcEw8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following
is a reconciliation of the beginning and ending balances of warrants liability measured at fair value on a recurring basis using Level
3 inputs:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zRBbX1KQWYJi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANT (Details - Warrant Liability)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BF_zEsJTGJAr8X9" style="display: none"&gt;Schedule of Warranty Liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: left; padding-bottom: 1pt"&gt;Balance at the beginning of period&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_c20220101__20220331_zb0FgH8HVBn2" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Balance at the beginning of period"&gt;312,320&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_d0_c20210101__20211231_zdfF0NYdyda8" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Balance at the beginning of period"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Warrants issued to investors&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_d0_c20220101__20220331_z3hoiL8ruSBl" style="padding-bottom: 1pt; text-align: right" title="Warrants issued to investors"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20210101__20211231_zv5ZxRxu2TWl" style="padding-bottom: 1pt; text-align: right" title="Warrants issued to investors"&gt;287,520&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Warrants redeemed&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--WarrantsRedeemed_pp0p0_d0_c20220101__20220331_zh3tOl2AGX5j" style="padding-bottom: 1pt; text-align: right" title="Warrants redeemed"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--WarrantsRedeemed_pp0p0_d0_c20210101__20211231_z1ihNezgdBFj" style="padding-bottom: 1pt; text-align: right" title="Warrants redeemed"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Fair value change of warrants included in earnings&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_pp0p0_d0_c20220101__20220331_zUhCxqG5iC59" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value change of warrants included in earnings"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_pp0p0_c20210101__20211231_zsGpfdw9VAof" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value change of warrants included in earnings"&gt;24,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20220101__20220331_z6J3cmCtUIzl" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end of period"&gt;312,320&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20210101__20211231_zbozojyq2qs3" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end of period"&gt;312,320&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following
is a summary of the warrant activity:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock_zdRW7EME5sqj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANT (Details - Warrant Activity)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B3_zuMpDTHKvy61" style="display: none"&gt;Schedule of warrant activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Number
                                            of&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise
                                            Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Term
                                            in&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Years&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%; padding-bottom: 1pt"&gt;Outstanding at January 1, 2022&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zZg4p29h3n1i" style="padding-bottom: 1pt; width: 11%; text-align: right" title="Warrants outstanding, beginning balance"&gt;256,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zs74PakyxSi4" style="padding-bottom: 1pt; width: 11%; text-align: right" title="Average exercise price, outstanding beginning"&gt;3.75&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 11%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_zBEPjacYxVe8" title="Weighted average remaining contractual term"&gt;2.66&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Exercisable at January 1, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--WarrantsExercisable_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z15yeeroRkRg" style="padding-bottom: 1pt; text-align: right" title="Warrants exercisable beginning"&gt;256,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AverageExercisePriceExerciasable_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zhAgzTReyVCg" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, exerciasable beginning"&gt;3.75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_zlzBpKCdBSdl" title="Weighted average remaining contractual term"&gt;2.66&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Granted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z3E0O5QkUjpf" style="padding-bottom: 1pt; text-align: right" title="Warrants Granted"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--AverageExercisePriceGranted_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z6gEqiS9i7Ie" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, granted"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Exercised / surrendered&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--WarrantsExercisedSurrendered_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zK5E6F6fRhpj" style="padding-bottom: 1pt; text-align: right" title="Warrants Exercised / surrendered"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AverageExercisePriceExercisedSurrendered_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zXfaY0ifyBf2" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, exercised / surrendered"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zzc0c0qavmZd" style="padding-bottom: 1pt; text-align: right" title="Warrants expired"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--WarrantWeightedAverageExercisePriceExpired_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zDZP7SIzuO22" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, expired"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding at March 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zKfnjL9vFa27" style="padding-bottom: 1pt; text-align: right" title="Warrants outstanding, ending balance"&gt;256,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zjRsP5UP5Jg6" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, outstanding ending"&gt;3.75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAverageRemainingContractualTermOutsanding_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zazAkIfoMZe8" title="Weighted Average Remaining Contractual Term, outsanding"&gt;2.66&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Exercisable at March 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WarrantsExercisable_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zXlwjtrWVvug" style="padding-bottom: 1pt; text-align: right" title="Warrants exercisable at ending"&gt;256,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AverageExercisePriceExerciasable_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zS9dqwVk5Po8" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, exerciasable ending"&gt;3.75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAverageRemainingContractualTermExercisable_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z8BZmieWyzSi" title="Weighted Average Remaining Contractual Term, exercisable"&gt;2.66&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:GuaranteesTextBlock>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_zZNzhkd1ivsb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANT (Details - Assumptions used)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B3_zolyDeAvVSP1" style="display: none"&gt;Schedule Assumption used&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Appraisal Date (Inception Date)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;C
                                            Warrant&lt;br/&gt; August 10, &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;D
                                            Warrant&lt;br/&gt; August 10, &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 70pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; padding-bottom: 1pt"&gt;Market price per share (USD/share)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharePrice_c20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)"&gt;1.47&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharePrice_c20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)"&gt;0.66&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Exercise price (USD/price)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)"&gt;2.50&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)"&gt;5.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Risk free rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zJtleOeWH7x5" title="Risk free rate"&gt;0.14&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zVFfXxfSE29g" title="Risk free rate"&gt;0.14&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Dividend yield&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zDeljX4piFi5" title="Dividend yield"&gt;0.00&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zphHp84WtXFb" title="Dividend yield"&gt;0.00&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Expected term/ Contractual life (years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zYIzg7iLiKB3" title="Expected term/ Contractual life (years)"&gt;1.39&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zxdp9jeBwaYb" title="Expected term/ Contractual life (years)"&gt;1.39&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Expected volatility&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zcNQumQ3wbUh" title="Expected volatility"&gt;56.36&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zSN0k9tl3Cn4" title="Expected volatility"&gt;56.36&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Appraisal Date (Inception Date)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;C Warrant&lt;br/&gt; September 27,&lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;D Warrant&lt;br/&gt; September 27,&lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 70pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; padding-bottom: 1pt"&gt;Market price per share (USD/share)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharePrice_iI_c20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zQ0OvoIHBHq8" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)"&gt;1.71&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharePrice_c20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Market price per share (USD/share)"&gt;0.73&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Exercise price (USD/price)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)"&gt;2.50&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Exercise price (USD/price)"&gt;5.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Risk free rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zHuA0VWtRLg5" title="Risk free rate"&gt;0.15&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zZ62Z2LHUAKb" title="Risk free rate"&gt;0.15&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Dividend yield&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zmshSCeRiq89" title="Dividend yield"&gt;0.00&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zsqMuDZuGT9h" title="Dividend yield"&gt;0.00&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Expected term/ Contractual life (years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zA066G7UQiv5" title="Expected term/ Contractual life (years)"&gt;1.26&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zlViy1eBJLhi" title="Expected term/ Contractual life (years)"&gt;1.26&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Expected volatility&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zRsOtfaKSvWc" title="Expected volatility"&gt;52.93&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zjlhNqiuyjSj" title="Expected volatility"&gt;52.93&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2021-08-10_custom_CWarrantMember"
      decimals="INF"
      unitRef="USDPShares">1.47</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2021-08-10_custom_DWarrantMember"
      decimals="INF"
      unitRef="USDPShares">0.66</us-gaap:SharePrice>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-08-10_custom_CWarrantMember"
      decimals="INF"
      unitRef="USDPShares">2.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-08-10_custom_DWarrantMember"
      decimals="INF"
      unitRef="USDPShares">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-012021-08-10_custom_CWarrantMember"
      decimals="INF"
      unitRef="Pure">0.0014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-012021-08-10_custom_DWarrantMember"
      decimals="INF"
      unitRef="Pure">0.0014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-01-012021-08-10_custom_CWarrantMember"
      decimals="INF"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-01-012021-08-10_custom_DWarrantMember"
      decimals="INF"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-01-012021-08-10_custom_CWarrantMember">P1Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-01-012021-08-10_custom_DWarrantMember">P1Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-012021-08-10_custom_CWarrantMember"
      decimals="INF"
      unitRef="Pure">0.5636</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-012021-08-10_custom_DWarrantMember"
      decimals="INF"
      unitRef="Pure">0.5636</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharePrice
      contextRef="AsOf2021-09-27_custom_CWarrantMember"
      decimals="INF"
      unitRef="USDPShares">1.71</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2021-09-27_custom_DWarrantMember"
      decimals="INF"
      unitRef="USDPShares">0.73</us-gaap:SharePrice>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-09-27_custom_CWarrantMember"
      decimals="INF"
      unitRef="USDPShares">2.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-09-27_custom_DWarrantMember"
      decimals="INF"
      unitRef="USDPShares">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-012021-09-27_custom_CWarrantMember"
      decimals="INF"
      unitRef="Pure">0.0015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-012021-09-27_custom_DWarrantMember"
      decimals="INF"
      unitRef="Pure">0.0015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-01-012021-09-27_custom_CWarrantMember"
      decimals="INF"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-01-012021-09-27_custom_DWarrantMember"
      decimals="INF"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-01-012021-09-27_custom_CWarrantMember">P1Y3M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-01-012021-09-27_custom_DWarrantMember">P1Y3M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-012021-09-27_custom_CWarrantMember"
      decimals="INF"
      unitRef="Pure">0.5293</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-012021-09-27_custom_DWarrantMember"
      decimals="INF"
      unitRef="Pure">0.5293</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zRBbX1KQWYJi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANT (Details - Warrant Liability)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BF_zEsJTGJAr8X9" style="display: none"&gt;Schedule of Warranty Liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: left; padding-bottom: 1pt"&gt;Balance at the beginning of period&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_c20220101__20220331_zb0FgH8HVBn2" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Balance at the beginning of period"&gt;312,320&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_d0_c20210101__20211231_zdfF0NYdyda8" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Balance at the beginning of period"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Warrants issued to investors&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_d0_c20220101__20220331_z3hoiL8ruSBl" style="padding-bottom: 1pt; text-align: right" title="Warrants issued to investors"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20210101__20211231_zv5ZxRxu2TWl" style="padding-bottom: 1pt; text-align: right" title="Warrants issued to investors"&gt;287,520&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Warrants redeemed&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--WarrantsRedeemed_pp0p0_d0_c20220101__20220331_zh3tOl2AGX5j" style="padding-bottom: 1pt; text-align: right" title="Warrants redeemed"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--WarrantsRedeemed_pp0p0_d0_c20210101__20211231_z1ihNezgdBFj" style="padding-bottom: 1pt; text-align: right" title="Warrants redeemed"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Fair value change of warrants included in earnings&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_pp0p0_d0_c20220101__20220331_zUhCxqG5iC59" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value change of warrants included in earnings"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_pp0p0_c20210101__20211231_zsGpfdw9VAof" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value change of warrants included in earnings"&gt;24,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20220101__20220331_z6J3cmCtUIzl" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end of period"&gt;312,320&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20210101__20211231_zbozojyq2qs3" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end of period"&gt;312,320&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">312320</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">0</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">287520</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualPeriodIncreaseDecrease
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ProductWarrantyAccrualPeriodIncreaseDecrease>
    <us-gaap:ProductWarrantyAccrualPeriodIncreaseDecrease
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">24800</us-gaap:ProductWarrantyAccrualPeriodIncreaseDecrease>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">312320</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">312320</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock_zdRW7EME5sqj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANT (Details - Warrant Activity)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B3_zuMpDTHKvy61" style="display: none"&gt;Schedule of warrant activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Number
                                            of&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise
                                            Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Term
                                            in&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Years&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%; padding-bottom: 1pt"&gt;Outstanding at January 1, 2022&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zZg4p29h3n1i" style="padding-bottom: 1pt; width: 11%; text-align: right" title="Warrants outstanding, beginning balance"&gt;256,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zs74PakyxSi4" style="padding-bottom: 1pt; width: 11%; text-align: right" title="Average exercise price, outstanding beginning"&gt;3.75&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 11%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_zBEPjacYxVe8" title="Weighted average remaining contractual term"&gt;2.66&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Exercisable at January 1, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--WarrantsExercisable_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z15yeeroRkRg" style="padding-bottom: 1pt; text-align: right" title="Warrants exercisable beginning"&gt;256,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AverageExercisePriceExerciasable_iS_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zhAgzTReyVCg" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, exerciasable beginning"&gt;3.75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_zlzBpKCdBSdl" title="Weighted average remaining contractual term"&gt;2.66&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Granted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z3E0O5QkUjpf" style="padding-bottom: 1pt; text-align: right" title="Warrants Granted"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--AverageExercisePriceGranted_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z6gEqiS9i7Ie" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, granted"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Exercised / surrendered&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--WarrantsExercisedSurrendered_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zK5E6F6fRhpj" style="padding-bottom: 1pt; text-align: right" title="Warrants Exercised / surrendered"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AverageExercisePriceExercisedSurrendered_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zXfaY0ifyBf2" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, exercised / surrendered"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zzc0c0qavmZd" style="padding-bottom: 1pt; text-align: right" title="Warrants expired"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--WarrantWeightedAverageExercisePriceExpired_d0_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zDZP7SIzuO22" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, expired"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding at March 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zKfnjL9vFa27" style="padding-bottom: 1pt; text-align: right" title="Warrants outstanding, ending balance"&gt;256,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zjRsP5UP5Jg6" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, outstanding ending"&gt;3.75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAverageRemainingContractualTermOutsanding_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zazAkIfoMZe8" title="Weighted Average Remaining Contractual Term, outsanding"&gt;2.66&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Exercisable at March 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WarrantsExercisable_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zXlwjtrWVvug" style="padding-bottom: 1pt; text-align: right" title="Warrants exercisable at ending"&gt;256,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AverageExercisePriceExerciasable_iE_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zS9dqwVk5Po8" style="padding-bottom: 1pt; text-align: right" title="Average exercise price, exerciasable ending"&gt;3.75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAverageRemainingContractualTermExercisable_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z8BZmieWyzSi" title="Weighted Average Remaining Contractual Term, exercisable"&gt;2.66&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2021-12-31_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Shares">256000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-12-31_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="USDPShares">3.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2022-01-01to2022-03-31">P2Y7M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2022-01-01to2022-03-31">P2Y7M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="From2022-01-012022-03-31_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2022-01-012022-03-31_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-03-31_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Shares">256000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-03-31_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="USDPShares">3.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:LeasesOfLesseeDisclosureTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_802_eus-gaap--LeasesOfLesseeDisclosureTextBlock_ztCPw4fOw6ae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 9 &#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_826_zxWDTRzOgcCd"&gt;LEASES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has two non-cancelable lease agreements
for certain of the office and accommodation as well as fish farming containers for research and develop advanced technology for water
circulation applying in fishery with original lease periods expiring between 2022 and 2023. The lease terms may include options to extend
or terminate the lease when it is reasonably certain the Company will exercise that option. The Company recognizes rental expense on
a straight-line basis over the lease term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The components of lease expense for the three months ended March 31,
2022 and March 31, 2021 were as follows:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--LeaseCostTableTextBlock_zsAAkdKcnPF7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details - Lease costs)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BE_zVB7hE2UFac" style="display: none"&gt;Components of lease expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Statement of Income Location&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three months ended &lt;br/&gt; March 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three months ended &lt;br/&gt; March 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Lease Costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: justify; padding-bottom: 1pt"&gt;Operating lease expense&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24%; text-align: center; padding-bottom: 1pt"&gt;General and administrative expenses&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLeaseExpense_pp0p0_c20220101__20220331_zUgL9JhLDzbb" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Operating lease expense"&gt;11,788&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingLeaseExpense_c20210101__20210331_pp0p0" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Operating lease expense"&gt;1,218&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total net lease costs&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LeaseCost_c20220101__20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total net lease costs"&gt;11,788&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LeaseCost_c20210101__20210331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total net lease costs"&gt;1,218&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Maturity of lease liabilities under our non-cancelable operating leases
as of December 31, 2021 and March 31, 2022 are US$ nil.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:LeasesOfLesseeDisclosureTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--LeaseCostTableTextBlock_zsAAkdKcnPF7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details - Lease costs)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BE_zVB7hE2UFac" style="display: none"&gt;Components of lease expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Statement of Income Location&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three months ended &lt;br/&gt; March 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three months ended &lt;br/&gt; March 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Lease Costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: justify; padding-bottom: 1pt"&gt;Operating lease expense&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24%; text-align: center; padding-bottom: 1pt"&gt;General and administrative expenses&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLeaseExpense_pp0p0_c20220101__20220331_zUgL9JhLDzbb" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Operating lease expense"&gt;11,788&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingLeaseExpense_c20210101__20210331_pp0p0" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Operating lease expense"&gt;1,218&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total net lease costs&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LeaseCost_c20220101__20220331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total net lease costs"&gt;11,788&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LeaseCost_c20210101__20210331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total net lease costs"&gt;1,218&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">11788</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">1218</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseCost
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">11788</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">1218</us-gaap:LeaseCost>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_80C_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zurhctaYBSth" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note
10&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_822_z0xzanoc8udg"&gt;OTHER PAYABLES AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zWMjxoS4liwg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B0_z2kcpJ0g7eOe" style="display: none"&gt;Schedule of payables&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20220331_zn44z4h1Zp3c" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20211231_zV4mvrnmUm4d" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March
    31, &lt;br/&gt;
    2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31, &lt;br/&gt;
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0_maOAPAAzlpa_z0mZVfeq3Wn6" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 70%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;VAT payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,742&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maOAPAAzlpa_z6Y8UvO3JUae" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Salary payable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,255&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;89,775&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOAPAAzlpa_zSqCaOvLFhQk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Others&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,390&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,628&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzlpa_zskZ7Bea6exa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;69,387&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;142,426&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;









</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zWMjxoS4liwg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B0_z2kcpJ0g7eOe" style="display: none"&gt;Schedule of payables&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20220331_zn44z4h1Zp3c" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20211231_zV4mvrnmUm4d" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March
    31, &lt;br/&gt;
    2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31, &lt;br/&gt;
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0_maOAPAAzlpa_z0mZVfeq3Wn6" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 70%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;VAT payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,742&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maOAPAAzlpa_z6Y8UvO3JUae" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Salary payable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,255&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;89,775&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOAPAAzlpa_zSqCaOvLFhQk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Others&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,390&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,628&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzlpa_zskZ7Bea6exa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;69,387&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;142,426&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">7742</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">40023</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">31255</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">89775</us-gaap:AccruedSalariesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">30390</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">12628</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">69387</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">142426</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_80B_eus-gaap--IncomeTaxDisclosureTextBlock_zBCMoWHPAHp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Note 11
&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_82C_zoZ35SQXaG3h"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company and its subsidiary, and the consolidated
VIE file tax returns separately.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;1) Value-added tax (&#x201c;VAT&#x201d;)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;PRC&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Pursuant to the Provisional Regulation of the
PRC on VAT and the related implementing rules, all entities and individuals (&#x201c;taxpayers&#x201d;) that are engaged in the sale of
products in the PRC are generally required to pay VAT, at a rate of which was changed from &lt;span id="xdx_905_ecustom--ValueAddedTaxRate_iI_dp_c20211231_zWMfCmiNFeU8" title="Value added tax rate"&gt;16&lt;/span&gt;% to &lt;span id="xdx_90C_ecustom--ValueAddedTaxRate_c20220331_pdd" title="Value added tax rate"&gt;13&lt;/span&gt;% on April 1, 2019 of the gross sales
proceeds received, less any deductible VAT already paid or borne by the taxpayers. GZ WFH also subjected to 10% for the installment service
provided.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="text-decoration: underline"&gt;Taiwan&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Pursuant to the Value-added and Non-value-added
Business Tax Act and the related implementing rules, all entities and individuals (&#x201c;taxpayers&#x201d;) that are engaged in the sale
of products in the Taiwan are generally required to pay VAT, at a rate of 5%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;2) Income tax&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;United States &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December 22, 2017, the Tax Cuts and Jobs Act
(the &#x201c;Tax Act&#x201d;) was signed into legislation. The Tax Act significantly revises the U.S. corporate income tax by, among other
things, lowering the statutory corporate tax rate from 34% to 21%, imposing a mandatory one-time tax on accumulated earnings of foreign
subsidiaries, introducing new tax regimes, and changing how foreign earnings are subject to U.S. tax.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December 22, 2017, Staff Accounting Bulletin
No. 118 (&#x201c;SAB 118&#x201d;) was issued to provide guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement
period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740.
The Company has completed the assessment of the income tax effect of the Tax Act and there were no adjustments recorded to the provisional
amounts.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Coronavirus Aid, Relief and Economy Security
Act (the &#x201c;CARES Act&#x201d;) was signed into law on 27 March 2020. The CARES Act temporarily eliminates the 80% taxable income limitation
(as enacted under the Tax Cuts and Jobs Act of 2017) for NOL deductions for 2018-2020 tax years and reinstated NOL carrybacks for the
2018-2020 tax years. Moreover, the CARES Act also temporarily increases the business interest deduction limitations from 30% to 50% of
adjusted taxable income for the 2019 and 2020 taxable year. Lastly, the Tax Act technical correction classifies qualified improvement
property as 15-year recovery period, allowing the bonus depreciation deduction to be claimed for such property retroactively as if it
was included in the Tax Act at the time of enactment. The Company does not anticipate a significant tax impact on its financial statements
and will continue to examine the impact the CARES Act may have on its business.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company evaluated the Global Intangible Low
Taxed Income (&#x201c;GILTI&#x201d;) inclusion on current earnings and profits of greater than 10% owned foreign controlled corporations.
The Company has evaluated whether it has additional provision amount resulted by the GILTI inclusion on current earnings and profits
of its foreign controlled corporations. The law also provides that corporate taxpayers may benefit from a 50% reduction in the GILTI
inclusion, which effectively reduces the &lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20220331__us-gaap--IncomeTaxAuthorityAxis__country--US_zV4VYhboKQfg" title="Effective income tax rate"&gt;21&lt;/span&gt;% U.S. corporate tax rate on the foreign income to an effective rate of &lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20210331__us-gaap--IncomeTaxAuthorityAxis__country--US_zvjahn1hx6fe" title="Effective income tax rate"&gt;10.5&lt;/span&gt;%. The GILTI inclusion
further provides for a foreign tax credit in connection with the foreign taxes paid. In 2019, the Company recorded a GILTI inclusion
of $&lt;span id="xdx_90D_ecustom--GlobalIntangibleLowTaxedIncome_c20220101__20220331_pp0p0" title="Global Intangible Low Taxed Income"&gt;152,829&lt;/span&gt;. The Company has elected to treat the financial statement impact of GILTI as current period expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The reverse merger was completed on December
31, 2018 and the tax losses of US subsidiary was not in the scope as of December 31, 2018. As of December 31, 2019, net operating loss
carried forward which was available to offset future taxable income for the Company in the United States was $&lt;span id="xdx_90D_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20191231__us-gaap--IncomeTaxAuthorityAxis__country--US_ziwTIVA27cwk" title="Net operating loss carryforwards"&gt;99,817&lt;/span&gt;. There is a full
valuation allowance applied against these loss carry forward as management determined it was not more likely than not that these net
operating losses would be utilized in the foreseeable future.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Hong Kong&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The HK tax reform has introduced two-tiered profits
tax rates for corporations. Under the two-tiered profits tax rates regime, the profits tax rate for the first HK$2 million (approximately
$257,931) of assessable profits will be lowered to &lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20220331__us-gaap--IncomeTaxAuthorityAxis__country--HK_zSgDuT1sqNi1" title="Effective income tax rate"&gt;8.25&lt;/span&gt;% (half of the rate specified in Schedule 8 to the Inland Revenue Ordinance (IRO))
for corporations. Assessable profits above HK$2 million (approximately $257,931) will continue to be subject to the rate of 16.5% for
corporations. The Company assessed that the HK entity will not earn a profit greater than HK$2 million (approximately $257,931), it is
subject to a corporate income tax rate of 8.25%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2021, the Company&#x2019;s
subsidiary in Hong Kong had net operating loss carry forwards available to offset future taxable income. The net operating losses will
be carryforward indefinitely under Hong Kong Profits Tax regulation. There is a full valuation allowance applied against these loss carry
forward as management determined it was not more likely than not that these net operating losses would be utilized in the foreseeable
future.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;PRC&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;WFOE and the consolidated VIE established in
the PRC are subject to the PRC statutory income tax rate of &lt;span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20220331__us-gaap--IncomeTaxAuthorityAxis__custom--PrcMember_z9fCgaCJArC6" title="Effective income tax rate"&gt;25&lt;/span&gt;%, according to the PRC Enterprise Income Tax (&#x201c;EIT&#x201d;) law.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In accordance
with the relevant tax laws and regulations of the PRC, a company registered in the PRC is subject to income taxes within the PRC at the
applicable tax rate on taxable income. All the PRC subsidiaries were subject to income tax at a rate of 25% for the year ended December
31, 2021. According to PRC tax regulations, the PRC net operating loss can generally carry forward for no longer than five years starting
from the year subsequent to the year in which the loss was incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="text-decoration: underline"&gt;Taiwan&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The
Company&#x2019;s loss before income taxes is primarily derived from the operations in Taiwan and income tax expense is primarily incurred
in Taiwan.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;As
a result of amendments to the &#x201c;Taiwan Income Tax Act&#x201d; enacted by the Office of the President of Taiwan on February 7, 2018,
the statutory income tax rate increased from&#160;17% to&#160;20% and the undistributed earning tax, or a surtax, decreased from&#160;10%
to&#160;5% effective from January 1, 2018. As a result, the statutory income tax rate in Taiwan is 20%&#160;for the years ended August
31, 2021 and 2020. An additional surtax, of which rate was reduced from&#160;10% to&#160;5% being applied to the Company starting from
September 1, 2018, is assessed on undistributed income for the entities in Taiwan, but only to the extent such income is not distributed
or set aside as a legal reserve before the end of the following year. The&#160;5% surtax is recorded in the period the income is earned,
and the reduction in the surtax liability is recognized in the period the distribution to stockholders or the setting aside of legal
reserve is finalized in the following year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The components of the income tax (benefit) expense
are:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zNBlCeB3s3Fj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Income tax expense)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BA_zWIYPtJ5eEq2" style="display: none"&gt;Income tax components&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20220101__20220331_z22ivmCU75wb" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20210101__20210331_zg7NLvQLywSh" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Three
                                            months ended &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;March
                                            31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CurrentIncomeTaxExpenseBenefit_maITEBzz8A_zFcIrk11lfEl" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Current&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;59,845&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredIncomeTaxExpenseBenefit_d0_maITEBzz8A_zAY8oAF2jPAh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Deferred&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,315&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzz8A_zqkoR6pJjKW8" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Total income tax expense&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;62,160&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The reconciliation of income taxes expenses computed
at the Taiwan statutory tax rate (2021: at PRC statutory rate) applicable to income tax expense is as follows:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zIhHDT4qwibj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Reconcilation of income tax)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BF_zgAKvp0kzcGc" style="display: none"&gt;Reconciliation of income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Three
                                            months ended&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/p&gt;

&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Taiwan (2021-PRC) income tax statutory rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20220101__20220331_zrN7nGv33YV8" title="PRC income tax statutory rate"&gt;20.00&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20210101__20210331_ztPAilGbJTO8" title="PRC income tax statutory rate"&gt;25.00&lt;/span&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Impact of different tax rates in other jurisdictions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20220101__20220331_z0vYRtCjweX8" title="Impact of different tax rates in other jurisdictions"&gt;1.20&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20210101__20210331_zAqgeGCddJ52" title="Impact of different tax rates in other jurisdictions"&gt;5.93&lt;/span&gt;%)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Tax effect of non-deductible expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(&lt;span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20220101__20220331_zC4vbbbjpPF8" title="Tax effect of non-deductible expense"&gt;15.85&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20210101__20210331_zigsnhYgJ0ij" title="Tax effect of non-deductible expense"&gt;0.00&lt;/span&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Utilization of tax losses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--TaxEffectOfNontaxableIncomeLoss_dp0_c20220101__20220331_z0jLXLkNfC39" title="Tax effect of utilization of tax losses previously recognized"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(&lt;span id="xdx_907_ecustom--TaxEffectOfNontaxableIncomeLoss_dp_c20210101__20210331_zJwFVApCWW65" title="Tax effect of utilization of tax losses previously recognized"&gt;2.07&lt;/span&gt;%)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Others&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsOther_dp_c20220101__20220331_zYqrjFjLQnn1" title="Others"&gt;1.00&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsOther_dp0_c20210101__20210331_z0TDxFcxKeng" title="Others"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Changes in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20220331_zNWp2yL6lI06" title="Changes in valuation allowance"&gt;5.35&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210101__20210331_zI01XUU8de11" title="Changes in valuation allowance"&gt;36.6&lt;/span&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Effective tax rate&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20220331_zfTk65wv4xnj" title="Effective tax rate"&gt;1.00&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20210331_zcGWOudRGmB6" title="Effective tax rate"&gt;53.60&lt;/span&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;3) Deferred tax assets (liabilities), net&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The tax effects of temporary differences representing
deferred income tax assets and liabilities result principally from the following:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zOpb9kfrk5Sc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Deferred taxes)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&lt;span id="xdx_8B8_zzI2HQsnYHV4" style="display: none"&gt;Schedule of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20220331_zeov4IFQyBO5" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20211231_zPfQc6vrLjB8" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;March 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;December 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGrossAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_d0_maDTAGzr6G_z0UxfON8Cqfa" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Tax loss carried forward&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_i01I_pp0p0_d0_maDTAGzr6G_zyd46Wka0yk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Allowance for doubtful receivables&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_d0_mtDTAGzr6G_maDTANzRmV_zWDL49L0RdAj" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;b style="display: none"&gt;Total deferred tax assets&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsValuationAllowanceCurrents_i01NI_pp0p0_di0_msDTANzRmV_z2SBASl55znj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_d0_mtDTANzRmV_zFqyAMJYNsRh" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Total deferred tax assets, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;March 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;December 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_i01NI_pp0p0_di0_maDITLzGX1_z91AKMAQgoF6" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Property and equipment, difference in depreciation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredIncomeTaxLiabilities_i01NTI_pp0p0_di0_mtDITLzGX1_zbzCUzarUte7" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Deferred tax liabilities, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zcUl80h0jStd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The valuation allowance as of March 31, 2022
and December 31, 2021 was primarily provided for the deferred income tax assets if it is more likely than not that these items will expire
before the Company is able to realize its benefits, or that the future deductibility is uncertain. The ultimate realization of deferred
income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become
deductible or utilizable. Management considers projected future taxable income and tax planning strategies in making this assessment.
The movement for the valuation allowance is as following.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--SummaryOfValuationAllowanceTextBlock_z2d2NOuYyQSb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Valuation Allowance)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BD_zoHuHUzAQc8" style="display: none"&gt;Movement in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;March 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;December 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; font-weight: bold; text-align: justify"&gt;Balance at beginning of the year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pp0p0_c20220101__20220331_zatVc5YIS4Hd" style="width: 13%; text-align: right" title="Valuation allowance, beginning"&gt;95,844&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pp0p0_d0_c20210101__20211231_zWTTI0X5EAp3" style="width: 13%; text-align: right" title="Valuation allowance, beginning"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Additions of valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20220101__20220331_pp0p0" style="text-align: right" title="Additions to valuation allowance"&gt;43,102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pp0p0_c20210101__20211231_zBe1D7KEGk98" style="text-align: right" title="Additions to valuation allowance"&gt;95,844&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Reductions of valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20220101__20220331_zHtO5OuCig0l" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions in valuation allowance"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20210101__20211231_zKAN78REQQAk" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions in valuation allowance"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Balance at the end of the year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20220101__20220331_zltgf9v29d6c" style="border-bottom: Black 2.5pt double; text-align: right" title="Valuation allowance, ending balance"&gt;138,946&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20210101__20211231_zpCa8Roa4Wzd" style="border-bottom: Black 2.5pt double; text-align: right" title="Valuation allowance, ending balance"&gt;95,844&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;PRC Withholding
Tax on Dividends&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The current PRC Enterprise Income Tax Law imposes
a 10% withholding income tax for dividends distributed by foreign-invested enterprises to their immediate holding companies outside the
PRC. A lower withholding tax rate will be applied if there is a tax treaty arrangement between the PRC and the jurisdiction of the foreign
holding company. Distributions to holding companies in Hong Kong that satisfy certain requirements specified by PRC tax authorities,
for example, will be subject to a 5% withholding tax rate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of
December&#160;31, 2021, the Company had not recorded any withholding tax on the retained earnings
of its foreign-invested enterprises in the PRC, since the Company intended to reinvest its earnings to potentially continue its business
in mainland China, namely the manufacturing of the RASs through GZ GST, and its foreign-invested enterprises do not intend to declare
dividends to their immediate foreign holding companies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of March
31, 2022, the Company had not recorded any withholding tax on the retained earnings of its foreign-invested enterprises in the PRC, and
the Company decided not to reinvest its earnings since it is not continuing its business in mainland China, and its foreign-invested
enterprises do not intend to declare dividends to their immediate foreign holding companies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-01-012022-03-31_country_US"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-012021-03-31_country_US"
      decimals="INF"
      unitRef="Pure">0.105</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2019-12-31_country_US"
      decimals="0"
      unitRef="USD">99817</us-gaap:OperatingLossCarryforwards>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-01-012022-03-31_country_HK"
      decimals="INF"
      unitRef="Pure">0.0825</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-01-012022-03-31_custom_PrcMember"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zNBlCeB3s3Fj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Income tax expense)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BA_zWIYPtJ5eEq2" style="display: none"&gt;Income tax components&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20220101__20220331_z22ivmCU75wb" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20210101__20210331_zg7NLvQLywSh" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Three
                                            months ended &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;March
                                            31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CurrentIncomeTaxExpenseBenefit_maITEBzz8A_zFcIrk11lfEl" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Current&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;59,845&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredIncomeTaxExpenseBenefit_d0_maITEBzz8A_zAY8oAF2jPAh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Deferred&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,315&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzz8A_zqkoR6pJjKW8" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Total income tax expense&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;62,160&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">9</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">59845</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">2315</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">9</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">62160</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zIhHDT4qwibj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Reconcilation of income tax)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BF_zgAKvp0kzcGc" style="display: none"&gt;Reconciliation of income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Three
                                            months ended&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/p&gt;

&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Taiwan (2021-PRC) income tax statutory rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20220101__20220331_zrN7nGv33YV8" title="PRC income tax statutory rate"&gt;20.00&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20210101__20210331_ztPAilGbJTO8" title="PRC income tax statutory rate"&gt;25.00&lt;/span&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Impact of different tax rates in other jurisdictions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20220101__20220331_z0vYRtCjweX8" title="Impact of different tax rates in other jurisdictions"&gt;1.20&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20210101__20210331_zAqgeGCddJ52" title="Impact of different tax rates in other jurisdictions"&gt;5.93&lt;/span&gt;%)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Tax effect of non-deductible expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(&lt;span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20220101__20220331_zC4vbbbjpPF8" title="Tax effect of non-deductible expense"&gt;15.85&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20210101__20210331_zigsnhYgJ0ij" title="Tax effect of non-deductible expense"&gt;0.00&lt;/span&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Utilization of tax losses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--TaxEffectOfNontaxableIncomeLoss_dp0_c20220101__20220331_z0jLXLkNfC39" title="Tax effect of utilization of tax losses previously recognized"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(&lt;span id="xdx_907_ecustom--TaxEffectOfNontaxableIncomeLoss_dp_c20210101__20210331_zJwFVApCWW65" title="Tax effect of utilization of tax losses previously recognized"&gt;2.07&lt;/span&gt;%)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Others&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsOther_dp_c20220101__20220331_zYqrjFjLQnn1" title="Others"&gt;1.00&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsOther_dp0_c20210101__20210331_z0TDxFcxKeng" title="Others"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Changes in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20220331_zNWp2yL6lI06" title="Changes in valuation allowance"&gt;5.35&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210101__20210331_zI01XUU8de11" title="Changes in valuation allowance"&gt;36.6&lt;/span&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Effective tax rate&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20220331_zfTk65wv4xnj" title="Effective tax rate"&gt;1.00&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20210331_zcGWOudRGmB6" title="Effective tax rate"&gt;53.60&lt;/span&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Pure">0.2000</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Pure">0.2500</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Pure">0.0120</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Pure">0.0593</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Pure">0.1585</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Pure">0.0000</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Pure">0.0100</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Pure">-0</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Pure">0.0535</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Pure">0.366</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Pure">0.0100</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Pure">0.5360</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zOpb9kfrk5Sc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Deferred taxes)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&lt;span id="xdx_8B8_zzI2HQsnYHV4" style="display: none"&gt;Schedule of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20220331_zeov4IFQyBO5" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20211231_zPfQc6vrLjB8" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;March 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;December 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGrossAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_d0_maDTAGzr6G_z0UxfON8Cqfa" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Tax loss carried forward&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_i01I_pp0p0_d0_maDTAGzr6G_zyd46Wka0yk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Allowance for doubtful receivables&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_d0_mtDTAGzr6G_maDTANzRmV_zWDL49L0RdAj" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;b style="display: none"&gt;Total deferred tax assets&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsValuationAllowanceCurrents_i01NI_pp0p0_di0_msDTANzRmV_z2SBASl55znj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_d0_mtDTANzRmV_zFqyAMJYNsRh" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Total deferred tax assets, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;March 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;December 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_i01NI_pp0p0_di0_maDITLzGX1_z91AKMAQgoF6" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Property and equipment, difference in depreciation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredIncomeTaxLiabilities_i01NTI_pp0p0_di0_mtDITLzGX1_zbzCUzarUte7" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Deferred tax liabilities, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">0</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">-0</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-0</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">-0</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-0</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:SummaryOfValuationAllowanceTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--SummaryOfValuationAllowanceTextBlock_z2d2NOuYyQSb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Valuation Allowance)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BD_zoHuHUzAQc8" style="display: none"&gt;Movement in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;March 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;December 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; font-weight: bold; text-align: justify"&gt;Balance at beginning of the year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pp0p0_c20220101__20220331_zatVc5YIS4Hd" style="width: 13%; text-align: right" title="Valuation allowance, beginning"&gt;95,844&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pp0p0_d0_c20210101__20211231_zWTTI0X5EAp3" style="width: 13%; text-align: right" title="Valuation allowance, beginning"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Additions of valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20220101__20220331_pp0p0" style="text-align: right" title="Additions to valuation allowance"&gt;43,102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pp0p0_c20210101__20211231_zBe1D7KEGk98" style="text-align: right" title="Additions to valuation allowance"&gt;95,844&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Reductions of valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20220101__20220331_zHtO5OuCig0l" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions in valuation allowance"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20210101__20211231_zKAN78REQQAk" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions in valuation allowance"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Balance at the end of the year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20220101__20220331_zltgf9v29d6c" style="border-bottom: Black 2.5pt double; text-align: right" title="Valuation allowance, ending balance"&gt;138,946&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20210101__20211231_zpCa8Roa4Wzd" style="border-bottom: Black 2.5pt double; text-align: right" title="Valuation allowance, ending balance"&gt;95,844&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">95844</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">43102</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">95844</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">138946</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">95844</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zvtXanx0xRj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 12&#160;&#160;&#160;&#160;&#160; &lt;span id="xdx_825_zLrNTLLxqjUa"&gt;RELATED PARTY BALANCES AND
TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Due to related parties&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The balance due to related parties was as following:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zPZQSQoiiX9e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_8BB_z5aIQXWUmNp" style="display: none"&gt;Schedule of related party transactions&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify; padding-bottom: 1pt"&gt;Mr. Yin-Chieh Cheng (1)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_fKDEp_zYGNXSMd5e27" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties"&gt;7,653&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_d0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_fKDEp_zqCqxQ9us1v7" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Mountain Share Transfer, LLC (2)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferMember_fKDIp_z8kOPGm38MAf" style="padding-bottom: 1pt; text-align: right" title="Due to related parties"&gt;7,681&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferMember_fKDIp_zmlC1mm3w1Ta" style="padding-bottom: 1pt; text-align: right" title="Due to related parties"&gt;39,341&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_c20220331_pp0p0" style="padding-bottom: 2.5pt; text-align: right" title="Due from related parties"&gt;15,334&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_c20211231_pp0p0" style="padding-bottom: 2.5pt; text-align: right" title="Due from related parties"&gt;39,341&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Due from a related party&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The balance due from a related party was as following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify; padding-bottom: 1pt"&gt;Taisi Electrical &amp;amp; Plumbing Co. Pte Ltd. (3)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TaisiElectricMember_fKDMp_zh2O3aSAwF3h" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties"&gt;2,073,362&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TaisiElectricMember_fKDMp_zMEU1ccVhgm9" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties"&gt;1,615,217&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Note:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&lt;span id="xdx_F05_z9Yq5JGix94k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_zKpw4KlepWn5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr. Yin-Chieh Cheng (&#x201c;Mr.
    Cheng&#x201d;) is the chairman the Company, and he holds 42.5% shares of the Company. The balance due to Mr. Cheng as of March 31,
    2022 mainly represented the amount paid by Mr. Cheng on behalf of the Company. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&lt;span id="xdx_F05_zZ7CsgsUqw3d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;p id="xdx_F1F_z2rkY9MMOZ69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Mountain Share Transfer, LLC is company 100%
    controlled by Erik S. Nelson, a greater than 5% stockholder of the Company. The balances represented the amount paid on behalf of
    the Company for its daily operation purpose.&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span id="xdx_F08_zkGiWhWHfv07" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zZVheyzozH05" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr. Tsai Wen-Chih is the
    director of XFC and has control power over Taisi Electrical &amp;amp; Plumbing Co. Pte Ltd. The Company took over the receivable amount
    of $877,809 from acquisition of XFC in December 2020. None of the receivables have been impaired and it is expected that the full
    contractual amounts can be collected.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A1_zJU7RnjrkcH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zPZQSQoiiX9e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_8BB_z5aIQXWUmNp" style="display: none"&gt;Schedule of related party transactions&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify; padding-bottom: 1pt"&gt;Mr. Yin-Chieh Cheng (1)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_fKDEp_zYGNXSMd5e27" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties"&gt;7,653&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_d0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_fKDEp_zqCqxQ9us1v7" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Mountain Share Transfer, LLC (2)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferMember_fKDIp_z8kOPGm38MAf" style="padding-bottom: 1pt; text-align: right" title="Due to related parties"&gt;7,681&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferMember_fKDIp_zmlC1mm3w1Ta" style="padding-bottom: 1pt; text-align: right" title="Due to related parties"&gt;39,341&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_c20220331_pp0p0" style="padding-bottom: 2.5pt; text-align: right" title="Due from related parties"&gt;15,334&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_c20211231_pp0p0" style="padding-bottom: 2.5pt; text-align: right" title="Due from related parties"&gt;39,341&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Due from a related party&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The balance due from a related party was as following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify; padding-bottom: 1pt"&gt;Taisi Electrical &amp;amp; Plumbing Co. Pte Ltd. (3)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TaisiElectricMember_fKDMp_zh2O3aSAwF3h" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties"&gt;2,073,362&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TaisiElectricMember_fKDMp_zMEU1ccVhgm9" style="padding-bottom: 1pt; width: 13%; text-align: right" title="Due from related parties"&gt;1,615,217&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Note:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&lt;span id="xdx_F05_z9Yq5JGix94k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_zKpw4KlepWn5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr. Yin-Chieh Cheng (&#x201c;Mr.
    Cheng&#x201d;) is the chairman the Company, and he holds 42.5% shares of the Company. The balance due to Mr. Cheng as of March 31,
    2022 mainly represented the amount paid by Mr. Cheng on behalf of the Company. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&lt;span id="xdx_F05_zZ7CsgsUqw3d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;p id="xdx_F1F_z2rkY9MMOZ69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Mountain Share Transfer, LLC is company 100%
    controlled by Erik S. Nelson, a greater than 5% stockholder of the Company. The balances represented the amount paid on behalf of
    the Company for its daily operation purpose.&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span id="xdx_F08_zkGiWhWHfv07" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zZVheyzozH05" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr. Tsai Wen-Chih is the
    director of XFC and has control power over Taisi Electrical &amp;amp; Plumbing Co. Pte Ltd. The Company took over the receivable amount
    of $877,809 from acquisition of XFC in December 2020. None of the receivables have been impaired and it is expected that the full
    contractual amounts can be collected.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2022-03-31_custom_YinChiehChengMember"
      decimals="0"
      id="Fact000929"
      unitRef="USD">7653</us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2021-12-31_custom_YinChiehChengMember"
      decimals="0"
      id="Fact000931"
      unitRef="USD">0</us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="AsOf2022-03-31_custom_MountainShareTransferMember"
      decimals="0"
      id="Fact000933"
      unitRef="USD">7681</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="AsOf2021-12-31_custom_MountainShareTransferMember"
      decimals="0"
      id="Fact000935"
      unitRef="USD">39341</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">15334</us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">39341</us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2022-03-31_custom_TaisiElectricMember"
      decimals="0"
      id="Fact000945"
      unitRef="USD">2073362</us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2021-12-31_custom_TaisiElectricMember"
      decimals="0"
      id="Fact000947"
      unitRef="USD">1615217</us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zcAmT7Si6RCf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 1&lt;/b&gt;&lt;b&gt;3&lt;/b&gt;&lt;b&gt;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_827_zyw1oTG59h34"&gt;COMMON
STOCK&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s
authorized number of common stock is &lt;span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_c20220331_zSZdU6cplEMd" title="Common stock, shares authorized"&gt;&lt;span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20211231_zuoQRaVUFu2j" title="Common stock, shares authorized"&gt;200,000,000&lt;/span&gt;&lt;/span&gt; shares with par value of $&lt;span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220331_zg8eSKwPrUc4" title="Common stock par value"&gt;&lt;span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231_zIOOnQPTblda" title="Common stock par value"&gt;0.001&lt;/span&gt;&lt;/span&gt; each, and issued ordinary shares were &lt;span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_c20220331_zDQnqSfhN78e" title="Common stock, shares issued"&gt;10,707,150&lt;/span&gt;
shares and 9,131,786 as of March
31, 2022 and December 31, 2021, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;All number
of shares, share amounts and per share data presented in the accompanying consolidated financial statements and related notes have been
retroactively restated to reflect the reverse merger transaction and subsequent issuance of shares stated above, except for authorized
common shares, which were not affected.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-03-31" decimals="INF" unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-03-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2022-03-31" decimals="INF" unitRef="Shares">10707150</us-gaap:CommonStockSharesIssued>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_800_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zjMIYiYkiqz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 1&lt;/b&gt;&lt;b&gt;4&lt;/b&gt;&lt;b&gt;&#160;&#160;&#160;&#160;&lt;span id="xdx_82B_zFHLijvWP3Ql"&gt;SHARE-BASED
COMPENSATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December
27, 2018, Nocera granted Mr. Yin-Chieh Cheng quarterly option awards of &lt;span id="xdx_904_ecustom--WarrantsGranted_c20181201__20181227__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember_pdd" title="Warrants granted"&gt;250,000&lt;/span&gt; Series A warrants for 20 quarters (5 years) for a total
of &lt;span id="xdx_90E_ecustom--WarrantsGranted_c20181201__20181227__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember_pdd" title="Warrants granted"&gt;5,000,000&lt;/span&gt; Series A warrants with an exercise price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20181227__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember_pdd" title="Warrants exercise price"&gt;0.50&lt;/span&gt; per share, subject to continued employment for services as Chairman of
the Board of Directors (&#x201c;Board&#x201d;) and a Director.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 1,
2020, Nocera granted Mr. Shun-Chih Chuang and Mr. Hsien-Wen Yu &lt;span id="xdx_90F_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShunChihChuangMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zWovoEZYipZ2" title="Warrants granted"&gt;50,000&lt;/span&gt; shares of Class A warrants and &lt;span id="xdx_902_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HsienWenYuMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zQOrbiZU3579" title="Warrants granted"&gt;60,000&lt;/span&gt; shares of Class A warrants
separately, each with an exercise price of $&lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200601_pdd" title="Warrants exercise price"&gt;0.50&lt;/span&gt; per share, for serving as the Company&#x2019;s Chief Financial Officer and Chief Operating
Officer, respectively. The Company also granted 2 employees &lt;span id="xdx_903_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted"&gt;50,000&lt;/span&gt; shares of Class A warrants with an exercise price of $&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200601__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants exercise price"&gt;0.50&lt;/span&gt; per share.
The Class A warrants consist of the right to purchase one share for $0.50 per share from the date of issuance until April 23, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 1,
2020, Nocera granted Mr. Michael A. Littman &lt;span id="xdx_906_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted"&gt;50,000&lt;/span&gt; shares of Class A warrants with an exercise price of $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants exercise price"&gt;0.50&lt;/span&gt; per share and &lt;span id="xdx_907_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_pdd" title="Warrants granted"&gt;50,000&lt;/span&gt; shares
of Class B warrants with exercise price of $&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_pdd" title="Warrants exercise price"&gt;1.00&lt;/span&gt; per share. Mr. Littman exercised &lt;span id="xdx_905_ecustom--WarrantsGranted_c20210802__20210811__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted"&gt;50,000&lt;/span&gt; shares of Class A warrants and &lt;span id="xdx_906_ecustom--WarrantsGranted_c20210802__20210811__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_pdd" title="Warrants granted"&gt;50,000&lt;/span&gt; shares
of Class B warrants on August 11, 2021. The Class B warrants consist of the right to purchase one share for $1.00 per share separately
from the date of issuance until April 23, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December
1, 2021, Nocera granted Mr. Shun-Chih Chuang and Mr. Hsien-Wen Yu &lt;span id="xdx_90D_ecustom--WarrantsGranted_c20211129__20211202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShunChihChuangMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zvtHH6Oz1MHd" title="Warrants granted"&gt;75,000&lt;/span&gt; shares of Class A warrants and &lt;span id="xdx_901_ecustom--WarrantsGranted_c20211129__20211202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HsienWenYuMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted"&gt;60,000&lt;/span&gt; shares of Class A warrants
separately, each with an exercise price of $&lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20211202_pdd" title="Warrants exercise price"&gt;0.50&lt;/span&gt; per share, for serving as the Company&#x2019;s Chief Financial Officer and Chief Operating
Officer, respectively. The Company also granted 2 employees &lt;span id="xdx_904_ecustom--WarrantsGranted_c20211129__20211202__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants granted"&gt;70,000&lt;/span&gt; shares of Class A warrant with an exercise price of $&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20211202__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_pdd" title="Warrants exercise price"&gt;0.50&lt;/span&gt; per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December
31, 2021, the Company issued an aggregate of &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20211201__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShunChihChuangMember_zCmbkNb21aSa" title="Issued for services"&gt;505,000&lt;/span&gt; shares of common stock to Mr. Shun-Chih Chuang and a total of five consultants in
consideration for services rendered.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The estimated fair value of share-based compensation
for employees is recognized as a charge against income on a ratable basis over the requisite service period, which is generally the vesting
period of the award. The fair value of stock option grant was estimated on the date of grant using the Black-Scholes option pricing model
under the following assumptions:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zvCyXL0fZQO4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHARE-BASED COMPENSATION (Details - assumptions)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B1_zPZHyVmdkp69" style="display: none"&gt;Assumptions used&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: justify"&gt;Dividend yield&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: right"&gt;N/A&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: right"&gt;N/A&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 66%; text-align: justify; padding-bottom: 1pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 13%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220331_z6HPq8IQRbGj" title="Risk-free interest rate"&gt;1.16&lt;/span&gt;%&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 13%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231_zde4z729rsl2" title="Risk-free interest rate"&gt;1.16&lt;/span&gt;%&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Expected term (in years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220331_z5gLUDDuzWkh" title="Expected term (in years)"&gt;4.31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zG3Es5HDzOcj" title="Expected term (in years)"&gt;4.31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Volatility&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220331_zGRaIVOagcLk" title="Volatility"&gt;48.15&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231_zfLeAlsy2i36" title="Volatility"&gt;48.15&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company
estimated the grant date fair value of time-based stock option awards using the Black-Scholes option valuation model, which requires
assumptions involving an estimate of the fair value of the underlying common stock on the date of grant, the expected term of the options,
volatility, discount rate and dividend yield. The Company calculated expected option terms based on the &#x201c;simplified&#x201d; method
for &#x201c;plain vanilla&#x201d; options due to the limited exercise information. The &#x201c;simplified method&#x201d; calculates the expected
term as the average of the vesting term and the original contractual term of the options. The Company calculated volatility using the
average adjusted volatility of quick companies feature of Capital IQ for a period of time reflective of the expected option term, while
the discount rate was estimated using the interest rate for a treasury note with the same contractual term as the options granted. Dividend
yield is estimated at our current dividend rate, which adjusts for any known future changes in the rate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the three
months ended March 31, 2022
and year ended December 31, 2021,
$&lt;span id="xdx_90E_ecustom--ReverseMergerRecapitalization_pp0p0_c20220101__20220331_zStVeRRfoNHi" title="Reverse merger recapitalization"&gt;606,055&lt;/span&gt;
and $&lt;span id="xdx_904_ecustom--ReverseMergerRecapitalization_pp0p0_c20210101__20211231_ztu7eiXz3zFa" title="Reverse merger recapitalization"&gt;6,638,371&lt;/span&gt;
share-based compensation expenses was recognized into additional paid-in capital of the Company,
respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December
31, 2021, total unrecognized compensation cost related to unvested share-based compensation awards was $&lt;span id="xdx_904_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pp0p0_c20211231_zsHVYDOe32r8" title="Unrecognized compensation costs"&gt;11,114,097&lt;/span&gt;. This amount is expected
to be recognized as stock-based compensation expense in the Company&#x2019;s consolidated statements of operations and comprehensive income
over the remaining vesting period of &lt;span id="xdx_909_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20220101__20220331_zFEYpVW4MX8b" title="Unrecognized compensation cost amortization period"&gt;1.99&lt;/span&gt; years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;









</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2018-12-27_custom_SeriesAWarrantMember"
      decimals="INF"
      unitRef="USDPShares">0.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-06-01"
      decimals="INF"
      unitRef="USDPShares">0.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-06-01_custom_ClassAWarrantMember"
      decimals="INF"
      unitRef="USDPShares">0.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-06-01_custom_MichaelALittmanMember_custom_ClassAWarrantMember"
      decimals="INF"
      unitRef="USDPShares">0.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-06-01_custom_MichaelALittmanMember_custom_ClassBWarrantMember"
      decimals="INF"
      unitRef="USDPShares">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-12-02"
      decimals="INF"
      unitRef="USDPShares">0.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-12-02_custom_ClassAWarrantMember"
      decimals="INF"
      unitRef="USDPShares">0.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2021-12-012021-12-31_custom_ShunChihChuangMember"
      decimals="INF"
      unitRef="Shares">505000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zvCyXL0fZQO4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHARE-BASED COMPENSATION (Details - assumptions)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B1_zPZHyVmdkp69" style="display: none"&gt;Assumptions used&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;March 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: justify"&gt;Dividend yield&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: right"&gt;N/A&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: right"&gt;N/A&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 66%; text-align: justify; padding-bottom: 1pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 13%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220331_z6HPq8IQRbGj" title="Risk-free interest rate"&gt;1.16&lt;/span&gt;%&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 13%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231_zde4z729rsl2" title="Risk-free interest rate"&gt;1.16&lt;/span&gt;%&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Expected term (in years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220331_z5gLUDDuzWkh" title="Expected term (in years)"&gt;4.31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zG3Es5HDzOcj" title="Expected term (in years)"&gt;4.31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Volatility&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220331_zGRaIVOagcLk" title="Volatility"&gt;48.15&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231_zfLeAlsy2i36" title="Volatility"&gt;48.15&lt;/span&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Pure">0.0116</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.0116</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2022-01-01to2022-03-31">P4Y3M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-01-012021-12-31">P4Y3M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Pure">0.4815</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.4815</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">11114097</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2022-01-01to2022-03-31">P1Y11M26D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:PreferredStockTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_803_eus-gaap--PreferredStockTextBlock_z7iRHUZ7yJHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 1&lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_82C_zOfazsI0vUPb"&gt;PREFERRED
STOCK&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In August
2021, the Company issued &lt;span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zMyvMIdakyYd" title="Preferred Stock, Shares Issued"&gt;80,000&lt;/span&gt; shares of preferred shares of $&lt;span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_c20210801_zm4X2T5IVjK2" title="Sale of stock, price"&gt;1.00&lt;/span&gt; each at an issue price of $&lt;span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20210801_zfuyGsrpHU28" title="Share price"&gt;2.50&lt;/span&gt; per share to certain investors credited
as fully paid. The preferred shares are non-voting and non-redeemable. The holder of the preferred shares will have priority over the
holders of ordinary shares of the Company on the assets and funds of the Company available for distribution in a distribution of assets
on liquidation, winding up or dissolution of the Company. The holder of the preferred shares shall not have the right to attend or vote
at any general meeting of the Company (except a general meeting for winding up of the Company or a resolution is to be proposed which
if passed would vary or abrogate the rights or privileges of such holder).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:PreferredStockTextBlock>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">80000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2021-08-01"
      decimals="INF"
      unitRef="USDPShares">1.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2021-08-01"
      decimals="INF"
      unitRef="USDPShares">2.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_808_eus-gaap--EarningsPerShareTextBlock_zISuPgiiRhI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 16 &#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_82C_zxWhvspfwHol"&gt;(LOSS) INCOME PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table sets forth the computation
of basic and diluted income (loss) per common share for the quarters ended March 31, 2022 and 2021.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXyGPZVIU9b9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - (LOSS) EARNINGS PER SHARE (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B1_z9yq6RhnB7C7" style="display: none"&gt;Schedule of earnings (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20220101__20220331_z8URAQdjdX9h" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20210101__20210331_z3Owc1yVkrE4" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;For
                                            three months ended &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;March
                                            31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NumeratorAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify; padding-bottom: 2.5pt"&gt;Net (loss) income attributable to the Company&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;(805,720&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;49,490&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DenominatorAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Weighted-average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;- Basic&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,677,150&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,131,786&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;- Diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,677,150&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;13,821,506&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--LossIncomePerShareAbstract_i01B_z4vQx9r7V4o7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;(Loss) income per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;- Basic&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.0755&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.0054&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_i01_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;- Diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.0755&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.0036&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Basic net income per common share is computed
using the weighted average number of the common shares outstanding during the period ended March 31, 2021. Diluted income per share is
computed using the weighted average number of ordinary shares and ordinary equivalent shares outstanding which include &lt;span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210331_zALCEbez29gl" title="Antidilutive shares"&gt;5,560,000&lt;/span&gt; warrants
outstanding as of March 31, 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2022-01-01to2022-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXyGPZVIU9b9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - (LOSS) EARNINGS PER SHARE (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B1_z9yq6RhnB7C7" style="display: none"&gt;Schedule of earnings (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20220101__20220331_z8URAQdjdX9h" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20210101__20210331_z3Owc1yVkrE4" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;For
                                            three months ended &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;March
                                            31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NumeratorAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify; padding-bottom: 2.5pt"&gt;Net (loss) income attributable to the Company&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;(805,720&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;49,490&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DenominatorAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Weighted-average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;- Basic&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,677,150&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,131,786&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;- Diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,677,150&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;13,821,506&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--LossIncomePerShareAbstract_i01B_z4vQx9r7V4o7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;(Loss) income per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;- Basic&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.0755&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.0054&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_i01_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;- Diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.0755&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.0036&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">-805720</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">49490</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Shares">10677150</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Shares">9131786</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="Shares">10677150</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Shares">13821506</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="USDPShares">-0.0755</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="USDPShares">0.0054</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="USDPShares">-0.0755</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="USDPShares">0.0036</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Shares">5560000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2022-01-01to2022-03-31">&lt;p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zUnnlm6OjxNc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 17 &#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_826_zz1D3GFem5l6"&gt;SUBSEQUENT EVENT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has evaluated subsequent events through
the issuance of the unaudited condensed consolidated financial statements and except for the event discloses blow, no other subsequent
event is identified that would have required adjustment or disclosure in the consolidated financial statements.&#160;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000929"
          xlink:label="Fact000929"
          xlink:type="locator"/>
        <link:footnote id="Footnote000948" xlink:label="Footnote000948" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Mr. Yin-Chieh Cheng (&#x201c;Mr.
    Cheng&#x201d;) is the chairman the Company, and he holds 42.5% shares of the Company. The balance due to Mr. Cheng as of March 31,
    2022 mainly represented the amount paid by Mr. Cheng on behalf of the Company. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000929"
          xlink:to="Footnote000948"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000931"
          xlink:label="Fact000931"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000931"
          xlink:to="Footnote000948"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000933"
          xlink:label="Fact000933"
          xlink:type="locator"/>
        <link:footnote id="Footnote000949" xlink:label="Footnote000949" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Mountain Share Transfer, LLC is company 100%
    controlled by Erik S. Nelson, a greater than 5% stockholder of the Company. The balances represented the amount paid on behalf of
    the Company for its daily operation purpose.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000933"
          xlink:to="Footnote000949"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000935"
          xlink:label="Fact000935"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000935"
          xlink:to="Footnote000949"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000945"
          xlink:label="Fact000945"
          xlink:type="locator"/>
        <link:footnote id="Footnote000950" xlink:label="Footnote000950" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Mr. Tsai Wen-Chih is the
    director of XFC and has control power over Taisi Electrical &amp; Plumbing Co. Pte Ltd. The Company took over the receivable amount
    of $877,809 from acquisition of XFC in December 2020. None of the receivables have been impaired and it is expected that the full
    contractual amounts can be collected.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000945"
          xlink:to="Footnote000950"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000947"
          xlink:label="Fact000947"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000947"
          xlink:to="Footnote000950"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>87
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M7[#O?#0E]TK!#E*E3:K4%GTP8N4*L7R)8G7!_]DD6Y9"[L:LZU!>%4JU@^T
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M*E)+4=-V'Z9]<),#L9K$S':@VZ_?<9)FA(5+JXT/Q';.^^8Y)X[M[IJ+)QD
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MMPKHUE[H&2Z&( 3XQ,VX\6,E7&"/XL=+'O1L)C/  9U/50JMH^;UH:@2?+N
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M*R*NM>P=P]5-3G$G;&(C%1OYA7).&7P!,I04=YJ^V@?!-N8'2EHWQ!A'H=>
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M#> &  "$+@  &    'AL+W=O<FMS:&5E=',O<VAE970U+GAM;*V:;7/B-A"
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M.4<VSM2OZ$F>CPW&K[NDP^"4G'%G$!RMEL!($9"_8R1U72<!HRJ4?>9+0>X
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MH],=OW>"VQ=&KF;BU7M! PEL$!(QH8>Y6J!D*(?CG1@P)(]3<)QL(V]7/*B
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MF6WJ:5"5D2V\*L:4V#+E"C*,B=IN?:+R):L"5PVT*&Q160A-)<IV$_HGH#0
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M^7#@@&B636,H7MD!7W&EUX4]YGH_HS .^CWCND5;PP1H-_[D-U!+ P04
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MJ*P!G:\E7=;=P@;H_V"S?P%02P,$%     @ @(GT5"=A(/V5 @  L 4  !D
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M]V]3<-V;UDV"K>,[LK*!7J4X+.EO #HVH/VUI4NHGW" X8_%XC]02P,$%
M  @ @(GT5 ZR\2&) @  C@4  !D   !X;"]W;W)K<VAE971S+W-H965T,38N
M>&ULI53;;MLP#'WW5Q!>L2>C=F3GUB4!G,O0 +T$2=IA&/:@V$QL5+8\26G:
MOY]D.UX&I,& O5@BQ7-X*)D<'+AXD0FB@K>,Y7)H)TH5-ZXKHP0S*J]Y@;D^
MV7*14:5-L7-E(9#&)2AC+O&\CIO1-+='@]*W$*,!WRN6YK@0(/=91L7[&!D_
M#.V6?70LTUVBC,,=#0JZPQ6JIV(AM.4V+'&:82Y3GH/ [= .6S?CP,27 <\I
M'N3)'DPE&\Y?C#&/A[9G!"'#2!D&JI=7G"!CADC+^%5SVDU* SS=']F_EK7K
M6C94XH2S;VFLDJ'=LR'&+=TSM>2'6ZSK:1N^B#-9?N%0Q?I]&Z*]5#RKP5I!
MEN;52M_J>S@!]+P/ *0&D%)WE:A4.:6*C@:"'T"8:,UF-F6I)5J+2W/S*"LE
M]&FJ<6KTN+Z=+6$1?@_'=[,5A ]3"">3Y=-L"G?S<#R_FZ_GL]7 53J70;A1
MS3NN>,D'O#[<\UPE$F9YC/'?>%=K;(22H] QN4AX3\4U^"T'B$?(!3Z_*=PO
M^?P/^!;TG6X82J!Y#&$4B3UE$GZ$&ZF$_E5^GBNY8@S.,YKVN9$%C7!HZ_Z0
M*%[1'GW^U.IX7R[H#1J]P27V_WBHB[SG53]PA5;+@W]+:JWTJ(CW#(%OH:CO
MU=(/%B66>;$I1IAM4!C#NH(KZSE<'^.@ZW0# H'G>,2W5I3IR="<Z7C2;D.O
M[W2[;>M1)2@D^)[C]SUH$:=#>M::*\J@TW?\7A=: 7$"TH%SU^V>]$B&8E=.
M @D1W^>J:I?&VPR;L.JQ/^'5I-*5[=)< L.MAGK7W;8-HNK^RE"\*#MNPY7N
MWW*;Z(&)P@3H\RW7]UL;)D$S@D>_ 5!+ P04    " " B?14]1PN*(</  "=
M*0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6S%6EMO&SF6?J]?07B2
M@0W(LBYV;*>3 (Z3[LYT.@EB)[/8P3Q0*LIBIU14DRPKFE^_WSF\5,DNN[L7
M"^R++561A^?ZG0OU8F/L-[=4RHOOJZIV+_>6WJ^?'QVY^5*MI!N:M:KQ9F'L
M2GI\M3=';FV5+'G3JCJ:C$;/CE92UWNO7O"S3_;5"]/X2M?JDQ6N6:VDW;Y6
ME=F\W!OOI0>?]<W2TX.C5R_6\D9=*?]E_<GBVU&F4NJ5JITVM;!J\7+O8OS\
M]3&MYP5?M=JXSF=!DLR,^49?WI4O]T;$D*K4W!,%B7^WZE)5%1$"&[]'FGOY
M2-K8_9RH_\BR0Y:9=.K25/_4I5^^W#O;$Z5:R*;RG\WF9Q7E.2%Z<U,Y_BLV
M8>UTNB?FC?-F%3>#@Y6NPW_Y/>JAL^%L],"&2=PP8;[#0<SE&^GEJQ?6;(2E
MU:!&'UA4W@WF=$U&N?(6;S7V^5?O/EQ^_/6MN+[XK[=7+XX\*-+SHWG<_3KL
MGCRP>RI^-;5?.O&V+E6YN_\(G&1V)HF=UY-'"?XJ[5!,QP,Q&4TFC]";9O&F
M3&_ZD'CUW*R4N);?Q1OMYI5QC57B7Q<SYRT<XM]](@>*Q_T4*4B>N[6<JY=[
MB *G[*W:>_7WOXV?C7YXA-_CS._Q8]3_T!R/[N[G[8/Q2HS'19>TN%XJ<6E6
M:UEOA:Q+H;U#7,Z<+C5"<\#//-;,3>U,I4OI55E\??=6+'2EA(<ZK?*-K;%+
MK:7%ZVH[%.,#\556C3J4)=R!E^W__6]GD\GHAZ\7U_QI_,.!^/3Y4GQJK&MD
M[84W?- G:VXU1;JLQ&=UTU22@]8LZ&U!._ -1#)G5E7$E-"K=:6 $E[7-\(V
ME7+@OJH$/?%:N2!>7>I;73:R<IDC<+>66V5=YLLOI1<2_J'J&P 2;>.CG(3,
M9E&LK2F;.305GQ-7M/Q&U<KBS"V8^KW1ED0W L2)87 #HH)41-)LEGJ^%!OI
MQ'PI:SID8<U*C)^)\11NJC>ROJ>;KDY)F@^F/KQMGQ6O&P='<([=_&+N_[]T
M5$"^NSJ*(OU5-9T\'8K)@8CA2X[TI=8DRI7'"B<^UN*-FJO53%DQF1!<C$\'
M\<#OXK+Q0:9_F)DCC13[]"H*%;6412)C.'U3LS#@J%(WV@7_&W*@)+72(KW0
M<YB&A8##@A6B_&5X-42LV+5A 73+]HR":66@=X.%MO!+V #J1S)4ELS!RH-0
MC3=VVZ'!,48?V#^FQT])69/QTP%9TSC:*I$(:H0F;32U.O0Z'LK9;MZLFF!^
M)6U-IY)BD<:1J.HB![LF9X#<;#>B6B.3A@"_ 3T7L("=E=XN@6>11DN7K N"
MOR'3$I>L#9 8/F FV'"Q@$;GI@DN^;JI*H5/Q0<#$!F?9?^[NGA-WW=,I9UK
MHNL09I1PK 8 5<]5E#M1!9NL71)&+1:*O#+@2;+H4,0#$BE'.E62D@2%2[&&
MC4P9G-XM35.5HC9>J.]>02DSM37X!]6++701+-4ACQA!CB%"HF1+@J$Y@R[%
M' 2@+Q!<\:8.YPVRJ1475Y?B]'@T++I@O23DB-M"D$L'+W1\2I2NXWY![CMB
M)WR U3;TIS9"EK^AUB B#H:'%Y9!Q;1KW4)S 5<&CVX8$XC%PUMM&P29+@<
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M5SZH^OY0#XPLW9F]E(9N .XUHRL7*FM WU>2%O%N8 /L+W&#?P!02P,$%
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MOL%0.P%ZOU"4-O6#4]!^U9W]"U!+ P04    " " B?14VPE[XB\"  #?!
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MU+F<L\T];O.YTGPQRX7YPJ;Q'0PLB&LA6;$%*P4%+9N5O&WKL >X<3X!>%N
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M>ED2C1>2/='<E-/@+( <5Z1FYEXVG['S<^+X,LFT_T+3YIXD 62U-I)W8*N
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M',;4PE$: ]K?"*$/$W- _:<P^0M02P,$%     @ @(GT5(&!#%-; P  _0X
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M-)NUL@4G&S6NS D7%E>/:S&? I4!XOV2$'Y8R"_0$V__/U!+ P04    " "
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M-_*OOXD)1PFLI:35ZLLSQ?*2(>\(NM6W[HH*>2!T,Y)5%C"U0,ZO*16'COI
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MB1/^ 7U$=S<3]/[=AY$IY*#*U0SK 3Y7 ]BO#'!)V#$:X"-D6[;=X7ZF=Y]
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MA338+]RPP(X.RB;@^E)*LPOL!NT_(OT+4$L#!!0    ( (")]%0("K'QD@(
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M#'"=H-;7C,F70'>RYL<5_0502P,$%     @ @(GT5";2 S>, @  Q@8  !D
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MU^F&A'F0,!\(UI!O6,DW_ _R(9IPH:+OQ94=$Q%O>[C.C3ZZWF3F#F/TQ*A
M&*.D>&*[0Q32I[9 (Y#=\B!A/A"L(?FHDGQDG,&5EI%)-$-E%D5?ERRY9Z+U
MR6A$=546$D8@81XDS >"-<2]J,2]>..UT@5D1$#"""3,@X3Y0+!&1%Q6$7$)
MM58R@KI*"PDCD# /$N9?FA=H#<FP4[\V.T;1%C&5IZ9H,ZJK;* T DKS0&D^
M%*TI\5%E!+]QIBX[ !48D#0"2O- :3X4K1D8;AT8+E3"-I,Z*PQ)(R7M!^^W
MSZU<XPLN5,^:BM3U)VPL9NA;=9^BQ3;:ZH^]OC?-Z1BTF 1*(Z T#Y3F0]&:
M&M<5)=Q_ZW0,6HH"I1%0F@=*\Z%HS<"HZUO87."ZDG*OM5YS@3*XSL2M1:V2
M,CS*8P-GX#C.BYJ6V5MGW4"K6J T'XK6U*TN;&%SH6@9!5O*8KV(_A0IE="T
MRMKH']1I?0U:W0*E$5":!TKSH6A-_>LJ%QZ]=4('+8Z!T@@HS0.E^5"T9F#4
M%3)L++=T6E^#%KM :024YI6T'ZW#_X]"%JXK6=A<RCHAI<]/2^F@E2Y0&@&E
M>: T'XK6W%)15\5<YXU3N@M:2P.E$5":!TKSH6C-P*AK::ZQ)-,EI9M)G14&
M+8J!TKR2UO@_^XM\#N6PD,T^VB>6,+')=_1)%/!]JHHM8]75:M?@+-\K9]?-
MBRV'2RHV42I1S-;:U#D?Z5&(8A=?<:+X+M]U=L^5XDE^N&4T9")KH']?<ZZ>
M3S('U5[*Z;]02P,$%     @ @(GT5$V*,MR\ @  O H  !D   !X;"]W;W)K
M<VAE971S+W-H965T-C N>&ULK99=;]HP%(;_RE$V39O4D0\"=!U$ZDBK55LW
M!/NXF'9AD@-8=>+,-M#]^]E.B.@4HB*%"V+'?E_[//%)SGC/Q8/<("IXS%@N
M)\Y&J>+*=66RP8S('B\PUR,K+C*B=%>L75D()*D59<P-/&_H9H3F3C2V]V8B
M&O.M8C3'F0"YS3(B_GY QO<3QW<.-^9TO5'FAAN-"[+&!:KOQ4SHGEN[I#3#
M7%*>@\#5Q+GVK^*1F6\G_*"XET=M,)$L.7\PG;MTXGAF0\@P4<:!Z,L.I\B8
M,=+;^%-Y.O621GC</KC?VMAU+$LB<<K93YJJS<2Y="#%%=DR->?[CUC%,S!^
M"6?2_L.^G!N^<R#92L6S2JQWD-&\O)+'BL.1P ]/"()*$#Q7T*\$_><*PDH0
M6C)E*)9#3!2)QH+O09C9VLTT+$RKUN'3W#SVA1)ZE&J=BF;SF]N;^?PFAL6W
MK]-/\#I&12B3\(4(0<PS>0-OX26X(#=$H!R[2J]JM&Y2K?"A7"$XL<(]$3WH
M^Q<0>$'0()^VRV-,:KG?((_;Y=?;=0^\1KFK4=6\@II78/WZ)_RFC$@)? 4+
MQ9,'^/59C\.=PDS^;D)3FH7-9B:EKV1!$IPX.F<EBATZT:L7_M![WP2J2[.X
M([,G$/LUQ'Z;>[0@# U#:1A>0"%H@DWT6EW.I=>E65R:#:R9>;/N(GVX=@U(
MPAI)V([$9-=I$JWB<TET:1:79KY_A"+H#9IA#&H8@W88*"A*N(:9_@B@$)@>
MTNT>LR6*QE1KM3P749=F<4=F3U .:Y3#+M]7PRXA=FD6=V3V!.*HACAJ/8__
M'<,+L-DJX4[*+:9-'$N_X5%27'KZ5Z=%">A9L^+6O9T;N7M4*IBZ3G^=US27
MP'"E[;W>2!]64=9*94?QPE8/2ZYT+6*;&UU>HC 3]/B*<W7HF(*D+EBC?U!+
M P04    " " B?144I^7:@L#   C"0  &0   'AL+W=O<FMS:&5E=',O<VAE
M970V,2YX;6RM5FMOVC 4_2M6-DU4&N1%$N@@$J^ME=8.@;I^F/;!)!=B+;&9
M;:#]][,32'D$5E7] K9SS\DY]\:^[FP8_R,2 (F>LI2*KI%(N;PV31$ED&'1
M8$N@ZLF<\0Q+->4+4RPYX#@'9:GI6)9O9IA0(^SD:V,>=MA*IH3"F".QRC+,
MG_N0LDW7L(W=PH0L$JD7S+"SQ N8@GQ8CKF:F25+3#*@@C"*.,R[1L^^'K1U
M?![PD\!&[(V1=C)C[(^>W,9=P]*"((5(:@:L_M8P@#351$K&WRVG4;Y2 _?'
M._:ON7?E988%#%CZ2&*9=(V6@6*8XU4J)VQS UL_GN:+6"KR7[0I8IN^@:*5
MD"S;@I6"C-#B'S]M\[ '4#S5 &<+<(X!S3, =PMP<Z.%LMS6$$L<=CC;(*ZC
M%9L>Y+G)T<H-H;J*4\G54Z)P,JQ]_S&=7J%1;W)_>_]MBL:C"9K>]"8C5!N"
MQ"055ZB.'J9#5/MXU3&E>J4&FM&6OE_0.V?H773'J$P$&M$8XD.\J:26>IV=
MWKYSD? .\P9R[<_(L1RG0L_@]7#[@ARW3)^;\[EG^$:84T(7 HV!HVF".:!?
MO9F07'V>OZO25= UJ^GTEKT62QQ!UU![4@!?@Q%^^F#[UI<JK^]$=N"\63IO
M7F(/[]4)4TN94-\'H1'+ &$I.9FM))ZE@"1#,@$T8-D2T^>J3!3T7DZOSYIU
M6&]97N!8'7.];_(TKMENME^B#M1[I7KO8MT>\^T-<1VO@:O3"@E=.X'4.2<D
MIK&J:95F[SVK]TYD!_[]TK]_L7IUU,>"1%4>"Z"_EV_;\H/ ]HX+<QK8MET[
M:/G5I0E*:<%_I U)NI+'IT4A+GBMN(I M^6HN#/J6J6ZUEL35P!;^Q^TU; "
MSSN2=AJGPBRO62VL70IKOSUM[5=*.XW3TMSCG)E[_28#OLC;L$ 16U%9'.7E
M:MGI>WF#.UKOJQM T;!?:(KK@SJH%X0*E,)<45J-0.T67K3D8B+9,N]J,R95
MC\R'B;K% -<!ZOF<,;F;Z!>4]Z+P'U!+ P04    " " B?14 :8223,"  "F
M!   &0   'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q]E-V.VC 0A5_%<J5J
M5ZK(#X%6-(D$+-6N5'814=N+JA<F&1)K'3NU#=F^?6TGI%0"N""V,^?S&7LF
M<2ODJZH -'JK&5<)KK1N9IZG\@IJHD:B 6[>[(6LB39367JJD4 *)ZJ9%_K^
MU*L)Y3B-W=I&IK$X:$8Y;"12A[HF\L\"F&@3'.#3PI:6E;8+7AHWI(0,]+=F
M(\W,&R@%K8$K*CB2L$_P/)@M(AOO KY3:-79&-E,=D*\VLE3D6#?&@(&N;8$
M8AY'6 )C%F1L_.Z9>-C2"L_')_H7E[O)94<4+ 7[00M=)?@31@7LR8'IK6@?
MH<]G8GFY8,K]H[:+C2*,\H/2HN[%QD%->?<D;_TYG G"X(H@[ 6A\]UMY%P^
M$$W26(H621MM:';@4G5J8XYR>RF9EN8M-3J=WGU]R;)[]/2\?%FOT&:U1=GC
M?+M"=P^@"64*/1,IB3VY^]C39D,K\_(>ONC@X17X&*T%UY5"*UY \;_>,T8'
MM^')[2*\"5P3.4+CX ,*_3! JB(2U WL>#B$L<..KV!71'+*2X4V(%%FJ>CG
M?*>T-#7SZU+:'2ZZC+-]-%,-R2'!IE$4R"/@]/V[8.I_OF$V&LQ&M^CIG&M:
M4':P=W+Q"#J+'63J(+8SC^ED,O7-+_:.Y[M[9[53@RQ=ARB4BP/771D-JT,3
MSKO:^Q?>=;"YG9)RA1CLC=0??9Q@)+NNZ"9:-*X2=T*;NG;#RGQ(0-H \WXO
MA#Y-[ ;#IRG]"U!+ P04    " " B?144+2"[S<#  #R$P  #0   'AL+W-T
M>6QE<RYX;6S=6%UOVC 4_2N1NTZM-#5 UI2L@+0A59JT397:A[U5ACA@R;$S
MQW2P7S_?. D?]46L#QLLJ,2^)^?<8_NF=CLHS4JPASEC)ECF0I9#,C>F^!"&
MY73.<EI>J8))BV1*Y]38KIZ%9:$934L@Y2+L=3IQF%,NR6@@%_E=;LI@JA;2
M#$G<A@)W^YP.23=^3P(G-U8I&Y*GB[<_%LK<O@G<_>S=V5GGZ?)V-WY1 9<D
M](I>'R!ZU>G@P@!BXO&!XOO54?F;;?F&<&[56O8Y1NY[R&LF2DL.&]*^ 572
M8;WFHT&FY'KI(^("-C?-6?!,Q9",J> 3S8&5T9R+E0OW(#!50NG V)JS9KH0
M*7\YN.MZ4(ZU3LZETE5NE\%]3^K'=X"F!P:Y$*W!'G&!T:"@QC M[VRG>K@*
MOH""NOVX*JS#F::K;N^:K G5S2:9*)TRW:;IDB8T&@B6@1W-9W.X&U6$ !JC
M<MM(.9TI22L/#:-N6-DI$^(!WM7OV9;V,MM8U0ZLJ6R;UE#==#*N _J;:DY[
M4S9ZE6Y0\&=E/BWL<&35AV)A]YIE?%GUEUEK %/OXNJT*,3JH^ SF3,W^(,3
MC@:TX05SI?DOFPU*96H#3)/@F6G#IYN1GYH6CVQIFG):9KCGW@EZ_KOS/&.2
M:2HV3=O:/^99?K7C>G/[%YZK7RN[CKTFHYOC]UAOZ,=N,CX%DR>QW/U3,)D<
MO\GH.#V&]2%CXR2S=8YIHP&<%X?D&YQ-Q3II,%EP8;BL>W.>IDR^.,Y8>4,G
M]@^:+7W[?,HRNA#FL06'9-W^RE*^R)/VJ7N8B/JI=?L+#*\;MX=5FXO+E"U9
M.JZ[>C:IFH%MV*SU!81=Y*ZZ_ C&<9@? 0S+@SG .(Z%Y?F?QM-'Q^,PS%O?
MB_113A_E.)8/&5<?+(^?D]C+/](DB:(XQF9T//8Z&&/S%L?PXU?#O $#RP.9
M_FRN\=7&*V1_'6!KNJ]"L)'BE8B-%)]K0/SS!HPD\:\VE@<8V"I@M0/Y_7F@
MIOR<*()5Q;QA;S".) F&0"WZ:S2.D=F)X>-?'^PMB:(D\2. ^1U$$8; VX@C
MF /P@"%15.V#._M1V.Q3X?J_?*/?4$L#!!0    ( (")]%27BKL<P    !,"
M   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8
M$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*N
MU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I
M2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3
MZ:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ @(GT5'2V
M]-L*!0  RB@   \   !X;"]W;W)K8F]O:RYX;6S%FEMSFS@4@/^*QD_MS'9M
M<W';3-T9Q2B)IAA8($[SM$.PW&C*Q0,XZ?;7K\"F%JES=E_.^,E&,/!Q$.<[
MDOCT7%;?'\KR._F19T4]'STVS?9B/*[31Y$G]9_E5A1JSZ:L\J11F]6W<;VM
M1+*N'X5H\FQL3":S<9[(8O3Y4W^NH!KK&V4CTD:6A6IL&U92/-?'_>TF>9*U
M?)"9;/Z9C[K_F1B17!8RES_%>CZ:C$C]6#[?E)7\619-DD5I56;9?#3=[UB)
MJI'I;\U1"QDG#W77TB0/8:) YJ/91)UP(ZNZZ8[HSI\HQB>A#MYO[9KR2F:-
MJ)RD$==5N=O*XEM[&G478^TVNCCTO_L@7E3_)XSE9B-3X93I+A=%LX]C);(6
ML*@?Y;8>D2+)Q7RT*)]$U=Z/N@!?[^^M45!:I*H+J794?-WAX:%P+V8A7Y*%
M[SG,BYC3_HM\ESLT5AL:I % &F>$_-O0($T TCPGI*E!6@"D=4Y(2X.T 4C[
MG)"V!CD#(&>XD$'(O04/J$OH(N8K'G,6$>HYQ ^OJ<<UR/< Y'M<R.AVN:3A
M/?&O2,2O/7[%%]2+%?'"O_5B'?(# /D!%_) $Y&0+1A?T4N7_4$\%FMT'P&Z
MC]B=<<6\V _5X]4S]@1*V1/LKL<"RAW"O@;MZW'H=O$-"PF-(J9C@F9!5DL0
M^@$+X_L.C_UURX.EBN3+1SN%O#)%%LNU[SMWW'5U'D@A4V2'W-$P5"_HH*=!
MMI@BZ\)E-!KV>T@+4V0O[+MX0._;%+'O]2IWA+=*$"ZGESHF)(8ILAF4%_PE
M(S'].@P=Y($IL@A"YG;U7$#;%_*2NM1;'$(8JQZG8T(FF"*K0 5NZ7LDBOW%
M%YT)RO]39 %$-S1D[R[IO@Y9MBF7QMS78V9 -C#P;7#%PE#1O0R; 65_ SG[
MOW']*'I+#B^#$@'I JGC@2,*Y,P?W5Y&RDE*2(2U@M>Y( ,8R 8 *[;!4,>
MQ& @BP'&U <[!F0, ]D8KY66Y$V<="1'3,@8!KHQ?M68![+ZK<X&F<- -@=8
M; X[)&0. ]D<0+'9AE3'A&1B(,ND+SA//683LHB);)&^\CP)!GG$1/;(O@0]
MB07YPT3V!UB+#J>DP#DI]$FI8RUZ,H:01$QDB8!%Z3"&D$1,9(F\5@#^+A$3
MDHB)+)%7"J[^J>N8D$_,<TY)#68@3<@G)K)/8$Q]#M*$?&(B^^3U L<132+U
M26?(+A:R708%3D>6#=*0!1G&0I^G@BJ<P<0]9!P+V3A@A>/H:<B"C&,A&P?$
M'"1U"UP'07;/L1 [U1TAW5C(NCE48K_ R#M"ZWJ7;[LC]14Y"]*-A:R;$YAW
M254E14-<F3SHF)!N+&3= )@T;08)$M*-A:R;OLH]4KHBJ05)R[H9=DW(-A:R
M;>"B5\^4-F0;&]DVJMH]%&C'</(B+7-!FN2'_@;9D'=L9.^<P@Q%6A:I;(_6
M,2'OV,C>.87IB(VH*K%6\=0Q(>_8R-XYA;E*LEUW)*$Z)N0=&WT!7A^0]:A>
MFY+:CU5T3' %'EE"\-!L\*9#$K*1):2O%_Q'-"$)V=ACGE='D"^K=!N2D(T]
MYH$P!Z6;#5G(1K;0BP6/E\]=_SP$LM ,V4*'\3BCH<>]ZT@?D;? .B9DH=EY
MUFGZJ.J8D(5FG87&_;=S:[&1A5A[ZA*U:D^3+ TJTO[LU_PMNUW3V^RR;*':
M_,(MDW7_*5[_&>'G?P%02P,$%     @ @(GT5'=+<84& @  \20  !H   !X
M;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<\W92VKC0!2%X:T8+2#E^U*2)LZH
M)YDVV8!PR@]B6T*EII/=MW$&]A$]Z$FH,Q(EH:L?!!^B]/0K'[IIWY_*;C^4
MQ<?Q<"JK9C=-PX^4RGJ7CUVYZX=\.E_9]..QF\[+<9N&;OW>;7/2Y;)-X^V,
MYOGI=N;B]7/(_S.QWVSVZ_RS7_\^YM/TC\'I3S^^EUW.4[-X[<9MGE9-^CA<
M3Y=T.<C=>7*S>'E;->/+FS2I=I!"D-8/,@BR^D$.05X_*" HZ@>U$-36#[J'
MH/OZ00\0]% _Z!&"'NL'R1)E7!(DS; FT%J0:R'P6A!L(1!;D&PA,%L0;2%0
M6Y!M(7!;$&XAD%N0;B&P6Q!O(=!;46\ET%M1;R706V<?VP1Z*^JM!'HKZJT$
M>BOJK01Z*^JM!'HKZJT$>BOJK01Z*^JM!'H;ZFT$>AOJ;01Z&^IM!'K;;+.$
M0&]#O8U ;T.]C4!O0[V-0&]#O8U ;T.]C4!O0[V-0&]'O9U ;T>]G4!O1[V=
M0&]'O9U ;Y]M=A/H[:BW$^CMJ+<3Z.VHMQ/H[:BW$^CMJ+<3Z!VH=Q#H':AW
M$.@=J'<0Z!VH=Q#H':AW$.@=LY^5!'H'ZAT$>@?J'01Z!^H=!'H'ZAT$>K>H
M=TN@=XMZMP1ZMZAW^YUZE^GSD,NUYVN-S_].JJ?SO?GZ^,ORZ^3LO5QP3K<5
MY?DO4$L#!!0    ( (")]%3_)Z=UXP$  &PD   3    6T-O;G1E;G1?5'EP
M97-=+GAM;,W:74_",!0&X+]"=FM8Z=?\B'"CWJH7_H&Z'61A6YNV(/Q[NP$F
M&B4:3'QO6*#M><]ZDN>*ZZ>MHS#:M$T7IMDB1G?%6"@7U)J06T==6IE;WYJ8
MOOH7YDRY-"_$Q&12L-)VD;HXCGV-;'9]2W.S:N+H;I-^#K7MIIFG)F2CF]W&
M/FN:&>>:NC0QK;-U5WU*&>\3\G1RV!,6M0MG:4/&ODSH5[X/V)][6)/W=46C
M1^/CO6G3+K9I6(C;AD)^O,07/=KYO"ZILN6J34?RX#R9*BR(8MODNZ)GQY-C
MNF':??*3\X<RQP+3SD=O74@3\_3[N,-(^M-CEPJ1C_7Q5WQ/3*5/?C_JIUU1
M]</L=+VOUB^'>00V/$Z_XX\S?J__RSX$2!\2I \%TH<&Z:, Z>,<I(\+D#XN
M0?K@$Y1&4$3E**1R%%,Y"JH<156.PBI'<96CP,I19!4HL@H4606*K )%5H$B
MJT"15:#(*E!D%2BR"A19)8JL$D56B2*K1)%5HL@J4625*+)*%%DEBJP215:%
M(JM"D56AR*I09%4HLBH4616*K I%5H4BJT*15:/(JE%DU2BR:A19-8JL&D56
MC2*K1I%5H\BJ460M4&0M4&0M_E/69VN7?QP_///6U-TAGPU_,IJ] 5!+ 0(4
M Q0    ( (")]%0'04UB@0   +$    0              "  0    !D;V-0
M<F]P<R]A<' N>&UL4$L! A0#%     @ @(GT5+*77H/N    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ @(GT
M5)E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " " B?14RGB[#3<$  !R#P  &
M@($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ @(GT
M5+?#B58[!P  .1X  !@              ("!>@P  'AL+W=O<FMS:&5E=',O
M<VAE970R+GAM;%!+ 0(4 Q0    ( (")]%37IE7Q& ,  -(*   8
M      " @>L3  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M" " B?14CK:^*%0%  "/%0  &               @($Y%P  >&PO=V]R:W-H
M965T<R]S:&5E=#0N>&UL4$L! A0#%     @ @(GT5+:_10W@!@  A"X  !@
M             ("!PQP  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4
M Q0    ( (")]%3AG<8,L 8  .,<   8              " @=DC  !X;"]W
M;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " " B?14RC3?N[@/  "&
M*0  &               @(&_*@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL
M4$L! A0#%     @ @(GT5*[N99D("@  I!H  !@              ("!K3H
M 'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( (")]%0*PV]8
MT0(  '$&   8              " @>M$  !X;"]W;W)K<VAE971S+W-H965T
M.2YX;6Q02P$"% ,4    " " B?14@I=-UI<"  "6!0  &0
M@('R1P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( (")
M]%19 _?\LP(  /T%   9              " @<!*  !X;"]W;W)K<VAE971S
M+W-H965T,3$N>&UL4$L! A0#%     @ @(GT5%G<"=P, P  S08  !D
M         ("!JDT  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M    " " B?14)V$@_94"  "P!0  &0              @('M4   >&PO=V]R
M:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( (")]%1NAA[BU@4  .L0
M   9              " @;E3  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL
M4$L! A0#%     @ @(GT5.=\#*K: P  9 @  !D              ("!QED
M 'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " " B?14#K+Q
M(8D"  ".!0  &0              @('770  >&PO=V]R:W-H965T<R]S:&5E
M=#$V+GAM;%!+ 0(4 Q0    ( (")]%3U'"XHAP\  )TI   9
M  " @9=@  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @
M@(GT5*UAKE)2!   T D  !D              ("!57   'AL+W=O<FMS:&5E
M=',O<VAE970Q."YX;6Q02P$"% ,4    " " B?14Y5R^)NP"   Z!@  &0
M            @('>=   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4
M Q0    ( (")]%1_\G%$Y 4  .$-   9              " @0%X  !X;"]W
M;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ @(GT5-L)>^(O @
MWP0  !D              ("!''X  'AL+W=O<FMS:&5E=',O<VAE970R,2YX
M;6Q02P$"% ,4    " " B?148+U'MH,#  #R!P  &0              @(&"
M@   >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( (")]%0T
M!RDFH@(  .,%   9              " @3R$  !X;"]W;W)K<VAE971S+W-H
M965T,C,N>&UL4$L! A0#%     @ @(GT5)'7W=@_"@  6AP  !D
M     ("!%8<  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (")]%2B)JN&P0(   $&   9              "
M@:&<  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ @(GT
M5/S>U4QV @  9 4  !D              ("!F9\  'AL+W=O<FMS:&5E=',O
M<VAE970S,"YX;6Q02P$"% ,4    " " B?14XHHRNB4$   ?"P  &0
M        @(%&H@  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0
M   ( (")]%1*@Z94>@(  ),%   9              " @:*F  !X;"]W;W)K
M<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ @(GT5-&L,3J$ @  5@4
M !D              ("!4ZD  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q0
M2P$"% ,4    " " B?14#6R)X3H$  "'"P  &0              @($.K
M>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( (")]%20=96,
M/00  $8)   9              " @7^P  !X;"]W;W)K<VAE971S+W-H965T
M,S4N>&UL4$L! A0#%     @ @(GT5*:E5SN$ @  604  !D
M ("!\[0  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " "
MB?148^X&Q-T"   @!@  &0              @(&NMP  >&PO=V]R:W-H965T
M<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( (")]%2!@0Q36P,  /T.   9
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M970T,BYX;6Q02P$"% ,4    " " B?14PYMJFX@#   *$0  &0
M    @(%ER0  >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (
M (")]%3CS8:[;@(  *\%   9              " @23-  !X;"]W;W)K<VAE
M971S+W-H965T-#0N>&UL4$L! A0#%     @ @(GT5/]MY&A( @  ' 8  !D
M             ("!R<\  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"
M% ,4    " " B?143$[*TNH%  "[,   &0              @(%(T@  >&PO
M=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( (")]%2NZV^=V0(
M /('   9              " @6G8  !X;"]W;W)K<VAE971S+W-H965T-#<N
M>&UL4$L! A0#%     @ @(GT5,/A W E P  Z0D  !D              ("!
M>=L  'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " " B?14
M#WO-8&8"   O!@  &0              @('5W@  >&PO=V]R:W-H965T<R]S
M:&5E=#0Y+GAM;%!+ 0(4 Q0    ( (")]%0("K'QD@(  ,0&   9
M      " @7+A  !X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%
M  @ @(GT5";2 S>, @  Q@8  !D              ("!.^0  'AL+W=O<FMS
M:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    " " B?14JB[;JAP#   5"0
M&0              @('^Y@  >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+
M 0(4 Q0    ( (")]%1JR&.QP@(  "D)   9              " @5'J  !X
M;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ @(GT5")/C@ND
M @  - <  !D              ("!2NT  'AL+W=O<FMS:&5E=',O<VAE970U
M-"YX;6Q02P$"% ,4    " " B?14I#9;SE\#  !E$   &0
M@($E\   >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( (")
M]%3 &.@>&@4  )$2   9              " @;OS  !X;"]W;W)K<VAE971S
M+W-H965T-38N>&UL4$L! A0#%     @ @(GT5,,F"EEB @  4P8  !D
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M=#8Q+GAM;%!+ 0(4 Q0    ( (")]%0!IA)),P(  *8$   9
M  " @0L* 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @
M@(GT5%"T@N\W P  \A,   T              ( !=0P! 'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    " " B?14EXJ[',     3 @  "P              @ '7
M#P$ 7W)E;',O+G)E;'-02P$"% ,4    " " B?14=+;TVPH%  #**   #P
M            @ ' $ $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ @(GT
M5'=+<84& @  \20  !H              ( !]Q4! 'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ @(GT5/\GIW7C 0  ;"0  !,
M         ( !-1@! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $8 1@ A
)$P  21H!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>108</ContextCount>
  <ElementCount>202</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>37</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets</Role>
      <ShortName>INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity</Role>
      <ShortName>INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/PrincipalActivitiesAndOrganization</Role>
      <ShortName>PRINCIPAL ACTIVITIES AND ORGANIZATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/SummaryOfSignificantAccountingPolicy</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - ACCOUNTS RECEIVABLE, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/AccountsReceivableNet</Role>
      <ShortName>ACCOUNTS RECEIVABLE, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/PrepaidExpensesAndOtherAssetsNet</Role>
      <ShortName>PREPAID EXPENSES AND OTHER ASSETS, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - PROPERTY AND EQUIPMENT, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/PropertyAndEquipmentNet</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - GOODWILL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/Goodwill</Role>
      <ShortName>GOODWILL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - WARRANTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/Warrants</Role>
      <ShortName>WARRANTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/Leases</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/OtherPayablesAndAccruedLiabilities</Role>
      <ShortName>OTHER PAYABLES AND ACCRUED LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/RelatedPartyBalancesAndTransactions</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - COMMON STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/CommonStock</Role>
      <ShortName>COMMON STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - SHARE-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/Share-basedCompensation</Role>
      <ShortName>SHARE-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - PREFERRED STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/PreferredStock</Role>
      <ShortName>PREFERRED STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - (LOSS) INCOME PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/LossIncomePerShare</Role>
      <ShortName>(LOSS) INCOME PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - SUBSEQUENT EVENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/SubsequentEvent</Role>
      <ShortName>SUBSEQUENT EVENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/SummaryOfSignificantAccountingPolicyPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/SummaryOfSignificantAccountingPolicyTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nocera.company/role/SummaryOfSignificantAccountingPolicy</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - ACCOUNTS RECEIVABLE, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/AccountsReceivableNetTables</Role>
      <ShortName>ACCOUNTS RECEIVABLE, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nocera.company/role/AccountsReceivableNet</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nocera.company/role/Inventories</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetTables</Role>
      <ShortName>PREPAID EXPENSES AND OTHER ASSETS, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nocera.company/role/PrepaidExpensesAndOtherAssetsNet</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nocera.company/role/PropertyAndEquipmentNet</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - GOODWILL (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/GoodwillTables</Role>
      <ShortName>GOODWILL (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nocera.company/role/Goodwill</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - WARRANTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/WarrantsTables</Role>
      <ShortName>WARRANTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nocera.company/role/Warrants</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/LeasesTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nocera.company/role/Leases</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesTables</Role>
      <ShortName>OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nocera.company/role/OtherPayablesAndAccruedLiabilities</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nocera.company/role/IncomeTaxes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/RelatedPartyBalancesAndTransactionsTables</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nocera.company/role/RelatedPartyBalancesAndTransactions</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - SHARE-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/Share-basedCompensationTables</Role>
      <ShortName>SHARE-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nocera.company/role/Share-basedCompensation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - (LOSS) INCOME PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/LossIncomePerShareTables</Role>
      <ShortName>(LOSS) INCOME PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nocera.company/role/LossIncomePerShare</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/SummaryOfSignificantAccountingPolicyTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/SummaryOfSignificantAccountingPolicyTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/AccountsReceivableNetDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/AccountsReceivableNetTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/InventoriesDetails</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/InventoriesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetDetails</Role>
      <ShortName>PREPAID EXPENSES AND OTHER ASSETS, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/PropertyAndEquipmentNetDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/PropertyAndEquipmentNetDetailsNarrative</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - GOODWILL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/GoodwillDetails</Role>
      <ShortName>GOODWILL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/GoodwillTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - WARRANT (Details - Assumptions used)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/WarrantDetails-AssumptionsUsed</Role>
      <ShortName>WARRANT (Details - Assumptions used)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/WarrantsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - WARRANT (Details - Warrant Liability)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/WarrantDetails-WarrantLiability</Role>
      <ShortName>WARRANT (Details - Warrant Liability)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/WarrantsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - WARRANT (Details - Warrant Activity)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/WarrantDetails-WarrantActivity</Role>
      <ShortName>WARRANT (Details - Warrant Activity)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/WarrantsTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - LEASES (Details - Lease costs)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/LeasesDetails-LeaseCosts</Role>
      <ShortName>LEASES (Details - Lease costs)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/LeasesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails</Role>
      <ShortName>OTHER PAYABLES AND ACCRUED LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - TAXATION (Details - Income tax expense)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/TaxationDetails-IncomeTaxExpense</Role>
      <ShortName>TAXATION (Details - Income tax expense)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - TAXATION (Details - Reconcilation of income tax)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax</Role>
      <ShortName>TAXATION (Details - Reconcilation of income tax)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - TAXATION (Details - Deferred taxes)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/TaxationDetails-DeferredTaxes</Role>
      <ShortName>TAXATION (Details - Deferred taxes)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - TAXATION (Details - Valuation Allowance)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/TaxationDetails-ValuationAllowance</Role>
      <ShortName>TAXATION (Details - Valuation Allowance)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/IncomeTaxesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000057 - Disclosure -  RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/RelatedPartyBalancesAndTransactionsTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - COMMON STOCK (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/CommonStockDetailsNarrative</Role>
      <ShortName>COMMON STOCK (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/CommonStock</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - SHARE-BASED COMPENSATION (Details - assumptions)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/Share-basedCompensationDetails-Assumptions</Role>
      <ShortName>SHARE-BASED COMPENSATION (Details - assumptions)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/Share-basedCompensationTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/Share-basedCompensationDetailsNarrative</Role>
      <ShortName>SHARE-BASED COMPENSATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/Share-basedCompensationTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - PREFERRED STOCK (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/PreferredStockDetailsNarrative</Role>
      <ShortName>PREFERRED STOCK (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/PreferredStock</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - (LOSS) EARNINGS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/LossEarningsPerShareDetails</Role>
      <ShortName>(LOSS) EARNINGS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="nocera_s1a2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - (LOSS) INCOME PER SHARE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nocera.company/role/LossIncomePerShareDetailsNarrative</Role>
      <ShortName>(LOSS) INCOME PER SHARE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nocera.company/role/LossIncomePerShareTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-1/A" original="nocera_s1a2.htm">nocera_s1a2.htm</File>
    <File>ncra-20220331.xsd</File>
    <File>ncra-20220331_cal.xml</File>
    <File>ncra-20220331_def.xml</File>
    <File>ncra-20220331_lab.xml</File>
    <File>ncra-20220331_pre.xml</File>
    <File>nocera_ex0501.htm</File>
    <File>nocera_ex107.htm</File>
    <File>nocera_ex2301.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>image_013.jpg</File>
    <File>image_015.jpg</File>
    <File>image_017.jpg</File>
    <File>image_023.jpg</File>
    <File>image_024.jpg</File>
    <File>image_029.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="507">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="19">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>92
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "nocera_s1a2.htm": {
   "axisCustom": 0,
   "axisStandard": 10,
   "contextCount": 108,
   "dts": {
    "calculationLink": {
     "local": [
      "ncra-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ncra-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "nocera_s1a2.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ncra-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ncra-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ncra-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 352,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 45,
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 48
   },
   "keyCustom": 1,
   "keyStandard": 201,
   "memberCustom": 20,
   "memberStandard": 17,
   "nsprefix": "NCRA",
   "nsuri": "http://nocera.company/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://nocera.company/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - INVENTORIES",
     "role": "http://nocera.company/role/Inventories",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET",
     "role": "http://nocera.company/role/PrepaidExpensesAndOtherAssetsNet",
     "shortName": "PREPAID EXPENSES AND OTHER ASSETS, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - PROPERTY AND EQUIPMENT, NET",
     "role": "http://nocera.company/role/PropertyAndEquipmentNet",
     "shortName": "PROPERTY AND EQUIPMENT, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - GOODWILL",
     "role": "http://nocera.company/role/Goodwill",
     "shortName": "GOODWILL",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - WARRANTS",
     "role": "http://nocera.company/role/Warrants",
     "shortName": "WARRANTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - LEASES",
     "role": "http://nocera.company/role/Leases",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES",
     "role": "http://nocera.company/role/OtherPayablesAndAccruedLiabilities",
     "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - INCOME TAXES",
     "role": "http://nocera.company/role/IncomeTaxes",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS",
     "role": "http://nocera.company/role/RelatedPartyBalancesAndTransactions",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - COMMON STOCK",
     "role": "http://nocera.company/role/CommonStock",
     "shortName": "COMMON STOCK",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "role": "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets",
     "shortName": "INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - SHARE-BASED COMPENSATION",
     "role": "http://nocera.company/role/Share-basedCompensation",
     "shortName": "SHARE-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - PREFERRED STOCK",
     "role": "http://nocera.company/role/PreferredStock",
     "shortName": "PREFERRED STOCK",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - (LOSS) INCOME PER SHARE",
     "role": "http://nocera.company/role/LossIncomePerShare",
     "shortName": "(LOSS) INCOME PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - SUBSEQUENT EVENT",
     "role": "http://nocera.company/role/SubsequentEvent",
     "shortName": "SUBSEQUENT EVENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies)",
     "role": "http://nocera.company/role/SummaryOfSignificantAccountingPolicyPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables)",
     "role": "http://nocera.company/role/SummaryOfSignificantAccountingPolicyTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsAndNontradeReceivableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - ACCOUNTS RECEIVABLE, NET (Tables)",
     "role": "http://nocera.company/role/AccountsReceivableNetTables",
     "shortName": "ACCOUNTS RECEIVABLE, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsAndNontradeReceivableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - INVENTORIES (Tables)",
     "role": "http://nocera.company/role/InventoriesTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Tables)",
     "role": "http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetTables",
     "shortName": "PREPAID EXPENSES AND OTHER ASSETS, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)",
     "role": "http://nocera.company/role/PropertyAndEquipmentNetTables",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "role": "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - GOODWILL (Tables)",
     "role": "http://nocera.company/role/GoodwillTables",
     "shortName": "GOODWILL (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GuaranteesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - WARRANTS (Tables)",
     "role": "http://nocera.company/role/WarrantsTables",
     "shortName": "WARRANTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GuaranteesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - LEASES (Tables)",
     "role": "http://nocera.company/role/LeasesTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)",
     "role": "http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesTables",
     "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://nocera.company/role/IncomeTaxesTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)",
     "role": "http://nocera.company/role/RelatedPartyBalancesAndTransactionsTables",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - SHARE-BASED COMPENSATION (Tables)",
     "role": "http://nocera.company/role/Share-basedCompensationTables",
     "shortName": "SHARE-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - (LOSS) INCOME PER SHARE (Tables)",
     "role": "http://nocera.company/role/LossIncomePerShareTables",
     "shortName": "(LOSS) INCOME PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)",
     "role": "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-012022-03-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2021-01-012021-03-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative)",
     "role": "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2021-01-012021-03-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)",
     "role": "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
     "shortName": "INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "us-gaap:AccountsAndNontradeReceivableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details)",
     "role": "http://nocera.company/role/AccountsReceivableNetDetails",
     "shortName": "ACCOUNTS RECEIVABLE, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "us-gaap:AccountsAndNontradeReceivableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - INVENTORIES (Details)",
     "role": "http://nocera.company/role/InventoriesDetails",
     "shortName": "INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsAndOtherReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)",
     "role": "http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetDetails",
     "shortName": "PREPAID EXPENSES AND OTHER ASSETS, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsAndOtherReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)",
     "role": "http://nocera.company/role/PropertyAndEquipmentNetDetails",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)",
     "role": "http://nocera.company/role/PropertyAndEquipmentNetDetailsNarrative",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - GOODWILL (Details)",
     "role": "http://nocera.company/role/GoodwillDetails",
     "shortName": "GOODWILL (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31_custom_XinFengConstructionCoLtdMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2021-12-02",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - WARRANT (Details - Assumptions used)",
     "role": "http://nocera.company/role/WarrantDetails-AssumptionsUsed",
     "shortName": "WARRANT (Details - Assumptions used)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "us-gaap:GuaranteesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2021-08-10_custom_CWarrantMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "us-gaap:GuaranteesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProductWarrantyAccrualClassifiedCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - WARRANT (Details - Warrant Liability)",
     "role": "http://nocera.company/role/WarrantDetails-WarrantLiability",
     "shortName": "WARRANT (Details - Warrant Liability)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "us-gaap:GuaranteesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ProductWarrantyAccrualClassifiedCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock",
       "us-gaap:GuaranteesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - WARRANT (Details - Warrant Activity)",
     "role": "http://nocera.company/role/WarrantDetails-WarrantActivity",
     "shortName": "WARRANT (Details - Warrant Activity)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock",
       "us-gaap:GuaranteesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - LEASES (Details - Lease costs)",
     "role": "http://nocera.company/role/LeasesDetails-LeaseCosts",
     "shortName": "LEASES (Details - Lease costs)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)",
     "role": "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity",
     "shortName": "INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:SalesAndExciseTaxPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)",
     "role": "http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails",
     "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:SalesAndExciseTaxPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000052 - Disclosure - TAXATION (Details - Income tax expense)",
     "role": "http://nocera.company/role/TaxationDetails-IncomeTaxExpense",
     "shortName": "TAXATION (Details - Income tax expense)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000053 - Disclosure - TAXATION (Details - Reconcilation of income tax)",
     "role": "http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax",
     "shortName": "TAXATION (Details - Reconcilation of income tax)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000054 - Disclosure - TAXATION (Details - Deferred taxes)",
     "role": "http://nocera.company/role/TaxationDetails-DeferredTaxes",
     "shortName": "TAXATION (Details - Deferred taxes)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000055 - Disclosure - TAXATION (Details - Valuation Allowance)",
     "role": "http://nocera.company/role/TaxationDetails-ValuationAllowance",
     "shortName": "TAXATION (Details - Valuation Allowance)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-012022-03-31_country_US",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000056 - Disclosure - INCOME TAXES (Details Narrative)",
     "role": "http://nocera.company/role/IncomeTaxesDetailsNarrative",
     "shortName": "INCOME TAXES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-012022-03-31_country_US",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000057 - Disclosure -  RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)",
     "role": "http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000058 - Disclosure - COMMON STOCK (Details Narrative)",
     "role": "http://nocera.company/role/CommonStockDetailsNarrative",
     "shortName": "COMMON STOCK (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000059 - Disclosure - SHARE-BASED COMPENSATION (Details - assumptions)",
     "role": "http://nocera.company/role/Share-basedCompensationDetails-Assumptions",
     "shortName": "SHARE-BASED COMPENSATION (Details - assumptions)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2021-12-02",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000060 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative)",
     "role": "http://nocera.company/role/Share-basedCompensationDetailsNarrative",
     "shortName": "SHARE-BASED COMPENSATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "role": "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows",
     "shortName": "INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:IncreaseDecreaseInDeferredIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2021-08-01",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfStockPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000061 - Disclosure - PREFERRED STOCK (Details Narrative)",
     "role": "http://nocera.company/role/PreferredStockDetailsNarrative",
     "shortName": "PREFERRED STOCK (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "AsOf2021-08-01",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfStockPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000062 - Disclosure - (LOSS) EARNINGS PER SHARE (Details)",
     "role": "http://nocera.company/role/LossEarningsPerShareDetails",
     "shortName": "(LOSS) EARNINGS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2021-01-012021-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000063 - Disclosure - (LOSS) INCOME PER SHARE (Details Narrative)",
     "role": "http://nocera.company/role/LossIncomePerShareDetailsNarrative",
     "shortName": "(LOSS) INCOME PER SHARE (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2021-01-012021-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION",
     "role": "http://nocera.company/role/PrincipalActivitiesAndOrganization",
     "shortName": "PRINCIPAL ACTIVITIES AND ORGANIZATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY",
     "role": "http://nocera.company/role/SummaryOfSignificantAccountingPolicy",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsAndNontradeReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - ACCOUNTS RECEIVABLE, NET",
     "role": "http://nocera.company/role/AccountsReceivableNet",
     "shortName": "ACCOUNTS RECEIVABLE, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nocera_s1a2.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsAndNontradeReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 37,
   "tag": {
    "NCRA_AllCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Customers [Member]"
       }
      }
     },
     "localname": "AllCustomersMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_CWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "C Warrant [Member]"
       }
      }
     },
     "localname": "CWarrantMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/WarrantDetails-AssumptionsUsed"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_ClassAWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Warrant [Member]"
       }
      }
     },
     "localname": "ClassAWarrantMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_ClassBWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Warrant [Member]"
       }
      }
     },
     "localname": "ClassBWarrantMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_CustomerAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer A [Member]"
       }
      }
     },
     "localname": "CustomerAMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_CustomerBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer B [Member]"
       }
      }
     },
     "localname": "CustomerBMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_CustomerCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer C [Member]"
       }
      }
     },
     "localname": "CustomerCMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_DWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "D Warrant [Member]"
       }
      }
     },
     "localname": "DWarrantMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/WarrantDetails-AssumptionsUsed"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_HsienWenYuMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hsien Wen Yu [Member]"
       }
      }
     },
     "localname": "HsienWenYuMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_MichaelALittmanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Michael A Littman [Member]"
       }
      }
     },
     "localname": "MichaelALittmanMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_MountainShareTransferMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mountain Share Transfer [Member]"
       }
      }
     },
     "localname": "MountainShareTransferMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_PrcMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prc [Member]"
       }
      }
     },
     "localname": "PrcMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_RetentionReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retention receivables"
       }
      }
     },
     "localname": "RetentionReceivables",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "NCRA_SeriesAWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Warrant [Member]"
       }
      }
     },
     "localname": "SeriesAWarrantMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_ShunChihChuangMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shun Chih Chuang [Member]"
       }
      }
     },
     "localname": "ShunChihChuangMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_StatutoryAndOtherReservesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statutory And Other Reserves [Member]"
       }
      }
     },
     "localname": "StatutoryAndOtherReservesMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_TaisiElectricMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taisi Electric [Member]"
       }
      }
     },
     "localname": "TaisiElectricMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_ThreeCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Three Customers [Member]"
       }
      }
     },
     "localname": "ThreeCustomersMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_TotalNoceraStockholdersEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Nocera Stockholders Equity [Member]"
       }
      }
     },
     "localname": "TotalNoceraStockholdersEquityMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_TwoCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Customers [Member]"
       }
      }
     },
     "localname": "TwoCustomersMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_XinFengConstructionCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Xin Feng Construction Co Ltd [Member]"
       }
      }
     },
     "localname": "XinFengConstructionCoLtdMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/GoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "NCRA_YinChiehChengMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yin Chieh Cheng [Member]"
       }
      }
     },
     "localname": "YinChiehChengMember",
     "nsuri": "http://nocera.company/20220331",
     "presentation": [
      "http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties",
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "country_HK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "HONG KONG"
       }
      }
     },
     "localname": "HK",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://nocera.company/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://nocera.company/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r430",
      "r432",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/GoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/GoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nocera.company/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r153",
      "r237",
      "r238",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations",
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r153",
      "r237",
      "r238",
      "r407"
     ],
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations",
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsAndNontradeReceivableTextBlock": {
     "auth_ref": [
      "r158",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable.",
        "label": "ACCOUNTS RECEIVABLE, NET"
       }
      }
     },
     "localname": "AccountsAndNontradeReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/AccountsReceivableNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.",
        "label": "Other receivables from third party"
       }
      }
     },
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "OTHER PAYABLES AND ACCRUED LIABILITIES"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/OtherPayablesAndAccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r39",
      "r360"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGross": {
     "auth_ref": [
      "r24",
      "r154"
     ],
     "calculation": {
      "http://nocera.company/role/AccountsReceivableNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r154",
      "r155"
     ],
     "calculation": {
      "http://nocera.company/role/AccountsReceivableNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/AccountsReceivableNetDetails",
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r18",
      "r379",
      "r394"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Income tax payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r9",
      "r42"
     ],
     "calculation": {
      "http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Salary payable"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r13",
      "r185"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r28",
      "r50",
      "r51",
      "r52",
      "r395",
      "r412",
      "r413"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r49",
      "r52",
      "r59",
      "r60",
      "r61",
      "r97",
      "r98",
      "r99",
      "r321",
      "r349",
      "r408",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r26",
      "r360"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r97",
      "r98",
      "r99",
      "r275",
      "r276",
      "r277",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r32",
      "r156",
      "r161",
      "r162",
      "r163"
     ],
     "calculation": {
      "http://nocera.company/role/AccountsReceivableNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Less: Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive shares"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/LossIncomePerShareDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r16",
      "r91",
      "r140",
      "r143",
      "r149",
      "r159",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r315",
      "r322",
      "r336",
      "r358",
      "r360",
      "r378",
      "r393"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r38",
      "r91",
      "r159",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r315",
      "r322",
      "r336",
      "r358",
      "r360"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r91",
      "r159",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r315",
      "r322",
      "r336",
      "r358"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative",
      "http://nocera.company/role/WarrantDetails-AssumptionsUsed",
      "http://nocera.company/role/WarrantDetails-WarrantActivity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r11",
      "r80"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r74",
      "r80",
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r74",
      "r337"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r89",
      "r91",
      "r113",
      "r114",
      "r115",
      "r118",
      "r120",
      "r128",
      "r129",
      "r130",
      "r159",
      "r195",
      "r200",
      "r201",
      "r202",
      "r206",
      "r207",
      "r211",
      "r212",
      "r216",
      "r220",
      "r227",
      "r336",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical",
      "http://nocera.company/role/PreferredStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PreferredStockDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Exercise price (USD/price)",
        "periodEndLabel": "Average exercise price, outstanding ending",
        "periodStartLabel": "Average exercise price, outstanding beginning",
        "verboseLabel": "Warrants exercise price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative",
      "http://nocera.company/role/WarrantDetails-AssumptionsUsed",
      "http://nocera.company/role/WarrantDetails-WarrantActivity"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "periodEndLabel": "Warrants outstanding, ending balance",
        "periodStartLabel": "Warrants outstanding, beginning balance"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/WarrantDetails-WarrantActivity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r44",
      "r384",
      "r400"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r97",
      "r98",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/CommonStockDetailsNarrative",
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/CommonStockDetailsNarrative",
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/CommonStockDetailsNarrative",
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r23",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23",
      "r360"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock ($0.001 par value; authorized 200,000,000 shares; 10,707,150 shares issued and outstanding as of March 31, 2022 and 10,607,150 shares issued and outstanding as of December 31, 2021, respectively)"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r55",
      "r57",
      "r58",
      "r64",
      "r387",
      "r403"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive (loss) income attributable to the Company"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r134",
      "r135",
      "r153",
      "r333",
      "r334",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations",
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r134",
      "r135",
      "r153",
      "r333",
      "r334",
      "r414",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations",
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r134",
      "r135",
      "r153",
      "r333",
      "r334",
      "r414",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations",
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r131",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentrations of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r134",
      "r135",
      "r153",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration percentage",
        "verboseLabel": "Concentration risk"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations",
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r134",
      "r135",
      "r153",
      "r333",
      "r334",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations",
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r67",
      "r363"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Loss [Abstract]"
       }
      }
     },
     "localname": "CreditLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r92",
      "r295",
      "r302",
      "r304"
     ],
     "calculation": {
      "http://nocera.company/role/TaxationDetails-IncomeTaxExpense": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-IncomeTaxExpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r133",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations",
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Schedule of prepaid expenses and other assets"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r279",
      "r280"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred tax asset, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r78",
      "r92",
      "r296",
      "r302",
      "r303",
      "r304"
     ],
     "calculation": {
      "http://nocera.company/role/TaxationDetails-IncomeTaxExpense": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-IncomeTaxExpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r19",
      "r20",
      "r286",
      "r380",
      "r392"
     ],
     "calculation": {
      "http://nocera.company/role/TaxationDetails-DeferredTaxes": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Deferred tax liabilities, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r287"
     ],
     "calculation": {
      "http://nocera.company/role/TaxationDetails-DeferredTaxes": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-DeferredTaxes"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r289"
     ],
     "calculation": {
      "http://nocera.company/role/TaxationDetails-DeferredTaxes": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r293",
      "r294"
     ],
     "calculation": {
      "http://nocera.company/role/TaxationDetails-DeferredTaxes": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Tax loss carried forward"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances": {
     "auth_ref": [
      "r293",
      "r294"
     ],
     "calculation": {
      "http://nocera.company/role/TaxationDetails-DeferredTaxes": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated returns and sales allowances.",
        "label": "Allowance for doubtful receivables"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "periodEndLabel": "Valuation allowance, ending balance",
        "periodStartLabel": "Valuation allowance, beginning"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-ValuationAllowance"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-DeferredTaxes"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r293",
      "r294"
     ],
     "calculation": {
      "http://nocera.company/role/TaxationDetails-DeferredTaxes": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property and equipment, difference in depreciation"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r78",
      "r183"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation expenses",
        "verboseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows",
      "http://nocera.company/role/PropertyAndEquipmentNetDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r242",
      "r243",
      "r271",
      "r272",
      "r274",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "SHARE-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividend payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r6",
      "r25",
      "r95",
      "r198",
      "r200",
      "r201",
      "r205",
      "r206",
      "r207",
      "r353"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due from a related party"
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToOtherRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r95",
      "r353",
      "r383",
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount payable to related parties classified as other.",
        "label": "Due from related parties"
       }
      }
     },
     "localname": "DueToOtherRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r39",
      "r95",
      "r198",
      "r200",
      "r201",
      "r205",
      "r206",
      "r207",
      "r353"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to related parties"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets",
      "http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r65",
      "r102",
      "r103",
      "r104",
      "r105",
      "r106",
      "r110",
      "r113",
      "r118",
      "r119",
      "r120",
      "r124",
      "r125",
      "r331",
      "r332",
      "r388",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic",
        "verboseLabel": "- Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://nocera.company/role/LossEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r65",
      "r102",
      "r103",
      "r104",
      "r105",
      "r106",
      "r113",
      "r118",
      "r119",
      "r120",
      "r124",
      "r125",
      "r331",
      "r332",
      "r388",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "(LOSS) INCOME PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/LossIncomePerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r337"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r93",
      "r282",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r282",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Changes in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther": {
     "auth_ref": [
      "r282",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other deductions.",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Other, Percent",
        "verboseLabel": "Others"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r282",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Tax effect of non-deductible expense"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r282",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Impact of different tax rates in other jurisdictions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings": {
     "auth_ref": [
      "r282",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.",
        "label": "PRC income tax statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-ReconcilationOfIncomeTax"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Unrecognized compensation costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Unrecognized compensation cost amortization period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r59",
      "r60",
      "r61",
      "r97",
      "r98",
      "r99",
      "r101",
      "r107",
      "r109",
      "r127",
      "r160",
      "r227",
      "r234",
      "r275",
      "r276",
      "r277",
      "r298",
      "r299",
      "r330",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r349",
      "r408",
      "r409",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtendedProductWarrantyAccrual": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate extended product warranty liability. Does not include the ending balance for the standard product warranty liability.",
        "label": "Warrant liability"
       }
      }
     },
     "localname": "ExtendedProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r15",
      "r182"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "negatedLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r14",
      "r167",
      "r168",
      "r175",
      "r180",
      "r360",
      "r377"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/GoodwillDetails",
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r176",
      "r178",
      "r180",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "GOODWILL"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r66",
      "r91",
      "r140",
      "r142",
      "r145",
      "r148",
      "r150",
      "r159",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r336"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesAndProductWarrantiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guarantees and Product Warranties [Abstract]"
       }
      }
     },
     "localname": "GuaranteesAndProductWarrantiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GuaranteesTextBlock": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for each guarantee obligation, or each group of similar guarantee obligations, including (a) the nature of the guarantee, including its term, how it arose, and the events or circumstances that would require the guarantor to perform under the guarantee; (b) the maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee; (c) the current carrying amount of the liability, if any, for the guarantor's obligations under the guarantee; and (d) the nature of any recourse provisions under the guarantee, and any assets held either as collateral or by third parties, and any relevant related party disclosure. Excludes disclosures about product warranties.",
        "label": "WARRANTS"
       }
      }
     },
     "localname": "GuaranteesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Warrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r140",
      "r142",
      "r145",
      "r148",
      "r150",
      "r376",
      "r385",
      "r389",
      "r405"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "(Loss) Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r114",
      "r118",
      "r119",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "verboseLabel": "- Diluted"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/LossEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r93",
      "r283",
      "r285",
      "r290",
      "r300",
      "r306",
      "r308",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r94",
      "r108",
      "r109",
      "r139",
      "r281",
      "r301",
      "r307",
      "r406"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://nocera.company/role/TaxationDetails-IncomeTaxExpense": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense",
        "totalLabel": "Total income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://nocera.company/role/TaxationDetails-IncomeTaxExpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Cash paid for Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseDueFromOtherRelatedParties": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables due from related parties classified as other.",
        "label": "Increase (Decrease) Due from Other Related Parties",
        "negatedLabel": "Amount due from a related party"
       }
      }
     },
     "localname": "IncreaseDecreaseDueFromOtherRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Increase (Decrease) in Accrued Taxes Payable",
        "verboseLabel": "Income tax payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income tax"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.",
        "label": "Advance to suppliers"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInNotesPayableCurrent": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes.",
        "label": "Increase (Decrease) in Notes Payable, Current",
        "verboseLabel": "Notes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInNotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayable": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Increase (Decrease) in Other Accounts Payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Other payables and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r72",
      "r75",
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Cash paid for interest expenses"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r37",
      "r360"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://nocera.company/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventories",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets",
      "http://nocera.company/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r33",
      "r165"
     ],
     "calculation": {
      "http://nocera.company/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessAndRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r37",
      "r165"
     ],
     "calculation": {
      "http://nocera.company/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of items which are partially completed at the time of measurement and unprocessed items that will go through the production process and become part of the final product. This element may be used when the reporting entity combines work in process and raw materials into an aggregate amount.",
        "label": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessAndRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r347",
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Total net lease costs"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/LeasesDetails-LeaseCosts"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Components of lease expenses"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOfLesseeDisclosureTextBlock": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.",
        "label": "LEASES"
       }
      }
     },
     "localname": "LeasesOfLesseeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r41",
      "r91",
      "r144",
      "r159",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r316",
      "r322",
      "r323",
      "r336",
      "r358",
      "r359"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r31",
      "r91",
      "r159",
      "r336",
      "r360",
      "r382",
      "r398"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDER EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r8",
      "r43",
      "r91",
      "r159",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r316",
      "r322",
      "r323",
      "r336",
      "r358",
      "r359",
      "r360"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansPayableToBankCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of current portion of long-term loans payable to bank due within one year or the operating cycle if longer.",
        "label": "Bank borrowing"
       }
      }
     },
     "localname": "LoansPayableToBankCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r47",
      "r91",
      "r159",
      "r195",
      "r200",
      "r201",
      "r202",
      "r206",
      "r207",
      "r336",
      "r381",
      "r397"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Non-controlling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r74",
      "r76",
      "r79"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r53",
      "r56",
      "r61",
      "r63",
      "r79",
      "r91",
      "r100",
      "r102",
      "r103",
      "r104",
      "r105",
      "r108",
      "r109",
      "r116",
      "r140",
      "r142",
      "r145",
      "r148",
      "r150",
      "r159",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r332",
      "r336",
      "r386",
      "r402"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net (loss) income attributable to the company"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r53",
      "r56",
      "r61",
      "r108",
      "r109",
      "r318",
      "r325"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Less: Net loss attributable to non-controlling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105",
      "r110",
      "r111",
      "r117",
      "r120",
      "r140",
      "r142",
      "r145",
      "r148",
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net (loss) income attributable to the Company"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/LossEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r97",
      "r98",
      "r99",
      "r234",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Other expense"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes payable"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTotalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r140",
      "r142",
      "r145",
      "r148",
      "r150"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "(Loss) Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r346",
      "r348"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating lease right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r345"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/LeasesDetails-LeaseCosts"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r3",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "PRINCIPAL ACTIVITIES AND ORGANIZATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PrincipalActivitiesAndOrganization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.",
        "label": "Other payables and accrued liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets",
      "http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Others"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r313",
      "r314",
      "r320"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Foreign currency translation Adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Foreign currency translation (loss) gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r54",
      "r57",
      "r313",
      "r314",
      "r320"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Total comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other current assets.",
        "label": "PREPAID EXPENSES AND OTHER ASSETS, NET"
       }
      }
     },
     "localname": "OtherCurrentAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PrepaidExpensesAndOtherAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsToAcquireOilAndGasPropertyAndEquipment": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to purchase long lived physical asset for use in the normal oil and gas operations and to purchase mineral interests in oil and gas properties not intended for resale.",
        "label": "Payments to Acquire Oil and Gas Property and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquireOilAndGasPropertyAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r22",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r22",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical",
      "http://nocera.company/role/PreferredStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockTextBlock": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.",
        "label": "PREFERRED STOCK"
       }
      }
     },
     "localname": "PreferredStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r22",
      "r360"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock ($0.001 par value; authorized 10,000,000 shares; Series A Preferred Stock, 2,000,000 authorized, 80,000 shares issued and outstanding as of March 31, 2022 and December 31, 2021)"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.",
        "label": "Others"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other assets, net",
        "verboseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets",
      "http://nocera.company/role/PrepaidExpensesAndOtherAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations",
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyAccrualClassifiedCurrent": {
     "auth_ref": [
      "r42",
      "r188",
      "r189"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Product Warranty Accrual, Current",
        "periodEndLabel": "Balance at the end of period",
        "periodStartLabel": "Balance at the beginning of period"
       }
      }
     },
     "localname": "ProductWarrantyAccrualClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/WarrantDetails-WarrantLiability"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPeriodIncreaseDecrease": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the standard and extended product warranty liability.",
        "label": "Fair value change of warrants included in earnings"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/WarrantDetails-WarrantLiability"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.",
        "label": "Warrants issued to investors"
       }
      }
     },
     "localname": "ProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/WarrantDetails-WarrantLiability"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r2",
      "r53",
      "r56",
      "r61",
      "r73",
      "r91",
      "r100",
      "r108",
      "r109",
      "r140",
      "r142",
      "r145",
      "r148",
      "r150",
      "r159",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r313",
      "r317",
      "r319",
      "r325",
      "r326",
      "r332",
      "r336",
      "r389"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net (loss) income",
        "totalLabel": "Net (loss) income",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows",
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r187",
      "r416",
      "r417",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "PROPERTY AND EQUIPMENT, NET"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PropertyAndEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r12",
      "r184"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r186",
      "r360",
      "r390",
      "r399"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets",
      "http://nocera.company/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PropertyAndEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r239",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties",
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r239",
      "r352",
      "r355",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties",
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r350",
      "r351",
      "r353",
      "r356",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "RELATED PARTY BALANCES AND TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/RelatedPartyBalancesAndTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfBankDebt": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to settle a bank borrowing during the year.",
        "label": "Repayments of Bank Debt",
        "negatedLabel": "Bank borrowing"
       }
      }
     },
     "localname": "RepaymentsOfBankDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r27",
      "r234",
      "r360",
      "r396",
      "r411",
      "r413"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "(Accumulated losses) Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r97",
      "r98",
      "r99",
      "r101",
      "r107",
      "r109",
      "r160",
      "r275",
      "r276",
      "r277",
      "r298",
      "r299",
      "r330",
      "r408",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r137",
      "r138",
      "r141",
      "r146",
      "r147",
      "r151",
      "r152",
      "r153",
      "r236",
      "r237",
      "r363"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r87",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of stock, price"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PreferredStockDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "VAT payable"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r134",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of accounts receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/AccountsReceivableNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of payables"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/OtherPayablesAndAccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Income tax components"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of deferred income taxes"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of earnings (loss) per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/LossIncomePerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Reconciliation of income tax expense"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r179",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r10",
      "r34",
      "r35",
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock": {
     "auth_ref": [
      "r82",
      "r83",
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of acquisition of assets or a business through noncash (or part noncash) transactions. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Disclosure may include the equity interest acquired, value of assets acquired, value of liabilities acquired, net monetary assets acquired, number of shares, warrants or options issued as consideration for a business or asset acquired and other information necessary to a fair presentation.",
        "label": "Schedule of warrant activity"
       }
      }
     },
     "localname": "ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/WarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations",
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Warranty Liability"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/WarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "Schedule of related party transactions"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/RelatedPartyBalancesAndTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r240",
      "r241",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative",
      "http://nocera.company/role/WarrantDetails-AssumptionsUsed",
      "http://nocera.company/role/WarrantDetails-WarrantActivity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule Assumption used"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/WarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Assumptions used"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r89",
      "r128",
      "r129",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r220",
      "r225",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PreferredStockDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r132",
      "r134",
      "r135",
      "r136",
      "r333",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentrations of credit risk"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [
      "r21",
      "r22",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A preferred stock.",
        "label": "Series A Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical",
      "http://nocera.company/role/PreferredStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Warrants Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/WarrantDetails-WarrantActivity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/WarrantDetails-AssumptionsUsed"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Expected volatility",
        "verboseLabel": "Volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetails-Assumptions",
      "http://nocera.company/role/WarrantDetails-AssumptionsUsed"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Risk free rate",
        "verboseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetails-Assumptions",
      "http://nocera.company/role/WarrantDetails-AssumptionsUsed"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative",
      "http://nocera.company/role/WarrantDetails-AssumptionsUsed",
      "http://nocera.company/role/WarrantDetails-WarrantActivity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.",
        "label": "Warrants expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/WarrantDetails-WarrantActivity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative",
      "http://nocera.company/role/WarrantDetails-AssumptionsUsed",
      "http://nocera.company/role/WarrantDetails-WarrantActivity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Market price per share (USD/share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/WarrantDetails-AssumptionsUsed"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Expected term/ Contractual life (years)",
        "verboseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetails-Assumptions",
      "http://nocera.company/role/WarrantDetails-AssumptionsUsed"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/WarrantDetails-WarrantActivity"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Share price"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PreferredStockDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r86",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICY"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SummaryOfSignificantAccountingPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r89",
      "r91",
      "r113",
      "r114",
      "r115",
      "r118",
      "r120",
      "r128",
      "r129",
      "r130",
      "r159",
      "r195",
      "r200",
      "r201",
      "r202",
      "r206",
      "r207",
      "r211",
      "r212",
      "r216",
      "r220",
      "r227",
      "r336",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical",
      "http://nocera.company/role/PreferredStockDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r45",
      "r59",
      "r60",
      "r61",
      "r97",
      "r98",
      "r99",
      "r101",
      "r107",
      "r109",
      "r127",
      "r160",
      "r227",
      "r234",
      "r275",
      "r276",
      "r277",
      "r298",
      "r299",
      "r330",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r349",
      "r408",
      "r409",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/GoodwillDetails",
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical",
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r97",
      "r98",
      "r99",
      "r127",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/GoodwillDetails",
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheetsParenthetical",
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Issued for services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/Share-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Common stock issuance, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Consultancy services settled by equities"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r22",
      "r23",
      "r234",
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Share-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r23",
      "r29",
      "r30",
      "r91",
      "r157",
      "r159",
      "r336",
      "r360"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "TOTAL NOCERA, INC.\u2019S STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r60",
      "r91",
      "r97",
      "r98",
      "r99",
      "r101",
      "r107",
      "r159",
      "r160",
      "r234",
      "r275",
      "r276",
      "r277",
      "r298",
      "r299",
      "r311",
      "r312",
      "r324",
      "r330",
      "r336",
      "r338",
      "r339",
      "r343",
      "r349",
      "r409",
      "r410"
     ],
     "calculation": {
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "TOTAL STOCKHOLDER EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedBalanceSheets",
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r90",
      "r212",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r226",
      "r234",
      "r235",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "COMMON STOCK"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/CommonStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r361",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "SUBSEQUENT EVENT"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Movement in valuation allowance"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosures of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r289"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Additions to valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/TaxationDetails-ValuationAllowance"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/WarrantDetails-WarrantActivity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r112",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "- Diluted",
        "verboseLabel": "Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://nocera.company/role/LossEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of common shares outstanding",
        "verboseLabel": "Weighted-average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://nocera.company/role/LossEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r110",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "- Basic",
        "verboseLabel": "Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nocera.company/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://nocera.company/role/LossEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "310",
   "URI": "https://asc.fasb.org/topic&trid=2196771"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "326",
   "URI": "https://asc.fasb.org/topic&trid=82887179"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907644&loc=d3e11281-110244"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12524-110249"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1),(c)(5)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "https://asc.fasb.org/topic&trid=2155896"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "840",
   "URI": "https://asc.fasb.org/topic&trid=2208923"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3),(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916"
  },
  "r419": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r421": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r422": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r423": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r424": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r425": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r426": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r427": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r428": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r429": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r431": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r432": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r433": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r434": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r435": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r436": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r437": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r438": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r439": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>93
<FILENAME>0001683168-22-005051-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-22-005051-xbrl.zip
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MG2^VW^ID"W)CKC/\]?;_#%'&+]^M&'T_U]=&3;/-=LE$&!"RQ"3)+%"F9Q2
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MC+))6CR>UN#CT.;H]-B-)Q5"FN(Q=V#,3H4/[$QVWHL,NIO5;L,824YD&=Q
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M>; L7@</?W;%]8-2?0T%T*Z%3?O0+)&T(,-OE]L-*O=CEYRO^1U8_#3+)+F
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MP'PRZY*W5<<[STSD^<<:B X67.B=C,.,CD0ZG4DM.Y"-U%0+CQ$N.4W=J$T
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M6.:<->L/="VT*S'O"$+9M/FX7.CN8GGX%)*SKQKSRVD@5<BA L,0XWQMBM7
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M</:_ T(9^P]02P<(<.(U9AXH   G*P  4$L#!!0 " @( )N)]%0
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M7S P,RYJ<&>55V585%O4/C,P#,T,'8)T*@T2THUT"1)*@X"T$B(EB/0 TC&
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M<VIWGQ06.A(B*IK?:!2Z3X$( @1>O<))8!M*BY7V.-Y3,S04N.2#[I@S"NP
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M!IK,:,*Z#DPJ5+44;IYA/9CT66F(S&<+ZTPK5#;>FTBNQ6 L$!&V)>JTMD&
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M[/L.875_*6$EDWX3HKWAF3P.F:T#/(9'3.".E-+5UJ[,9MDJ_[>%J=I>.]?
MPDL<A2^:*_*'4DF()JR+L:L)8]E2C;K;<P$SGV;^EF.JXO=4-+L^YLY4'YL
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M2(_*-A;Q=*I6G\YV88VGI&J(6.<6QX:VG05!(5Q/2/MG</W5 $)@\^XK_/B
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M+?=,\Z'>=GP U@]\CLVOU,(;XILC$?YBIKU^"%G5*!7X3?-,1CY2FBN*;V!
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MVF1BIO"&R%T[2IIR?QSEQ#U3Y3[H9=5; X>YEQ (GM>-5C]WO%"RM(8(UYR
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M4F*=9,27IK,!XH+(K5<SB(:%QA:.8K;.3UY<4-82=F_5)P=@Y,;(6[\'4#L
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MY"WFN>WHV$(G>E ]4]1![FK$3/3G3JMJ\0+A=A3_9 &R>UU*[SQYLM,OPS#
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M(YN]6UP.DJV@;QD=KGJ ;6&#]I%UW8+C:!WCM"6N,:M7S\2&=5-*ZQW\YB%
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MZXR 2+^FI7;J=XF?X>Q1Y-[2D_"K$HYW5S0E'P0(UTSMU\S"_+F1YJMIO)U
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M+FA6R3O+5(;:-"N%0@.UOVU&JV1=MD-92\%R2'&A95O+5YOP9H/RNYB#.0O
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MR/5&LZN#LL([/U%4A>=+WP"4XMVD-PX^SLG0F$ZO# ://' ZUKL!-#D,RKY
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M[FSLT)BG+6DY:LR/EKQV78BK;2^Z$N%;WR\F0@IG%Z;GG_^967CW]\__'F1
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M,2B3Q3ZRA,RZ/)5@4MG@B YNFD-3M\"F(S2'6%:(NX!,ZEZ2H=PIVB;T+,@
M?O'D]7<K*[31FKSA+^\5=^\T2!!)%^L#:6X 2ZG-U.[XOA^68B@7S>ST PP^
M"5D$V EP#[*_2ZU7F-Y-\=I+/C(ETF_(B=WU,0T#@J_;S"KYVUVI=U&HE,;X
M%]85D,?OPB@%DY']91+1(-U%ED\RV0(9>/1&VV\0*!@[>"GKEGW!.X#!G@MX
M56C?,0GXT70?86K5F9ZGIF0*!9J43D(MCJ].FH4<KYY/Y:G9GY ]IKSK83,J
MH@JIZ$63439!Q)6<1Z&JVIJU#M6:^3?+LG?^_ \_63")SRM]#C^U-^YRT5J8
MD)-)5W/81]J[\G 3I7"0U=ZIDV$Z9G2-3NCUX>ER?ITCGVTYT!ZKOO$[7PI/
MBG8$;YMG\W%F_+\_"ER=Q]GF%UJ,2((T19<C',^0 .( ^PI'6F O?V^B88L[
M7AN-F)Q6_ULF;+K"RBA$#8BI5.8ASEC=*("]]LRYU6"&*R\-B9&#,Y++L^UV
M*"=*N^:[8I61YS/?PRI>C_\8O6+6NQ3O&7STW>@C?H=E3,IP$Y/?&(S(CW<;
M@]56PMB<PD)SJH]2VA8XJGTH5;7KR;T"*HM(.'K8L=CET%9Y;UWGD7+<NR4G
M8LB9BB-YUP)3^?C'Q?2*Q9F2(D87QD_$%-0/@DE '(%O1!,\<##X$5&9KW3#
M<7?&$_:O^GT2S-P=!X0F@HMM!]%I#T<_A+/%;M:M9AN,3ODKS%6_G..+EC?(
M#P5D4%!L9(_ [ YBY.^%\_AQX)A&<6\S3_L+(=RZ1G;A1T>^T>?C^I%N=2YO
M((P;BD9UW''*0^E@!!",\+():OX8,[W3X;GQ8@SG],\$/8=SJ@X6^7%MQ#+Q
M_-S<(?=ES:974.I[RWO2\+?A*GE1UJ'[>L;%O-V@"41DMF 2I7C-#2!])O+W
M3OASP*J@)-S^3GLU4%.UMM&.IXBO59'VK?#_^6.&7_C_T_B,_RLVYO(UE RK
M*5;%+H%-RFLO4+P!"!M),Q^]]5,X=Q1L'[A2\LCL<OG,[S\!=@3>M3\C=T+#
ME^1+W9TXC;+'<>^@R>KUEE2QA,F;[,T"WY1<1+Y1;8=HD1><6_H,K)V4+-)C
M!]OD\8?6,4)1..W\S0O?WT0KE]H-*@\BZ<E$]Q68./$&.;\L-%F/RYI=JD$N
M"$.Z8"P,+R)?U9;@"',>_8R5.F?WR7;F19YE":=IL(FDY.(XL3X6*_08Z#4[
M<W!E.['QY&.K,:'R2(L]!D'.#(NJW<]R?'(Y=0\.S^0D.\RJRA*+E4Z;[_BQ
M;3<)Q.ZUS^SHA[OULX4Q:9^&)?3QQ79#'B2]4?[[-%JHXP*.- L747? W%\9
MNS!-<2<K20.B91WS"_9[)^NC9K]!%N_/!K.]M0RO*_ZRD/<&\5CK1T?O$^BC
M)6I""#.O=IL\4T6Y0QZEES,%:* >=KXE%B+T)#7.I$^$,TZ5<V*E@$*8CQ6-
MX&CU4_:6 R1Y>B5UJM+81S[<R%5EYI'JO,.Y,9(7,Y$9Z1K^_4GP# \-IU7%
M2&Y,J5(@5TY,Z5MJC48MY=1#/K'+,6R+WI+V'<L=C=<VR5'4_1IL=E\>IC*O
M^DGBG- :+4 \==0@R^"#F $#@9*],2;X8\9[Y4JD^)S\]SJ"=/7,%0C&!\/-
M:&6!:,]6_3193%=>U:G>YPJ2,Z$45X[G;8R)H8L@0BGCH\@X *>?+<X3>XYJ
MGK%9(8>T=U9X2>A=HH:.;9O'[89$" KD3)7:?GQ#>>'CZ>HR_+@?%D4R_<E$
MRE7%LY,ZDEWN*J/!2S)&ULLES3+]46)0\T4*HZA:6Q+@-U./BRB2^TL0\\+=
MH0C1J!"$ZS7],$5D,W<^>K(4PM#.I?<Z/]\>O<:KIO]Q!U&I_ Y]UFXF]O'^
M*,*7&-W75A_IN)8VW@:51(=RR79NX<2/]=MN ,26RJ%'HP@U_":LV;*NF1"/
M=_@%]2VE)W!@)'$^+F-9AG\=(^D.&47X5/OCGI9W_0PO[J:J:+T0[8K%F,8N
MS\LJ%7GH40=5.C,7T%Q.NN>\XRN*0BB8C.ZI+7US,"71\2@Z+?\&(-?7-'@\
MPL.]=Z^MX=/\"PI6[6_O/U=.@,7%0,4:-?()E6%GQ"/?_PC\O^>R,EI:T!D'
MY!.5:%M&>'5GD-A^B(W4#&@0I\4SSN;63,^EL[ ]+EIUE,H@^70_=:5P@"P2
M3]_&XDSD0.?3_+-N,;Q??D5WD]=."B?$/C)OBJO.VM%U0^)VE5E<%5A#PD_H
M=,V9&]*1WMLO2U[H.Z/D5(J$YTVY,4!#2_V.]%+ 9R -5 ?PS>D$'B5/;# #
ML6@WK&[_^:FA!RJR\DNMU]*.*5EJ8;FL](L D2JBMLI/E B'WT4\M'@?]WR;
M\X[&1),U!ADQN7S6080-17K\</]8M< 9XDH?11,6OD>G65WI\\O$3VOX]\=X
M,M#)^^VN1$</;Z:QB 0WF?-#EGC=]0\[;T+>EH\++(]5UD]]$MP'O1/<Y_CV
M5.6KI>COI0"J9ZS,'VOE+O4K7>ELEJP+YYAK>2S.BGYU']-2#-;*^2'2W5/=
M2ODS-_F?;E[H_.:]0ZR]D.._NI[=2K"24UV(_^J-[$I5B8O#O9:E0",)@@VF
M?_^+H)E>>X83-C-_/LYF".KB7#'<K8MD.'YG%#7+]HZ#S:=\^Z+O<3:M#Z6^
M04>D <LZ]UOE\![N9Y7UB-X [&+8>Y9BOGH'E?W@?UQ:IC1C&C<\+R!$^R>;
M*)4>=29R'N^XO: W?"1<!EJR^H+I0M@M^5!*:CD^[$5>\;$Q/V,-YJ@'5;UC
M^M&S( F4A%C=_:U5MMG>UN")B3'%3J/@V#?N$5Z"%J]@H%<CT]7D)*YQ3VH*
M8P=&005X50]Q;6+B6V85^AU)UVPXC>&3RR2&79?NB:?QJD_X<AMFGT$_D4AT
M?ZNU)K8'+44AY5_OC,+#8R3;*I^"F)12]GTF0_W $-!2=83C)UE^M,1UV\;N
MF83A?@I[.%V:ZZEGL"IG(+_$^-+3^H+[\BHSSD?IG:7*J,6.6_D:8H1>;-U1
MOX-\.Y8Y5FH1\_;WD8W5H67LLVA/7LXX@4C/1(*>(V&9\CT@0C+4#V@/9A1S
M799SF=@Q]E$5@"I2-J%6.]FW.$1?Q?": /\^H_D 8LF5XB#K_%T9VZ6P8_H=
M*/O7Q=@X-SA./9^M3L;L4#9R]$&?*X[3%O5PSN+1([BN6_K*($<%U@J#[/2V
M7X"D=ZHO^Q1+Q,W,]#?43T#4NF;# AR_D'8!?*<C]W7;XNL+(/I:9D3P /=!
M)ONZW)BI$=+2 V:P@+^_:(8.1:C&WXP*T<_XGRF]H<EB<?FWQ!^DA^Z(SMG=
MVS(^S[]K/=UQ7B[^N.Y1EJ'!.R'*U7-"258V&<EL)[V3IF;8BTZHQG+?@QRV
M>Q"KAFJ68''^)"%.*TZV4L[=PZ<!4A0=5%,]9<2=$EJ5SJU'7AX8K\](G$@>
M1)<MA/L+4GS_&H2&?J6G2;LJ'I357#I70JU>)Z[,-PY"T,UW[7(JV-(0Q&V+
MX?*/L328>XLKD@$+8(11&UK="7Q17.QI.Z,"#- UZ IQB>K5-; A-*K% (-2
MZ:\6X>A)4CC6-UOP$(:J1'$SF1!M;");A:(6R+&8I1J<Q=+6]#NCWC&QRZ@L
M!Z;?I-$*I&PD[UL2K1Y\X9@T>] [N3;8!H]8D,7BHZ1P#DN>4;D:<=N]'A\H
M=Z5[@E][K/ZI?L2RSD0XWOQ2G@CJB9;<(UPR@%HM%?\579'34$\*2?\@+VK^
M#<8%Y(\4C:/T,8"^=E :=',9R^\KG[%TZU?6<M^TE_?1UV13ZCOCK45JO_FQ
MK^VUI_S,G;)](JI](MK7=F,B]@4G*O4L9T[.;H#JB?K&1,!+<Y&)I!KOT8'M
M#P/>0\+=)P5'\<E>\]&5[1-?$D_4A=0G*L\K?UF\"=B?6);0</R7/(EA./$+
M@0_SAAAUD"'PRTF]K\^R7WD)1.V5!^%'J&21JE-^M^2]%U.6,]+2TA;TJ+3:
M5K9W@_:1D:Q:?^9(Q.!AMZ]O4'9J)P;4WL03Y2G>V!S:(.7XB?54V]7F85?@
M>--?Y!#9U##8X0809JB>$ =]?97BQ/S2'!\+[-";2; "]'@PF/<^VRWX<__<
M1NJX('STC>9T\\Z80#U;8_Y>_:6TLAWE8"34RG49+#TN@A)DWW@590F2D=T)
MG6#@<.<%X>W<X@R< :O?E2PKSX'V#!.[,FQ;DYQ=M/L1YDQ1G/I)_[EN\+-5
M]O&CW5"V=YQO=6LXCL5['<P(Y.\[)/=BXPZ6KU/8"TI*ZA"10.L&0F^_:[8_
MSK/KQ:<(^E-8R'E\KR^4RD=KLD>2G0[C7J*)7 9'-]\]]H@Z$XM8V3J8OHHY
M#9DADMXEM#? CI[^0I\F3UQH[.&Q%W\>O&[N;+I?64/6].6C'_(\SGO<Y].F
MM$9! 3S%#3P#.BT>7C##JN"DEZAIA%0(4R=GG@ ]!(24EXA1AN77TW[@42&_
MP16-Z0B#FB!]0==EV+TI$UY9-.'LC,C>&#62M=F1&EPC;>FS1X>J\)MIIJKL
MHZO' /VASOGENESSLD\>'94IOSBE3[5TD[T2E2[:N83Y#3ASIQ3VH8SHKD\V
MVBG=B3=.1?D:$?(K:S\L9@K@_$-@Q_1IUXYGIHLKXZ7)%19_)TH^N9V8G46-
M:0;AG V_-R-^[);[BE257^4V ?L?IHI]QO9V_O2[8^@WDK(=,")W)WSM/78#
MK;5-5%>%;5VV>ZA$-J*\0FY>A)0B"-G^# .I^,G@J$U94-Q!RE=_)19Q)KQJ
M<AWN;OJ<?O(X,K-&3'X;#*MI!,.XA9Q^P5(T^DE@E6\ 9*_,KJ6U^]F7W,?T
M@3< 2F+T?:D;0-#\,A#'*PC#KMG,^TT __1'(:>%8'9F@!>/]YITFD3*]0;S
M*&JST^3:M8=XX" ,]=[HI0#$PZEB#O?6H6M.UTAQZ !!Z)1MV,H!FF-E[@=6
MG^U>B?51WHKH3Y*^TR"L0TD6T'?$L ")>C6CO=^$.>PKWQO3#]D!5E,''Y\!
MIX$$LK[%2OV'_39.>1TD)[.N/O<I+NB(Q\B0-5?5#<XP</SRX'2Z=M [TON0
M^(Y3CR+JS$NAF9^6WOA7=CZ&OK=B8,UFF%:_S_M@3_%2S\&3!RJ9B25N_YS0
M$0&IKOL;OI 9^"X0"V?']G1.-('\1OVX L3'FFT=^A^UQ7Y.HT6O135H7<8@
MD.X/@3F)\C-R]X&\)SL2"^/:[S!4(<M]I BSNSL2W^FK,#]JZAIJ#;+#B/6L
MS0'LZTWB*<\Q7(6V5==\V&I4_[O???QSD(%3PB0-78AC3C@]>R<_OR*6&QWS
MO,E$K7VY*^:TP[S/5RY<_3-C:OQZ-_EU96-EG5"'-'0PQPGV26,Z3,\,J]3T
MB#LLF7X*U5KGV_6[:*I;+VY &O3Z]'$O-9RH5L[A=!YC79IWOD@!LQ$T5)T.
MGL"D(1SSGNO< .Y>2M?_ -4UV/KN! 7SH"*56>V+&O@*6NC$+&8;E2L++FX
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M-:B#E+V(JK/KRI;J$*FOZO$K%/G+?,-Z]I*-FF>+3QW?43BA^#-FRP\WSP3
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MB&Z.;$GNK>X4^U>NC6!7Q_?S4L_=CQEZ&UBLFH55?T\:Y1:8"2[)EH,4J*Y
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MIJ2[K<>FUOTQ_#9'3L!G7MND<X(6>K1=>WQ4)EL,>$S'[_.:O#C_5_NZ')K
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MYT47<O[^>5(4N98[T4IT;5%GPC_JS0T1B[AU%K!VS$6)*D&!PB,1SR#&90-
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M@N>C]<FWJ@$SZ^RR-: +V!/_/PG)01\$LQE/)_\'4$L'"/TUP<[5Y   L^\
M %!+ P04  @(" ";B?14                #0   &EM86=E7S Q-2YJ<&?4
MO'5<55N[-CR11D %Z900!&GI$I562KHEI;N%10A(=W>#E'2[I+M34NE&NM?Z
M%NZ]SQ&?=[OW?L[SO;_S+G[SC['F6&-<=X[K'F-.H!/0+\!M"1%Q$0 .#@[0
MAOT!T"G@*8""A(2,A(B"C(R,BHJ"AGX7 _WF370"+.Q;=TD(R4A)"(F)R:D8
M:<@I'E(2$]-R/GC(S/+HT2,R&FY^+E8^1K9'K%>#P*&BHJ+?1,?'P,!GO4=\
MC_4??Z"?@#LH-^S@UN#A*( ;=^#@[\!!6P R (!#A/O^ 7[_P-V 1T!$0D9!
M1;L)ZU!Q&[@!!P]_ P$>$1$! 7;7%78?0+B#B'6/10@)6_85,H7575:/L#04
MRB<EC3AR@]^HV'2L/5'1</'P"0BI[]/0/J![Q,[!R<7-\_29L(BHF+C$2WD%
M125E%55=/7T#P]=&QC:V=O8.CD[.7F^]?7S?^?F'1T1&1<?$QL6G9V1F9>?D
MYKTO+2NOJ*RJKJEM:FYI;6OOZ.P:&AX9'1N?^#SY=7YA<6EY975M?7=O_^#P
MZ/CD].Q*+C@ 'NZ/S_]1KCLPN6X@(, C(%_)!7?#X:K#'03$>RQ(6$*RR*^L
ML"E8/5#N/@E+*VE$I623^X:C8SV(ADOUZ"OU[I5HWR7[>X)Y_EN2_9=@_RW7
M)( .#P<S'OP=0!"8W<UIV0(]WK6#Q!A$&\S>\$ /PYI.+^GLSV/W@ (W$UK)
M]ONEH0"8 0JT*FJU0(%3VEKP^2 46,TL$FE >>GE;\]'5^W_/C,\8B;9^^=?
MR/[\A5+RH,)FVD1(P1C$P!GO@M'B+JB?7Q!R404%<$2O-S5=A$F[2+PVV,%Q
M?V]@T5)?[;->BV7#-%#3\J[HQ?XP%-CI!NW*7V\JK)3+PB (E*F=QJUJ?:NI
MAXW%=P %SO?F+A3(?FH[;=UUH;6_]3^%J^A3N*O;8H\]E2FI]RSZ0X_#$^F>
M57PH@/<\?F]R8I?LPO4S:$)@' H(,]!(X$UDO<OONERV^QO@+B-YL0_CYWKZ
MGT ![][YD-.5'"@P%PT%YG-__B(_H'[0[@4/RDK#<-%66LPVWT ITAG6@QAG
MQ;17Z&P:$]-3K5P]T@^?I[674,9K]J7H"5IHG<9-08%?*K-5PX@P*LQ=P^A8
MAL@C]EEHZ6G*]J+-"_#0(0;CLQ=/VN9'I\T5DBF\?7,[,CX/;WI-C4,,[*'
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M2&VB9'$P:/3KJ6?2^=?N4Q^%-_= 1=XP!A2V?F8]0*@7KRO3<8M$93TT&EW
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M6BQ%.0DP4OW!&T(,I]"%X5I6CL$:^%+7%*2=.6U&JECURI:L#33D99O]38%
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M[,,7_1I'L*!<P@-[[?6@+@&L\TX_=5*5ZCY"!/;Q!>"J^LA)_><AB>Q$=?(
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MGNUF "I^]F>+<;58PS$B-+[]/"R9!OE/VO;I(W0J&U3TZ2\ %<R,I.W;IR4
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M,D,?LPMJ.S<RIC<"Z7^DT-UXPM16CR&&\%&(4)M>;):O@E]F<ZR8PW)B5,B
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ME05F^'$36Y)X%$H02+1#)?H,E?6_R'.;3PQH+X:ZW4)XMYS R_0CX3D6W07
M8T_QK5JA-T3/ *.+,T71%V_:]X$5G%<]2>Q79$+O7?PDYW3!%&DMY/9[1J,!
M^<TYT##&NHLQX?*2*PV^='?%_0F&%V)%*@R2M%C4)@M+[:*?D;GD1M$_^\#N
M6O-H57P"1TVQ@:MR(SWX+$*#&O<E*/19!*5J]$I*8&FX9B77BR%Y88#]&/[]
M/)1,R8278GL/Z;_2^^:>7P!,=A"E([E%-YI0F5R;Y>X7;Q:>A4;')U4P@515
ME,;:>6MU"$P2!>"E+.QU'RUO!QA^30MJ)-SBD1?)$YG*(/?U0$@EO;QHT'*O
M6K832 ^8;B4;'.N-Z/2S@@,PNO%L@Q0O[U9<03#,Y%/!L9%4>&![*^[(Y"_$
M3M K2(_HP.N9X'4*%PF,!)9@MQ-X H,FL>6AB/6U@A,Z=I+[37T3@[2+VNCO
M5(^G;N=*KE#8;Z1\/O21R[,WI<.02.J;<0VE$MY12T9ASN9$,'RP" ANE'1*
M6E$)7L4)<^!=8:LM]F_CMH]C;B!KSRA:'#WH)J?:(ARR%P:8KR:N<A7&Q V-
MTEU>Q_+?U".E(%):C9-GY[Y,. <8,K.Y;ZX71@=X9K$N&T-P%]$C=>\S'50$
M*;F)PF+#9(.-I6= ^M;V!0,%U24Q1#$&;F-ER5N!P:!G]AX08ML4?7RP]_(0
MQK)E!]V>HQ<$.^A^6%L(+CP_HSHX"&JOR7 C=GIT5;=/18*4KSMM4II]Z.G[
M.64WXLJ#;*+\+B:57+MNZ1*WD?7U["S*:'Q96$93:V$+]T@$@#:A93 H<+R6
MKGXT,5W/[_D$SVD+ 6?+>A1)6TB6IR/_:O=I%S0_FF'_,O^(EG3D"3U!.WNQ
MV]YGYDR#^]IRLN^U <C:&SQ[66$2?7H%@Z="5!\"529X)-$>9S[15%I'X!4M
M,HJ+#Z_.'IA_54%)!][%03@A02\Q'1\6 ]>N/6V .<0/D]T\626F.9$<*?5O
M0F*@9G>;CV?F+J5'K2/ ?7:ZFA3OPK.Q6N_P_KRO?[W@^?8&?9P??45+'670
MQPY])!-8S59<P%Q4D$"&WW1DJU:H8IYP:<40]HHM;5(0XN0#R]@GZ@C\3 =9
M,V[,C XR:/(=F>O6\-5]5F\-,&U[V\U3Q]3P9$\/;M=2' &Y;;G.UH@9$;!X
MD]^F\N"_4GQ#4B(!,L(;7%:P\QW"P8 3>6$[-8>'2+&8+<4R/F+@\":R>@T;
MNZA*L_WH3KH)WR'AES*Z)$\G$_L+P#[5^RRK542=MR@&<-/NB?KU'@_G:T@,
MFM8S+40)Y9H3)M5%,ISBQI-C31-\$-?[[%XOZ%$3!L3JUPA.QO:5IYG$N>EK
MAFH#J5[FTA#BD&(([$W=E>LM*7KT?F8+\PV<746BTXM[ST30Y[+6Z)W?ONEP
MSB^'E"Z]9DH?&W^Z,ZS*5E%6F-2+$_18+?".IRZBS1Z,ZRC6,E;D63[!:F=B
MO9$Y:V!3GC3S.GH= ;>0CBO%.K\5R6OYZDKGU>,>+J6YC0K>U-%5^<G&9*?D
M+CI5=;H(+ACJ2#/W 0SXJ2/.5WIXNV Z)-%J28X&V<J4?>T(OXZ\T51K2IBF
M.*9A,032Q<DAL'6(HFR5CT0_??:BHCXXWB"*M!U+!MCDN"6WWJ[+9K/AS]PL
M.$!/(N)>H)F"PMX&LD_2\\V<3QC&8@\27UQLA^HQCP@6Z<DF-D5BVPB>2_ZD
MPU8Q(T_P4C(W5=/C$8+1B[V]1IN<I\786QTN[H%"OGNU>&G4T5^S]ZJ/@@I5
MG$'$>J;3?KHU2JV4A5MNG/1TOMATK[KO&'P*\[(H5T8D)/1%JX_;+/;H"LR8
ME-KWSR4P4C).*M&VMTFTTZ&4AB6$&=[OM Z1D!^8ZOOLH3PHHFQ"7JSF<K=T
M^$&7V.S]H!Y3^=CBP@&K[CM&&,Y:E=/5T3K%E0H!KUZ0I0)A&%]@NKV1<3@>
MA'U#M 4?QZ"^W36M6])[O\#2;!-VIQ7N.39+G74MS_')L8XPW ".NEX@,W!>
M3,LIA5O)&F%,KBB4:*]Z[TS??#UA4D.5KK</ H 0%E6I@HGGPW/J-ALLW2RC
MG*BY)<F?YPZPAN7GEOIKY(-J4WG\D$!Y9'?,=TQ1$S\P,CHULXWU2JZ>.5P
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MB'AO^7FDIJW6C"06/5_W@HJJ"3S-.P12)@3RP $YE5<<68O0D-?G]X:LJZF
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M) V6WV)6'SN,:H?_1&&+71Q:]:1G&$@1+%QJ6QS%]UP&";JJF=?H2IFE70!
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M\O]YD5S/_@]02P<(R<_RWK*P  "J[@  4$L#!!0 " @( )N)]%0
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ME9Y?QA#']L!S@(%=0'9.$/\[M3\S^Y\E%O[_E=G_2NQ_YS4.,-%0@9-'<PZ
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M,TS@_"771 IN(Q/(/ON;P9IN%  JA6B$93[]8N-/ 2I_2;7L@7U9_^L]V+;
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M0<KL^1#S95A*4>,C,A;Y?2Q=ZT$$;'+6!8J#>VC?D?TS8._^IY#]"NPW7),
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M/Y? H2"Q5@$"(%/.O/N^@:PC='?O^LN]UF0FS$')J[USN9,;I #JU#J6U:8
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MD=5I_^V11W;=H#U6[BU3V6">PF(2]_=ALU4-\!L.ERS:$O0)0ZU,_DKFE.C
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M70($\/ T$@+@"X0 W(@/TB& ]RZ2$$"2" 10'WH^\.##QNF^B4K%8)?K5)G
M!1F,\==6H3?I&B#[E[-=%K0LN!D?]&QSI:7W\E3*"_=/5D9[RZI%R$]SL1U'
MXYC"F5GZ,U[%L@?2%8L0H)6&/2:\FZ1.N*OO88$RB)/J)DT'%@;&X2JQM(9D
M;\TA ,>U[$L5H>_O-QJP!Z:F=R(*XH2_VGZY1D5HU<M_B[9#>^OVY/:2?TD
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MHZSF_[-BK]6:6CAEBQA1E)4G9R-VA9P6>5%36#Y'5>+MM9U$PE!?QWXN\SA
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MMGH0BHED0U%&Z@4S6EZP4%)?YK_,PSE");A&BEX <X _._9P@<[MPDI$32R
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M@G^&%=3,G^N%*7^4A*771&D#>"L[H]Q"UCHFI/Z[ZZ-*OO^^V$#+<\!H[PI
M<@6X_Y>LP-W\]_B?U_^ _3W[WU^*.2/_*;;\1:3#%4 HL?_<Z<<7!RX[:ZX
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MXZ-]"LQJ7*U2X9>8;N([*J^P4EX-D^TD2#TJL8,7,*A*,.G.-TPT?>@8=G(
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M9;)/%D/TSQ;56S@^CN&N.\9F/\>JB5,[BR&1YIA>@VYT+W)W+7&%=A(CD(@
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MB8$+S-U)5O>%XP%$$1'#FPVYLJY+0\<EI^?-?ESV_2<G5X .M&,YA"R<N"O
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M9N3S7:O-*J:G$]X]735L&E5;I$S7+,W7SR?)\3>,%EM&"!NDJ?D3LC#$:J,
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M56J=&F%QFU*D%[[,VT!%YCPLRY HYH+@A_^'2^)V[C\ 4$L'"!Q+,;L"I0
M"<\  %!+ P04  @(" ";B?14                #0   &EM86=E7S R-"YJ
M<&?M>G=4%4N7;Y,SB&0D29!P ,D9#D% 0,E!L@HB&4F2/2""2A00% 0..8B
M) E*D)QS!LDYYWC":Z_>[[MW9KXU,^^?-^^MUZQ:5%=55]7>M??^_7;W08^C
MYX KZBIJ*@ &!@9P'_P#T%. $H"/BXN'BX./AX='0(!/2$Q)0DQ$1$QWE8*,
MDI&>F8F1GH&!A9V?DX65EXV!@4N<FU= 4$1$A)E34E9"2(9?6$3HYR08! 0$
MQ$3$M"0DM$+7&:X+_;<O= - C@^,8>)A8; "F.086.08Z&: &0 P<##^N(#?
M%P8F%C8.+AX^ 2$1.*#B"H")@86%B8V%@X.-#?8&@/T -CG.U>N""K@4.@_P
M6%TIA8)BTO'9%$N^4^D.[+$+/W1[3D!(34-+1\]Q@Y.+FT=$5$Q<0E)*Z9:R
MBNIM-74]?0-#HWO&)E;6CVP>V]K9NWMX/O7R]O$-?A$2^O+5Z[#8N+?Q">_>
M)R9E9&9EY^3FY7\L+2NO^%)955W3V-3<TMK6WM$Y.#0\,CHV/C$YO["XM+RR
MNK:^L7]P>'1\<GIV?O%3+@P "^//ZS^4BQR4"Q,;&PL;[Z=<&)A>/P>08^-<
M%\2]JJ"#]\"5@E4H")]2,2:]Y#L!F[#N'M5#MP%":G:1>8[]GZ+](=E_3;#G
M_UN2_4.P?\HU"1!C88"'AT4.0('3"ZX<-=:6:[?;"--*Y *UL=8^251L/F>M
M@M_U=KQQGRVYG8ADUJ/T!"\*N>E(#W!]PJVJJMR_I5/1TE"9:/E:_?UTT!L*
MAN>2O?8IR&U4/,Q+Y$"]@^>VXTDGO6"%>^@=:ZNXY"1@8]TATK1@>?CA(&FF
MM*ID9$^OZOMJ1?7@"#=5JGY;<6'S]2M=TBYQO"%HH#Z4A;F-$B-;F?'C3=D
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M7XQ ]W63FH CW\@(+QU<@R=NA2.WYX*/1##LP[B%9)4!/H-AV!(=R''-+-&
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M,JIH*U),9,U^M+C9E,6:VB;-W",L<U%*8$"\9,M6RO$N:)9Z>SW\GN+CVC"
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M].0_*S#TQ/\"4$L'")'K]MB<+@  OS<  %!+ P04  @(" ";B?14
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M>!9\F[]OH>U^\J'NH2]$==^ \<I00:YX0CS0II"/]\GGH480]?&:@"A.% 7
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M90=#[C4X-$++G[6KB7B.\RT)KZG^:6_M+79N+Y'Y3\2B4OB,T\LF3   ?D_
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MV92AH](A7)X-03C*(=WO*B2OW(1;!WJU\J"58-:9J"N4 AM(\^],0 $="F8
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MH+,D3!\DC:8P8,#\I1 %SPX4./WQOP!02P<(PC#V9J<<   V'@  4$L#!!0
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MOC8RM3Y_,L<#O:]8\'*I#)21JB'S1M,L$[V[=7$XI5#G3WO8Y#A,L >MGI.
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MKBF59Q4(#1 QNPZ.&5$MD.(HU4''P2+A$:V34(C_"^C[$P8H^3GTF)N?1$8
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M*1,SO[J\-&??:%/V?'@Q'IX/^^9X02CK3Z[&B^'XPIA.1L/^MU;IX;[YFT_
M^S(!*:9S8V;UK>%G\VQD_=T86XN6>^C9=IP\FB>ORF@.QY^M\6(R([K2*F;%
MUT*'Q8Z!*JZ>G+ Z;DW-X<"PODYI,W^JWXM/ULPPYW-K,6^?Q[R,MY* 4Y8
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M^@]5;O+-_P!02P<(SB*Y1J43  !*]   4$L#!!0 " @( )N)]%0
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M"5GNM%J+6RUBF([JAA>Z*40+[##U%)&NGLK%3J#F[7N%Q5*'!J9?6MKL&L(
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MS2A*@'N1A%XPS_+\I(R)LN\O88BTQ0,BJRIB5ZN=ES<F=J%?N:"!L;SWX0J
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M9(NWT^RZB-0C;).&L]&V'?1FY*T7]TX.>XQ]LE EQ+106XW^ U%%.*W(Y$M
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M<;GX@'ZB_W6BOML-"=7=MM9#9STV 5#366N>>"\U*1PQQTT(IT6^Q?QD^$U
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M3 )VM+:Z1\^48U@C[S39G@EV)[F>2AA,6V5"*"3/J^6;.PR]$^D#3BFFA*4
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M^7]-UO/EPGMUJTZ$\?L?DCBTR ^M47":Y=D(O).K62D-AI9&B(J3J&SFJ-:
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MYW?0QY6X<?!S:K[]'BYGALFPT_JJO:<9?1VGR'PQ\VN)9;#N$(;)-D=."^M
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MK"<=Y%1 $$<B(53[IVOZ%_VY_HG^UUV08_K+_P=02P<(N%]ID+U#  !<UP,
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MAIM455Y0O/Q'$G#YP+I)>V'?9U!B X@B3;2F7-M<IBZ\]MC7$YKHB9AV=-8
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M1PFU6D@^R]Q,O,\Y\6-UK9?^2L['MY/9<OE=%@B9CQ;)THBD!:;OVNXVR&@
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MF\OMEXYR,Q@SKO?QG@^>;5'MI$>$!Y2^+Z0#/\,AW7['<ZN8$Z[S4FZN!S\
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M3/H7]C_LECG]S?\'4$L'"$$X>6L.-   @T\# %!+ P04  @(" ";B?14
M            $0   &YO8V5R85]E># U,#$N:'1M[5IK;]LX%OUNP/^!:VPS
M+2 G3CR9V8G= 'FV6;AID+C3[4=:HFRV,J525%SWU^^Y)&5+3IRF@Z2S6Z1
M$XLB[_/<!Z_3?SU\,]AO-OJO3PZ.\9O1O_[P;#@XV>]ON=]XN^5?]P_?'G]@
M5\,/@Y.7K3A59H]M=S+#AG(J<G8N9NPRG7(5N(6 70DMXQ8.XNC%]Y[KL2G7
M8ZGV&&WM])@17TR;)W*,)2W'$]/:[Q_NGWR9R)$T;'=SN[]U"*DO'I??AAKE
M6>\1685"&:%;):.S-Z_8U>71RU8XC9-TG&Y^S,8M=C 8OFRU'EN$!R._T.;A
M"/Z[2.9LIQ/@_\[._[*@YVDH- _8F0HW'Y!L]Y0]/RQD$DDU9H<O G:>;K+M
M?^W2_A"? G;,38IWE]%#LOV/_#J1[%CF9C.PAX9<9D*R(VG@CAVPQ<*,JT="
MYL<B-S*>/[B;UG"Y%'NL_PZ_QE!8<R-3Q:X,-V**"&%X.$WUE%VUM]GS4YF(
M9H.<T.UVVSN__=K9_>-%?^O=8\7H#[;$@$<2-+B*V"OHGI %]AZ7J5^4*A)$
MM+.Y*]5CJ;O"Y+U@$WXMF/C"IU*)B)F)8&M1T&S48<!64! P#LMA<P1*SXG4
M1A)]+M+>6F@1;C:TW8/3:<RJ203DH-PUCS@+4YVE_C 1;C:6E(_2:<;5?(44
M"IE4/$'NC"%IQ+)"YP6'&B:U2B)Y%%H:\O5!:(CU]A_=[ET:U$]4V34;$.L@
MTS*A=$1Y.F!206BE1&AEGDDSL6S3.(9SD*U&<_OLA<?Z'GLN7P!WC(_'6HQA
M(!)J)_B]LQ/L=CHLGW -UJM"V=458>(JZ0V=TWH.<:93B)*;-/P4L']V-CN=
M;99QS:YY4@B6">UXK+(X<N>NZ%S=R%*%26'S<I&17;N[55&;#3/A!BB<LY%@
M>9K<=$(!.^L9C"IT[N5DZ;70") D-0YU&1FP!^/ .DMKS+C6('3#'N_]>MTB
M8 ?6X83GXH:%=P-@-^@L+8RUJLKK.+";IM]DPXI+)9"4Y.G"Y<V&L]*J -O=
MW6![9W>M2I<B Q_8 O!'J-ZF(;M+P9+^0KUFXQ[ZW:(><;D"8 PX'/%,&IY4
MPBA@@\&1S9N7 BZL11C>!-;ANJ9+OL!J%0A,(0 C*CI7X41$!?+,F0,,T(3L
M8#AB:W& T,>AK<M1V :LV:X.)*2BY[D5:B3,3 A5"SI:7^7^<#W$WYC6SP !
MK>6U-8YQB2>3"H&4(]63"W)!)DG26<!FR*;U(E FSYSR*/)&1CXDR\M8VM<L
M!4D]DT";),9N'<9."R01^#:/N4M\2*<C06(870AK<*2A+!& IJ?K$;#D:4&1
M9R*$UJH>BEZ&$,B&;$0M+\*)DX9%:5@0"/"F+!<$.'R.:*ERE'@B*F5(:*MG
M2TL42UDQ2F1(HF";A%CNA64D%0J98T7ZS7P-C0B#$4/*AWFYGI.=>'0M<SX"
MA&$<H>RG(J<'335&UUV3"\/B5*-46-=LH@I:BSK'V.H'ZY3\>)X7Q)!J2UH8
M1AC(A 4"/B.ZC!R[BDE,QD(5<*Z";*0?$BS+T81P4VBR)6U)D#(2%O*,A]3D
MELZ"KU0X+P_9$SQI-E O<@CMCO("/X$#>]#O7/@#3AI-I3$.(H4UVL+=BR!$
MM83N4R) 0/+O*U36D[4)WM%UH/HI@OB04Y 6F7<@C"/&*4*I!/[H(YJ+LI):
M,-A220$DOH3"/[#/!;I-"WR+,3J;2-C-/R\Q!V@C4BD?,.H"RKATX+39U[4H
MMGNRQ0%[X744NKR I'S,*3+04LQ=+B:"(-UL\"H;J>YH,D%1PL?(X6A*9)3,
M/?& Q07U<AF7D55!I:H-G2G2**;6E.YZ;/>:#=M%T%*]RBU >'NM_2YU24$>
M4M;A*A3+S@_%95JQ0[/A#;'H)^Z6 =RQFE$_>2V2^4,9JMFXU5+V*(Q5M]8]
M9*Q9Z/YN1U;SZM@D%#BM7.%&6% !29&0QQZT=6D#9%8P"875L/1+-:G?[A*I
MG5-PWL:+Q3@PPE^XLK*@*A/*2KZ1M<%#U1-/7'W216;".?7"Z'"O7:;T]1$)
M=BH3--@)G\%T: -#VZZ09)ZV:W%C%J)=D2;5^2]N I=;>"!GXS*4.&>,7O@.
M"CG?UTU;)!':U+M3[K3:T6:I/A;*(J52MFB'/59YJT4B1;SHT9<Y17PND")&
M=-6/1"Q4_I,DU9^'R8+\/]IM=BI%$NVQ"SX6/=#X7 "( JQ8N^VGW?WCLS]+
M.1SU]B@U)IWNL=\RTV,C1 <N7N7:8<*1%;;!'K"6$=@-#PX')^SH9#"X.#@^
M/CM_];+5:=GGJXN#H_+9<_#4PC1)>)9#DO)3#]$7F0E9H?.LQ\@B[5Q^%<XL
MQ.:RI'%-'5O(DW):8M*L/CY)1&Q/')<G/.EN]]G2!\/CVW;\^FS-(+ABS-*,
M/3:<9Q#P0",3A#UVCNN),_4YKJMO79W=8Z]E!/^0P3WK"JFMDA:]7B=3]]FM
MH_BJ(EO#2_I!GL!O>/06YXZTX)_:(RI%$#.SB/ .AP6MMZ'G11T+%FE5X-:H
M5S4AO1VJ_K_#YRWZZEON1*X)L@U0F>A=A]5LV"SN*X^M7'9>!1$^I/K3HC+Z
M@17NP)+HT<8"5PXW&KB;X:C>\*WCUVS<AR'5/&%+#O/T(B)![*B15K8\>^IN
M']6#R+-97ZHWV?ORZM%LJ+12EMVMAJ2@"I@769;X2_E$YHL^TO<!XMI7OKB@
M&P@+)UR-G=2V]CKEW?U(4FS"7F7+:KP2EDN(3HHNFS]'>7IO[T&Y6([(8C0?
MU/W$=3/2F%)1H^^^%/2;US75Y&ZT]7&A;2>PPJ+(K<_IIDFC%S<.<7<R;K-;
M.1T:V OB&V[<O,ZNP3LTZ%L[-2YAFNG4=J]T^Z5!CNM&. T@3>E1>^$=N[$%
MEO*%,7)[*XE2=+-^,TUUHJET/9N_LE 3"2,I+[K!=4G;VZB_JJ(Y39<T:3ZG
MJ<VA29%3^<I/:W]?A-W*D-A9Y;)(_)4!.A=)O2=='FDV3KXX6-M>&TTQ]CTX
M2N__5<(*@)?UO%J_5^O[=\M8*^]KVX"6+2UW%_M667YNE,K=SK-O?$<T//X+
MA_NG;\^'58W;,4<#/]_[ELXWNI@_!8!G-'US.T=8Y4%_BVCO+ZOX7U+_NU7^
MUH&_6Y2'LWC_;+__;G\KWV)'7$\%;I!O</7Z^C5E&WR*OO%4R(0!VNZ+2FQ^
M<LCC.N1;;KC-_+ZS_4')L?MX5?V)[Q/?)[Y/?)_X/O%]XGL7W_M,,7<J4[8!
MS\W34/-QAYIDWYT?.KY\[ 'C=^-_B_X W/U%./WA^'\!4$L'""%M:,FN"0
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M T"P3Z"9B_94NR^>>Q.QL^?-OW!]<[_X/M\S4\[+E&IIME27.$7W!=#6D:$
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MWDU$50PY,\0?SP_QYRV7%6:A2SR*]%"=B%K71Z2JDU3_!5!+!P@A[JA8G@8
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MK;]^;:V6YYG!@D^2KH@ H/U(=$40RRMQ!/)O3WP((R$O@V8*RPK:PPN4CG@
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MVF9MZ\X+YC'L!=<*%CS%MJ@8S#A[R3.7GXZM<G:07S7Z_2B\ECTT(GMD2>X
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MQ$.XHW>$QO#@QOEAGQ@JO*\^HBN77I*9D!(# KHD$="EU0Q1C4G[BHNH@T%
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MT-J'VA0/9[FGU43815<],C*UEN;&%S<*')@0!&]DZ=PP\(:H #).2>X@V!+
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MZ#U^E,QNE$_M9C4YT7_6SC!8N=4\T2%_'GOISE(?*R2URG5M\;&KIU9X:6Q
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MHBK.-Q-6#'=7C<7E&P9V*0E=IDGC-SW>QN !3$W!,A)C,0T&.!7:&Y8#,95
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M)CH-'[\ZUFK 60_X\Q$@3VCCMXK<V%KU5'W4H([7"QS4,>&L'[FGZJ0+,Y.
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M?MFJ .GE/$%*\#0C%-V\Y\E*,4>_X?LA%\\^(1O?3(Y,&SPO\4JH#M44\C8
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M1F0?N+&--F'K*6+Q77<X!BAQX*"77&[T GS[#AP=H#%.>#'\N>9[K6$L#3A
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MPLRR6R:7X.3\\.'!U^,@>G$F,W'N3-\L'_<F?+W%>OZB?S/#N,WZ'0VC/V]
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M;KX//\5_0SGJ8EK<J"!97^-(7?LBELUL\QH529H4DAOIDLX*K6P]DM>',,X
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M!.^F8MR8XNZP8M;O[_G Y=U$\&6Q;&/NYIW=!M*X9,+HF=#Q&=B"W13:&)0
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M7U"G@YE8]:0GSE&1(M792+A(KB7L4MI:>[>A6<E!N3*9PAI+DFI.!2V'J\N
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M_]U2*MNH;=E0T12_(6I00.!)F0-2#>M85767.@PIDPDT&_]KGGW"&,?H1S8
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M-J'I>HE-'@9P=$6#8DTY&VM>JSLJ! O",S#,X?0R@V9$M3?L4+HXOSN( %K
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M6<-Y_HN@9:24B>_OY8U#29$6 4*A;N*R8D>/0U*2NGK+I:&T"S+=@)JK:B7
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M*C&VH089_'"@+]D BX3)K])[:9#P&OV*U:YYCX<^%7>$IF-(A( +V"MYPR-
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MDD(/$41!UV9XQT]3DTUI0Y:J'$O:'>ZMML2EP6NP,NX/(.--M7U',67$?*H
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M0J7?9MK'N10PG\I[R^(3C#O7R%[K('@W1B&/DWQK?P\=3T2]9!WQC_H?V"%
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MZIA>P%6=+%.N8U8'X7>52=-S!I5T[0\^QDA_#;6I:N<#7[T\])J2OIU W*I
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M=B[&JPX,,X=B+9GKG5AQ5*S8XD2?D/11"M!$[YJ-^Q#.:*QY@,-I**>\@%T
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M9<T.(AW2/5^1RB2SSHCJIQM'CE-K'S>Y;>58OTD?DG# 8^'3ZQRZ';D\P-2
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MO4 .3LU+%*]8J J::P^9S 2V];]AAD4I$XPF$Y']34:J>6KS!O#] 3L^D09
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M7(:7_P97<VW# Y>*.YWNXTXO$'<Z;N_C3IMS3GH_.1?AM:, UWLUU%(A+'&
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MUR;CSL@P3+\.0$CA6OWA&0=<ZRLL<?26?^ERAW2AK\"254^%4U<<7\^K">/
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M]9>)X5YIGU%(GXT9@^EKB%:EHJ#])^)Q5G;J3]3;I-VBX2+][%9P14+/GSP
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M__W_88MR1_J-6R[#*-C9(E6VM0N*,DE-B&E>8&FL?/K(A4;NGG2G)+XM1:&
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M346N4G7K&VO7[NTXKFW/Y!2J*39$Y9@@$\$E1"X6I?23-1@Z>8M97L5UR5,
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M$RO7)\/YGNVCHG8;D9><KJH)6BY6/DCL.CDVMN@C'](/7O>,<QK(QF\G'S^
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M_T&DUG;=1+Z!=:K[M *?Q3R7$(L<E78K8UY Q&6+.@_:BIBEM; 0!/=M21+
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M+=WF&W>+XIS.X)-:%VOZUENJ=X)?\XZ^D]_59_?0Q4]G3!ZI!OT(5$69:\>
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M)[QZ\B*O.A"<N'V!<\$P_K6$+#_:Z@[.33PZ+?/"\7DA,)Y*WUH&[+DKMM%
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M"<1LN'^2OEL[-G/(*V_WQ,Q4-LR0;=_.V_P@S!V?OT?%"+@^?S/GSV,6?(
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MKW#S$ZPM%R9A&1@7RV5+Y'U,\BP)7IK4#.*GRO;W%O)M&0:JRH[(D1@*Y@V
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M6HN%8>'N,6:FL'>^Y2-3P8_O+>''Y1NO!#_>_N[AQYNE>FGL/PY*H%8'NQ[
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M5-Q(HQ'W,;VE7^7?<+H+DV',;(66^3_:'3:*X:-D)&,<7V+U1(5  X#RD8P
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M02SD11IEJFS[YC+;_AK9]IUEMGT.B#=.-5X<49^; FK-)P''>7-;8Q.:$B.
M,\:@1\1;F&0VW1@-Z\0Q);=;:W15(K_%CMDX+2*-^-4QQ(B?:\##&T:S%I<3
MA6-^6VQE?D/8BE)$BD8='#B<07NOQ;7J?NFV?,*L#[YK427_>30\53WOLX$N
M6G-[5?QF%[L<)>BA]0T0!Q-S_#5Y^\59:8S9J)_-BU+#]=NPLO-VMQ/ZG0%0
M_-.U;Y3(R![E)\7 @W'U79[PN7<<Z.G>DBF:W'-!*3L?<5+""A(0+VI@HZV,
MMA3TAOV7^U, ^!OVLA1MBL-5[,656)KJ.JYJP97N#C#?L3:K*\YO32"X'KFK
M^C*F0ICPE)G#V6GOXN8KIVVJ/AX&HU$+&)4GUW. E;U@[N^GI*K!MJSO6"W1
M+-PI'<HCO;HBT5#LJQ$M,DPN+R==,/Y<AJ1^?&V+-7P44B2*R$V_3,6UF"91
MP&+2V!G((Y=@="E\2LT^D=LFAU^VU'!AXTMY;^(/ #ZYQ5>5Z9=PSSQ>^<J:
MURVYB7103(0Z;/L2O'"8[,IK;*8R#9.: 5Y3N @3-9R&4&W:HS/3=&N/T]]E
M>KMYOR%JJ1;+5X'+L_;0NZ"MD-JF2&JJVR!HN Q OI[E-JBLP]UJ']LCGEWO
M-U _^GR3C]#[E7<5#3^= JQ3Y:LK53EZ2/*W3J67GU@[=T]58C&BHRL?RS+Y
M;;I1M.!OWX$6/%P(+>B%>U'J+ZE1"2--6?XS.FHC1&R(>E<JY>:]T5]S=:67
M1DTK. <B^B@/%A>2/U-1>0A'K/*(F8 D!4TP&+#NL:A&6*_2=V%;/5DL/6Q#
M8M1/HS(KJ_%:IC*6Y#Q$9S[05)[?\_GN.SV?[Y[@?.ZBV?*04VDSCNBAO-JI
M#,I;+T4IK^K NH?2M26_GU/9)-O=MYU6>R\XN$6*X,^#*'V1$_62Q_<D=9GL
MT.9I[X6V$1\D,1N.V&9;7:'%^)2!I$5A<)SV-H35Y&1H?&]>*O@;"@*XP;AH
M7C4E/0-_:TL]W; L!UXMAW0MCKQ!P<ECK8_UX:DI=(TS*136!MSR03:)<76X
MX"M#"F:LC1\/1L8B9FG&!SIPU;G8MN637H7 -G.Q=4WF=<'!*AS8;6(N0% %
M*BW8"7=V\'^['',7!.P&=ZY#]%B;"H"IB\%$6# 74X=$%FS'Q9$TLR&L2 K^
M,8WWWSP/YO%.S.[)T1\*:A$2UEN."?^/9D^&B+J21%Y\!_0#-D;1UO#BA8:^
MVE*"XP[(0VCO>-D;9D,->MSY%+,'2J^PNF)V>@-$-7V#8?TQM2V57N;)IZO@
MJ3(9KA^K$3N&5K22QZ]I!06S#/WK)-5J6NG8/W23+?##-=:&Q>4OHY2AVW.1
MF"X)V1EUQ>"*P(\3$ )(6$E:^.R/LI''0]5$1VB%A\-==4?1G 71'_J.1N9Q
MGW0);3FQW5*MYZ2&#T*.S:G"SRYH.:]CQEF0>VB11IFJKF%KB;7^&G4-N\NZ
MACFH:V!K:T[K&/C2^1B!FR?VIMXYEFFQ3P7/EH*\='6_LE)_[/I^BF^B?A3\
M-BX2 JL^=#)=9V2DQ'.ZI^?6NN_JVSEY/ U3E_C.SCC*6P2[>QM;[3;>W?BO
MK2UQ70M*^HD-+(MW&M]0RZ2N5^@W:IV>.?UCIGT7QB56,C"LY3&]+!]FFI;C
M-C8MXN^@R^&:2]361G6]Y(E3V;[$&&ZB/,G&A0Y?\\I.FV8A_7+8 X(J.BZ,
M*<E#$;H]@_(J4MIM5H;P]R(5SM.IW\ZTM8D[WHU[$65Q&D8,W88(YV%<.*2<
MPBXNFX_N+^B1<</C@ZR+ 0G\)?;DD2%.AIM4Z!CI;QIM=46R%' [T *X'Z0\
MUG7,P/ZR(-[&R9,0)CJ_YI(8JMY&<];]G(LT9N5@QQ;P>-$1KR-9B67[(-:U
M2U"$PCDP(JC8;CS)).]2Q;N'W7:KG'1S?GYA;5=O/3UX9,<X8@;77X5XTV-6
ME4]M_WC/W.I866NM*K5+FA[X-(2P=PV]WVD:NRSVZ*I-<<KL8>:^^<;CK$?+
M50OPV(I:X#ZG^Y3#'=-C.^TAFJ;AU \("]8=!(YT]#\9]Z[50 #<?^!^@:$J
M],+5'7P::7N9I[S:FSSC8:D=+]$6Z!0Y740[<OL,47.+$#:(6.*TXIFF8.J3
M Y\$B5"RBY^#M6C=^YVMP>1DPQ3CX#4NK73V@FY&'78O;.T$=4EEO((G0^11
M>[4G]Y]:05S&R" N"+TF_'*MRZ_- +)@N S&[EM78OVI-_7[IJVU!/?9 R9S
M8 L/&N:+]6"]=8HC.7:8T^;I@'S(3KHLT/Q^BA5?_E:"K<%VM.<CAGYE#HYF
MLQ3>W9K'TJ9+X4K.&<4"$5-46"1-9RTW+>-ABTU!1H@(,2/L:@V#X2#NXW\5
MUR:L[5M&2Y\R?9[Q259PP35LN(>.#:V@$Z86IE[2]#VO(L20X%./&*F7EU@6
M,RJ= Z,LMG\T\%E*X=/P%5O:';MLX\:KX!/WT"&#NA'!Y-0A">['R9_+U>@7
M?_FS@$-D87N<HG106JF]5I%5)$:P69"5N/9!A(:SUE\W64;>RSK_Y@X3 !=$
M65L$IBCK)4;+-'QS08*XQZD>NG!: =8.#C:R;J^R,@].F0-'UQ-F5FU41RP"
MO;STXL*T!/'@K+-T^++HVEZUQ#@5"?1\:\Y-< (&Y0G1D(PSC@'\>!!-7%TC
M0A5]C;%/D;0/EWIQ7=@HSP;@$XY&6&-+;QP*GPY, @$<, &#/,W9F-!6S"<Q
MA\!W3P >*";( TR(7UZQ9QIYURWEE2X(BZM$A\&O/\2.&.S8F)#*1)@(J6BK
M%%@R;(M<0C<1;)4!<9\)9))O#&4=\I8(#-^!@Q:V,/$LD3J6\&H@B^X)-Y"U
MN;LG@:S-W?W-VDC6Z9EEY58E4!1C[J<R9Z<P(21$G<#UK<:N5.6*U8OYM:;@
ME4L#8ZSD=G.L"W2-.RB<;F2[&16*&@3/@*7ICWM@DFK(#PXI?WQUQ458&5WE
M=-1<Y=^OJ@EOI8W24'5!G'5RABENA3=* Z4VQ>E8,X$"Y;HWHYY&L/_QR!W>
MY-5=>J]>GA4%;8G>=X;2"]XG+G#%'/JLP@NEZ3PE *9N-,)Q:JRG>1;-KJVO
M3K$G#;.\!4THMM,J?D:3Z@TSQJM"[XX=&"V8!GR JJ#"P/RS_K..1\Y[[WKH
M_(6P)E#F71T;P>]J;>)X5#AE%FEUA=8:]R>U1I H3GTE-/4144=+K CR7I1T
M[N$4TA35SY#;;E]Z!"F2""-0**5\Q+7PR6V5H=O!$TPNP._'"'T1]W6Z!J6'
M HQ<:=:\CU1*H $4^BKM;!%[$7+JV)0*%#YPR47=7/@"Q*0[,I;Z*!OJF/&"
MT'ZP*7&%L1U=I>J.JK&IAXAV,63[DRMDW-=!72$H(?3^L.(7T0W1H9H* 4<D
M+#C-J'SLI;W!P=R09B4A8N40.7[M(H+[UK7%D]P5CA+)GJT!@04%WWR,GX--
M $<O*:ZD8 $VC, E<X,JQS-=$//SP-4V9.00!04N,NX<UJU8<(B0O# Y(-D0
MT:Q'>C"RB["Z<^Z=V$52FJ\2JE2>"]P64N,8#!JP-D9_PTX)"PPG#,1MJ$U1
M[MD1@TF\P1)&\SPBNNV2M T1QDB#%NT6;'B5S(GIA]-[CX*\U8!3/'Q^0YD'
MHBR9BT&*4KC*VU? @066)46V$?P9<V4+KC37TQ%$^$7-0A8FM86"KUW1MC:4
MEJ.PGT.UH+5<Z1T&A=%K%I@K29W,##QJ021].<JSU.1L_Q+\%RI<&'99G?,:
MU3E[R^J<.3Q;U#9  *BE6H9ZM4\A'X,D7;ZMU/U"6UA8C9/4A'V<GKFZK])=
MPBX)%\Z2\O>M,DD_E&QBJDK.Z=<22J=4'?PE&XS='+9G%S)&1I2F&.O$_FOT
M6."?DK1G=Z9V,< *H#"]9>@(D5_>H&F/O#4U$1^ZZR5X1 ;&^+6OM,?&.932
M0%"\<--/I5TRG]^8BL_CX'7(Y]R&6:GP5_OG+LJ'8)#U**808?G.9BOXC.Y*
M$;P'49T$I_W@["@X ^NOT^Z$P<%H$,&3PN#W@V"SM;FY7T<QP<.B!T9T;Z.K
M.>>0H)Z23U'1C_X5'#)9 9;@81CR0\(M4P=\U/ P_Q(<#."62KEFYIA91U97
M])-GZ.)'>7^>F];4'B<%PYXF_5SF: @&6(3?QX )J^[:-;3='@6EQ4T]VN'I
M0:AV-Z=P![*(%-?'"!I'+=BM=1J=-X+?DQLAB.%8<HZ!<$N)S9K:;8U69S^/
MQ9G![U' .88+HY\-LDOR6.0=<,@2C79A GMTU"(+%7[KKQ<%ON4Y]N4C1VJ4
M.U??MQ"A\4KUY0F$#+R]O=U:B];7VNMKOZT'N5=Y(*V$_[;Y#O\/K+ZF+L-H
M=,5PH$+,^X^MC58KZ VRPN(ME6=$UQ#>;1&6L8"'1H!-.04/9(*L#;A*A41$
MGQ'90T,^'D=!X I/L=Y+.:8FM-;ZG3(BBM!WFZYV#,&06-$3:6CT&BEP8<E[
MO)[X6N1XKJ$UM37>%%)],\K):=.3HBN;N<R;FKLC\L&EQ23>VL#$G?\E0<63
M#AO&0LV+9"*SKGQ7Y)JM$XDL1@:J(4ZU>MGDWJGZ@"N?+J)DP"%C3+_"HRX)
MZ)K3RES]B$U>Z1@!F8N1UH$:\4,TGPQ>!'<:&X.*BXD;E^"-A=W$% 1&9B@R
M+EV<@3,W/?(<$Z#SN!EMM]^T>2$X G/0 Y$\QC@-'7@Z)PG&8/+LJQ,T8XBA
M:.#\"I=_D-APG*.EKHGI7BLUG!D1(7*H<@J"C=13!5J!N)6X>ZR:&_2/\WB:
M$6DZ9&WA*-1MW$4N+";+Z,,N3)@I W["QRH.NR<WEGY++X5[AU;^<U J@RQ%
MTAW>)8[:U^XZH[/;/:_9&M"4VT95ABPF/,Y+"$-@98'3O;1$J//<Y='45-!-
M^J)XN_$@NQ65?/^FW??:E*7PVBFCWE4""X?GIE;Q4W6UIKX04Y#I^7IC&MMD
ML2A3P*EE]L$*++C"QNO0V3T;"B_?=#U0HJ";HA!S3ZJ_=?N[MKH-[=5"*E0>
M)LONK<2(\%[_! OKB *;IEF3(^<Z1SN.V!;3+OS!^@8:AYP[OXT=P=)'E\\U
M3S;DW L<W^HM*U:'2;;+=<N[&7SS7L[;)4:6\&<ZCMQ<?6H(X>?9XD;_[^SH
MD,/MTE/N4MV3#)BB-.1FPQBU X?I:"@7#9/+0^NX+^B)-)Q7<H%":;.;[U%>
MWF'0$)F)_K$-HK9N"R.Y%JT.YW/:)VP$9Q1AM\85!7LLT@/=<W)FKXDU!*.B
MPG5.L*4P*(9Z>L2>XQZN5*[>-W+=4B).RU&N-X+W6:E JY?=. W%2(O!ERR>
M8N]1G%RYCK[B^=.P30'+*\2PN#W($*$%H)J54_0.;I(OOWA:YD+SOF+,+"&]
M4/)4PTCAE.A88C3W$:":S-)AIOE":A7]6MJ;;'!3N?-,^AYV^GHXXB7AK9$U
MYR02<X-,0K]"WR46I!1_1#$IT%ACW.S>5=Q'/3K,XV'D-'3C<2 B%H<DR[V'
MU0TXKVP/Y89ICV2<V'@ 22'YXV$T45"5;B9&5^DIQF$TQ$VY!R$;!HPO@C9S
M-I*#JGOM[VRH7H@_!+HA]&%DD9=3B&*5-PJ=\T)@CEW JIIY>I\VXH(3)GQ=
M#2%2Z9@M=H9SD+! $)T?NC]T8;EG"2M7T]$5AD05!+@P"4820ID6WW ]8DPA
M59"D!!3@GP)G#ZEA08*JF)4>8Q(;7\C]H@07")T%7D36"1.;]DD%]^N7XQ-N
MW;F;\'3]0X$E<)0.'DT,)53,;7,:BVI\@:[EA+DM!LE7. I760:.)9(E@KE!
M=0/]!/OS$;O"KXSSYFSS]",$!0!!RM"'FNB&S>.%_0ZA=-#G_YP-DMYDKF_J
MC)+E-NB34G5^'RE-.4?>UY>]0!:8LDQ2W$(4QX";'5.AV*2PTL5XA&I1*I +
M#O2G$RQM16$B-W'$'7*@5AWR5&/613RTF@LFRQT3PC=>H@5/ AL71FQIQL$D
M&_,]>RMAE3Y&GI/N>,3V [%ZRE'E.7)HF'YO/DO7#^TQQO"<7A#4$/"&/%]>
M%4'0T31^/Q[B2A!\D[:.HH(C)!I;GH??9  81KT92B<,5K;1\B3TRA(Z1#92
M#D9ZQ@&K&(2PXKH96[6:S%^>?_8?^!W4""S2*%/5.^PLZQU>M]YA?UGO,/.I
M:AF*TZ=@T/X,UQN614<HDK620(F=I/_O/Q2=#IY$ZAP]^^/@].@L./IP_/OQ
M;Q^.5E?>GYP&[[^<?SD]"LX./AR]\J1?1BM]MCZE8W>'7*L1&?= >43$3?#S
MYF)BQW]Q0%$\BY/SPV"8I&AZQ_'(,X[ ?>HGO9%34N$89&@MR3 <BO"@P*K9
M>G& (FQUD5!!TU<""^9)1#1D(7$.-G6\-QMQJ7S5::DQ&)F4F,1_; 1G9L+C
M+F9I*$C+B&:U4W%-, ?),^Y7<3SKF;3%#BQMCR)W>#O*R:*H3_A]N+E<R^*^
M<E'[?@8#E"'D\"G)]1!KH?%U=,G1UHYPKF(:H@_./1@<SQZ8!?5C9G-H&C:,
M\D4A4M5IIR2(MP>WCLRMKNR'6WM[8;L!;U+;HIU]]R'G7#]YC0A_$N(NK\"_
M&OHD)X*1"56%"W_K!@$;L/?0K1#A6U^0;3N _4"Q1]=H,-'SU[  7)-]B[E[
M*JO&]1<@P@*OA:A@JB:S\LFH&M4(*1Z;6<)/.NR&I%GCSR[XHV4AMB755'-0
M93[6#$I[:ZN6ZICS:-S[43L$]T/ *B5*AR4E&WR(\6)()-*J>@>>@W]+"C>N
MUS0X(0Y(#PM_S\^.<^Q;R%I("WFH_0ZS<],K$INSYD$31$"]!DD@R$A*""Z(
MY'K-O4[#+B4@RJVXF(YSM_ONZ]'DN8KD+XY3FC)-@GHV<1J"S<2J3*)L$WHV
MC&S8?3G2*A/<>XK>F*>G(+%P%:SMM]8Y!^J@O'"W_ZV4.'@-.A3D*X7Z2PT<
M(I^\)@DGJ/O(2MHWV1N8A^T+IW4H-/U*UUUV(1*?FU(M?ENOH=Q^T3"8],>Y
M=H!47M#'Z<#G;R ]CK-Y2=$X KT3#6&6Q</O-NI;-YHC. :/QUV3RL+:QF()
M,'%>-X_C-R0 !B.,+<,*!#FMNBD&B/^BRB%\R4OP;$;\40IS:<1X-D"F&ISB
M1X%.^1Y;J\9CF\(O1N2J.K2J'QH]T!\?B9IS-Z"/"R[UP]NV07&H;'R=#H$/
MIJ[IXB,D6;B3;]G\>U9YN?O/L?N@!0GFX#:.OPXHS2F=MX/Q=;W+Y&C#"_HC
MZ#Q,O= C2@IQ=>6"G8_NQ%-6E-[$LA-NN7L/_C-=_E3O S(X%!6H.K4F[O*2
MLO9,^LR[X$)#.($A! .M7NK9$Z4-QIN]H>NJX,IWM#4 M(^Y=#-O6 L,92"6
MU"4EB:GT;F+*[M M35-1&72IRTY:\'L/W, \.=0M)2C#D=.9L2 &W!\)]F2C
M!AA,0I.>1^L-.TK$M1?8(G$][C7MU=B1>,C 4E:)L8V[8+]A*^C$\>EJ!6*B
M=WI$W?:YXR2Q!P2&Q2!*OP:]JY@*^,R7,DG PJY>9R.!67%08T!:AE@(.8I[
M5RF^_53%FOKFPIG("X6UF7W&G6?,2Y@#GQ DT=6ETS9@>%:?G\=1IX0C/^_C
M;C[&7'![&[&!6WOJ.G#E><$FIW6/#!<)ECCPN>#\NL9=T!!"TZUK<6!5!8[9
M+3?;>/?FF"TIKM PLVN\)J@U6 QD4I0>H!45>9"A[WUS/1"8?(:6H6HE8]@Z
M-JSC$4?>,R;>^ENC&P.LUZAB,#Z!UI\-,"BC,2\$I@^OLEO,[YH"#EM%8'*,
M[(9>QZ.EF3A'A@)N)DN7Z<ZSXLR)\(B\_&ND0RV+%DE4#_'=C)?F?^"5[_6E
M:#R7:%"0QGBRK!";[!6!/@K:FZC+VMN($%<R8R@ M!26!146U!)@3."E ZK!
M,UU9:K@4Y3JBFGA3I*(ZA;X:4@#5Z?5U_13KD[0[&OU"(#L..5W!"+$B9@>F
M;5JF2UPXSH X&G^Q;F[%>L@FL#20D6>S]^8_]</4VK*4X[F58^-&&;)7%-Z8
MRB?ZEDN0TVPE26(1UVI8]GE;P6@R]"M T6!F7X]K>R\(K 9;]!"%C/'O(XHI
M,DV>U'V+EU"R[1;0;[ZC=?,X-4%3KMP&(Q4K^?JK*YQZ]G,-:\FZ])28.EWP
M?/\U1E-?MXDS(FC:&/_+W:RHBQ@\NLENO+SD7TMK*/K._9C+ZLLQ]H3+Z#U<
MW>LX2ATH!^LPD)7/;I9MZ'QP>(#N52H*1HV&.C/6^YJJIDVI(ZY1V;BS#+76
M^]) .]_XE)H6;,[0!6&N9,2H@E?N ]/L;.LB<1DD VL\K2JJ$0>T"/7-NAW/
M'%JX0QIGO=[PU8]K:?B[ZNAVEW5TKUI'M]]:UM'-@M9XA0*[35-@]^73NZ/3
M/T^/SX\__?Y=%-.=^5<+5F88XDV-:A5</H<VFUQ6ICR'.L0N\YA[8KOQZ!:C
M<F,+J>D4\H#Y%EUK/0,;+QRS/,/Z$]@,A0LY<S+DB%NS)G>I?&YU13ZH)%:"
M^X-->VYDV?UJY:_VN[F!B(J*4F-7X=%FG?I_,Q1:JRN4TW#>U'U1LIX+')ZL
M'5JLODOA+0"&BAQB_LYM05EE%<-2^%%R20F69]4E.ANKH;2;.@6YJ!G(U%WA
MRYB&#]L[]1I)C6=R[*:[Y@P_4]/-QKJY3O']R8JOPOERW_TKH^_LZ!U[&^,5
MPSJH[A;]X@A*^=:2)3.CM?%:D1$Z=0/<S8]SU^/:T\ZW_GJ?<EG:F_</8]1]
M]^TG/1R_=O/@I[<,D55PJ]CT*_6-K[;<!'\3_A1E]"+;X!!$/?P,YY?=M<[F
M7BC_6Z\YSM71[[G:](WOW.-I-ZS&$OV_#XT6_;^['EHW^+S._)M$H4F=UPIL
M=1ZUILH4PO\(5?!4A_U9=NB;9KQ<G]?6<,;1TWGB=&"6NQO[V\,74Q3W?_ E
MU=9C9O,BJJBSL5TO/><9W$OW21Y]^V''JW' !QPP>D;0S\9@];_0&7O@M)<+
M-9UH/TEFYH6[TK^8<C6.BI1;D[S81\CY+"_<P5#0U]>(T^.Z_/1%!$9S.VZT
M+X= ;[CXB/SZ<:$51]ZSNV-&K:,T+3V!BYS<#XD'O[J2=>'5(J4)-<U33KN/
M5\O \&V"!(01!.4/,B$AIPDP#!RTF,)27B0ID=+WP,:)>A/">G"#*U0M98,1
M: 1AV@A??VSZ-AJ6VN +,<+4)<)F#Y/4/)-S) 5%;P6AT"36.2E44"2+>@$)
M33"T%6F<4J.EK^<3]_9F0:HZRY+CU%A*?A'EPK"](:0CBHVAKU)4)FZZDDQ>
M"3576E1-,%$;6"_RC.#T$#P%8]\UJ\R[FAE!%" OZLJA U :@R"J"#>X%Q/.
M$R6.1YFV>/SC_SY4&P:*)[P1'!B94$C#\HNZYYH/A/YI=44([TP9,4;Y*)Q&
M*D8@B%A(#0"6NS-.PR[O 9T:;%M@_J,X^))2^S-2R\7FB7JV;$DK 7 9UJZJ
MAIE+1/B&H4Y MMX<# 89H;P$)T-&"7R!D5_F^"I,]R6JTK@F\(XL8-R<Z E^
M8X9&VG'QSB82-$-X-:+)$M-RQGUF"+\5Y2.JD!>X7BH+VMH6B-#[5&CHW4E4
M7S(NY-P%XR&UB6'CF^%[A4=L;G?"[5:KOOVWTLZ!ITV_8?O0IUL)Z5A 1,Z"
MF'R%N\Z[FIA90?&$''BYJK9C/5>CXJ1[S>6+'@D/&VH^_AK*<:1R7"!T*EUO
M</5[70>FF**4LK!MUMS<.^0R$DI?U*@ K3]@MENV(; ,S3$5').@U)B-@-I_
M)=<,N<8E(M>Q0P4H SZXAQNS-'Y/%^M!X3^7\?NK*Z#M%/[=$.51^J!+3.2:
M\$+WI_*P9F/,HHUWO37Q^]QC75N/^O3A[UJ3_BDUF-BQT(C3_>TSZC#(DQW0
MD)3<O;JYLXAA@TBP(4#K^K#WH>IZE07)->)VHH&1*7T[O1)=CKP9."7&7]9M
MP7-!LZ+7=&396P,BV!L/!J&ST>6+V#=<=%]]X?U'>V,S .-@X'*XB]S$!G&>
MJ(2I'BK^:QBGA2!Y6O770P21:J*-)N.J#$N*)HE2^,:X:)Y;1^>V82K^AL_(
MRCZ=VGSYJ7C)@!2KUP8/GJPSYX6P>[ZXE]0[N:06R.XYKV:DL=;YMM!"0:8
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ML7"I*;B>8IM0$C3Q5Y_:&G#2V .ELYZ2CB68CHUE1(4(LT/'\J2"=4+WXZG
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M;LM,7N@_-0+C-7JX?XNH*R_%<,= \O?DY# L!-T*@O],G^TCCAW?%9\BQHE
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MP=1NM_;6]HS?7MF*]5"'@9V^X'P%7)Z/&:7=KAT&97+=-QW=-"FXD:1'" 7
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M@>M8>)=XRFH2O AX]5E1NBLG2[7[N9H**)3W0Z5L2*6U6/B*::# )&SKJPA
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MB@3,F_R\AC,5N?2HTYE<[*8K5>>^HOOIX]D&*S=3 M8H@C@ BVXFU'*=3C#
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M*UOK+-#ZH/$J4)O1\1_RT$9S>6BU9S;E5(8";WQ8?="V[D'%#?&2?#,3V^D
M1P@P"8X_R,S@P0G=((DRWW$Z?=<',L8]P,9T0H<R(,C< QV:;#-)^*& UW'
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M4Q^,O8Y<D@': DR0MRO9FDJ&&5,X=HQ\6;M@&4'/UTA>YD)W= WW7+BXD'(
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M'UA5P'HYX :RFE?!'[(X@/?LWU,U+Q_G.\L%8>&&JCX%_;E'GLM85?P!-*'
M)%#I.GS&F/@2AJ0C\3&2LQ)K\\!0&+ZSNC!FJD2G%^)2[3K=R#MV,T;L-%27
MP3C8 7(J)PHX!2<]2#P)F>]*((5]M/V<GU*=UXK-+?RJU8Y3+1U+D".UQXXN
M+("/2:J"<0VB(I] E*%RK&#J8@J]7B##)_^$-]>YE[I@[ELP7D^:OA2P<:JW
MJ C!]=$8H#2CQ%<[I0"I#\^YX[8I@H$YA)1BK(Q']EFS&5,L4/0ESNY@1V3Y
M+LTR7\9/8Y_QL^:,GTIYG_*SC<^+8Q*8]NC'AE_M#/EH;%V[T8_=TOD^YDE9
M&5(-,)O=)0<$Z#=!)"'7#%B3]MA!M?F@",B#W/E1+&$P, 9*.)5M%MJI2I)-
MHL&*N03ELAQ*H$:03D"I^3K_1E:>8KXZ%2O@/U.W22> XT$U206IB>7$5',(
MPEL67K,+8V@I"=@?2>KA^06''!0&0>"3S@<6N*^J&CW"#C<Z &A#&U%>%'J=
M3/(5'8G'.4%ET^<TX7!8HW3;5',M'B.M8J5JDRX]I%,9.$-2)P98:41U=C)2
MG)XEZNE8%( X$\8^&93%S[VYW7@$Y$RE^$T %Z0.A)I!:&14N+#Z2:E:?4O!
M2.,=_%\\.,XP8'O *(Y$FSB:E 4O 6@8%S1^#(R;&)WYM%$Z/GX[XM[YOQ$:
MX\^8>?E0VZNS5U.($E962#'GHC!'9O$3VXG@(YXP.4?FC&%-;ZG<M$^P _F(
M9GS8.<_ QGJ(WW(RT.90F^8_DOD4J)D9:$]O8#P[3PPS13QG^!OFB< (X_+3
M$ N9+*O-:O^\6:OA#+29-SGOA>4O@;3M1X&KQ &]SGC/WLK$-K- -WB7__M+
M=6XK(&>^/*4[P[)^OPNM7_\@GCFKDRR!-HS-L1N;+R]B\W.WA7X>6<T\JBF?
MG^?K>4L9[;N8,_*RFV'GGLQ7$>+2G/N) B5'E&PB(]JLU;SH+B>)."E &R=O
M)X5*E%+8FF"^5]Y.X!.C'YN_Y[;ZR@3'0*51JC7?3ES.T^=9^0ZJL(/:\W>P
MEE>M">']LA]'_;14'S^==3W59JW4&*>V-3S57$BF7+&MK^IL#LDYG?9G2?9Y
M#_8IXQC/O#QV\+FR?]Y5;-/V25A6YMG"!K*+<<*LENJ#N>]E_,/SW0Q]CUQ)
MGGCAY4P>2M[/:;54G4V>-,SS"70;#@*,[U)Y02<Q7GRTB3CGS_' I,[:K .F
M6*A@2]5Y'# *U.2W!6YD8@WAYGIP-L'N;RS:]/TH<W4GN2^WP 3><.?"J_&B
M[#TF.^@Q4;Q_$QT3F[6:];A);J1TWR WR?%)J=G8:C=))4>MW&PGB2:#I3M)
M*O52Y7ACG"03C-6-]I+HN]IN+\EQJ3K^RO=>DKV79".< \V34F4V>;X.+\D&
MNTA6D\ZBT@P_8KX[Y>E:7QAF!#.T%IY?J*93NUA-^J*9M49XLC @MM2Z#09N
MVSK!SH+I_HL%XP XJ>^#KNF(),9*1W01TL0H$[ Q51UNWXUZF&YO=4.G+QZ#
M\ >ETC%T"SJFC,("6:SA(&IU3LE'L9#6DJBL05X3%4*GX_2-]>Y4H5/FCG+.
M7#5)(-A@"=S]J'K&Z3)JE4LI._1T*=$1JR:X,X_+0#L**M@Q6AH?$-BR&_,$
MAZKPV#AO+MOA3HC$@[!QB%'EJ.L:8;L_$(25>N*X<.>Q+I5-\:#(Y1C%V*G"
M(=.34'_XF[HON5JY7N:.9-!E+UNVV*"GU .-T %;FURW.@,7SIG:-V"W&@,_
M3I>W&/U\X*0'"1VXK"K6@UAZ#*Z0N4-0)0;L"ZW$3__-J:_I2K#C>23]S='B
MO+]KO8'/".]D5=1IC9U5'PXTZ(!V=3_$TRH6_I,$F!%*KR.R#A+?Z>!@HB.K
MJE7SC/PB)2XS)P UIO%=J?'A<ZS.=8ZRDF[T++M&MY$)=8-CIV?+"CF>5/4C
M,4@ZPT(RMS$$Z>7&U(.)NZ1A?GQ(+?WX7]S[QD#']KBW @).&VU71'ZEW$[=
M:VW^]V$R$*X.<#-]3.G M#3#3@+&Y^4L>(=Y[,J\9XE0D^NE#!Y]1 !*:_J<
M.]E;)Z_2;UQ(L3S%-L!<G-WF'CF[*X=V:9;Y*O2:^PJ]K"=S]15ZE7V%WA8^
MKR^91M)F/1I!0V4[3ZNJ*UV2K^0ZPRYU1I"UJ"%U9Z3H734D(X I)VW_A$-$
M7%]%!@GU8$X![!P#9*KK< ]4W62I6#"*VLA6XJ[N B$]J>Y^,""(S'!'&/QW
MQ)#2W8.S(+0)XB9(58RE(4%_Y1;.92$"\D4B@LAFAE,*G@)-F+ .#?6:3@+J
M!*:MY"D#4GPGV/Z'>N ,@H@(S]:(*#S[D;2.0O."095C.-J.H0  @XJIBI$[
MN4:Z#U"Q$&I("-D9:VB%.U2AWZ)GI1(]>$Y5)D>[QF ^W58H6,WS@PD&CE;"
MY76JIL(*OR/.T!"#U^&9<L'F%K8YT47+V%0&]TH_G&NPNQT#J=';I"8Z*::?
M!D@AA"SZ(_HK>@2OH3[N(A2'_X.!BWQ,/P-[R6W+'@'H;9 UNU2S1C-E*-,:
M(TJNWGQ3M8^/C^UR^93^\*9BEZLUNXZ?3OO\>;NBK3.]M53QRK51!WDI%N^_
M7B]G&B_1(>Y"'F.-$*I:%(/5Q\ V'D)OSR[NIH92('OLU(7FR(INW<G<*"A7
M>#=.K,"Z0)J4K)8Y#SK)O"@H%OI.1W9G8[:)D*6$-83N"T&=&R?"<Z.4Q,;L
MLI>5:OB(ZU%KZ"1" A8:3>ETJV;5*5,!(6GTH6PY.^ARWO"_@CW*SCVADTND
M896[GQX5(PIQ;I"L)W5]"3-NIU_(8A*D?R@6^$M'CYB;*EM@&""EJ7"-+0&#
M!'VWC7B^&"F@OQ&R(?F S++YM+">6IHCIBN>N4(MD.78<!?_29SV4!_)K*K_
MW7@]S"F^(J:8B^B0!M[\%3F*6Q+@=N?XAMJS! :C+3/>A,+TQ19Z$B&#4,L,
M!L-]9OP'P9W-;49E<U&-D9A<(FYG,/@5"H2;Y51*FE'CV5$XLJQV38P(^-=T
MNF0CBXVG$<:3]WG^N$135J$7GERWL:<V@FZ4+@471IC(@S"XD]M0S-$?@>72
M7<$U0T/_:9L?GEY-"F:1>?$I@(>M%ZQ.C)B1+?%1X71EJP;-&-*^WB7KO=.!
MU=])QZ%JFQUTX43O'73)CD"S,4XUJ2D&FD@7<^8E[&);X(ZWC0FH]WXA(=VH
M3X6_:R_;V-V()@#WR_8^H83#<_#1E V%@UC42,?2Y7R&?\Y2/)N92":<B(P#
M2FG''FX$VD[G5:INZ#Q:B-06NB#SL0=E^(-=QL%]R!H(8<UB?+Q3+-P'04<*
M8&QO0DN"CR*@#,$]JKX@I$)X0=N1+:&(>R0^-Q>17U!Q68V%SCX1 IA+(IV_
M:PS?==H**8_@J]4<&FGR)X5BQI<C=0L\5,:2"'Q$&Z<F8D;LD7!U$#Z8FHG
M9"FZ>/XJ%EX^LC)72BA2G6Y<DTMB#;KH&B\1X97Q[ZYJ[,(=>EAM R4.RW2
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M3'R6I+WLK1@159-,^!:&%N:CL<>03\])T=%&,BPT-B$BA.A *4^Y0P[H"2)
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M^90(0XU0H"*CB-O#*C)2CEVU.$982K],O"VEWYE=+6U=]F;65" <4[L=)@R
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M4B[5W_*^1@^MFX1X_MHMRDS:T2/CC,!N.UAR3T?F2[9&4 #F&N"3\&WTVY:
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MF6E.<F(&)(#%6@U=KN1\3.GS]OK0"@?6A*U:!/N*YNZ;HJ7T >?,@,)!(\[
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MK)ENZM>5AX<F]W^EX>@C=UFK7W/7U[>'.V95!TLL,:5.![%-[>84,O1R"<Z
MD\PI3\<C#!=.%V=),XQS 9>(KN ,6RE+YOC 5!U;,Y'*F0HP0@/K3S+O@BX1
ME7H]G8[V<>1;>Y0>J<NF(AC60P;&T!MC:)/!/RROF/ ,D/3:;#&_:>:!"ULI
MQ$,KQ:Y;*0J'5HK(G#Z+]OEJV:>%8]QY.#\)D&"NP>$P,E*J6KNK\%R]44VR
M%\/W1EJ*K\B$VET3<$F*Z>N-=NVN?@/#*2]JC5:-C*EL-:_K%Y4V_L=YY;K2
MJ-:XUJ=:K9WDT$H?J"<M2V(S#N];W 6H#=CN1E82$QNYX0PO/3YJD1OS_18
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MF1*92K[7?Y2^/%];I6W=A>_<Z1);Z-Q=3' _8I*YG0H"QDPAMZ<"L10_&PJ
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MULJ77WX.[[8_C,R#D(,5TJ>*QO4HD#ON]@K'7$*3##+%$E\L[*N\K(*KC4?
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MPMSA.$RX0F!O E1(^,-6H C XAI*EYW)E?KT4/I9?GU>*WT95]@*"HM/5&*
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M_>X_ LYI5Z+C1CR #A8WD]2#Q9TRB[N<;HM[>;QC)<6PJG&41%Y)R&1Y(<*
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M?' 9WOBE8"-C*%4GDMKH3'YJ#;V+\C\'M^N,S5JA;)':?R (KL59*/P=%HV
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M!<^UL)_?_\@-)>-1P6^ CV:"+^TA4+'>:T=)OJ2%$*>1@;Z6SED#!$21P=J
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M4-" JPY %\+[SA7N 2JX>.YE@'U<_1&1X>SZBX:EBWR=Z#^,)LLF7?S@P0"
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M<GSDC#28^;!;5.$+/,^]-_@%5\J(/%CV^>[8ZF<VEA,>H\8S"2SHO@ODT99
MI2,6 ?&B%E/>.J=W,198P:-G8456B1Y>L.#YBX_G())W[G'G.L7<14QY8P$>
M('_4&[#S0^"#N3'^L)'O''Y3,;H\N?4+#.\ZJ:C%F.\B&M)F!4,]\!CQ(:AU
MY[/=>:Z+I1^D475Z>2R=9Q$7%D5A?A5'7$ELV3F*V_+L<(?HTW0^\Q6LJ*;N
MY@8 @^0>)Y=WKT=JHUB](A2\/I-**?PO&?4ED@20_(J4D6,NN1A+D6I+'Q)(
M\0IVB=%04]Z. LCYC8$JB%US-,WP+*Y$@[/A_$HBC\'4D+;LP?Y*HH"V6?PU
M?A$<_E 'L?"06_Q] I."+),9H A!99DO[*?3UX"!PS:H\LX%@1$'X(X@;V19
M3AGU\5&("\,SY]!8K,&<"#]7(;<_N1;U2(>G N/L>,67+IA%]%:DN2P.+*&A
M/:1_\P$-EQCVHY0>":V$P,Y)S$C 7 3^AD8M;I+*\+G!(&];#^K-2V&+G<E/
M\^7Q]UCZ9?MF;N^^0$7H3.[*U5SMN9R=/*>II*?6F8R^FC]'GRX&5S?%=%;.
ME Z5,[NNG!$/E3.+R\\4]9OYI?OEEWXO[T"Z_PG,(/@O@9$$+2]-5W&[JFZQ
M+/049,X;-%#RCYB,](#.Q*SD/DW$T?.@G93^=F8*B(M'"G#3,P7PY7*5+98^
M%4SMQQ?EW7^M^YN;RMW/XZ/F)=>J7S7JE_5JI='F*M5J\[[1KC>NN-OF=;WZ
M<W=S!>+G@W/)5,QF?XJ$8_K?.7R0R_GX(-H#.I/F[47MUZ35:KYDD^,#MU[,
MA;60[TPFUJ#WJR0TR\]=V%QI*L2G\T_#"%2*O:5I$8%DKJU)V*^C]2QAPZV.
MCT*G11#CGQ17C0R$[5]:.#8=V/+U9F+3%#]D!#D%%L6#=#\)Z'@# .XU @F9
M T#H42%,[64<KRJ56R\2!R$'?S<U<4)M>$5(D^/L\UL(F[6T.@(^[Y0G019^
MJ)BF?]Q%J^;UZKGC1Y6A/_OM&U+KL_$AL8C?;,X9NB'KQ)5FTSG\Y0N^Q]$0
MJ:Y;=!:9FY(#0)RF]/ \/(WS#9PR#'S-$E1C^OZR-5_C+<U=N&RP9)8(B;[Z
M>8C"Q0[A$!.F:P1KIRJ:!C&,J78F(7/ZQ0W:CI%D<"07-%-R)K#&*!=@3!-X
MR(V$'2-.)"UXHOA&?/0Z"W2,L&-'LU6!5B@5 N6_6(["/#XZ<9H]*1MIP#DJ
M%.K8!HF_^C[\GM,P8DT3"DA(9)\H/$[B^A)V6@,=+W-*X%;1&".=M?!+1 8I
MK1A!19[XY@%^"RU*<;G#&F"7F!MB3 ],QB733_1*5[QZH:5?HT4O5/BA8H]Z
M[BN\%5*8KI_-^Y3C4)+1&38>W!HVYX KP&:0(80NV11U3*HT>C3OP8BDS[S!
M+8"#R-XK!!,)::8$#;XQ*VD0RX!.1%I=1[<O;-W_3][>K>H:N$R4S>X4\ZF*
MU:IBP4\+C)L%W^I,QM^[WW\_"+6>;RGWAI-0IHV72F>B6P^_ZTKVX@E[\_\%
MX"&B0P'B *(W:<2X4\I(,[MATVN)5FGJ$+=3B'6!N5YWZTN]JLG>#+YZ%%^D
M8I#4W9D6*[@#82-]A,2.,5GM(TAYL( 1-*$-993L4>A94FWO!0HH:5JJ[&6V
M06&0U C\T[.)9!VCA]85T,)5$G2P2-X3RR6K\Z"FRY@.*H*"J2 \[/UP*Q,5
MJ[)"&IB^ >),''MXKTJF/OAFMW0E%>PWDD5TZ^:)RM 0LSDD4B*DOQ [#WX!
M@V^MOJVZ>)J#'*I(H"$!ZCS0BVN7>1>&FP8ET+%-WI@84,G:0PXR.0^7&$P2
M_812-N^<K/I3"Z7<VQ "4G)*^R>M%]V'$1CDX_:NSE3EUQ9ILEMDP"^PH2%T
MY-%TF7XF&RC3G_GV^?@<\]4  _]$B_.]N ",GH#949J-&LAB!?H+'P6QJJFG
M5-D19S[M/,\TK-/3&^F7;C@?-8-= NT7W?V+TR7P6ZE^[ZI5Z5M+<+L$ F\@
MO+1TV\L"5$8;YNR<LQ..+.>ORY! C]J9/6G$M3'UQB6^N'H2H.%4](V/OL6F
MP+O_RF'[6\D5\[?;M#MM,%JZ1:Q1<J+(EH_ JJH9BY-/1V7RRHI,+KI,+KX!
M)@=4S;#YN&!H/\?-]L_N8)ML+KIL+B;"YB%GC8G1PU9>N8P>YAA!(GP=1G\K
M/FL[4-A-$S'0=\!2\!(V>89#UF1G0F@$^6VBH$ +,&3.P$@ST#PWE"([Y'[G
ML:5B?4@P/-J"\0(09FKV ^S9[%.IAO]>2E"G[(^51LM,N69^R7]1K_'&SF0H
MYB]?7S,/O4=8YT-Q3Q[^@?-F^G*G' MQ<\LBW-S)!;(D137Q=X(^Q_LU7)TY
MRS^B)MW>K;]M+,IV*B]^''2^SC.=R??<0]9J7M5_?NF[YY85<Z1*XP_8<(>V
MXUF7S.=BN"Y9^G9'I0L:NDYB*8VCDC(<!)*[?4$ )3Q0E>?LT W%"^8HH.7_
MWHF1<\HA[PM+X7HWQ+]=@_OG/W)11%HH.O."/3MY(!KE'5Z(X_"1MQ2NQU-+
M4;7@\U&^'@;*]$*4D"?'?FK/Z)MW.8=<RVG4,.F")JD=FE-5&X7"WW,L.,>0
MYBIS"C[$O^>H@^#'A+_#2EP6UK((<TI)ICV[XBX\.Y;'QMZ*P\P[<^Z<7U<<
MO^Y+WNR.QK=JY?[7'+]NY&)EB][=7)2MZ.!-G3<>WPZ[7)FP==W4O9O'H:LS
M]>[%I;I^M&]J*,<;$1?[Y^?&[>6WBIW);U]<_#$_LG-^/\1%*)QEYT=#UA:7
MC:Z[E9PX]UX[3_K:3T4@,H7R=^[(W[GX5'B\UX>3LO26KZOS..4O7SA;$'9/
MB\4[S?H+4^9_T-7CLOZ3I%\4S@?7%[+REJ^>>%F_?);/QL3Z2;M7(5?/G(B*
M>Q]5(P0UUMALZPNZ;+36=LYSY@A\^7#7T2<X G__JOPH/B#][J7PEN^Z:JRN
M6>:LF(\L\*$QP*@L_R?)VEN]7%U9^_%X_?BI^/#]OEY^RY=KK+(&?ETF25G;
MEH<W>\W.[H3?]P7R4PK@\@^_;"NJ.E/B\OW+34_Y88\&Y@YT0/+W[>R18ZIT
M*9\5<VNK <*YZU^Z^RA[YW_XY1LF>]F'6L,2OV7$W]FW>/\F)GOBF;C^%1Q)
M]MQ+V&W"#O95)+/1?EX7=;XS:4XD[4?U]4$J;;S$8[UQ")7.9/R[6&Q7^M]S
M4/2["QARG4G^NOB[JC\J7R8QX&'#Z0OEP_2%74]?R!ZF+RP>^E)MM<Q\S58:
M^L9[2W8]:(&5/>-;27_42+O+XMYZO[6_]+N=2?M'OOZC5?DD%7M)-:%E.I/?
MW\9?VU^,UGBHT,7@4/3L RNIUC,"DD._Y%O:_)U,!CW=!)ENE7>@ZYTMY/;F
M'D"KN29+A@P#V60R&L/R]Y576EY?>2%3<(=0.^@D[5U5-@".+0IP#9$S]M48
M,;N]2O&>3J8MLJ$ 3AW9HZW0\0&*,Y,16M;HJA76Q^[2P"4!Z50;*6SG@7]X
ML[-/D'O4=9E,(O<OCO&*SQ4V!QFH1M]KH+[J[D4(+.8C T!IOS49%$:!HQVV
MS@AJY R1F]TG#C/$9Z YX]HPLW.@H&?DK$[PHR>X()2T&L-8\^ H==-"(_/#
MEGL)O!O??\-/6P K0Q*XX.<: DN+P/']-;\.+E<:O4:JSQ%S\,' SBEB<_2E
MH:*.\14_'G9UE3RJE/WH+^]>I<8\[,E+L#1C^;0P"W#"!ZY.1I_VQP[W$O5Q
M8KZG\+!U(P[[!^K1I[V%&!B)_%><"1<>.&IO.$J<XJC >AB QS]>U9E@SKCN
MP%T'[EK,7=D/W$6@T=SR=GY1@,A8RP,C'1AI,2/EL'>-C:$>K%B>ST?.H*C
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M9HFE93CAPJ[/.8@.-GQ6S&;?[YA$ZL',N!V8&5\#YGWKXMU_>7QMYL%4F.G
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M'"IC?"XL"=]#]#$(9+,O:"" 9!6''])M,. 1GMEA_1/F*R$J]?OHR^&'[+&
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M[I#S)-Y>8!.[GIU6S+L%@7P>JN])-OM@*0/_7LR<M( B[WP@%:Q5XI4I--P
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MX',!J=D-4Q.K#@$\9 S>+6-@Q^5CD/73.0-O&H#-O3C$]Z.+[R^\<QOM/JY
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M"20SOIM57H$ @:-3>564YRN>C;>)(I.1HW5DU2YUTH9L=AF[!)C/,+##%V0
M_# ](@Z5H,3NG."K*!H+MII9J)OZ(H[!<]=%0#!8!F&+H@N<0W_LXU4E"UZ'
MBL=205'#=?T@%ZC.F]VP/)L+V646 -PBQH*T< L(W68&ANH9D#>ENX#&>!38
M72<Z]PF_@?5O71#'^JKZWZ,*T4S=IAX7YJEQIN"CT^/K*]K$T;2F%>8K6K@4
MTR+4D9S40H1SLB\<9Q&JY))\MB>U%TQ:\D>G$K(DH/\N 6GH(UUUC>V74L\1
M"HH<@,^/EXT81I*UPJ.8XG_G-C2WKUU%V-$LG0TV9!V<\"]</5L1"LL9WL7S
M;--:4BX/!0EX')2O2@1KB+;&<*C89&'O ]4_E/DD1;H+QT;HTFW("L[*1 $+
MKQ[)<#N1:HK"UB3K'6N S> =GO"VKU]R6H+*>#5D?5:18&\K*!M*.OOS8VIQ
M4'W@Z#;W(&;(0S]HLQ;\TCX?G!!*9TH2_8,(N,-;5J[ #E5,E_-4=,'KN(&Z
MK,)N6<0OLH*[O2NHJ]?7:DY-[W#UG/O0;93#O;L?PM2&HPI<?S7('@5C=^Q8
M0FB62&@#N%Y$$FW]D<R_#U]ER@C4.!'QZ:JF: R] _U#%E !T>["Q"3=Z<5H
M9.!?B0+^?X<:=[20GQC68,B"5U-VEB1+U$!'$VRQU<]T3'T3NU_PF_V.4ES9
M[@^R^!>;^]Q2"_"YN,G/@FD?S.:_FS&B9@Q -"9L6T9&0T4$6Y&.IJ;AB*EB
MK0H<"6]+<0,7V#5BQXX=,Y<-G8;_8A<,LJ\.TIG:TA;S,/!8AY:.-8"F$QRQ
MHS*)(^JCLJ(SX95XS$E9Q=I'CO>1M)T1;2BKGMG?S5HUR4R?Z?W*;G!F:+7!
MX!.&H) ZU%H'>PKXSK KY[P[3QSAUNF=,+AW#6L%(A%<3H>P8>MU$ ;,9*9T
MG7ZW_6*Z, _1A4^>2CP*1"6.J=]$2^KH2%BG<-*)+2!Y>=E=@)?!_#B7ZNPD
M*/B4A_Y\F[ >L%$-X'LP"[OXHN5B[3,LQ:##V74>VF:1:_K\.>PPNR!C7C6C
MX?)<F^#G65T3T%VB_("5ATGN-2!1IIF [=*"K3!KG/LMZ,51+F+REZ[;MRI8
M-Y&84+7:P-^L8XKY%TB3(9K,NHR"]0D6:$A,<+.H!O4"Z39X=#R0 ]FAKLF'
M@LV&=NEE3P,;1G63"XA?H\ MGG)7V-U'+^Z#B+:Z*C"_T5.W2OUS>G& 0ZBU
MA<H&72<:V9EE,I$-7+;!X6CS/'7]&9S7#.O1D&I[G.0]?4X+G,&.@[[?XZMU
MQTDN1N$&F")?!FO%@]U:>#VF;HNENS<&C]F^)J]]S694Y![< N>- 1%5!CL0
MQ"KPVW0YFTW28,2 (MNAD<'"DO[/)AV&Y*OUBJAWYIJ-"N9G6(=F0?/'0H.@
M32XT19[GNU<]1^T29^[>(UW5=JY-DU"\+;@ 8!MIKZP_E&'CX=6 _8LZC0,R
M"#]JHG7$H6Q20"R\'U2(\&IO+Q\.1</DLYO'1-3MH,0KVJQH"GI(.\^T>&<F
MPTV"'(ZEOYDYH?@S3GS7$7?PZR?Q,^^ A;5X/TP?)Y$.CP/^RP@&"HH \WK0
MUZK\8#BN!GW47!I&O+OM5+3['/EP6%L+G7LLWYGUE//__#77B88_"?/'\C;'
M Q "E!JE['\A9NXZ)0_\^64LQ+Y15QL\?@46>*9, 25325\8E5_.0J&0+!2*
M#H#HM(J;CMFO]OI'H'FU+Y.^4.T3VCPQ'4K8[ ZO!N1VX+PM<MXI:$R*8LOQ
M3(']IGVXG_6:4.<NOG!%=*PNJ-B&62"WBO!5$XW6558"/)Q;D<M!\5G4*9-'
MLF2)"L_OLK=3G*)5%I!),:2IT&\WY#??RVG>GO<]H;?(.ZNH)['*0C 29%)?
M[M=9E6ZI>0;>+X^@R".BC(^%.[1<*:B%_PC0WY$Q<J-J=/V6ZC@-^FK+\)H1
M- T/J_#8$S3_YS1IN68PS50YT-T.%BBO9EGY5&BJ1E4M#!4A*JG3((:8GQXS
M6>P U0S9=H]@K9Q&Z-8G,47/<'O3)8;;FUQ]&2Z)C8Y,(:6#7\RX$'.%&*=3
MG#0B_1[MA6-'QAENM87X<:_!K1S)FF4HSMWCE];P3/ZUES6T;33X&2^U<XD-
M&HU9;1W4Z>Z@X:)PM]N.Y+'-GFC )P=-LL^:1*A8/?@+;)1?F2!97YH6FL"2
M74(#6O/DIDC#@O!F7DBHZ0<^V6<^64UP-,G09"9'IKB KT2,KO90W;!RVFQF
M@7)>V=*8X4C;9!#,5VV&/8T#?_XY_#EM$8=DS^PBTW5%6\/'D&AE(J Y&!(T
MA,GBZX8L$;LG&#-_6-?4(8@,0).*!\U[X%B;8RGS#!AB ^:.Y1'C68XN@7X7
M&,4H7!FHG6CBQSCPZVHK@8>S0-;?^6-X'AJ<^$SDZ$S)%:>497NZ9AAV_HG>
MF+]!Q)>I.7$L4 Q>^MT. ^+%XL55EH(I(Y4/+IF2^)Y,L<>_8P6W @>IX#[8
ML]QY9LAZF?1__)FKK2/T EC1O^?BY_/%9#:;FQ$I*[X?GWV0!FQ=2[H&N41
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MY*4+<>'L>3]V-EK_*(YAY3-+Q,\([_GJB*I1CSQ'G@Z^VAX!/T_BB$Z],?6
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M8%N$:]G,P$"F-P71D.86'+"^X@L%1C$Y8$",W[%/L0:1$ZK$(F>?1DE1>AF
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M9V5?,# Q+FIP9U!+ 0(4 !0 " @( )N)]%2W3X4*61(  &<5   -
M         %DH  !I;6%G95\P,#(N:G!G4$L! A0 %  (" @ FXGT5$;J?0!G
M$P  N!0   T                 [3H  &EM86=E7S P,RYJ<&=02P$"%  4
M  @(" ";B?14_37!SM7D  "S[P  #0                "/3@  :6UA9V5?
M,#$S+FIP9U!+ 0(4 !0 " @( )N)]%3)S_+>LK   *KN   -
M     )\S 0!I;6%G95\P,34N:G!G4$L! A0 %  (" @ FXGT5'#B-68>*
M)RL   T                 C.0! &EM86=E7S Q-RYJ<&=02P$"%  4  @(
M" ";B?14'$LQNP*E   )SP  #0                #E# ( :6UA9V5?,#(S
M+FIP9U!+ 0(4 !0 " @( )N)]%21Z_;8G"X  +\W   -
M "*R @!I;6%G95\P,C0N:G!G4$L! A0 %  (" @ FXGT5,(P]F:G'   -AX
M  T                 ^> " &EM86=E7S R.2YJ<&=02P$"%  4  @(" ";
MB?14;G'0VWP,   7?P  $0                #;_0( ;F-R82TR,#(R,#,S
M,2YX<V102P$"%  4  @(" ";B?14SB*Y1J43  !*]   %0
M  "6"@, ;F-R82TR,#(R,#,S,5]C86PN>&UL4$L! A0 %  (" @ FXGT5&"@
M# <*&@  J7T! !4                 ?AX# &YC<F$M,C R,C S,S%?9&5F
M+GAM;%!+ 0(4 !0 " @( )N)]%2X7VF0O4,  %S7 P 5
M ,LX P!N8W)A+3(P,C(P,S,Q7VQA8BYX;6Q02P$"%  4  @(" ";B?1403AY
M:PXT  "#3P, %0                #+? , ;F-R82TR,#(R,#,S,5]P<F4N
M>&UL4$L! A0 %  (" @ FXGT5"%M:,FN"0  /RX  !$
M'+$# &YO8V5R85]E># U,#$N:'1M4$L! A0 %  (" @ FXGT5"'NJ%B>!@
M4%4  !                  ";L# &YO8V5R85]E>#$P-RYH=&U02P$"%  4
M  @(" ";B?14A,,&@40"  #+"   $0                #EP0, ;F]C97)A
M7V5X,C,P,2YH=&U02P$"%  4  @(" ";B?14C;GR=I*> P#I-QT #P
M          !HQ , ;F]C97)A7W,Q83(N:'1M4$L%!@     2 !( 5P0  #=C
$!P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
